<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
     xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>The American Archives of Medical Sciences — Published Articles</title>
    <link>https://aams-journal.us</link>
    <atom:link href="https://aams-journal.us/researchbib-feed.xml" rel="self" type="application/rss+xml"/>
    <description>Full-metadata feed for ResearchBib and academic indexing harvesters. Includes Dublin Core author, subject, DOI, ISSN, and rights metadata.</description>
    <language>en-us</language>
    <copyright>Open Access under Creative Commons Attribution 4.0 International (CC BY 4.0)</copyright>
    <lastBuildDate>Wed, 08 Jul 2026 09:41:00 GMT</lastBuildDate>
    <ttl>60</ttl>
    <item>
      <title>PEDIATRIC DENTISTRY: THE IMPORTANCE OF ORAL HEALTH CARE IN CHILDREN</title>
      <link>https://aams-journal.us/journals/dentistry/articles/c7245bb7-0af9-4b3e-97e1-13c5386ae073</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/c7245bb7-0af9-4b3e-97e1-13c5386ae073</guid>
      <pubDate>Sat, 20 Jun 2026 00:00:00 GMT</pubDate>
      <author>Shukurova Madina¹</author>
      <description>Pediatric dentistry is a specialized field of dentistry dedicated to the prevention, diagnosis, treatment, and management of oral and dental diseases in infants, children, and adolescents. Oral health is an essential component of general health and significantly influences the physical, psychological, and social development of children. Dental disorders occurring during childhood can negatively affect nutrition, speech development, academic performance, self-confidence, and overall quality of life. Among the most common oral diseases affecting children are dental caries, gingivitis, malocclusion, enamel defects, and traumatic dental injuries. The prevalence of these conditions remains a major public health concern worldwide despite significant advancements in preventive and restorative dental care.
The purpose of this study is to analyze the importance of pediatric dentistry, evaluate the major oral health problems affecting children, investigate preventive and therapeutic approaches, and assess the role of parents, educators, and healthcare professionals in maintaining oral health. The study is based on an extensive review of scientific literature, clinical guidelines, and evidence-based research published in recent years. The findings indicate that early dental intervention, regular dental examinations, proper oral hygiene practices, balanced nutrition, fluoride application, and parental education significantly reduce the incidence of oral diseases. Furthermore, the integration of preventive programs within schools and communities contributes to improved oral health outcomes and reduced treatment costs. Pediatric dentistry therefore plays a crucial role in establishing lifelong oral health habits and ensuring healthy growth and development among children.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781921222912-PEDIATRIC_DENTISTRY__THE_IMPORTANCE_OF_ORAL_HEALTH.pdf" type="application/pdf" length="0"/>
      <dc:creator>Shukurova Madina¹</dc:creator>
      <dc:creator>Raximberdiyev Rustam²</dc:creator>
      <dc:subject>Pediatric dentistry</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>children</dc:subject>
      <dc:subject>dental caries</dc:subject>
      <dc:subject>oral hygiene</dc:subject>
      <dc:subject>fluoride therapy</dc:subject>
      <dc:subject>preventive dentistry</dc:subject>
      <dc:subject>gingivitis</dc:subject>
      <dc:subject>dental development</dc:subject>
      <dc:subject>child healthcare</dc:subject>
      <dc:subject>dental prevention</dc:subject>
      <dc:subject>pediatric oral diseases.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>DENTAL CARIES IN CHILDREN: PREVENTION, EARLY DIAGNOSIS, AND MODERN MANAGEMENT APPROACHES</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/d0a903f8-e7e9-4bea-bfa7-a36337d9a4a1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/d0a903f8-e7e9-4bea-bfa7-a36337d9a4a1</guid>
      <pubDate>Sat, 20 Jun 2026 00:00:00 GMT</pubDate>
      <author>Shukurova Madina¹</author>
      <description>Dental caries is one of the most common chronic diseases affecting children worldwide and remains a major public health concern despite significant advances in preventive dentistry. The disease is characterized by the progressive destruction of tooth hard tissues caused by the interaction between cariogenic microorganisms, dietary carbohydrates, and host-related factors. Childhood dental caries can negatively affect oral function, nutrition, speech development, academic performance, and psychosocial well-being. Untreated caries may result in pain, infection, tooth loss, and reduced quality of life. The purpose of this study is to examine the etiology, risk factors, prevention strategies, diagnostic methods, and contemporary treatment approaches for dental caries in children. A comprehensive review of scientific literature was conducted to evaluate current evidence regarding pediatric caries management. The findings indicate that effective prevention depends on a combination of oral hygiene education, fluoride exposure, dietary control, parental involvement, and regular dental examinations. Early diagnosis and minimally invasive treatment approaches significantly improve clinical outcomes and preserve tooth structure. The study concludes that preventive dentistry remains the most effective strategy for reducing the global burden of childhood dental caries and promoting lifelong oral health.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781927592713-DENTAL_CARIES_IN_CHILDREN__PREVENTION__EARLY_DIAGN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Shukurova Madina¹</dc:creator>
      <dc:creator>Tursunov Bekzod²</dc:creator>
      <dc:subject>Dental caries</dc:subject>
      <dc:subject>pediatric dentistry</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>fluoride</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>childhood disease</dc:subject>
      <dc:subject>oral hygiene</dc:subject>
      <dc:subject>cariogenic bacteria</dc:subject>
      <dc:subject>tooth decay</dc:subject>
      <dc:subject>minimally invasive dentistry.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 106-120</dc:source>
    </item>
    <item>
      <title>DRY EYE DISEASE: MODERN PERSPECTIVES ON ETIOPATHOGENESIS, DIAGNOSIS, AND CLINICAL MANAGEMENT</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/084fbacc-e5fd-4b08-b377-892f18a8c707</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/084fbacc-e5fd-4b08-b377-892f18a8c707</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
      <author>Shodmanov Abbos Asqarovich</author>
      <description>Dry Eye Disease (DED) is one of the most prevalent ocular surface disorders encountered in modern ophthalmological practice and represents a significant cause of discomfort, visual disturbance, and reduced quality of life. The condition is characterized by loss of tear film homeostasis accompanied by ocular symptoms, in which tear film instability, hyperosmolarity, inflammation, neurosensory abnormalities, and ocular surface damage play central pathogenic roles. The global prevalence of DED has increased substantially due to population aging, prolonged digital device use, environmental pollution, and lifestyle changes. Patients commonly present with ocular dryness, burning sensation, foreign body sensation, redness, fluctuating vision, and ocular fatigue. Recent advances in ocular surface imaging, tear film analysis, and molecular diagnostics have improved understanding of disease mechanisms and facilitated more accurate diagnosis. Modern therapeutic strategies include artificial tears, anti-inflammatory medications, tear conservation techniques, biologic therapies, and lifestyle modifications. This article reviews current knowledge regarding the epidemiology, pathophysiology, risk factors, diagnostic methods, treatment options, and future perspectives in Dry Eye Disease management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1782182239411-DRY_EYE_DISEASE__MODERN_PERSPECTIVES_ON_ETIOPATHOG.pdf" type="application/pdf" length="0"/>
      <dc:creator>Shodmanov Abbos Asqarovich</dc:creator>
      <dc:subject>Dry Eye Disease</dc:subject>
      <dc:subject>tear film instability</dc:subject>
      <dc:subject>ocular surface disease</dc:subject>
      <dc:subject>meibomian gland dysfunction</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>artificial tears</dc:subject>
      <dc:subject>tear hyperosmolarity</dc:subject>
      <dc:subject>ocular discomfort</dc:subject>
      <dc:subject>ocular surface.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLINICAL AND EPIDEMIOLOGICAL ASPECTS OF PELVIC INFLAMMATORY DISEASE</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/5080ed00-ae21-49f7-b82b-4c8e0a2c9801</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/5080ed00-ae21-49f7-b82b-4c8e0a2c9801</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
      <author>Xudoyberdiyeva</author>
      <description>Pelvic inflammatory disease (PID) remains one of the most significant reproductive health problems affecting women worldwide. The condition encompasses a spectrum of inflammatory disorders involving the upper female genital tract, including the uterus, fallopian tubes, ovaries, and surrounding pelvic structures. Delayed diagnosis and inadequate treatment may result in serious complications such as chronic pelvic pain, infertility, ectopic pregnancy, and recurrent infections. This study aimed to evaluate the clinical and epidemiological characteristics of pelvic inflammatory disease and identify factors associated with disease occurrence and progression. A comprehensive analysis of clinical manifestations, risk factors, diagnostic approaches, and treatment outcomes was conducted. The findings demonstrate that early recognition and timely intervention are crucial for preventing long-term reproductive complications and improving women&apos;s health outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781791755579-CLINICAL_AND_EPIDEMIOLOGICAL_ASPECTS_OF_PELVIC_INF.pdf" type="application/pdf" length="0"/>
      <dc:creator>Xudoyberdiyeva</dc:creator>
      <dc:creator>Z.</dc:creator>
      <dc:subject>pelvic inflammatory disease</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>gynecology</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>chronic pelvic pain</dc:subject>
      <dc:subject>sexually transmitted infections</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>fallopian tubes</dc:subject>
      <dc:subject>pelvic infection</dc:subject>
      <dc:subject>women&apos;s health.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>DIABETIC RETINOPATHY: CURRENT APPROACHES TO PATHOGENESIS, DIAGNOSIS, PREVENTION, AND TREATMENTDIABETIC RETINOPATHY: CURRENT APPROACHES TO PATHOGENESIS, DIAGNOSIS, PREVENTION, AND TREATMENTDIABETIC RETINOPATHY: CURRENT APPROACHES TO PATHOGENESIS, DIAGNOSIS, PREVENTION, AND TREATMENT</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/fa297958-f775-492d-adc0-14b05f383946</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/fa297958-f775-492d-adc0-14b05f383946</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes mellitus and remains a leading cause of preventable blindness among working-age adults worldwide. The disease develops as a consequence of chronic hyperglycemia-induced damage to retinal blood vessels, resulting in vascular leakage, retinal ischemia, neovascularization, and progressive visual impairment. With the increasing global prevalence of diabetes mellitus, the burden of diabetic retinopathy continues to grow, creating significant clinical and socioeconomic challenges. Early stages of the disease are often asymptomatic, making regular ophthalmological screening essential for timely diagnosis and intervention. Recent advances in retinal imaging, artificial intelligence-assisted screening, anti-vascular endothelial growth factor therapy, corticosteroid implants, and vitreoretinal surgery have significantly improved patient outcomes. Nevertheless, diabetic retinopathy remains a major cause of vision loss due to delayed diagnosis and inadequate metabolic control. This article reviews the epidemiology, pathophysiology, clinical manifestations, diagnostic techniques, therapeutic strategies, and future perspectives related to diabetic retinopathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781749098569-DIABETIC_RETINOPATHY__CURRENT_APPROACHES_TO_PATHOG.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Toshtemirova Fotima²</dc:creator>
      <dc:subject>Diabetic retinopathy</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>retinal ischemia</dc:subject>
      <dc:subject>macular edema</dc:subject>
      <dc:subject>anti-VEGF therapy</dc:subject>
      <dc:subject>retinal imaging</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>blindness prevention</dc:subject>
      <dc:subject>retinal neovascularization</dc:subject>
      <dc:subject>vitreoretinal surgery.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>GLAUCOMA: MODERN CONCEPTS OF PATHOGENESIS, EARLY DIAGNOSIS, AND CONTEMPORARY TREATMENT APPROACHES</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/7356eeb2-7518-43c3-a243-752ccdc68d10</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/7356eeb2-7518-43c3-a243-752ccdc68d10</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Glaucoma is a chronic progressive optic neuropathy characterized by structural damage to the optic nerve head and corresponding visual field defects. It is recognized as one of the leading causes of irreversible blindness worldwide and represents a significant public health challenge. The disease is commonly associated with elevated intraocular pressure; however, glaucomatous damage may also occur in individuals with normal intraocular pressure levels. The pathogenesis of glaucoma involves a complex interaction of mechanical, vascular, genetic, and neurodegenerative factors that ultimately lead to retinal ganglion cell death and optic nerve degeneration. Early diagnosis remains crucial because visual loss caused by glaucoma is permanent and often asymptomatic during the initial stages of the disease. Advances in imaging technologies, functional testing, and pharmacological and surgical interventions have substantially improved disease detection and management. This article reviews current understanding of glaucoma epidemiology, pathophysiology, risk factors, diagnostic strategies, therapeutic options, and future directions in clinical ophthalmology.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781758634667-GLAUCOMA__MODERN_CONCEPTS_OF_PATHOGENESIS__EARLY_D.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Olmosov Abbos ²</dc:creator>
      <dc:subject>Glaucoma</dc:subject>
      <dc:subject>optic neuropathy</dc:subject>
      <dc:subject>intraocular pressure</dc:subject>
      <dc:subject>retinal ganglion cells</dc:subject>
      <dc:subject>visual field loss</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>neuroprotection</dc:subject>
      <dc:subject>trabeculectomy</dc:subject>
      <dc:subject>blindness prevention.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 76-90</dc:source>
    </item>
    <item>
      <title>KERATOCONUS: CONTEMPORARY INSIGHTS INTO ETIOLOGY, DIAGNOSIS, AND ADVANCED MANAGEMENT STRATEGIES</title>
      <link>https://aams-journal.us/journals/surgery/articles/a817aa86-b5ef-40e2-8ef5-e6df6f1a1e45</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/a817aa86-b5ef-40e2-8ef5-e6df6f1a1e45</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Keratoconus is a progressive, non-inflammatory corneal ectatic disorder characterized by localized corneal thinning, protrusion, and irregular astigmatism, resulting in significant visual impairment. The disease typically begins during adolescence or early adulthood and may continue to progress for several decades. Structural weakening of the corneal stroma leads to a cone-shaped protrusion that distorts incoming light and compromises visual quality. Although the exact etiology remains incompletely understood, genetic predisposition, biomechanical abnormalities, oxidative stress, environmental influences, and chronic eye rubbing are recognized as important contributing factors. Recent advances in corneal imaging technologies have enabled earlier detection and more accurate monitoring of disease progression. Corneal collagen cross-linking has emerged as the first treatment capable of halting keratoconus progression, while modern contact lens designs and surgical procedures provide effective visual rehabilitation. This article reviews current concepts regarding keratoconus epidemiology, pathogenesis, diagnosis, treatment options, and future perspectives in clinical ophthalmology.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781749632750-KERATOCONUS__CONTEMPORARY_INSIGHTS_INTO_ETIOLOGY__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Jo&apos;raqulov Jasur²</dc:creator>
      <dc:subject>Keratoconus</dc:subject>
      <dc:subject>corneal ectasia</dc:subject>
      <dc:subject>corneal thinning</dc:subject>
      <dc:subject>collagen cross-linking</dc:subject>
      <dc:subject>corneal topography</dc:subject>
      <dc:subject>irregular astigmatism</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>corneal biomechanics</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>contact lenses.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 46-60</dc:source>
    </item>
    <item>
      <title>AGE-RELATED MACULAR DEGENERATION: MODERN UNDERSTANDING OF PATHOGENESIS, DIAGNOSTIC STRATEGIES, AND THERAPEUTIC ADVANCES</title>
      <link>https://aams-journal.us/journals/genetics/articles/a5905853-c90f-486d-a370-6cae7bb182b7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/a5905853-c90f-486d-a370-6cae7bb182b7</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Age-related macular degeneration (AMD) is a chronic progressive retinal disorder affecting the macula and represents one of the leading causes of irreversible vision loss among elderly individuals worldwide. The disease primarily impairs central vision, significantly affecting reading ability, facial recognition, driving performance, and overall quality of life. AMD is classified into dry (atrophic) and wet (neovascular) forms, each characterized by distinct pathological mechanisms and clinical manifestations. The pathogenesis involves a complex interaction of aging processes, genetic predisposition, oxidative stress, chronic inflammation, complement system dysregulation, and environmental risk factors. Advances in retinal imaging technologies, including optical coherence tomography and OCT angiography, have revolutionized diagnosis and monitoring. Furthermore, anti-vascular endothelial growth factor therapies have dramatically improved outcomes for patients with neovascular AMD. Despite substantial progress in treatment, AMD remains a major public health concern due to population aging and the absence of definitive cures for advanced atrophic disease. This article reviews contemporary knowledge regarding epidemiology, pathogenesis, diagnosis, treatment, and future directions in age-related macular degeneration management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781749926747-AGE_RELATED_MACULAR_DEGENERATION__MODERN_UNDERSTAN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Istamova Mohinabonu²</dc:creator>
      <dc:subject>Age-related macular degeneration</dc:subject>
      <dc:subject>macula</dc:subject>
      <dc:subject>retinal degeneration</dc:subject>
      <dc:subject>drusen</dc:subject>
      <dc:subject>anti-VEGF therapy</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>central vision loss</dc:subject>
      <dc:subject>retinal pigment epithelium</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>neovascularization.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Problems with sutures during appendectomy during pregnancy</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/dc2a0bf0-243d-4918-9a32-1f7af2d1b676</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/dc2a0bf0-243d-4918-9a32-1f7af2d1b676</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Ravshanova Sevinch¹</author>
      <description>Effective closure of the abdominal wall, fascia, and appendix stump is crucial to prevent postoperative complications such as wound dehiscence, infection, adhesions, and hernia formation. This article explores technical challenges, physiological factors of pregnancy influencing suture integrity, and evidence-based approaches to optimize surgical outcomes. Changes in maternal anatomy, increased intra-abdominal pressure, and hormonal modulation of connective tissue elasticity contribute to altered wound healing and suture tension. Selection of appropriate suture material, technique, and timing is critical. The review highlights clinical data on absorbable versus non-absorbable sutures, continuous versus interrupted methods, and minimally invasive approaches. Early recognition and management of suture-related complications reduce morbidity, prevent adverse fetal outcomes, and support maternal recovery. Appendectomy is the most frequently performed non-obstetric surgery during pregnancy, and suture-related complications can significantly impact both maternal recovery and fetal outcomes. Pregnancy introduces physiological changes, including increased intra-abdominal pressure, hormonal modulation of connective tissue elasticity, and altered tissue perfusion, all of which affect wound healing and suture integrity. Common complications include wound dehiscence, fascial disruption, postoperative infection, adhesion formation, and incisional hernia. This article examines the incidence, risk factors, and clinical consequences of suture-related problems in pregnant patients undergoing appendectomy, emphasizing preventive strategies and surgical techniques tailored to gestational physiology. Evidence indicates that careful selection of suture material, appropriate closure methods, and minimally invasive approaches reduce postoperative morbidity, enhance maternal recovery, and protect fetal health. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781674830953-Problems_with_sutures_during_appendectomy_during_p.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ravshanova Sevinch¹</dc:creator>
      <dc:creator>Bozorova Shaxrizoda²</dc:creator>
      <dc:subject>appendectomy</dc:subject>
      <dc:subject>pregnancy</dc:subject>
      <dc:subject>suture complications</dc:subject>
      <dc:subject>wound healing</dc:subject>
      <dc:subject>fascia closure</dc:subject>
      <dc:subject>absorbable sutures</dc:subject>
      <dc:subject>postoperative infection</dc:subject>
      <dc:subject>maternal outcomes</dc:subject>
      <dc:subject>fetal safety</dc:subject>
      <dc:subject>surgical technique</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 46-60</dc:source>
    </item>
    <item>
      <title>ACUTE OTITIS MEDIA IN CHILDREN: CLINICAL FEATURES, DIAGNOSTIC APPROACHES, AND MODERN TREATMENT STRATEGIES IN OTORHINOLARYNGOLOGY</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/8be9bb4b-5efd-449e-83c7-e6ef0a418260</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/8be9bb4b-5efd-449e-83c7-e6ef0a418260</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Ziyadullayev Yorqinjon¹</author>
      <description>Acute Otitis Media (AOM) is among the most common infectious diseases encountered in pediatric otorhinolaryngology and represents a major cause of healthcare visits, antibiotic prescriptions, and childhood morbidity worldwide. The condition is characterized by acute inflammation of the middle ear cavity, usually resulting from bacterial or viral infections that develop following dysfunction of the Eustachian tube. Acute otitis media occurs predominantly in infants and young children due to anatomical and immunological factors that increase susceptibility to middle ear infections. Clinical manifestations include ear pain, fever, irritability, hearing impairment, sleep disturbances, and feeding difficulties. Although most cases resolve without serious consequences, delayed diagnosis or inadequate treatment may lead to complications such as mastoiditis, hearing loss, tympanic membrane perforation, and intracranial infections. Advances in diagnostic techniques, antimicrobial therapy, vaccination programs, and preventive strategies have significantly improved disease management. This article reviews current knowledge regarding the epidemiology, pathogenesis, diagnosis, treatment, complications, and prevention of acute otitis media in children.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781693712902-ACUTE_OTITIS_MEDIA_IN_CHILDREN__CLINICAL_FEATURES_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ziyadullayev Yorqinjon¹</dc:creator>
      <dc:creator>Khatamov J.A.²</dc:creator>
      <dc:subject>Acute otitis media</dc:subject>
      <dc:subject>middle ear infection</dc:subject>
      <dc:subject>pediatric otolaryngology</dc:subject>
      <dc:subject>Eustachian tube dysfunction</dc:subject>
      <dc:subject>hearing loss</dc:subject>
      <dc:subject>tympanic membrane</dc:subject>
      <dc:subject>antibiotic therapy</dc:subject>
      <dc:subject>childhood infections.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 06, pp. 31-45</dc:source>
    </item>
    <item>
      <title>SUDDEN SENSORINEURAL HEARING LOSS: ETIOLOGY, DIAGNOSTIC CHALLENGES, AND MODERN TREATMENT APPROACHES IN OTORHINOLARYNGOLOGY</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/e5bc3e43-2662-4e31-9094-061e0a3ba018</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/e5bc3e43-2662-4e31-9094-061e0a3ba018</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Juraqulov Muhammadali¹</author>
      <description>Sudden Sensorineural Hearing Loss (SSNHL) is an otological emergency characterized by a rapid decline in hearing function, typically occurring within 72 hours and involving a loss of at least 30 decibels across three consecutive frequencies. The condition affects individuals of all age groups and may result in significant disability if diagnosis and treatment are delayed. Although numerous etiological factors have been proposed, including viral infections, vascular compromise, autoimmune disorders, and cochlear membrane rupture, the exact cause remains unidentified in the majority of cases. Recent advances in audiological assessment, radiological imaging, and pharmacological therapy have improved clinical outcomes. Early recognition and prompt intervention are critical for hearing recovery. This article reviews the epidemiology, pathophysiology, clinical presentation, diagnostic evaluation, therapeutic strategies, and future perspectives regarding sudden sensorineural hearing loss in contemporary otorhinolaryngology practice.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781692875641-SUDDEN_SENSORINEURAL_HEARING_LOSS__ETIOLOGY__DIAGN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Juraqulov Muhammadali¹</dc:creator>
      <dc:creator>Rasulova K.A.²</dc:creator>
      <dc:subject>Sudden sensorineural hearing loss</dc:subject>
      <dc:subject>cochlea</dc:subject>
      <dc:subject>audiometry</dc:subject>
      <dc:subject>corticosteroids</dc:subject>
      <dc:subject>inner ear disorders</dc:subject>
      <dc:subject>hearing impairment</dc:subject>
      <dc:subject>otology</dc:subject>
      <dc:subject>tinnitus</dc:subject>
      <dc:subject>vestibular dysfunction.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>GLAUCOMA: MODERN DIAGNOSTIC METHODS, RISK FACTORS, AND ADVANCES IN CLINICAL MANAGEMENT</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/ed62c752-57ef-4a68-a587-8f5987331bc0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/ed62c752-57ef-4a68-a587-8f5987331bc0</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Glaucoma is a chronic progressive optic neuropathy characterized by structural damage to the optic nerve and corresponding visual field defects. It represents one of the leading causes of irreversible blindness worldwide and poses a significant challenge for ophthalmologists due to its often asymptomatic early stages. The disease encompasses a heterogeneous group of disorders that share a common feature of retinal ganglion cell degeneration and optic nerve damage. Elevated intraocular pressure remains the most important modifiable risk factor; however, glaucoma may also develop in individuals with normal intraocular pressure, indicating the involvement of vascular, genetic, and neurodegenerative mechanisms. Recent advancements in diagnostic imaging, including optical coherence tomography, scanning laser ophthalmoscopy, and automated perimetry, have improved the ability to detect glaucoma at earlier stages. Simultaneously, innovations in pharmacological therapy, laser procedures, and minimally invasive glaucoma surgery have expanded treatment options and improved long-term outcomes. This article reviews current knowledge regarding glaucoma pathogenesis, epidemiology, diagnosis, treatment approaches, and future perspectives in disease management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781694638016-GLAUCOMA__MODERN_DIAGNOSTIC_METHODS__RISK_FACTORS_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Ikhtiyor Kholmatov²</dc:creator>
      <dc:subject>Glaucoma</dc:subject>
      <dc:subject>optic neuropathy</dc:subject>
      <dc:subject>intraocular pressure</dc:subject>
      <dc:subject>visual field loss</dc:subject>
      <dc:subject>retinal ganglion cells</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>laser trabeculoplasty</dc:subject>
      <dc:subject>minimally invasive glaucoma surgery.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 61-75</dc:source>
    </item>
    <item>
      <title>AGE-RELATED MACULAR DEGENERATION: CURRENT UNDERSTANDING OF PATHOGENESIS, DIAGNOSIS, AND THERAPEUTIC STRATEGIES</title>
      <link>https://aams-journal.us/journals/surgery/articles/25248612-1263-4c1a-bc73-4e7a40b3fc8f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/25248612-1263-4c1a-bc73-4e7a40b3fc8f</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Age-related macular degeneration (AMD) is one of the most common causes of irreversible visual impairment among elderly individuals worldwide. The disease primarily affects the macula, the central region of the retina responsible for detailed vision, reading ability, facial recognition, and color perception. As global life expectancy increases, the prevalence of AMD continues to rise, creating substantial medical, social, and economic challenges. AMD is classified into dry (atrophic) and wet (neovascular) forms, each characterized by distinct pathological mechanisms and clinical manifestations. The development of advanced retinal imaging techniques and intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has significantly improved the diagnosis and management of AMD, particularly in patients with neovascular disease. Despite these advances, AMD remains a leading cause of blindness because of its chronic progressive nature and the absence of curative treatment for many cases. This article reviews current knowledge regarding the epidemiology, pathogenesis, risk factors, diagnostic methods, treatment options, and future directions in AMD research and clinical care.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781694890018-AGE_RELATED_MACULAR_DEGENERATION__CURRENT_UNDERSTA.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Hatamova Ugʻiloy²</dc:creator>
      <dc:subject>Age-related macular degeneration</dc:subject>
      <dc:subject>macula</dc:subject>
      <dc:subject>retinal degeneration</dc:subject>
      <dc:subject>anti-VEGF therapy</dc:subject>
      <dc:subject>choroidal neovascularization</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>retinal disease</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>retinal imaging.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CHARACTERISTICS OF PREGNANCY IN WOMEN OF REPRODUCTIVE AGE WITH METABOLIC CHANGES</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/c3a82d0b-a5a8-43da-b24f-98a7fa2f676f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/c3a82d0b-a5a8-43da-b24f-98a7fa2f676f</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Abdulazizkhodjieva Rukhona¹</author>
      <description>Metabolic changes are increasingly recognized as major determinants of maternal and fetal health during pregnancy. The growing prevalence of obesity, insulin resistance, metabolic syndrome, dyslipidemia, and gestational diabetes mellitus has significantly affected reproductive outcomes worldwide. Pregnancy itself is characterized by profound physiological metabolic adaptations designed to support fetal growth and development. However, pre-existing or pregnancy-induced metabolic disturbances may disrupt these adaptive mechanisms, leading to maternal complications, adverse obstetric outcomes, and long-term health consequences for both mother and child. The present study aimed to evaluate the characteristics of pregnancy in women of reproductive age with metabolic changes and to assess their impact on maternal and fetal outcomes. Clinical, biochemical, hormonal, and obstetric data were analyzed in pregnant women presenting with various metabolic abnormalities. The study demonstrated that metabolic disorders are associated with increased risks of gestational hypertension, preeclampsia, gestational diabetes, cesarean delivery, fetal macrosomia, preterm birth, and neonatal complications. Early identification and management of metabolic alterations can significantly improve pregnancy outcomes and reduce maternal-fetal morbidity. The findings emphasize the importance of multidisciplinary prenatal care and metabolic monitoring throughout pregnancy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781696655879-CHARACTERISTICS_OF_PREGNANCY_IN_WOMEN_OF_REPRODUCT.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abdulazizkhodjieva Rukhona¹</dc:creator>
      <dc:creator>Makhkamova Mushtaribegim²</dc:creator>
      <dc:subject>pregnancy</dc:subject>
      <dc:subject>metabolic changes</dc:subject>
      <dc:subject>reproductive age</dc:subject>
      <dc:subject>gestational diabetes mellitus</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:subject>dyslipidemia</dc:subject>
      <dc:subject>maternal health</dc:subject>
      <dc:subject>fetal development</dc:subject>
      <dc:subject>metabolic syndrome.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 136-150</dc:source>
    </item>
    <item>
      <title>MYOPIA IN CHILDREN AND ADOLESCENTS: EPIDEMIOLOGY, RISK FACTORS, PROGRESSION MECHANISMS, AND MODERN CONTROL STRATEGIES</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/07a9a0df-8767-4fed-b16e-382d71953aaa</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/07a9a0df-8767-4fed-b16e-382d71953aaa</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Myopia is one of the most prevalent refractive disorders worldwide and has emerged as a major public health concern due to its rapidly increasing incidence among children and adolescents. Characterized by excessive axial elongation of the eyeball or increased refractive power of the optical system, myopia causes distant objects to appear blurred while near vision remains relatively preserved. Although low and moderate myopia can be corrected effectively with optical devices, progressive myopia significantly increases the risk of severe ocular complications including retinal detachment, myopic maculopathy, glaucoma, cataract, and irreversible vision loss. Recent decades have witnessed a dramatic increase in myopia prevalence, particularly in East Asia, leading researchers to describe the condition as a global epidemic. Environmental factors, genetic predisposition, prolonged near work, educational pressure, and reduced outdoor activity contribute significantly to disease development and progression. Advances in diagnostic methods and myopia control interventions, including low-dose atropine, orthokeratology, multifocal contact lenses, and specialized spectacle designs, have created new opportunities for slowing disease progression. This article reviews current knowledge regarding epidemiology, pathogenesis, diagnosis, risk factors, treatment strategies, and future perspectives in myopia management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781695617749-MYOPIA_IN_CHILDREN_AND_ADOLESCENTS__EPIDEMIOLOGY__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Eshimov Elbek²</dc:creator>
      <dc:subject>Myopia</dc:subject>
      <dc:subject>refractive error</dc:subject>
      <dc:subject>axial elongation</dc:subject>
      <dc:subject>childhood myopia</dc:subject>
      <dc:subject>atropine therapy</dc:subject>
      <dc:subject>orthokeratology</dc:subject>
      <dc:subject>myopia control</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>retinal complications</dc:subject>
      <dc:subject>visual impairment.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>KERATOCONUS: CONTEMPORARY CONCEPTS IN ETIOPATHOGENESIS, DIAGNOSIS, AND MODERN TREATMENT APPROACHES</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/979a50ac-d24c-41ea-839b-6398d42eba29</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/979a50ac-d24c-41ea-839b-6398d42eba29</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Keratoconus is a progressive, non-inflammatory corneal ectatic disorder characterized by localized thinning and protrusion of the cornea, resulting in irregular astigmatism, myopia, and significant visual impairment. It typically develops during adolescence and early adulthood, with progression continuing for many years before stabilization. The condition represents one of the most important causes of visual disability among young individuals and remains a major focus of contemporary ophthalmological research. Although the exact etiology remains incompletely understood, genetic predisposition, biomechanical abnormalities, oxidative stress, environmental influences, and inflammatory mediators have been implicated in disease development. Significant advances in corneal imaging technologies, including corneal topography, tomography, and biomechanical assessment, have facilitated earlier diagnosis and more accurate monitoring of disease progression. Furthermore, the introduction of corneal collagen cross-linking has fundamentally altered the natural course of keratoconus by providing an effective method to halt disease progression. This article reviews current knowledge regarding the epidemiology, pathogenesis, diagnosis, clinical manifestations, treatment strategies, and future perspectives of keratoconus management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781695121153-KERATOCONUS__CONTEMPORARY_CONCEPTS_IN_ETIOPATHOGEN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Kasimov Turdali²</dc:creator>
      <dc:subject>Keratoconus</dc:subject>
      <dc:subject>corneal ectasia</dc:subject>
      <dc:subject>corneal collagen cross-linking</dc:subject>
      <dc:subject>corneal topography</dc:subject>
      <dc:subject>corneal tomography</dc:subject>
      <dc:subject>irregular astigmatism</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>corneal biomechanics</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>corneal transplantation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 06, pp. 46-60</dc:source>
    </item>
    <item>
      <title>ANATOMY OF THE CARPAL TUNNEL AND CARPAL TUNNEL SYNDROME</title>
      <link>https://aams-journal.us/journals/neurology/articles/b0d9c20e-19d1-4ba0-bc69-20610b3f1fda</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/b0d9c20e-19d1-4ba0-bc69-20610b3f1fda</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Syed Shahnawaz Ahmed¹</author>
      <description>The carpal tunnel is a narrow osteofibrous canal located on the palmar aspect of the wrist that serves as a passageway for the median nerve and flexor tendons. Due to its confined anatomical structure, any condition that increases pressure within the tunnel may compress the median nerve and result in carpal tunnel syndrome (CTS), the most common entrapment neuropathy of the upper extremity. Carpal tunnel syndrome is associated with pain, numbness, paresthesia, muscle weakness, and functional impairment of the hand. The aim of this study was to examine the anatomical characteristics of the carpal tunnel, analyze the pathophysiological mechanisms underlying median nerve compression, and evaluate current approaches to diagnosis and management. Understanding the relationship between anatomy and clinical manifestations is essential for early recognition and effective treatment. Advances in imaging techniques, electrophysiological testing, and surgical interventions have improved diagnostic accuracy and patient outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781698886236-ANATOMY_OF_THE_CARPAL_TUNNEL_AND_CARPAL_TUNNEL_SYN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Syed Shahnawaz Ahmed¹</dc:creator>
      <dc:subject>carpal tunnel</dc:subject>
      <dc:subject>median nerve</dc:subject>
      <dc:subject>carpal tunnel syndrome</dc:subject>
      <dc:subject>wrist anatomy</dc:subject>
      <dc:subject>nerve compression</dc:subject>
      <dc:subject>entrapment neuropathy</dc:subject>
      <dc:subject>electrophysiology</dc:subject>
      <dc:subject>hand function</dc:subject>
      <dc:subject>orthopedic disorders</dc:subject>
      <dc:subject>peripheral neuropathy.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 06, pp. 46-60</dc:source>
    </item>
    <item>
      <title>CATARACT: EPIDEMIOLOGY, PATHOPHYSIOLOGY, DIAGNOSTIC EVALUATION, AND MODERN SURGICAL MANAGEMENT</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/c111c9e4-365b-490b-a9d5-568c7584c4b2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/c111c9e4-365b-490b-a9d5-568c7584c4b2</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Cataract is the leading cause of reversible blindness and visual impairment worldwide, accounting for a substantial proportion of preventable vision loss among aging populations. The condition is characterized by progressive opacification of the crystalline lens, resulting in decreased visual acuity, reduced contrast sensitivity, glare, impaired color perception, and deterioration of overall visual function. Although aging remains the most significant risk factor, cataract formation is influenced by numerous genetic, metabolic, environmental, and systemic factors. Advances in ophthalmic diagnostics, microsurgical techniques, and intraocular lens technology have transformed cataract surgery into one of the most successful and frequently performed procedures in modern medicine. Phacoemulsification combined with intraocular lens implantation has become the gold standard treatment, providing rapid visual rehabilitation and excellent postoperative outcomes. Despite substantial progress in surgical management, cataract remains a major public health concern, particularly in low-resource regions where access to ophthalmic care is limited. This article reviews the epidemiology, pathogenesis, clinical manifestations, diagnostic methods, treatment approaches, and future perspectives related to cataract management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781695378168-CATARACT__EPIDEMIOLOGY__PATHOPHYSIOLOGY__DIAGNOSTI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Eshnazarova Umida²</dc:creator>
      <dc:subject>Cataract</dc:subject>
      <dc:subject>lens opacity</dc:subject>
      <dc:subject>phacoemulsification</dc:subject>
      <dc:subject>intraocular lens</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>age-related cataract</dc:subject>
      <dc:subject>cataract surgery</dc:subject>
      <dc:subject>blindness prevention</dc:subject>
      <dc:subject>ocular aging.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 91-105</dc:source>
    </item>
    <item>
      <title>LARYNGOPHARYNGEAL REFLUX: CURRENT CONCEPTS IN PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT IN OTORHINOLARYNGOLOGY</title>
      <link>https://aams-journal.us/journals/neurology/articles/b98811d5-4c09-4016-ad18-8bc05e3f7f28</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/b98811d5-4c09-4016-ad18-8bc05e3f7f28</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Anqasov Ibratjon¹</author>
      <description>Laryngopharyngeal reflux (LPR) is a common disorder encountered in otorhinolaryngology characterized by the retrograde flow of gastric contents into the larynx, pharynx, and upper aerodigestive tract. Unlike gastroesophageal reflux disease (GERD), laryngopharyngeal reflux often occurs without classic symptoms such as heartburn and regurgitation, making diagnosis particularly challenging. Chronic exposure of the upper airway mucosa to gastric acid, pepsin, bile salts, and digestive enzymes leads to inflammation, mucosal injury, and functional impairment of laryngeal structures. Patients frequently present with chronic cough, hoarseness, throat clearing, globus sensation, dysphagia, and voice disturbances. If left untreated, laryngopharyngeal reflux may contribute to chronic laryngitis, vocal fold pathology, airway stenosis, and reduced quality of life. Recent advances in diagnostic technologies and therapeutic strategies have improved disease recognition and management. This article reviews current evidence regarding epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, treatment options, and preventive measures related to laryngopharyngeal reflux.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781694003349-LARYNGOPHARYNGEAL_REFLUX__CURRENT_CONCEPTS_IN_PATH.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anqasov Ibratjon¹</dc:creator>
      <dc:creator>Khatamov J.A.²</dc:creator>
      <dc:subject>Laryngopharyngeal reflux</dc:subject>
      <dc:subject>reflux laryngitis</dc:subject>
      <dc:subject>chronic cough</dc:subject>
      <dc:subject>hoarseness</dc:subject>
      <dc:subject>voice disorders</dc:subject>
      <dc:subject>proton pump inhibitors</dc:subject>
      <dc:subject>pepsin</dc:subject>
      <dc:subject>otorhinolaryngology</dc:subject>
      <dc:subject>upper airway inflammation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 06, pp. 31-45</dc:source>
    </item>
    <item>
      <title>MODERN APPROACHES TO THE DIAGNOSIS AND MANAGEMENT OF DIABETIC RETINOPATHY: CLINICAL SIGNIFICANCE AND FUTURE PERSPECTIVES</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/9af7429b-331b-48e7-905e-a74fac9618e8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/9af7429b-331b-48e7-905e-a74fac9618e8</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Diabetic retinopathy (DR) remains one of the leading causes of preventable blindness and visual impairment among working-age adults worldwide. The increasing prevalence of diabetes mellitus has resulted in a parallel rise in ocular complications, making diabetic retinopathy a significant public health concern. Chronic hyperglycemia causes progressive microvascular damage within the retina, leading to vascular leakage, ischemia, neovascularization, and eventually irreversible vision loss if left untreated. Advances in ophthalmic imaging technologies, including optical coherence tomography (OCT), OCT angiography (OCTA), and ultra-widefield retinal imaging, have revolutionized the early detection and monitoring of retinal changes associated with diabetes. Simultaneously, treatment strategies have evolved considerably over the past decade, with anti-vascular endothelial growth factor (anti-VEGF) therapy becoming the cornerstone of management for diabetic macular edema and proliferative diabetic retinopathy. This article reviews the pathophysiological mechanisms underlying diabetic retinopathy, contemporary diagnostic approaches, current treatment modalities, and emerging innovations that may further improve visual outcomes. Understanding the complex interactions between metabolic control, retinal vascular pathology, and therapeutic intervention is essential for reducing the global burden of diabetes-related blindness.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781752300106-MODERN_APPROACHES_TO_THE_DIAGNOSIS_AND_MANAGEMENT_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Shernazarov Farrukh²</dc:creator>
      <dc:subject>Diabetic retinopathy</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>retinal vascular disease</dc:subject>
      <dc:subject>diabetic macular edema</dc:subject>
      <dc:subject>anti-VEGF therapy</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>retinal imaging</dc:subject>
      <dc:subject>proliferative diabetic retinopathy</dc:subject>
      <dc:subject>vision loss</dc:subject>
      <dc:subject>ophthalmology.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 06, pp. 31-45</dc:source>
    </item>
    <item>
      <title>ALLERGIC RHINITIS: MODERN PERSPECTIVES ON PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT IN OTORHINOLARYNGOLOGY</title>
      <link>https://aams-journal.us/journals/genetics/articles/c71f1b63-2fbc-4501-b843-e421a76a119f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/c71f1b63-2fbc-4501-b843-e421a76a119f</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Yazdanov Zafar¹</author>
      <description>Allergic rhinitis is one of the most prevalent chronic diseases encountered in otorhinolaryngology and allergy practice. It is an immunoglobulin E (IgE)-mediated inflammatory disorder of the nasal mucosa that develops following exposure to environmental allergens in sensitized individuals. The disease affects hundreds of millions of people worldwide and is associated with substantial impairment in quality of life, educational performance, work productivity, and sleep quality. Common symptoms include nasal congestion, rhinorrhea, sneezing, itching, and postnasal drip. Allergic rhinitis frequently coexists with asthma, chronic rhinosinusitis, otitis media, and conjunctivitis, highlighting its systemic nature. Advances in immunology, molecular diagnostics, and targeted therapies have significantly improved understanding of disease mechanisms and management strategies. This article reviews contemporary concepts regarding the epidemiology, pathogenesis, clinical manifestations, diagnostic evaluation, treatment approaches, and preventive measures related to allergic rhinitis in modern otorhinolaryngology.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781693327979-ALLERGIC_RHINITIS__MODERN_PERSPECTIVES_ON_PATHOGEN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yazdanov Zafar¹</dc:creator>
      <dc:creator>Nasretdinova M.T.²</dc:creator>
      <dc:subject>Allergic rhinitis</dc:subject>
      <dc:subject>nasal allergy</dc:subject>
      <dc:subject>immunoglobulin E</dc:subject>
      <dc:subject>allergen sensitization</dc:subject>
      <dc:subject>nasal obstruction</dc:subject>
      <dc:subject>antihistamines</dc:subject>
      <dc:subject>intranasal corticosteroids</dc:subject>
      <dc:subject>immunotherapy</dc:subject>
      <dc:subject>otorhinolaryngology.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>RETINAL DETACHMENT: PATHOGENESIS, CLINICAL FEATURES, DIAGNOSTIC APPROACHES, AND MODERN SURGICAL MANAGEMENT</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/ad595794-88fb-4958-a9dd-d2787fdf1f03</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/ad595794-88fb-4958-a9dd-d2787fdf1f03</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jalalova Dilfuza Zuhridinovna¹</author>
      <description>Retinal detachment is one of the most serious ophthalmological emergencies and represents a major cause of severe visual impairment and blindness when not diagnosed and treated promptly. The condition occurs when the neurosensory retina separates from the underlying retinal pigment epithelium, disrupting metabolic support and photoreceptor function. Depending on the underlying mechanism, retinal detachment may be classified as rhegmatogenous, tractional, or exudative. Rhegmatogenous retinal detachment is the most common form and usually results from retinal tears that permit fluid accumulation within the subretinal space. Advances in diagnostic imaging, vitreoretinal surgery, and postoperative management have significantly improved anatomical and functional outcomes. Nevertheless, delayed diagnosis remains associated with poor visual prognosis, particularly when macular involvement occurs. This article reviews the epidemiology, pathophysiology, risk factors, diagnostic methods, treatment options, and future perspectives related to retinal detachment management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781695837575-RETINAL_DETACHMENT__PATHOGENESIS__CLINICAL_FEATURE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova Dilfuza Zuhridinovna¹</dc:creator>
      <dc:creator>Yaxshinorov Islombek²</dc:creator>
      <dc:subject>Retinal detachment</dc:subject>
      <dc:subject>vitreoretinal surgery</dc:subject>
      <dc:subject>retinal tear</dc:subject>
      <dc:subject>rhegmatogenous retinal detachment</dc:subject>
      <dc:subject>vitrectomy</dc:subject>
      <dc:subject>scleral buckle</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>retinal imaging</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>retinal disease.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 06, pp. 46-60</dc:source>
    </item>
    <item>
      <title>CHARACTERISTICS OF REPRODUCTIVE DISORDERS IN WOMEN WITH TYPE 1 DIABETES MELLITUS LIVING IN CONDITIONS OF SEVERE IODINE DEFICIENCY IN THE FERGANA REGION</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/4c1f7369-697f-40bd-a17c-6e8b7658271c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/4c1f7369-697f-40bd-a17c-6e8b7658271c</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Karimova Mukima¹</author>
      <description>Type 1 diabetes mellitus (T1DM) is one of the most significant endocrine disorders affecting women of reproductive age and is associated with numerous metabolic, hormonal, and reproductive complications. In regions characterized by severe iodine deficiency, additional endocrine disturbances may further aggravate reproductive dysfunction. The Fergana region has historically been recognized as an area with insufficient iodine intake, leading to widespread thyroid abnormalities among the population. The coexistence of T1DM and iodine deficiency may create a complex endocrine environment that negatively influences ovarian function, menstrual regularity, fertility, and pregnancy outcomes. This study aimed to investigate the characteristics of reproductive disorders in women with T1DM living under conditions of severe iodine deficiency in the Fergana region. A comprehensive clinical, hormonal, and ultrasonographic assessment was conducted among reproductive-aged women diagnosed with T1DM. The study evaluated menstrual disturbances, ovarian dysfunction, infertility prevalence, thyroid status, metabolic control, and reproductive hormone profiles. The findings demonstrated a high frequency of menstrual irregularities, delayed puberty, anovulation, infertility, thyroid dysfunction, and adverse reproductive outcomes among women with T1DM residing in iodine-deficient areas. Poor glycemic control and thyroid hormone imbalance were strongly associated with reproductive abnormalities. The study highlights the necessity of integrated endocrine monitoring, optimization of metabolic control, and iodine deficiency correction to improve reproductive health in this vulnerable population.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781696398491-CHARACTERISTICS_OF_REPRODUCTIVE_DISORDERS_IN_WOMEN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Karimova Mukima¹</dc:creator>
      <dc:creator>Makhkamova Mushtaribegim²</dc:creator>
      <dc:subject>Type 1 diabetes mellitus</dc:subject>
      <dc:subject>iodine deficiency</dc:subject>
      <dc:subject>reproductive disorders</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>menstrual dysfunction</dc:subject>
      <dc:subject>thyroid hormones</dc:subject>
      <dc:subject>ovarian function</dc:subject>
      <dc:subject>endocrine disorders</dc:subject>
      <dc:subject>fertility</dc:subject>
      <dc:subject>Fergana region.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 136-150</dc:source>
    </item>
    <item>
      <title>CHRONIC RHINOSINUSITIS: MODERN APPROACHES TO DIAGNOSIS, TREATMENT, AND PREVENTION IN OTORHINOLARYNGOLOGY</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/95a83211-3172-422e-9082-c0defc462a86</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/95a83211-3172-422e-9082-c0defc462a86</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Kasimov. M¹</author>
      <description>Chronic rhinosinusitis (CRS) is one of the most common diseases encountered in otorhinolaryngology and significantly affects the quality of life of millions of individuals worldwide. The condition is characterized by persistent inflammation of the nasal cavity and paranasal sinus mucosa lasting for more than twelve weeks despite appropriate medical treatment. Chronic rhinosinusitis contributes to substantial healthcare expenditures, reduced work productivity, and increased morbidity. The pathogenesis of CRS is multifactorial and involves complex interactions among microbial infections, allergic reactions, environmental factors, anatomical abnormalities, and host immune responses. Recent advances in diagnostic techniques and therapeutic strategies have improved disease management and patient outcomes. This article reviews current concepts regarding the epidemiology, etiology, clinical manifestations, diagnostic evaluation, treatment modalities, and preventive measures for chronic rhinosinusitis. The findings emphasize the importance of individualized treatment plans and multidisciplinary approaches in achieving long-term disease control and improving patient quality of life.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781692221008-CHRONIC_RHINOSINUSITIS__MODERN_APPROACHES_TO_DIAGN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kasimov. M¹</dc:creator>
      <dc:creator>Nasretdinova M.T.²</dc:creator>
      <dc:subject>Chronic rhinosinusitis</dc:subject>
      <dc:subject>paranasal sinuses</dc:subject>
      <dc:subject>nasal obstruction</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>endoscopic sinus surgery</dc:subject>
      <dc:subject>otorhinolaryngology</dc:subject>
      <dc:subject>diagnosis</dc:subject>
      <dc:subject>treatment</dc:subject>
      <dc:subject>prevention.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>OBSTRUCTIVE SLEEP APNEA SYNDROME: CURRENT DIAGNOSTIC APPROACHES AND TREATMENT STRATEGIES IN OTORHINOLARYNGOLOGY</title>
      <link>https://aams-journal.us/journals/surgery/articles/8410f974-2fad-41be-8726-3099d0832e14</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/8410f974-2fad-41be-8726-3099d0832e14</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate>
      <author>Muxtorov. A¹</author>
      <description>Obstructive Sleep Apnea Syndrome (OSAS) is a common sleep-related breathing disorder characterized by recurrent episodes of partial or complete upper airway obstruction during sleep. These episodes result in intermittent hypoxia, sleep fragmentation, and significant physiological stress affecting multiple organ systems. The prevalence of OSAS has increased substantially over recent decades due to rising obesity rates, aging populations, and improved diagnostic awareness. Untreated OSAS is associated with cardiovascular disease, hypertension, stroke, metabolic dysfunction, cognitive impairment, and reduced quality of life. Otorhinolaryngologists play a critical role in identifying anatomical factors contributing to airway obstruction and implementing both surgical and non-surgical treatment strategies. Recent advances in diagnostic technologies, sleep monitoring systems, and minimally invasive interventions have improved patient outcomes. This article reviews current knowledge regarding the epidemiology, pathophysiology, clinical manifestations, diagnosis, treatment options, and preventive measures related to obstructive sleep apnea syndrome.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781692509868-OBSTRUCTIVE_SLEEP_APNEA_SYNDROME__CURRENT_DIAGNOST.pdf" type="application/pdf" length="0"/>
      <dc:creator>Muxtorov. A¹</dc:creator>
      <dc:creator>Rasulova K.A.²</dc:creator>
      <dc:subject>Obstructive sleep apnea syndrome</dc:subject>
      <dc:subject>sleep-disordered breathing</dc:subject>
      <dc:subject>upper airway obstruction</dc:subject>
      <dc:subject>polysomnography</dc:subject>
      <dc:subject>continuous positive airway pressure</dc:subject>
      <dc:subject>otorhinolaryngology</dc:subject>
      <dc:subject>snoring</dc:subject>
      <dc:subject>hypoxia</dc:subject>
      <dc:subject>sleep medicine.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLINICAL AND FUNCTIONAL ASSESSMENT OF AUTONOMIC DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS</title>
      <link>https://aams-journal.us/journals/neurology/articles/f7eaef03-639f-4962-9315-0ef2f6b7df7d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/f7eaef03-639f-4962-9315-0ef2f6b7df7d</guid>
      <pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate>
      <author>Muxamadiyeva Kamila</author>
      <description>Autonomic dysfunction is a common yet frequently underdiagnosed complication of diabetes mellitus that affects multiple organ systems and significantly contributes to morbidity and mortality. Diabetic autonomic neuropathy develops as a consequence of chronic hyperglycemia, oxidative stress, microvascular damage, and metabolic disturbances that impair autonomic nerve fibers. The condition may involve cardiovascular, gastrointestinal, genitourinary, sudomotor, and metabolic regulatory functions, leading to substantial impairment in quality of life. The aim of this study was to evaluate the clinical manifestations and functional characteristics of autonomic dysfunction in patients with diabetes mellitus and to determine the relationship between disease duration, metabolic control, and severity of autonomic impairment. Clinical examination, autonomic function testing, and laboratory investigations were performed in diabetic patients. The results demonstrated a high prevalence of cardiovascular autonomic abnormalities, gastrointestinal symptoms, and sudomotor disturbances, particularly among individuals with long-standing diabetes and poor glycemic control. Early detection of autonomic dysfunction and comprehensive management strategies may contribute to improved clinical outcomes and prevention of severe complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781613936301-CLINICAL_AND_FUNCTIONAL_ASSESSMENT_OF_AUTONOMIC_DY.pdf" type="application/pdf" length="0"/>
      <dc:creator>Muxamadiyeva Kamila</dc:creator>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>autonomic dysfunction</dc:subject>
      <dc:subject>diabetic autonomic neuropathy</dc:subject>
      <dc:subject>cardiovascular autonomic neuropathy</dc:subject>
      <dc:subject>autonomic nervous system</dc:subject>
      <dc:subject>glycemic control</dc:subject>
      <dc:subject>neuropathy</dc:subject>
      <dc:subject>heart rate variability</dc:subject>
      <dc:subject>neurological complications</dc:subject>
      <dc:subject>functional assessment.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>BETWEEN FLOW AND FAILURE: THE PARADOX OF AV MALFORMATIONS</title>
      <link>https://aams-journal.us/journals/surgery/articles/56963199-f965-4ac7-bf26-4bd297474879</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/56963199-f965-4ac7-bf26-4bd297474879</guid>
      <pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate>
      <author>Aira Shahid¹</author>
      <description>Arteriovenous malformations (AVMs) represent complex vascular anomalies characterized by direct connections between arterial and venous systems without an intervening capillary network. These lesions create abnormal hemodynamic conditions that may remain clinically silent for years while simultaneously carrying a substantial risk of hemorrhage, neurological impairment, and functional disability. The paradox of AV malformations lies in their ability to maintain high-volume blood flow while progressively compromising normal tissue perfusion and structural integrity. This study examines contemporary perspectives on the pathophysiology, clinical manifestations, diagnostic evaluation, and therapeutic management of AV malformations. Particular emphasis is placed on the relationship between abnormal vascular dynamics and neurological outcomes. Advances in neuroimaging, endovascular techniques, microsurgery, and stereotactic radiosurgery have significantly improved diagnostic accuracy and treatment efficacy. Understanding the balance between vascular flow and tissue failure remains essential for optimizing patient management and reducing morbidity associated with these challenging vascular disorders.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781621536356-BETWEEN_FLOW_AND_FAILURE__THE_PARADOX_OF_AV_MALFOR.pdf" type="application/pdf" length="0"/>
      <dc:creator>Aira Shahid¹</dc:creator>
      <dc:creator>Zainab Aijaz²</dc:creator>
      <dc:subject>arteriovenous malformation</dc:subject>
      <dc:subject>cerebrovascular disease</dc:subject>
      <dc:subject>intracranial hemorrhage</dc:subject>
      <dc:subject>vascular anomalies</dc:subject>
      <dc:subject>neurovascular disorders</dc:subject>
      <dc:subject>cerebral circulation</dc:subject>
      <dc:subject>endovascular therapy</dc:subject>
      <dc:subject>radiosurgery</dc:subject>
      <dc:subject>neurological deficits</dc:subject>
      <dc:subject>vascular pathology.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.413/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLINICAL AND NEUROPHYSIOLOGICAL FEATURES OF DIABETIC PERIPHERAL NEUROPATHY AND MODERN APPROACHES TO MANAGEMENT</title>
      <link>https://aams-journal.us/journals/neurology/articles/41c2c9cd-0533-4133-8dcd-33f1c6534fc3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/41c2c9cd-0533-4133-8dcd-33f1c6534fc3</guid>
      <pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate>
      <author>Qodirov Umid¹</author>
      <description>Diabetic peripheral neuropathy is one of the most common and disabling chronic complications of diabetes mellitus. It develops as a consequence of prolonged hyperglycemia, metabolic disturbances, microvascular dysfunction, and oxidative stress, resulting in structural and functional damage to peripheral nerves. The condition significantly affects quality of life through sensory impairment, neuropathic pain, motor dysfunction, and increased risk of foot ulceration and amputation. The aim of this study was to evaluate the clinical and neurophysiological characteristics of diabetic peripheral neuropathy and to analyze contemporary approaches to its diagnosis and management. Clinical examination, neurological assessment, and neurophysiological investigations were performed in patients with diabetes mellitus. The findings demonstrated a close relationship between disease duration, glycemic control, and severity of neuropathic manifestations. Modern therapeutic strategies, including metabolic control, pharmacological treatment, lifestyle modification, and multidisciplinary care, contributed to symptom reduction and functional improvement. Early diagnosis and comprehensive management remain essential for preventing progression and improving patient outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781593654658-CLINICAL_AND_NEUROPHYSIOLOGICAL_FEATURES_OF_DIABET.pdf" type="application/pdf" length="0"/>
      <dc:creator>Qodirov Umid¹</dc:creator>
      <dc:creator>Xusanov Mustafo²</dc:creator>
      <dc:creator>Ro&apos;zimurodov Javohir³</dc:creator>
      <dc:subject>diabetic peripheral neuropathy</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>nerve conduction studies</dc:subject>
      <dc:subject>neuropathic pain</dc:subject>
      <dc:subject>neurophysiology</dc:subject>
      <dc:subject>peripheral nerves</dc:subject>
      <dc:subject>glycemic control</dc:subject>
      <dc:subject>neurological complications</dc:subject>
      <dc:subject>diabetic foot</dc:subject>
      <dc:subject>rehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>children, appendicitis, peritonitis, intestinal obstruction, regional lymphatic antibiotic therapy.</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/a6255c76-dc48-43b4-9f29-2e3eefd4e2c1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/a6255c76-dc48-43b4-9f29-2e3eefd4e2c1</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Begnaeva Mukhiba Usmonovna</author>
      <description>Background: The study involved 78 children diagnosed with chronic viral hepatitis. The patients were divided into two groups: Group I (36 children) received standard therapy, including conventional hepatoprotectors and choleretic drugs; Group II (42 children) received ursodeoxycholic acid (Ursosan) as a monotherapy at a dose of 1 capsule per day. Comparative biochemical assessments confirmed a distinct positive therapeutic effect of Ursosan monotherapy. In children receiving Ursosan, a statistically significant decrease in biochemical markers of cholestasis, particularly alkaline phosphatase, was observed. The multifaceted beneficial impact of Ursosan on the clinical course of chronic viral hepatitis was demonstrated, supporting its recommendation as a standalone treatment or as a core component of combination therapy. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781161631545-children__appendicitis__peritonitis__intestinal_ob.pdf" type="application/pdf" length="0"/>
      <dc:creator>Begnaeva Mukhiba Usmonovna</dc:creator>
      <dc:creator>Khayitov Ulugbek Khuzaqulovich</dc:creator>
      <dc:subject>Chronic viral hepatitis</dc:subject>
      <dc:subject>hepatocytes</dc:subject>
      <dc:subject>Ursosan</dc:subject>
      <dc:subject>alkaline phosphatase</dc:subject>
      <dc:subject>total bilirubin.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>ENDOMETRIOSIS: MODERN PERSPECTIVES ON PATHOGENESIS, DIAGNOSIS, AND TREATMENT</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/a460485a-295f-4d7c-89cc-7b8d61e327b5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/a460485a-295f-4d7c-89cc-7b8d61e327b5</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Rustamova Umida¹</author>
      <description>Endometriosis is a chronic estrogen-dependent gynecological disorder characterized by the presence of endometrial-like tissue outside the uterine cavity. It affects millions of women worldwide and is one of the leading causes of chronic pelvic pain, infertility, and reduced quality of life. Despite extensive research, the exact mechanisms underlying the development of endometriosis remain incompletely understood. Recent advances in molecular biology, genetics, immunology, and imaging technologies have significantly improved understanding of disease pathogenesis and expanded opportunities for early diagnosis and individualized treatment. The aim of this study was to analyze contemporary concepts regarding the pathogenesis, diagnostic approaches, and therapeutic strategies for endometriosis. The findings indicate that endometriosis is a multifactorial disease involving hormonal, immunological, inflammatory, genetic, and environmental factors. Early recognition and comprehensive management can substantially improve clinical outcomes and reproductive health. Modern treatment strategies combining medical therapy, minimally invasive surgery, and multidisciplinary care contribute to symptom control and improved quality of life.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781164117654-ENDOMETRIOSIS__MODERN_PERSPECTIVES_ON_PATHOGENESIS.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rustamova Umida¹</dc:creator>
      <dc:creator>Nag’matov Shamshod²</dc:creator>
      <dc:subject>endometriosis</dc:subject>
      <dc:subject>chronic pelvic pain</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>estrogen</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>laparoscopy</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>hormonal therapy</dc:subject>
      <dc:subject>gynecology</dc:subject>
      <dc:subject>women&apos;s health.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 76-90</dc:source>
    </item>
    <item>
      <title>THE USE OF ULTRASOUND IN THE DIAGNOSIS OF DESTRUCTIVE PNEUMONIA IN CHILDREN</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/67b146dd-6d49-4618-9c36-21eb789528bd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/67b146dd-6d49-4618-9c36-21eb789528bd</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>U. Kh. Khayitov</author>
      <description>Background: Ultrasound diagnostics is one of the most rapidly developing methods of clinical patient examination. For many years, it was widely believed that lung ultrasound was unfeasible due to the presence of air, which acts as an insurmountable barrier to ultrasound waves.
Materials and Methods: We observed 148 patients with various forms of acute destructive pneumonia admitted to the purulent-septic department of the Regional Children&apos;s Multidisciplinary Medical Center between 2015 and 2025.
Results: The study demonstrated that the accuracy of ultrasound diagnostics in cases of pyothorax and pyopneumothorax reached 100%. A crucial practical advantage of utilizing ultrasound in pleural cavity examinations is its ability to determine the optimal puncture site. Furthermore, destructive foci are detected via ultrasound earlier than through conventional radiography.
Conclusion: These findings provide a strong rationale for recommending the widespread implementation of ultrasound as a primary screening and diagnostic tool for managing destructive pneumonia in pediatric patients.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781160785740-THE_USE_OF_ULTRASOUND_IN_THE_DIAGNOSIS_OF_DESTRUCT.pdf" type="application/pdf" length="0"/>
      <dc:creator>U. Kh. Khayitov</dc:creator>
      <dc:subject>children</dc:subject>
      <dc:subject>destructive pneumonia</dc:subject>
      <dc:subject>ultrasound diagnostics</dc:subject>
      <dc:subject>pyothorax</dc:subject>
      <dc:subject>pyopneumothorax.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 06, pp. 16-30</dc:source>
    </item>
    <item>
      <title>THE ROLE OF COMPOSITE RESTORATIONS IN MODERN DENTISTRY: CLINICAL IMPORTANCE, MATERIAL DEVELOPMENT, AND CONTEMPORARY CHALLENGES</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/f6cb0f44-1354-4b8b-96da-c219bd316228</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/f6cb0f44-1354-4b8b-96da-c219bd316228</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Quroqboyev Sardor¹</author>
      <description>Composite restorative materials have become an integral component of modern restorative dentistry due to their aesthetic properties, minimally invasive application techniques, and continuous technological improvements. Over recent decades, substantial progress in material science has significantly enhanced the physical, mechanical, and biological characteristics of dental composites, allowing their widespread use in both anterior and posterior restorations. The aim of this study was to evaluate the clinical importance of composite restorations, analyze recent developments in composite material technology, and identify contemporary challenges associated with their clinical application. A comprehensive review of clinical outcomes, material properties, and restorative techniques was performed. The findings demonstrated that modern composite restorations provide excellent aesthetics, reliable functional performance, and preservation of healthy tooth structure. However, challenges related to polymerization shrinkage, wear resistance, marginal integrity, and long-term durability continue to influence treatment outcomes. The study highlights the importance of evidence-based material selection, proper clinical protocols, and ongoing technological innovation in optimizing restorative success.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781161867857-THE_ROLE_OF_COMPOSITE_RESTORATIONS_IN_MODERN_DENTI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Quroqboyev Sardor¹</dc:creator>
      <dc:creator>Erkinov Shoxruxbek²</dc:creator>
      <dc:creator>Saidqulov Bunyod³</dc:creator>
      <dc:creator>Sodiqova Shoira Amriddinovna⁴</dc:creator>
      <dc:subject>composite restorations</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>dental materials</dc:subject>
      <dc:subject>resin composites</dc:subject>
      <dc:subject>adhesive dentistry</dc:subject>
      <dc:subject>polymerization shrinkage</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>esthetic restorations</dc:subject>
      <dc:subject>biomaterials</dc:subject>
      <dc:subject>clinical outcomes.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>THE ROLE OF REGIONAL LYMPHATIC ANTIBIOTIC THERAPY IN ACUTE ABDOMINAL DISEASES IN CHILDREN</title>
      <link>https://aams-journal.us/journals/surgery/articles/65e52f12-b0fb-4d36-9661-d2f323dd13ac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/65e52f12-b0fb-4d36-9661-d2f323dd13ac</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Khayitov U.H.</author>
      <description>Timely diagnosis and treatment of acute surgical diseases of the abdominal organs in children remain a relevant problem in pediatric surgery. The targeted use of modern diagnostic technologies (ultrasound and laparoscopy) makes it possible to avoid most diagnostic errors.
The aim of the study was to investigate the effectiveness of regional lymphatic antibiotic therapy in children with abdominal organ pathology complicated by peritonitis (destructive appendicitis, peritonitis, and intestinal obstruction). Children under 18 years of age with suppurative processes of the abdominal organs in the postoperative period who were examined and treated over the past 10 years in the pediatric surgery department of the Samarkand Regional Multidisciplinary Children’s Medical Center were included in the study. The studies conducted in children with suppurative diseases of the abdominal organs (main and control groups) demonstrated high effectiveness of regional lymphatic antibiotic therapy, which was manifested by stabilization of the patient’s clinical condition, earlier normalization of clinical and laboratory parameters, and a significant reduction in the rate of postoperative complications.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781161075713-THE_ROLE_OF_REGIONAL_LYMPHATIC_ANTIBIOTIC_THERAPY_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khayitov U.H.</dc:creator>
      <dc:subject>children</dc:subject>
      <dc:subject>appendicitis</dc:subject>
      <dc:subject>peritonitis</dc:subject>
      <dc:subject>intestinal obstruction</dc:subject>
      <dc:subject>regional lymphatic antibiotic therapy.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MODERN METHODS OF TREATING CARIES</title>
      <link>https://aams-journal.us/journals/surgery/articles/164ba554-2af4-4b41-8586-b0a9790690c7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/164ba554-2af4-4b41-8586-b0a9790690c7</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Hikmatova Dildora¹</author>
      <description>This in the article tooth career in treatment used advanced and effective methods analysis It was made . caries initial in stages detection , tooth tissues maximum at the level save to stay minimally invasive targeted approaches , laser using treatment and remineralization therapy place illuminating Also , modern dental of technologies treatment quality in progress importance seeing released . 
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781160505240-MODERN_METHODS_OF_TREATING_CARIES.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hikmatova Dildora¹</dc:creator>
      <dc:creator>Karabayeva Zarafshan²</dc:creator>
      <dc:creator>Pirnazarova Hurliman³</dc:creator>
      <dc:creator>Sodikova Shoira⁴</dc:creator>
      <dc:subject>tooth career</dc:subject>
      <dc:subject>innovation treatment</dc:subject>
      <dc:subject>laser therapy</dc:subject>
      <dc:subject>remineralization</dc:subject>
      <dc:subject>dental technologies</dc:subject>
      <dc:subject>dental enamel</dc:subject>
      <dc:subject>prophylactic dentistry</dc:subject>
      <dc:subject>diagnostics methods</dc:subject>
      <dc:subject>conservative treatment</dc:subject>
      <dc:subject>aesthetic dentistry.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Infertility Associated with Thyroid Dysfunction</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/b90da380-7d05-4911-ad63-ba795b3eafc6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/b90da380-7d05-4911-ad63-ba795b3eafc6</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Rahimova Madina Mannonovna</author>
      <description>Infertility remains a significant reproductive health concern affecting millions of couples worldwide. Among the numerous factors contributing to impaired fertility, thyroid dysfunction has emerged as an important endocrine disorder influencing reproductive capacity in both women and men. Thyroid hormones play a critical role in regulating metabolism, growth, development, and reproductive physiology. Alterations in thyroid function may disrupt hormonal balance, interfere with ovulation, impair implantation, and negatively affect pregnancy outcomes. The present study examines the relationship between thyroid dysfunction and infertility, focusing on the physiological mechanisms involved and their clinical implications. Current evidence indicates that both hypothyroidism and hyperthyroidism can adversely affect reproductive function through disturbances in the hypothalamic-pituitary-gonadal axis. Early diagnosis and appropriate management of thyroid disorders contribute significantly to improving fertility outcomes and increasing the likelihood of successful conception. Understanding the impact of thyroid dysfunction on reproductive health is essential for optimizing infertility evaluation and treatment strategies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781162124838-Infertility_Associated_with_Thyroid_Dysfunction.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rahimova Madina Mannonovna</dc:creator>
      <dc:subject>infertility</dc:subject>
      <dc:subject>thyroid dysfunction</dc:subject>
      <dc:subject>hypothyroidism</dc:subject>
      <dc:subject>hyperthyroidism</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>thyroid hormones</dc:subject>
      <dc:subject>ovulation</dc:subject>
      <dc:subject>endocrine disorders</dc:subject>
      <dc:subject>fertility</dc:subject>
      <dc:subject>pregnancy.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 61-75</dc:source>
    </item>
    <item>
      <title>Endocrine Disorders that Occur in the Body as a Result of Improper Use of Gadgets</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/1747f336-6531-405c-8dd6-fb9a199f645f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/1747f336-6531-405c-8dd6-fb9a199f645f</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Rahimova Madina Mannonovna</author>
      <description>The widespread use of digital devices has become an integral part of modern life, particularly among children, adolescents, and young adults. While gadgets such as smartphones, tablets, laptops, and gaming devices provide numerous educational and communication benefits, excessive and improper use may negatively affect human health. Recent studies suggest that prolonged exposure to screens, disrupted sleep patterns, sedentary behavior, and chronic psychological stress associated with excessive gadget use may influence endocrine system function. The endocrine system regulates metabolism, growth, reproduction, stress responses, and numerous physiological processes through hormone secretion. Disturbances in hormonal balance caused by unhealthy digital habits may contribute to metabolic disorders, obesity, insulin resistance, reproductive dysfunction, thyroid abnormalities, and alterations in stress hormone regulation. This study examines the relationship between improper gadget use and endocrine disorders, highlighting potential biological mechanisms and associated health consequences. Understanding these interactions is essential for developing preventive strategies aimed at protecting endocrine health in the digital era.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781162483421-Endocrine_Disorders_that_Occur_in_the_Body_as_a_Re.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rahimova Madina Mannonovna</dc:creator>
      <dc:subject>endocrine disorders</dc:subject>
      <dc:subject>gadgets</dc:subject>
      <dc:subject>screen time</dc:subject>
      <dc:subject>hormonal imbalance</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>thyroid function</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:subject>cortisol</dc:subject>
      <dc:subject>sleep disturbance</dc:subject>
      <dc:subject>digital health.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 06, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Stress Affects the Body During Puberty</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/0c14dc50-2f58-432e-b032-f5175dc43685</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/0c14dc50-2f58-432e-b032-f5175dc43685</guid>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <author>Rahimova Madina Mannonovna</author>
      <description>Puberty is a critical developmental stage characterized by profound biological, psychological, and social changes. During this period, adolescents experience rapid growth, hormonal fluctuations, emotional maturation, and increased environmental demands. Exposure to stress during puberty may significantly influence physical health, emotional wellbeing, cognitive function, and behavioral development. The present study examines the effects of stress on the adolescent body during puberty and explores the physiological and psychological mechanisms involved. Clinical observations and contemporary scientific evidence indicate that chronic stress can disrupt hormonal regulation, impair immune function, alter sleep patterns, and negatively affect growth and development. Increased levels of stress hormones, particularly cortisol, may interfere with normal pubertal progression and contribute to anxiety, depression, academic difficulties, and social challenges. The findings emphasize the importance of early identification of stress-related symptoms and implementation of effective coping strategies. Understanding the impact of stress during puberty is essential for promoting healthy adolescent development and preventing long-term health consequences.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781162745943-Stress_Affects_the_Body_During_Puberty.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rahimova Madina Mannonovna</dc:creator>
      <dc:subject>stress</dc:subject>
      <dc:subject>puberty</dc:subject>
      <dc:subject>adolescence</dc:subject>
      <dc:subject>cortisol</dc:subject>
      <dc:subject>hormonal changes</dc:subject>
      <dc:subject>mental health</dc:subject>
      <dc:subject>emotional development</dc:subject>
      <dc:subject>growth</dc:subject>
      <dc:subject>psychological wellbeing</dc:subject>
      <dc:subject>adolescent health.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 31-45</dc:source>
    </item>
    <item>
      <title>DYNAMICS OF CHANGES IN ANATOMICAL AND PHYSIOLOGICAL OCULAR PARAMETERS IN PATIENTS WITH CONGENITAL MYOPIA</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/f4b8747b-55ba-4629-b8af-889fb640d979</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/f4b8747b-55ba-4629-b8af-889fb640d979</guid>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <author>Saidavzal Abdurakhmanovich Boboev</author>
      <description>Congenital myopia is a complex refractive disorder characterized by the presence of myopia at birth or during early infancy and is frequently associated with progressive anatomical and physiological alterations of the eye. The condition affects multiple ocular structures, including the cornea, sclera, retina, choroid, vitreous body, and optic nerve, resulting in significant changes in visual function and ocular development. Monitoring the dynamics of ocular parameters is essential for understanding disease progression, predicting visual outcomes, and optimizing therapeutic interventions. Anatomical changes are primarily associated with axial elongation of the eyeball, thinning of retinal and choroidal tissues, scleral remodeling, and modifications of optic disc morphology. Physiological alterations include changes in accommodation, retinal sensitivity, visual acuity, binocular function, and ocular blood flow. These processes may progress throughout childhood and adolescence, increasing the risk of pathological complications such as retinal degeneration, posterior staphyloma, macular abnormalities, and retinal detachment. Modern diagnostic technologies, including optical coherence tomography, ocular biometry, ultrasonography, fundus imaging, and electrophysiological testing, enable detailed assessment of disease dynamics. This study evaluates the changes in anatomical and physiological ocular parameters observed in patients with congenital myopia and examines their relationship with disease progression, visual function, and long-term prognosis. The findings emphasize the importance of continuous monitoring and early intervention to preserve visual health and reduce the risk of severe ocular complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781108275402-DYNAMICS_OF_CHANGES_IN_ANATOMICAL_AND_PHYSIOLOGICA.pdf" type="application/pdf" length="0"/>
      <dc:creator>Saidavzal Abdurakhmanovich Boboev</dc:creator>
      <dc:subject>Congenital myopia</dc:subject>
      <dc:subject>axial length</dc:subject>
      <dc:subject>ocular biometry</dc:subject>
      <dc:subject>retinal thickness</dc:subject>
      <dc:subject>choroidal thickness</dc:subject>
      <dc:subject>visual acuity</dc:subject>
      <dc:subject>accommodation</dc:subject>
      <dc:subject>ocular development</dc:subject>
      <dc:subject>pediatric ophthalmology</dc:subject>
      <dc:subject>pathological myopia.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>FEATURES OF THE CLINICAL COURSE OF CONGENITAL MYOPIA IN CHILDREN</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/9e190a5d-7077-4d51-afa3-4701d18f7d3a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/9e190a5d-7077-4d51-afa3-4701d18f7d3a</guid>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <author>Saidavzal Abdurakhmanovich Boboev</author>
      <description>Congenital myopia is a relatively uncommon but clinically significant refractive disorder that is present at birth or develops during the first months of life. Unlike school-age myopia, congenital myopia is frequently associated with abnormalities of ocular growth, structural alterations of the retina and choroid, amblyopia, strabismus, and various developmental disorders. The disease may demonstrate a stable course in some children, while in others it progresses rapidly, resulting in significant visual impairment and increased risk of ocular complications. Early recognition of congenital myopia is essential because timely intervention can improve visual development and reduce the likelihood of long-term disability. The clinical course of congenital myopia is influenced by genetic factors, axial elongation of the eyeball, retinal maturation, accommodative function, and associated ocular abnormalities. Modern diagnostic technologies enable detailed evaluation of refractive status, axial length, retinal integrity, and functional visual outcomes. This study analyzes the clinical characteristics, progression patterns, diagnostic features, and management strategies associated with congenital myopia in children. The findings indicate that regular ophthalmological monitoring, early optical correction, amblyopia therapy, and individualized treatment approaches contribute significantly to maintaining visual function and preventing disease progression.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781107999731-FEATURES_OF_THE_CLINICAL_COURSE_OF_CONGENITAL_MYOP.pdf" type="application/pdf" length="0"/>
      <dc:creator>Saidavzal Abdurakhmanovich Boboev</dc:creator>
      <dc:subject>Congenital myopia</dc:subject>
      <dc:subject>childhood myopia</dc:subject>
      <dc:subject>refractive errors</dc:subject>
      <dc:subject>visual development</dc:subject>
      <dc:subject>amblyopia</dc:subject>
      <dc:subject>axial length</dc:subject>
      <dc:subject>retinal changes</dc:subject>
      <dc:subject>pediatric ophthalmology</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>ocular growth.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 46-60</dc:source>
    </item>
    <item>
      <title>TREATMENT AND REHABILITATION OF CHILDREN WITH CONGENITAL MYOPIA</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/47d7f090-8f71-45bd-ad2e-bf57fbc8052d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/47d7f090-8f71-45bd-ad2e-bf57fbc8052d</guid>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <author>Amin Abduazizovich Yusupov¹</author>
      <description>Congenital myopia is a visual disorder characterized by the presence of nearsightedness at birth or during the first months of life. The condition may significantly affect visual development, educational performance, social adaptation, and overall quality of life if not diagnosed and managed appropriately. Effective treatment and rehabilitation strategies are essential to optimize visual function, prevent secondary complications, and promote normal development of the visual system. The aim of this study was to evaluate modern approaches to the treatment and rehabilitation of children with congenital myopia and to assess their effectiveness in improving visual outcomes. Comprehensive ophthalmological examinations, individualized optical correction, amblyopia therapy, visual rehabilitation programs, and regular follow-up monitoring were implemented. The results demonstrated significant improvement in visual acuity, binocular vision, and functional visual performance among children receiving early and continuous intervention. The findings emphasize the importance of multidisciplinary rehabilitation programs and personalized treatment strategies for achieving favorable long-term outcomes in pediatric patients with congenital myopia.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781109418304-TREATMENT_AND_REHABILITATION_OF_CHILDREN_WITH_CONG.pdf" type="application/pdf" length="0"/>
      <dc:creator>Amin Abduazizovich Yusupov¹</dc:creator>
      <dc:creator>Saidavzal Abdurakhmanovich Boboev²</dc:creator>
      <dc:subject>congenital myopia</dc:subject>
      <dc:subject>pediatric ophthalmology</dc:subject>
      <dc:subject>visual rehabilitation</dc:subject>
      <dc:subject>optical correction</dc:subject>
      <dc:subject>amblyopia</dc:subject>
      <dc:subject>binocular vision</dc:subject>
      <dc:subject>low vision therapy</dc:subject>
      <dc:subject>visual development</dc:subject>
      <dc:subject>refractive disorders</dc:subject>
      <dc:subject>child rehabilitation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>OPTIMIZATION OF THE DIAGNOSIS, CLINICAL MANAGEMENT, AND TREATMENT OF CONGENITAL MYOPIA</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/ee12b4b8-dd20-4c2c-a110-5fd81b70504d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/ee12b4b8-dd20-4c2c-a110-5fd81b70504d</guid>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <author>Saidavzal Abdurakhmanovich Boboev</author>
      <description>Congenital myopia is a significant ophthalmological condition characterized by the presence of nearsightedness at birth or during the first year of life. The disorder is associated with structural abnormalities of the eyeball, genetic predisposition, and disturbances in visual system development. Early diagnosis and appropriate management are essential to prevent visual impairment, amblyopia, strabismus, and long-term complications affecting quality of life. The aim of this study was to optimize diagnostic approaches, clinical management strategies, and treatment methods for congenital myopia in pediatric patients. A comprehensive evaluation including ophthalmological examination, refractive assessment, biometric measurements, and functional visual testing was performed. The findings demonstrated that early identification of refractive abnormalities combined with individualized therapeutic interventions significantly improved visual outcomes. Modern diagnostic technologies and multidisciplinary treatment approaches contributed to better disease control, stabilization of refractive progression, and enhancement of visual function. The study emphasizes the importance of timely diagnosis and evidence-based management protocols in children with congenital myopia.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781107761876-OPTIMIZATION_OF_THE_DIAGNOSIS__CLINICAL_MANAGEMENT.pdf" type="application/pdf" length="0"/>
      <dc:creator>Saidavzal Abdurakhmanovich Boboev</dc:creator>
      <dc:subject>Congenital myopia</dc:subject>
      <dc:subject>pediatric ophthalmology</dc:subject>
      <dc:subject>refractive errors</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>amblyopia</dc:subject>
      <dc:subject>axial length</dc:subject>
      <dc:subject>optical correction</dc:subject>
      <dc:subject>retinal assessment</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>clinical management.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 06, pp. 16-30</dc:source>
    </item>
    <item>
      <title>EFFECTIVENESS OF OPTICAL CORRECTION IN PATIENTS WITH CONGENITAL MYOPIA</title>
      <link>https://aams-journal.us/journals/surgery/articles/d10d5eda-15d4-4b56-86d5-fbc7ebf33813</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/d10d5eda-15d4-4b56-86d5-fbc7ebf33813</guid>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <author>Amin Abduazizovich Yusupov¹</author>
      <description>Congenital myopia is a refractive disorder present at birth or developing during early infancy and is characterized by excessive refractive power or increased axial length of the eye, resulting in blurred retinal image formation. Early visual deprivation caused by uncorrected congenital myopia may significantly affect visual development and increase the risk of amblyopia, strabismus, impaired binocular vision, and reduced quality of life. Optical correction remains the primary method for restoring retinal image clarity and supporting normal visual maturation in affected individuals. Various correction modalities, including spectacles, contact lenses, and advanced optical devices, have demonstrated effectiveness in improving visual acuity, enhancing binocular function, and reducing the incidence of secondary visual complications. The success of optical correction depends on early diagnosis, accurate refractive assessment, patient compliance, degree of myopia, and the presence of associated ocular abnormalities. Contemporary ophthalmological practice emphasizes individualized correction strategies tailored to the specific needs of each patient. This study evaluates the effectiveness of optical correction in patients with congenital myopia and examines its impact on visual development, functional outcomes, disease progression, and long-term visual prognosis. The findings indicate that timely and appropriate optical correction significantly improves visual performance and contributes to the preservation of ocular function throughout childhood and adolescence.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781108885949-EFFECTIVENESS_OF_OPTICAL_CORRECTION_IN_PATIENTS_WI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Amin Abduazizovich Yusupov¹</dc:creator>
      <dc:creator>Saidavzal Abdurakhmanovich Boboev²</dc:creator>
      <dc:subject>Congenital myopia</dc:subject>
      <dc:subject>optical correction</dc:subject>
      <dc:subject>refractive errors</dc:subject>
      <dc:subject>spectacles</dc:subject>
      <dc:subject>contact lenses</dc:subject>
      <dc:subject>visual acuity</dc:subject>
      <dc:subject>amblyopia</dc:subject>
      <dc:subject>pediatric ophthalmology</dc:subject>
      <dc:subject>binocular vision</dc:subject>
      <dc:subject>visual development.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>DIGITAL WORKFLOW IN PROSTHODONTICS: CLINICAL EFFECTIVENESS OF CAD/CAM TECHNOLOGIES IN FIXED PROSTHETIC REHABILITATION</title>
      <link>https://aams-journal.us/journals/surgery/articles/8c27af1e-0155-4e52-a464-1e9346bf9781</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/8c27af1e-0155-4e52-a464-1e9346bf9781</guid>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <author>Islomov Lazizbek¹</author>
      <description>The integration of digital technologies into prosthodontic practice has transformed contemporary approaches to fixed prosthetic rehabilitation. Computer-aided design and computer-aided manufacturing (CAD/CAM) systems have introduced new possibilities for improving diagnostic accuracy, treatment planning, restoration fabrication, and clinical outcomes. The purpose of this study was to evaluate the clinical effectiveness of CAD/CAM technologies in fixed prosthodontic rehabilitation and to assess their influence on restoration quality, treatment efficiency, and patient satisfaction. A comprehensive analysis of digitally fabricated fixed restorations was performed using clinical, functional, and aesthetic criteria. The findings demonstrated that CAD/CAM-based workflows provide highly accurate restorations with excellent marginal adaptation, predictable aesthetics, reduced treatment duration, and improved patient comfort. Digital protocols contributed to enhanced communication between clinicians and dental laboratories while minimizing procedural errors associated with conventional techniques. The study confirms that digital prosthodontic workflows represent a reliable and effective approach for modern fixed prosthetic rehabilitation and may significantly improve long-term treatment outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1781107507154-DIGITAL_WORKFLOW_IN_PROSTHODONTICS__CLINICAL_EFFEC.pdf" type="application/pdf" length="0"/>
      <dc:creator>Islomov Lazizbek¹</dc:creator>
      <dc:creator>Buzrukzoda Javokhirkhon Davron²</dc:creator>
      <dc:subject>CAD/CAM technology</dc:subject>
      <dc:subject>digital dentistry</dc:subject>
      <dc:subject>prosthodontics</dc:subject>
      <dc:subject>fixed prosthetic rehabilitation</dc:subject>
      <dc:subject>digital workflow</dc:subject>
      <dc:subject>dental restoration</dc:subject>
      <dc:subject>intraoral scanning</dc:subject>
      <dc:subject>computer-aided design</dc:subject>
      <dc:subject>computer-aided manufacturing</dc:subject>
      <dc:subject>prosthetic treatment.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 31-45</dc:source>
    </item>
    <item>
      <title>THE IMPACT OF VITAMIN D DEFICIENCY ON REPRODUCTIVE HEALTH AND PREGNANCY OUTCOMES IN WOMEN</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/89cdc945-106d-49fe-ac41-f9c64e8aa58f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/89cdc945-106d-49fe-ac41-f9c64e8aa58f</guid>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <author>Saypillayeva Mehribonu¹</author>
      <description>Vitamin D deficiency has emerged as a major public health concern affecting women of reproductive age worldwide. Beyond its well-established role in calcium homeostasis and skeletal health, vitamin D is increasingly recognized as an important regulator of reproductive function, endocrine balance, immune modulation, and fetal development. Insufficient vitamin D levels have been associated with menstrual irregularities, ovulatory dysfunction, infertility, polycystic ovary syndrome, and adverse pregnancy outcomes. This study aimed to evaluate the impact of vitamin D deficiency on female reproductive health and pregnancy outcomes through clinical and laboratory assessment. A comprehensive analysis of reproductive indicators, hormonal parameters, and pregnancy-related complications was performed among women with varying vitamin D status. The findings demonstrated that inadequate vitamin D levels were associated with impaired reproductive function, increased risk of infertility, gestational complications, and unfavorable neonatal outcomes. Early identification and correction of vitamin D deficiency may contribute to improved reproductive health and pregnancy success. The results emphasize the importance of integrating vitamin D assessment into routine reproductive and prenatal healthcare programs.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780977036759-THE_IMPACT_OF_VITAMIN_D_DEFICIENCY_ON_REPRODUCTIVE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Saypillayeva Mehribonu¹</dc:creator>
      <dc:creator>Abdusamiyeva Charos²</dc:creator>
      <dc:subject>vitamin D deficiency</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>pregnancy outcomes</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>polycystic ovary syndrome</dc:subject>
      <dc:subject>gestational diabetes</dc:subject>
      <dc:subject>maternal health</dc:subject>
      <dc:subject>fetal development</dc:subject>
      <dc:subject>endocrine function</dc:subject>
      <dc:subject>prenatal care.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 31-45</dc:source>
    </item>
    <item>
      <title>MODERN APPROACHES IN THE CLINICAL AND ANALYTICAL ASSESSMENT OF NEUROPATHIES OBSERVED IN CHILDHOOD</title>
      <link>https://aams-journal.us/journals/neurology/articles/73c57982-8687-48fa-9434-ce1e66179d2a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/73c57982-8687-48fa-9434-ce1e66179d2a</guid>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <author>G’AYBIYEV A.A.¹</author>
      <description>Childhood neuropathies constitute a heterogeneous group of neurological disorders affecting peripheral nerves and resulting in sensory, motor, and autonomic dysfunction. Early diagnosis remains challenging due to the diversity of clinical manifestations, age-related developmental characteristics, and the complexity of underlying etiological factors. Advances in pediatric neurology, neurophysiology, molecular diagnostics, and laboratory medicine have significantly improved the ability to detect and characterize neuropathic conditions during childhood. The present study examines modern clinical and analytical approaches used in the assessment of pediatric neuropathies and evaluates their diagnostic value in identifying disease severity and progression. Comprehensive neurological examination, electrophysiological testing, biochemical analysis, genetic investigations, and neuroimaging techniques were integrated into the diagnostic process. The findings indicate that multidisciplinary assessment strategies improve diagnostic accuracy, facilitate early intervention, and contribute to better long-term neurological outcomes. Modern analytical technologies allow identification of neuropathic disorders at earlier stages and support individualized treatment planning. The study emphasizes the importance of combining clinical expertise with advanced diagnostic methods in the evaluation of childhood neuropathies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780974985744-MODERN_APPROACHES_IN_THE_CLINICAL_AND_ANALYTICAL_A.pdf" type="application/pdf" length="0"/>
      <dc:creator>G’AYBIYEV A.A.¹</dc:creator>
      <dc:creator>KULMATOVA N.²</dc:creator>
      <dc:subject>childhood neuropathy</dc:subject>
      <dc:subject>pediatric neurology</dc:subject>
      <dc:subject>peripheral nervous system</dc:subject>
      <dc:subject>electrophysiology</dc:subject>
      <dc:subject>nerve conduction studies</dc:subject>
      <dc:subject>genetic diagnostics</dc:subject>
      <dc:subject>neurophysiology</dc:subject>
      <dc:subject>clinical assessment</dc:subject>
      <dc:subject>neurological disorders</dc:subject>
      <dc:subject>pediatric healthcare.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 06, pp. 16-30</dc:source>
    </item>
    <item>
      <title>COMPARATIVE ANALYSIS OF CLINICAL, NEUROSONOGRAPHIC AND TOMOGRAPHIC DATA IN CSF DYNAMIC DISORDERS IN CHILDREN</title>
      <link>https://aams-journal.us/journals/neurology/articles/ab94953f-04c0-408c-910d-c9d7ea0090e5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/ab94953f-04c0-408c-910d-c9d7ea0090e5</guid>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <author>Ergashev Sukhrob¹</author>
      <description>Cerebrospinal fluid (CSF) dynamic disorders are among the most important neurological conditions encountered in pediatric practice and may significantly influence brain development, neurological function, and long-term quality of life. Accurate diagnosis requires integration of clinical findings with modern neuroimaging techniques capable of assessing structural and functional alterations within the central nervous system. The present study aimed to perform a comparative analysis of clinical manifestations, neurosonographic findings, and tomographic characteristics in children diagnosed with CSF dynamic disorders. A total of 110 pediatric patients with suspected disturbances of cerebrospinal fluid circulation were examined using neurological assessment, neurosonography, computed tomography, and magnetic resonance imaging. Comparative evaluation demonstrated significant correlations between clinical severity and neuroimaging abnormalities. Neurosonography proved highly valuable for early screening and monitoring in infants, whereas tomographic methods provided detailed visualization of ventricular enlargement, intracranial pressure-related changes, and associated structural abnormalities. The findings support the use of a comprehensive diagnostic approach combining clinical examination and modern imaging technologies to improve diagnostic accuracy and optimize management strategies for pediatric patients with CSF circulation disorders.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780975335062-COMPARATIVE_ANALYSIS_OF_CLINICAL__NEUROSONOGRAPHIC.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ergashev Sukhrob¹</dc:creator>
      <dc:creator>Ibragimova Shakhzoda²</dc:creator>
      <dc:subject>cerebrospinal fluid</dc:subject>
      <dc:subject>CSF dynamics</dc:subject>
      <dc:subject>hydrocephalus</dc:subject>
      <dc:subject>neurosonography</dc:subject>
      <dc:subject>magnetic resonance imaging</dc:subject>
      <dc:subject>computed tomography</dc:subject>
      <dc:subject>pediatric neurology</dc:subject>
      <dc:subject>intracranial pressure</dc:subject>
      <dc:subject>ventricular system</dc:subject>
      <dc:subject>neuroimaging.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLINICAL-NEUROLOGICAL AND INSTRUMENTAL ASSESSMENT OF THE INFLUENCE OF CARBOHYDRATE METABOLISM ON THE COURSE OF DIABETIC NEUROPATHY</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/5e916dc0-5275-49eb-b837-39534f997ae0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/5e916dc0-5275-49eb-b837-39534f997ae0</guid>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <author>Eshimova Shokhsanam¹</author>
      <description>Diabetic neuropathy is one of the most common and disabling chronic complications of diabetes mellitus, significantly affecting patients’ quality of life and functional capacity. Disturbances in carbohydrate metabolism play a crucial role in the development and progression of peripheral nerve damage through complex metabolic, vascular, and inflammatory mechanisms. The present study aimed to evaluate the influence of carbohydrate metabolism on the clinical course of diabetic neuropathy using neurological examination and instrumental diagnostic methods. A total of 150 patients with diabetes mellitus and varying degrees of neuropathic manifestations were examined. Clinical assessment included neurological evaluation of sensory, motor, and autonomic functions, while instrumental investigations involved electroneuromyography, quantitative sensory testing, and laboratory analysis of glycemic parameters. The results demonstrated a significant association between poor glycemic control and increased severity of neuropathic symptoms, nerve conduction abnormalities, and functional impairment. Patients with prolonged hyperglycemia exhibited more pronounced neurological deficits and structural nerve dysfunction. The findings emphasize the importance of strict metabolic control in preventing progression of diabetic neuropathy and improving neurological outcomes. Comprehensive clinical and instrumental evaluation provides valuable information for early diagnosis, monitoring, and individualized management of diabetic neuropathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780974646340-CLINICAL_NEUROLOGICAL_AND_INSTRUMENTAL_ASSESSMENT_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Eshimova Shokhsanam¹</dc:creator>
      <dc:creator>Abdukakhkharova Rukhshona²</dc:creator>
      <dc:subject>diabetic neuropathy</dc:subject>
      <dc:subject>carbohydrate metabolism</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>hyperglycemia</dc:subject>
      <dc:subject>nerve conduction</dc:subject>
      <dc:subject>neurological assessment</dc:subject>
      <dc:subject>electroneuromyography</dc:subject>
      <dc:subject>peripheral neuropathy</dc:subject>
      <dc:subject>glycemic control</dc:subject>
      <dc:subject>diabetic complications.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 16-30</dc:source>
    </item>
    <item>
      <title>CLASSIFICATION, PHYSICOCHEMICAL PROPERTIES, AND CLINICAL PERFORMANCE OF FILLED POLYMER RESTORATIVE MATERIALS IN CONTEMPORARY ANTERIOR TOOTH RESTORATION</title>
      <link>https://aams-journal.us/journals/surgery/articles/6816ae40-b207-4ff7-9542-3e25b405f477</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/6816ae40-b207-4ff7-9542-3e25b405f477</guid>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <author>Sodikova Shoira Amriddinovna¹</author>
      <description>Filled polymer restorative materials have become indispensable in contemporary esthetic dentistry due to their ability to reproduce the natural appearance, function, and structural integrity of anterior teeth. The increasing demand for minimally invasive treatment and highly esthetic restorations has accelerated the development of advanced composite materials with improved physicochemical and mechanical characteristics. Modern filled polymer restorative systems combine organic resin matrices with inorganic filler particles, producing materials that exhibit excellent optical properties, enhanced strength, improved wear resistance, and superior adhesive performance. Anterior teeth require restorative materials capable of mimicking natural translucency, fluorescence, opalescence, and color stability while maintaining long-term durability under functional and environmental challenges. Various categories of composite materials, including microfilled, hybrid, microhybrid, nanofilled, nanohybrid, flowable, and bulk-fill composites, have been developed to satisfy specific clinical requirements. Advances in nanotechnology, filler engineering, and polymer chemistry have significantly improved restoration longevity and esthetic outcomes. Clinical evidence demonstrates high survival rates and patient satisfaction when appropriate materials and adhesive protocols are utilized. This review evaluates the classification, physicochemical characteristics, and clinical effectiveness of filled polymer restorative materials in anterior tooth restoration, emphasizing their role in achieving predictable functional and esthetic rehabilitation.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780555884346-CLASSIFICATION__PHYSICOCHEMICAL_PROPERTIES__AND_CL.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sodikova Shoira Amriddinovna¹</dc:creator>
      <dc:creator>Norqulov Olloyorjon²</dc:creator>
      <dc:creator>Toʻychiboyeva Gulsevar²</dc:creator>
      <dc:creator>Zokirov Samandar²</dc:creator>
      <dc:subject>Filled polymer restorative materials</dc:subject>
      <dc:subject>anterior restorations</dc:subject>
      <dc:subject>composite resins</dc:subject>
      <dc:subject>nanohybrid composites</dc:subject>
      <dc:subject>esthetic dentistry</dc:subject>
      <dc:subject>physicochemical properties</dc:subject>
      <dc:subject>adhesive dentistry</dc:subject>
      <dc:subject>dental biomaterials</dc:subject>
      <dc:subject>color stability</dc:subject>
      <dc:subject>restorative materials.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 16-30</dc:source>
    </item>
    <item>
      <title>IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE FOLLOWING MICROPULSE TRANSSCLERAL CYCLOPHOTOCOAGULATION IN NEOVASCULAR GLAUCOMA: A RETROSPECTIVE ANALYSIS</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/05d38064-489f-4c42-a22a-5257e0a8e7a0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/05d38064-489f-4c42-a22a-5257e0a8e7a0</guid>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <author>Boboev Siyovush Saidavzalzoda¹</author>
      <description>Neovascular glaucoma (NVG) is one of the most severe and prognostically unfavorable variants of secondary glaucoma, characterized by persistent elevation of intraocular pressure (IOP), progressive deterioration of visual function, and a pronounced negative impact on patients’ quality of life. The condition arises from pathological neovascularization of the iris and the anterior chamber angle, leading to fibrovascular membrane formation and obstruction of aqueous humor outflow, rendering IOP resistant to conventional therapy. NVG is most commonly associated with proliferative diabetic retinopathy and ischemic central retinal vein occlusion, which provoke retinal ischemia, activation of vascular endothelial growth factor (VEGF), and aberrant anterior-segment angiogenesis. Given that NVG impairs not only visual function but also emotional well-being, social activity, and independence, treatment evaluation must incorporate quality-of-life assessment. The present study examines changes in quality of life before and after micropulse transscleral cyclophotocoagulation (MTSCPC) using the validated NEI VFQ-25 questionnaire, demonstrating that MTSCPC yields statistically significant improvements across all measured domains.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780547520251-IMPROVEMENT_OF_HEALTH_RELATED_QUALITY_OF_LIFE_FOLL.pdf" type="application/pdf" length="0"/>
      <dc:creator>Boboev Siyovush Saidavzalzoda¹</dc:creator>
      <dc:creator>Toshtemirova Zukhra Maruf kizi²</dc:creator>
      <dc:subject>neovascular glaucoma</dc:subject>
      <dc:subject>secondary glaucoma</dc:subject>
      <dc:subject>micropulse transscleral cyclophotocoagulation</dc:subject>
      <dc:subject>intraocular pressure</dc:subject>
      <dc:subject>quality of life</dc:subject>
      <dc:subject>visual function</dc:subject>
      <dc:subject>psychoemotional status</dc:subject>
      <dc:subject>social functioning</dc:subject>
      <dc:subject>NEI VFQ-25</dc:subject>
      <dc:subject>laser treatment</dc:subject>
      <dc:subject>retinal ischemia</dc:subject>
      <dc:subject>neovascularization.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>IMPACT OF MICROPULSE TRANSSCLERAL CYCLOPHOTOCOAGULATION ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEOVASCULAR GLAUCOMA: A RETROSPECTIVE OBSERVATIONAL STUDY</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/52efd7f1-49dd-4b9d-8d39-67cd196d507a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/52efd7f1-49dd-4b9d-8d39-67cd196d507a</guid>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <author>Boboev Siyovush Saidavzalzoda¹</author>
      <description>Background: Neovascular glaucoma (NVG) constitutes one of the most clinically formidable and prognostically adverse subtypes of secondary glaucoma, hallmarked by pharmacologically intractable intraocular pressure (IOP) elevation, inexorable deterioration of visual function, and profound degradation of patients’ health-related quality of life (HRQoL). Its pathophysiological substrate resides in the ischaemia-driven upregulation of vascular endothelial growth factor (VEGF) and cognate proangiogenic cytokines, which orchestrate aberrant neovascularisation across the iris stroma and iridocorneal angle, culminating in fibrovascular membrane elaboration and mechanically obstructed aqueous humour egress. 
Objective: To rigorously characterise the magnitude and domain-specific distribution of HRQoL changes attributable to micropulse transscleral cyclophotocoagulation (MTSCPC) in a cohort of NVG patients, employing the psychometrically validated National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25). 
Methods: A structured retrospective observational study was conducted among 30 patients with confirmed NVG diagnoses. Comprehensive ophthalmological assessment and NEI VFQ-25 administration were performed at baseline and upon completion of the postoperative surveillance interval. 
Results: MTSCPC produced a statistically significant elevation of the composite NEI VFQ-25 score from 45.2 ± 8.7 to 68.4 ± 9.3 points (p &lt; 0.001), with concordant improvements across all domain subscales, including visual function, psychoemotional equilibrium, daily activity performance, social functioning, and overall visual satisfaction. 
Conclusion: MTSCPC exerts a pluridimensional beneficial effect on HRQoL in NVG patients, supporting its incorporation as a standard-of-care component in advanced glaucoma management protocols.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780547019807-IMPACT_OF_MICROPULSE_TRANSSCLERAL_CYCLOPHOTOCOAGUL.pdf" type="application/pdf" length="0"/>
      <dc:creator>Boboev Siyovush Saidavzalzoda¹</dc:creator>
      <dc:creator>Toshtemirova Zukhra Maruf kizi²</dc:creator>
      <dc:subject>neovascular glaucoma; micropulse transscleral cyclophotocoagulation; intraocular pressure; health-related quality of life; NEI VFQ-25; vascular endothelial growth factor; retinal ischaemia; fibrovascular membrane; visual function; psychoemotional status; social functioning; secondary glaucoma.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>COMPARATIVE ANALYSIS OF THE RESULTS OF VARIOUS TOOTH-PRESERVING SURGICAL METHODS IN THE COMPLEX TREATMENT OF FOCAL PERIODONTAL LESIONS</title>
      <link>https://aams-journal.us/journals/dentistry/articles/636200c3-6b61-416e-9217-05375123d350</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/636200c3-6b61-416e-9217-05375123d350</guid>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <author>Iskhakova Z.¹</author>
      <description>Focal periodontal lesions represent a significant challenge in contemporary periodontology because they involve localized destruction of periodontal tissues, progressive alveolar bone loss, formation of periodontal pockets, and eventual compromise of tooth stability. Preservation of natural dentition remains a primary objective of modern dental treatment, making tooth-preserving surgical interventions an essential component of comprehensive periodontal therapy. Various surgical approaches have been developed to eliminate infection, regenerate lost periodontal structures, improve attachment levels, and restore functional integrity. These include open flap debridement, guided tissue regeneration, bone grafting procedures, regenerative periodontal surgery, root resection techniques, and minimally invasive microsurgical interventions. The effectiveness of these procedures depends on defect morphology, disease severity, patient-related factors, and postoperative maintenance. Recent advances in regenerative biomaterials, growth factors, and microsurgical techniques have significantly enhanced treatment outcomes. Comparative evaluation of different tooth-preserving methods is necessary for identifying optimal therapeutic strategies and improving long-term prognosis. This study analyzes the clinical effectiveness, regenerative potential, and functional outcomes of various tooth-preserving surgical approaches used in the complex management of focal periodontal lesions. The findings demonstrate that modern regenerative procedures achieve superior clinical attachment gain, greater bone fill, reduced pocket depth, and improved long-term tooth retention compared with conventional surgical techniques.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780553941312-COMPARATIVE_ANALYSIS_OF_THE_RESULTS_OF_VARIOUS_TOO.pdf" type="application/pdf" length="0"/>
      <dc:creator>Iskhakova Z.¹</dc:creator>
      <dc:creator>Normuradov N.²</dc:creator>
      <dc:subject>Periodontal lesions</dc:subject>
      <dc:subject>tooth-preserving surgery</dc:subject>
      <dc:subject>periodontal regeneration</dc:subject>
      <dc:subject>guided tissue regeneration</dc:subject>
      <dc:subject>bone grafting</dc:subject>
      <dc:subject>clinical attachment level</dc:subject>
      <dc:subject>periodontal therapy</dc:subject>
      <dc:subject>regenerative surgery</dc:subject>
      <dc:subject>alveolar bone loss</dc:subject>
      <dc:subject>periodontal treatment.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>OPTIMIZATION OF THE ALGORITHM FOR SURGICAL TREATMENT OF FOCAL PERIODONTAL LESIONS BASED ON THE USE OF MODERN TOOTH-PRESERVING TECHNOLOGIES</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/2ca9b881-03b7-41a7-8109-9f794944e1fb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/2ca9b881-03b7-41a7-8109-9f794944e1fb</guid>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <author>Iskhakova Z.¹</author>
      <description>Focal periodontal lesions remain one of the most complex challenges in contemporary periodontal practice due to their multifactorial etiology, progressive tissue destruction, and potential to compromise long-term tooth survival. Preservation of natural dentition has become a fundamental principle of modern dentistry, leading to the development of innovative surgical approaches aimed at restoring periodontal structures while minimizing tissue trauma. The optimization of treatment algorithms based on modern tooth-preserving technologies is essential for improving clinical outcomes and ensuring long-term periodontal stability. Contemporary surgical management incorporates advanced diagnostic methods, regenerative procedures, minimally invasive surgical techniques, biological mediators, guided tissue regeneration, bone grafting materials, enamel matrix derivatives, and microsurgical interventions. These technologies enable clinicians to achieve greater clinical attachment gain, enhanced bone regeneration, improved wound healing, and superior functional outcomes compared with traditional treatment protocols. The integration of individualized treatment planning and evidence-based therapeutic decision-making further contributes to successful management of localized periodontal destruction. This study evaluates the effectiveness of optimized surgical algorithms utilizing modern tooth-preserving technologies and analyzes their impact on periodontal regeneration, tissue preservation, treatment predictability, and long-term tooth retention. The findings support the implementation of comprehensive regenerative approaches as the most effective strategy for managing focal periodontal lesions and preserving natural dentition.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780554246885-OPTIMIZATION_OF_THE_ALGORITHM_FOR_SURGICAL_TREATME.pdf" type="application/pdf" length="0"/>
      <dc:creator>Iskhakova Z.¹</dc:creator>
      <dc:creator>Normuradov N.²</dc:creator>
      <dc:subject>Focal periodontal lesions</dc:subject>
      <dc:subject>tooth-preserving surgery</dc:subject>
      <dc:subject>periodontal regeneration</dc:subject>
      <dc:subject>guided tissue regeneration</dc:subject>
      <dc:subject>minimally invasive surgery</dc:subject>
      <dc:subject>periodontal algorithm</dc:subject>
      <dc:subject>bone grafting</dc:subject>
      <dc:subject>regenerative therapy</dc:subject>
      <dc:subject>periodontal treatment</dc:subject>
      <dc:subject>clinical attachment.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLASSIFICATION, MECHANICAL CHARACTERISTICS, AND CLINICAL EFFECTIVENESS OF FILLED POLYMER RESTORATIVE MATERIALS IN POSTERIOR TOOTH RESTORATION</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/e4ca31ed-8bac-4663-8347-2775b5c1f3a8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/e4ca31ed-8bac-4663-8347-2775b5c1f3a8</guid>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <author>Sodikova Shoira Amriddinovna¹; Saidazimova Azizaxon²; Tursunbayev Ozodbek²; Gulyamuxammedova Shaxinbonu²</author>
      <description>Filled polymer restorative materials have become the cornerstone of modern restorative dentistry due to their excellent esthetic properties, adhesive capabilities, and continuously improving mechanical performance. Posterior teeth are exposed to significant masticatory forces, thermal fluctuations, and mechanical stress, creating demanding conditions for restorative materials. The development of filled polymer composites has revolutionized posterior tooth restoration by providing materials capable of restoring function while preserving natural tooth structure and maintaining esthetic appearance. Advances in filler technology, resin matrix composition, polymerization chemistry, and nanotechnology have significantly enhanced the strength, wear resistance, fracture toughness, and longevity of these materials. Contemporary restorative systems include microfilled, hybrid, microhybrid, nanohybrid, nanofilled, bulk-fill, and fiber-reinforced composites, each possessing distinct mechanical and clinical characteristics. Material selection depends on cavity size, occlusal load, esthetic requirements, and long-term functional expectations. Understanding the classification and performance of filled polymer restorative materials is essential for achieving predictable clinical outcomes. This review evaluates current classifications, mechanical properties, and clinical effectiveness of filled polymer restoratives used in posterior tooth rehabilitation, emphasizing recent developments that contribute to improved durability, patient satisfaction, and restoration longevity.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780554649420-CLASSIFICATION__MECHANICAL_CHARACTERISTICS__AND_CL.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sodikova Shoira Amriddinovna¹; Saidazimova Azizaxon²; Tursunbayev Ozodbek²; Gulyamuxammedova Shaxinbonu²</dc:creator>
      <dc:subject>Filled polymer restorative materials</dc:subject>
      <dc:subject>composite resins</dc:subject>
      <dc:subject>posterior restorations</dc:subject>
      <dc:subject>nanohybrid composites</dc:subject>
      <dc:subject>bulk-fill composites</dc:subject>
      <dc:subject>mechanical properties</dc:subject>
      <dc:subject>wear resistance</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>polymer matrix</dc:subject>
      <dc:subject>dental biomaterials.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Evaluation of Occlusal Stability in Patients after Prosthodontic Rehabilitation</title>
      <link>https://aams-journal.us/journals/surgery/articles/3cebb446-9154-4486-ade7-afbe61e2fafa</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/3cebb446-9154-4486-ade7-afbe61e2fafa</guid>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <author>Zikirova Hulkar Alisher kizi¹</author>
      <description>Occlusal stability is a fundamental determinant of long-term success in prosthodontic rehabilitation. Proper occlusal relationships contribute to functional efficiency, preservation of oral structures, patient comfort, and overall treatment predictability. Disturbances in occlusal balance following prosthetic treatment may result in masticatory dysfunction, temporomandibular joint disorders, excessive tooth wear, and prosthetic complications. This study aimed to evaluate occlusal stability in patients following prosthodontic rehabilitation and to assess factors influencing functional adaptation and treatment outcomes. A total of 130 patients who underwent fixed, removable, or implant-supported prosthetic rehabilitation were clinically examined over a twelve-month observation period. Occlusal contacts, mandibular movements, masticatory efficiency, patient satisfaction, and prosthetic integrity were assessed using contemporary diagnostic methods. The findings demonstrated that well-planned prosthodontic treatment significantly improved occlusal harmony and functional performance. Most patients achieved satisfactory adaptation and maintained stable occlusal relationships throughout the follow-up period. The results emphasize the importance of comprehensive occlusal evaluation during prosthetic treatment planning and post-treatment monitoring. Long-term occlusal stability remains a key factor in achieving successful prosthodontic rehabilitation and preserving oral health.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780551646019-Evaluation_of_Occlusal_Stability_in_Patients_after.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zikirova Hulkar Alisher kizi¹</dc:creator>
      <dc:creator>Inogamov Sherzod Muxamatisakovich²</dc:creator>
      <dc:subject>occlusal stability</dc:subject>
      <dc:subject>prosthodontic rehabilitation</dc:subject>
      <dc:subject>occlusion</dc:subject>
      <dc:subject>masticatory function</dc:subject>
      <dc:subject>prosthetic dentistry</dc:subject>
      <dc:subject>implant-supported prostheses</dc:subject>
      <dc:subject>temporomandibular joint</dc:subject>
      <dc:subject>oral rehabilitation</dc:subject>
      <dc:subject>dental prosthesis</dc:subject>
      <dc:subject>treatment outcomes.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>NEUROPLASTICITY AND FUNCTIONAL RECOVERY AFTER ISCHEMIC STROKE: CURRENT PERSPECTIVES AND REHABILITATION STRATEGIES</title>
      <link>https://aams-journal.us/journals/neurology/articles/f89f694a-1397-49ae-830c-938fd54ee31a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/f89f694a-1397-49ae-830c-938fd54ee31a</guid>
      <pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate>
      <author>Jo&apos;rayev Ulug&apos;bek¹</author>
      <description>Ischemic stroke remains one of the leading causes of long-term disability and mortality worldwide, imposing substantial medical, social, and economic burdens on patients, families, and healthcare systems. Functional recovery following ischemic stroke is largely dependent on neuroplasticity, a dynamic biological process that enables the nervous system to reorganize its structure, function, and neural connections in response to injury. Advances in neuroscience have significantly expanded understanding of post-stroke neuroplastic mechanisms, including synaptic remodeling, axonal sprouting, cortical reorganization, neurogenesis, and adaptive changes within distributed neural networks. These biological processes provide the foundation for recovery of motor, sensory, cognitive, language, and behavioral functions following cerebral ischemia. Modern rehabilitation strategies increasingly focus on enhancing neuroplastic potential through intensive, task-specific, and multidisciplinary interventions. Physical therapy, occupational therapy, speech-language rehabilitation, robotic-assisted treatment, virtual reality technologies, neuromodulation techniques, and brain-computer interface systems have demonstrated promising effects on functional restoration. Early initiation of rehabilitation, individualized treatment planning, and integration of innovative therapeutic approaches contribute significantly to improved clinical outcomes. This review examines current perspectives regarding neuroplasticity after ischemic stroke and evaluates contemporary rehabilitation strategies aimed at maximizing neurological recovery and improving quality of life among stroke survivors.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780485665811-NEUROPLASTICITY_AND_FUNCTIONAL_RECOVERY_AFTER_ISCH.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jo&apos;rayev Ulug&apos;bek¹</dc:creator>
      <dc:creator>Taganklichev Serdar²</dc:creator>
      <dc:creator>Ravshanov Suhrob³</dc:creator>
      <dc:subject>Ischemic stroke</dc:subject>
      <dc:subject>neuroplasticity</dc:subject>
      <dc:subject>functional recovery</dc:subject>
      <dc:subject>stroke rehabilitation</dc:subject>
      <dc:subject>cortical reorganization</dc:subject>
      <dc:subject>neurogenesis</dc:subject>
      <dc:subject>motor recovery</dc:subject>
      <dc:subject>neuromodulation</dc:subject>
      <dc:subject>brain-computer interface</dc:subject>
      <dc:subject>neurological rehabilitation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Digital Technologies in Prosthodontics: Clinical Applications and Treatment Outcomes</title>
      <link>https://aams-journal.us/journals/surgery/articles/fadc7bd9-6df5-451a-b4b5-9adee424da3b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/fadc7bd9-6df5-451a-b4b5-9adee424da3b</guid>
      <pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate>
      <author>Khurramov Suhrobjon¹</author>
      <description>The rapid development of digital technologies has transformed modern prosthodontics by improving diagnostic accuracy, treatment planning, fabrication processes, and clinical outcomes. Digital dentistry integrates computer-aided design and computer-aided manufacturing (CAD/CAM), intraoral scanning, three-dimensional imaging, artificial intelligence, and additive manufacturing techniques into routine prosthodontic practice. These technologies facilitate highly precise restorations while reducing treatment time and enhancing patient comfort. The present study aimed to evaluate the clinical applications of digital technologies in prosthodontics and assess their influence on treatment outcomes. A total of 118 patients requiring prosthetic rehabilitation participated in the investigation. Digital workflows involving intraoral scanning, virtual treatment planning, CAD/CAM fabrication, and three-dimensional printing were utilized according to individual clinical indications. Clinical evaluation included assessment of restoration accuracy, treatment duration, patient satisfaction, marginal adaptation, occlusal stability, and prosthesis longevity. The findings demonstrated that digital technologies significantly improved clinical efficiency, reduced procedural errors, enhanced communication between clinicians and dental laboratories, and increased patient acceptance. Restorations produced through digital workflows exhibited excellent functional performance and favorable aesthetic outcomes. The study confirms that digital technologies represent an essential component of contemporary prosthodontics and contribute substantially to the optimization of patient-centered dental care.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780505122025-Digital_Technologies_in_Prosthodontics__Clinical_A.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khurramov Suhrobjon¹</dc:creator>
      <dc:creator>Akhmedov Alisher²</dc:creator>
      <dc:subject>digital prosthodontics</dc:subject>
      <dc:subject>CAD/CAM</dc:subject>
      <dc:subject>intraoral scanning</dc:subject>
      <dc:subject>digital dentistry</dc:subject>
      <dc:subject>three-dimensional printing</dc:subject>
      <dc:subject>prosthetic rehabilitation</dc:subject>
      <dc:subject>virtual treatment planning</dc:subject>
      <dc:subject>dental technology</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>clinical outcomes.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Modern Approaches in Prosthodontics: Innovations, Clinical Applications, and Future Perspectives</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/738e39e0-7895-49a5-9a28-e3708b0908d4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/738e39e0-7895-49a5-9a28-e3708b0908d4</guid>
      <pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate>
      <author>Kholbekov Shakhboz¹</author>
      <description>Prosthodontics has undergone substantial transformation over recent decades due to rapid technological advancements, improvements in biomaterials, and the integration of digital workflows into clinical practice. Modern prosthodontic treatment extends beyond the replacement of missing teeth and now focuses on achieving optimal functional, aesthetic, biological, and psychological outcomes. Innovations such as computer-aided design and manufacturing (CAD/CAM), intraoral scanning, artificial intelligence, three-dimensional printing, digital smile design, and implant-supported rehabilitation have significantly enhanced treatment precision and predictability. The aim of this study was to analyze contemporary approaches in prosthodontics, evaluate their clinical applications, and explore future directions for prosthetic rehabilitation. Clinical observations were conducted among patients receiving treatment through modern prosthodontic protocols utilizing digital and conventional techniques. Parameters including restoration accuracy, treatment efficiency, patient satisfaction, functional outcomes, and long-term stability were assessed. The findings demonstrated that modern technologies contribute to improved restoration quality, reduced treatment time, enhanced communication between clinicians and laboratories, and greater patient acceptance. Emerging innovations continue to expand therapeutic possibilities and support individualized treatment planning. The study confirms that integration of advanced technologies and evidence-based clinical approaches represents the future of prosthodontic practice.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780505501515-Modern_Approaches_in_Prosthodontics__Innovations__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kholbekov Shakhboz¹</dc:creator>
      <dc:creator>Khojimurodov Burkhon²</dc:creator>
      <dc:subject>prosthodontics</dc:subject>
      <dc:subject>digital dentistry</dc:subject>
      <dc:subject>CAD/CAM</dc:subject>
      <dc:subject>dental implants</dc:subject>
      <dc:subject>three-dimensional printing</dc:subject>
      <dc:subject>artificial intelligence</dc:subject>
      <dc:subject>prosthetic rehabilitation</dc:subject>
      <dc:subject>digital workflow</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>personalized treatment.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>THE IMPACT OF POLYCYSTIC OVARY SYNDROME ON REPRODUCTIVE, METABOLIC, AND ENDOCRINE HEALTH IN WOMEN</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/b055e7ff-7e8e-49a9-b555-1e8b5e15aed7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/b055e7ff-7e8e-49a9-b555-1e8b5e15aed7</guid>
      <pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate>
      <author>Qurbontosheva Zarnigor</author>
      <description>Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age and represents a major public health concern due to its complex clinical manifestations and long-term health consequences. The syndrome is characterized by a combination of hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, although clinical presentation varies considerably among affected individuals. Beyond its reproductive implications, PCOS is increasingly recognized as a multifactorial metabolic and endocrine condition associated with insulin resistance, obesity, dyslipidemia, impaired glucose tolerance, type 2 diabetes mellitus, cardiovascular risk factors, and psychological disturbances. The disorder significantly impacts fertility, menstrual regularity, hormonal balance, and overall quality of life. Recent advances in endocrinology have improved understanding of the molecular and physiological mechanisms underlying PCOS, highlighting the roles of genetic susceptibility, insulin signaling abnormalities, chronic low-grade inflammation, and neuroendocrine dysfunction. Early diagnosis and comprehensive management are essential for preventing long-term complications and improving reproductive outcomes. Contemporary therapeutic strategies include lifestyle modification, pharmacological interventions, fertility treatments, metabolic risk reduction, and individualized endocrine management. This review examines the effects of PCOS on reproductive, metabolic, and endocrine health, emphasizing current perspectives on pathophysiology, diagnosis, and evidence-based treatment approaches.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780448853918-THE_IMPACT_OF_POLYCYSTIC_OVARY_SYNDROME_ON_REPRODU.pdf" type="application/pdf" length="0"/>
      <dc:creator>Qurbontosheva Zarnigor</dc:creator>
      <dc:subject>Polycystic Ovary Syndrome</dc:subject>
      <dc:subject>PCOS</dc:subject>
      <dc:subject>hyperandrogenism</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>endocrine disorders</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>ovarian dysfunction</dc:subject>
      <dc:subject>women&apos;s health.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 121-135</dc:source>
    </item>
    <item>
      <title>Evaluation of Aesthetic and Functional Outcomes of Full-Ceramic Restorations in Prosthetic Dentistry</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/29898935-66aa-416c-9f8c-c0346575983a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/29898935-66aa-416c-9f8c-c0346575983a</guid>
      <pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate>
      <author>Sheraliyev Firdavs¹</author>
      <description>The growing demand for highly aesthetic and biologically compatible dental restorations has significantly increased the use of full-ceramic materials in contemporary prosthetic dentistry. Full-ceramic restorations are recognized for their superior optical properties, excellent tissue compatibility, and ability to mimic natural tooth structures. This study aimed to evaluate the aesthetic and functional outcomes of full-ceramic restorations in patients undergoing prosthetic treatment. A total of 120 patients requiring fixed prosthetic rehabilitation were examined and treated with full-ceramic crowns and bridges fabricated using modern CAD/CAM technology. Clinical evaluation included assessment of marginal adaptation, color stability, periodontal tissue response, occlusal function, patient satisfaction, and restoration durability. Follow-up examinations were performed at six and twelve months after prosthetic placement. The results demonstrated high levels of aesthetic satisfaction, excellent integration with surrounding oral tissues, and favorable functional performance. Minimal complications were observed during the observation period, and most patients reported significant improvement in chewing efficiency, speech comfort, and self-confidence. The findings indicate that full-ceramic restorations represent an effective and predictable treatment option capable of providing long-term functional stability and natural esthetic outcomes. The study supports the increasing role of ceramic-based prosthetic rehabilitation in modern restorative dentistry and highlights its contribution to improving oral health and quality of life.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780502856021-Evaluation_of_Aesthetic_and_Functional_Outcomes_of.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sheraliyev Firdavs¹</dc:creator>
      <dc:creator>Islamova Nilufar²</dc:creator>
      <dc:subject>full-ceramic restorations</dc:subject>
      <dc:subject>prosthetic dentistry</dc:subject>
      <dc:subject>dental ceramics</dc:subject>
      <dc:subject>aesthetics</dc:subject>
      <dc:subject>CAD/CAM technology</dc:subject>
      <dc:subject>fixed prostheses</dc:subject>
      <dc:subject>biocompatibility</dc:subject>
      <dc:subject>oral rehabilitation</dc:subject>
      <dc:subject>patient satisfaction</dc:subject>
      <dc:subject>restorative dentistry.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103./aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MIGRAINE: CURRENT UNDERSTANDINGS AND MODERN TREATMENT APPROACHES</title>
      <link>https://aams-journal.us/journals/neurology/articles/d51fd6ed-84e5-431b-9523-ed67adea2c5b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/d51fd6ed-84e5-431b-9523-ed67adea2c5b</guid>
      <pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate>
      <author>Mir Owais Anjum¹</author>
      <description>Migraine is a prevalent and disabling neurological disorder characterized by recurrent episodes of moderate to severe headache accompanied by a variety of neurological, gastrointestinal, and autonomic symptoms. It affects individuals of all ages and significantly impairs quality of life, work productivity, and social functioning. Recent advances in neuroscience have substantially improved understanding of migraine pathophysiology, revealing the involvement of complex neurovascular mechanisms, cortical spreading depolarization, trigeminovascular activation, neurogenic inflammation, and altered pain processing pathways within the central nervous system. These discoveries have transformed migraine from a condition previously considered primarily vascular in origin into a multifaceted neurological disease involving genetic, environmental, and biochemical factors. Modern diagnostic approaches emphasize clinical evaluation supported by international classification criteria and advanced neuroimaging techniques when necessary. Therapeutic strategies have evolved considerably with the introduction of targeted treatments including calcitonin gene-related peptide (CGRP) antagonists, monoclonal antibodies, neuromodulation devices, and personalized preventive interventions. Traditional pharmacological therapies continue to play an important role, while emerging treatment modalities provide new opportunities for patients with refractory disease. This review examines current concepts regarding migraine pathogenesis, diagnostic evaluation, clinical manifestations, and contemporary therapeutic approaches, highlighting recent developments that contribute to improved disease management and patient outcomes. Migraine is a chronic neurobiological disorder characterized by recurrent attacks of headache and a broad spectrum of neurological, sensory, autonomic, and systemic manifestations. It affects hundreds of millions of individuals worldwide and represents one of the leading causes of disability among people of working age. Contemporary scientific evidence demonstrates that migraine is not merely a vascular headache syndrome but rather a complex disorder involving dysfunction of neuronal networks, genetic predisposition, altered sensory processing, neuroinflammatory reactions, and abnormal activation of pain pathways within the central nervous system. Significant progress in neuroimaging, molecular biology, and headache research has enhanced understanding of the mechanisms responsible for migraine initiation and progression. Activation of the trigeminovascular system, release of calcitonin gene-related peptide, cortical spreading depolarization, central sensitization, and disturbances in neurotransmitter regulation have emerged as key factors contributing to symptom development. These discoveries have transformed therapeutic strategies and enabled the development of targeted biological treatments capable of addressing specific disease mechanisms. Modern management incorporates acute pharmacological interventions, preventive therapies, monoclonal antibodies, neuromodulation technologies, lifestyle optimization, and individualized treatment planning. Early recognition and appropriate management are essential for reducing disease burden, preventing chronic progression, and improving quality of life. Continued investigation of migraine biology remains crucial for the development of more effective diagnostic tools and therapeutic approaches capable of providing long-term symptom control and functional recovery.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780481640480-MIGRAINE__CURRENT_UNDERSTANDINGS_AND_MODERN_TREATM.pdf" type="application/pdf" length="0"/>
      <dc:creator>Mir Owais Anjum¹</dc:creator>
      <dc:subject>Migraine</dc:subject>
      <dc:subject>headache disorders</dc:subject>
      <dc:subject>trigeminovascular system</dc:subject>
      <dc:subject>CGRP</dc:subject>
      <dc:subject>neuroinflammation</dc:subject>
      <dc:subject>cortical spreading depression</dc:subject>
      <dc:subject>migraine prevention</dc:subject>
      <dc:subject>monoclonal antibodies</dc:subject>
      <dc:subject>neuromodulation</dc:subject>
      <dc:subject>neurological disorders.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 06, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLASSIFICATION OF FILLING MATERIALS</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/bba0582d-2d39-4601-9473-cedf8658781c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/bba0582d-2d39-4601-9473-cedf8658781c</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Kholboeva Nasiba Asrorovna¹</author>
      <description>Filling materials represent one of the most important components of restorative dentistry and play a crucial role in the preservation of dental tissues, restoration of function, and improvement of esthetics. The continuous development of dental biomaterials has led to the introduction of numerous restorative systems with different physical, chemical, mechanical, and biological properties. Proper selection of filling materials is essential for achieving long-term clinical success and ensuring compatibility with oral tissues. Dental restorative materials are classified according to their composition, method of polymerization, clinical application, esthetic properties, and functional characteristics. Modern materials include amalgams, composite resins, glass ionomer cements, resin-modified glass ionomers, compomers, ceramics, and bioactive restorative materials. Each category possesses unique advantages and limitations that influence clinical performance and treatment outcomes. Advances in adhesive technology and biomaterial science have significantly improved the durability, biocompatibility, wear resistance, and esthetic quality of contemporary restorations. The present study reviews the classification of filling materials, their properties, clinical indications, advantages, disadvantages, and their role in modern restorative dentistry. Understanding the characteristics of various restorative materials enables clinicians to make evidence-based decisions and optimize patient care. Continuous innovation in dental material science is expected to further enhance restorative treatment effectiveness and contribute to the preservation of natural dentition. The classification of filling materials constitutes a fundamental aspect of restorative dentistry and serves as the basis for selecting appropriate materials capable of restoring lost dental tissues while maintaining biological compatibility, functional efficiency, and esthetic appearance. The rapid development of dental biomaterials has significantly expanded the range of restorative options available to clinicians, resulting in materials with diverse physical, chemical, mechanical, and therapeutic characteristics. Modern restorative systems are designed not only to replace damaged tooth structures but also to preserve healthy tissues, enhance adhesion, reduce microleakage, and contribute to long-term oral health. Various categories of filling materials have been developed to address specific clinical requirements, including metallic restoratives, resin-based composites, glass ionomer cements, hybrid materials, ceramics, and bioactive restorative systems. Each group exhibits unique properties that influence clinical performance, longevity, wear resistance, fluoride release, esthetics, and patient satisfaction. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780400065048-CLASSIFICATION_OF_FILLING_MATERIALS.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kholboeva Nasiba Asrorovna¹</dc:creator>
      <dc:creator>Absamatova Mokhlaroyim²</dc:creator>
      <dc:creator>Temirov Muhammad².</dc:creator>
      <dc:subject>Filling materials</dc:subject>
      <dc:subject>dental restorations</dc:subject>
      <dc:subject>composite resin</dc:subject>
      <dc:subject>amalgam</dc:subject>
      <dc:subject>glass ionomer cement</dc:subject>
      <dc:subject>compomer</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>dental biomaterials</dc:subject>
      <dc:subject>adhesive systems.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 106-120</dc:source>
    </item>
    <item>
      <title>ONCOLOGICAL DISEASES, THEIR PATHOLOGY AND CAUSES OF ORIGIN</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/d2ec239e-44aa-4db1-9dcb-cf95021cbae9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/d2ec239e-44aa-4db1-9dcb-cf95021cbae9</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Toshtemirova Khadicha¹</author>
      <description>Oncological diseases represent a diverse group of pathological conditions characterized by uncontrolled cellular proliferation, abnormal tissue growth, invasion of surrounding structures, and the potential for metastasis to distant organs. Cancer remains one of the leading causes of morbidity and mortality worldwide, posing substantial medical, social, and economic challenges. The development of malignant neoplasms is a complex multistep process involving genetic mutations, epigenetic alterations, dysregulation of cellular signaling pathways, impaired apoptosis, uncontrolled cell cycle progression, and interactions between tumor cells and the surrounding microenvironment. Numerous risk factors contribute to carcinogenesis, including hereditary predisposition, environmental exposures, lifestyle behaviors, infectious agents, hormonal influences, chronic inflammation, and occupational hazards. Advances in molecular biology and cancer pathology have significantly improved understanding of the mechanisms underlying tumor initiation, progression, angiogenesis, immune evasion, and metastatic dissemination. Contemporary diagnostic methods, including histopathological examination, molecular profiling, genomic sequencing, biomarker analysis, and advanced imaging techniques, facilitate earlier detection and more accurate classification of malignant diseases. Improved knowledge of cancer biology has also led to the development of targeted therapies, immunotherapeutic approaches, precision medicine strategies, and personalized treatment protocols. Despite substantial progress in prevention, diagnosis, and therapy, cancer continues to present a major global health burden. Comprehensive understanding of pathological mechanisms and etiological factors remains essential for developing effective preventive measures, improving therapeutic outcomes, and reducing cancer-related mortality. Therefore, investigation of oncological diseases and their underlying causes continues to be a priority within modern biomedical research and clinical medicine. Oncological diseases constitute a major category of non-communicable disorders characterized by progressive cellular abnormalities that result in uncontrolled tissue growth, destruction of normal anatomical structures, and dissemination of malignant cells throughout the body. These conditions remain among the leading causes of death worldwide and represent a substantial challenge for healthcare systems due to their biological complexity, increasing incidence, and significant socioeconomic impact. The development of cancer involves a prolonged sequence of molecular and cellular events that gradually transform normal cells into malignant populations capable of autonomous growth and resistance to physiological regulatory mechanisms. Numerous endogenous and exogenous factors contribute to this transformation, including inherited genetic alterations, environmental carcinogens, chronic inflammatory processes, hormonal influences, infectious agents, metabolic disturbances, and lifestyle-related exposures. Advances in molecular pathology have revealed that carcinogenesis is driven by accumulation of genetic mutations, epigenetic modifications, chromosomal instability, dysregulation of signaling pathways, and alterations within the tumor microenvironment. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780406992164-ONCOLOGICAL_DISEASES__THEIR_PATHOLOGY_AND_CAUSES_O.pdf" type="application/pdf" length="0"/>
      <dc:creator>Toshtemirova Khadicha¹</dc:creator>
      <dc:creator>Maydonov Mahsud²</dc:creator>
      <dc:subject>Cancer</dc:subject>
      <dc:subject>oncology</dc:subject>
      <dc:subject>carcinogenesis</dc:subject>
      <dc:subject>malignant neoplasm</dc:subject>
      <dc:subject>tumor pathology</dc:subject>
      <dc:subject>genetic mutations</dc:subject>
      <dc:subject>metastasis</dc:subject>
      <dc:subject>oncogenes</dc:subject>
      <dc:subject>tumor suppressor genes</dc:subject>
      <dc:subject>cancer risk factors</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1395</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>PREPARATION OF HARD DENTAL TISSUES</title>
      <link>https://aams-journal.us/journals/dentistry/articles/089cda80-e3aa-49c0-a777-b3f174e52791</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/089cda80-e3aa-49c0-a777-b3f174e52791</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Kholboeva Nasiba Asrorovna¹</author>
      <description>Preparation of hard dental tissues is a fundamental procedure in restorative, prosthetic, and aesthetic dentistry aimed at removing diseased tissue, creating optimal cavity geometry, and ensuring long-term success of dental restorations. The process involves controlled modification of enamel and dentin while preserving maximum healthy tooth structure and maintaining pulpal vitality. Advances in adhesive dentistry, rotary instrumentation, laser technology, air-abrasion systems, and minimally invasive treatment concepts have significantly transformed traditional preparation techniques. Contemporary approaches emphasize conservation of healthy tissues, enhancement of bonding effectiveness, reduction of patient discomfort, and improvement of restoration longevity. Proper preparation requires comprehensive understanding of tooth anatomy, histological characteristics of enamel and dentin, biomechanical principles, and restorative material properties. Factors such as cavity design, marginal integrity, retention form, resistance form, surface conditioning, and protection of the pulp-dentin complex play critical roles in clinical outcomes. Incorrect preparation may result in microleakage, postoperative sensitivity, restoration failure, secondary caries, and pulpal complications. Therefore, adherence to evidence-based preparation protocols is essential for achieving predictable therapeutic success. This study reviews the biological foundations, clinical principles, modern techniques, and practical considerations associated with preparation of hard dental tissues in contemporary dental practice. Preparation of hard dental tissues is a critical stage in restorative dentistry that directly influences the durability, functionality, and biological compatibility of dental restorations. Contemporary approaches to tooth preparation emphasize preservation of natural structures while ensuring complete elimination of pathological changes and creation of optimal conditions for restorative procedures. Hard dental tissues possess unique structural and mechanical properties that require careful consideration during clinical intervention. Enamel exhibits exceptional mineralization and resistance to wear, whereas dentin provides elasticity and shock absorption, making both tissues essential for maintaining tooth integrity. Advances in adhesive dentistry, rotary instrumentation, laser technologies, air-abrasion systems, and minimally invasive treatment concepts have transformed traditional preparation methods and reduced unnecessary removal of healthy tissues. Modern preparation protocols prioritize biological preservation, enhanced bonding performance, improved marginal adaptation, and long-term restoration stability. Numerous clinical studies have demonstrated that conservative preparation techniques contribute to greater tooth survival, reduced postoperative complications, and improved patient satisfaction. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780398593076-PREPARATION_OF_HARD_DENTAL_TISSUES.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kholboeva Nasiba Asrorovna¹</dc:creator>
      <dc:creator>Mamedov Izmir²</dc:creator>
      <dc:creator>Khomidov Parviz²</dc:creator>
      <dc:subject>Hard dental tissues</dc:subject>
      <dc:subject>tooth preparation</dc:subject>
      <dc:subject>enamel</dc:subject>
      <dc:subject>dentin</dc:subject>
      <dc:subject>cavity preparation</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>adhesive dentistry</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>rotary instruments</dc:subject>
      <dc:subject>dental restoration.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MODERN APPROACHES TO THE TREATMENT OF DENTAL CARIES</title>
      <link>https://aams-journal.us/journals/dentistry/articles/0dbc93fe-4b02-4dd9-aeda-e9bb9e2d4bfc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/0dbc93fe-4b02-4dd9-aeda-e9bb9e2d4bfc</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Ruzieva Kamola Axtamovna</author>
      <description>Dental caries remains one of the most prevalent chronic diseases worldwide and continues to represent a major public health challenge affecting individuals of all age groups. Traditionally, treatment of dental caries focused primarily on the mechanical removal of diseased tooth tissue followed by restoration of the resulting cavity. However, advances in cariology, biomaterials, preventive dentistry, and minimally invasive treatment concepts have significantly transformed contemporary caries management. Modern approaches emphasize early diagnosis, risk assessment, preservation of healthy dental tissues, remineralization of non-cavitated lesions, and biological control of the disease process. Contemporary therapeutic strategies integrate preventive, non-invasive, micro-invasive, and restorative techniques aimed at controlling disease progression while maintaining maximum tooth structure. Technologies such as digital diagnostics, laser fluorescence devices, quantitative light-induced fluorescence systems, and artificial intelligence-assisted imaging have improved the detection of early lesions before extensive tissue destruction occurs. Preventive interventions involving fluoride therapy, calcium-phosphate remineralizing agents, antimicrobial treatments, sealants, and behavioral modifications have demonstrated significant effectiveness in reducing caries incidence and progression. Minimally invasive restorative procedures utilize advanced adhesive systems and bioactive materials that promote tissue preservation and long-term restoration success. Recent developments in regenerative dentistry, nanotechnology, and bioactive restorative materials further support biological repair processes and enhance therapeutic outcomes. These modern approaches have shifted the focus of caries management from surgical intervention toward comprehensive disease control, emphasizing prevention, conservation, and patient-centered care. Consequently, contemporary caries treatment strategies contribute to improved oral health, enhanced quality of life, and long-term preservation of natural dentition. Modern approaches to the treatment of dental caries have fundamentally transformed clinical dentistry by shifting therapeutic objectives from extensive operative intervention toward biological preservation and long-term disease control. Dental caries is now recognized as a dynamic, multifactorial process involving complex interactions among cariogenic microorganisms, dietary sugars, host susceptibility, saliva composition, and environmental influences. Contemporary management strategies focus on identifying disease activity at its earliest stages and implementing targeted preventive and therapeutic measures capable of interrupting lesion progression before irreversible destruction of dental tissues occurs. Advances in diagnostic technologies, including digital imaging systems, laser fluorescence devices, optical detection methods, and artificial intelligence-assisted assessment tools, have significantly enhanced the ability to detect early enamel demineralization and hidden lesions. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780396805115-MODERN_APPROACHES_TO_THE_TREATMENT_OF_DENTAL_CARIE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ruzieva Kamola Axtamovna</dc:creator>
      <dc:subject>Dental caries</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>remineralization</dc:subject>
      <dc:subject>fluoride therapy</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>caries management</dc:subject>
      <dc:subject>preventive dentistry</dc:subject>
      <dc:subject>adhesive restoration</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>restorative treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103.aams/0498</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>DRT7 PROTEIN AS A POTENTIAL TEMPLATE FOR DNA SYNTHESIS: MOLECULAR MECHANISMS AND BIOLOGICAL IMPLICATIONS</title>
      <link>https://aams-journal.us/journals/genetics/articles/5005cab5-405c-48ca-b8a2-b31147c8c050</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/5005cab5-405c-48ca-b8a2-b31147c8c050</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Mashad Ali Hazarika¹</author>
      <description>The central dogma of molecular biology describes the flow of genetic information from DNA to RNA and subsequently to proteins. For decades, DNA has been regarded as the primary repository of hereditary information, while proteins have been viewed as functional products encoded by nucleic acids. However, emerging theoretical models and experimental observations have raised questions regarding the possibility of proteins influencing genetic information storage and transmission beyond conventional regulatory mechanisms. The hypothetical DRT7 protein has been proposed as a model molecule capable of participating in template-directed DNA synthesis through highly specific structural interactions with nucleic acid precursors. Such a concept challenges traditional understanding of genetic information flow and suggests the existence of alternative pathways for molecular inheritance. The present study explores the theoretical biological properties of DRT7, its potential role as a structural template for DNA formation, and its implications for molecular evolution, epigenetic inheritance, genome stability, and synthetic biology. Analysis of protein–nucleic acid interactions suggests that highly ordered protein conformations may theoretically guide nucleotide assembly under specific biochemical conditions. Furthermore, advances in structural biology, artificial protein engineering, and molecular nanotechnology provide new opportunities to investigate non-classical mechanisms of information transfer. Understanding whether proteins can contribute directly to genetic templating may expand current concepts of heredity and reveal novel approaches for genome engineering and therapeutic development. The DRT7 model highlights the importance of exploring unconventional biological hypotheses that may redefine established paradigms within molecular genetics. The concept of DRT7 as a protein capable of functioning as a structural template for DNA synthesis introduces a novel perspective in molecular biology and challenges traditional interpretations of genetic information transfer. Classical biological models describe DNA as the primary carrier of hereditary information, whereas proteins are considered functional products derived from nucleic acid sequences. However, recent developments in structural biology, molecular self-organization, protein engineering, and epigenetic research have stimulated interest in alternative mechanisms through which biological information may be stored and transmitted. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780402845510-DRT7_PROTEIN_AS_A_POTENTIAL_TEMPLATE_FOR_DNA_SYNTH.pdf" type="application/pdf" length="0"/>
      <dc:creator>Mashad Ali Hazarika¹</dc:creator>
      <dc:subject>DRT7</dc:subject>
      <dc:subject>protein template</dc:subject>
      <dc:subject>DNA synthesis</dc:subject>
      <dc:subject>molecular genetics</dc:subject>
      <dc:subject>protein inheritance</dc:subject>
      <dc:subject>nucleic acid assembly</dc:subject>
      <dc:subject>synthetic biology</dc:subject>
      <dc:subject>epigenetics</dc:subject>
      <dc:subject>genome engineering</dc:subject>
      <dc:subject>molecular evolution</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1397</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 05, pp. 31-45</dc:source>
    </item>
    <item>
      <title>DIGITAL TECHNOLOGIES IN DENTISTRY</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/76ff795c-8d78-498a-853d-4c89451e6418</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/76ff795c-8d78-498a-853d-4c89451e6418</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Amrakulov Damir¹</author>
      <description>Digital technologies have transformed modern dentistry by improving diagnostic accuracy, treatment planning, clinical efficiency, patient communication, and long-term therapeutic outcomes. The integration of digital systems into dental practice has led to significant advancements in restorative dentistry, orthodontics, implantology, endodontics, prosthodontics, periodontology, and oral surgery. Technologies such as digital radiography, cone-beam computed tomography, intraoral scanners, computer-aided design and computer-aided manufacturing systems, three-dimensional printing, artificial intelligence, and digital workflow platforms have revolutionized traditional clinical procedures. These innovations enable clinicians to obtain highly detailed anatomical information, create precise digital models, perform virtual treatment planning, and fabricate restorations with exceptional accuracy. Digital dentistry contributes to improved patient comfort through reduction of conventional impression procedures, minimization of treatment time, and enhancement of procedural predictability. Three-dimensional imaging techniques provide comprehensive visualization of dental and maxillofacial structures, facilitating safer surgical interventions and more accurate implant placement. Artificial intelligence and machine learning algorithms increasingly support diagnostic interpretation, risk assessment, and clinical decision-making. Digital technologies also improve communication among clinicians, laboratories, and patients through efficient data sharing and virtual treatment simulations. Although implementation requires significant financial investment and specialized training, the benefits include increased productivity, improved clinical outcomes, enhanced patient satisfaction, and reduced procedural errors. Continuous technological development continues to expand the capabilities of digital dentistry and is expected to play an increasingly important role in the future of oral healthcare</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780401856404-DIGITAL_TECHNOLOGIES_IN_DENTISTRY.pdf" type="application/pdf" length="0"/>
      <dc:creator>Amrakulov Damir¹</dc:creator>
      <dc:creator>Karimov Shokhjakhon²</dc:creator>
      <dc:creator>Shakhriev Aziz³</dc:creator>
      <dc:creator>Sodikova Shoira⁴</dc:creator>
      <dc:subject>Digital dentistry</dc:subject>
      <dc:subject>intraoral scanner</dc:subject>
      <dc:subject>CAD/CAM</dc:subject>
      <dc:subject>artificial intelligence</dc:subject>
      <dc:subject>cone-beam computed tomography</dc:subject>
      <dc:subject>three-dimensional printing</dc:subject>
      <dc:subject>digital workflow</dc:subject>
      <dc:subject>implantology</dc:subject>
      <dc:subject>dental technology</dc:subject>
      <dc:subject>oral healthcare</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 121-135</dc:source>
    </item>
    <item>
      <title>THE IMPORTANCE OF EARLY DIAGNOSIS OF ORAL DISEASES</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/b7b27c82-b2a8-40ed-9787-798e926d76cb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/b7b27c82-b2a8-40ed-9787-798e926d76cb</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Ruzieva Kamola Axtamovna</author>
      <description>Early diagnosis of oral diseases plays a fundamental role in modern dental practice and represents one of the most effective strategies for improving oral health outcomes and preventing severe complications. Many oral conditions, including dental caries, periodontal diseases, oral potentially malignant disorders, oral cancer, mucosal lesions, salivary gland disorders, and infectious diseases, initially develop with minimal or no symptoms. As a result, delayed diagnosis frequently leads to disease progression, increased treatment complexity, higher healthcare costs, and reduced quality of life. Contemporary dentistry increasingly emphasizes preventive care and early detection through regular clinical examinations, advanced diagnostic technologies, risk assessment protocols, and patient education. Modern diagnostic tools such as digital radiography, cone-beam computed tomography, fluorescence imaging, salivary biomarkers, artificial intelligence-assisted screening systems, and molecular diagnostic methods have significantly enhanced clinicians’ ability to identify pathological changes at their earliest stages. Early intervention enables implementation of minimally invasive treatment strategies that preserve healthy tissues, improve therapeutic success, and reduce long-term morbidity. In addition to improving oral health, timely diagnosis contributes to the detection of systemic conditions that manifest within the oral cavity, thereby supporting comprehensive patient care. The integration of technological innovations with evidence-based screening programs has strengthened preventive dentistry and facilitated more accurate disease monitoring. Consequently, early diagnosis has become a cornerstone of contemporary oral healthcare, promoting disease prevention, improving prognosis, and enhancing overall patient well-being through timely and effective therapeutic management. Early identification of pathological changes within the oral cavity represents a critical component of contemporary dental medicine and serves as a foundation for effective prevention, timely intervention, and successful long-term treatment outcomes. Numerous oral disorders develop gradually and remain clinically silent during their initial phases, making routine diagnostic evaluation essential for recognizing abnormalities before extensive tissue destruction occurs. Advances in diagnostic science have dramatically improved the capacity of clinicians to detect disease at molecular, cellular, and structural levels, facilitating implementation of conservative therapeutic strategies that preserve function and minimize complications. Contemporary screening approaches incorporate comprehensive clinical examination, digital imaging technologies, fluorescence-based detection systems, salivary diagnostics, cytological analysis, and artificial intelligence-assisted assessment tools. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780397595623-THE_IMPORTANCE_OF_EARLY_DIAGNOSIS_OF_ORAL_DISEASES.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ruzieva Kamola Axtamovna</dc:creator>
      <dc:subject>Early diagnosis</dc:subject>
      <dc:subject>oral diseases</dc:subject>
      <dc:subject>preventive dentistry</dc:subject>
      <dc:subject>oral cancer screening</dc:subject>
      <dc:subject>periodontal disease</dc:subject>
      <dc:subject>dental caries</dc:subject>
      <dc:subject>diagnostic technologies</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>salivary biomarkers</dc:subject>
      <dc:subject>disease prevention</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103.aams/0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 91-105</dc:source>
    </item>
    <item>
      <title>MODERN SURGICAL APPROACHES IN THE MANAGEMENT OF IMPACTED THIRD MOLARS AND THEIR COMPLICATIONS</title>
      <link>https://aams-journal.us/journals/surgery/articles/9f8069a7-22fb-4872-9b66-1425e5c66d10</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/9f8069a7-22fb-4872-9b66-1425e5c66d10</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Almardonov Tursunali¹</author>
      <description>Impacted third molars, commonly known as wisdom teeth, represent one of the most frequent conditions encountered in oral and maxillofacial surgery. Failure of complete eruption may result from insufficient jaw space, abnormal tooth angulation, developmental disturbances, or anatomical obstructions. Impacted third molars are associated with numerous pathological conditions, including pericoronitis, dental caries, periodontal disease, root resorption of adjacent teeth, odontogenic cysts, and localized infections. Advances in diagnostic imaging, surgical planning, anesthesia, and postoperative management have significantly improved treatment outcomes and reduced complication rates. Contemporary surgical approaches emphasize minimally invasive techniques, preservation of surrounding anatomical structures, reduction of surgical trauma, and acceleration of postoperative recovery. Three-dimensional imaging modalities, particularly cone-beam computed tomography, provide detailed visualization of tooth position and proximity to vital structures such as the inferior alveolar nerve and maxillary sinus. Modern surgical protocols incorporate atraumatic extraction techniques, piezoelectric surgery, microsurgical instruments, and evidence-based postoperative care. Appropriate patient assessment, accurate diagnosis, and individualized treatment planning contribute significantly to successful management and prevention of complications. Current evidence demonstrates that modern surgical interventions improve clinical outcomes, decrease postoperative discomfort, and enhance overall patient satisfaction.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780401484939-MODERN_SURGICAL_APPROACHES_IN_THE_MANAGEMENT_OF_IM.pdf" type="application/pdf" length="0"/>
      <dc:creator>Almardonov Tursunali¹</dc:creator>
      <dc:creator>Axmadov Inomjon²</dc:creator>
      <dc:subject>Impacted third molars</dc:subject>
      <dc:subject>wisdom teeth</dc:subject>
      <dc:subject>oral surgery</dc:subject>
      <dc:subject>cone-beam computed tomography</dc:subject>
      <dc:subject>minimally invasive surgery</dc:subject>
      <dc:subject>pericoronitis</dc:subject>
      <dc:subject>inferior alveolar nerve</dc:subject>
      <dc:subject>postoperative complications</dc:subject>
      <dc:subject>tooth extraction</dc:subject>
      <dc:subject>oral and maxillofacial surgery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1396</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 05, pp. 46-60</dc:source>
    </item>
    <item>
      <title>MODERN METHODS OF TEETH WHITENING: EFFECTIVENESS AND SAFETY</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/4d536c70-cea1-42c3-b97a-d5212ed6a5aa</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/4d536c70-cea1-42c3-b97a-d5212ed6a5aa</guid>
      <pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate>
      <author>Amrakulov Damir¹</author>
      <description>Tooth discoloration is a common esthetic concern that affects individuals of different ages and has a significant impact on self-confidence, social interactions, and overall quality of life. Advances in cosmetic dentistry have led to the development of numerous whitening techniques aimed at improving dental appearance while preserving oral health. Modern whitening methods include in-office bleaching procedures, dentist-supervised home bleaching systems, over-the-counter whitening products, laser-assisted bleaching, light-activated whitening technologies, and recently developed minimally invasive whitening protocols. These techniques primarily rely on hydrogen peroxide or carbamide peroxide as active agents capable of penetrating enamel and dentin to oxidize chromogenic molecules responsible for discoloration. The effectiveness of whitening procedures depends on factors such as stain etiology, concentration of bleaching agents, duration of treatment, enamel characteristics, and patient compliance. Contemporary studies demonstrate that professionally supervised whitening procedures achieve predictable and long-lasting esthetic results with acceptable safety profiles. However, potential adverse effects including tooth sensitivity, gingival irritation, enamel surface alterations, and transient pulpal responses require careful consideration. Modern clinical protocols emphasize individualized treatment planning, accurate diagnosis of discoloration causes, controlled application techniques, and comprehensive patient education to maximize efficacy while minimizing complications. Technological advancements continue to improve whitening outcomes through enhanced bleaching formulations, innovative delivery systems, and evidence-based treatment approaches. Consequently, contemporary tooth whitening has become a safe, effective, and widely accepted component of esthetic dental practice.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780402234027-MODERN_METHODS_OF_TEETH_WHITENING__EFFECTIVENESS_A.pdf" type="application/pdf" length="0"/>
      <dc:creator>Amrakulov Damir¹</dc:creator>
      <dc:creator>Karimov Shokhjakhon²</dc:creator>
      <dc:creator>Shakhriev Aziz³</dc:creator>
      <dc:creator>Sodikova Shoira⁴</dc:creator>
      <dc:subject>Teeth whitening</dc:subject>
      <dc:subject>dental bleaching</dc:subject>
      <dc:subject>hydrogen peroxide</dc:subject>
      <dc:subject>carbamide peroxide</dc:subject>
      <dc:subject>esthetic dentistry</dc:subject>
      <dc:subject>tooth discoloration</dc:subject>
      <dc:subject>laser whitening</dc:subject>
      <dc:subject>enamel safety</dc:subject>
      <dc:subject>dental sensitivity</dc:subject>
      <dc:subject>cosmetic dentistry</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-06-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 61-75</dc:source>
    </item>
    <item>
      <title>CHANGES IN BLOOD BIOCHEMISTRY IN ACUTE RENAL FAILURE</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/2e286bd2-57f9-4a38-b4c0-f962d3525da6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/2e286bd2-57f9-4a38-b4c0-f962d3525da6</guid>
      <pubDate>Sat, 30 May 2026 00:00:00 GMT</pubDate>
      <author>Turdiyev Qilichbek¹</author>
      <description>Acute renal failure, currently referred to as acute kidney injury (AKI), is a clinical syndrome characterized by the rapid decline of renal function over hours to days, resulting in impaired excretion of metabolic waste products, disturbances of electrolyte homeostasis, acid-base imbalance, and accumulation of uremic toxins. Blood biochemical abnormalities develop early during the disease process and serve as essential indicators for diagnosis, assessment of disease severity, therapeutic monitoring, and prediction of clinical outcomes. The present study aimed to evaluate biochemical alterations occurring in patients with acute renal failure and to determine their clinical significance during diagnosis and management. Comprehensive analysis demonstrated that elevations of serum creatinine, blood urea nitrogen, potassium, phosphorus, inflammatory biomarkers, and metabolic acids are accompanied by reductions in glomerular filtration rate, serum bicarbonate, calcium, hemoglobin, and albumin concentrations. Recognition of these biochemical changes enables early intervention, optimization of treatment strategies, and reduction of complications associated with acute kidney injury</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783007114950-CHANGES_IN_BLOOD_BIOCHEMISTRY_IN_ACUTE_RENAL_FAILU.pdf" type="application/pdf" length="0"/>
      <dc:creator>Turdiyev Qilichbek¹</dc:creator>
      <dc:creator>Elmirzayev Akhmad²</dc:creator>
      <dc:creator>Uzokova Oyjamol³</dc:creator>
      <dc:subject>acute kidney injury</dc:subject>
      <dc:subject>acute renal failure</dc:subject>
      <dc:subject>serum creatinine</dc:subject>
      <dc:subject>blood urea nitrogen</dc:subject>
      <dc:subject>electrolytes</dc:subject>
      <dc:subject>metabolic acidosis</dc:subject>
      <dc:subject>biochemical markers</dc:subject>
      <dc:subject>renal dysfunction</dc:subject>
      <dc:subject>nephrology</dc:subject>
      <dc:subject>laboratory diagnosis.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-30</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 181-195</dc:source>
    </item>
    <item>
      <title> Experimental-Morphological Assessment of Ischemic Damage to the Optic Nerve</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/60ddfbf9-c00c-48d3-8c4c-6c1884f0b476</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/60ddfbf9-c00c-48d3-8c4c-6c1884f0b476</guid>
      <pubDate>Sat, 30 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Ischemic damage to the optic nerve represents one of the most significant pathological conditions affecting the visual system and remains a major cause of permanent vision loss worldwide. The optic nerve is responsible for transmitting visual information from retinal ganglion cells to the visual centers of the brain. Because of its exceptionally high metabolic activity and continuous dependence on oxygen and glucose, the optic nerve is extremely sensitive to disturbances in blood circulation. Even a short interruption of blood supply can initiate irreversible cellular injury, leading to degeneration of neural tissue and progressive visual dysfunction. Ischemic optic neuropathy develops when the vascular supply of the optic nerve becomes insufficient to meet metabolic demands. This insufficiency may result from vascular occlusion, systemic hypotension, elevated intraocular pressure, inflammatory vascular disease, diabetes mellitus, hypertension, or age-related vascular abnormalities. The resulting ischemia activates a complex cascade of biochemical and molecular events that ultimately produce structural destruction of the optic nerve.
The pathophysiological mechanisms underlying ischemic optic nerve injury involve multiple interconnected processes. Reduced oxygen delivery rapidly decreases oxidative phosphorylation within mitochondria, causing depletion of intracellular adenosine triphosphate (ATP). Failure of ATP-dependent ion pumps disrupts ionic homeostasis, resulting in intracellular accumulation of sodium and calcium ions together with cellular edema. Excessive calcium influx activates numerous proteolytic enzymes, phospholipases, and endonucleases that progressively damage cellular proteins, membrane phospholipids, and nuclear DNA. Simultaneously, ischemia stimulates excessive release of glutamate, which activates N-methyl-D-aspartate receptors and further increases intracellular calcium concentration through excitotoxic mechanisms. Mitochondrial dysfunction promotes excessive production of reactive oxygen species, causing oxidative damage to lipids, proteins, and nucleic acids. These pathological events activate apoptotic pathways that ultimately lead to retinal ganglion cell death and irreversible degeneration of optic nerve fibers.
Experimental investigation of ischemic optic neuropathy has become an essential approach for understanding disease mechanisms because direct examination of early pathological changes in human patients remains limited. Animal models provide reproducible conditions that closely simulate the pathological processes occurring during optic nerve ischemia while allowing precise control over experimental variables. Morphological assessment using histopathology, immunohistochemistry, morphometry, and electron microscopy enables detailed evaluation of tissue injury at microscopic and ultrastructural levels. These techniques provide valuable information regarding neuronal degeneration, myelin destruction, inflammatory reactions, vascular abnormalities, and glial activation, thereby facilitating the development of effective neuroprotective strategies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783067889218-_Experimental_Morphological_Assessment_of_Ischemic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>Experimental Morphology</dc:subject>
      <dc:subject>Optic Nerve Ischemia</dc:subject>
      <dc:subject>Ischemic Optic Neuropathy</dc:subject>
      <dc:subject>Optic Nerve Damage</dc:subject>
      <dc:subject>Histopathological Changes</dc:subject>
      <dc:subject>Morphological Assessment</dc:subject>
      <dc:subject>Retinal Ganglion Cells</dc:subject>
      <dc:subject>Neurodegeneration</dc:subject>
      <dc:subject>Ocular Ischemia</dc:subject>
      <dc:subject>Experimental Study.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-30</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MODERN APPROACHES TO NEUROPROTECTION IN ACUTE ISCHEMIC OPTIC NEUROPATHY: A CLINICAL AND EXPERIMENTAL ANALYSIS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/2510d0fc-e6c5-40b8-aa71-af84267301e7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/2510d0fc-e6c5-40b8-aa71-af84267301e7</guid>
      <pubDate>Sat, 30 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy (AION) is one of the most common causes of sudden painless vision loss in adults and remains a major challenge in neuro-ophthalmology due to its complex pathophysiology and limited treatment options. Progressive ischemic damage to retinal ganglion cells and optic nerve axons often results in permanent visual impairment despite conventional therapy. Neuroprotection has recently emerged as a promising therapeutic strategy aimed at preserving neuronal viability, reducing secondary degeneration, and improving visual outcomes. This study evaluated current neuroprotective approaches through an integrated clinical and experimental analysis of structural, functional, and vascular changes in patients with acute ischemic optic neuropathy. Clinical findings were correlated with retinal imaging, functional ophthalmic assessment, and experimental evidence regarding neuroprotective mechanisms. The results demonstrated that early multimodal neuroprotective therapy combined with optimization of systemic vascular risk factors significantly improved structural preservation of the optic nerve and functional visual recovery. These findings support the incorporation of individualized neuroprotective strategies into contemporary management of acute ischemic optic neuropathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783056523024-MODERN_APPROACHES_TO_NEUROPROTECTION_IN_ACUTE_ISCH.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>acute ischemic optic neuropathy</dc:subject>
      <dc:subject>neuroprotection</dc:subject>
      <dc:subject>retinal ganglion cells</dc:subject>
      <dc:subject>optic nerve ischemia</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>neuro-ophthalmology</dc:subject>
      <dc:subject>oxidative stress</dc:subject>
      <dc:subject>neuroinflammation</dc:subject>
      <dc:subject>visual field</dc:subject>
      <dc:subject>clinical research.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-30</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Structural and Functional Assessment of the Visual Analyzer in Acute Ischemic Optic Neuropathy</title>
      <link>https://aams-journal.us/journals/dermatology/articles/fe5ea7b2-3e25-4400-9508-b4090d6b4b0c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/fe5ea7b2-3e25-4400-9508-b4090d6b4b0c</guid>
      <pubDate>Wed, 27 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy (AION) is a vision-threatening disorder characterized by sudden impairment of optic nerve perfusion, leading to structural damage of the visual pathway and rapid deterioration of visual function. It is one of the leading causes of acute optic nerve dysfunction in middle-aged and elderly individuals and is frequently associated with systemic vascular diseases such as hypertension, diabetes mellitus, atherosclerosis, hyperlipidemia, and cardiovascular disorders. The visual analyzer, which consists of the retina, optic nerve, optic chiasm, optic tract, lateral geniculate nucleus, optic radiations, and visual cortex, functions as an integrated system responsible for the perception and processing of visual information. Acute ischemic injury affecting any component of this pathway, particularly the optic nerve, disrupts signal transmission and leads to functional visual deficits that may become irreversible if treatment is delayed.
The optic nerve has one of the highest metabolic demands within the central nervous system because retinal ganglion cell axons require continuous oxygen and glucose delivery to maintain axonal transport and electrical conduction. Interruption of blood supply causes rapid depletion of intracellular adenosine triphosphate (ATP), resulting in failure of membrane ion pumps, intracellular calcium accumulation, mitochondrial dysfunction, oxidative stress, excitotoxic injury, inflammatory activation, and programmed cell death. These pathological mechanisms produce progressive degeneration of retinal ganglion cells and optic nerve fibers while simultaneously impairing conduction throughout the visual pathway.
Structural alterations within the visual analyzer are closely associated with measurable functional abnormalities. Morphological changes such as optic disc edema, retinal nerve fiber layer thinning, axonal degeneration, demyelination, retinal ganglion cell loss, and microvascular damage are accompanied by decreased visual acuity, visual field defects, impaired contrast sensitivity, delayed visual evoked potentials, reduced retinal electrophysiological activity, and diminished visual processing within central visual pathways. Simultaneous evaluation of structural and functional changes provides comprehensive information regarding disease severity, progression, and therapeutic response.
Recent advances in ocular imaging, electrophysiology, histopathology, immunohistochemistry, and digital morphometry have substantially improved the ability to investigate the relationship between structural injury and functional impairment in acute ischemic optic neuropathy. Comprehensive assessment of these alterations is essential for understanding disease mechanisms, establishing objective diagnostic criteria, and developing effective neuroprotective treatment strategies capable of preserving visual function.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783072111849-Structural_and_Functional_Assessment_of_the_Visual.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>Acute Ischemic Optic Neuropathy (AION)</dc:subject>
      <dc:subject>Visual Analyzer</dc:subject>
      <dc:subject>Structural Assessment</dc:subject>
      <dc:subject>Functional Assessment</dc:subject>
      <dc:subject>Optical Coherence Tomography (OCT)</dc:subject>
      <dc:subject>Visual Field Testing</dc:subject>
      <dc:subject>Optic Nerve Damage</dc:subject>
      <dc:subject>Retinal Nerve Fiber Layer (RNFL)</dc:subject>
      <dc:subject>Visual Function</dc:subject>
      <dc:subject>Ocular Imaging.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10,4103/ффьы,0498</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 02, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>THE EFFECT OF NEUROPROTECTIVE THERAPY ON THE MORPHOLOGICAL AND FUNCTIONAL STATUS OF THE OPTIC NERVE FOLLOWING ISCHEMIC INJURY</title>
      <link>https://aams-journal.us/journals/neurology/articles/0f4d6e96-9f86-440a-8cb5-a20fae2eec40</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/0f4d6e96-9f86-440a-8cb5-a20fae2eec40</guid>
      <pubDate>Wed, 27 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Ischemic injury of the optic nerve is one of the major causes of sudden visual impairment and irreversible blindness in adults. Damage to retinal ganglion cells and optic nerve axons continues even after restoration of blood supply due to secondary neurodegenerative mechanisms, including oxidative stress, mitochondrial dysfunction, inflammation, and apoptosis. Neuroprotective therapy has emerged as an important strategy aimed at preserving neuronal viability and maintaining visual function after ischemic injury. This study evaluated the influence of neuroprotective treatment on the morphological and functional status of the optic nerve using multimodal ophthalmic assessment. Clinical findings demonstrated that early neuroprotective intervention significantly preserved retinal nerve fiber layer integrity, reduced ganglion cell loss, improved visual function, and slowed progression of optic nerve atrophy. The results suggest that comprehensive neuroprotective therapy may improve long-term visual prognosis in patients with ischemic optic neuropathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783056884035-THE_EFFECT_OF_NEUROPROTECTIVE_THERAPY_ON_THE_MORPH.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>ischemic optic neuropathy</dc:subject>
      <dc:subject>neuroprotection</dc:subject>
      <dc:subject>optic nerve</dc:subject>
      <dc:subject>retinal ganglion cells</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>retinal nerve fiber layer</dc:subject>
      <dc:subject>visual field</dc:subject>
      <dc:subject>visual acuity</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>ophthalmology.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Individualized Surgical Strategy for the Protection of Ovarian Reserve in Reproductive-Age Women with Ovarian Endometriosis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/7469acda-dcb3-4a74-82ba-0b4269b02a7e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/7469acda-dcb3-4a74-82ba-0b4269b02a7e</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 GMT</pubDate>
      <author>L. R. Agababyan¹</author>
      <description>Background. Ovarian endometriosis is among the most clinically demanding subtypes of endometriotic disease in women of reproductive age and is independently associated with diminished ovarian reserve. Surgical excision remains the cornerstone of management, yet operative trauma may itself contribute to follicular loss, creating a difficult clinical trade-off between disease control and fertility protection.
Objective. To formulate and justify an individualized clinical and surgical algorithm aimed at preserving ovarian reserve in reproductive-age women undergoing surgery for ovarian endometrioma, with explicit criteria for hemostasis selection and perioperative reserve assessment.
Methods. A combined prospective–retrospective clinical observation was conducted in women of reproductive age with histologically confirmed ovarian endometriosis scheduled for surgical treatment. Preoperative ovarian reserve was evaluated by serum anti-Müllerian hormone (AMH) and transvaginal antral follicle count (AFC), together with menstrual and reproductive history. Tissue-sparing laparoscopic cystectomy was performed with patient-specific selection of hemostatic technique, prioritizing methods with minimal thermal impact. Follow-up assessments of AMH and AFC were obtained at 3, 6, and 12 months. Statistical significance was set at p &lt; 0.05.
Results. A reduction in postoperative AMH was observed across the cohort, but the magnitude of decline was strongly modified by baseline reserve, cyst size, laterality, and the chosen hemostatic strategy. Tissue-sparing dissection combined with suturing or hemostatic sealants was associated with a more moderate decrease in AMH and partial late recovery, whereas extensive stripping with bipolar coagulation produced the steepest decline. Bilateral endometriomas and prior ovarian surgery emerged as the most consistent predictors of marked reserve impairment.
Conclusion. An individualized surgical strategy guided by preoperative AMH and AFC, reproductive intent, and intraoperative restraint with regard to electrocoagulation provides a clinically feasible framework for protecting ovarian reserve. Routine, uniform application of stripping cystectomy with bipolar hemostasis should be replaced by a patient-tailored approach.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779714660678-Individualized_Surgical_Strategy_for_the_Protectio.pdf" type="application/pdf" length="0"/>
      <dc:creator>L. R. Agababyan¹</dc:creator>
      <dc:creator>S. Sh. Shonazarova²</dc:creator>
      <dc:subject>ovarian endometriosis; endometrioma; ovarian reserve; anti-Müllerian hormone; antral follicle count; laparoscopic cystectomy; hemostasis; fertility preservation; individualized management.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1394</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 106-120</dc:source>
    </item>
    <item>
      <title>MODERN APPROACHES TO THE DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME IN WOMEN OF REPRODUCTIVE AGE</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/29290c23-4ccf-4606-9e74-fbe37dcf7d06</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/29290c23-4ccf-4606-9e74-fbe37dcf7d06</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 GMT</pubDate>
      <author>Bahriddinova Ismigul¹</author>
      <description>Polycystic ovary syndrome is one of the most common endocrine and metabolic disorders affecting women of reproductive age and is characterized by hormonal imbalance, ovulatory dysfunction, hyperandrogenism, menstrual irregularities, metabolic disturbances, and reproductive complications. The syndrome demonstrates complex multifactorial pathophysiology involving genetic predisposition, insulin resistance, neuroendocrine dysregulation, ovarian dysfunction, chronic low-grade inflammation, and environmental influences. Clinical manifestations vary significantly among affected individuals and frequently include oligomenorrhea, amenorrhea, infertility, obesity, hirsutism, acne, alopecia, metabolic syndrome, and psychological disturbances. Early diagnosis and comprehensive management are critically important because untreated polycystic ovary syndrome increases the risk of infertility, type 2 diabetes mellitus, cardiovascular disease, endometrial hyperplasia, pregnancy complications, and long-term metabolic dysfunction. Modern diagnostic approaches involve integrated evaluation of clinical manifestations, biochemical hormonal assessment, ultrasonographic examination of ovarian morphology, and exclusion of other endocrine disorders. Laboratory analysis commonly includes measurement of luteinizing hormone, follicle-stimulating hormone, testosterone, dehydroepiandrosterone sulfate, insulin, glucose metabolism parameters, lipid profile, and anti-Müllerian hormone concentrations. Transvaginal ultrasonography remains an essential imaging method for identification of polycystic ovarian morphology and follicular abnormalities. Contemporary management strategies focus on individualized multidisciplinary treatment aimed at restoration of ovulatory function, reduction of hyperandrogenic symptoms, improvement of metabolic health, and prevention of long-term complications. Lifestyle modification involving dietary regulation, weight reduction, and physical activity remains the first-line therapeutic approach for overweight and obese patients. Pharmacological interventions include insulin-sensitizing agents, combined oral contraceptives, antiandrogen therapy, ovulation induction medications, and emerging hormonal treatments targeting metabolic and reproductive dysfunction. Advances in reproductive medicine, endocrinology, molecular diagnostics, and metabolic research have significantly improved understanding of disease mechanisms and optimization of therapeutic strategies. Comprehensive individualized management therefore plays a fundamental role in improving reproductive outcomes, metabolic stability, hormonal regulation, and quality of life in women affected by polycystic ovary syndrome.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779711111236-MODERN_APPROACHES_TO_THE_DIAGNOSIS_AND_MANAGEMENT_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Bahriddinova Ismigul¹</dc:creator>
      <dc:creator>Nomozov Alisher²</dc:creator>
      <dc:subject>Polycystic ovary syndrome</dc:subject>
      <dc:subject>reproductive endocrinology</dc:subject>
      <dc:subject>hyperandrogenism</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>ovarian dysfunction</dc:subject>
      <dc:subject>hormonal imbalance</dc:subject>
      <dc:subject>ultrasonography</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>ovulation induction</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1392</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 91-105</dc:source>
    </item>
    <item>
      <title> Role of Microcirculatory Disorders in the Development of Acute Ischemic Optic Neuropathy</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/f34bfa56-0ac6-4167-9ab3-ef55517683e9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/f34bfa56-0ac6-4167-9ab3-ef55517683e9</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy (AION) is one of the most common causes of sudden, painless vision loss in adults and represents a significant neuro-ophthalmological disorder associated with impaired blood perfusion of the optic nerve. The condition develops when the microvascular circulation supplying the optic nerve head becomes insufficient to maintain normal tissue metabolism. Unlike large-vessel occlusion, disturbances in the microcirculation involve structural and functional abnormalities of arterioles, capillaries, and venules that reduce oxygen delivery, impair nutrient exchange, and disrupt cellular homeostasis. Because the optic nerve has a high metabolic demand and limited capacity to tolerate hypoxia, even transient impairment of microvascular blood flow can initiate irreversible neuronal injury.
The optic nerve head receives its blood supply primarily from the posterior ciliary arteries through a dense capillary network. The integrity of this microvascular system is essential for maintaining continuous oxygenation of retinal ganglion cell axons. Alterations in vascular autoregulation, endothelial dysfunction, increased vascular resistance, capillary narrowing, platelet aggregation, and blood viscosity changes may compromise tissue perfusion despite the absence of complete vascular occlusion. Consequently, localized ischemia develops, initiating a cascade of biochemical and molecular events that progressively damage neural tissue.
Microcirculatory disorders contribute not only to the onset of ischemic injury but also to its progression. Reduced perfusion pressure decreases oxygen availability, resulting in mitochondrial dysfunction, depletion of intracellular adenosine triphosphate (ATP), disruption of ionic balance, excessive production of reactive oxygen species, activation of inflammatory mediators, and apoptosis of retinal ganglion cells. Persistent impairment of capillary circulation also delays tissue recovery after reperfusion, thereby extending the duration of hypoxia and promoting secondary neurodegeneration.
Systemic disorders including arterial hypertension, diabetes mellitus, hyperlipidemia, atherosclerosis, nocturnal hypotension, smoking, and advanced age frequently impair microvascular function and significantly increase the risk of acute ischemic optic neuropathy. Understanding the relationship between microcirculatory dysfunction and optic nerve ischemia is therefore essential for improving early diagnosis, identifying high-risk individuals, and developing effective therapeutic strategies aimed at preserving visual function.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783067582942-_Role_of_Microcirculatory_Disorders_in_the_Develop.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>Acute Ischemic Optic Neuropathy (AION)</dc:subject>
      <dc:subject>Microcirculatory Disorders</dc:subject>
      <dc:subject>Optic Nerve Ischemia</dc:subject>
      <dc:subject>Ocular Microcirculation</dc:subject>
      <dc:subject>Retinal Blood Flow</dc:subject>
      <dc:subject>Endothelial Dysfunction</dc:subject>
      <dc:subject>Vascular Dysfunction</dc:subject>
      <dc:subject>Ischemic Injury.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 76-90</dc:source>
    </item>
    <item>
      <title>MINIMALLY INVASIVE SURGICAL TECHNIQUES AND THEIR IMPACT ON POSTOPERATIVE RECOVERY</title>
      <link>https://aams-journal.us/journals/surgery/articles/bfe8ffb6-fe92-4982-9585-5a3e337e04c6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/bfe8ffb6-fe92-4982-9585-5a3e337e04c6</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 GMT</pubDate>
      <author>Azimov Amirjon</author>
      <description>Minimally invasive surgical techniques have significantly transformed modern operative medicine through reduction of surgical trauma, improvement of postoperative recovery, minimization of complications, and enhancement of patient outcomes across multiple surgical specialties. These techniques involve performance of surgical procedures through small incisions using advanced visualization systems, endoscopic equipment, laparoscopic instruments, robotic-assisted platforms, and image-guided technologies. Compared with conventional open surgery, minimally invasive procedures are associated with decreased tissue injury, reduced intraoperative blood loss, diminished postoperative pain, shorter hospitalization, accelerated functional rehabilitation, and lower risk of infectious complications. Modern minimally invasive approaches are increasingly utilized in general surgery, gynecology, urology, orthopedics, thoracic surgery, cardiovascular surgery, and neurosurgery. Physiological advantages of minimally invasive surgery are largely related to reduced inflammatory response, preservation of anatomical structures, decreased neuroendocrine stress activation, and minimized disruption of immune function. Patients undergoing minimally invasive procedures frequently demonstrate faster mobilization, improved cosmetic outcomes, reduced analgesic requirements, earlier return to normal activity, and improved quality of life during postoperative rehabilitation. Technological advancements including high-definition imaging systems, robotic surgical platforms, three-dimensional visualization, ultrasonic dissection devices, and computer-assisted navigation have substantially enhanced precision and safety of minimally invasive interventions. Despite numerous advantages, these techniques additionally require specialized surgical training, advanced operative skills, longer learning curves, and significant technological resources. Appropriate patient selection, perioperative planning, and multidisciplinary postoperative management remain essential for optimization of clinical outcomes. Contemporary research increasingly demonstrates that minimally invasive surgery contributes to reduced postoperative morbidity, decreased healthcare costs, and improved long-term recovery compared with traditional open surgical procedures. Continued progress in surgical technology, robotic systems, artificial intelligence, and enhanced recovery protocols will further expand the role of minimally invasive approaches in modern operative medicine and postoperative care.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779713889553-MINIMALLY_INVASIVE_SURGICAL_TECHNIQUES_AND_THEIR_I.pdf" type="application/pdf" length="0"/>
      <dc:creator>Azimov Amirjon</dc:creator>
      <dc:subject>Minimally invasive surgery</dc:subject>
      <dc:subject>laparoscopic surgery</dc:subject>
      <dc:subject>robotic surgery</dc:subject>
      <dc:subject>postoperative recovery</dc:subject>
      <dc:subject>surgical techniques</dc:subject>
      <dc:subject>endoscopic surgery</dc:subject>
      <dc:subject>enhanced recovery</dc:subject>
      <dc:subject>surgical complications</dc:subject>
      <dc:subject>operative medicine</dc:subject>
      <dc:subject>rehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1393</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 05, pp. 31-45</dc:source>
    </item>
    <item>
      <title>EARLY CHILDHOOD ASTHMA: DIAGNOSTIC CHALLENGES, PHENOTYPE RECOGNITION, AND STEPWISE MANAGEMENT IN PRESCHOOL-AGED CHILDREN</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/0adfc8e0-797d-4992-bc3d-ed3899cef7a1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/0adfc8e0-797d-4992-bc3d-ed3899cef7a1</guid>
      <pubDate>Sun, 24 May 2026 00:00:00 GMT</pubDate>
      <author>Maria Elena Vasquez</author>
      <description>Background: Asthma is the most common chronic respiratory disease of childhood, yet diagnosis in children younger than five years remains challenging because objective lung function testing is rarely feasible. Misclassification leads to both undertreatment and unnecessary chronic corticosteroid exposure. Methods: We reviewed contemporary guidelines and clinical evidence on the recognition of preschool wheeze phenotypes, the use of the modified Asthma Predictive Index (mAPI), and stepwise pharmacological management. Sources included GINA 2025, NAEPP 2020 updates, and 56 primary studies published between 2015 and 2025. Results: Episodic viral wheeze, multiple-trigger wheeze, and early-onset persistent asthma carry distinct trajectories. A positive mAPI in a child with recurrent wheezing increases the post-test probability of school-age asthma from 30 to over 70 percent. Daily low-dose inhaled corticosteroids remain first-line controller therapy for persistent symptoms, while intermittent high-dose ICS at the start of viral upper respiratory infections reduces severe exacerbations in selected phenotypes. Conclusion: Phenotype-guided diagnosis combined with a stepwise treatment approach individualized to symptom pattern, trigger profile, and family history reduces both morbidity and unnecessary exposure to chronic therapy in preschool children.</description>
      <dc:creator>Maria Elena Vasquez</dc:creator>
      <dc:creator>James A. O&apos;Connell</dc:creator>
      <dc:creator>Fatima Al-Hassani</dc:creator>
      <dc:creator>Olga Mikhailovna Larina</dc:creator>
      <dc:subject>preschool asthma</dc:subject>
      <dc:subject>pediatric wheeze</dc:subject>
      <dc:subject>inhaled corticosteroids</dc:subject>
      <dc:subject>asthma predictive index</dc:subject>
      <dc:subject>phenotype</dc:subject>
      <dc:subject>GINA guidelines</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0082</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 76-90</dc:source>
    </item>
    <item>
      <title>CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CONTEMPORARY REVIEW OF BIOMARKERS AND IMAGING MODALITIES</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/e84835db-1bb8-4f98-a012-cbbb523e07b2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/e84835db-1bb8-4f98-a012-cbbb523e07b2</guid>
      <pubDate>Sun, 24 May 2026 00:00:00 GMT</pubDate>
      <author>Daniel R. Whitman</author>
      <description>Background: Patients with type 2 diabetes mellitus (T2DM) carry a two- to four-fold higher risk of atherosclerotic cardiovascular disease (ASCVD) compared with non-diabetic peers. Traditional risk equations frequently underestimate this burden, prompting renewed interest in biomarker-driven and imaging-based stratification. Methods: We conducted a structured narrative review of peer-reviewed literature published between January 2015 and December 2025, identified through PubMed, Scopus, and Web of Science using predefined Boolean queries. Articles addressing risk biomarkers, coronary artery calcium (CAC) scoring, carotid intima-media thickness, and contemporary risk equations in adults with T2DM were included. Results: High-sensitivity cardiac troponin T, N-terminal pro–B-type natriuretic peptide, growth differentiation factor 15, and lipoprotein(a) consistently improved discrimination beyond standard models, with C-statistic gains of 0.02–0.06. CAC scoring offered the largest reclassification benefit among asymptomatic patients with intermediate clinical risk. Conclusion: A tiered approach combining a contemporary risk equation, selected biomarkers, and CAC imaging in intermediate-risk cases provides clinically meaningful refinement of cardiovascular risk estimation in T2DM and should inform individualized preventive therapy.</description>
      <dc:creator>Daniel R. Whitman</dc:creator>
      <dc:creator>Sofia Petrova</dc:creator>
      <dc:creator>Hiroshi Tanaka</dc:creator>
      <dc:creator>Aigerim Bekova</dc:creator>
      <dc:subject>type 2 diabetes mellitus</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>coronary artery calcium</dc:subject>
      <dc:subject>risk stratification</dc:subject>
      <dc:subject>preventive cardiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0081</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 61-75</dc:source>
    </item>
    <item>
      <title>CLASSIFICATION OF FILLED POLYMER RESTORATIVE MATERIALS. ADHESIVE SYSTEM</title>
      <link>https://aams-journal.us/journals/dentistry/articles/eecd4696-633a-4737-af8f-d0eaf26392ae</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/eecd4696-633a-4737-af8f-d0eaf26392ae</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Sodikova Shoira Amriddinovna¹</author>
      <description>Filled polymer restorative materials and adhesive systems represent fundamental components of modern restorative dentistry because they provide functional rehabilitation, aesthetic restoration, biological compatibility, and long-term preservation of dental tissues. Continuous scientific development in polymer chemistry, nanotechnology, biomaterials science, and adhesive dentistry has significantly improved physical, mechanical, and clinical properties of contemporary restorative systems. Filled polymer restorative materials are widely used in direct and indirect restorative procedures because of their excellent aesthetics, adhesive capacity, wear resistance, polishability, and conservative application techniques. Modern restorative dentistry increasingly emphasizes minimally invasive approaches aimed at preserving healthy dental structures through effective adhesive bonding and biomimetic rehabilitation. Polymer restorative materials consist primarily of organic resin matrices, inorganic filler particles, coupling agents, initiator systems, stabilizers, and pigments that collectively determine mechanical strength, polymerization characteristics, optical properties, and clinical durability. Classification of filled polymer restorative materials is based on filler particle size, filler composition, viscosity, curing mechanisms, polymerization methods, and clinical application. Contemporary materials include macrofilled composites, microfilled composites, hybrid composites, nanohybrid composites, nanofilled composites, flowable composites, packable composites, ormocers, giomers, and bulk-fill restorative systems. Nanotechnology has significantly enhanced restorative dentistry by improving filler distribution, mechanical resistance, translucency, surface smoothness, and polish retention of modern composite materials. Adhesive systems additionally represent essential components of restorative procedures because they establish micromechanical and chemical bonding between restorative materials and dental tissues. Modern adhesive dentistry significantly reduces the need for extensive cavity preparation and allows preservation of healthy enamel and dentin structures. Adhesive systems are classified according to etching strategy, number of clinical steps, interaction with smear layer, and mechanism of hybrid layer formation. Current adhesive systems include etch-and-rinse adhesives, self-etch adhesives, universal adhesives, and multimode bonding systems. Advances in adhesive technologies have improved bond strength, marginal adaptation, reduction of microleakage, postoperative sensitivity control, and long-term restoration stability. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779371058031-CLASSIFICATION_OF_FILLED_POLYMER_RESTORATIVE_MATER.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sodikova Shoira Amriddinovna¹</dc:creator>
      <dc:creator>Obidova Farzona Firdavsovna²</dc:creator>
      <dc:subject>Filled polymer materials</dc:subject>
      <dc:subject>composite restorations</dc:subject>
      <dc:subject>adhesive dentistry</dc:subject>
      <dc:subject>dental composites</dc:subject>
      <dc:subject>bonding systems</dc:subject>
      <dc:subject>nanocomposites</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>hybrid layer</dc:subject>
      <dc:subject>polymerization</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1389</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MULTIMODAL EVOKED POTENTIALS AS A NEUROPHYSIOLOGICAL BATTERY IN MULTIPLE SCLEROSIS FOLLOW-UP</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/22c971d3-98ae-45ce-97e6-e83b5473b43b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/22c971d3-98ae-45ce-97e6-e83b5473b43b</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Tuychiyeva Mokhinur Komilovna</author>
      <description>Multiple sclerosis is a chronic immune-mediated demyelinating disorder of the central nervous system characterized by multifocal inflammatory lesions, progressive axonal degeneration, and variable neurological disability affecting sensory, motor, visual, and cognitive pathways. Accurate long-term monitoring of disease activity and neurological progression remains essential for evaluating therapeutic effectiveness, predicting prognosis, and identifying subclinical deterioration. Multimodal evoked potentials have emerged as valuable neurophysiological tools for assessment of functional integrity within sensory and motor pathways affected by demyelinating processes in multiple sclerosis. Visual evoked potentials, somatosensory evoked potentials, brainstem auditory evoked potentials, and motor evoked potentials collectively provide objective information regarding conduction abnormalities, demyelination severity, axonal dysfunction, and dissemination of lesions throughout the central nervous system. These neurophysiological techniques allow detection of clinically silent lesions and contribute significantly to early diagnosis, disease monitoring, prognostic evaluation, and assessment of therapeutic response. Visual evoked potentials are particularly sensitive for identifying optic nerve demyelination and delayed conduction associated with optic neuritis, whereas somatosensory evoked potentials evaluate dorsal column and sensory pathway integrity. Brainstem auditory evoked potentials assess conduction through auditory pathways and brainstem structures, while motor evoked potentials provide important information regarding corticospinal tract dysfunction and motor disability progression. Integration of multimodal evoked potential studies improves diagnostic sensitivity compared with isolated neurophysiological testing and offers comprehensive evaluation of widespread central nervous system involvement. Neurophysiological abnormalities frequently correlate with lesion burden observed on magnetic resonance imaging and may additionally reflect functional impairment not fully detectable through structural neuroimaging alone. Contemporary advances in digital electrophysiology, signal processing, and neurodiagnostic methodology have enhanced reliability and clinical utility of multimodal evoked potentials in multiple sclerosis follow-up. Comprehensive neurophysiological monitoring therefore represents an important component of individualized disease management and contributes substantially to optimization of therapeutic strategies, prediction of neurological outcomes, and long-term assessment of disease progression in patients with multiple sclerosis.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780310051611-MULTIMODAL_EVOKED_POTENTIALS_AS_A_NEUROPHYSIOLOGIC.pdf" type="application/pdf" length="0"/>
      <dc:creator>Tuychiyeva Mokhinur Komilovna</dc:creator>
      <dc:subject>Multiple sclerosis</dc:subject>
      <dc:subject>multimodal evoked potentials</dc:subject>
      <dc:subject>visual evoked potentials</dc:subject>
      <dc:subject>somatosensory evoked potentials</dc:subject>
      <dc:subject>motor evoked potentials</dc:subject>
      <dc:subject>neurophysiology</dc:subject>
      <dc:subject>demyelination</dc:subject>
      <dc:subject>neurodiagnostics</dc:subject>
      <dc:subject>magnetic resonance imaging</dc:subject>
      <dc:subject>neurological monitoring</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1386</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 76-90</dc:source>
    </item>
    <item>
      <title>CARDIOVASCULAR SYSTEM AND CARDIAC FUNCTION: HEMODYNAMIC REGULATION, PHYSIOLOGICAL ADAPTATIONS, AND CLINICAL SIGNIFICANCE</title>
      <link>https://aams-journal.us/journals/genetics/articles/9f77c03c-2942-46ba-9e93-8597ab0f79b0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/9f77c03c-2942-46ba-9e93-8597ab0f79b0</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Obidova Farzona¹</author>
      <description>The cardiovascular system represents one of the most complex and essential physiological systems in the human body because it maintains continuous circulation of blood, delivery of oxygen and nutrients, removal of metabolic waste products, regulation of body temperature, maintenance of acid-base balance, and coordination of neurohumoral homeostasis. Cardiac function depends on highly integrated interactions between myocardial contractility, vascular resistance, blood volume, autonomic nervous regulation, endocrine activity, and cellular metabolic processes. Hemodynamic regulation ensures stable perfusion of tissues and organs under both resting and stress-related physiological conditions through precise coordination of cardiac output, stroke volume, venous return, arterial pressure, and peripheral vascular tone. Physiological adaptations of the cardiovascular system occur in response to exercise, aging, environmental changes, pregnancy, emotional stress, and pathological conditions, allowing maintenance of circulatory stability and tissue oxygenation. Modern cardiovascular physiology increasingly emphasizes molecular, neurohumoral, and biomechanical mechanisms involved in regulation of cardiac performance and vascular function. Advances in hemodynamic monitoring, echocardiography, electrophysiology, molecular cardiology, and imaging technologies have significantly improved understanding of myocardial physiology and cardiovascular adaptation. Cardiac contractility is regulated by intracellular calcium homeostasis, autonomic nervous system activity, myocardial energy metabolism, and endocrine signaling pathways including renin-angiotensin-aldosterone mechanisms and natriuretic peptide systems. Vascular endothelial function additionally plays a fundamental role in maintenance of vascular tone, coagulation balance, inflammatory responses, and tissue perfusion through production of nitric oxide, endothelin, prostacyclin, and other vasoactive mediators. Disturbances in hemodynamic regulation and physiological adaptation contribute significantly to development of cardiovascular diseases including hypertension, ischemic heart disease, arrhythmias, heart failure, cardiomyopathy, and vascular dysfunction. The present study evaluates physiological mechanisms of cardiovascular regulation, cardiac adaptation, and their clinical significance in maintenance of systemic homeostasis and prevention of cardiovascular pathology. Clinical findings confirm that preservation of normal hemodynamic balance and cardiovascular adaptability is critically important for maintaining organ perfusion, metabolic stability, and long-term cardiovascular health. Integration of cardiovascular physiology, molecular biology, hemodynamic assessment, and clinical cardiology therefore remains essential for understanding mechanisms of cardiovascular disease development and improving modern therapeutic strategies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779370788256-CARDIOVASCULAR_SYSTEM_AND_CARDIAC_FUNCTION__HEMODY.pdf" type="application/pdf" length="0"/>
      <dc:creator>Obidova Farzona¹</dc:creator>
      <dc:creator>S.T. Eshkobilova²</dc:creator>
      <dc:subject>Cardiovascular system</dc:subject>
      <dc:subject>cardiac function</dc:subject>
      <dc:subject>hemodynamic regulation</dc:subject>
      <dc:subject>cardiac output</dc:subject>
      <dc:subject>vascular physiology</dc:subject>
      <dc:subject>myocardial contractility</dc:subject>
      <dc:subject>autonomic regulation</dc:subject>
      <dc:subject>circulatory adaptation</dc:subject>
      <dc:subject>cardiovascular physiology</dc:subject>
      <dc:subject>clinical cardiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1388</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>PATHOPHYSIOLOGICAL MECHANISMS AND THERAPEUTIC APPROACHES IN CHRONIC PERIODONTITIS</title>
      <link>https://aams-journal.us/journals/neurology/articles/66d6e299-3feb-4b05-8fae-dcd966ae82bb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/66d6e299-3feb-4b05-8fae-dcd966ae82bb</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Zoyirov Tulkin Elnazarovich</author>
      <description>Chronic periodontitis is a progressive inflammatory disease of the supporting structures of the teeth characterized by destruction of periodontal ligament fibers, alveolar bone resorption, gingival inflammation, periodontal pocket formation, and gradual tooth instability resulting from complex interactions between pathogenic microorganisms, host immune responses, genetic predisposition, and systemic risk factors. The disease represents one of the most prevalent chronic oral disorders worldwide and significantly affects oral health, masticatory function, aesthetics, psychosocial well-being, and overall quality of life. Pathophysiological mechanisms involve dysbiosis of subgingival microbiota, activation of inflammatory cytokines, oxidative stress, immune dysfunction, connective tissue degradation, osteoclastic bone resorption, vascular alterations, and chronic inflammatory destruction of periodontal tissues. Major periodontal pathogens including Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola initiate persistent inflammatory responses leading to progressive periodontal tissue breakdown. Systemic conditions such as diabetes mellitus, cardiovascular disease, smoking, hormonal imbalance, stress, obesity, and immunological disorders significantly aggravate disease severity and accelerate progression of periodontal destruction. Clinical manifestations commonly include gingival bleeding, swelling, periodontal pocket formation, halitosis, gingival recession, tooth mobility, suppuration, alveolar bone loss, and eventual tooth loss. The present study investigates pathophysiological mechanisms, inflammatory pathways, microbial factors, diagnostic criteria, therapeutic interventions, and long-term management strategies associated with chronic periodontitis. Modern diagnostic technologies including periodontal probing, radiographic imaging, microbiological analysis, inflammatory biomarker assessment, and molecular diagnostic methods significantly improve early disease detection and individualized treatment planning. Contemporary therapeutic approaches increasingly integrate non-surgical periodontal therapy, scaling and root planing, antimicrobial treatment, laser therapy, regenerative procedures, host modulation therapy, probiotics, surgical interventions, and preventive oral hygiene strategies aimed at controlling chronic inflammation and preserving periodontal structures. Clinical evidence demonstrates that comprehensive multidisciplinary treatment significantly improves periodontal stability, oral function, and long-term dental prognosis in patients with chronic periodontitis.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779369732731-PATHOPHYSIOLOGICAL_MECHANISMS_AND_THERAPEUTIC_APPR.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zoyirov Tulkin Elnazarovich</dc:creator>
      <dc:subject>Chronic periodontitis</dc:subject>
      <dc:subject>periodontal disease</dc:subject>
      <dc:subject>inflammatory mechanisms</dc:subject>
      <dc:subject>alveolar bone loss</dc:subject>
      <dc:subject>periodontal therapy</dc:subject>
      <dc:subject>oral microbiota</dc:subject>
      <dc:subject>gingival inflammation</dc:subject>
      <dc:subject>periodontal pockets</dc:subject>
      <dc:subject>connective tissue destruction</dc:subject>
      <dc:subject>dental rehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1385</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLINICAL EFFECTIVENESS OF MINIMALLY INVASIVE TECHNIQUES IN RESTORATIVE DENTAL TREATMENT</title>
      <link>https://aams-journal.us/journals/surgery/articles/51680549-3892-4825-8ac5-3d51f307c221</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/51680549-3892-4825-8ac5-3d51f307c221</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Zoyirov Tulkin Elnazarovich</author>
      <description>Minimally invasive dentistry has become one of the most important directions in contemporary restorative dental practice because it focuses on preservation of healthy tooth structure, early diagnosis of pathological processes, prevention of disease progression, and biological rehabilitation of oral tissues. Traditional restorative approaches frequently involved extensive mechanical preparation and removal of significant amounts of sound dental tissues, which often weakened structural integrity of teeth and increased the risk of long-term complications. Modern minimally invasive techniques emphasize selective tissue removal, adhesive restorative procedures, biomimetic rehabilitation, and preservation of natural tooth anatomy while maintaining functional and aesthetic outcomes. Contemporary restorative methods including atraumatic restorative treatment, air abrasion, chemo-mechanical caries removal, laser-assisted cavity preparation, resin infiltration, adhesive dentistry, and bioactive restorative systems significantly improve patient comfort and long-term treatment success. Advances in adhesive materials, bioactive composites, glass ionomer technologies, nanomaterials, and digital restorative systems have expanded clinical possibilities for conservative management of dental caries and structural defects. Minimally invasive restorative strategies additionally contribute to reduction of postoperative sensitivity, preservation of pulpal vitality, improvement of periodontal health, and enhancement of patient satisfaction. The present study evaluates the clinical effectiveness, biological advantages, functional outcomes, and long-term prognosis associated with minimally invasive techniques in restorative dental treatment. Modern diagnostic technologies including digital radiography, laser fluorescence, transillumination systems, operating microscopy, and caries risk assessment facilitate early identification of dental pathology and improve precision of conservative treatment planning. Clinical findings demonstrate that minimally invasive restorative approaches significantly improve preservation of dental tissues, reduce procedural trauma, minimize postoperative complications, and enhance longevity of restorations compared with conventional aggressive preparation techniques. Integration of preventive dentistry, adhesive technologies, biomimetic materials, and conservative operative principles therefore represents a major advancement in restorative dental science and contributes substantially to long-term oral health preservation.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779367297010-CLINICAL_EFFECTIVENESS_OF_MINIMALLY_INVASIVE_TECHN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zoyirov Tulkin Elnazarovich</dc:creator>
      <dc:subject>Minimally invasive dentistry</dc:subject>
      <dc:subject>restorative treatment</dc:subject>
      <dc:subject>adhesive dentistry</dc:subject>
      <dc:subject>biomimetic restoration</dc:subject>
      <dc:subject>selective caries removal</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>conservative dentistry</dc:subject>
      <dc:subject>resin infiltration</dc:subject>
      <dc:subject>atraumatic restorative treatment</dc:subject>
      <dc:subject>dental rehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1382</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>THE ROLE OF BIOACTIVE RESTORATIVE MATERIALS IN THE MANAGEMENT OF NON-CARIOUS CERVICAL LESIONS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/91f8b1a4-5f05-4a57-b8cb-53c4160cb1b1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/91f8b1a4-5f05-4a57-b8cb-53c4160cb1b1</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Zoyirov Tulkin Elnazarovich</author>
      <description>Non-carious cervical lesions represent a multifactorial pathological condition characterized by progressive loss of dental hard tissues in the cervical region of teeth unrelated to bacterial caries. These lesions develop as a consequence of complex interactions between mechanical stress, abrasion, erosion, abfraction, occlusal overload, chemical exposure, and age-related structural changes affecting enamel and dentin integrity. Progressive destruction of cervical tooth structures frequently leads to dentin hypersensitivity, aesthetic impairment, plaque accumulation, gingival irritation, structural weakening of teeth, and decreased oral health-related quality of life. Bioactive restorative materials have emerged as an important advancement in restorative dentistry because of their ability to interact biologically with dental tissues, promote remineralization, release therapeutic ions, enhance chemical adhesion, and improve long-term restoration stability. Modern bioactive materials including glass ionomer cements, resin-modified glass ionomers, giomers, calcium silicate-based materials, bioactive composites, and biomimetic restorative systems demonstrate favorable biological properties including fluoride release, calcium-phosphate ion exchange, antibacterial activity, dentin remineralization, and reduction of postoperative sensitivity. The present study investigates etiological mechanisms, clinical manifestations, diagnostic evaluation, and therapeutic effectiveness of bioactive restorative materials in management of non-carious cervical lesions. Modern diagnostic approaches including clinical examination, occlusal analysis, radiographic evaluation, dentin hypersensitivity testing, and assessment of occlusal stress significantly improve early identification and individualized treatment planning. Contemporary therapeutic strategies increasingly emphasize minimally invasive dentistry, preservation of tooth structure, adhesive rehabilitation, occlusal correction, preventive oral hygiene, and application of biologically active restorative materials aimed at long-term functional and aesthetic rehabilitation. Clinical evidence demonstrates that bioactive restorative systems significantly improve marginal adaptation, dentin protection, remineralization, restoration durability, and patient comfort while reducing recurrence and postoperative hypersensitivity associated with non-carious cervical lesions.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779368382614-THE_ROLE_OF_BIOACTIVE_RESTORATIVE_MATERIALS_IN_THE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zoyirov Tulkin Elnazarovich</dc:creator>
      <dc:subject>Non-carious cervical lesions</dc:subject>
      <dc:subject>bioactive restorative materials</dc:subject>
      <dc:subject>dentin hypersensitivity</dc:subject>
      <dc:subject>glass ionomer cement</dc:subject>
      <dc:subject>biomimetic dentistry</dc:subject>
      <dc:subject>cervical abrasion</dc:subject>
      <dc:subject>abfraction</dc:subject>
      <dc:subject>remineralization</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>adhesive rehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1384</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 76-90</dc:source>
    </item>
    <item>
      <title>MODERN LABORATORY DIAGNOSTIC METHODS IN THE EARLY DETECTION OF INFECTIOUS AND INFLAMMATORY DISEASES</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/ff1cb423-327d-4962-9b56-8dad0de93bcf</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/ff1cb423-327d-4962-9b56-8dad0de93bcf</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Ganjiyeva Munisa Komil qizi</author>
      <description>Early and accurate diagnosis of infectious and inflammatory diseases remains one of the most important priorities in modern clinical medicine because delayed detection frequently contributes to severe complications, systemic organ damage, prolonged hospitalization, antimicrobial resistance, and increased mortality. Contemporary laboratory diagnostics have undergone significant technological advancement and now provide highly sensitive, specific, and rapid methods for identification of infectious agents, inflammatory biomarkers, immune responses, and molecular pathological changes during the earliest stages of disease development. Modern laboratory techniques including polymerase chain reaction, real-time molecular diagnostics, enzyme-linked immunosorbent assays, immunofluorescence testing, flow cytometry, automated hematological analysis, microbiological culture systems, serological assays, and next-generation sequencing substantially improve diagnostic precision and therapeutic decision-making. Infectious diseases caused by bacterial, viral, fungal, and parasitic pathogens often demonstrate nonspecific clinical manifestations during early stages, making laboratory investigation critically important for timely identification and initiation of targeted therapy. Inflammatory diseases additionally involve complex immune-mediated processes associated with activation of cytokines, acute-phase proteins, cellular immune responses, and biochemical markers that can be accurately detected through advanced laboratory analysis. Biomarkers such as C-reactive protein, procalcitonin, erythrocyte sedimentation rate, interleukins, tumor necrosis factor-alpha, leukocyte indices, and specific antibodies play essential roles in evaluation of inflammatory activity and differentiation between infectious and noninfectious pathological conditions. Molecular diagnostic technologies significantly reduce diagnostic time and allow rapid detection of microbial genetic material even before development of overt clinical symptoms. Automated laboratory systems and artificial intelligence-assisted diagnostic platforms further enhance efficiency, reproducibility, and analytical accuracy. Integration of microbiological, immunological, hematological, biochemical, and molecular diagnostic methods therefore represents a fundamental component of contemporary medical practice. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779379262483-MODERN_LABORATORY_DIAGNOSTIC_METHODS_IN_THE_EARLY_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ganjiyeva Munisa Komil qizi</dc:creator>
      <dc:subject>Laboratory diagnostics</dc:subject>
      <dc:subject>infectious diseases</dc:subject>
      <dc:subject>inflammatory diseases</dc:subject>
      <dc:subject>polymerase chain reaction</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>molecular diagnostics</dc:subject>
      <dc:subject>immunology</dc:subject>
      <dc:subject>microbiology</dc:subject>
      <dc:subject>serological testing</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1391</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 46-60</dc:source>
    </item>
    <item>
      <title>DIFFERENTIAL DIAGNOSIS OF CHRONIC ENCEPHALITIS VS. NEURODEGENERATIVE DISEASES (ALZHEIMER’S DISEASE AND FRONTOTEMPORAL DEMENTIA)</title>
      <link>https://aams-journal.us/journals/dentistry/articles/25a8a8eb-56ec-44ec-9ba7-05a2d6eec06e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/25a8a8eb-56ec-44ec-9ba7-05a2d6eec06e</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Tuychiyeva Mokhinur Komilovna</author>
      <description>Chronic encephalitis and neurodegenerative disorders such as Alzheimer’s disease and frontotemporal dementia represent complex neurological conditions characterized by progressive cognitive decline, behavioral disturbances, neuropsychiatric manifestations, and impairment of functional activity. Despite similarities in clinical presentation, these disorders differ significantly in etiology, pathophysiology, inflammatory activity, neuroimaging characteristics, cerebrospinal fluid biomarkers, progression patterns, and therapeutic response. Accurate differential diagnosis is critically important because chronic encephalitis may be reversible or partially treatable if identified during early stages, whereas neurodegenerative diseases are usually characterized by progressive neuronal degeneration and irreversible cognitive deterioration. Chronic encephalitis involves persistent inflammatory processes affecting the central nervous system and may result from autoimmune, viral, paraneoplastic, infectious, or immune-mediated mechanisms. Long-standing inflammation contributes to neuronal dysfunction, gliosis, synaptic disruption, and diffuse cerebral injury leading to cognitive impairment and psychiatric symptoms. Alzheimer’s disease is primarily associated with accumulation of beta-amyloid plaques and hyperphosphorylated tau protein causing progressive cortical atrophy and memory dysfunction. Frontotemporal dementia is characterized by degeneration of frontal and temporal lobes accompanied by behavioral abnormalities, executive dysfunction, language impairment, and personality changes. Clinical differentiation among these disorders requires comprehensive neurological evaluation including neuropsychological testing, magnetic resonance imaging, electroencephalography, cerebrospinal fluid analysis, autoimmune antibody screening, molecular biomarkers, and assessment of inflammatory activity. Neuroimaging studies play an essential role in identifying inflammatory lesions, cortical atrophy patterns, hippocampal degeneration, white matter abnormalities, and metabolic changes. Cerebrospinal fluid analysis additionally contributes to diagnosis through detection of inflammatory markers, oligoclonal bands, viral antibodies, tau proteins, amyloid alterations, and neuronal injury biomarkers. Early recognition of chronic encephalitis is especially important because immunotherapy, antiviral treatment, corticosteroids, plasmapheresis, and immunomodulatory strategies may significantly improve neurological outcomes. Advances in neuroimmunology, molecular diagnostics, biomarker research, and neuroimaging technologies have substantially improved differentiation between inflammatory encephalitic conditions and primary neurodegenerative disorders. Comprehensive understanding of clinical, radiological, immunological, and pathological differences therefore remains essential for accurate diagnosis, optimization of therapeutic strategies, and improvement of long-term neurological prognosis.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1780310112574-DIFFERENTIAL_DIAGNOSIS_OF_CHRONIC_ENCEPHALITIS_VS_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Tuychiyeva Mokhinur Komilovna</dc:creator>
      <dc:subject>Chronic encephalitis</dc:subject>
      <dc:subject>Alzheimer’s disease</dc:subject>
      <dc:subject>frontotemporal dementia</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>cognitive impairment</dc:subject>
      <dc:subject>neuroinflammation</dc:subject>
      <dc:subject>differential diagnosis</dc:subject>
      <dc:subject>MRI</dc:subject>
      <dc:subject>cerebrospinal fluid</dc:subject>
      <dc:subject>autoimmune encephalitis</dc:subject>
      <dc:subject>dementia</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1387</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>DENTAL GROUPS, THEIR ANATOMY, HISTOLOGY, AND PHYSIOLOGY</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/509afecf-1e2e-4d14-bf01-d9d27aea7d4a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/509afecf-1e2e-4d14-bf01-d9d27aea7d4a</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Obidova Farzona Firdavsovna¹</author>
      <description>Dental groups represent highly specialized anatomical structures essential for mastication, phonetics, aesthetics, occlusal balance, and maintenance of overall oral health. Human dentition consists of different categories of teeth including incisors, canines, premolars, and molars, each possessing unique anatomical, histological, and physiological characteristics adapted to specific functional requirements within the stomatognathic system. Teeth are composed of mineralized and soft tissues organized in a complex structural arrangement that ensures resistance to mechanical stress, protection of internal structures, sensory perception, and participation in metabolic and biological processes. Dental anatomy focuses on morphology, crown configuration, root structure, occlusal surfaces, and positional relationships of teeth within the dental arches. Histological organization of dental tissues includes enamel, dentin, cementum, and dental pulp, each demonstrating specialized cellular composition and biological function. Enamel represents the hardest mineralized tissue in the human body and serves as the primary protective barrier against physical, chemical, and bacterial influences. Dentin forms the major structural component of teeth and provides elasticity, sensory transmission, and support for enamel. Cementum covers the root surface and participates in attachment of periodontal ligament fibers essential for stabilization of teeth within alveolar bone. Dental pulp contains vascular, nervous, connective, and cellular elements responsible for nutrition, immune defense, reparative dentinogenesis, and sensory regulation. Physiology of dental tissues involves complex interactions among mastication, occlusal force distribution, salivary protection, sensory innervation, mineral metabolism, and periodontal adaptation. Development, eruption, and functional adaptation of teeth are regulated through coordinated genetic, molecular, hormonal, and biomechanical mechanisms. Disturbances in anatomical integrity, histological organization, or physiological function may contribute to development of caries, periodontal disease, occlusal disorders, pulpal pathology, and tooth loss. Modern advances in dental anatomy, oral histology, molecular biology, and biomaterials science have significantly improved understanding of dental tissue organization and physiological adaptation. Clinical evidence confirms that comprehensive knowledge of dental groups and their structural and functional properties remains essential for restorative dentistry, prosthodontics, orthodontics, periodontology, oral surgery, and preventive dental care. Integration of anatomical, histological, and physiological principles therefore represents a fundamental basis for modern dental science and clinical practice.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779371438780-DENTAL_GROUPS__THEIR_ANATOMY__HISTOLOGY__AND_PHYSI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Obidova Farzona Firdavsovna¹</dc:creator>
      <dc:creator>Turumova Marjona Baxodirovna²</dc:creator>
      <dc:subject>Dental anatomy</dc:subject>
      <dc:subject>oral histology</dc:subject>
      <dc:subject>tooth physiology</dc:subject>
      <dc:subject>incisors</dc:subject>
      <dc:subject>canines</dc:subject>
      <dc:subject>premolars</dc:subject>
      <dc:subject>molars</dc:subject>
      <dc:subject>enamel</dc:subject>
      <dc:subject>dentin</dc:subject>
      <dc:subject>dental pulp</dc:subject>
      <dc:subject>cementum</dc:subject>
      <dc:subject>periodontal ligament</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1390</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MODERN METHODS FOR THE PREVENTION AND TREATMENT OF DENTAL CARIES IN THERAPEUTIC DENTISTRY</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/74ff031f-3aff-426a-82de-83f0e3e49b79</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/74ff031f-3aff-426a-82de-83f0e3e49b79</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Zoyirov Tulkin Elnazarovich</author>
      <description>Dental caries remains one of the most prevalent chronic diseases worldwide and continues to represent a major public health challenge affecting individuals of all age groups. The disease is characterized by progressive demineralization and destruction of dental hard tissues caused by complex interactions between cariogenic microorganisms, fermentable carbohydrates, host susceptibility, salivary composition, and environmental risk factors. Untreated carious lesions may lead to pulpal inflammation, tooth loss, impaired mastication, aesthetic dysfunction, speech difficulties, and reduction in quality of life. Contemporary therapeutic dentistry increasingly emphasizes preventive care, early diagnosis, minimally invasive intervention, remineralization strategies, and biological preservation of natural dental structures. Modern preventive and therapeutic approaches focus not only on restoration of structural defects but also on control of etiological factors responsible for disease initiation and progression. Advances in cariology, adhesive dentistry, digital diagnostics, biomaterials science, nanotechnology, and preventive medicine have significantly improved effectiveness of caries management and long-term oral rehabilitation. Preventive methods including fluoride therapy, pit and fissure sealants, oral hygiene programs, dietary counseling, antimicrobial therapy, salivary stimulation, probiotics, and remineralizing agents have demonstrated substantial effectiveness in reducing incidence and progression of dental caries. Contemporary diagnostic technologies such as laser fluorescence devices, digital radiography, transillumination systems, quantitative light-induced fluorescence, and optical coherence tomography facilitate early identification of demineralization before cavitation develops. Minimally invasive therapeutic techniques including selective caries removal, atraumatic restorative treatment, resin infiltration, adhesive restoration, air abrasion, and bioactive restorative systems significantly improve preservation of healthy dental tissues and reduce postoperative complications. Bioactive restorative materials including glass ionomer cements, resin-modified glass ionomers, giomers, nanocomposites, and calcium-phosphate-based biomaterials demonstrate favorable antibacterial activity, fluoride release, remineralization potential, and improved biological compatibility. The present study evaluates modern preventive and therapeutic methods used in management of dental caries in contemporary therapeutic dentistry and analyzes their clinical effectiveness, biological advantages, and long-term outcomes. Clinical findings confirm that integration of preventive strategies, minimally invasive restorative procedures, advanced biomaterials, and patient-centered oral hygiene programs significantly improves caries control, preservation of natural dentition, and overall oral health status.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779367682639-MODERN_METHODS_FOR_THE_PREVENTION_AND_TREATMENT_OF.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zoyirov Tulkin Elnazarovich</dc:creator>
      <dc:subject>Dental caries</dc:subject>
      <dc:subject>preventive dentistry</dc:subject>
      <dc:subject>minimally invasive treatment</dc:subject>
      <dc:subject>remineralization</dc:subject>
      <dc:subject>fluoride therapy</dc:subject>
      <dc:subject>adhesive restoration</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>therapeutic dentistry</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>caries management</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1383</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>ENDODONTIC TREATMENT OUTCOMES USING CONTEMPORARY IRRIGATION AND OBTURATION TECHNIQUES</title>
      <link>https://aams-journal.us/journals/dentistry/articles/97aefc65-e665-4fc2-bead-619dd68cf962</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/97aefc65-e665-4fc2-bead-619dd68cf962</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate>
      <author>Zoyirov Tulkin Elnazarovich</author>
      <description>Endodontic treatment is a fundamental component of restorative dentistry aimed at preservation of natural dentition through elimination of infected pulp tissue, disinfection of root canal systems, prevention of reinfection, and long-term maintenance of periapical health. Successful endodontic therapy depends on effective biomechanical preparation, microbial eradication, adequate irrigation, and three-dimensional obturation of complex root canal anatomy. Contemporary irrigation and obturation techniques have significantly improved clinical outcomes by enhancing debridement efficiency, removal of smear layer, penetration of antimicrobial solutions, and sealing quality within root canal systems. Modern irrigation protocols involving sodium hypochlorite, chlorhexidine, ethylenediaminetetraacetic acid, ultrasonic activation, sonic agitation, laser-assisted disinfection, and negative-pressure irrigation systems demonstrate improved antimicrobial effectiveness and enhanced cleaning of inaccessible anatomical regions including lateral canals, isthmuses, apical ramifications, and dentinal tubules. Contemporary obturation methods including warm vertical compaction, thermoplasticized gutta-percha, carrier-based systems, bioceramic sealers, hydraulic condensation, and injectable obturation techniques provide superior adaptation to canal walls and reduction of microleakage. The present study evaluates clinical effectiveness, antimicrobial efficacy, radiographic healing, postoperative complications, and long-term prognosis associated with contemporary irrigation and obturation approaches in endodontic therapy. Modern diagnostic technologies including cone-beam computed tomography, electronic apex locators, operating microscopy, digital radiography, and microbial assessment significantly improve treatment precision and facilitate preservation of periapical tissues. Clinical findings demonstrate that advanced irrigation activation systems and bioactive obturation materials significantly enhance root canal disinfection, reduce postoperative pain, improve periapical healing, and increase long-term success rates of endodontic treatment. Integration of minimally invasive instrumentation, antimicrobial irrigation, bioceramic materials, and three-dimensional obturation strategies has become essential for predictable preservation of endodontically treated teeth and improvement of oral health outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779366851645-ENDODONTIC_TREATMENT_OUTCOMES_USING_CONTEMPORARY_I.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zoyirov Tulkin Elnazarovich</dc:creator>
      <dc:subject>Endodontic treatment</dc:subject>
      <dc:subject>root canal therapy</dc:subject>
      <dc:subject>irrigation techniques</dc:subject>
      <dc:subject>obturation methods</dc:subject>
      <dc:subject>bioceramic sealers</dc:subject>
      <dc:subject>sodium hypochlorite</dc:subject>
      <dc:subject>thermoplasticized gutta-percha</dc:subject>
      <dc:subject>root canal disinfection</dc:subject>
      <dc:subject>periapical healing</dc:subject>
      <dc:subject>contemporary endodontics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1381</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 61-75</dc:source>
    </item>
    <item>
      <title>THE IMPACT OF ALLERGIC RHINITIS ON QUALITY OF LIFE AND RESPIRATORY HEALTH IN PEDIATRIC PATIENTS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/19017230-b4b3-47ed-9b4c-253e471ea161</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/19017230-b4b3-47ed-9b4c-253e471ea161</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Prof. Nasretdinova M.T¹</author>
      <description>Allergic rhinitis is one of the most common chronic inflammatory diseases affecting the pediatric population and represents a significant public health concern due to its increasing prevalence and substantial impact on respiratory function, physical development, cognitive performance, emotional well-being, and overall quality of life. The disorder develops as an immunoglobulin E-mediated hypersensitivity reaction following exposure to environmental allergens including pollen, house dust mites, animal dander, molds, and air pollutants. Complex immunopathological mechanisms involve activation of mast cells, eosinophilic inflammation, cytokine release, mucosal edema, increased vascular permeability, and chronic inflammatory remodeling of the upper respiratory tract. Clinical manifestations commonly include nasal obstruction, rhinorrhea, sneezing, nasal itching, conjunctival irritation, sleep disturbances, mouth breathing, fatigue, impaired concentration, and decreased academic performance. Persistent allergic inflammation additionally contributes to increased risk of asthma, recurrent respiratory infections, sinusitis, otitis media, and lower airway dysfunction. This study investigates the influence of allergic rhinitis on respiratory health and quality of life in pediatric patients with emphasis on immunopathogenesis, clinical manifestations, diagnostic evaluation, associated respiratory complications, psychosocial effects, and contemporary therapeutic approaches. Modern diagnostic strategies include allergological testing, nasal endoscopy, pulmonary function assessment, immunological evaluation, and quality-of-life analysis aimed at improving diagnostic precision and individualized treatment planning. Contemporary management increasingly incorporates allergen avoidance, antihistamines, intranasal corticosteroids, leukotriene receptor antagonists, immunotherapy, biologic agents, respiratory rehabilitation, and environmental control measures. Clinical findings demonstrate that early diagnosis, comprehensive allergy management, and individualized therapeutic strategies significantly improve respiratory function, reduce inflammatory complications, enhance sleep quality, optimize psychosocial adaptation, and improve long-term quality of life in pediatric patients with allergic rhinitis. Allergic rhinitis is a chronic immunologically mediated inflammatory disease of the upper respiratory tract that significantly affects respiratory health, psychosocial adaptation, cognitive performance, sleep quality, and overall well-being in pediatric patients. The disorder develops due to hypersensitivity reactions triggered by environmental allergens such as pollen, dust mites, molds, animal dander, and airborne pollutants, resulting in persistent inflammation of nasal mucosa and progressive respiratory dysfunction. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779292562271-THE_IMPACT_OF_ALLERGIC_RHINITIS_ON_QUALITY_OF_LIFE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Prof. Nasretdinova M.T¹</dc:creator>
      <dc:creator>Jonuzokov O.K²</dc:creator>
      <dc:creator>Normurodov N.A³</dc:creator>
      <dc:creator>Xudoyberdiyev O.S⁴</dc:creator>
      <dc:subject>Allergic rhinitis</dc:subject>
      <dc:subject>pediatric allergy</dc:subject>
      <dc:subject>respiratory health</dc:subject>
      <dc:subject>nasal inflammation</dc:subject>
      <dc:subject>immunoglobulin E</dc:subject>
      <dc:subject>asthma</dc:subject>
      <dc:subject>pediatric respiratory disease</dc:subject>
      <dc:subject>allergen exposure</dc:subject>
      <dc:subject>quality of life</dc:subject>
      <dc:subject>immunotherapy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1375</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLINICAL CHARACTERISTICS AND THERAPEUTIC MANAGEMENT OF VASOMOTOR RHINITIS IN FEMALE PATIENTS</title>
      <link>https://aams-journal.us/journals/surgery/articles/c664dcbc-17fd-4252-a8dd-32ed999ceb11</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/c664dcbc-17fd-4252-a8dd-32ed999ceb11</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Prof. Nasretdinova M.T¹</author>
      <description>Vasomotor rhinitis is a chronic non-allergic inflammatory disorder of the nasal mucosa characterized by dysregulation of autonomic neurovascular control mechanisms leading to persistent nasal congestion, rhinorrhea, sneezing, mucosal edema, and respiratory discomfort in the absence of infectious or allergic etiological factors. Female patients demonstrate increased susceptibility to vasomotor rhinitis due to hormonal fluctuations, autonomic nervous system instability, vascular hypersensitivity, endocrine influences, emotional stress, and environmental triggers affecting nasal vascular regulation. The disease significantly influences respiratory comfort, sleep quality, emotional well-being, occupational performance, and overall quality of life. Pathophysiological mechanisms involve neurogenic inflammation, parasympathetic hyperactivity, vascular dilation, mucosal hyperreactivity, epithelial dysfunction, and impaired nasal airflow regulation. Common provoking factors include temperature changes, strong odors, tobacco smoke, air pollution, hormonal imbalance, psychological stress, spicy foods, cosmetic products, and environmental irritants. Clinical manifestations frequently include persistent nasal obstruction, watery nasal discharge, episodic sneezing, headache, facial pressure, reduced concentration, sleep disturbance, fatigue, and chronic mucosal irritation. The present study investigates clinical characteristics, hormonal and neurovascular influences, diagnostic features, therapeutic approaches, and long-term management strategies of vasomotor rhinitis in female patients. Modern diagnostic methods including rhinoscopy, nasal endoscopy, autonomic assessment, hormonal evaluation, allergy exclusion testing, and rhinomanometry significantly improve diagnostic accuracy and facilitate individualized treatment planning. Contemporary therapeutic management increasingly incorporates intranasal corticosteroids, antihistamines, anticholinergic therapy, saline irrigation, physiotherapy, stress reduction, hormonal stabilization, lifestyle modification, and minimally invasive surgical interventions aimed at improving nasal function and reducing chronic symptoms. Clinical observations demonstrate that comprehensive individualized treatment significantly improves respiratory function, symptom control, and quality of life among female patients with vasomotor rhinitis.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779298717514-CLINICAL_CHARACTERISTICS_AND_THERAPEUTIC_MANAGEMEN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Prof. Nasretdinova M.T¹</dc:creator>
      <dc:creator>Tadjibayev D.A²</dc:creator>
      <dc:creator>Normurodov N.A³</dc:creator>
      <dc:creator>Tangirov I.I⁴</dc:creator>
      <dc:subject>Vasomotor rhinitis</dc:subject>
      <dc:subject>female patients</dc:subject>
      <dc:subject>chronic rhinitis</dc:subject>
      <dc:subject>nasal obstruction</dc:subject>
      <dc:subject>autonomic dysfunction</dc:subject>
      <dc:subject>hormonal imbalance</dc:subject>
      <dc:subject>non-allergic rhinitis</dc:subject>
      <dc:subject>neurogenic inflammation</dc:subject>
      <dc:subject>respiratory disorders</dc:subject>
      <dc:subject>therapeutic management</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1379</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>THE INFLUENCE OF OCCLUSAL DISORDERS ON THE LONGEVITY OF PROSTHODONTIC RESTORATIONS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/384594a4-9b96-408f-8fb9-0372bea9a9db</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/384594a4-9b96-408f-8fb9-0372bea9a9db</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Niyozov Orifjon¹</author>
      <description>Occlusal harmony plays a fundamental role in the long-term clinical success, biomechanical stability, and functional durability of prosthodontic restorations. Disturbances in occlusal relationships significantly affect distribution of masticatory forces, temporomandibular joint function, periodontal stability, muscular coordination, and integrity of restorative materials. Occlusal disorders including malocclusion, premature contacts, bruxism, occlusal trauma, parafunctional activity, and temporomandibular dysfunction contribute to accelerated wear, fracture, loosening, marginal failure, and biomechanical overload of prosthetic restorations. This study investigates the influence of occlusal abnormalities on longevity and clinical performance of fixed and removable prosthodontic constructions with emphasis on biomechanical stress distribution, prosthetic complications, periodontal response, implant stability, temporomandibular adaptation, and patient-related functional outcomes. Contemporary diagnostic methods including articulator analysis, digital occlusal assessment, electromyography, radiographic imaging, and computerized bite-force evaluation were analyzed to determine their role in prevention and correction of occlusal imbalance. The findings demonstrate that accurate occlusal diagnosis, balanced force distribution, individualized prosthetic planning, and early management of occlusal dysfunction significantly improve restoration survival, reduce mechanical and biological complications, preserve oral structures, and enhance long-term prosthodontic success. Modern prosthodontics increasingly integrates digital occlusal analysis, biomaterials science, implant biomechanics, and interdisciplinary treatment protocols aimed at optimizing functional harmony and prolonging restoration longevity. Occlusal balance is one of the most important determinants influencing functional stability, structural durability, and long-term clinical success of prosthodontic restorations. Disturbances in occlusal relationships significantly affect biomechanical force distribution within the stomatognathic system and may lead to progressive deterioration of restorative materials, periodontal tissues, temporomandibular joints, and implant-supported constructions. Occlusal disorders including malocclusion, premature contacts, parafunctional habits, traumatic occlusion, bruxism, and temporomandibular dysfunction contribute to excessive mechanical stress, muscular hyperactivity, prosthetic instability, marginal failure, ceramic fracture, peri-implant overload, and accelerated wear of restorative surfaces. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779290717530-THE_INFLUENCE_OF_OCCLUSAL_DISORDERS_ON_THE_LONGEVI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Niyozov Orifjon¹</dc:creator>
      <dc:creator>Inogamov Sherzod²</dc:creator>
      <dc:subject>Occlusal disorders</dc:subject>
      <dc:subject>prosthodontic restorations</dc:subject>
      <dc:subject>malocclusion</dc:subject>
      <dc:subject>prosthetic longevity</dc:subject>
      <dc:subject>occlusal trauma</dc:subject>
      <dc:subject>temporomandibular dysfunction</dc:subject>
      <dc:subject>bruxism</dc:subject>
      <dc:subject>implant biomechanics</dc:subject>
      <dc:subject>prosthodontics</dc:subject>
      <dc:subject>occlusal analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1372</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 61-75</dc:source>
    </item>
    <item>
      <title>CLINICAL AND PATHOPHYSIOLOGICAL FEATURES OF MIGRAINE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES</title>
      <link>https://aams-journal.us/journals/neurology/articles/28c69ebe-814a-45c9-ae59-68c78a5df122</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/28c69ebe-814a-45c9-ae59-68c78a5df122</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Niyozov Shahzod</author>
      <description>Migraine is a chronic neurovascular disorder characterized by recurrent episodes of moderate to severe headache accompanied by neurological, gastrointestinal, sensory, and autonomic manifestations that significantly impair quality of life and functional capacity. The disease affects individuals of various age groups and represents one of the leading causes of neurological disability worldwide. Migraine pathophysiology involves complex interactions between genetic predisposition, cortical neuronal hyperexcitability, trigeminovascular activation, neurogenic inflammation, vascular dysregulation, neurotransmitter imbalance, and central sensitization mechanisms. Clinical manifestations include unilateral pulsating headache, photophobia, phonophobia, nausea, vomiting, visual aura, sensory disturbances, cognitive dysfunction, and autonomic symptoms that vary in severity and frequency among patients. This study investigates the clinical and pathophysiological characteristics of migraine with emphasis on molecular mechanisms, diagnostic evaluation, neuroimaging findings, triggering factors, disease progression, and contemporary therapeutic strategies. Modern diagnostic approaches include neurological examination, headache classification systems, magnetic resonance imaging, functional neuroimaging, electrophysiological assessment, and biomarker analysis aimed at improving diagnostic precision and differentiation from secondary headache disorders. Contemporary therapeutic management increasingly incorporates individualized pharmacological therapy, calcitonin gene-related peptide inhibitors, triptans, monoclonal antibodies, neuromodulation techniques, preventive medications, behavioral interventions, and lifestyle modification strategies. The findings demonstrate that early diagnosis, comprehensive evaluation of triggering mechanisms, and personalized therapeutic approaches significantly reduce migraine frequency, improve functional outcomes, decrease neurological disability, and enhance overall patient quality of life. Migraine is a chronic neurological disorder characterized by recurrent attacks of moderate or severe headache associated with sensory, autonomic, cognitive, and gastrointestinal disturbances that significantly reduce functional capacity and quality of life. The disorder represents one of the most common causes of neurological disability worldwide and affects individuals across different age groups, with higher prevalence among women due to hormonal and neuroendocrine influences. Modern scientific understanding demonstrates that migraine is not solely a vascular pathology but rather a multifactorial neurovascular condition involving abnormal neuronal excitability, cortical spreading depression, trigeminovascular activation, neurogenic inflammation, neurotransmitter imbalance, and dysregulation of central pain-processing pathways. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779291177552-CLINICAL_AND_PATHOPHYSIOLOGICAL_FEATURES_OF_MIGRAI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Niyozov Shahzod</dc:creator>
      <dc:subject>Migraine</dc:subject>
      <dc:subject>neurovascular disorder</dc:subject>
      <dc:subject>trigeminovascular system</dc:subject>
      <dc:subject>cortical spreading depression</dc:subject>
      <dc:subject>headache</dc:subject>
      <dc:subject>CGRP inhibitors</dc:subject>
      <dc:subject>aura</dc:subject>
      <dc:subject>neurological disease</dc:subject>
      <dc:subject>migraine therapy</dc:subject>
      <dc:subject>neuroinflammation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1373</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 76-90</dc:source>
    </item>
    <item>
      <title>THE IMPORTANCE OF TARGETED THERAPY IN AUTOIMMUNE DISEASES</title>
      <link>https://aams-journal.us/journals/dentistry/articles/60a2adeb-36ea-4760-827f-98801c80e289</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/60a2adeb-36ea-4760-827f-98801c80e289</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Yarmatova Mohina¹</author>
      <description>Autoimmune diseases comprise a heterogeneous group of chronic inflammatory disorders characterized by dysregulation of the immune system and loss of self-tolerance. These conditions affect multiple organs and significantly impair patients&apos; quality of life while increasing long-term morbidity and healthcare costs. Conventional immunosuppressive therapies have substantially improved disease control; however, their non-selective mechanisms frequently lead to systemic adverse effects and incomplete remission. The development of targeted therapy has transformed the management of autoimmune diseases by selectively inhibiting specific molecular pathways responsible for immune activation and chronic inflammation. The present study reviews the clinical significance of targeted therapy in autoimmune disorders, emphasizing its mechanisms of action, therapeutic efficacy, safety profile, and future perspectives. Current evidence indicates that targeted therapeutic agents effectively reduce disease activity, preserve organ function, decrease relapse rates, and improve long-term clinical outcomes while minimizing generalized immunosuppression. Personalized treatment strategies based on immunological and molecular characteristics represent a major advancement in modern autoimmune disease management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783003252519-THE_IMPORTANCE_OF_TARGETED_THERAPY_IN_AUTOIMMUNE_D.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yarmatova Mohina¹</dc:creator>
      <dc:creator>Keldiyarov Tohir²</dc:creator>
      <dc:creator>Uzoqova Oyjamol³</dc:creator>
      <dc:subject>autoimmune diseases</dc:subject>
      <dc:subject>targeted therapy</dc:subject>
      <dc:subject>biologic agents</dc:subject>
      <dc:subject>immune modulation</dc:subject>
      <dc:subject>cytokines</dc:subject>
      <dc:subject>monoclonal antibodies</dc:subject>
      <dc:subject>Janus kinase inhibitors</dc:subject>
      <dc:subject>precision medicine</dc:subject>
      <dc:subject>chronic inflammation</dc:subject>
      <dc:subject>immunology.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 76-90</dc:source>
    </item>
    <item>
      <title>IMMUNOSUPPRESSIVE THERAPY AFTER KIDNEY TRANSPLANTATION</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/5ede5199-b8ce-4a2c-8988-c0e412c1ac52</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/5ede5199-b8ce-4a2c-8988-c0e412c1ac52</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Norbekov Raximjon¹</author>
      <description>Kidney transplantation is considered the optimal treatment for patients with end-stage renal disease, offering superior survival, improved quality of life, and better long-term clinical outcomes compared with dialysis. Despite remarkable advances in surgical techniques and perioperative care, immune-mediated graft rejection remains one of the principal challenges affecting transplant success. Immunosuppressive therapy plays a fundamental role in preventing acute and chronic rejection while preserving allograft function. The objective of this study was to evaluate contemporary immunosuppressive strategies following kidney transplantation, assess their clinical effectiveness, and analyze complications associated with long-term immunomodulation. The review demonstrates that individualized immunosuppressive protocols significantly improve graft survival while minimizing adverse effects. Careful monitoring of immunological status, drug concentrations, and patient-specific risk factors remains essential for achieving optimal transplant outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783002748707-IMMUNOSUPPRESSIVE_THERAPY_AFTER_KIDNEY_TRANSPLANTA.pdf" type="application/pdf" length="0"/>
      <dc:creator>Norbekov Raximjon¹</dc:creator>
      <dc:creator>Almamatov Ortiq²</dc:creator>
      <dc:creator>Uzoqova Oyjamol³</dc:creator>
      <dc:subject>kidney transplantation</dc:subject>
      <dc:subject>immunosuppressive therapy</dc:subject>
      <dc:subject>renal transplantation</dc:subject>
      <dc:subject>graft rejection</dc:subject>
      <dc:subject>calcineurin inhibitors</dc:subject>
      <dc:subject>tacrolimus</dc:subject>
      <dc:subject>mycophenolate mofetil</dc:subject>
      <dc:subject>corticosteroids</dc:subject>
      <dc:subject>transplant immunology</dc:subject>
      <dc:subject>graft survival.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 151-165</dc:source>
    </item>
    <item>
      <title>CLINICAL EVALUATION OF IMPLANT-SUPPORTED PROSTHESES IN ORAL REHABILITATION</title>
      <link>https://aams-journal.us/journals/dentistry/articles/932556b7-7e7d-4178-9114-e22cec150bd1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/932556b7-7e7d-4178-9114-e22cec150bd1</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Nishonov Zokhidjon¹</author>
      <description>Implant-supported prosthetic rehabilitation has become one of the most significant advancements in modern restorative dentistry due to its high clinical success rate, functional stability, aesthetic effectiveness, and positive influence on oral health and quality of life. Loss of teeth caused by caries, periodontal disease, trauma, congenital anomalies, or systemic pathology leads to impairment of mastication, speech, facial aesthetics, temporomandibular function, and psychosocial well-being. Conventional removable prostheses frequently demonstrate limitations related to retention, stability, bone resorption, and patient comfort, whereas implant-supported prostheses provide improved biomechanical support and preservation of alveolar bone structure through osseointegration. This study investigates the clinical effectiveness of implant-supported prosthetic rehabilitation with emphasis on osseointegration, peri-implant tissue response, functional outcomes, prosthetic stability, aesthetic restoration, patient satisfaction, and long-term treatment success. Particular attention is directed toward implant survival, biomechanical loading, peri-implant health, prosthetic complications, radiographic bone stability, and contemporary digital planning techniques. The findings demonstrate that implant-supported prostheses significantly improve chewing efficiency, speech function, facial harmony, oral comfort, and psychological confidence while maintaining favorable peri-implant tissue stability and long-term functional outcomes. Contemporary implantology increasingly integrates digital technologies, biomaterials science, guided surgical protocols, regenerative procedures, and individualized prosthetic planning to optimize rehabilitation success and improve patient-centered oral healthcare. Implant-supported prosthetic rehabilitation has become an essential component of modern restorative dentistry due to its high functional reliability, biological compatibility, aesthetic effectiveness, and positive impact on oral health and patient quality of life. Loss of teeth caused by periodontal disease, extensive carious destruction, traumatic injury, congenital anomalies, or systemic pathological conditions leads to significant disturbances in mastication, speech, facial symmetry, temporomandibular function, and psychosocial adaptation. Progressive alveolar bone resorption following tooth extraction additionally complicates oral rehabilitation and negatively influences prosthetic stability and facial appearance. Implant-supported prostheses provide stable fixation through direct osseointegration within alveolar bone and therefore ensure superior biomechanical support, functional efficiency, and preservation of oral structures compared with conventional removable prosthetic systems. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779289974308-CLINICAL_EVALUATION_OF_IMPLANT_SUPPORTED_PROSTHESE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nishonov Zokhidjon¹</dc:creator>
      <dc:creator>Inogamov Sherzod²</dc:creator>
      <dc:subject>Dental implants</dc:subject>
      <dc:subject>implant-supported prostheses</dc:subject>
      <dc:subject>oral rehabilitation</dc:subject>
      <dc:subject>osseointegration</dc:subject>
      <dc:subject>peri-implant tissues</dc:subject>
      <dc:subject>prosthodontics</dc:subject>
      <dc:subject>implant dentistry</dc:subject>
      <dc:subject>bone preservation</dc:subject>
      <dc:subject>prosthetic stability</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1371</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 46-60</dc:source>
    </item>
    <item>
      <title>HORMONAL AND NEUROVASCULAR MECHANISMS OF VASOMOTOR RHINITIS IN WOMEN</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/00151cad-8f31-4732-a559-1c6a678b0fb6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/00151cad-8f31-4732-a559-1c6a678b0fb6</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Prof. Nasretdinova M.T¹</author>
      <description>Vasomotor rhinitis is a chronic non-allergic disorder of the nasal mucosa characterized by dysregulation of neurovascular control mechanisms resulting in persistent nasal congestion, rhinorrhea, mucosal edema, sneezing, and respiratory discomfort without evidence of infectious or allergic inflammation. Women demonstrate increased susceptibility to vasomotor rhinitis because hormonal fluctuations significantly influence vascular permeability, autonomic nervous system activity, glandular secretion, mucosal blood flow, and neurogenic inflammatory responses within nasal tissues. Estrogen, progesterone, prolactin, thyroid hormones, and endocrine instability associated with menstruation, pregnancy, menopause, and hormonal therapy contribute to chronic nasal hyperreactivity and impaired physiological regulation of respiratory mucosa. Neurovascular dysfunction involving parasympathetic hyperactivity, sensory nerve stimulation, inflammatory neuropeptide release, endothelial dysfunction, and vascular hypersensitivity further intensifies mucosal swelling and chronic respiratory symptoms. Clinical manifestations frequently include persistent nasal obstruction, watery rhinorrhea, recurrent sneezing, headache, sleep disturbances, facial pressure, chronic fatigue, emotional instability, and reduced quality of life. Environmental irritants, emotional stress, tobacco smoke, perfumes, temperature fluctuations, and occupational pollutants additionally aggravate chronic neurovascular dysregulation and worsen respiratory discomfort. The present study investigates hormonal and neurovascular mechanisms, endocrine influences, autonomic dysfunction, diagnostic features, therapeutic strategies, and long-term clinical management of vasomotor rhinitis in women. Modern diagnostic methods including rhinoscopy, nasal endoscopy, rhinomanometry, hormonal analysis, autonomic nervous system assessment, cytological evaluation, and allergy exclusion testing significantly improve diagnostic accuracy and facilitate individualized therapeutic planning. Contemporary management increasingly integrates intranasal corticosteroids, anticholinergic medications, hormonal stabilization, saline irrigation, physiotherapy, stress reduction, neurovascular modulation, lifestyle modification, and minimally invasive procedures aimed at restoring nasal physiological balance and improving respiratory function. Clinical evidence demonstrates that comprehensive individualized treatment significantly improves symptom control and quality of life among women with chronic vasomotor rhinitis.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779299195184-HORMONAL_AND_NEUROVASCULAR_MECHANISMS_OF_VASOMOTOR.pdf" type="application/pdf" length="0"/>
      <dc:creator>Prof. Nasretdinova M.T¹</dc:creator>
      <dc:creator>Tadjibayev D.A²</dc:creator>
      <dc:creator>Normurodov N.A³</dc:creator>
      <dc:creator>Toshpo’latov O.U⁴</dc:creator>
      <dc:subject>Vasomotor rhinitis</dc:subject>
      <dc:subject>women</dc:subject>
      <dc:subject>hormonal imbalance</dc:subject>
      <dc:subject>neurovascular dysfunction</dc:subject>
      <dc:subject>autonomic nervous system</dc:subject>
      <dc:subject>chronic rhinitis</dc:subject>
      <dc:subject>nasal obstruction</dc:subject>
      <dc:subject>neurogenic inflammation</dc:subject>
      <dc:subject>endocrine regulation</dc:subject>
      <dc:subject>respiratory disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1380</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 106-120</dc:source>
    </item>
    <item>
      <title>CLINICAL FEATURES AND MODERN TREATMENT APPROACHES OF ALLERGIC RHINITIS IN CHILDREN</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/c2116ceb-7d81-4340-a121-431b10005623</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/c2116ceb-7d81-4340-a121-431b10005623</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Prof. Nasretdinova M.T¹</author>
      <description>Allergic rhinitis is one of the most prevalent chronic inflammatory respiratory disorders affecting pediatric populations worldwide and represents a major clinical and public health concern due to its increasing incidence, recurrent progression, and significant impact on respiratory health, cognitive development, emotional well-being, and quality of life. The disease develops as an immunoglobulin E-mediated hypersensitivity reaction following exposure to environmental allergens including pollen, house dust mites, molds, animal dander, and atmospheric pollutants. Complex immunopathological mechanisms involve activation of mast cells, eosinophilic infiltration, cytokine release, mucosal edema, vascular hyperpermeability, epithelial dysfunction, and chronic inflammatory remodeling of the upper respiratory tract. Clinical manifestations commonly include persistent nasal congestion, rhinorrhea, sneezing, nasal itching, conjunctival irritation, mouth breathing, snoring, sleep disturbances, recurrent respiratory infections, and impaired concentration. Chronic allergic inflammation additionally contributes to bronchial hyperreactivity, asthma progression, sinusitis, otitis media, impaired school performance, and psychosocial dysfunction in children. This study investigates the clinical characteristics, respiratory complications, diagnostic evaluation, and contemporary therapeutic approaches for allergic rhinitis in pediatric patients. Modern diagnostic methods including allergological testing, nasal endoscopy, pulmonary function assessment, immunological analysis, and quality-of-life evaluation significantly improve diagnostic accuracy and facilitate individualized treatment planning. Contemporary management increasingly integrates antihistamines, intranasal corticosteroids, leukotriene receptor antagonists, allergen-specific immunotherapy, biologic therapy, environmental control strategies, respiratory rehabilitation, and multidisciplinary pediatric care. Clinical findings demonstrate that early diagnosis and comprehensive individualized treatment significantly reduce inflammatory activity, improve respiratory function, enhance sleep quality, decrease disease progression, and optimize long-term quality of life in children with allergic rhinitis.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779294191281-CLINICAL_FEATURES_AND_MODERN_TREATMENT_APPROACHES_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Prof. Nasretdinova M.T¹</dc:creator>
      <dc:creator>Jonuzokov O.K²</dc:creator>
      <dc:creator>Normurodov N.A³</dc:creator>
      <dc:creator>Murodov K.A⁴</dc:creator>
      <dc:subject>Allergic rhinitis</dc:subject>
      <dc:subject>pediatric allergy</dc:subject>
      <dc:subject>nasal inflammation</dc:subject>
      <dc:subject>respiratory disease</dc:subject>
      <dc:subject>immunoglobulin E</dc:subject>
      <dc:subject>antihistamines</dc:subject>
      <dc:subject>intranasal corticosteroids</dc:subject>
      <dc:subject>immunotherapy</dc:subject>
      <dc:subject>pediatric respiratory health</dc:subject>
      <dc:subject>airway inflammation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1376</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics</dc:source>
    </item>
    <item>
      <title>THE IMPACT OF DIABETES MELLITUS ON CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/1391a650-f372-4940-a3b4-23e0ea331ebc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/1391a650-f372-4940-a3b4-23e0ea331ebc</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Appazova Linura¹</author>
      <description>Acute myocardial infarction (AMI) remains one of the leading causes of mortality and long-term disability worldwide. Diabetes mellitus is recognized as one of the strongest independent risk factors for coronary artery disease and significantly influences both the clinical presentation and prognosis of myocardial infarction. Chronic hyperglycemia promotes endothelial dysfunction, accelerated atherosclerosis, chronic inflammation, oxidative stress, and platelet hyperactivity, thereby increasing the severity of coronary artery obstruction and myocardial injury. The present study aimed to evaluate the influence of diabetes mellitus on the clinical course, in-hospital complications, and short-term outcomes of patients admitted with acute myocardial infarction. A comparative analysis was performed between diabetic and non-diabetic patients using clinical characteristics, laboratory findings, electrocardiographic data, echocardiographic parameters, and treatment outcomes. The findings demonstrated that diabetes mellitus was associated with larger infarct size, reduced left ventricular function, increased incidence of heart failure, arrhythmias, recurrent ischemic events, and prolonged hospitalization. Early identification of diabetes-related cardiovascular risk and comprehensive metabolic management may significantly improve survival and reduce adverse cardiovascular events after acute myocardial infarction.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783004577341-THE_IMPACT_OF_DIABETES_MELLITUS_ON_CLINICAL_OUTCOM.pdf" type="application/pdf" length="0"/>
      <dc:creator>Appazova Linura¹</dc:creator>
      <dc:creator>Shaymatova Dilshod²</dc:creator>
      <dc:creator>Uzoqova Oyjamol³</dc:creator>
      <dc:subject>acute myocardial infarction</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>coronary artery disease</dc:subject>
      <dc:subject>hyperglycemia</dc:subject>
      <dc:subject>cardiovascular complications</dc:subject>
      <dc:subject>cardiac biomarkers</dc:subject>
      <dc:subject>left ventricular dysfunction</dc:subject>
      <dc:subject>prognosis</dc:subject>
      <dc:subject>reperfusion therapy</dc:subject>
      <dc:subject>cardiology.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 166-180</dc:source>
    </item>
    <item>
      <title>INFLUENCE OF INDUSTRIAL DUST EXPOSURE ON THE DEVELOPMENT OF ATROPHIC RHINITIS AMONG CEMENT FACTORY EMPLOYEES</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/18f59ce8-47fb-43af-80bb-d0e8ac86b42d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/18f59ce8-47fb-43af-80bb-d0e8ac86b42d</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Prof. Nasretdinova M.T¹</author>
      <description>Atrophic rhinitis is a chronic degenerative disease of the nasal mucosa characterized by progressive atrophy of mucosal epithelium, glandular structures, vascular components, and underlying osseous tissue accompanied by dryness, crust formation, unpleasant odor, impaired mucociliary clearance, and respiratory dysfunction. Occupational exposure to industrial dust represents one of the most important environmental risk factors contributing to chronic irritation and degenerative changes within upper respiratory pathways. Cement factory employees are continuously exposed to high concentrations of cement dust particles containing silica, calcium oxide, aluminum compounds, and various chemical irritants capable of inducing chronic inflammatory and atrophic processes within nasal tissues. Prolonged inhalation of industrial dust leads to epithelial injury, vascular compromise, oxidative stress, inflammatory infiltration, impaired local immunity, and progressive destruction of nasal mucosal structures. Clinical manifestations commonly include nasal dryness, obstruction, crusting, epistaxis, reduced olfactory sensitivity, mucosal ulceration, chronic irritation, and secondary bacterial colonization significantly affecting respiratory comfort and occupational quality of life. The present study investigates the relationship between occupational cement dust exposure and development of atrophic rhinitis among industrial workers with emphasis on pathophysiological mechanisms, occupational risk factors, clinical manifestations, diagnostic evaluation, respiratory complications, and preventive strategies. Modern diagnostic approaches including rhinoscopy, endoscopic examination, cytological analysis, microbiological evaluation, pulmonary assessment, and occupational exposure monitoring significantly improve early identification of degenerative nasal changes and facilitate individualized management. Contemporary prevention and treatment strategies increasingly incorporate environmental protection measures, respiratory safety programs, nasal hydration therapy, anti-inflammatory management, occupational monitoring, and multidisciplinary rehabilitation aimed at preserving respiratory health and preventing progression of chronic mucosal degeneration. Clinical findings demonstrate that prolonged occupational exposure to cement dust substantially increases the risk of chronic atrophic rhinitis and negatively influences respiratory function and quality of life among industrial employees.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779296977016-INFLUENCE_OF_INDUSTRIAL_DUST_EXPOSURE_ON_THE_DEVEL.pdf" type="application/pdf" length="0"/>
      <dc:creator>Prof. Nasretdinova M.T¹</dc:creator>
      <dc:creator>Shadiyev A.E²</dc:creator>
      <dc:creator>Normurodov N.A³</dc:creator>
      <dc:creator>Renatova G.S⁴</dc:creator>
      <dc:subject>Atrophic rhinitis</dc:subject>
      <dc:subject>industrial dust</dc:subject>
      <dc:subject>cement factory workers</dc:subject>
      <dc:subject>occupational respiratory disease</dc:subject>
      <dc:subject>nasal mucosal atrophy</dc:subject>
      <dc:subject>cement dust exposure</dc:subject>
      <dc:subject>respiratory health</dc:subject>
      <dc:subject>occupational pathology</dc:subject>
      <dc:subject>chronic rhinitis</dc:subject>
      <dc:subject>mucociliary dysfunction</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1377</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>OCCUPATIONAL RISK FACTORS AND CLINICAL MANIFESTATIONS OF ATROPHIC RHINITIS IN CEMENT INDUSTRY WORKERS</title>
      <link>https://aams-journal.us/journals/surgery/articles/7aa58119-8789-4b83-9bc8-5ab44913808e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/7aa58119-8789-4b83-9bc8-5ab44913808e</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Prof. Nasretdinova M.T¹</author>
      <description>Atrophic rhinitis is a chronic progressive respiratory disorder characterized by degeneration of nasal mucosa, reduction of glandular secretion, impaired mucociliary clearance, widening of nasal cavities, crust formation, and chronic inflammatory destruction of upper respiratory tissues. Occupational exposure to industrial cement dust is considered one of the most important environmental risk factors contributing to development of chronic degenerative nasal pathology among industrial workers. Employees of cement manufacturing enterprises are continuously exposed to airborne particulate matter containing silica, calcium oxide, aluminum compounds, magnesium salts, and various abrasive chemical substances capable of inducing persistent respiratory irritation and structural damage to nasal mucosa. Long-term inhalation of industrial dust contributes to epithelial injury, inflammatory infiltration, oxidative stress activation, vascular compromise, microbial colonization, and progressive atrophy of respiratory tissues. Clinical manifestations commonly include nasal dryness, crust accumulation, unpleasant odor, recurrent epistaxis, nasal obstruction, reduced olfactory sensitivity, burning sensation, chronic irritation, respiratory discomfort, and recurrent upper airway infections significantly affecting occupational performance and quality of life. The present study investigates occupational risk factors, pathophysiological mechanisms, clinical manifestations, respiratory complications, and preventive approaches associated with atrophic rhinitis among cement industry workers. Modern diagnostic methods including rhinoscopy, nasal endoscopy, cytological examination, microbiological investigation, pulmonary assessment, and environmental workplace monitoring significantly improve early detection of degenerative respiratory changes and facilitate individualized management. Contemporary preventive and therapeutic strategies increasingly integrate industrial ventilation systems, respiratory protective equipment, humidification therapy, nasal irrigation, anti-inflammatory management, occupational rehabilitation, and multidisciplinary medical supervision aimed at reducing respiratory morbidity and preserving long-term airway function. Clinical findings demonstrate that prolonged occupational exposure to cement dust substantially increases the prevalence and severity of atrophic rhinitis among industrial workers.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779298080566-OCCUPATIONAL_RISK_FACTORS_AND_CLINICAL_MANIFESTATI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Prof. Nasretdinova M.T¹</dc:creator>
      <dc:creator>Shadiyev A.E²</dc:creator>
      <dc:creator>Normurodov N.A³</dc:creator>
      <dc:creator>Abdiyeva G.Sh⁴</dc:creator>
      <dc:subject>Atrophic rhinitis</dc:subject>
      <dc:subject>occupational disease</dc:subject>
      <dc:subject>cement industry</dc:subject>
      <dc:subject>industrial dust exposure</dc:subject>
      <dc:subject>respiratory pathology</dc:subject>
      <dc:subject>nasal mucosal atrophy</dc:subject>
      <dc:subject>occupational health</dc:subject>
      <dc:subject>cement factory workers</dc:subject>
      <dc:subject>chronic rhinitis</dc:subject>
      <dc:subject>respiratory rehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1378</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>NEUROPHYSIOLOGICAL MECHANISMS AND MODERN TREATMENT APPROACHES IN ISCHEMIC STROKENEUROPHYSIOLOGICAL MECHANISMS AND MODERN TREATMENT APPROACHES IN ISCHEMIC STROKE</title>
      <link>https://aams-journal.us/journals/neurology/articles/d8ee919e-81ba-454a-ac2d-b90d30704f69</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/d8ee919e-81ba-454a-ac2d-b90d30704f69</guid>
      <pubDate>Wed, 20 May 2026 00:00:00 GMT</pubDate>
      <author>Eshmoʻminov Jahongir</author>
      <description>Ischemic stroke is one of the leading causes of mortality, long-term neurological disability, and cognitive impairment worldwide. The disease develops as a result of acute interruption of cerebral blood flow leading to oxygen deprivation, neuronal ischemia, metabolic failure, excitotoxicity, neuroinflammation, and progressive neuronal death. Complex neurophysiological mechanisms underlying ischemic stroke involve cerebral hypoperfusion, disruption of ionic homeostasis, glutamate-mediated excitotoxicity, mitochondrial dysfunction, oxidative stress, inflammatory activation, apoptosis, and impairment of neurovascular coupling. Clinical manifestations vary according to localization and severity of ischemic injury and may include hemiparesis, sensory deficits, aphasia, cognitive dysfunction, visual disturbances, impaired coordination, and altered consciousness. This study investigates neurophysiological mechanisms of ischemic stroke with emphasis on cerebral ischemic cascade, neuronal injury, neuroplasticity, diagnostic evaluation, reperfusion therapy, neuroprotective strategies, and contemporary rehabilitation approaches. Modern diagnostic technologies including computed tomography, magnetic resonance imaging, perfusion imaging, Doppler ultrasonography, and electrophysiological assessment significantly improve early detection and therapeutic decision-making. Contemporary treatment approaches increasingly incorporate intravenous thrombolysis, mechanical thrombectomy, neurocritical care, neuroprotective therapy, stem cell research, neuromodulation, and multidisciplinary rehabilitation aimed at minimizing neuronal damage and improving functional recovery. The findings demonstrate that rapid diagnosis, early reperfusion therapy, individualized rehabilitation, and comprehensive neuroprotective management substantially reduce mortality, limit neurological disability, and improve long-term clinical outcomes and quality of life in patients with ischemic stroke.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779291678907-NEUROPHYSIOLOGICAL_MECHANISMS_AND_MODERN_TREATMENT.pdf" type="application/pdf" length="0"/>
      <dc:creator>Eshmoʻminov Jahongir</dc:creator>
      <dc:subject>Ischemic stroke</dc:subject>
      <dc:subject>cerebral ischemia</dc:subject>
      <dc:subject>neurophysiology</dc:subject>
      <dc:subject>thrombolysis</dc:subject>
      <dc:subject>neuroprotection</dc:subject>
      <dc:subject>cerebral infarction</dc:subject>
      <dc:subject>neuroplasticity</dc:subject>
      <dc:subject>reperfusion therapy</dc:subject>
      <dc:subject>stroke rehabilitation</dc:subject>
      <dc:subject>neuronal injury</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1374</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 91-105</dc:source>
    </item>
    <item>
      <title>General characteristics of caries. Clinical diagnosis of caries, comparative diagnosis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/dfa668ba-01e4-4036-9ece-88c6191b7bae</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/dfa668ba-01e4-4036-9ece-88c6191b7bae</guid>
      <pubDate>Tue, 19 May 2026 00:00:00 GMT</pubDate>
      <author>Komilova Parizoda Botir qizi</author>
      <description>Dental caries remains one of the most prevalent chronic diseases affecting individuals of all age groups worldwide and continues to represent a major public health problem due to its progressive destructive impact on hard dental tissues and oral health. Caries is a multifactorial pathological process characterized by demineralization and subsequent destruction of enamel, dentin, and cementum resulting from interaction among cariogenic microorganisms, fermentable carbohydrates, host susceptibility, saliva composition, and environmental risk factors. Early diagnosis and accurate comparative differentiation of carious lesions from non-carious dental defects are essential for successful treatment planning, prevention of complications, and preservation of tooth structure. This study investigates the general characteristics of dental caries with emphasis on etiology, pathogenesis, classification, clinical manifestations, modern diagnostic methods, and comparative differential diagnosis. The findings demonstrate that comprehensive clinical examination combined with radiographic assessment, laser fluorescence analysis, transillumination methods, and modern diagnostic technologies significantly improve early detection of carious lesions and differentiation from erosion, abrasion, fluorosis, hypoplasia, wedge-shaped defects, and other non-carious conditions. Contemporary minimally invasive dentistry increasingly focuses on early diagnosis, preventive management, and preservation of healthy dental tissues to optimize long-term oral health outcomes. Dental caries is one of the most widespread chronic pathological conditions affecting the hard tissues of teeth and remains a significant challenge in preventive and restorative dentistry. The disease develops as a result of complex interaction between cariogenic microorganisms, fermentable carbohydrates, saliva composition, oral hygiene status, tooth susceptibility, and environmental influences leading to progressive demineralization and destruction of enamel and dentin. Early identification of carious lesions and accurate differentiation from non-carious dental defects are critically important for preservation of dental tissues and prevention of irreversible complications. This study presents an expanded analysis of the general characteristics of dental caries with particular emphasis on etiological factors, pathogenic mechanisms, clinical manifestations, lesion progression, diagnostic technologies, and comparative differential diagnosis. Modern diagnostic methods including visual-tactile examination, radiographic assessment, laser fluorescence analysis, transillumination techniques, and digital imaging significantly improve detection of early and hidden lesions while enhancing diagnostic precision. Comparative diagnostic evaluation between carious lesions and conditions such as dental erosion, abrasion, attrition, fluorosis, enamel hypoplasia, and wedge-shaped defects enables selection of appropriate therapeutic strategies and prevention of unnecessary invasive procedures. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779209914055-General_characteristics_of_caries__Clinical_diagno.pdf" type="application/pdf" length="0"/>
      <dc:creator>Komilova Parizoda Botir qizi</dc:creator>
      <dc:subject>Dental caries</dc:subject>
      <dc:subject>demineralization</dc:subject>
      <dc:subject>enamel destruction</dc:subject>
      <dc:subject>clinical diagnosis</dc:subject>
      <dc:subject>comparative diagnosis</dc:subject>
      <dc:subject>differential diagnosis</dc:subject>
      <dc:subject>cariogenic bacteria</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>dental examination</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1368</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 31-45</dc:source>
    </item>
    <item>
      <title>ISCHEMIC STROKE: PATHOPHYSIOLOGY, RISK FACTORS, EARLY DIAGNOSIS, AND CONTEMPORARY TREATMENT STRATEGIES</title>
      <link>https://aams-journal.us/journals/neurology/articles/a4f5a33e-c24c-4bbe-8c0f-13655a36f673</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/a4f5a33e-c24c-4bbe-8c0f-13655a36f673</guid>
      <pubDate>Tue, 19 May 2026 00:00:00 GMT</pubDate>
      <author>Eshtemirov Farrux</author>
      <description>Ischemic stroke is one of the leading causes of mortality, long-term disability, and neurological impairment worldwide and remains a major global healthcare challenge due to its rapid onset, complex pathophysiology, and severe functional consequences. The condition develops as a result of acute interruption of cerebral blood flow leading to oxygen deprivation, neuronal ischemia, metabolic failure, inflammatory activation, and irreversible brain tissue injury. Early diagnosis and rapid therapeutic intervention are critically important for reduction of neuronal damage, preservation of neurological function, and improvement of long-term clinical outcomes. This study investigates the pathophysiological mechanisms, major risk factors, diagnostic approaches, and modern treatment strategies associated with ischemic stroke. Particular emphasis is placed on vascular occlusion, cerebral ischemic cascade, hypertension, diabetes mellitus, atrial fibrillation, atherosclerosis, neuroimaging technologies, thrombolytic therapy, mechanical thrombectomy, neuroprotection, and rehabilitation strategies. The findings demonstrate that integration of early neuroimaging, rapid clinical assessment, reperfusion therapy, and multidisciplinary stroke management significantly improves survival rates, reduces neurological disability, and enhances recovery of functional independence. Contemporary stroke medicine increasingly combines advanced imaging technology, evidence-based pharmacological intervention, minimally invasive endovascular procedures, and personalized rehabilitation programs aimed at optimizing neurological recovery and prevention of recurrent cerebrovascular events. Ischemic stroke remains one of the most serious acute neurological disorders and represents a leading cause of mortality, chronic disability, cognitive impairment, and long-term functional dependence worldwide. The disease develops as a consequence of sudden reduction or complete interruption of cerebral blood flow resulting in oxygen deprivation, metabolic failure, neuronal ischemia, inflammatory activation, and irreversible destruction of brain tissue. Rapid progression of ischemic injury causes extensive structural and functional neurological impairment if urgent medical intervention is not initiated during the early therapeutic window. This study presents an expanded analysis of ischemic stroke with particular emphasis on pathophysiological mechanisms, vascular and metabolic risk factors, clinical manifestations, modern neuroimaging diagnostics, reperfusion therapy, endovascular intervention, neuroprotective strategies, and multidisciplinary rehabilitation approaches. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779210530373-ISCHEMIC_STROKE__PATHOPHYSIOLOGY__RISK_FACTORS__EA.pdf" type="application/pdf" length="0"/>
      <dc:creator>Eshtemirov Farrux</dc:creator>
      <dc:subject>Ischemic stroke</dc:subject>
      <dc:subject>cerebral ischemia</dc:subject>
      <dc:subject>thrombolysis</dc:subject>
      <dc:subject>mechanical thrombectomy</dc:subject>
      <dc:subject>neuroimaging</dc:subject>
      <dc:subject>cerebrovascular disease</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>atherosclerosis</dc:subject>
      <dc:subject>neurological deficit</dc:subject>
      <dc:subject>stroke rehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1369</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MODERN APPROACHES IN AESTHETIC COSMETOLOGY: SKIN REJUVENATION TECHNIQUES AND THEIR CLINICAL EFFECTIVENESS</title>
      <link>https://aams-journal.us/journals/dermatology/articles/3726a3a5-e648-441a-8068-01055ccadc07</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/3726a3a5-e648-441a-8068-01055ccadc07</guid>
      <pubDate>Tue, 19 May 2026 00:00:00 GMT</pubDate>
      <author>Ganjiyeva Munisa Komil qizi</author>
      <description>Modern aesthetic cosmetology has undergone substantial scientific and technological advancement during recent decades, leading to development of highly effective minimally invasive and noninvasive skin rejuvenation techniques aimed at improving skin quality, delaying age-related changes, and enhancing facial aesthetics. Aging of the skin is a complex biological process influenced by intrinsic genetic mechanisms and extrinsic environmental factors including ultraviolet radiation, oxidative stress, pollution, hormonal alterations, smoking, and lifestyle-related metabolic disturbances. Structural degeneration of collagen, elastin, hyaluronic acid, and microvascular circulation contributes to wrinkle formation, skin laxity, pigmentation disorders, dehydration, and loss of tissue elasticity. This study investigates contemporary approaches in aesthetic cosmetology with emphasis on laser therapy, chemical peeling, botulinum toxin injections, dermal fillers, microneedling, platelet-rich plasma therapy, radiofrequency procedures, mesotherapy, and combined rejuvenation protocols. Particular attention is directed toward mechanisms of action, clinical effectiveness, tissue remodeling, safety profile, and long-term aesthetic outcomes. The findings demonstrate that individualized multimodal treatment strategies significantly improve skin texture, hydration, elasticity, pigmentation balance, and overall facial rejuvenation while minimizing recovery time and procedural complications. Contemporary cosmetology increasingly integrates regenerative medicine, biomolecular technologies, personalized treatment planning, and minimally invasive procedures to optimize clinical effectiveness and patient satisfaction. Modern aesthetic cosmetology represents a rapidly advancing medical and scientific field focused on correction of age-related skin alterations, restoration of tissue quality, and enhancement of facial aesthetics through minimally invasive and noninvasive therapeutic technologies. Progressive degeneration of collagen fibers, elastin structures, extracellular matrix components, microvascular circulation, and epidermal regenerative capacity contributes significantly to wrinkle formation, skin laxity, pigmentation disturbances, dehydration, and reduction of tissue elasticity during intrinsic and extrinsic aging. Environmental influences including ultraviolet radiation, oxidative stress, smoking, hormonal imbalance, pollution, and metabolic disorders accelerate dermal degeneration and intensify visible signs of aging. This study presents an expanded evaluation of contemporary skin rejuvenation techniques with emphasis on laser resurfacing, chemical peeling, botulinum toxin injections, dermal fillers, microneedling, platelet-rich plasma therapy, radiofrequency procedures, mesotherapy, and multimodal regenerative protocols. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779212217653-MODERN_APPROACHES_IN_AESTHETIC_COSMETOLOGY__SKIN_R.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ganjiyeva Munisa Komil qizi</dc:creator>
      <dc:subject>Aesthetic cosmetology</dc:subject>
      <dc:subject>skin rejuvenation</dc:subject>
      <dc:subject>laser therapy</dc:subject>
      <dc:subject>dermal fillers</dc:subject>
      <dc:subject>botulinum toxin</dc:subject>
      <dc:subject>microneedling</dc:subject>
      <dc:subject>platelet-rich plasma</dc:subject>
      <dc:subject>collagen remodeling</dc:subject>
      <dc:subject>anti-aging therapy</dc:subject>
      <dc:subject>minimally invasive cosmetology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1370</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Clinical and Epidemiological Evaluation of the Effectiveness of Prevention of Periodontal Diseases Associated with the Consumption of Groundwater</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/40127ae4-60ef-4ece-8333-45342d0a4c5d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/40127ae4-60ef-4ece-8333-45342d0a4c5d</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Abbosov Mustafo Mardonovich¹</author>
      <description>Periodontal diseases remain one of the most common chronic inflammatory conditions affecting the oral cavity worldwide. Environmental, nutritional, and hygienic factors significantly influence the prevalence and progression of periodontal pathology. Among these factors, the quality and mineral composition of groundwater consumed by the population play an important role in oral and periodontal health. This study aimed to conduct a clinical and epidemiological evaluation of the effectiveness of preventive measures against periodontal diseases associated with groundwater consumption. A total of 240 individuals aged 18–60 years living in regions with varying groundwater mineralization levels participated in the study. Clinical examinations included assessment of oral hygiene status, gingival bleeding index, periodontal pocket depth, and community periodontal index. Preventive interventions included oral hygiene education, professional dental cleaning, fluoride-containing products, balanced dietary recommendations, and monitoring of groundwater quality. The results demonstrated that populations consuming groundwater with imbalanced mineral composition showed significantly higher prevalence of gingivitis and periodontitis compared to populations consuming water with optimal mineral levels. After implementation of preventive programs for twelve months, significant improvement in periodontal indices and reduction in inflammatory manifestations were observed. The findings confirm that preventive strategies combined with monitoring of groundwater quality contribute to reducing periodontal disease prevalence and improving oral health indicators. The study emphasizes the importance of integrating environmental and dental preventive approaches into public healthcare systems. Periodontal disorders remain among the most widespread chronic oral conditions affecting different population groups across the world. The occurrence and progression of inflammatory lesions in periodontal tissues are closely associated not only with microbial factors and inadequate oral hygiene but also with environmental influences, including the quality of consumed drinking water. Groundwater serves as a primary source of water supply for many rural and semi-urban communities, and its chemical composition may significantly affect oral tissue metabolism, mineral balance, and immune resistance within the oral cavity. The present study was aimed at conducting a comprehensive clinical and epidemiological assessment of preventive approaches directed at reducing periodontal pathology associated with long-term groundwater consumption. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779103713957-Clinical_and_Epidemiological_Evaluation_of_the_Eff.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abbosov Mustafo Mardonovich¹</dc:creator>
      <dc:creator>Sanakulov Jamshed Obloberdiyevich²</dc:creator>
      <dc:subject>periodontal diseases</dc:subject>
      <dc:subject>groundwater</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>gingivitis</dc:subject>
      <dc:subject>periodontitis</dc:subject>
      <dc:subject>mineral composition</dc:subject>
      <dc:subject>dental hygiene</dc:subject>
      <dc:subject>public health.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1360</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MODERN DIAGNOSTIC METHODS AND TREATMENT APPROACHES IN GLAUCOMA MANAGEMENT</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/251118d1-5cf5-4358-a98f-8d3277a34f84</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/251118d1-5cf5-4358-a98f-8d3277a34f84</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Ganjiyeva Munisa Komil qizi</author>
      <description>Glaucoma represents one of the leading causes of irreversible blindness worldwide and remains a major ophthalmological challenge due to its progressive neurodegenerative nature and frequently asymptomatic early stages. The disease is characterized by progressive optic nerve damage, retinal ganglion cell loss, visual field deterioration, and impairment of visual function associated primarily with elevated intraocular pressure and vascular dysregulation. This study investigates modern diagnostic methods and contemporary treatment approaches in glaucoma management with emphasis on early detection, structural and functional assessment of optic nerve damage, intraocular pressure monitoring, imaging technologies, pharmacological therapy, laser interventions, minimally invasive glaucoma surgery, and advanced microsurgical procedures. The findings demonstrate that integration of high-resolution diagnostic imaging, automated perimetry, optical coherence tomography, and individualized therapeutic strategies significantly improves early diagnosis, disease monitoring, and long-term visual prognosis. Modern glaucoma management increasingly combines technological innovation, neuroprotective approaches, personalized treatment planning, and multidisciplinary ophthalmological care to reduce disease progression and preserve visual function and quality of life. Glaucoma remains one of the most serious chronic ophthalmological diseases and is among the leading causes of irreversible blindness worldwide due to progressive degeneration of the optic nerve and retinal ganglion cells. The disease develops gradually and frequently progresses asymptomatically during early stages, making timely diagnosis and continuous monitoring critically important for preservation of visual function. Glaucomatous optic neuropathy is associated with elevated intraocular pressure, vascular dysregulation, oxidative stress, neuroinflammation, impaired ocular perfusion, mitochondrial dysfunction, and age-related neurodegenerative changes. This study provides an expanded analysis of contemporary diagnostic methods and modern therapeutic approaches utilized in glaucoma management with emphasis on optical coherence tomography, computerized perimetry, retinal nerve fiber layer assessment, tonometry, gonioscopy, neuroprotective strategies, pharmacological therapy, laser procedures, minimally invasive glaucoma surgery, and microsurgical interventions. The investigation demonstrates that integration of advanced imaging technologies and individualized therapeutic planning significantly improves early detection, slows disease progression, stabilizes visual fields, and enhances long-term visual prognosis. Modern glaucoma management increasingly combines technological innovation, personalized ophthalmological care, neuroprotective treatment, and minimally invasive surgical techniques aimed at preserving retinal ganglion cell integrity and preventing irreversible visual disability.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779123576031-MODERN_DIAGNOSTIC_METHODS_AND_TREATMENT_APPROACHES.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ganjiyeva Munisa Komil qizi</dc:creator>
      <dc:subject>Glaucoma</dc:subject>
      <dc:subject>intraocular pressure</dc:subject>
      <dc:subject>optic nerve</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>visual field analysis</dc:subject>
      <dc:subject>neuroprotection</dc:subject>
      <dc:subject>glaucoma surgery</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>retinal nerve fiber layer</dc:subject>
      <dc:subject>minimally invasive glaucoma surgery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1367</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 05, pp. 31-45</dc:source>
    </item>
    <item>
      <title>THE ROLE OF HORMONAL DISORDERS IN FEMALE INFERTILITY: CLINICAL AND THERAPEUTIC PERSPECTIVES</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/104c2f7e-56a5-4cc3-8ee6-0fd44821e32c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/104c2f7e-56a5-4cc3-8ee6-0fd44821e32c</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Allamuratova Zebiniso¹</author>
      <description>Hormonal disorders represent one of the leading causes of female infertility and significantly affect reproductive function through disruption of ovulation, menstrual cyclicity, endometrial receptivity, and hormonal regulation of the hypothalamic-pituitary-ovarian axis. Endocrine abnormalities including polycystic ovary syndrome, hyperprolactinemia, thyroid dysfunction, adrenal disorders, insulin resistance, and luteal phase insufficiency contribute substantially to impaired fertility and adverse reproductive outcomes. This study investigates the clinical and therapeutic significance of hormonal disorders in female infertility with emphasis on endocrine pathophysiology, diagnostic evaluation, reproductive dysfunction, metabolic disturbances, and modern therapeutic approaches. The findings demonstrate that early identification and correction of hormonal imbalance significantly improve ovulatory function, pregnancy rates, and reproductive prognosis. Comprehensive multidisciplinary management involving endocrinological evaluation, hormonal therapy, metabolic correction, lifestyle modification, and assisted reproductive technologies remains essential for optimization of fertility outcomes and improvement of women’s reproductive health. Hormonal disorders constitute one of the most important pathological mechanisms underlying female infertility and significantly influence reproductive capacity through disruption of endocrine regulation, ovulatory function, follicular maturation, implantation processes, and menstrual cyclicity. Reproductive physiology depends on highly coordinated interaction between the hypothalamus, pituitary gland, ovaries, thyroid gland, adrenal glands, and peripheral metabolic tissues. Disturbance of this endocrine balance results in anovulation, menstrual irregularities, impaired oocyte quality, reduced endometrial receptivity, and increased risk of unsuccessful conception and pregnancy loss. This study provides an expanded analysis of hormonal disorders associated with female infertility with particular emphasis on polycystic ovary syndrome, hyperprolactinemia, thyroid dysfunction, adrenal abnormalities, insulin resistance, obesity-related endocrine imbalance, and luteal phase insufficiency. The investigation additionally evaluates modern diagnostic methods, hormonal profiling, metabolic assessment, individualized therapeutic strategies, ovulation induction protocols, and assisted reproductive technologies utilized in management of endocrine-related infertility. </description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779114783036-THE_ROLE_OF_HORMONAL_DISORDERS_IN_FEMALE_INFERTILI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Allamuratova Zebiniso¹</dc:creator>
      <dc:creator>Toshpoʻlatova Nilufar²</dc:creator>
      <dc:creator>Muhammadiyeva Umida³</dc:creator>
      <dc:subject>Female infertility</dc:subject>
      <dc:subject>hormonal disorders</dc:subject>
      <dc:subject>polycystic ovary syndrome</dc:subject>
      <dc:subject>endocrine dysfunction</dc:subject>
      <dc:subject>ovulation disorders</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>hyperprolactinemia</dc:subject>
      <dc:subject>thyroid disease</dc:subject>
      <dc:subject>assisted reproductive technologies</dc:subject>
      <dc:subject>infertility treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1366</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Preparation and Filling of a Black Class 3 Carious Cavity</title>
      <link>https://aams-journal.us/journals/dentistry/articles/ad9d91ac-e26f-426c-b252-14cbbdc55dcb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/ad9d91ac-e26f-426c-b252-14cbbdc55dcb</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Anvarova Omina¹</author>
      <description>Black Class 3 carious lesions represent defects localized on proximal surfaces of anterior teeth without involvement of the incisal angle and remain an important clinical problem in restorative dentistry due to aesthetic, functional, and structural complications. Successful treatment requires precise cavity preparation, effective elimination of infected tissues, preservation of healthy dental structures, and appropriate restorative filling techniques ensuring long-term functional and aesthetic outcomes. This study investigates clinical principles of preparation and filling of Black Class 3 carious cavities with emphasis on cavity design, adhesive protocols, restorative materials, isolation techniques, anatomical reconstruction, polymerization methods, and prevention of secondary caries. The findings demonstrate that minimally invasive preparation combined with modern adhesive composite restoration significantly improves marginal adaptation, structural durability, aesthetic integration, and patient satisfaction. Contemporary restorative approaches emphasizing preservation of enamel and dentin integrity contribute substantially to optimization of treatment outcomes and prevention of recurrent carious destruction. Preparation and restoration of Black Class 3 carious cavities remain among the most significant procedures in modern restorative dentistry because lesions localized on proximal surfaces of anterior teeth directly affect aesthetics, phonetics, mastication, and structural integrity of dental tissues. Black Class 3 lesions develop primarily as a consequence of bacterial plaque accumulation, carbohydrate fermentation, acid-mediated enamel demineralization, and progressive destruction of dentin structures within interproximal regions of anterior teeth. Successful treatment requires comprehensive elimination of infected tissues, preservation of healthy enamel and dentin, restoration of proximal anatomy, and achievement of long-term adhesive stability. This study presents an expanded analysis of operative preparation and filling techniques for Black Class 3 carious cavities with particular emphasis on minimally invasive cavity design, adhesive protocols, composite resin restoration, polymerization methods, contour reconstruction, and prevention of secondary carious lesions. The findings demonstrate that contemporary adhesive restorative systems significantly improve mechanical retention, marginal adaptation, color integration, anatomical morphology, and long-term clinical durability of restorations. Minimally invasive preparation combined with modern composite technology contributes substantially to preservation of tooth vitality, improvement of oral aesthetics, and enhancement of functional rehabilitation in anterior dental regions.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779112423936-Preparation_and_Filling_of_a_Black_Class_3_Carious.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anvarova Omina¹</dc:creator>
      <dc:creator>Raximjonova Dilnura²</dc:creator>
      <dc:creator>Ramazanov Shaxriyor³</dc:creator>
      <dc:creator>Sodikova Shoira⁴</dc:creator>
      <dc:subject>Black Class 3 cavity</dc:subject>
      <dc:subject>dental caries</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>composite restoration</dc:subject>
      <dc:subject>cavity preparation</dc:subject>
      <dc:subject>adhesive systems</dc:subject>
      <dc:subject>anterior teeth</dc:subject>
      <dc:subject>aesthetic dentistry</dc:subject>
      <dc:subject>resin composite</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1363</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Personalized Osteosynthesis of Mandibular Condylar Process Fractures: Integrating 3D Diagnostics, Morphometry, and Finite Element Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/c542c9a2-e75b-4d47-b0ab-7eac59b29b86</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/c542c9a2-e75b-4d47-b0ab-7eac59b29b86</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Musayev Sh.Sh.</author>
      <description>Background: Mandibular condylar process fractures account for 25–52% of all mandibular fractures and present unique anatomical and biomechanical complexity that challenges both diagnosis and treatment. Advances in 3D computed tomography, cone-beam CT, quantitative morphometry, and finite element analysis offer the basis for patient-specific osteosynthesis; however, these modalities have not been systematically integrated into a unified clinical framework.
Methods: A comprehensive systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted for publications from January 2000 to December 2024. Eligible studies addressed classification, 3D diagnostic imaging, condylar morphometry, virtual surgical planning, patient-specific implant design, and FEA of fixation constructs. After screening, 187 studies were included. Evidence was synthesized narratively by domain.
Results: 3D CT-based classification improves interobserver agreement from κ 0.42–0.58 (2D radiography) to 0.73–0.89. Condylar neck width varies from 6.9 to 11.2 mm and head length from 16.8 to 22.4 mm across populations, significantly exceeding standard implant size ranges. FEA consistently identifies the anteromedial condylar neck cortex as the peak-stress region (von Mises stress exceeding cortical yield at 120–160 MPa in suboptimal constructs). PSIs designed with integrated morphometric and FEA data reduce maximum bone stress by 38% and fixation micromotion from 142 μm to 61 μm versus standard plates. Hardware complication rates of 3.2% for PSIs compare favourably with 8.7–14.3% for conventional implants in published series.
Conclusion: Integration of 3D diagnostics, morphometric analysis, and FEA provides a scientifically robust pathway to personalized MCPF osteosynthesis with demonstrably superior biomechanical performance. High-quality randomized clinical trials, standardized morphometric reference databases, and consensus FEA validation protocols are urgently required to translate these computational advances into routine clinical practice.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779113767982-Personalized_Osteosynthesis_of_Mandibular_Condylar.pdf" type="application/pdf" length="0"/>
      <dc:creator>Musayev Sh.Sh.</dc:creator>
      <dc:creator>Shomurodov K.E.</dc:creator>
      <dc:subject>mandibular condylar fracture; osteosynthesis; finite element analysis; patient-specific implants; 3D diagnostics; morphometry</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1365</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>The impact of orthopedic rehabilitation on dental health-related quality of life in patients with complete edentulism</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/ed0567e0-f4ef-4ca2-a5ce-9e971770867c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/ed0567e0-f4ef-4ca2-a5ce-9e971770867c</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Ranakulov Akbarjon Ikromjon ugli¹</author>
      <description>Complete edentia remains one of the most complex medical and social problems in modern dentistry, significantly affecting the functional state of the dental system, psychological health, and social adaptation of patients. Tooth loss is accompanied by impaired chewing efficiency, changes in diction, deterioration in facial aesthetics, decreased self-esteem, and limitation of daily activities. The aim of this study was to evaluate the effect of orthopedic rehabilitation on the quality of life of patients with complete edentia. The study involved 102 patients aged 47 to 79 years who underwent orthopedic treatment using complete removable dentures and implant-supported structures. Functional status, emotional comfort, level of social activity, and satisfaction with dental status were assessed before treatment and during follow-up. The results showed that orthopedic rehabilitation contributes to a significant improvement in chewing function, normalization of speech activity, and an increase in psychological stability and social confidence in patients. The highest rates of adaptation and satisfaction were recorded in patients with implant-supported orthopedic structures. The study confirms the importance of timely orthopedic care for restoring not only dental function but also the overall quality of life of patients with complete tooth loss.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779103571614-The_impact_of_orthopedic_rehabilitation_on_dental_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ranakulov Akbarjon Ikromjon ugli¹</dc:creator>
      <dc:creator>Ortikova Nargiza Khayrullayevna²</dc:creator>
      <dc:subject>complete edentia</dc:subject>
      <dc:subject>orthopedic dentistry</dc:subject>
      <dc:subject>quality of life</dc:subject>
      <dc:subject>dental health</dc:subject>
      <dc:subject>prosthetics</dc:subject>
      <dc:subject>implant-supporting structures</dc:subject>
      <dc:subject>removable dentures</dc:subject>
      <dc:subject>chewing function</dc:subject>
      <dc:subject>social adaptation</dc:subject>
      <dc:subject>dental rehabilitation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1359</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 31-45</dc:source>
    </item>
    <item>
      <title>METABOLOMICS AND ARTIFICIAL INTELLIGENCE IN EARLY DISEASE DIAGNOSIS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/d0f7cc27-5755-415f-a942-95d8bc0ee5fc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/d0f7cc27-5755-415f-a942-95d8bc0ee5fc</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Shafia kazmi¹</author>
      <description>Metabolomics and artificial intelligence represent rapidly developing interdisciplinary fields that significantly improve early disease diagnosis, precision medicine, and predictive healthcare strategies. Metabolomics enables comprehensive analysis of low-molecular-weight metabolites reflecting dynamic biochemical processes within living organisms, whereas artificial intelligence facilitates rapid interpretation of complex metabolic datasets through advanced computational algorithms and machine learning technologies. This study investigates the integration of metabolomics and artificial intelligence in early disease diagnosis with particular attention to biomarker identification, metabolic pathway analysis, predictive modeling, clinical decision support, and disease risk stratification. The findings demonstrate that artificial intelligence-assisted metabolomic analysis substantially increases diagnostic accuracy, improves early detection of pathological processes, and enhances personalized therapeutic planning in oncology, cardiovascular disorders, neurological diseases, metabolic syndrome, and infectious pathology. Early implementation of metabolomics combined with artificial intelligence contributes significantly to preventive medicine, individualized healthcare, and reduction of disease-related morbidity and mortality. Metabolomics and artificial intelligence are transforming modern medical diagnostics through integration of biochemical profiling and advanced computational analysis for identification of pathological processes during preclinical stages of disease development. Metabolomics provides detailed evaluation of small-molecule metabolites reflecting dynamic cellular metabolism, while artificial intelligence enables rapid interpretation of large multidimensional biological datasets using machine learning and predictive algorithms. This study presents an expanded analysis of the role of metabolomics and artificial intelligence in early disease diagnosis with emphasis on biomarker discovery, metabolic pathway alterations, predictive modeling, computational diagnostics, and personalized medicine strategies. The findings demonstrate that artificial intelligence-assisted metabolomic analysis significantly improves sensitivity and specificity of disease detection, facilitates identification of subtle metabolic abnormalities before appearance of clinical symptoms, and supports individualized therapeutic decision-making. Integration of metabolomics with artificial intelligence demonstrates substantial clinical value in oncology, cardiovascular pathology, neurodegenerative diseases, endocrine disorders, inflammatory conditions, and infectious diseases. Early implementation of these technologies contributes to optimization of preventive medicine, reduction of diagnostic delay, improvement of patient prognosis, and advancement of precision healthcare systems.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779108080720-METABOLOMICS_AND_ARTIFICIAL_INTELLIGENCE_IN_EARLY_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Shafia kazmi¹</dc:creator>
      <dc:creator>Iqraa Alim²</dc:creator>
      <dc:subject>Metabolomics</dc:subject>
      <dc:subject>artificial intelligence</dc:subject>
      <dc:subject>machine learning</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>precision medicine</dc:subject>
      <dc:subject>predictive modeling</dc:subject>
      <dc:subject>bioinformatics</dc:subject>
      <dc:subject>metabolic profiling</dc:subject>
      <dc:subject>clinical diagnostics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1361</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Comparative Analysis of Conventional and Digital Impression Techniques in Prosthodontic Treatment</title>
      <link>https://aams-journal.us/journals/dentistry/articles/489988c2-b3dd-4189-bc2b-c8ed2ed06c7d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/489988c2-b3dd-4189-bc2b-c8ed2ed06c7d</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Abdullayeva Malikabonu Umedjonovna¹ Akhmedov Alisher Astanovich²</author>
      <description>Accurate impression procedures play a decisive role in the success of prosthodontic treatment because the precision of fixed and removable restorations directly depends on the quality of reproduced oral structures. Conventional impression methods have been used for decades and remain widely applied in restorative dentistry; however, the rapid development of digital technologies has introduced new possibilities for improving diagnostic accuracy, patient comfort, and laboratory efficiency. The present study aimed to conduct a comparative analysis of conventional and digital impression techniques in prosthodontic treatment and to evaluate their clinical effectiveness, accuracy, treatment duration, and patient satisfaction. A total of 120 patients requiring prosthodontic rehabilitation participated in the investigation. Participants were divided into two equal groups according to the impression technique used. Conventional elastomeric impression materials were utilized in the first group, while intraoral digital scanning systems were applied in the second group. Clinical evaluation included assessment of marginal adaptation of prosthetic constructions, number of repeated impressions, patient comfort, working time, and clinician satisfaction. The findings demonstrated that digital impression techniques provided higher patient comfort, reduced chairside time, improved communication between clinician and laboratory technician, and minimized the frequency of repeated procedures. Conventional impressions, although still clinically effective, were associated with greater patient discomfort and increased risk of dimensional inaccuracies caused by material deformation and improper handling. The study confirms that digital impression systems represent a highly effective alternative to traditional methods in modern prosthodontic practice and contribute to optimization of clinical workflow and prosthetic precision.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779102370988-Comparative_Analysis_of_Conventional_and_Digital_I.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abdullayeva Malikabonu Umedjonovna¹ Akhmedov Alisher Astanovich²</dc:creator>
      <dc:subject>prosthodontics</dc:subject>
      <dc:subject>digital dentistry</dc:subject>
      <dc:subject>conventional impression</dc:subject>
      <dc:subject>intraoral scanner</dc:subject>
      <dc:subject>CAD/CAM</dc:subject>
      <dc:subject>prosthetic rehabilitation</dc:subject>
      <dc:subject>dental technology</dc:subject>
      <dc:subject>impression accuracy</dc:subject>
      <dc:subject>fixed prosthesis</dc:subject>
      <dc:subject>restorative dentistry.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1358</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CRISPR and gene editing chemistry</title>
      <link>https://aams-journal.us/journals/genetics/articles/e34c1bc4-2ef3-401c-87b5-4bec5664461b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/e34c1bc4-2ef3-401c-87b5-4bec5664461b</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Limrah khan¹</author>
      <description>CRISPR and gene editing chemistry represent revolutionary advancements in molecular biology, biotechnology, and precision medicine that have transformed modern understanding of genetic engineering and targeted therapeutic intervention. CRISPR technology enables precise modification of genomic sequences through programmable nucleic acid recognition and enzymatic cleavage mechanisms, while gene editing chemistry provides molecular tools for controlled alteration of DNA structure and cellular genetic function. This study investigates molecular mechanisms, biochemical principles, therapeutic applications, and technological advancements of CRISPR and gene editing chemistry with particular attention to Cas enzymes, guide RNA interactions, DNA repair pathways, genome modification strategies, and biomedical applications in genetic diseases, oncology, infectious pathology, and regenerative medicine. The findings demonstrate that CRISPR-mediated gene editing significantly improves precision of genomic modification, accelerates development of personalized medicine, and creates new opportunities for treatment of previously incurable hereditary disorders. Despite substantial progress, ethical concerns, off-target effects, genomic instability, and regulatory challenges remain important limitations requiring further scientific investigation and international biomedical regulation. CRISPR and gene editing chemistry represent one of the most important scientific breakthroughs in contemporary molecular biology and precision medicine, providing unprecedented opportunities for targeted genomic modification and correction of pathogenic mutations. CRISPR technology utilizes programmable RNA-guided nucleases capable of recognizing and cleaving specific DNA sequences with high precision, while gene editing chemistry encompasses molecular mechanisms regulating nucleic acid interactions, enzymatic DNA cleavage, repair pathways, and genomic reconstruction. This study presents an expanded analysis of CRISPR systems and gene editing chemistry with emphasis on biochemical mechanisms of Cas proteins, guide RNA specificity, DNA repair dynamics, therapeutic genome engineering, and translational biomedical applications. The findings demonstrate that CRISPR-mediated genome modification significantly improves accuracy of genetic correction, facilitates development of personalized therapeutic strategies, and expands possibilities for treatment of hereditary diseases, oncological disorders, infectious pathology, and degenerative conditions. Rapid advancement of molecular engineering technologies continues to transform modern medicine, although important challenges including off-target effects, genomic instability, immunogenicity, ethical concerns, and biosafety regulation remain critical areas requiring further scientific investigation and international oversight.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779111897110-CRISPR_and_gene_editing_chemistry.pdf" type="application/pdf" length="0"/>
      <dc:creator>Limrah khan¹</dc:creator>
      <dc:creator>Rifza khan²</dc:creator>
      <dc:subject>CRISPR</dc:subject>
      <dc:subject>gene editing</dc:subject>
      <dc:subject>genome engineering</dc:subject>
      <dc:subject>Cas9</dc:subject>
      <dc:subject>guide RNA</dc:subject>
      <dc:subject>molecular biology</dc:subject>
      <dc:subject>biotechnology</dc:subject>
      <dc:subject>genetic therapy</dc:subject>
      <dc:subject>DNA repair</dc:subject>
      <dc:subject>precision medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1362</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>THE ROLE OF VITAMIN D IN FEMALE REPRODUCTIVE HEALTH AND PREGNANCY OUTCOMES</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/20d9ed89-4116-49df-84be-37eb0e624a46</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/20d9ed89-4116-49df-84be-37eb0e624a46</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Umarov Zafar¹</author>
      <description>Vitamin D is increasingly recognized as an important regulator of female reproductive physiology in addition to its established role in calcium and bone metabolism. The presence of vitamin D receptors in the ovaries, endometrium, placenta, pituitary gland, and decidual tissue suggests that this hormone-like vitamin participates in follicular maturation, endometrial receptivity, embryo implantation, placental development, and immune regulation during pregnancy. Vitamin D deficiency is highly prevalent among women of reproductive age and has been associated with infertility, menstrual irregularities, polycystic ovary syndrome, endometriosis, recurrent pregnancy loss, gestational diabetes mellitus, hypertensive disorders of pregnancy, preterm birth, and impaired fetal growth. This study aimed to evaluate the influence of vitamin D status on female reproductive health and pregnancy outcomes through comprehensive clinical assessment. The findings indicate that maintaining adequate serum vitamin D concentrations before conception and throughout pregnancy contributes to improved reproductive function, healthier placental development, reduced maternal complications, and better neonatal outcomes. Early screening and individualized correction of vitamin D deficiency should therefore be considered an important component of reproductive healthcare.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783005015713-THE_ROLE_OF_VITAMIN_D_IN_FEMALE_REPRODUCTIVE_HEALT.pdf" type="application/pdf" length="0"/>
      <dc:creator>Umarov Zafar¹</dc:creator>
      <dc:creator>Jumaboyeva Mashhura²</dc:creator>
      <dc:creator>Uzoqova Oyjamol³</dc:creator>
      <dc:subject>vitamin D</dc:subject>
      <dc:subject>female reproductive health</dc:subject>
      <dc:subject>pregnancy</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>gestational diabetes</dc:subject>
      <dc:subject>preeclampsia</dc:subject>
      <dc:subject>placental function</dc:subject>
      <dc:subject>reproductive endocrinology</dc:subject>
      <dc:subject>maternal health</dc:subject>
      <dc:subject>fetal development.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 151-165</dc:source>
    </item>
    <item>
      <title>Light-Cured Composite Materials in Restorative Dentistry: Composition, Polymerization Mechanisms, Clinical Applications, and Long-Term Performance</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/58468b54-dddf-40fe-983d-5b957f697823</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/58468b54-dddf-40fe-983d-5b957f697823</guid>
      <pubDate>Mon, 18 May 2026 00:00:00 GMT</pubDate>
      <author>Tagiyeva Sabina¹</author>
      <description>Light-cured composite materials represent one of the most significant advancements in contemporary restorative dentistry due to their superior aesthetic characteristics, adhesive properties, mechanical durability, and minimally invasive clinical application. These restorative biomaterials consist of organic resin matrices, inorganic filler particles, coupling agents, photoinitiator systems, pigments, and stabilizing compounds that undergo polymerization following exposure to visible blue light. This study investigates the composition, polymerization mechanisms, physical characteristics, clinical applications, advantages, limitations, and technological development of light-cured composite materials in restorative dentistry. Particular attention is focused on adhesive bonding, polymerization kinetics, mechanical resistance, marginal adaptation, aesthetic integration, biocompatibility, and long-term clinical performance. The findings demonstrate that modern light-cured composite systems significantly improve restoration durability, anatomical reconstruction, color stability, and preservation of healthy dental tissues. Contemporary nanotechnology and advanced photopolymerization systems continue to optimize clinical effectiveness and expand the therapeutic potential of composite restorative materials in aesthetic and functional rehabilitation of dental structures. Light-cured composite materials represent one of the most important achievements in contemporary restorative dentistry due to their high aesthetic quality, adhesive capability, mechanical durability, and minimally invasive clinical application. These biomaterials consist of complex organic and inorganic components that undergo photopolymerization following activation by visible blue light, resulting in formation of rigid and stable restorative structures closely integrated with dental tissues. This study presents an expanded analysis of light-cured composite materials with emphasis on chemical composition, polymerization mechanisms, adhesive interaction with enamel and dentin, mechanical characteristics, optical properties, clinical applications, and long-term restorative performance. The findings demonstrate that modern nanotechnology-based composite systems significantly improve marginal adaptation, anatomical reconstruction, wear resistance, surface smoothness, and color stability while preserving healthy dental structures. Advanced photopolymerization systems and adhesive technologies contribute substantially to optimization of restorative outcomes and enhancement of functional and aesthetic rehabilitation in operative dentistry. Continuous development of composite chemistry and biomaterial engineering remains essential for improving longevity, biocompatibility, and clinical effectiveness of light-cured restorative systems.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1779112729401-Light_Cured_Composite_Materials_in_Restorative_Den.pdf" type="application/pdf" length="0"/>
      <dc:creator>Tagiyeva Sabina¹</dc:creator>
      <dc:creator>Yarashova Sevinch²</dc:creator>
      <dc:creator>Musinova Parizoda³</dc:creator>
      <dc:creator>Sodikova Shoira⁴</dc:creator>
      <dc:subject>Light-cured composites</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>photopolymerization</dc:subject>
      <dc:subject>resin composite</dc:subject>
      <dc:subject>adhesive systems</dc:subject>
      <dc:subject>nanocomposites</dc:subject>
      <dc:subject>dental biomaterials</dc:subject>
      <dc:subject>aesthetic restoration</dc:subject>
      <dc:subject>polymerization shrinkage</dc:subject>
      <dc:subject>dental restoration</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1364</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 46-60</dc:source>
    </item>
    <item>
      <title>STRUCTURAL AND FUNCTIONAL CHANGES IN EPIRETINAL MEMBRANE: CLINICAL AND TOMOGRAPHIC ASSESSMENT</title>
      <link>https://aams-journal.us/journals/surgery/articles/ad161293-622e-4662-9e84-5d120d6f5737</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/ad161293-622e-4662-9e84-5d120d6f5737</guid>
      <pubDate>Sun, 17 May 2026 00:00:00 GMT</pubDate>
      <author>Ismoilov Jasur Jamshetovich</author>
      <description>Epiretinal membrane (ERM) is a vitreoretinal interface disorder characterized by the formation of fibrocellular tissue on the inner retinal surface, leading to progressive structural distortion of the macula and impairment of visual function. The prevalence of ERM increases with age and represents an important cause of visual morbidity among elderly populations. Recent advances in optical coherence tomography (OCT) have significantly enhanced the ability to detect and evaluate retinal changes associated with ERM. The aim of this study was to investigate structural and functional alterations occurring in patients with epiretinal membrane through comprehensive clinical and tomographic assessment. A detailed analysis of retinal morphology, visual acuity, macular thickness, and vitreoretinal interface abnormalities was performed. The findings demonstrated significant associations between retinal structural distortion and deterioration of visual performance. OCT proved highly effective for early diagnosis, monitoring disease progression, and evaluating the severity of retinal changes. Clinical and tomographic correlation provides valuable information for therapeutic decision-making and long-term management of patients with epiretinal membrane.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1782308285201-STRUCTURAL_AND_FUNCTIONAL_CHANGES_IN_EPIRETINAL_ME.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ismoilov Jasur Jamshetovich</dc:creator>
      <dc:subject>epiretinal membrane</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>macular disorders</dc:subject>
      <dc:subject>retinal thickness</dc:subject>
      <dc:subject>vitreoretinal interface</dc:subject>
      <dc:subject>visual acuity</dc:subject>
      <dc:subject>retinal traction</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>retinal imaging.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>THE IMPACT OF DIABETES MELLITUS ON THE DEVELOPMENT AND PROGRESSION OF CHRONIC KIDNEY DISEASE</title>
      <link>https://aams-journal.us/journals/neurology/articles/81ced1f4-532d-45b7-8370-ac129a26cc7f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/81ced1f4-532d-45b7-8370-ac129a26cc7f</guid>
      <pubDate>Sat, 16 May 2026 00:00:00 GMT</pubDate>
      <author>Turdiyev Qilichbek¹</author>
      <description>Chronic kidney disease (CKD) is one of the fastest-growing public health challenges worldwide and represents a major cause of morbidity, mortality, and healthcare expenditure. Diabetes mellitus has become the leading etiological factor responsible for the development of CKD, accounting for a substantial proportion of patients requiring renal replacement therapy. Persistent hyperglycemia induces structural and functional alterations within the renal microvasculature, resulting in progressive nephron loss, glomerular sclerosis, tubulointerstitial fibrosis, and gradual decline of renal function. This study aimed to evaluate the influence of diabetes mellitus on the onset, progression, and clinical outcomes of chronic kidney disease through comprehensive clinical, laboratory, and instrumental assessment. A comparative analysis was performed to determine the relationship between glycemic control, renal biomarkers, cardiovascular risk factors, and disease progression. The findings demonstrate that poor metabolic control significantly accelerates deterioration of kidney function, increases albuminuria, enhances cardiovascular complications, and worsens long-term prognosis. Early diagnosis, individualized glycemic management, nephroprotective therapy, and multidisciplinary follow-up are essential for delaying CKD progression and improving patient survival.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783005729047-THE_IMPACT_OF_DIABETES_MELLITUS_ON_THE_DEVELOPMENT.pdf" type="application/pdf" length="0"/>
      <dc:creator>Turdiyev Qilichbek¹</dc:creator>
      <dc:creator>Elmirzayev Akhmad²</dc:creator>
      <dc:creator>Uzokova Oyjamol³</dc:creator>
      <dc:subject>chronic kidney disease</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>diabetic kidney disease</dc:subject>
      <dc:subject>diabetic nephropathy</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>glomerular filtration rate</dc:subject>
      <dc:subject>renal function</dc:subject>
      <dc:subject>hyperglycemia</dc:subject>
      <dc:subject>nephrology</dc:subject>
      <dc:subject>cardiovascular risk.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 106-120</dc:source>
    </item>
    <item>
      <title>DIAGNOSTIC VALUE OF OPTICAL COHERENCE TOMOGRAPHY AND VISUAL FIELD PERIMETRY IN EVALUATING THE EFFECTIVENESS OF NEUROPROTECTIVE THERAPY IN ISCHEMIC OPTIC NEUROPATHY</title>
      <link>https://aams-journal.us/journals/dentistry/articles/be61f29f-e4d3-4a2f-9cec-33cf98b8f9ba</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/be61f29f-e4d3-4a2f-9cec-33cf98b8f9ba</guid>
      <pubDate>Sat, 16 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Ischemic optic neuropathy (ION) is one of the leading causes of sudden visual impairment resulting from insufficient blood supply to the optic nerve. Although neuroprotective therapy has become an important component of modern treatment strategies, objective assessment of therapeutic effectiveness remains challenging. Optical coherence tomography (OCT) and automated visual field perimetry provide complementary structural and functional information that can accurately monitor disease progression and treatment response. This study aimed to evaluate the diagnostic value of OCT and perimetry in assessing the effectiveness of neuroprotective therapy in patients with ischemic optic neuropathy. A comprehensive ophthalmic examination incorporating retinal imaging and functional visual assessment demonstrated that combined interpretation of morphological and functional parameters significantly improved monitoring of disease progression and therapeutic outcomes. The integration of OCT and perimetry offers a reliable approach for individualized clinical management and long-term follow-up of patients with ischemic optic neuropathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783055186081-DIAGNOSTIC_VALUE_OF_OPTICAL_COHERENCE_TOMOGRAPHY_A.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>ischemic optic neuropathy</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>visual field perimetry</dc:subject>
      <dc:subject>neuroprotective therapy</dc:subject>
      <dc:subject>retinal nerve fiber layer</dc:subject>
      <dc:subject>ganglion cell complex</dc:subject>
      <dc:subject>visual function</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>prognosis.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 05, pp. 91-105</dc:source>
    </item>
    <item>
      <title>TRANSIENT ISCHEMIC ATTACK — A PRECURSOR TO STROKE DEVELOPMENT</title>
      <link>https://aams-journal.us/journals/neurology/articles/07c7655a-b41d-4b90-96d9-d809ef3ccc86</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/07c7655a-b41d-4b90-96d9-d809ef3ccc86</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 GMT</pubDate>
      <author>Nazarova N.R¹</author>
      <description>Transient ischemic attack is a serious cerebrovascular disorder characterized by temporary interruption of cerebral blood circulation leading to short-term neurological dysfunction without permanent brain infarction. Despite transient clinical manifestations, the condition represents one of the most significant predictors of future ischemic stroke and long-term cerebrovascular complications. This study investigates transient ischemic attack as a precursor to stroke development with particular attention to vascular risk factors, cerebral hemodynamic disturbances, neurological manifestations, diagnostic strategies, and prevention of recurrent ischemic events. The findings demonstrate that transient ischemic attacks are strongly associated with endothelial dysfunction, atherosclerosis, thromboembolic processes, hypertension, diabetes mellitus, and cardiovascular disease contributing to progressive cerebral ischemia and increased risk of stroke. Early diagnosis, rapid neurological assessment, vascular imaging, antithrombotic therapy, and aggressive risk factor modification significantly reduce probability of recurrent cerebrovascular events and improve long-term neurological prognosis. Transient ischemic attack is a critical cerebrovascular condition characterized by temporary interruption of cerebral blood flow resulting in reversible neurological dysfunction without formation of permanent cerebral infarction. Despite short duration of symptoms, the condition represents one of the most important predictors of subsequent ischemic stroke and long-term neurological disability. This study presents an expanded analysis of transient ischemic attack as an early precursor to stroke development with emphasis on vascular pathophysiology, cerebral hemodynamic instability, endothelial dysfunction, thromboembolic mechanisms, clinical manifestations, and preventive therapeutic strategies. The findings demonstrate that transient ischemic episodes are strongly associated with chronic vascular pathology including arterial hypertension, diabetes mellitus, carotid artery stenosis, atrial fibrillation, dyslipidemia, and systemic atherosclerosis leading to progressive impairment of cerebral circulation. Early neurological assessment, neurovascular imaging, rapid initiation of antithrombotic therapy, and aggressive correction of vascular risk factors significantly reduce probability of recurrent ischemic episodes and future stroke development. Comprehensive multidisciplinary management remains essential for prevention of irreversible neurological injury and reduction of cerebrovascular morbidity and mortality.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778865132176-TRANSIENT_ISCHEMIC_ATTACK___A_PRECURSOR_TO_STROKE_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nazarova N.R¹</dc:creator>
      <dc:creator>Mahsudova X.N²</dc:creator>
      <dc:creator>Hidoyatova D.N³</dc:creator>
      <dc:subject>Transient ischemic attack</dc:subject>
      <dc:subject>ischemic stroke</dc:subject>
      <dc:subject>cerebrovascular disease</dc:subject>
      <dc:subject>cerebral ischemia</dc:subject>
      <dc:subject>neurological deficits</dc:subject>
      <dc:subject>vascular disorders</dc:subject>
      <dc:subject>thromboembolism</dc:subject>
      <dc:subject>stroke prevention</dc:subject>
      <dc:subject>cerebral circulation</dc:subject>
      <dc:subject>neurovascular pathology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1357</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 61-75</dc:source>
    </item>
    <item>
      <title>CARDIO-ONCOLOGY: A RISING FRONTIER</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/679ff2a9-db3e-4c66-b678-7b7981250233</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/679ff2a9-db3e-4c66-b678-7b7981250233</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 GMT</pubDate>
      <author>Inayath Ali D¹</author>
      <description>Cardio-oncology has emerged as one of the fastest developing interdisciplinary fields in modern medicine due to increasing survival rates among cancer patients and growing recognition of cardiovascular complications associated with oncological therapy. Advances in chemotherapy, immunotherapy, targeted biological agents, and radiation therapy have significantly improved cancer prognosis; however, many antineoplastic treatments exert substantial cardiotoxic effects leading to myocardial dysfunction, arrhythmias, hypertension, thromboembolic complications, vascular injury, and heart failure. This study investigates the clinical significance of cardio-oncology with particular attention to mechanisms of cancer therapy–related cardiotoxicity, cardiovascular risk assessment, early diagnostic strategies, prevention of myocardial injury, and optimization of multidisciplinary treatment approaches. The findings demonstrate that timely cardiovascular monitoring, early detection of subclinical cardiac dysfunction, and individualized cardioprotective interventions significantly improve long-term survival and quality of life in oncology patients. Integration of cardiology and oncology remains essential for minimizing treatment-related cardiovascular complications and improving overall therapeutic outcomes. Cardio-oncology has become one of the most important and rapidly developing interdisciplinary directions in contemporary medicine due to increasing survival rates among cancer patients and growing prevalence of cardiovascular complications associated with oncological therapy. Advances in chemotherapy, targeted biological treatment, immunotherapy, hormonal therapy, and radiation oncology have significantly improved long-term cancer outcomes; however, many therapeutic agents exert substantial cardiotoxic effects that may lead to myocardial dysfunction, arrhythmias, hypertension, thromboembolic events, vascular injury, and chronic heart failure. This study presents an expanded analysis of cardio-oncology as an emerging medical frontier with particular attention to mechanisms of treatment-related cardiotoxicity, cardiovascular risk stratification, diagnostic monitoring, prevention of myocardial injury, and optimization of multidisciplinary therapeutic strategies. The findings demonstrate that early cardiovascular evaluation, biomarker surveillance, advanced cardiac imaging, and individualized cardioprotective interventions significantly improve preservation of cardiac function and enhance quality of life in oncology patients. Integrated cooperation between cardiology and oncology specialists remains essential for minimizing cardiovascular morbidity and improving long-term survival in patients receiving anticancer therapy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778861304522-CARDIO_ONCOLOGY__A_RISING_FRONTIER.pdf" type="application/pdf" length="0"/>
      <dc:creator>Inayath Ali D¹</dc:creator>
      <dc:creator>Avanthika CK²</dc:creator>
      <dc:subject>Cardio-oncology</dc:subject>
      <dc:subject>cardiotoxicity</dc:subject>
      <dc:subject>chemotherapy</dc:subject>
      <dc:subject>heart failure</dc:subject>
      <dc:subject>cancer therapy</dc:subject>
      <dc:subject>cardiovascular complications</dc:subject>
      <dc:subject>oncology</dc:subject>
      <dc:subject>myocardial dysfunction</dc:subject>
      <dc:subject>targeted therapy</dc:subject>
      <dc:subject>cardioprotection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1355</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>STROKE: EARLY RECOGNITION AND EMERGENCY MANAGEMENT</title>
      <link>https://aams-journal.us/journals/neurology/articles/8749c79f-5df9-49ce-a03a-60bd8b321558</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/8749c79f-5df9-49ce-a03a-60bd8b321558</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 GMT</pubDate>
      <author>Hazim Wasim¹</author>
      <description>Stroke remains one of the leading causes of mortality, long-term disability, and neurological impairment worldwide and represents a major medical emergency requiring immediate diagnosis and rapid therapeutic intervention. Early recognition of stroke symptoms and timely initiation of emergency management significantly improve neurological recovery, reduce brain tissue damage, and decrease mortality rates. This study investigates the clinical importance of early stroke identification and modern emergency management strategies with particular attention to acute neurological assessment, diagnostic imaging, reperfusion therapy, stabilization of vital functions, and prevention of secondary brain injury. The findings demonstrate that rapid recognition of neurological deficits, immediate transportation to specialized stroke centers, and early implementation of thrombolytic or endovascular treatment substantially improve patient prognosis and functional outcomes. Comprehensive multidisciplinary emergency care remains essential for minimizing neurological complications and enhancing long-term rehabilitation potential in patients with acute cerebrovascular disorders. Stroke remains one of the most severe acute neurological disorders and is a leading cause of mortality, permanent disability, and long-term functional impairment worldwide. Rapid recognition of early clinical manifestations and immediate initiation of emergency medical management are critically important for preservation of viable brain tissue and improvement of neurological recovery. This study presents an expanded analysis of early stroke recognition and modern emergency management strategies with particular attention to pathophysiological mechanisms of cerebral ischemia, diagnostic assessment, reperfusion therapy, stabilization of vital functions, and prevention of secondary neuronal injury. The findings demonstrate that rapid identification of neurological deficits, urgent neuroimaging, timely thrombolytic intervention, and coordinated multidisciplinary emergency care significantly improve survival and reduce severity of long-term disability. Comprehensive acute stroke management aimed at restoring cerebral perfusion and minimizing ischemic damage remains essential for optimizing rehabilitation potential and improving quality of life in patients with cerebrovascular disease.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778860194343-STROKE__EARLY_RECOGNITION_AND_EMERGENCY_MANAGEMENT.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hazim Wasim¹</dc:creator>
      <dc:creator>Mohammad Kaif²</dc:creator>
      <dc:subject>Stroke</dc:subject>
      <dc:subject>ischemic stroke</dc:subject>
      <dc:subject>hemorrhagic stroke</dc:subject>
      <dc:subject>emergency management</dc:subject>
      <dc:subject>thrombolysis</dc:subject>
      <dc:subject>neurological deficit</dc:subject>
      <dc:subject>cerebrovascular disease</dc:subject>
      <dc:subject>acute stroke care</dc:subject>
      <dc:subject>reperfusion therapy</dc:subject>
      <dc:subject>neurorehabilitation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1354</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>THE IMPACT OF POLYCYSTIC OVARY SYNDROME ON REPRODUCTIVE AND METABOLIC HEALTH IN WOMEN</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/9fdbb451-4fdc-4932-a98d-8d7888437a70</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/9fdbb451-4fdc-4932-a98d-8d7888437a70</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 GMT</pubDate>
      <author>Tuychiyeva Nasiba¹</author>
      <description>Polycystic ovary syndrome is one of the most common endocrine and metabolic disorders affecting women of reproductive age and represents a major challenge in gynecology, endocrinology, and reproductive medicine. The syndrome is characterized by hormonal imbalance, chronic anovulation, hyperandrogenism, insulin resistance, and polycystic ovarian morphology, leading to significant reproductive, metabolic, and psychological complications. This study investigates the impact of polycystic ovary syndrome on reproductive and metabolic health with particular attention to infertility, menstrual dysfunction, obesity, insulin resistance, dyslipidemia, cardiovascular risk, and long-term endocrine disturbances. The findings demonstrate that metabolic dysregulation and hormonal imbalance play central roles in progression of reproductive impairment and systemic complications associated with the syndrome. Early diagnosis, lifestyle modification, hormonal regulation, and individualized multidisciplinary management significantly improve reproductive outcomes and reduce metabolic risk in affected women. Polycystic ovary syndrome is one of the most prevalent endocrine and metabolic disorders affecting women of reproductive age and is associated with substantial reproductive, hormonal, metabolic, and psychological complications. The syndrome is characterized by chronic anovulation, hyperandrogenism, insulin resistance, menstrual irregularities, and polycystic ovarian morphology, resulting in significant impairment of fertility and systemic metabolic balance. This study presents an expanded analysis of the impact of polycystic ovary syndrome on reproductive and metabolic health with particular attention to infertility, endocrine dysregulation, obesity, chronic inflammation, insulin resistance, cardiovascular risk, and long-term metabolic complications. The findings demonstrate that hormonal imbalance and metabolic dysfunction interact closely in progression of ovarian abnormalities and systemic pathological changes. Early diagnosis, lifestyle-oriented intervention, hormonal regulation, metabolic correction, and multidisciplinary therapeutic management significantly improve reproductive function and reduce risk of long-term endocrine and cardiovascular complications in affected women.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778862321039-THE_IMPACT_OF_POLYCYSTIC_OVARY_SYNDROME_ON_REPRODU.pdf" type="application/pdf" length="0"/>
      <dc:creator>Tuychiyeva Nasiba¹</dc:creator>
      <dc:creator>Raupova Fotima²</dc:creator>
      <dc:creator>Qaxorova Zuxra³</dc:creator>
      <dc:subject>Polycystic ovary syndrome</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>hyperandrogenism</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>endocrine disorders</dc:subject>
      <dc:subject>menstrual dysfunction</dc:subject>
      <dc:subject>women’s health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1356</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>DEVELOPMENT OF A PROGNOSTIC MODEL FOR THE COURSE OF ACUTE ISCHEMIC OPTIC NEUROPATHY BASED ON CLINICAL, MORPHOLOGICAL, AND FUNCTIONAL DATA</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/e8d0e4ae-d412-4ff0-89ca-aca31d43ac96</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/e8d0e4ae-d412-4ff0-89ca-aca31d43ac96</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy (AION) is one of the leading causes of sudden irreversible visual loss among middle-aged and elderly individuals. Despite significant advances in ophthalmic imaging and functional diagnostics, predicting disease progression and long-term visual outcomes remains a considerable clinical challenge. Early identification of prognostic factors may improve therapeutic decision-making, optimize patient follow-up, and reduce the risk of permanent visual disability. The present study aimed to develop a prognostic model for the clinical course of acute ischemic optic neuropathy using integrated clinical, morphological, and functional parameters. A comprehensive evaluation including ophthalmological examination, optical coherence tomography, visual field assessment, and electrophysiological testing was performed. The study demonstrated that combining structural retinal changes with functional visual parameters significantly improved prediction of disease progression and visual prognosis. The proposed prognostic approach may facilitate individualized treatment planning and enhance long-term clinical outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783054877977-DEVELOPMENT_OF_A_PROGNOSTIC_MODEL_FOR_THE_COURSE_O.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>acute ischemic optic neuropathy</dc:subject>
      <dc:subject>optic nerve</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>visual field</dc:subject>
      <dc:subject>retinal nerve fiber layer</dc:subject>
      <dc:subject>ganglion cell complex</dc:subject>
      <dc:subject>electrophysiology</dc:subject>
      <dc:subject>prognosis</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>predictive model.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CLINICAL AND FUNCTIONAL CHARACTERISTICS OF ACUTE ISCHEMIC OPTIC NEUROPATHY DEPENDING ON THE DEGREE OF ISCHEMIC DAMAGE TO THE OPTIC NERVE</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/3e03aa2a-3aa2-40a9-8772-44cf065c2973</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/3e03aa2a-3aa2-40a9-8772-44cf065c2973</guid>
      <pubDate>Wed, 13 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy is a severe vascular disorder of the optic nerve characterized by sudden impairment of visual function resulting from insufficient blood supply to optic nerve structures. The condition represents one of the leading causes of acute optic nerve damage and irreversible visual loss among middle-aged and elderly individuals. This study investigates the clinical and functional characteristics of acute ischemic optic neuropathy depending on the severity of ischemic injury to the optic nerve with particular attention to visual acuity impairment, visual field defects, retinal and optic disc changes, vascular disturbances, and neurofunctional abnormalities. The findings demonstrate that severity of ischemic damage significantly influences progression of visual dysfunction, structural optic nerve injury, and long-term visual prognosis. Early diagnosis, vascular stabilization, neuroprotective therapy, and individualized multidisciplinary management contribute substantially to preservation of residual visual function and reduction of irreversible optic nerve degeneration. Acute ischemic optic neuropathy is a severe vascular-neurodegenerative disorder characterized by sudden impairment of optic nerve perfusion resulting in rapid visual dysfunction and progressive structural damage of optic nerve fibers. The disease represents one of the leading causes of acute optic nerve injury and irreversible visual loss among patients with systemic vascular pathology. This study presents an expanded analysis of clinical and functional characteristics of acute ischemic optic neuropathy depending on severity of ischemic involvement of the optic nerve. Particular attention is focused on visual acuity reduction, visual field impairment, retinal nerve fiber layer degeneration, optic disc edema, vascular insufficiency, and electrophysiological abnormalities associated with different degrees of ischemic injury. The findings demonstrate that severity of ischemia significantly influences progression of neurodegenerative changes, extent of visual dysfunction, and long-term visual prognosis. Early diagnosis, vascular stabilization, neuroprotective therapy, and comprehensive multidisciplinary management substantially improve preservation of residual visual function and reduce progression of irreversible optic nerve atrophy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778649111630-CLINICAL_AND_FUNCTIONAL_CHARACTERISTICS_OF_ACUTE_I.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>Acute ischemic optic neuropathy</dc:subject>
      <dc:subject>optic nerve ischemia</dc:subject>
      <dc:subject>visual impairment</dc:subject>
      <dc:subject>optic disc edema</dc:subject>
      <dc:subject>visual field defects</dc:subject>
      <dc:subject>retinal circulation</dc:subject>
      <dc:subject>neuro-ophthalmology</dc:subject>
      <dc:subject>ischemic injury</dc:subject>
      <dc:subject>optic neuropathy</dc:subject>
      <dc:subject>vascular disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1352</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>DIABETIC NEPHROPATHY: MODERN APPROACHES TO DIAGNOSIS, CLINICAL MANAGEMENT, AND INDICATIONS FOR HEMODIALYSIS</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c8a486d9-f254-4022-81f1-a79798c227fa</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c8a486d9-f254-4022-81f1-a79798c227fa</guid>
      <pubDate>Wed, 13 May 2026 00:00:00 GMT</pubDate>
      <author>Khakberdiyev Zubaydulla¹</author>
      <description>Diabetic nephropathy is one of the most serious chronic microvascular complications of diabetes mellitus and remains the leading cause of chronic kidney disease and end-stage kidney disease worldwide. Progressive deterioration of renal structure and function resulting from persistent hyperglycemia contributes significantly to cardiovascular morbidity, premature mortality, and reduced quality of life. Advances in nephrology and diabetology have improved early diagnosis and therapeutic management; however, many patients continue to progress to renal failure requiring renal replacement therapy. This study aimed to evaluate current approaches to the diagnosis and clinical management of diabetic nephropathy while emphasizing evidence-based indications for initiation of hemodialysis. Clinical, laboratory, and imaging parameters were analyzed to assess disease progression and therapeutic outcomes. The findings demonstrate that early detection through routine screening of albuminuria and estimated glomerular filtration rate, combined with optimized metabolic control and nephroprotective therapy, significantly delays renal deterioration. Timely initiation of hemodialysis in advanced disease improves metabolic stability, reduces uremic complications, and enhances patient survival. A multidisciplinary management strategy remains fundamental for preserving renal function and improving long-term clinical outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783006263241-DIABETIC_NEPHROPATHY__MODERN_APPROACHES_TO_DIAGNOS.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khakberdiyev Zubaydulla¹</dc:creator>
      <dc:creator>Turdiyev Qilichbek²</dc:creator>
      <dc:creator>Uzogova Oyjamol³</dc:creator>
      <dc:subject>diabetic nephropathy</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>chronic kidney disease</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>estimated glomerular filtration rate</dc:subject>
      <dc:subject>hemodialysis</dc:subject>
      <dc:subject>renal replacement therapy</dc:subject>
      <dc:subject>nephrology</dc:subject>
      <dc:subject>hyperglycemia</dc:subject>
      <dc:subject>renal failure.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MORPHOMETRIC CHANGES OF THE OPTIC DISC AND RETINAL NERVE FIBER LAYER IN ACUTE ISCHEMIC OPTIC NEUROPATHY</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/cb816f88-f6a2-4817-9cb3-409c97aa4597</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/cb816f88-f6a2-4817-9cb3-409c97aa4597</guid>
      <pubDate>Wed, 13 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy is a severe vascular-neurodegenerative disorder characterized by sudden impairment of optic nerve circulation leading to structural and functional damage of visual pathways. Morphometric evaluation of the optic disc and retinal nerve fiber layer plays a crucial role in assessment of disease severity, progression of neuronal degeneration, and prediction of visual prognosis. This study investigates morphometric changes of the optic disc and retinal nerve fiber layer in patients with acute ischemic optic neuropathy using modern ophthalmological imaging technologies. Particular attention is focused on optic disc edema, retinal nerve fiber layer thickness alterations, structural remodeling of optic nerve tissue, microvascular disturbances, and correlation between morphometric abnormalities and visual dysfunction. The findings demonstrate that severity of ischemic injury significantly influences structural degeneration of retinal nerve fibers and progression of optic nerve atrophy. Early identification of morphometric alterations using optical coherence tomography contributes substantially to timely diagnosis, monitoring of disease progression, and optimization of neuroprotective therapeutic strategies. Acute ischemic optic neuropathy is a severe vascular-neurodegenerative disorder characterized by sudden impairment of optic nerve blood supply leading to progressive structural and functional damage of visual pathways. Morphometric alterations of the optic disc and retinal nerve fiber layer represent important indicators of severity of ischemic injury and progression of neuronal degeneration. This study presents an expanded analysis of morphometric changes occurring in the optic disc and retinal nerve fiber layer during acute ischemic optic neuropathy with particular attention to optic disc edema, retinal nerve fiber layer remodeling, ganglion cell degeneration, microcirculatory disturbances, and correlation between structural abnormalities and visual dysfunction. The findings demonstrate that severity of ischemic damage significantly influences degree of morphometric alteration, progression of optic nerve atrophy, and long-term visual prognosis. Early detection of structural retinal abnormalities using advanced ophthalmological imaging technologies contributes substantially to timely diagnosis, therapeutic monitoring, and preservation of residual visual function in patients with ischemic optic nerve injury.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778651046112-MORPHOMETRIC_CHANGES_OF_THE_OPTIC_DISC_AND_RETINAL.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>Acute ischemic optic neuropathy</dc:subject>
      <dc:subject>optic disc</dc:subject>
      <dc:subject>retinal nerve fiber layer</dc:subject>
      <dc:subject>morphometric changes</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>optic nerve edema</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>retinal imaging</dc:subject>
      <dc:subject>optic atrophy</dc:subject>
      <dc:subject>ischemic injury</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1353</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>DETECTION OF EARLY STAGES OF EPIRETINAL MEMBRANE CHANGES IN ELDERLY PEOPLE USING OCT</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/8ab371a2-f9f0-414b-8bfa-33b64e89f875</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/8ab371a2-f9f0-414b-8bfa-33b64e89f875</guid>
      <pubDate>Wed, 13 May 2026 00:00:00 GMT</pubDate>
      <author>Ismoilov Jasur Jamshetovich</author>
      <description>Epiretinal membrane (ERM) is a common age-related vitreoretinal disorder characterized by the formation of a thin fibrocellular layer on the inner surface of the retina. Although early stages of ERM may remain asymptomatic, progressive membrane contraction can lead to retinal distortion, visual impairment, metamorphopsia, and reduced quality of life. Optical coherence tomography (OCT) has emerged as the most sensitive and noninvasive imaging modality for the early detection and monitoring of epiretinal membrane changes. The aim of this study was to evaluate the effectiveness of OCT in identifying early-stage epiretinal membrane alterations in elderly individuals and to assess structural retinal changes associated with disease progression. Clinical and imaging data from elderly patients undergoing routine ophthalmological examinations were analyzed. The findings demonstrated that OCT enables visualization of subtle retinal abnormalities before significant visual symptoms occur. Early identification of epiretinal membrane formation may facilitate timely clinical monitoring and improve long-term visual outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1782307780383-DETECTION_OF_EARLY_STAGES_OF_EPIRETINAL_MEMBRANE_C.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ismoilov Jasur Jamshetovich</dc:creator>
      <dc:subject>epiretinal membrane</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>elderly patients</dc:subject>
      <dc:subject>retinal disorders</dc:subject>
      <dc:subject>vitreoretinal interface</dc:subject>
      <dc:subject>macular pathology</dc:subject>
      <dc:subject>retinal imaging</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>visual function.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>EVALUATION OF THE EFFECTIVENESS OF NEUROPROTECTIVE THERAPY IN ACUTE ISCHEMIC OPTIC NEUROPATHY</title>
      <link>https://aams-journal.us/journals/genetics/articles/d3a06e34-b616-413e-a37b-d0703ffeb87c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/d3a06e34-b616-413e-a37b-d0703ffeb87c</guid>
      <pubDate>Wed, 13 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy (AION) is one of the leading causes of sudden painless vision loss in adults and remains a major challenge in neuro-ophthalmology due to the limited regenerative capacity of the optic nerve. Secondary neuronal degeneration following ischemic injury significantly contributes to irreversible visual impairment. Neuroprotective therapy has emerged as a promising strategy aimed at preserving retinal ganglion cells, reducing axonal damage, and improving visual outcomes. This study evaluated the clinical effectiveness of neuroprotective therapy in patients with acute ischemic optic neuropathy using comprehensive structural and functional ophthalmic assessment. Clinical examination, optical coherence tomography (OCT), automated visual field analysis, and electrophysiological testing were used to monitor treatment response. The findings demonstrated that early neuroprotective intervention significantly preserved optic nerve morphology, reduced neuronal degeneration, improved visual function, and delayed the progression of optic nerve atrophy. These results support the integration of neuroprotective therapy into routine clinical management of acute ischemic optic neuropathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783057742948-EVALUATION_OF_THE_EFFECTIVENESS_OF_NEUROPROTECTIVE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>acute ischemic optic neuropathy</dc:subject>
      <dc:subject>neuroprotective therapy</dc:subject>
      <dc:subject>retinal ganglion cells</dc:subject>
      <dc:subject>optic nerve ischemia</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>visual field</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>visual acuity</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>treatment effectiveness.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>OPTIMIZING MANAGEMENT TACTICS WHEN PATIENTS WITH HYPERTENSION RECEIVE BURN TRAUMA</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/07f1a098-8295-4bcb-939a-82d0130d5a57</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/07f1a098-8295-4bcb-939a-82d0130d5a57</guid>
      <pubDate>Tue, 12 May 2026 00:00:00 GMT</pubDate>
      <author>Kodirov Dilshod¹</author>
      <description>Burn trauma is a severe form of injury that initiates complex local and systemic inflammatory responses, frequently resulting in significant hemodynamic instability, metabolic disturbances, and multiorgan dysfunction. In patients with pre-existing hypertension, burn injury presents additional therapeutic challenges because chronic vascular remodeling, endothelial dysfunction, impaired cardiovascular reserve, and associated comorbidities may substantially influence clinical outcomes. The coexistence of hypertension and burn trauma requires individualized management strategies that simultaneously address tissue perfusion, blood pressure regulation, fluid resuscitation, renal protection, cardiovascular stability, infection prevention, and wound healing. This study aimed to evaluate current management tactics for hypertensive patients following burn trauma and identify clinical factors associated with improved prognosis. The findings indicate that early multidisciplinary intervention, careful hemodynamic monitoring, individualized fluid therapy, optimized antihypertensive treatment, and comprehensive critical care significantly reduce complications and improve recovery. Tailored treatment protocols should therefore be incorporated into modern burn management to optimize outcomes in patients with chronic hypertension.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783007797933-OPTIMIZING_MANAGEMENT_TACTICS_WHEN_PATIENTS_WITH_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kodirov Dilshod¹</dc:creator>
      <dc:creator>Uzokova Oyjamol²</dc:creator>
      <dc:subject>burn trauma</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>fluid resuscitation</dc:subject>
      <dc:subject>cardiovascular complications</dc:subject>
      <dc:subject>critical care</dc:subject>
      <dc:subject>blood pressure management</dc:subject>
      <dc:subject>burn injury</dc:subject>
      <dc:subject>wound healing</dc:subject>
      <dc:subject>renal protection</dc:subject>
      <dc:subject>intensive care.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 166-180</dc:source>
    </item>
    <item>
      <title>Morphological Mechanisms of Optic Nerve Damage in Acute Ischemic Optic Neuropathy</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/a6c43788-dcb5-40bc-95c6-e66e7b46431e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/a6c43788-dcb5-40bc-95c6-e66e7b46431e</guid>
      <pubDate>Tue, 12 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy (AION) is one of the most important causes of sudden and irreversible visual loss resulting from insufficient blood supply to the optic nerve head. The disease is characterized by rapid interruption of oxygen and nutrient delivery, leading to structural and functional impairment of retinal ganglion cell axons that form the optic nerve. The optic nerve is highly susceptible to ischemic injury because of its elevated metabolic requirements and limited energy reserves. Even a brief reduction in tissue perfusion may initiate a sequence of morphological and molecular alterations that ultimately culminate in permanent neuronal degeneration and visual dysfunction. Although considerable progress has been made in understanding the clinical manifestations of AION, the precise morphological mechanisms responsible for optic nerve destruction remain incompletely understood.
The pathogenesis of acute ischemic optic neuropathy involves a complex interaction between vascular insufficiency, metabolic failure, oxidative stress, inflammatory activation, mitochondrial dysfunction, apoptosis, and secondary neurodegeneration. The initial ischemic insult disrupts oxidative phosphorylation within mitochondria, causing rapid depletion of intracellular adenosine triphosphate (ATP). Failure of ATP-dependent membrane pumps results in intracellular accumulation of sodium and calcium ions, osmotic swelling, membrane instability, and activation of proteolytic enzymes. Simultaneously, excessive release of excitatory neurotransmitters promotes calcium overload, further accelerating cellular injury through excitotoxic mechanisms. Increased production of reactive oxygen species damages lipids, proteins, and nucleic acids, while activation of inflammatory pathways amplifies secondary tissue destruction.
Morphological alterations begin within minutes after ischemia and progressively involve neurons, glial cells, vascular structures, connective tissue, and myelin sheaths. Early reversible changes gradually progress toward irreversible degeneration if tissue perfusion is not restored. Histopathological examination, immunohistochemistry, morphometric analysis, and electron microscopy provide essential information regarding the temporal sequence of these structural changes and contribute to understanding disease progression. Comprehensive evaluation of morphological mechanisms is therefore fundamental for identifying therapeutic targets capable of preserving optic nerve integrity and visual function.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783068181033-Morphological_Mechanisms_of_Optic_Nerve_Damage_in_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>Morphological Mechanisms</dc:subject>
      <dc:subject>Acute Ischemic Optic Neuropathy (AION)</dc:subject>
      <dc:subject>Optic Nerve Damage</dc:subject>
      <dc:subject>Optic Nerve Ischemia</dc:subject>
      <dc:subject>Histopathological Changes</dc:subject>
      <dc:subject>Retinal Ganglion Cells</dc:subject>
      <dc:subject>Neurodegeneration</dc:subject>
      <dc:subject>Axonal Degeneration</dc:subject>
      <dc:subject>Ocular Ischemia</dc:subject>
      <dc:subject>Morphological Alterations.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Determinative Role of Molecular and Morphological Markers in the Assessment of Destructive and Proliferative Processes of the Oral Mucosa in Leukoplakia and Optimization of Treatment Tactics</title>
      <link>https://aams-journal.us/journals/surgery/articles/8c5e9716-cad1-40a4-8f84-baef7ffcedad</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/8c5e9716-cad1-40a4-8f84-baef7ffcedad</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>Makhmudova Ugiloy Bakhtiyarovna</author>
      <description>Oral leukoplakia is one of the most significant precancerous diseases of the oral mucosa characterized by chronic epithelial alterations, dysplastic transformation, proliferative instability, and increased risk of malignant progression. Early identification of destructive and proliferative changes within oral mucosal tissues remains essential for timely diagnosis, accurate prognosis, and optimization of therapeutic strategies. This study investigates the determinative role of molecular and morphological markers in evaluation of pathological processes in oral leukoplakia with particular attention to epithelial dysplasia, inflammatory destruction, proliferative activity, angiogenesis, and malignant transformation potential. Histopathological analysis, immunohistochemical assessment, and molecular biological evaluation were used to determine the prognostic significance of cellular and extracellular markers associated with tissue remodeling and carcinogenesis. The findings demonstrate that combined assessment of molecular and morphological indicators significantly improves diagnostic precision, allows stratification of malignant risk, and contributes to development of personalized treatment tactics in patients with oral leukoplakia. Integration of biomarker analysis into clinical practice enhances early detection of aggressive pathological changes and improves long-term therapeutic outcomes. Oral leukoplakia is one of the most clinically significant precancerous disorders of the oral cavity characterized by chronic epithelial alterations, dysplastic transformation, proliferative instability, and progressive destructive changes within the oral mucosa. Timely identification of molecular and morphological indicators associated with pathological tissue remodeling remains critically important for prediction of malignant transformation and optimization of therapeutic management. This study presents an expanded analysis of the determinative role of molecular and morphological markers in assessment of destructive and proliferative processes in oral leukoplakia. Particular attention is given to epithelial dysplasia, inflammatory destruction, angiogenesis, cellular proliferation, apoptosis dysregulation, and structural connective tissue remodeling. Histopathological, immunohistochemical, and molecular biological evaluation demonstrated that expression of proliferative and oncogenic markers strongly correlates with severity of epithelial instability and progression of pathological tissue transformation. The findings confirm that integrated biomarker analysis significantly improves diagnostic precision, supports stratification of malignant risk, and contributes to development of individualized treatment tactics aimed at prevention of oral carcinoma progression and stabilization of mucosal remodeling processes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778515828636-Determinative_Role_of_Molecular_and_Morphological_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Makhmudova Ugiloy Bakhtiyarovna</dc:creator>
      <dc:subject>Oral leukoplakia</dc:subject>
      <dc:subject>molecular markers</dc:subject>
      <dc:subject>morphological markers</dc:subject>
      <dc:subject>epithelial dysplasia</dc:subject>
      <dc:subject>oral mucosa</dc:subject>
      <dc:subject>proliferative activity</dc:subject>
      <dc:subject>carcinogenesis</dc:subject>
      <dc:subject>immunohistochemistry</dc:subject>
      <dc:subject>precancerous lesions</dc:subject>
      <dc:subject>personalized treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1350</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 07, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CHANGES IN STABILOMETRIC PARAMETERS (CENTER OF PRESSURE) IN PATIENTS WITH VERTEBROBASILAR INSUFFICIENCY FOLLOWING STABILOMETRIC PLATFORM-BASED REHABILITATION</title>
      <link>https://aams-journal.us/journals/neurology/articles/14f5919a-da39-43c7-9ca0-70d925ef661c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/14f5919a-da39-43c7-9ca0-70d925ef661c</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>Ismoilova M.F.¹</author>
      <description>Vertebrobasilar insufficiency is a chronic cerebrovascular disorder characterized by impaired blood circulation within the vertebrobasilar arterial system, frequently resulting in dizziness, postural instability, gait disturbance, impaired coordination, and increased risk of falls. Stabilometric assessment has become an important diagnostic and rehabilitative tool for evaluating postural control and balance dysfunction in patients with vestibular and cerebrovascular disorders. This study investigates changes in stabilometric parameters, particularly center of pressure indicators, in patients with vertebrobasilar insufficiency following rehabilitation using a stabilometric platform. Particular attention is given to postural sway dynamics, balance stability, vestibular adaptation, sensorimotor integration, and rehabilitation effectiveness. The findings demonstrate that stabilometric platform-based rehabilitation significantly improves postural control, reduces instability, enhances proprioceptive regulation, and normalizes center of pressure displacement parameters. Objective stabilometric monitoring provides valuable information regarding functional recovery and therapeutic effectiveness during neurorehabilitation. Vertebrobasilar insufficiency is a chronic cerebrovascular disorder associated with impaired blood circulation within the vertebral and basilar arterial systems, leading to disturbances in vestibular regulation, postural control, coordination, and balance stability. Patients frequently experience dizziness, gait impairment, instability during standing, visual disturbances, and increased risk of falls, which significantly reduce functional independence and quality of life. Modern neurorehabilitation increasingly utilizes stabilometric technologies for objective assessment and correction of balance dysfunction through analysis of center of pressure dynamics and postural sway characteristics. This study presents an expanded evaluation of changes in stabilometric parameters in patients with vertebrobasilar insufficiency following rehabilitation using stabilometric platforms with biofeedback training. Particular attention is given to restoration of vestibular compensation, improvement of proprioceptive integration, reduction of postural oscillations, and normalization of center of pressure displacement during static and dynamic balance testing. The findings demonstrate that stabilometric rehabilitation significantly improves postural stability, enhances sensorimotor coordination, reduces pathological sway patterns, and contributes to greater functional adaptation during everyday activity. Objective stabilometric monitoring also provides valuable quantitative information regarding rehabilitation effectiveness and progression of neurofunctional recovery.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778499369729-CHANGES_IN_STABILOMETRIC_PARAMETERS__CENTER_OF_PRE.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ismoilova M.F.¹</dc:creator>
      <dc:creator>Kim O.V.²</dc:creator>
      <dc:subject>Vertebrobasilar insufficiency</dc:subject>
      <dc:subject>stabilometry</dc:subject>
      <dc:subject>center of pressure</dc:subject>
      <dc:subject>postural balance</dc:subject>
      <dc:subject>rehabilitation</dc:subject>
      <dc:subject>vestibular dysfunction</dc:subject>
      <dc:subject>stabilometric platform</dc:subject>
      <dc:subject>neurorehabilitation</dc:subject>
      <dc:subject>gait instability</dc:subject>
      <dc:subject>cerebrovascular disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1348</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 31-45</dc:source>
    </item>
    <item>
      <title>THE ROLE OF X-RAY SURGERY IN COMPLICATED FORMS OF GALLSTONE DISEASE</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/cad0602f-858c-4ba6-980a-150fec487125</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/cad0602f-858c-4ba6-980a-150fec487125</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>Sunnatova Maftuna Otabek qizi</author>
      <description>Complicated forms of gallstone disease remain a major problem in abdominal surgery due to the high frequency of biliary obstruction, inflammatory complications, cholangitis, pancreatitis, and postoperative morbidity. The development of minimally invasive radiological interventions has significantly improved diagnostic accuracy and therapeutic effectiveness in patients with complex hepatobiliary pathology. This study investigates the role of X-ray surgery in the management of complicated gallstone disease, focusing on minimally invasive fluoroscopic and endovascular techniques used for diagnosis, decompression, stone extraction, biliary drainage, and restoration of bile duct patency. Particular attention is given to the clinical effectiveness of radiologically guided procedures, reduction of surgical trauma, improvement of postoperative recovery, and prevention of severe complications. The findings demonstrate that X-ray surgical technologies provide highly effective minimally invasive treatment options in patients with obstructive jaundice, choledocholithiasis, biliary strictures, and acute inflammatory complications associated with gallstone disease. Integration of interventional radiology into hepatobiliary surgery significantly improves therapeutic outcomes and reduces perioperative risk in high-risk patient populations. Complicated forms of gallstone disease continue to represent one of the most serious problems in hepatobiliary surgery because biliary obstruction, acute inflammatory processes, septic complications, and pancreatic involvement may rapidly progress to life-threatening conditions. Development of minimally invasive interventional radiology has significantly expanded therapeutic possibilities in patients with severe biliary pathology and high operative risk. This study presents an expanded evaluation of the clinical role of X-ray surgery in diagnosis and treatment of complicated gallstone disease with particular attention to restoration of biliary drainage, elimination of obstructive syndromes, stabilization of inflammatory activity, and prevention of postoperative complications. Radiologically guided interventions including percutaneous biliary drainage, fluoroscopic stone extraction, balloon dilatation, and biliary stenting were analyzed as minimally invasive therapeutic strategies capable of reducing surgical trauma and improving recovery. The findings demonstrate that X-ray surgical procedures significantly improve bile duct decompression, normalize hepatobiliary function, reduce manifestations of cholestasis, and enhance postoperative rehabilitation. Integration of interventional radiology into modern hepatobiliary surgery contributes to reduction of perioperative mortality, shorter hospitalization, and improved long-term clinical outcomes in patients with complicated gallstone disease.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778500290316-THE_ROLE_OF_X_RAY_SURGERY_IN_COMPLICATED_FORMS_OF_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sunnatova Maftuna Otabek qizi</dc:creator>
      <dc:subject>Gallstone disease</dc:subject>
      <dc:subject>X-ray surgery</dc:subject>
      <dc:subject>interventional radiology</dc:subject>
      <dc:subject>choledocholithiasis</dc:subject>
      <dc:subject>biliary obstruction</dc:subject>
      <dc:subject>minimally invasive surgery</dc:subject>
      <dc:subject>obstructive jaundice</dc:subject>
      <dc:subject>biliary drainage</dc:subject>
      <dc:subject>fluoroscopy</dc:subject>
      <dc:subject>hepatobiliary surgery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1349</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>PATHOMORPHOLOGICAL CHANGES IN THE BRAIN, HEART, AND LIVER OF INFANTS WITH ANTEPARTUM FETAL DISTRESS</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/1aa8ebac-4ad2-4c89-8587-eee779ca51cc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/1aa8ebac-4ad2-4c89-8587-eee779ca51cc</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>Rahimqulova Zuxra¹</author>
      <description>Antepartum fetal distress remains one of the leading causes of perinatal morbidity and mortality worldwide. Prolonged intrauterine hypoxia adversely affects the development and function of vital organs, particularly the brain, heart, and liver. The present study aimed to investigate the pathomorphological alterations observed in these organs in infants who experienced fetal distress before birth. Histopathological evaluation revealed significant structural changes associated with chronic oxygen deprivation, circulatory disturbances, and metabolic imbalance. Cerebral tissue demonstrated edema, neuronal degeneration, and microvascular abnormalities. Cardiac examination revealed myocardial dystrophy, interstitial edema, and vascular congestion. Hepatic tissue showed degenerative changes in hepatocytes, sinusoidal dilatation, and signs of impaired metabolic activity. The findings emphasize the systemic impact of prenatal hypoxic injury and highlight the importance of early diagnosis and prevention of fetal distress to reduce neonatal complications and improve long-term outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1782309030959-PATHOMORPHOLOGICAL_CHANGES_IN_THE_BRAIN__HEART__AN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rahimqulova Zuxra¹</dc:creator>
      <dc:creator>Mustafoyeva Dilafruz²</dc:creator>
      <dc:creator>Ochilov Elyorjon³</dc:creator>
      <dc:creator>Alimova Ozoda⁴</dc:creator>
      <dc:subject>fetal distress</dc:subject>
      <dc:subject>perinatal hypoxia</dc:subject>
      <dc:subject>neonatal pathology</dc:subject>
      <dc:subject>brain injury</dc:subject>
      <dc:subject>myocardial changes</dc:subject>
      <dc:subject>liver pathology</dc:subject>
      <dc:subject>hypoxic-ischemic damage</dc:subject>
      <dc:subject>infant pathology</dc:subject>
      <dc:subject>histopathology</dc:subject>
      <dc:subject>perinatal medicine.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>PERSONALIZED ALGORITHM FOR THE PREVENTION AND TREATMENT OF POSTOPERATIVE FACIAL SCARS BASED ON A CLINICAL AND PROGNOSTIC MODEL</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/c6413815-8b27-488c-89a4-7a3f3ef1f204</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/c6413815-8b27-488c-89a4-7a3f3ef1f204</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>YUSUPOVA D.Z¹</author>
      <description>Postoperative facial scar formation remains a significant reconstructive and aesthetic challenge due to the complex interaction of local tissue factors, systemic conditions, inflammatory activity, and individual reparative characteristics. Development of pathological scars may lead to functional impairment, cosmetic deformity, psychological stress, and reduced quality of life. This study presents a personalized algorithm for prevention and treatment of postoperative facial scars based on a clinical and prognostic model integrating patient-specific risk factors, instrumental assessment, and dynamic monitoring of scar remodeling. Particular attention is given to prediction of pathological scar formation, optimization of individualized therapeutic strategies, and early implementation of preventive interventions. The findings demonstrate that personalized management significantly improves scar maturation, reduces hypertrophic and keloid transformation, enhances aesthetic outcomes, and increases treatment effectiveness during postoperative rehabilitation. Integration of prognostic analysis with regenerative and conventional therapeutic approaches allows more accurate selection of treatment protocols and improves long-term reconstructive results. Postoperative facial scar formation remains one of the most complex problems in reconstructive and aesthetic surgery because pathological remodeling may lead to persistent cosmetic deformities, functional limitations, emotional discomfort, and decreased quality of life. Modern approaches to scar prevention increasingly focus on personalized therapeutic algorithms based on clinical and prognostic assessment of individual patient characteristics, wound-healing dynamics, inflammatory response, and connective tissue metabolism. This study presents an expanded analysis of a personalized prevention and treatment model for postoperative facial scars integrating clinical risk stratification, instrumental monitoring, and individualized rehabilitation strategies. Special attention is given to prediction of pathological fibrosis, optimization of therapeutic timing, correction of microcirculatory disturbances, and regulation of collagen remodeling during postoperative recovery. The findings demonstrate that individualized preventive protocols significantly reduce the frequency of hypertrophic and keloid scar transformation, improve dermal remodeling, enhance tissue elasticity, and stabilize long-term aesthetic outcomes. Personalized therapeutic approaches combining regenerative medicine, pharmacological modulation, physiotherapy, and instrumental monitoring provide superior clinical effectiveness compared with generalized scar management strategies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778497763352-PERSONALIZED_ALGORITHM_FOR_THE_PREVENTION_AND_TREA.pdf" type="application/pdf" length="0"/>
      <dc:creator>YUSUPOVA D.Z¹</dc:creator>
      <dc:creator>ABDULLAEV Sh.Y²;</dc:creator>
      <dc:subject>Postoperative facial scars</dc:subject>
      <dc:subject>personalized treatment</dc:subject>
      <dc:subject>prognostic model</dc:subject>
      <dc:subject>scar prevention</dc:subject>
      <dc:subject>scar remodeling</dc:subject>
      <dc:subject>hypertrophic scars</dc:subject>
      <dc:subject>keloid</dc:subject>
      <dc:subject>reconstructive surgery</dc:subject>
      <dc:subject>regenerative therapy</dc:subject>
      <dc:subject>clinical algorithm</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1347</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>COMPARATIVE EFFECTIVENESS OF REDERMALIZATION, TRADITIONAL, AND COMBINED THERAPY IN THE TREATMENT OF POSTOPERATIVE FACIAL SCARS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/923ffe6e-2906-4c6c-87f6-b5945dd71b5d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/923ffe6e-2906-4c6c-87f6-b5945dd71b5d</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>YUSUPOVA D.Z¹</author>
      <description>Postoperative facial scars remain a major reconstructive and aesthetic concern because pathological scar formation may negatively affect facial appearance, tissue elasticity, psychological well-being, and social adaptation. Modern scar management increasingly focuses on regenerative therapeutic approaches capable of improving tissue remodeling and restoring normal dermal structure. This study investigates the comparative effectiveness of redermalization therapy, traditional treatment methods, and combined therapeutic approaches in the management of postoperative facial scars. Particular attention is given to scar thickness, vascularity, elasticity, pigmentation, collagen remodeling, inflammatory activity, and patient satisfaction during different stages of scar maturation. The findings demonstrate that combined therapeutic protocols integrating regenerative and conventional methods provide superior clinical and aesthetic outcomes compared with isolated treatment strategies. Redermalization therapy significantly improves tissue hydration, microcirculation, and collagen organization, while combined approaches demonstrate enhanced effectiveness in reducing fibrosis and accelerating physiological scar remodeling. Postoperative facial scar correction remains one of the most important challenges in reconstructive and aesthetic medicine because pathological scar formation may significantly affect cosmetic appearance, skin mobility, emotional state, and social adaptation. Contemporary therapeutic strategies increasingly combine regenerative technologies with conventional scar management methods to improve tissue remodeling and accelerate physiological healing processes. This study presents an expanded comparative evaluation of redermalization therapy, traditional scar treatment, and combined therapeutic protocols in patients with postoperative facial scars. Particular emphasis is placed on structural remodeling of connective tissue, restoration of dermal hydration, vascular stabilization, collagen reorganization, reduction of inflammatory activity, and improvement of long-term aesthetic outcomes. The findings demonstrate that regenerative approaches positively influence tissue metabolism and microcirculatory function, while combined therapeutic strategies provide the most effective correction of fibrotic deformities and pathological remodeling. Integrated treatment protocols significantly improve scar elasticity, reduce fibrosis intensity, normalize dermal architecture, and enhance patient satisfaction during postoperative rehabilitation.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778497319602-COMPARATIVE_EFFECTIVENESS_OF_REDERMALIZATION__TRAD.pdf" type="application/pdf" length="0"/>
      <dc:creator>YUSUPOVA D.Z¹</dc:creator>
      <dc:creator>ABDULLAEV Sh.Y²;</dc:creator>
      <dc:subject>Postoperative facial scars</dc:subject>
      <dc:subject>redermalization therapy</dc:subject>
      <dc:subject>scar remodeling</dc:subject>
      <dc:subject>hypertrophic scars</dc:subject>
      <dc:subject>reconstructive surgery</dc:subject>
      <dc:subject>regenerative medicine</dc:subject>
      <dc:subject>collagen remodeling</dc:subject>
      <dc:subject>scar treatment</dc:subject>
      <dc:subject>aesthetic rehabilitation</dc:subject>
      <dc:subject>combined therapy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1346</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>NON-ALCOHOLIC FATTY LIVER DISEASE IN YOUNG ADULTS: AN EMERGING PATHOLOGICAL CHALLENGE</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/50c79a42-01c1-4ece-92cd-ab38ca1a1fe0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/50c79a42-01c1-4ece-92cd-ab38ca1a1fe0</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>MOHAMMED FAHAD BIN AHAD FAROOQ</author>
      <description>Non-alcoholic fatty liver disease has become one of the most rapidly increasing chronic metabolic disorders among young adults worldwide and represents a major emerging public health challenge. The disease is characterized by excessive accumulation of fat within hepatocytes in the absence of significant alcohol consumption and is closely associated with obesity, insulin resistance, sedentary lifestyle, metabolic syndrome, and nutritional imbalance. Progression of non-alcoholic fatty liver disease may lead to non-alcoholic steatohepatitis, hepatic fibrosis, cirrhosis, cardiovascular complications, and increased mortality at a relatively young age. This study investigates the epidemiological, metabolic, inflammatory, and clinical characteristics of non-alcoholic fatty liver disease in young adults with particular attention to early diagnosis, pathophysiological mechanisms, risk factors, and modern therapeutic strategies. The findings demonstrate that metabolic dysregulation, chronic low-grade inflammation, oxidative stress, and insulin resistance play central roles in progression of hepatic steatosis and structural liver injury. Early identification and comprehensive lifestyle-oriented intervention remain essential for prevention of advanced hepatic and systemic complications. Non-alcoholic fatty liver disease has become one of the most significant chronic metabolic disorders affecting young adults and is increasingly recognized as an important global healthcare challenge. The disease is characterized by excessive accumulation of triglycerides within hepatocytes in the absence of significant alcohol intake and is strongly associated with obesity, insulin resistance, sedentary lifestyle, endocrine dysfunction, and metabolic syndrome. Early onset of hepatic steatosis in young individuals substantially increases the long-term risk of progressive liver fibrosis, non-alcoholic steatohepatitis, cardiovascular complications, and systemic metabolic disturbances. This study presents an expanded analysis of epidemiological, metabolic, inflammatory, and clinical aspects of non-alcoholic fatty liver disease in young adults with particular attention to pathophysiological mechanisms, early diagnostic approaches, and therapeutic management strategies. The findings demonstrate that chronic low-grade inflammation, oxidative stress, mitochondrial dysfunction, insulin resistance, and lipid metabolism disturbances play central roles in progression of hepatic injury and structural liver remodeling. Early screening, lifestyle modification, metabolic stabilization, and individualized multidisciplinary intervention remain critically important for prevention of irreversible hepatic damage and improvement of long-term clinical outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778516885912-NON_ALCOHOLIC_FATTY_LIVER_DISEASE_IN_YOUNG_ADULTS_.pdf" type="application/pdf" length="0"/>
      <dc:creator>MOHAMMED FAHAD BIN AHAD FAROOQ</dc:creator>
      <dc:subject>Non-alcoholic fatty liver disease</dc:subject>
      <dc:subject>hepatic steatosis</dc:subject>
      <dc:subject>young adults</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>chronic inflammation</dc:subject>
      <dc:subject>liver fibrosis</dc:subject>
      <dc:subject>steatohepatitis</dc:subject>
      <dc:subject>metabolic disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1351</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 07, pp. 1-15</dc:source>
    </item>
    <item>
      <title>RISK FACTORS OF PATHOLOGICAL POSTOPERATIVE FACIAL SCAR FORMATION: RESULTS OF A CLINICAL AND STATISTICAL ANALYSIS OF 260 PATIENTS</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/d81f4d48-738d-4ced-8822-92ca5a31feec</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/d81f4d48-738d-4ced-8822-92ca5a31feec</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>YUSUPOVA D.Z¹</author>
      <description>Pathological postoperative scar formation on the face remains a significant clinical and aesthetic problem in reconstructive and maxillofacial surgery. Abnormal scar development may lead to cosmetic deformities, functional impairment, psychological distress, and reduced quality of life. This study investigates the major risk factors associated with pathological facial scar formation through a clinical and statistical analysis of 260 postoperative patients. Particular attention is given to demographic characteristics, wound localization, surgical techniques, inflammatory complications, genetic predisposition, and patient-related factors influencing abnormal scar development. The findings demonstrate that prolonged inflammation, wound tension, delayed healing, endocrine disturbances, and infection significantly increase the likelihood of hypertrophic and keloid scar formation. Early identification of high-risk patients and implementation of preventive therapeutic strategies are essential for improving postoperative outcomes and minimizing aesthetic complications. Pathological postoperative scar formation in the facial region represents a serious reconstructive, dermatological, and aesthetic challenge that may significantly affect both physical appearance and psychosocial well-being. Abnormal connective tissue proliferation following surgical intervention develops as a result of complex interactions between inflammatory responses, collagen metabolism, fibroblast activity, vascular changes, and patient-specific predisposition. This study presents an expanded clinical and statistical evaluation of factors contributing to pathological scar development among postoperative facial surgery patients. Particular emphasis is placed on the influence of wound tension, postoperative inflammation, delayed epithelialization, infection, endocrine disturbances, genetic susceptibility, and local anatomical characteristics on scar maturation. The findings indicate that early recognition of high-risk individuals and implementation of preventive therapeutic strategies substantially improve postoperative healing quality and reduce the likelihood of hypertrophic and keloid scar formation.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778496157146-RISK_FACTORS_OF_PATHOLOGICAL_POSTOPERATIVE_FACIAL_.pdf" type="application/pdf" length="0"/>
      <dc:creator>YUSUPOVA D.Z¹</dc:creator>
      <dc:creator>ABDULLAEV Sh.Y²;</dc:creator>
      <dc:subject>Pathological scars</dc:subject>
      <dc:subject>facial surgery</dc:subject>
      <dc:subject>postoperative complications</dc:subject>
      <dc:subject>hypertrophic scar</dc:subject>
      <dc:subject>keloid</dc:subject>
      <dc:subject>wound healing</dc:subject>
      <dc:subject>scar formation</dc:subject>
      <dc:subject>maxillofacial surgery</dc:subject>
      <dc:subject>clinical analysis</dc:subject>
      <dc:subject>reconstructive surgery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1343</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 61-75</dc:source>
    </item>
    <item>
      <title>INSTRUMENTAL ASSESSMENT OF FACIAL SCAR TISSUE REMODELING: THE CAPABILITIES OF ULTRASOUND DERMOSONOGRAPHY AND THE POSAS SCALE</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/56a511b2-8615-4232-b883-401212fba0b4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/56a511b2-8615-4232-b883-401212fba0b4</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>YUSUPOVA D.Z¹</author>
      <description>Assessment of scar tissue remodeling in the facial region is an essential component of reconstructive and aesthetic medicine because pathological scars may significantly affect appearance, tissue mobility, and psychosocial well-being. Modern diagnostic methods increasingly focus on objective evaluation of scar structure, vascularity, elasticity, and maturation dynamics. This study investigates the clinical significance of ultrasound dermosonography and the Patient and Observer Scar Assessment Scale (POSAS) in evaluating facial scar remodeling. Particular attention is given to structural changes within scar tissue, collagen organization, vascular characteristics, inflammatory activity, and functional skin properties during different stages of healing. The findings demonstrate that combined use of instrumental imaging and standardized clinical scales significantly improves diagnostic accuracy, monitoring of therapeutic response, and prediction of long-term scar outcomes. Ultrasound dermosonography provides detailed visualization of scar thickness, echogenicity, and tissue architecture, while POSAS allows comprehensive subjective and objective assessment of scar quality and patient satisfaction. Evaluation of facial scar remodeling is an essential component of reconstructive and aesthetic medicine because pathological scar changes may significantly affect facial appearance, tissue elasticity, functional mobility, and psychosocial well-being. Modern diagnostic approaches increasingly emphasize objective and reproducible methods capable of assessing structural and functional characteristics of scar tissue during different stages of healing. This study presents an expanded clinical analysis of the diagnostic capabilities of ultrasound dermosonography and the Patient and Observer Scar Assessment Scale in the evaluation of facial scar remodeling. Particular attention is given to the assessment of collagen organization, tissue thickness, vascular activity, inflammatory persistence, elasticity changes, and maturation dynamics in hypertrophic, atrophic, normotrophic, and keloid scars. The findings demonstrate that combined instrumental and clinical evaluation significantly improves diagnostic precision, allows accurate monitoring of therapeutic response, and enhances prediction of long-term aesthetic and functional outcomes. Ultrasound dermosonography provides detailed visualization of dermal architecture and fibrotic transformation, while POSAS offers comprehensive multidimensional assessment integrating both clinical observation and patient-reported symptoms.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778496973854-INSTRUMENTAL_ASSESSMENT_OF_FACIAL_SCAR_TISSUE_REMO.pdf" type="application/pdf" length="0"/>
      <dc:creator>YUSUPOVA D.Z¹</dc:creator>
      <dc:creator>ABDULLAEV Sh.Y²;</dc:creator>
      <dc:subject>Facial scars</dc:subject>
      <dc:subject>scar remodeling</dc:subject>
      <dc:subject>ultrasound dermosonography</dc:subject>
      <dc:subject>POSAS scale</dc:subject>
      <dc:subject>hypertrophic scars</dc:subject>
      <dc:subject>keloid</dc:subject>
      <dc:subject>wound healing</dc:subject>
      <dc:subject>reconstructive surgery</dc:subject>
      <dc:subject>scar assessment</dc:subject>
      <dc:subject>skin ultrasound</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1345</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CURRENT APPROACHES TO FLUID RESUSCITATION AND BLOOD PRESSURE CONTROL IN HYPERTENSIVE BURN PATIENTS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/a98c5bc6-8192-4eb2-af1f-0517e6fa4a0d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/a98c5bc6-8192-4eb2-af1f-0517e6fa4a0d</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>Kodirov Dilshod¹</author>
      <description>Burn injuries trigger profound physiological disturbances characterized by extensive fluid loss, systemic inflammatory activation, endothelial dysfunction, and circulatory instability. In patients with pre-existing arterial hypertension, these alterations become more complex because chronic cardiovascular remodeling, impaired vascular compliance, and reduced autoregulatory capacity influence both tissue perfusion and response to fluid therapy. Appropriate fluid resuscitation combined with individualized blood pressure control is essential for preventing shock, preserving organ function, minimizing cardiovascular complications, and improving survival. The present study aimed to evaluate contemporary approaches to fluid resuscitation and hemodynamic management in hypertensive patients with thermal burn injuries. Clinical, laboratory, and hemodynamic parameters were analyzed to determine factors associated with favorable outcomes. The results demonstrated that individualized fluid administration guided by dynamic monitoring, together with carefully adjusted antihypertensive therapy, significantly reduced renal injury, cardiovascular complications, intensive care duration, and mortality. Modern multidisciplinary management strategies should therefore emphasize personalized hemodynamic optimization rather than uniform treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783008083026-CURRENT_APPROACHES_TO_FLUID_RESUSCITATION_AND_BLOO.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kodirov Dilshod¹</dc:creator>
      <dc:creator>Uzokova Oyjamol²</dc:creator>
      <dc:subject>burn injury</dc:subject>
      <dc:subject>arterial hypertension</dc:subject>
      <dc:subject>fluid resuscitation</dc:subject>
      <dc:subject>blood pressure control</dc:subject>
      <dc:subject>burn shock</dc:subject>
      <dc:subject>cardiovascular complications</dc:subject>
      <dc:subject>intensive care</dc:subject>
      <dc:subject>hemodynamic monitoring</dc:subject>
      <dc:subject>renal protection</dc:subject>
      <dc:subject>critical care.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 196-210</dc:source>
    </item>
    <item>
      <title>THE ROLE OF MICROCIRCULATORY AND METABOLIC DISORDERS IN THE DEVELOPMENT OF PATHOLOGICAL FACIAL SCARS: A CLINICAL AND PATHOGENETIC ANALYSIS</title>
      <link>https://aams-journal.us/journals/surgery/articles/c091196d-9318-46e3-8556-fab0e5899acd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/c091196d-9318-46e3-8556-fab0e5899acd</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 GMT</pubDate>
      <author>YUSUPOVA D.Z¹</author>
      <description>Pathological facial scar formation remains a significant clinical and aesthetic problem associated with impaired wound healing, chronic inflammation, and abnormal connective tissue remodeling. Increasing evidence suggests that disturbances in microcirculation and cellular metabolism play a central role in the pathogenesis of hypertrophic and keloid scars. This article investigates the influence of microvascular dysfunction, tissue hypoxia, metabolic imbalance, oxidative stress, and inflammatory activation on the development of pathological scars of the face. The study evaluates clinical manifestations, pathogenetic mechanisms, diagnostic indicators, and modern therapeutic approaches aimed at improving tissue regeneration and scar quality. The findings demonstrate that impaired local blood supply, altered oxygen utilization, endothelial dysfunction, and metabolic disturbances significantly contribute to excessive fibroblast activity and abnormal collagen deposition. Early correction of microcirculatory and metabolic abnormalities may improve wound healing outcomes and reduce the risk of pathological scar development. Pathological scar formation in the facial region represents a complex pathological process closely associated with disturbances of local microcirculation, tissue metabolism, inflammatory regulation, and connective tissue remodeling. Impaired blood supply, endothelial dysfunction, oxidative imbalance, and chronic tissue hypoxia significantly influence reparative processes and contribute to excessive collagen accumulation during wound healing. This study provides an expanded clinical and pathogenetic evaluation of the role of microvascular and metabolic abnormalities in the development of hypertrophic and keloid facial scars. Special attention is given to the interaction between inflammatory mediators, fibroblast hyperactivity, oxygen deficiency, and metabolic dysfunction in scar progression. The findings demonstrate that microcirculatory insufficiency and metabolic instability substantially worsen tissue regeneration and increase the likelihood of abnormal fibrotic transformation. Early correction of vascular and metabolic disturbances may improve postoperative healing quality and reduce severe aesthetic and functional complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778496571314-THE_ROLE_OF_MICROCIRCULATORY_AND_METABOLIC_DISORDE.pdf" type="application/pdf" length="0"/>
      <dc:creator>YUSUPOVA D.Z¹</dc:creator>
      <dc:creator>ABDULLAEV Sh.Y²;</dc:creator>
      <dc:subject>Pathological scars</dc:subject>
      <dc:subject>facial scars</dc:subject>
      <dc:subject>microcirculation</dc:subject>
      <dc:subject>metabolic disorders</dc:subject>
      <dc:subject>hypertrophic scar</dc:subject>
      <dc:subject>keloid</dc:subject>
      <dc:subject>wound healing</dc:subject>
      <dc:subject>oxidative stress</dc:subject>
      <dc:subject>tissue hypoxia</dc:subject>
      <dc:subject>collagen metabolism</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1344</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>INVESTIGATING THE IMPACT OF METABOLIC INFLAMMATION ON EARLY-ONSET CARDIOVASCULAR DISEASE</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/e8e0a262-0225-4db2-af6b-e6646f501f0a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/e8e0a262-0225-4db2-af6b-e6646f501f0a</guid>
      <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
      <author>Anisha Mondal¹</author>
      <description>Metabolic inflammation has emerged as a critical factor contributing to the development of early-onset cardiovascular disease in younger populations. Chronic low-grade inflammatory activity associated with obesity, insulin resistance, dyslipidemia, and metabolic syndrome significantly accelerates vascular dysfunction and atherosclerotic progression. This article examines the relationship between metabolic inflammation and premature cardiovascular pathology, focusing on underlying molecular mechanisms, inflammatory biomarkers, and clinical consequences. The study evaluates how metabolic disturbances influence endothelial injury, oxidative stress, lipid metabolism, and immune system activation. Modern diagnostic approaches and preventive management strategies are also discussed. The findings indicate that early identification of inflammatory and metabolic abnormalities plays a crucial role in reducing cardiovascular risk and improving long-term clinical outcomes. Persistent low-grade inflammatory activity associated with metabolic dysfunction has become an increasingly important factor in the development of premature cardiovascular pathology among younger populations. Abnormal glucose metabolism, excess adipose tissue accumulation, dyslipidemia, and insulin resistance contribute to chronic systemic inflammation that accelerates vascular injury and promotes early atherosclerotic changes. This study presents a comprehensive evaluation of the biological relationship between metabolic imbalance and cardiovascular deterioration, emphasizing inflammatory signaling pathways, endothelial dysfunction, oxidative stress, and immune activation. Particular attention is given to diagnostic biomarkers, early vascular alterations, and preventive therapeutic approaches aimed at reducing long-term cardiovascular risk. The findings demonstrate that identification and control of inflammatory metabolic abnormalities at early stages significantly improve vascular health and decrease the likelihood of severe cardiovascular complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778169515779-INVESTIGATING_THE_IMPACT_OF_METABOLIC_INFLAMMATION.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anisha Mondal¹</dc:creator>
      <dc:creator>A. Subha Laxmi²</dc:creator>
      <dc:creator>Shriya Mary³</dc:creator>
      <dc:creator>Zakiya Zakir⁴</dc:creator>
      <dc:subject>Metabolic inflammation</dc:subject>
      <dc:subject>cardiovascular disease</dc:subject>
      <dc:subject>early-onset cardiovascular disease</dc:subject>
      <dc:subject>atherosclerosis</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>endothelial dysfunction</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>inflammatory biomarkers</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1342</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Hormonal Imbalance and Its Impact on Reproductive Health in Women: Diagnosis and Management Approaches</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/07da67bd-308b-47d4-90cd-99a8882ab0d6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/07da67bd-308b-47d4-90cd-99a8882ab0d6</guid>
      <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
      <author>Abbosova Sanobar Aslanovna¹</author>
      <description>Hormonal balance is essential for maintaining normal reproductive function and overall health in women. Disturbances in endocrine regulation can significantly affect menstrual cycles, fertility, pregnancy outcomes, and psychological well-being. This article explores the causes, clinical manifestations, diagnostic methods, and modern management approaches related to hormonal imbalance in women. The study emphasizes the role of endocrine disorders such as polycystic ovary syndrome, thyroid dysfunction, hyperprolactinemia, and estrogen-progesterone imbalance in reproductive health complications. Current diagnostic techniques, including hormonal profiling and imaging methods, are discussed alongside pharmacological and lifestyle-based treatment strategies. The findings indicate that early diagnosis and individualized management improve reproductive outcomes and reduce long-term complications associated with endocrine disturbances. Endocrine regulation is fundamental to maintaining reproductive stability, metabolic balance, and overall physiological well-being in women. Disturbances in hormonal activity can affect multiple organ systems and lead to significant reproductive complications, including menstrual irregularities, impaired fertility, pregnancy-related disorders, and emotional instability. This study provides a detailed examination of the mechanisms associated with endocrine dysregulation and its influence on female reproductive function. Special attention is given to diagnostic advancements, hormonal assessment methods, and individualized therapeutic approaches aimed at restoring endocrine balance. The analysis also considers the contribution of lifestyle factors, metabolic disorders, environmental influences, and psychosocial stressors to hormonal disturbances. Findings indicate that timely recognition and comprehensive management substantially improve reproductive outcomes and reduce long-term health complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778166905079-Hormonal_Imbalance_and_Its_Impact_on_Reproductive_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abbosova Sanobar Aslanovna¹</dc:creator>
      <dc:creator>Husanova Shahlo Obloqul qizi²</dc:creator>
      <dc:creator>Uzoqova Oyjamol Narzullayevna³</dc:creator>
      <dc:subject>Hormonal imbalance</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>women’s health</dc:subject>
      <dc:subject>endocrine disorders</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>menstrual disorders</dc:subject>
      <dc:subject>polycystic ovary syndrome</dc:subject>
      <dc:subject>estrogen</dc:subject>
      <dc:subject>progesterone</dc:subject>
      <dc:subject>hormonal therapy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1339</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Awareness of hypertension or diabetes</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/f0132d3e-0b5c-432d-8705-8b83e800ad2a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/f0132d3e-0b5c-432d-8705-8b83e800ad2a</guid>
      <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
      <author>Arsh Kamboj¹</author>
      <description>Hypertension and diabetes mellitus are among the most common non-communicable diseases worldwide and represent major causes of cardiovascular complications, disability, and premature mortality. Public awareness regarding risk factors, early symptoms, preventive strategies, and long-term complications plays a critical role in reducing disease burden and improving health outcomes. This article evaluates the level of awareness related to hypertension and diabetes among adult populations and examines the influence of education, lifestyle, healthcare accessibility, and preventive practices on disease management. The study highlights the importance of regular screening, early diagnosis, lifestyle modification, and community-based health education programs in controlling these chronic conditions. The findings demonstrate that improved awareness significantly contributes to better disease prevention, treatment adherence, and reduction of long-term complications. Chronic metabolic and cardiovascular disorders continue to represent a major challenge for healthcare systems worldwide due to their high prevalence, progressive nature, and association with severe long-term complications. Public understanding of elevated blood pressure and impaired glucose regulation plays a decisive role in prevention, early recognition, treatment adherence, and reduction of disease-related morbidity. This study provides a comprehensive evaluation of community awareness regarding these conditions and examines how educational status, lifestyle behavior, healthcare accessibility, and preventive practices influence disease control. Particular attention is given to the importance of routine health screening, behavioral modification, and community-based educational strategies in improving long-term outcomes. The findings indicate that increased public knowledge contributes significantly to earlier diagnosis, improved self-management, and reduced risk of cardiovascular, renal, and neurological complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778168773697-Awareness_of_hypertension_or_diabetes.pdf" type="application/pdf" length="0"/>
      <dc:creator>Arsh Kamboj¹</dc:creator>
      <dc:creator>Praveen²</dc:creator>
      <dc:creator>Rythem³</dc:creator>
      <dc:creator>Sonu⁴</dc:creator>
      <dc:subject>Hypertension</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>public awareness</dc:subject>
      <dc:subject>non-communicable diseases</dc:subject>
      <dc:subject>preventive healthcare</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:subject>health education</dc:subject>
      <dc:subject>lifestyle modification</dc:subject>
      <dc:subject>chronic disease management</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1341</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 46-60</dc:source>
    </item>
    <item>
      <title>Chronic Kidney Disease: Pathophysiology, Early Diagnosis, and Modern Treatment Strategies</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/cc9ef9da-9e95-4939-b6d5-43b87da052f5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/cc9ef9da-9e95-4939-b6d5-43b87da052f5</guid>
      <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
      <author>Fayziyev Akbar Ubaydullayevich¹</author>
      <description>Chronic Kidney Disease (CKD) is a progressive and irreversible condition characterized by gradual loss of kidney function over time. It represents a major global public health concern due to its increasing prevalence, high morbidity, and strong association with cardiovascular complications and mortality. This article examines the underlying pathophysiological mechanisms of CKD, emphasizes the significance of early diagnosis, and reviews contemporary treatment approaches aimed at slowing disease progression and improving patient outcomes. The study highlights the importance of early screening in high-risk populations, advances in diagnostic biomarkers, and the integration of pharmacological and non-pharmacological management strategies. The findings demonstrate that timely intervention and multidisciplinary care significantly reduce complications and improve quality of life for individuals affected by CKD. Progressive impairment of renal function has become an increasingly significant medical and socioeconomic challenge across the world. Chronic disturbances in kidney structure and function contribute not only to metabolic imbalance but also to systemic complications affecting cardiovascular, hematological, and endocrine systems. This paper provides a detailed overview of the mechanisms involved in long-term renal deterioration, emphasizing the importance of identifying pathological changes before irreversible damage occurs. Special attention is given to current diagnostic approaches, including laboratory biomarkers and imaging techniques, as well as contemporary therapeutic methods aimed at slowing functional decline. The study also explores the impact of lifestyle factors, comorbid conditions, and healthcare accessibility on disease progression. Evidence suggests that early recognition and comprehensive management substantially improve patient survival and reduce the burden of advanced renal failure.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778166339534-Chronic_Kidney_Disease__Pathophysiology__Early_Dia.pdf" type="application/pdf" length="0"/>
      <dc:creator>Fayziyev Akbar Ubaydullayevich¹</dc:creator>
      <dc:creator>Abdiraimov Bobir Maxmudovich²</dc:creator>
      <dc:creator>Uzoqova Oyjamol Narzullayevna³</dc:creator>
      <dc:subject>Chronic Kidney Disease</dc:subject>
      <dc:subject>renal failure</dc:subject>
      <dc:subject>nephrology</dc:subject>
      <dc:subject>glomerular filtration rate</dc:subject>
      <dc:subject>kidney dysfunction</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>renal fibrosis</dc:subject>
      <dc:subject>dialysis</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1338</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>NEUROLOGICAL MANIFESTATIONS IN CHRONIC HEART FAILURE: STRATEGIES FOR OPTIMIZING CLINICAL MANAGEMENT</title>
      <link>https://aams-journal.us/journals/neurology/articles/e2b9ac31-fba6-4e0d-8d06-1109f675bf0d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/e2b9ac31-fba6-4e0d-8d06-1109f675bf0d</guid>
      <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
      <author>Jalolova D.R.¹</author>
      <description>Chronic heart failure is a progressive cardiovascular disorder associated not only with impaired cardiac function but also with significant neurological complications that negatively affect patient prognosis and quality of life. Reduced cerebral perfusion, systemic inflammation, neurohormonal activation, and vascular dysfunction contribute to the development of cognitive impairment, depression, stroke, sleep disturbances, and autonomic nervous system abnormalities in affected individuals. This article examines the neurological manifestations associated with chronic heart failure and evaluates current strategies for improving clinical management. Emphasis is placed on early recognition, diagnostic evaluation, multidisciplinary treatment approaches, and integrated patient care aimed at minimizing neurological complications and improving functional outcomes. The findings indicate that comprehensive cardiovascular and neurological assessment plays a critical role in reducing morbidity and enhancing long-term patient survival. Long-term impairment of cardiac function affects not only the circulatory system but also multiple neurological pathways responsible for cognition, emotional regulation, autonomic control, and cerebral perfusion. Persistent reduction in systemic blood flow, chronic inflammation, vascular abnormalities, and neurohormonal activation contribute to progressive neurological complications in individuals with chronic cardiac insufficiency. This study provides an expanded analysis of the neurological consequences associated with chronic heart dysfunction and evaluates current strategies aimed at improving clinical outcomes through integrated management. Particular emphasis is placed on cognitive decline, mood disorders, cerebrovascular complications, and autonomic disturbances that frequently accompany advanced cardiovascular disease. The findings demonstrate that early neurological assessment combined with multidisciplinary therapeutic intervention significantly improves patient stability, treatment adherence, and quality of life.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778167823993-NEUROLOGICAL_MANIFESTATIONS_IN_CHRONIC_HEART_FAILU.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalolova D.R.¹</dc:creator>
      <dc:creator>Kim O.V.²</dc:creator>
      <dc:subject>Chronic heart failure</dc:subject>
      <dc:subject>neurological manifestations</dc:subject>
      <dc:subject>cognitive impairment</dc:subject>
      <dc:subject>cerebral hypoperfusion</dc:subject>
      <dc:subject>stroke</dc:subject>
      <dc:subject>autonomic dysfunction</dc:subject>
      <dc:subject>neurocardiology</dc:subject>
      <dc:subject>depression</dc:subject>
      <dc:subject>cardiovascular disease</dc:subject>
      <dc:subject>clinical management</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1340</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 16-30</dc:source>
    </item>
    <item>
      <title>From Trend to Threat: The Growing Popularity of Vaping Among Youth</title>
      <link>https://aams-journal.us/journals/genetics/articles/02d25465-faec-4214-b126-73a0acf18b20</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/02d25465-faec-4214-b126-73a0acf18b20</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Rifat Azim</author>
      <description>The rapid increase in vaping among adolescents has transformed what was initially perceived as a safer alternative to smoking into a significant public health concern. This study examines the factors contributing to the rising popularity of e-cigarettes among youth, including marketing strategies, flavor availability, peer influence, and misconceptions regarding safety. Evidence suggests that vaping is associated with nicotine dependence, respiratory symptoms, and increased likelihood of transitioning to conventional cigarette smoking. The findings highlight the urgent need for preventive strategies, regulatory policies, and educational interventions to reduce youth exposure to vaping products. The increasing prevalence of vaping among adolescents has become a significant public health issue, shifting e-cigarette use from a perceived harm-reduction tool to a widespread behavioral risk. This expanded analysis examines the determinants, health implications, and social drivers of vaping among youth populations. Key influencing factors include flavored product availability, targeted digital marketing, peer influence, and misconceptions about reduced harm compared to traditional cigarettes. Evidence indicates that adolescent vaping is strongly associated with nicotine dependence, respiratory symptoms, and increased likelihood of future tobacco smoking. The findings emphasize the need for stronger preventive strategies and regulatory control.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778053844481-From_Trend_to_Threat__The_Growing_Popularity_of_Va.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rifat Azim</dc:creator>
      <dc:subject>Vaping</dc:subject>
      <dc:subject>e-cigarettes</dc:subject>
      <dc:subject>youth smoking</dc:subject>
      <dc:subject>nicotine addiction</dc:subject>
      <dc:subject>public health</dc:subject>
      <dc:subject>adolescent behavior</dc:subject>
      <dc:subject>respiratory health</dc:subject>
      <dc:subject>addiction</dc:subject>
      <dc:subject>tobacco control</dc:subject>
      <dc:subject>prevention.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1334</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>EARLY DETECTION OF AUTISM SPECTRUM DISORDER USING SCREENING TOOLS</title>
      <link>https://aams-journal.us/journals/neurology/articles/be4bf2d4-9a59-4f82-baac-eae04659c727</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/be4bf2d4-9a59-4f82-baac-eae04659c727</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Johan Mathew Jacob¹</author>
      <description>Early identification of Autism Spectrum Disorder (ASD) is essential for improving developmental outcomes and enabling timely intervention strategies. This article examines the role of standardized screening tools in the early detection of ASD among infants and young children. The study focuses on the effectiveness, accessibility, and limitations of commonly used screening instruments in clinical and community settings. By analyzing recent research and retrospective data, the paper highlights the importance of early behavioral markers, parental observations, and primary healthcare involvement. The findings emphasize that systematic screening programs significantly enhance early diagnosis rates and facilitate prompt therapeutic interventions, ultimately improving long-term cognitive, social, and behavioral outcomes in affected children. Timely recognition of neurodevelopmental differences in early childhood is essential for initiating supportive interventions that can significantly influence long-term outcomes. This paper examines the growing importance of structured screening approaches in identifying Autism Spectrum Disorder during the earliest stages of development. Emphasis is placed on behavioral indicators observable in infancy and toddlerhood, as well as the practical application of standardized assessment instruments in primary healthcare settings. The analysis highlights how early identification contributes to improved cognitive, communicative, and social functioning. It also considers barriers such as limited access to trained professionals, variability in developmental patterns, and cultural influences on reporting behaviors. Overall, the study demonstrates that systematic screening frameworks are a crucial component in advancing early childhood developmental care.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778055159568-EARLY_DETECTION_OF_AUTISM_SPECTRUM_DISORDER_USING_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johan Mathew Jacob¹</dc:creator>
      <dc:creator>Allen Majo Joseph²</dc:creator>
      <dc:creator>Arunachalam Vasanthi Avirash Ram³</dc:creator>
      <dc:subject>Autism Spectrum Disorder</dc:subject>
      <dc:subject>early detection</dc:subject>
      <dc:subject>screening tools</dc:subject>
      <dc:subject>developmental delay</dc:subject>
      <dc:subject>pediatric assessment</dc:subject>
      <dc:subject>behavioral screening</dc:subject>
      <dc:subject>early intervention</dc:subject>
      <dc:subject>child development</dc:subject>
      <dc:subject>diagnostic tools</dc:subject>
      <dc:subject>neurodevelopmental disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1336</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>IMPORTANCE OF IMMUNIZATION IN PREVENTING CHILDHOOD DISEASES</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/03d1d19c-2695-40e1-879c-fa4f6f56d155</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/03d1d19c-2695-40e1-879c-fa4f6f56d155</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Raza Mohd Mannan¹</author>
      <description>Immunization is one of the most effective public health interventions for reducing childhood morbidity and mortality worldwide. Vaccination programs have significantly decreased the incidence of infectious diseases such as measles, polio, diphtheria, pertussis, and hepatitis. This article examines the critical role of immunization in preventing childhood illnesses and improving overall pediatric health outcomes. It analyzes the effectiveness of routine vaccination schedules, identifies barriers to vaccine coverage, and discusses strategies to enhance immunization uptake. The findings demonstrate that comprehensive immunization programs not only protect individual children but also contribute to herd immunity, reducing disease transmission within communities. Strengthening public awareness and healthcare infrastructure remains essential for sustaining successful immunization efforts. Preventive healthcare strategies play a decisive role in reducing illness during early life stages, with vaccination standing out as one of the most impactful interventions. This paper provides an expanded examination of how immunization programs contribute to lowering the burden of infectious conditions among children. It explores the biological basis of immune protection, the population-level benefits of widespread vaccine uptake, and the long-term implications for public health systems. The analysis also considers disparities in coverage, societal attitudes toward vaccination, and structural challenges affecting program implementation. Evidence presented in this study demonstrates that consistent and timely immunization not only decreases disease incidence but also strengthens overall community resilience against outbreaks.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778055808750-IMPORTANCE_OF_IMMUNIZATION_IN_PREVENTING_CHILDHOOD.pdf" type="application/pdf" length="0"/>
      <dc:creator>Raza Mohd Mannan¹</dc:creator>
      <dc:creator>Pankaj²</dc:creator>
      <dc:creator>Aftab Mohd Adeeb³</dc:creator>
      <dc:creator>Khan Aatif Ajaz Ahmed⁴</dc:creator>
      <dc:subject>Immunization</dc:subject>
      <dc:subject>childhood diseases</dc:subject>
      <dc:subject>vaccination</dc:subject>
      <dc:subject>preventive healthcare</dc:subject>
      <dc:subject>herd immunity</dc:subject>
      <dc:subject>pediatric health</dc:subject>
      <dc:subject>infectious disease prevention</dc:subject>
      <dc:subject>vaccine coverage</dc:subject>
      <dc:subject>public health</dc:subject>
      <dc:subject>child mortality</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1337</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>BDNF and its role in post-stroke brain recovery: Interventions to Boost BDNF</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/06e6204d-662d-48ae-8e01-91f24aba0995</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/06e6204d-662d-48ae-8e01-91f24aba0995</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Abdul Rahman Adnan¹</author>
      <description>Brain-derived neurotrophic factor (BDNF) is a key neurotrophin involved in neuronal survival, synaptic plasticity, and neuroregeneration. After ischemic stroke, BDNF plays a crucial role in brain repair processes, including neurogenesis, angiogenesis, and functional recovery of damaged neural circuits. This study reviews the biological functions of BDNF in post-stroke recovery and evaluates interventions aimed at increasing its expression, such as physical exercise, pharmacological agents, nutritional strategies, and neurorehabilitation techniques. Evidence suggests that enhancing BDNF levels significantly improves motor and cognitive recovery outcomes in stroke patients, highlighting its therapeutic potential in neurorehabilitation. Brain-derived neurotrophic factor is a critical regulator of neuronal survival, synaptic plasticity, and adaptive neuroreorganization in the central nervous system. After ischemic stroke, reduced expression of this neurotrophin limits endogenous repair mechanisms, contributing to persistent neurological deficits. This expanded analysis evaluates the role of BDNF in post-stroke recovery and examines various interventions designed to enhance its expression. These include structured physical activity, pharmacological modulation, dietary optimization, and multidisciplinary rehabilitation programs. Evidence indicates that upregulation of BDNF is closely associated with improved motor performance, cognitive recovery, and enhanced neuroplasticity, making it a key therapeutic target in stroke rehabilitation.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778052300760-BDNF_and_its_role_in_post_stroke_brain_recovery__I.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abdul Rahman Adnan¹</dc:creator>
      <dc:creator>Ahamed Dhanish²</dc:creator>
      <dc:creator>Ahmed Shiraz³</dc:creator>
      <dc:creator>Vattapoyilummal Druvathej⁴</dc:creator>
      <dc:subject>BDNF</dc:subject>
      <dc:subject>stroke recovery</dc:subject>
      <dc:subject>neuroplasticity</dc:subject>
      <dc:subject>neurorehabilitation</dc:subject>
      <dc:subject>brain repair</dc:subject>
      <dc:subject>ischemic stroke</dc:subject>
      <dc:subject>neurotrophins</dc:subject>
      <dc:subject>exercise therapy</dc:subject>
      <dc:subject>neurogenesis</dc:subject>
      <dc:subject>synaptic plasticity.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1332</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Emerging trends in antibiotic resistance in tuberculosis</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/e44dc211-21f7-49b2-a2db-ed1a8fa36c17</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/e44dc211-21f7-49b2-a2db-ed1a8fa36c17</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Farhan Arif Shaikh¹</author>
      <description>Tuberculosis (TB) remains one of the leading infectious diseases worldwide, and the emergence of antibiotic-resistant strains has significantly complicated its control and treatment. This article explores current and emerging trends in antibiotic resistance in tuberculosis, including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). The paper analyzes underlying causes, diagnostic challenges, and recent advancements in treatment strategies. The study highlights the urgent need for improved surveillance systems, innovative therapeutic approaches, and global collaboration to address the growing threat of resistant TB strains. The growing burden of drug-resistant tuberculosis represents a critical challenge for modern medicine and public health systems worldwide. Resistance to anti-tuberculosis medications has evolved due to complex interactions between microbial adaptation, human behavior, and healthcare limitations. This paper provides an expanded overview of the patterns and dynamics of resistance development, emphasizing recent shifts in epidemiology and therapeutic responses. It also highlights the importance of early detection, personalized treatment approaches, and strengthened health policies. By examining contemporary data and scientific insights, this work aims to contribute to a deeper understanding of how resistance trends are shaping the future of tuberculosis control and management strategies on a global scale.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778053185761-Emerging_trends_in_antibiotic_resistance_in_tuberc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Farhan Arif Shaikh¹</dc:creator>
      <dc:subject>Tuberculosis</dc:subject>
      <dc:subject>antibiotic resistance</dc:subject>
      <dc:subject>MDR-TB</dc:subject>
      <dc:subject>XDR-TB</dc:subject>
      <dc:subject>drug resistance</dc:subject>
      <dc:subject>Mycobacterium tuberculosis</dc:subject>
      <dc:subject>treatment challenges</dc:subject>
      <dc:subject>global health</dc:subject>
      <dc:subject>antimicrobial resistance</dc:subject>
      <dc:subject>TB control</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1333</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CORRELATION BETWEEN OCT MORPHOMETRIC PARAMETERS AND FUNCTIONAL IMPAIRMENT IN ACUTE ISCHEMIC OPTIC NEUROPATHY</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/90b39b2d-4193-4e94-beb8-9d6f36f8dc23</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/90b39b2d-4193-4e94-beb8-9d6f36f8dc23</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D.Z.</author>
      <description>Acute ischemic optic neuropathy (AION) is a vision-threatening disorder characterized by sudden ischemic damage to the optic nerve, frequently resulting in irreversible visual dysfunction. Accurate assessment of disease severity requires simultaneous evaluation of structural retinal alterations and functional visual impairment. Optical coherence tomography (OCT) has become an essential imaging modality for quantitative analysis of retinal morphology, while functional examinations such as automated perimetry and visual acuity testing provide objective assessment of visual performance. The present study aimed to investigate the relationship between OCT morphometric parameters and functional visual deficits in patients with acute ischemic optic neuropathy. Comprehensive ophthalmic examination demonstrated a significant correlation between retinal nerve fiber layer thickness, ganglion cell complex integrity, optic nerve head morphology, and functional deterioration measured by visual acuity and automated perimetry. Integration of structural and functional data enables more accurate evaluation of disease severity, prediction of visual prognosis, and optimization of individualized treatment strategies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1783055658474-CORRELATION_BETWEEN_OCT_MORPHOMETRIC_PARAMETERS_AN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D.Z.</dc:creator>
      <dc:creator>Reymnazarova G.Dj.</dc:creator>
      <dc:creator>Vatanzoda O.V.</dc:creator>
      <dc:subject>acute ischemic optic neuropathy</dc:subject>
      <dc:subject>optical coherence tomography</dc:subject>
      <dc:subject>retinal nerve fiber layer</dc:subject>
      <dc:subject>ganglion cell complex</dc:subject>
      <dc:subject>visual field</dc:subject>
      <dc:subject>perimetry</dc:subject>
      <dc:subject>visual acuity</dc:subject>
      <dc:subject>morphometric analysis</dc:subject>
      <dc:subject>neuro-ophthalmology</dc:subject>
      <dc:subject>prognosis.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.4103/aams.0498</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 181-195</dc:source>
    </item>
    <item>
      <title>Comparative Study of Treatment Protocols in Type 2 Diabetes Mellitus</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/29a58ca2-1743-489d-b422-1f7ea4a3ef1b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/29a58ca2-1743-489d-b422-1f7ea4a3ef1b</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Md Asharaf Hasan¹</author>
      <description>Type 2 diabetes mellitus is a chronic metabolic disorder characterized by insulin resistance, progressive beta-cell dysfunction, and persistent hyperglycemia. Effective management requires a combination of lifestyle modification and pharmacological therapy. This study compares different treatment protocols used in the management of type 2 diabetes, including monotherapy, combination oral therapy, and insulin-based regimens. The aim is to evaluate their effectiveness in glycemic control, reduction of complications, and overall patient outcomes. Findings indicate that individualized treatment strategies based on disease severity, comorbidities, and patient characteristics result in better metabolic control and improved quality of life. Type 2 diabetes mellitus is a complex metabolic disorder requiring long-term management through a combination of lifestyle changes and pharmacological interventions. This expanded section evaluates different therapeutic strategies used in clinical practice, focusing on their comparative effectiveness in achieving glycemic control and reducing complications. Various treatment approaches, including monotherapy, combination oral regimens, and insulin-based strategies, demonstrate differing levels of efficacy depending on disease stage and patient characteristics. Evidence suggests that individualized treatment plans provide superior outcomes compared to standardized protocols, particularly in maintaining stable glucose levels and minimizing adverse effects.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778050554463-Comparative_Study_of_Treatment_Protocols_in_Type_2.pdf" type="application/pdf" length="0"/>
      <dc:creator>Md Asharaf Hasan¹</dc:creator>
      <dc:creator>Rakibul Hoque²</dc:creator>
      <dc:creator>Gnanavel Yuvarajan³</dc:creator>
      <dc:subject>Type 2 diabetes mellitus</dc:subject>
      <dc:subject>treatment protocols</dc:subject>
      <dc:subject>metformin</dc:subject>
      <dc:subject>insulin therapy</dc:subject>
      <dc:subject>combination therapy</dc:subject>
      <dc:subject>glycemic control</dc:subject>
      <dc:subject>oral hypoglycemic agents</dc:subject>
      <dc:subject>lifestyle modification</dc:subject>
      <dc:subject>HbA1c</dc:subject>
      <dc:subject>diabetes management.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1330</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>MEDICATION PRESCRIPTION PATTERNS, ANTIBIOTIC PRESCRIPTION PATTERNS IN A TERTIARY CARE HOSPITAL IN INDIA: A RETROSPECTIVE CROSS-SECTIONAL STUDY</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/239dd719-7626-4e4a-a72a-7e6e91741117</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/239dd719-7626-4e4a-a72a-7e6e91741117</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Naman Singh¹</author>
      <description>Rational prescribing is a cornerstone of effective healthcare delivery, yet inappropriate medication and antibiotic use remains a persistent concern in hospital settings, particularly in developing countries. This study evaluates prescription patterns in a tertiary care hospital in India with a specific focus on antibiotic utilization. By analyzing retrospective patient records, the research identifies trends in drug selection, frequency of antibiotic prescriptions, and adherence to standard treatment guidelines. The findings reveal areas of irrational prescribing, including overuse of broad-spectrum antibiotics and polypharmacy practices. The study underscores the importance of antimicrobial stewardship programs, regular prescription audits, and clinician education to optimize therapeutic outcomes and reduce the risk of antimicrobial resistance. The analysis of prescribing behavior in hospital environments provides critical insight into the quality and safety of patient care. In tertiary healthcare institutions, where diagnostic complexity and disease severity are higher, medication use tends to be more intensive and varied. This study explores patterns of drug utilization with particular attention to antibacterial agents, identifying deviations from rational therapeutic principles. It emphasizes the growing concern of excessive and inappropriate antimicrobial use, which contributes to the acceleration of resistance mechanisms. By examining retrospective clinical data, the study highlights systemic inefficiencies, prescriber habits, and institutional gaps that influence treatment decisions. The findings aim to support the development of targeted interventions to improve prescribing accuracy, enhance patient outcomes, and strengthen regulatory frameworks within hospital systems.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778054424573-MEDICATION_PRESCRIPTION_PATTERNS__ANTIBIOTIC_PRESC.pdf" type="application/pdf" length="0"/>
      <dc:creator>Naman Singh¹</dc:creator>
      <dc:creator>Ibne Ali²</dc:creator>
      <dc:creator>Mananjay Kumar³</dc:creator>
      <dc:subject>Prescription patterns</dc:subject>
      <dc:subject>antibiotics</dc:subject>
      <dc:subject>tertiary care hospital</dc:subject>
      <dc:subject>India</dc:subject>
      <dc:subject>drug utilization</dc:subject>
      <dc:subject>antimicrobial resistance</dc:subject>
      <dc:subject>polypharmacy</dc:subject>
      <dc:subject>rational use</dc:subject>
      <dc:subject>retrospective study</dc:subject>
      <dc:subject>healthcare quality</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1335</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Peculiarities of care for seriously ill and dying patients</title>
      <link>https://aams-journal.us/journals/dermatology/articles/388df79c-76e6-43bc-9326-5b78d116d742</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/388df79c-76e6-43bc-9326-5b78d116d742</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Nouman Khan¹</author>
      <description>Care for seriously ill and dying patients requires a holistic, patient-centered approach that integrates medical, psychological, social, and spiritual support. This article explores the unique aspects of caring for patients at the end of life, focusing on symptom management, ethical considerations, communication, and interdisciplinary care. The study highlights the importance of dignity, compassion, and individualized care planning to improve quality of life during the final stages. The provision of care for individuals with severe and terminal illnesses represents one of the most sensitive and complex responsibilities in healthcare practice. This work examines the multifaceted nature of such care, emphasizing the necessity of integrating clinical competence with empathy, ethical awareness, and cultural sensitivity. Particular attention is given to the ways in which healthcare professionals respond to progressive decline, irreversible conditions, and the psychosocial burdens experienced by patients and their families. The analysis highlights that effective support extends beyond physical symptom relief and must incorporate emotional stability, respect for personal values, and preservation of human dignity. The study also underlines the importance of structured communication, shared decision-making, and continuity of care across different stages of illness. By exploring contemporary approaches and practical challenges, this paper contributes to a deeper understanding of how care systems can better address the needs of patients approaching the end of life while supporting caregivers in delivering humane and ethically grounded services.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778051284967-Peculiarities_of_care_for_seriously_ill_and_dying_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nouman Khan¹</dc:creator>
      <dc:creator>Ahad Areeb²</dc:creator>
      <dc:creator>Shuaib Khan³</dc:creator>
      <dc:subject>Palliative care</dc:subject>
      <dc:subject>end-of-life care</dc:subject>
      <dc:subject>seriously ill patients</dc:subject>
      <dc:subject>hospice care</dc:subject>
      <dc:subject>symptom management</dc:subject>
      <dc:subject>ethical issues</dc:subject>
      <dc:subject>patient dignity</dc:subject>
      <dc:subject>communication</dc:subject>
      <dc:subject>interdisciplinary care</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1331</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Cardiovascular Disease and Risk Factors</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/2fbf5ce9-fef3-4655-ab4d-9be232cc27c2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/2fbf5ce9-fef3-4655-ab4d-9be232cc27c2</guid>
      <pubDate>Wed, 06 May 2026 00:00:00 GMT</pubDate>
      <author>Dr Muzaffar Majnoon Wani (MD)¹</author>
      <description>Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, encompassing conditions such as coronary artery disease, stroke, heart failure, and peripheral vascular disorders. This study examines the major modifiable and non-modifiable risk factors contributing to cardiovascular disease and their impact on disease development and progression. Key modifiable factors include hypertension, dyslipidemia, diabetes mellitus, smoking, obesity, sedentary lifestyle, and unhealthy diet, while age, sex, and genetic predisposition represent non-modifiable risks. Evidence indicates that early identification and management of these factors significantly reduce cardiovascular events and improve long-term outcomes. Preventive strategies remain central to reducing global disease burden. Cardiovascular disorders constitute a major global health burden, accounting for a substantial proportion of premature mortality and disability. This expanded section explores the complex interaction of behavioral, metabolic, environmental, and genetic determinants that contribute to the development of cardiovascular pathology. Conditions such as coronary artery disease, cerebrovascular events, and heart failure are closely linked to modifiable risk factors including elevated blood pressure, abnormal lipid levels, impaired glucose metabolism, tobacco use, obesity, and physical inactivity. Early identification and comprehensive management of these determinants significantly reduce disease incidence and improve long-term prognosis. Preventive strategies remain essential for controlling the increasing global burden.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1778049447253-Cardiovascular_Disease_and_Risk_Factors.pdf" type="application/pdf" length="0"/>
      <dc:creator>Dr Muzaffar Majnoon Wani (MD)¹</dc:creator>
      <dc:creator>Pobitra Mishra²</dc:creator>
      <dc:creator>Hazim Wasim³</dc:creator>
      <dc:subject>Cardiovascular disease</dc:subject>
      <dc:subject>risk factors</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>dyslipidemia</dc:subject>
      <dc:subject>diabetes</dc:subject>
      <dc:subject>smoking</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>atherosclerosis</dc:subject>
      <dc:subject>lifestyle modification.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1329</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Hepatitis and Liver Cancer: A Growing Concern, Knowledge, Attitude, and Practice (KAP) Study on Hepatitis B Vaccination</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/bf111c37-cbcb-48b3-9273-98e74d7d460f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/bf111c37-cbcb-48b3-9273-98e74d7d460f</guid>
      <pubDate>Sun, 03 May 2026 00:00:00 GMT</pubDate>
      <author>Mayank Tangad¹</author>
      <description>Hepatitis B infection remains a major global public health issue and is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma. Despite the availability of an effective vaccine, vaccination coverage remains suboptimal in many regions due to limited awareness, negative attitudes, and inadequate preventive practices. This study evaluates the knowledge, attitude, and practice (KAP) regarding hepatitis B vaccination and its relationship with the growing burden of liver cancer. Findings indicate that improved awareness and positive behavioral change are essential for reducing infection rates and preventing long-term hepatic complications. Strengthening vaccination programs and public health education is critical in controlling disease progression. Hepatitis B infection remains one of the leading infectious causes of chronic liver disease and hepatocellular carcinoma worldwide. Despite the availability of an effective and safe vaccine, prevention efforts are still limited by insufficient awareness, negative perceptions, and inconsistent vaccination practices in many populations. This expanded section analyzes knowledge, attitude, and practice patterns related to hepatitis B vaccination and their impact on disease prevention. The study highlights how gaps in understanding transmission routes, vaccine benefits, and long-term complications contribute to persistent infection rates. Strengthening immunization strategies and improving public health education are essential to reduce liver cancer burden in the future.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777810745212-Hepatitis_and_Liver_Cancer__A_Growing_Concern__Kno.pdf" type="application/pdf" length="0"/>
      <dc:creator>Mayank Tangad¹</dc:creator>
      <dc:creator>Leo prem²</dc:creator>
      <dc:creator>Thiraaj thirupathi³</dc:creator>
      <dc:creator>Haniya Nourin Thazhe Raroth Chalil⁴</dc:creator>
      <dc:subject>Hepatitis B</dc:subject>
      <dc:subject>liver cancer</dc:subject>
      <dc:subject>hepatocellular carcinoma</dc:subject>
      <dc:subject>vaccination</dc:subject>
      <dc:subject>knowledge attitude practice</dc:subject>
      <dc:subject>public health</dc:subject>
      <dc:subject>chronic liver disease</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>immunization</dc:subject>
      <dc:subject>viral hepatitis.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1328</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Contemporary Pharmacological Innovations in Type 1 Diabetes Management: Beyond Insulin Therapy</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/bdca4a1f-e3e8-4278-a57d-457fceec3af4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/bdca4a1f-e3e8-4278-a57d-457fceec3af4</guid>
      <pubDate>Sun, 03 May 2026 00:00:00 GMT</pubDate>
      <author>MOHAMMED FAHAD BIN AHAD FAROOQ</author>
      <description>Type 1 diabetes mellitus is a chronic autoimmune disorder characterized by destruction of pancreatic beta cells, resulting in absolute insulin deficiency. Although insulin replacement remains the cornerstone of therapy, recent pharmacological innovations have expanded treatment options beyond traditional insulin administration. This study explores emerging non-insulin-based therapeutic strategies aimed at improving glycemic control, reducing insulin requirements, and preventing long-term complications. New pharmacological approaches include immunomodulatory agents, adjunctive glucose-lowering drugs, beta-cell preservation therapies, and metabolic pathway modulators. Evidence suggests that combination therapies targeting multiple mechanisms may improve metabolic stability and quality of life in patients with type 1 diabetes. Type 1 diabetes mellitus is an autoimmune endocrine disorder characterized by progressive destruction of pancreatic beta cells and absolute insulin deficiency. While insulin replacement remains the primary therapeutic approach, recent pharmacological developments have introduced additional treatment options aimed at improving glycemic stability and reducing complications. This expanded section evaluates modern non-insulin pharmacological strategies used in type 1 diabetes management. These include sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, amylin analogs, glucagon receptor modulators, and emerging immunotherapeutic agents. Current evidence suggests that these therapies may improve metabolic control, reduce glycemic variability, and decrease insulin dose requirements in selected patients, although safety considerations remain essential.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777810267532-Contemporary_Pharmacological_Innovations_in_Type_1.pdf" type="application/pdf" length="0"/>
      <dc:creator>MOHAMMED FAHAD BIN AHAD FAROOQ</dc:creator>
      <dc:subject>Type 1 diabetes</dc:subject>
      <dc:subject>insulin therapy</dc:subject>
      <dc:subject>immunotherapy</dc:subject>
      <dc:subject>SGLT2 inhibitors</dc:subject>
      <dc:subject>beta-cell preservation</dc:subject>
      <dc:subject>pharmacological innovation</dc:subject>
      <dc:subject>glucagon</dc:subject>
      <dc:subject>autoimmune diabetes</dc:subject>
      <dc:subject>adjunct therapy</dc:subject>
      <dc:subject>metabolic control.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1327</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Pancreatic Fibrosis as a Driver of Glucose Dysregulation in Type 3c Diabetes</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/4a60bbd6-6248-4395-9c4b-124013a53023</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/4a60bbd6-6248-4395-9c4b-124013a53023</guid>
      <pubDate>Sun, 03 May 2026 00:00:00 GMT</pubDate>
      <author>Khan Aatif Ajaz Ahmed¹</author>
      <description>Type 3c diabetes mellitus, also known as pancreatogenic diabetes, develops secondary to diseases of the exocrine pancreas and is increasingly recognized as an underdiagnosed form of diabetes. Pancreatic fibrosis is considered a central pathological mechanism contributing to endocrine dysfunction and impaired glucose regulation in this condition. This study evaluates how fibrotic remodeling of pancreatic tissue affects insulin secretion, glucagon balance, incretin response, and overall metabolic control. Chronic inflammation, stellate cell activation, acinar destruction, and islet distortion are major contributors to fibrosis progression. Evidence indicates that progressive fibrotic replacement of pancreatic parenchyma leads to both endocrine and exocrine insufficiency, resulting in unstable glycemia, malabsorption, and increased risk of hypoglycemia. Understanding the relationship between fibrosis and metabolic dysfunction is essential for early diagnosis and targeted management. Pancreatic fibrosis is a progressive pathological process characterized by excessive deposition of extracellular matrix and destruction of normal pancreatic architecture, leading to both endocrine and exocrine dysfunction. In type 3c diabetes mellitus, fibrosis plays a central role in disrupting glucose homeostasis through loss of insulin-producing beta cells and impaired glucagon regulation. This expanded analysis focuses on the molecular and cellular mechanisms linking pancreatic fibrosis to metabolic dysregulation. Chronic inflammation, activation of pancreatic stellate cells, acinar cell loss, and islet structural distortion collectively contribute to progressive endocrine failure. The condition is frequently underdiagnosed and misclassified as type 2 diabetes, resulting in inappropriate management strategies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777809750586-Pancreatic_Fibrosis_as_a_Driver_of_Glucose_Dysregu.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khan Aatif Ajaz Ahmed¹</dc:creator>
      <dc:creator>Malik Atif²</dc:creator>
      <dc:subject>Type 3c diabetes</dc:subject>
      <dc:subject>pancreatic fibrosis</dc:subject>
      <dc:subject>pancreatogenic diabetes</dc:subject>
      <dc:subject>chronic pancreatitis</dc:subject>
      <dc:subject>insulin deficiency</dc:subject>
      <dc:subject>glucose dysregulation</dc:subject>
      <dc:subject>pancreatic stellate cells</dc:subject>
      <dc:subject>endocrine dysfunction</dc:subject>
      <dc:subject>exocrine insufficiency</dc:subject>
      <dc:subject>metabolic disease.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1326</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Hip Dislocation in Newborn Babies: Developmental Dysplasia of the Hip</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/36e9e0f8-19b2-45a6-a036-9ba4a7b13634</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/36e9e0f8-19b2-45a6-a036-9ba4a7b13634</guid>
      <pubDate>Sun, 03 May 2026 00:00:00 GMT</pubDate>
      <author>Dr. Dharmesh singh MBBS/MD (Doctor Of Medicine)¹</author>
      <description>Developmental dysplasia of the hip is one of the most common musculoskeletal disorders in newborns and infants, characterized by abnormal development of the acetabulum, femoral head instability, or complete hip dislocation. Early recognition is essential because untreated cases may lead to gait abnormalities, chronic pain, limb-length discrepancy, and early osteoarthritis. This study evaluates the etiology, risk factors, screening methods, and treatment outcomes of developmental dysplasia of the hip in newborn babies. Major contributing factors include female sex, breech presentation, positive family history, oligohydramnios, and first pregnancy. Clinical examination combined with ultrasonographic screening enables timely diagnosis. Early intervention with harness or brace treatment is associated with excellent outcomes and reduced need for surgery. Developmental dysplasia of the hip is one of the most important orthopedic disorders identified during the neonatal and early infant period. It includes a spectrum of abnormalities ranging from mild acetabular shallowness to instability, subluxation, and complete dislocation of the femoral head. This expanded section examines the biological basis, major risk factors, methods of early detection, and long-term clinical importance of the condition. Female sex, breech presentation, family history, first pregnancy, and restricted intrauterine positioning are among the most recognized contributors. If diagnosis is delayed, children may later develop gait disturbance, limb-length inequality, chronic pain, and premature degenerative joint disease. Early screening and timely treatment provide excellent functional outcomes in most patients.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777809003476-Hip_Dislocation_in_Newborn_Babies__Developmental_D.pdf" type="application/pdf" length="0"/>
      <dc:creator>Dr. Dharmesh singh MBBS/MD (Doctor Of Medicine)¹</dc:creator>
      <dc:creator>Harsh saini²</dc:creator>
      <dc:creator>Parneet³</dc:creator>
      <dc:creator>Kashish rao⁴</dc:creator>
      <dc:subject>Developmental dysplasia of the hip</dc:subject>
      <dc:subject>newborn</dc:subject>
      <dc:subject>hip dislocation</dc:subject>
      <dc:subject>infant orthopedics</dc:subject>
      <dc:subject>breech presentation</dc:subject>
      <dc:subject>Pavlik harness</dc:subject>
      <dc:subject>neonatal screening</dc:subject>
      <dc:subject>acetabular dysplasia</dc:subject>
      <dc:subject>congenital hip instability</dc:subject>
      <dc:subject>pediatric orthopedics.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-05-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1325</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 05, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Cardiovascular Diseases and Risk Factors</title>
      <link>https://aams-journal.us/journals/surgery/articles/4e90d9f6-87c0-4313-a285-595c0e386152</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/4e90d9f6-87c0-4313-a285-595c0e386152</guid>
      <pubDate>Wed, 29 Apr 2026 00:00:00 GMT</pubDate>
      <author>Khan Aatif Ajaz Ahmed¹</author>
      <description>Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, affecting millions of individuals each year. They include coronary artery disease, hypertension, heart failure, cerebrovascular disease, and peripheral vascular disorders. This study evaluates the major biological, behavioral, and environmental risk factors contributing to cardiovascular disease development and progression. Evidence indicates that hypertension, dyslipidemia, diabetes mellitus, obesity, smoking, sedentary lifestyle, and unhealthy nutrition are among the most significant modifiable determinants. Non-modifiable factors such as age, sex, and genetic predisposition also play important roles. Early identification of risk factors and implementation of preventive strategies are essential for reducing disease burden and improving population health outcomes. Cardiovascular diseases remain the foremost cause of death and long-term disability across the world, creating a major burden for healthcare systems and national economies. This expanded section examines the relationship between cardiovascular pathology and the principal factors that increase disease susceptibility. These disorders include coronary artery disease, stroke, heart failure, arrhythmias, and peripheral vascular conditions, all of which often develop gradually over many years. Scientific evidence demonstrates that elevated blood pressure, abnormal lipid metabolism, diabetes mellitus, obesity, smoking, sedentary behavior, chronic stress, and poor dietary patterns are among the most influential modifiable contributors. Non-modifiable determinants such as age, sex, and hereditary predisposition also significantly affect risk. Comprehensive prevention strategies focused on early identification and correction of these factors are essential for reducing morbidity and mortality.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777439873210-Cardiovascular_Diseases_and_Risk_Factors.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khan Aatif Ajaz Ahmed¹</dc:creator>
      <dc:creator>Junaid Mohd²</dc:creator>
      <dc:subject>Cardiovascular diseases</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>atherosclerosis</dc:subject>
      <dc:subject>risk factors</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>smoking</dc:subject>
      <dc:subject>dyslipidemia</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>heart disease.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1320</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 04, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Pathogenesis of Prolactin-Secreting Pituitary Adenomas: Genetic, Molecular, and Hormonal Mechanisms (Literature Review)</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/335e67d1-0df1-4d7a-b621-70f46bbe511a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/335e67d1-0df1-4d7a-b621-70f46bbe511a</guid>
      <pubDate>Wed, 29 Apr 2026 00:00:00 GMT</pubDate>
      <author>D.B. Abdumurodova¹</author>
      <description>The article examines the mechanisms of development of prolactin-secreting pituitary adenomas from the perspective of the interaction between genetic, molecular, and hormonal factors. It highlights that disturbances in the embryonic development stages of the pituitary gland, alterations in transcriptional regulatory systems, and clonal transformation of lactotroph cells play a crucial role in the pathogenesis of prolactinoma. The effects of key transcription factors such as Pit-1, Prop-1, and Hesx1, as well as mutations in genes including MEN1, PRKAR1A, and SF3B1, on cell proliferation and hormonal activity are analyzed. In addition, estrogen-dependent mechanisms, aromatase enzyme activity, and disruptions in signaling pathways are considered in the development of prolactinomas, while also substantiating the sex-related clinical features of the disease.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777443832376-Pathogenesis_of_Prolactin_Secreting_Pituitary_Aden.pdf" type="application/pdf" length="0"/>
      <dc:creator>D.B. Abdumurodova¹</dc:creator>
      <dc:creator>T.T. Atoev²</dc:creator>
      <dc:creator>G.Sh. Negmatova³</dc:creator>
      <dc:subject>prolactinoma</dc:subject>
      <dc:subject>pituitary adenoma</dc:subject>
      <dc:subject>pathogenesis</dc:subject>
      <dc:subject>transcription factors</dc:subject>
      <dc:subject>genetic mutations</dc:subject>
      <dc:subject>estrogens</dc:subject>
      <dc:subject>aromatase</dc:subject>
      <dc:subject>Pit-1</dc:subject>
      <dc:subject>MEN1</dc:subject>
      <dc:subject>SF3B1</dc:subject>
      <dc:subject>hormonal regulation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1323</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Molecular Basis of Vasopressin Deficiency and Its Clinical Significance</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/0d72e8c5-77b1-4183-aad5-0bfb41249054</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/0d72e8c5-77b1-4183-aad5-0bfb41249054</guid>
      <pubDate>Wed, 29 Apr 2026 00:00:00 GMT</pubDate>
      <author>Nazirova Gavhar Ilg&apos;or qizi¹</author>
      <description>Vasopressin deficiency is an important endocrine disorder characterized by impaired synthesis, transport, or secretion of arginine vasopressin, leading to disturbances in water balance and osmotic homeostasis. This study examines the molecular mechanisms responsible for vasopressin deficiency and evaluates its clinical significance in diagnostic and therapeutic practice. Genetic mutations involving the AVP gene, hypothalamic or pituitary damage, autoimmune processes, trauma, and infiltrative diseases are major causes of reduced hormone availability. Deficiency of vasopressin commonly results in central diabetes insipidus, presenting with polyuria, polydipsia, dehydration, and hypernatremia. Understanding the molecular pathways of vasopressin regulation is essential for accurate diagnosis and targeted management. Vasopressin deficiency is a clinically important endocrine disorder caused by impaired production, intracellular transport, storage, or release of arginine vasopressin, resulting in disruption of water and osmotic balance. This expanded section examines the molecular mechanisms responsible for hormone insufficiency and their diagnostic relevance. Genetic defects affecting the AVP precursor, neuronal degeneration within hypothalamic nuclei, autoimmune injury, traumatic lesions, tumors, and postoperative damage are recognized causes of reduced vasopressin activity. The condition most commonly manifests as central diabetes insipidus with excessive urination, intense thirst, dehydration risk, and electrolyte disturbances. Early recognition of the underlying molecular process is essential for effective treatment and prevention of complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777445290115-Molecular_Basis_of_Vasopressin_Deficiency_and_Its_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nazirova Gavhar Ilg&apos;or qizi¹</dc:creator>
      <dc:creator>Negmatova Gulzoda Shuhratovna²</dc:creator>
      <dc:creator>Atoev Toʻlqin Tolmasovich³</dc:creator>
      <dc:subject>Vasopressin deficiency</dc:subject>
      <dc:subject>arginine vasopressin</dc:subject>
      <dc:subject>central diabetes insipidus</dc:subject>
      <dc:subject>AVP gene</dc:subject>
      <dc:subject>hypothalamus</dc:subject>
      <dc:subject>posterior pituitary</dc:subject>
      <dc:subject>water balance</dc:subject>
      <dc:subject>polyuria</dc:subject>
      <dc:subject>hypernatremia</dc:subject>
      <dc:subject>endocrine disorders.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1324</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 04, pp. 91-105</dc:source>
    </item>
    <item>
      <title>Impact of Lifestyle Diseases in the Young Population</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/a2887475-8c53-40f1-99a4-79548f5834e1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/a2887475-8c53-40f1-99a4-79548f5834e1</guid>
      <pubDate>Wed, 29 Apr 2026 00:00:00 GMT</pubDate>
      <author>Rohit Kumar¹</author>
      <description>Lifestyle diseases are increasingly affecting adolescents and young adults, creating a growing global public health concern. Conditions once considered common mainly in older adults, such as obesity, type 2 diabetes mellitus, hypertension, dyslipidemia, and non-alcoholic fatty liver disease, are now being diagnosed at younger ages. This study evaluates the prevalence, causes, and health consequences of lifestyle-related disorders in the young population. Major contributing factors include physical inactivity, unhealthy dietary habits, excessive screen time, sleep disturbance, psychological stress, tobacco use, and alcohol consumption. Early onset of these conditions increases the risk of chronic complications, reduced productivity, and premature cardiovascular disease. The findings emphasize the urgent need for preventive strategies focused on youth health promotion. Lifestyle diseases have become an increasingly serious health problem among children, adolescents, and young adults, affecting both present well-being and future life expectancy. This expanded section examines the growing burden of disorders such as obesity, type 2 diabetes mellitus, hypertension, dyslipidemia, non-alcoholic fatty liver disease, and stress-related conditions in younger age groups. Rapid lifestyle transitions characterized by reduced physical activity, unhealthy dietary habits, excessive screen exposure, poor sleep quality, and psychological pressure have accelerated this trend. Early onset of these disorders increases the likelihood of chronic complications during productive years of life. Current evidence highlights the urgent need for preventive action aimed at promoting healthy behavior from an early age.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777441101285-Impact_of_Lifestyle_Diseases_in_the_Young_Populati.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rohit Kumar¹</dc:creator>
      <dc:creator>Ashish Gangwar²</dc:creator>
      <dc:creator>Arshi Gajnavi³</dc:creator>
      <dc:creator>Zoya Naaz⁴</dc:creator>
      <dc:subject>Lifestyle diseases</dc:subject>
      <dc:subject>young population</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:subject>type 2 diabetes</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>physical inactivity</dc:subject>
      <dc:subject>unhealthy diet</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>adolescent health.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1321</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>CRISPR-Cas9 and the Future of Gene Therapy</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/1cda34d7-90a0-488c-a01f-11802a6bbf0e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/1cda34d7-90a0-488c-a01f-11802a6bbf0e</guid>
      <pubDate>Wed, 29 Apr 2026 00:00:00 GMT</pubDate>
      <author>Fathima Janna¹</author>
      <description>CRISPR-Cas9 has emerged as one of the most transformative technologies in modern biomedical science, offering precise and efficient genome editing with broad therapeutic potential. This study examines the mechanism of CRISPR-Cas9, its current medical applications, and its future role in gene therapy. By enabling targeted modification of DNA sequences, the system provides new treatment possibilities for inherited disorders, cancer, infectious diseases, and degenerative conditions. Early clinical studies demonstrate encouraging results in diseases such as sickle cell anemia and beta-thalassemia. However, technical limitations, delivery challenges, ethical concerns, and off-target effects remain important barriers. The findings indicate that CRISPR-Cas9 may redefine the future of personalized medicine and curative therapy. CRISPR-Cas9 has become one of the most influential innovations in contemporary biomedical science, creating new opportunities for precise correction of genetic defects. This expanded section evaluates its significance in the future development of gene therapy and personalized medicine. By enabling targeted modification of specific DNA sequences, the technology offers potential treatment pathways for inherited disorders, malignancies, metabolic diseases, and selected infectious conditions. Early clinical outcomes in hemoglobinopathies and other monogenic diseases have demonstrated substantial therapeutic promise. Nevertheless, challenges related to delivery systems, off-target editing, long-term safety, and ethical governance remain central issues that must be resolved before broad clinical implementation.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777442337336-CRISPR_Cas9_and_the_Future_of_Gene_Therapy.pdf" type="application/pdf" length="0"/>
      <dc:creator>Fathima Janna¹</dc:creator>
      <dc:creator>Hestia Mujeeb²</dc:creator>
      <dc:creator>Aysha Manal Shabir³</dc:creator>
      <dc:creator>Shaniya Aslam⁴</dc:creator>
      <dc:subject>CRISPR-Cas9</dc:subject>
      <dc:subject>gene therapy</dc:subject>
      <dc:subject>genome editing</dc:subject>
      <dc:subject>personalized medicine</dc:subject>
      <dc:subject>inherited disease</dc:subject>
      <dc:subject>sickle cell anemia</dc:subject>
      <dc:subject>beta-thalassemia</dc:subject>
      <dc:subject>biotechnology</dc:subject>
      <dc:subject>DNA repair</dc:subject>
      <dc:subject>molecular medicine.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1322</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 04, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Role of Gene Mutations in Breast Cancer (Focus on BRCA Genes)</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/638490f5-1dd0-4574-88e6-857ad9cc4f35</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/638490f5-1dd0-4574-88e6-857ad9cc4f35</guid>
      <pubDate>Mon, 27 Apr 2026 00:00:00 GMT</pubDate>
      <author>Amna Fathima Palakkunnummal¹</author>
      <description>Breast cancer is one of the most common malignancies among women worldwide, and genetic predisposition plays a major role in a significant proportion of cases. Among hereditary factors, mutations in BRCA1 and BRCA2 genes are the most extensively studied due to their strong association with increased breast and ovarian cancer risk. This study evaluates the biological role of BRCA gene mutations, their contribution to tumor development, and their clinical importance in screening, prevention, and targeted therapy. Evidence shows that pathogenic variants in BRCA genes impair DNA repair through homologous recombination deficiency, resulting in genomic instability and carcinogenesis. Identification of these mutations has transformed modern oncology through personalized risk assessment and precision treatment strategies. Breast cancer is a multifactorial malignant disease in which inherited and acquired genetic alterations significantly influence tumor initiation and progression. This expanded section focuses on the role of BRCA1 and BRCA2 gene mutations as major hereditary risk factors associated with early onset and aggressive clinical behavior. These genes normally maintain genomic stability through high-fidelity DNA repair mechanisms. Pathogenic mutations impair this protective function, leading to accumulation of DNA damage and uncontrolled cellular proliferation. Current evidence demonstrates that identification of BRCA mutations has become essential for early screening, prevention strategies, prognostic evaluation, and selection of targeted therapies in modern oncology.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777265940734-Role_of_Gene_Mutations_in_Breast_Cancer__Focus_on_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Amna Fathima Palakkunnummal¹</dc:creator>
      <dc:creator>Liya Fathima²</dc:creator>
      <dc:creator>Ninsha Fathima Kuthukallinkal³</dc:creator>
      <dc:creator>Seadh Yasiq Mabrook⁴</dc:creator>
      <dc:subject>Breast cancer</dc:subject>
      <dc:subject>BRCA1</dc:subject>
      <dc:subject>BRCA2</dc:subject>
      <dc:subject>gene mutation</dc:subject>
      <dc:subject>hereditary cancer</dc:subject>
      <dc:subject>DNA repair</dc:subject>
      <dc:subject>genomic instability</dc:subject>
      <dc:subject>targeted therapy</dc:subject>
      <dc:subject>PARP inhibitors</dc:subject>
      <dc:subject>genetic screening.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1319</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Biomarkers Used in Screening Patients for Diabetic Nephropathy and Their Target Indicators</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/500a86b2-57d3-439f-a24a-6f476316d070</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/500a86b2-57d3-439f-a24a-6f476316d070</guid>
      <pubDate>Sun, 26 Apr 2026 00:00:00 GMT</pubDate>
      <author>Ganjiyeva Munisa Komil qizi</author>
      <description>Diabetic nephropathy is one of the most serious microvascular complications of diabetes mellitus and a leading cause of chronic kidney disease worldwide. Early detection through biomarker-based screening is essential for preventing progression to renal failure. This study evaluates conventional and emerging biomarkers used in screening patients for diabetic nephropathy and analyzes their target indicators related to glomerular, tubular, inflammatory, and oxidative damage. Traditional markers such as albuminuria and estimated glomerular filtration rate remain widely used, while novel biomarkers including cystatin C, neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and inflammatory mediators provide earlier and more sensitive detection. The findings emphasize the importance of combining multiple biomarkers for accurate diagnosis and risk stratification. Diabetic nephropathy remains one of the most significant chronic complications of diabetes mellitus and is a major contributor to chronic kidney disease and end-stage renal failure. This expanded section examines the role of laboratory biomarkers used for screening, early diagnosis, and progression monitoring. Conventional indicators such as urinary albumin excretion and estimated glomerular filtration rate continue to serve as the foundation of clinical assessment, while emerging biomarkers provide earlier recognition of structural and functional renal injury. Molecules reflecting tubular damage, inflammation, oxidative stress, and fibrosis offer additional prognostic value. Current evidence suggests that combined biomarker strategies improve diagnostic sensitivity and support more accurate risk stratification in diabetic patients.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777191484168-Biomarkers_Used_in_Screening_Patients_for_Diabetic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ganjiyeva Munisa Komil qizi</dc:creator>
      <dc:subject>Diabetic nephropathy</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>eGFR</dc:subject>
      <dc:subject>cystatin C</dc:subject>
      <dc:subject>NGAL</dc:subject>
      <dc:subject>KIM-1</dc:subject>
      <dc:subject>chronic kidney disease</dc:subject>
      <dc:subject>screening</dc:subject>
      <dc:subject>renal function.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-26</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1318</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Why Some People Never Feel Pain – Congenital Analgesia</title>
      <link>https://aams-journal.us/journals/genetics/articles/e5c52be5-96cd-40b0-94c7-fd04c70b888f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/e5c52be5-96cd-40b0-94c7-fd04c70b888f</guid>
      <pubDate>Sun, 26 Apr 2026 00:00:00 GMT</pubDate>
      <author>Yusra Ansari¹</author>
      <description>Congenital analgesia is a rare neurological condition characterized by the inability to perceive physical pain from birth despite otherwise preserved sensory modalities. This study explores the genetic, physiological, and clinical mechanisms underlying congenital analgesia and evaluates its consequences for health and daily life. Current evidence indicates that mutations affecting nociceptive pathways, ion channels, or peripheral nerve development impair the transmission of pain signals to the central nervous system. Although the absence of pain may appear advantageous, affected individuals are at high risk for unnoticed injuries, fractures, burns, and chronic tissue damage. The findings emphasize the protective role of pain as an essential biological warning system and highlight the importance of early diagnosis and multidisciplinary management. Congenital analgesia is a rare hereditary neurological disorder in which an individual is unable to perceive physical pain from birth. This expanded section examines the biological basis, clinical manifestations, and broader significance of the condition. Genetic abnormalities affecting nociceptors, peripheral nerve signaling, or sodium channel function interrupt normal transmission of painful stimuli to the brain. Although the absence of pain may appear beneficial, affected individuals are highly vulnerable to repeated injuries, infections, burns, fractures, and progressive tissue destruction. Current evidence demonstrates that pain is not merely an unpleasant sensation but a critical protective mechanism essential for survival and bodily integrity.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777185254340-Why_Some_People_Never_Feel_Pain___Congenital_Analg.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yusra Ansari¹</dc:creator>
      <dc:creator>Lubna Nizami²</dc:creator>
      <dc:creator>Anam Aliya³</dc:creator>
      <dc:subject>Congenital analgesia</dc:subject>
      <dc:subject>pain insensitivity</dc:subject>
      <dc:subject>nociception</dc:subject>
      <dc:subject>hereditary sensory neuropathy</dc:subject>
      <dc:subject>SCN9A mutation</dc:subject>
      <dc:subject>sodium channels</dc:subject>
      <dc:subject>peripheral nerves</dc:subject>
      <dc:subject>rare disease</dc:subject>
      <dc:subject>neurological disorder</dc:subject>
      <dc:subject>pain pathways.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-26</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1317</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Role of Medical Robots in Surgery: Advancements, Benefits, and Limitations of Robotic-Assisted Surgery Systems like the Da Vinci Surgical System</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/58772125-1329-4b00-b537-00cfb6d2d86d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/58772125-1329-4b00-b537-00cfb6d2d86d</guid>
      <pubDate>Fri, 24 Apr 2026 00:00:00 GMT</pubDate>
      <author>Ashesa Panigrahy¹</author>
      <description>Robotic-assisted surgery has become a major advancement in modern operative medicine by enhancing precision, control, and visualization during complex procedures. This study examines the technological progress, clinical benefits, and inherent limitations of robotic surgical systems, with particular focus on widely used platforms such as the Da Vinci Surgical System. Clinical outcomes were evaluated based on operative accuracy, complication rates, recovery time, and surgeon ergonomics. The findings indicate that robotic systems significantly improve surgical precision, reduce intraoperative trauma, and enhance postoperative recovery. However, high costs, technical complexity, and the need for specialized training remain limiting factors. These results highlight both the transformative potential and current constraints of robotic-assisted surgery in clinical practice. Robotic-assisted surgical technologies have significantly advanced operative medicine by improving precision, visualization, and control during complex procedures. This section provides an expanded evaluation of their clinical effectiveness, focusing on enhanced dexterity, reduced human error, and improved patient outcomes. Systems such as the Da Vinci Surgical System enable surgeons to perform delicate interventions with greater accuracy and stability. Clinical evidence demonstrates reductions in perioperative trauma, complication rates, and recovery time. Nevertheless, factors such as high implementation costs, technical dependence, and training requirements continue to limit universal adoption.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777025665154-Role_of_Medical_Robots_in_Surgery__Advancements__B.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ashesa Panigrahy¹</dc:creator>
      <dc:creator>Rashmi Narayani²</dc:creator>
      <dc:creator>Sameera Sanvi³</dc:creator>
      <dc:creator>Zahin Khan⁴</dc:creator>
      <dc:subject>Robotic surgery</dc:subject>
      <dc:subject>medical robots</dc:subject>
      <dc:subject>Da Vinci Surgical System</dc:subject>
      <dc:subject>minimally invasive surgery</dc:subject>
      <dc:subject>surgical precision</dc:subject>
      <dc:subject>patient outcomes</dc:subject>
      <dc:subject>healthcare technology</dc:subject>
      <dc:subject>operative innovation</dc:subject>
      <dc:subject>complications</dc:subject>
      <dc:subject>clinical efficiency.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1315</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 04, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Astrocyte neuron lactate shuttle system </title>
      <link>https://aams-journal.us/journals/surgery/articles/71edd3ed-9949-4f5d-89ad-3523ebfc8a48</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/71edd3ed-9949-4f5d-89ad-3523ebfc8a48</guid>
      <pubDate>Fri, 24 Apr 2026 00:00:00 GMT</pubDate>
      <author>Manasa Sankar Senthilrani¹</author>
      <description>The astrocyte–neuron lactate shuttle system is a key metabolic mechanism that supports neuronal energy demands through coordinated glial–neuronal interactions. This study examines the physiological role of astrocyte-derived lactate in neuronal metabolism, synaptic activity, and brain energy homeostasis. Evidence shows that astrocytes convert glucose into lactate, which is then transported to neurons as an essential energy substrate, particularly during periods of high neuronal activity. Disruption of this system is associated with neurodegenerative conditions and impaired cognitive function. The findings highlight the critical role of metabolic coupling in maintaining central nervous system function. The astrocyte–neuron lactate shuttle system is a fundamental metabolic pathway that ensures efficient energy transfer within the central nervous system. This section expands on its physiological importance in maintaining neuronal activity, synaptic transmission, and overall brain energy balance. Astrocytes convert glucose into lactate through glycolysis, which is subsequently transported to neurons and utilized as an efficient energy substrate during periods of increased demand. The analysis demonstrates that this metabolic coupling is essential for sustaining neuronal function, while its disruption contributes to impaired cognitive performance and neurodegenerative processes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777024891761-Astrocyte_neuron_lactate_shuttle_system_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Manasa Sankar Senthilrani¹</dc:creator>
      <dc:creator>Neeha Yumnam²</dc:creator>
      <dc:subject>Astrocyte</dc:subject>
      <dc:subject>neuron</dc:subject>
      <dc:subject>lactate shuttle</dc:subject>
      <dc:subject>brain metabolism</dc:subject>
      <dc:subject>energy homeostasis</dc:subject>
      <dc:subject>glycolysis</dc:subject>
      <dc:subject>neuroglia</dc:subject>
      <dc:subject>synaptic activity</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>glucose metabolism.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1314</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Role of Minimally Invasive Surgery in Modern Medicine</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/de492f3a-40ea-420e-a3f9-1726f2de51c7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/de492f3a-40ea-420e-a3f9-1726f2de51c7</guid>
      <pubDate>Fri, 24 Apr 2026 00:00:00 GMT</pubDate>
      <author>Name farika parveen</author>
      <description>Minimally invasive surgery has become a cornerstone of modern medical practice, offering effective treatment with reduced tissue trauma and faster recovery compared to conventional open procedures. This study evaluates the clinical effectiveness, safety, and outcomes of minimally invasive techniques across various surgical disciplines. Key parameters assessed include operative time, complication rates, postoperative pain, hospital stay duration, and patient recovery. The findings demonstrate that minimally invasive approaches significantly improve clinical outcomes while reducing morbidity and enhancing patient satisfaction. Despite these advantages, limitations related to technical complexity and equipment requirements remain relevant. The results highlight the growing importance of minimally invasive surgery in improving healthcare quality. Minimally invasive surgical techniques have transformed contemporary medical practice by enabling effective treatment with minimal disruption to normal anatomical structures. This section elaborates on their clinical value by examining reduced physiological stress, improved recovery dynamics, and enhanced procedural precision. Evidence indicates that such approaches significantly decrease perioperative complications, shorten hospitalization, and improve overall patient outcomes. At the same time, technological dependence and the requirement for advanced surgical expertise present important limitations. The analysis highlights the growing role of these techniques as a standard of care in multiple medical disciplines.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1777054320328-Role_of_Minimally_Invasive_Surgery_in_Modern_Medic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Name farika parveen</dc:creator>
      <dc:subject>Minimally invasive surgery</dc:subject>
      <dc:subject>laparoscopy</dc:subject>
      <dc:subject>endoscopy</dc:subject>
      <dc:subject>robotic surgery</dc:subject>
      <dc:subject>patient outcomes</dc:subject>
      <dc:subject>recovery</dc:subject>
      <dc:subject>surgical innovation</dc:subject>
      <dc:subject>complications</dc:subject>
      <dc:subject>healthcare efficiency</dc:subject>
      <dc:subject>clinical effectiveness.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1316</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Role of Artificial Intelligence in Early Diagnosis of Cardiovascular Diseases: Opportunities and Limitations</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/7396b0ef-845f-4cef-9b2f-ae8d30f85b47</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/7396b0ef-845f-4cef-9b2f-ae8d30f85b47</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate>
      <author>MOHAMMED FAHAD BIN AHAD FAROOQ</author>
      <description>Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, necessitating the development of innovative strategies for early detection and prevention. In recent years, artificial intelligence (AI) has emerged as a transformative tool in healthcare, offering new possibilities for improving the accuracy, efficiency, and timeliness of cardiovascular disease diagnosis. This paper explores the role of AI technologies in the early identification of cardiovascular conditions, highlighting both their potential benefits and inherent limitations. AI-driven methods, including machine learning, deep learning, and data mining algorithms, enable the analysis of large and complex datasets derived from medical imaging, electrocardiography, electronic health records, and wearable devices. These systems can identify subtle patterns and predictive markers that may not be detectable through conventional diagnostic approaches, thereby facilitating earlier intervention and risk stratification.
The application of AI in cardiovascular diagnostics has shown promising results in detecting conditions such as coronary artery disease, arrhythmias, heart failure, and stroke risk at preclinical or asymptomatic stages. Automated interpretation of imaging modalities, including echocardiography and computed tomography, enhances diagnostic precision while reducing clinician workload. Additionally, AI-powered predictive models contribute to personalized medicine by integrating multiple risk factors and providing individualized prognostic assessments. Despite these advantages, several challenges limit the widespread implementation of AI in clinical practice. These include issues related to data quality, algorithm transparency, potential bias, lack of standardization, regulatory concerns, and the need for clinical validation. Furthermore, ethical considerations regarding patient privacy, data security, and the role of human oversight remain critical.
In conclusion, artificial intelligence holds significant promise in revolutionizing early diagnosis of cardiovascular diseases by enabling more accurate and timely detection. However, its successful integration into healthcare systems requires addressing technical, ethical, and organizational challenges. A balanced approach that combines technological innovation with clinical expertise is essential to maximize the benefits of AI while minimizing its limitations in cardiovascular care.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776944819463-Role_of_Artificial_Intelligence_in_Early_Diagnosis.pdf" type="application/pdf" length="0"/>
      <dc:creator>MOHAMMED FAHAD BIN AHAD FAROOQ</dc:creator>
      <dc:subject>Artificial intelligence</dc:subject>
      <dc:subject>cardiovascular diseases</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>machine learning</dc:subject>
      <dc:subject>deep learning</dc:subject>
      <dc:subject>ECG</dc:subject>
      <dc:subject>medical imaging</dc:subject>
      <dc:subject>predictive modeling</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>clinical decision support.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-23</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1312</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 04, pp. 76-90</dc:source>
    </item>
    <item>
      <title>Aesthetic Restoration Methods of Anterior Teeth and Their Effectiveness</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e9660401-41b7-4090-ab3d-ac489afe4bdb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e9660401-41b7-4090-ab3d-ac489afe4bdb</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate>
      <author>Ernazarova Sarvinoz</author>
      <description>Aesthetic restoration of anterior teeth plays a crucial role in modern restorative dentistry, aiming to achieve optimal functional and visual outcomes. This study evaluates the effectiveness of contemporary restorative techniques, including direct composite restorations, ceramic veneers, and full-coverage crowns. Clinical performance was assessed based on parameters such as color stability, marginal adaptation, surface integrity, and patient satisfaction. The findings indicate that minimally invasive approaches, particularly composite resins and veneers, provide excellent aesthetic outcomes with high patient acceptance. However, long-term durability varies depending on material selection and clinical technique. The results emphasize the importance of individualized treatment planning to achieve optimal outcomes. Aesthetic restoration of anterior teeth focuses on achieving harmony between function, durability, and natural appearance using modern restorative materials and techniques. This section expands on the clinical effectiveness of various treatment options by analyzing their ability to reproduce natural tooth morphology, color, and translucency while maintaining structural integrity over time. Contemporary approaches emphasize minimally invasive procedures that preserve healthy dental tissues and enhance long-term outcomes. The evaluation demonstrates that different restoration methods provide varying levels of aesthetic stability, mechanical performance, and patient satisfaction, highlighting the importance of individualized treatment selection.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776945176542-Aesthetic_Restoration_Methods_of_Anterior_Teeth_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ernazarova Sarvinoz</dc:creator>
      <dc:creator>Murodova Sevara</dc:creator>
      <dc:creator>Nasridinova Kamola</dc:creator>
      <dc:creator>G’apporov Dilxush</dc:creator>
      <dc:subject>Aesthetic dentistry</dc:subject>
      <dc:subject>anterior teeth</dc:subject>
      <dc:subject>composite restorations</dc:subject>
      <dc:subject>ceramic veneers</dc:subject>
      <dc:subject>crowns</dc:subject>
      <dc:subject>color stability</dc:subject>
      <dc:subject>minimally invasive treatment</dc:subject>
      <dc:subject>dental materials</dc:subject>
      <dc:subject>smile design</dc:subject>
      <dc:subject>patient satisfaction.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-23</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1313</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 04, pp. 46-60</dc:source>
    </item>
    <item>
      <title>Retinal Microcirculatory Disturbances as Predictors of the Progression of Diabetic Nephropathy</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/7229aac1-3a0f-4589-9b57-7e24d777277a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/7229aac1-3a0f-4589-9b57-7e24d777277a</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Retinal microcirculatory impairment represents an early manifestation of systemic microangiopathy in patients with diabetes mellitus and may serve as a predictive marker for the progression of diabetic nephropathy. This study evaluates the relationship between retinal vascular alterations and the deterioration of renal function using advanced imaging techniques. Parameters such as vessel density, perfusion indices, and characteristics of the foveal avascular zone were analyzed alongside renal indicators including estimated glomerular filtration rate and albuminuria. The findings demonstrate that early reductions in retinal perfusion and capillary density are strongly associated with subsequent decline in renal function. These results support the concept that retinal microvascular changes precede and predict the progression of nephropathy, offering a non-invasive method for early risk assessment and monitoring in diabetic patients. Microcirculatory alterations within the retinal vascular network represent an early and measurable manifestation of systemic vascular dysfunction in diabetes mellitus. This section provides an expanded overview of how these changes can serve as predictive indicators for the progression of renal impairment. Quantitative assessment of perfusion characteristics, capillary integrity, and vascular density reveals significant deviations even at subclinical stages. Evidence demonstrates that these retinal parameters closely reflect ongoing pathological processes affecting renal microvasculature. The integration of high-resolution imaging techniques enables precise detection of these abnormalities, supporting their use as reliable, non-invasive biomarkers for identifying individuals at increased risk of disease progression.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776789084702-Retinal_Microcirculatory_Disturbances_as_Predictor.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Diabetic nephropathy</dc:subject>
      <dc:subject>retinal microcirculation</dc:subject>
      <dc:subject>OCT angiography</dc:subject>
      <dc:subject>vessel density</dc:subject>
      <dc:subject>foveal avascular zone</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>renal function</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>perfusion.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1302</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 04, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Morphological Changes of the Retina in Experimental Nephroretinal Syndrome: The Role of Apoptosis and Glial Activation</title>
      <link>https://aams-journal.us/journals/neurology/articles/efeaa215-1881-4669-b7b3-63fe549a3ea9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/efeaa215-1881-4669-b7b3-63fe549a3ea9</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Experimental nephroretinal syndrome provides a valuable model for investigating the cellular and molecular mechanisms underlying retinal damage associated with systemic microangiopathy. This study examines morphological alterations in retinal tissue with particular emphasis on apoptotic processes and glial cell activation. Histological and immunohistochemical analyses were used to evaluate neuronal loss, structural disorganization, and expression of apoptosis-related and glial markers. The findings demonstrate that retinal degeneration is closely associated with increased apoptotic activity and pronounced activation of glial elements, including Müller cells and astrocytes. These processes contribute to progressive disruption of retinal architecture and functional impairment. The results highlight the significance of neurodegenerative and inflammatory mechanisms in the pathogenesis of nephroretinal syndrome and provide a basis for the development of targeted therapeutic strategies. Experimental nephroretinal involvement is characterized by progressive structural disruption of retinal tissue driven by cellular death mechanisms and reactive glial responses. This section expands on the significance of programmed neuronal loss and activation of supporting cells as central contributors to retinal degeneration. Detailed morphological and immunohistochemical evaluation demonstrates that increased expression of apoptotic markers coincides with extensive remodeling of retinal layers and loss of cellular integrity. Simultaneously, activation of Müller cells and astrocytes reflects an adaptive but ultimately maladaptive response to injury, contributing to inflammatory signaling and structural disorganization. These combined processes highlight the complex interplay between neurodegeneration and glial reactivity in the development of retinal pathology under systemic pathological conditions.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776789671769-Morphological_Changes_of_the_Retina_in_Experimenta.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Nephroretinal syndrome</dc:subject>
      <dc:subject>retina</dc:subject>
      <dc:subject>apoptosis</dc:subject>
      <dc:subject>glial activation</dc:subject>
      <dc:subject>Müller cells</dc:subject>
      <dc:subject>astrocytes</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>immunohistochemistry</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>experimental model.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1303</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Relationship Between OCT/OCTA Parameters and Renal Function in Patients with Type 2 Diabetes Mellitus</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/9eecd2e3-f168-47b5-8308-85936d5d8ffc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/9eecd2e3-f168-47b5-8308-85936d5d8ffc</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Retinal imaging biomarkers obtained through optical coherence tomography (OCT) and OCT angiography (OCTA) are increasingly recognized as potential indicators of systemic microvascular damage in type 2 diabetes mellitus. This study evaluates the relationship between retinal structural and vascular parameters and renal function indicators, including estimated glomerular filtration rate and albuminuria. The results demonstrate significant correlations between retinal thinning, reduced vascular density, and worsening renal function. These findings suggest that OCT/OCTA parameters reflect systemic microangiopathy and may serve as non-invasive surrogate markers for early detection and monitoring of diabetic nephropathy progression.
Retinal OCT and OCT angiography parameters provide valuable insight into systemic microvascular status in type 2 diabetes mellitus, particularly in relation to renal dysfunction. This section summarizes the interdependence between retinal structural and vascular alterations and key renal biomarkers such as estimated glomerular filtration rate and albuminuria. The analysis demonstrates that retinal thinning and reduced microvascular perfusion closely parallel the degree of renal impairment. These findings support the hypothesis that retinal imaging can serve as a non-invasive indicator of diabetic kidney disease progression and overall microvascular damage burden.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776799712666-Relationship_Between_OCT_OCTA_Parameters_and_Renal.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Type 2 diabetes mellitus</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>OCT angiography</dc:subject>
      <dc:subject>renal function</dc:subject>
      <dc:subject>eGFR</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>retinal thickness</dc:subject>
      <dc:subject>vessel density</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>biomarkers.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1311</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 01, Issue 01, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Integrative Algorithm for Early Diagnosis and Monitoring of Nephroretinal Syndrome in Type 2 Diabetes Mellitus</title>
      <link>https://aams-journal.us/journals/surgery/articles/e9ce6e3e-25bf-4d50-b640-ff2fae7334c7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/e9ce6e3e-25bf-4d50-b640-ff2fae7334c7</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Nephroretinal syndrome in type 2 diabetes mellitus represents a combined microvascular complication involving simultaneous damage to the retina and kidneys. This study proposes an integrative diagnostic algorithm that combines retinal imaging, renal biomarkers, and systemic metabolic indicators for early detection and longitudinal monitoring of disease progression. Optical coherence tomography and OCT angiography parameters were analyzed alongside estimated glomerular filtration rate and albuminuria levels to construct a unified assessment model. The results demonstrate that combining ocular and renal parameters significantly improves early diagnostic accuracy compared to isolated organ-based evaluation. The proposed algorithm enables stratification of patients according to risk level and facilitates timely therapeutic intervention, highlighting its potential clinical utility in routine practice. Nephroretinal syndrome in type 2 diabetes mellitus requires an integrated diagnostic approach because retinal and renal damage develop simultaneously through shared microvascular mechanisms. This section presents the rationale and structure of a combined diagnostic and monitoring system that incorporates ophthalmic imaging, renal biomarkers, and systemic metabolic indicators. Multimodal assessment demonstrates that early structural retinal changes and subtle renal functional decline occur in parallel even before clinical symptoms become evident. The integration of these parameters significantly improves the ability to detect early-stage systemic microangiopathy and allows more accurate stratification of disease severity. The proposed approach emphasizes the importance of unified evaluation of target organs affected by diabetic microvascular injury.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776796309005-Integrative_Algorithm_for_Early_Diagnosis_and_Moni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Nephroretinal syndrome</dc:subject>
      <dc:subject>diabetes mellitus</dc:subject>
      <dc:subject>diagnostic algorithm</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>OCT angiography</dc:subject>
      <dc:subject>eGFR</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>monitoring.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1309</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Glial Activation and Vascular Disorders as Key Mechanisms of Retinal Damage in Nephroretinal Syndrome</title>
      <link>https://aams-journal.us/journals/genetics/articles/0716c2d9-d37b-4c67-aad4-0e01b99e963c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/0716c2d9-d37b-4c67-aad4-0e01b99e963c</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Retinal damage in nephroretinal syndrome is driven by a complex interaction between vascular dysfunction and glial cell activation, which together contribute to progressive neurovascular degeneration. This study evaluates the structural and functional alterations of retinal tissue with emphasis on the synergistic role of microvascular impairment and reactive gliosis. Advanced imaging and immunohistochemical methods were used to assess vascular density, perfusion status, and expression of glial activation markers. The findings demonstrate that early vascular insufficiency triggers a cascade of glial responses that initially aim to preserve retinal integrity but ultimately exacerbate tissue damage. The results confirm that combined vascular and glial mechanisms are central to disease progression and represent important targets for early diagnostic and therapeutic strategies. Retinal involvement in nephroretinal syndrome is characterized by a tightly interconnected cascade of vascular insufficiency and reactive glial responses that progressively damage the neurovascular unit. This section outlines the combined contribution of microcirculatory failure and glial cell activation in initiating and sustaining retinal degeneration. Quantitative and morphological evaluation demonstrates that early vascular compromise precedes structural disorganization, while subsequent activation of Müller cells and astrocytes amplifies inflammatory signaling and tissue remodeling. These parallel processes create a self-perpetuating cycle of injury that accelerates neuronal dysfunction. The findings support the concept that retinal pathology in systemic disease is not purely vascular or neural in origin but results from integrated dysfunction of supporting and vascular components.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776793335125-Glial_Activation_and_Vascular_Disorders_as_Key_Mec.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Nephroretinal syndrome</dc:subject>
      <dc:subject>glial activation</dc:subject>
      <dc:subject>vascular dysfunction</dc:subject>
      <dc:subject>retina</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>Müller cells</dc:subject>
      <dc:subject>astrocytes</dc:subject>
      <dc:subject>neurovascular unit</dc:subject>
      <dc:subject>ischemia</dc:subject>
      <dc:subject>retinal degeneration.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1305</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Experimental-Morphological Justification of the Systemic Nature of Retinal and Renal Damage in Type 2 Diabetes Mellitus</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/d91c0378-bd86-4086-b7a1-a837f7b96166</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/d91c0378-bd86-4086-b7a1-a837f7b96166</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Type 2 diabetes mellitus induces widespread microvascular and cellular alterations affecting multiple organs, with the retina and kidneys being among the primary targets. This experimental-morphological study investigates the systemic nature of concurrent retinal and renal injury, focusing on shared structural and pathological mechanisms. Histological, ultrastructural, and immunohistochemical analyses were used to evaluate microvascular remodeling, basement membrane thickening, and cellular degeneration in both organs. The findings demonstrate parallel progression of damage characterized by endothelial dysfunction, capillary rarefaction, and increased apoptotic activity. These changes confirm that retinal and renal lesions are not independent events but manifestations of a unified systemic microangiopathic process. The results provide experimental evidence supporting the concept of interconnected organ pathology in diabetes. Experimental morphological evidence indicates that type 2 diabetes mellitus produces synchronized structural damage in both retinal and renal tissues as part of a unified systemic microangiopathic process. This section summarizes the coordinated histopathological and ultrastructural alterations observed in experimental conditions, emphasizing endothelial injury, basement membrane remodeling, and progressive cellular degeneration. The data demonstrate that both organs exhibit parallel pathological trajectories characterized by microvascular rarefaction, increased apoptosis, and disruption of tissue architecture. These findings support the concept that retinal and renal complications are not isolated entities but interrelated manifestations of the same systemic metabolic disorder.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776794853960-Experimental_Morphological_Justification_of_the_Sy.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Type 2 diabetes mellitus</dc:subject>
      <dc:subject>retina</dc:subject>
      <dc:subject>kidney</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>experimental morphology</dc:subject>
      <dc:subject>endothelial dysfunction</dc:subject>
      <dc:subject>basement membrane</dc:subject>
      <dc:subject>apoptosis</dc:subject>
      <dc:subject>systemic disease</dc:subject>
      <dc:subject>microcirculation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1306</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 02, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Clinical and Diagnostic Criteria for Predicting Progression of Nephroretinal Syndrome Based on OCT and OCT-Angiography Data</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/e37e9a76-44e1-418a-a0a4-ef3f1d71ecc9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/e37e9a76-44e1-418a-a0a4-ef3f1d71ecc9</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Nephroretinal syndrome progression in type 2 diabetes mellitus is closely associated with combined retinal structural and microvascular alterations. This study evaluates clinical and diagnostic criteria for predicting disease progression using optical coherence tomography (OCT) and OCT angiography (OCTA). Key parameters including retinal layer thickness, ganglion cell complex integrity, vessel density, and perfusion indices were analyzed alongside renal functional markers. The results demonstrate that specific combinations of structural and vascular retinal changes strongly correlate with worsening renal function and systemic microangiopathy progression. The proposed diagnostic criteria enable early identification of high-risk patients and provide a reliable basis for prognostic assessment and monitoring of disease evolution. Prediction of nephroretinal syndrome progression in type 2 diabetes mellitus requires objective imaging-based and clinical indicators that reflect both retinal and systemic microvascular status. This section presents expanded diagnostic criteria derived from optical coherence tomography (OCT) and OCT angiography (OCTA), combined with renal functional parameters. The analysis focuses on structural retinal thinning, microvascular rarefaction, and perfusion deficits as early markers of systemic deterioration. The results demonstrate that specific imaging patterns, when integrated with renal biomarkers, significantly improve the accuracy of predicting disease progression. These findings support the use of combined ophthalmic and nephrological assessment for early risk stratification and longitudinal monitoring of diabetic microangiopathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776799361211-Clinical_and_Diagnostic_Criteria_for_Predicting_Pr.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Nephroretinal syndrome</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>OCT angiography</dc:subject>
      <dc:subject>prognostic criteria</dc:subject>
      <dc:subject>retinal thickness</dc:subject>
      <dc:subject>vessel density</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>type 2 diabetes mellitus</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>progression.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1310</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 01, Issue 01, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Relationship Between GCC and RNFL Thinning and eGFR and Albuminuria in Patients with Type 2 Diabetes Mellitus</title>
      <link>https://aams-journal.us/journals/dermatology/articles/3103a5aa-9114-468a-91d9-990ff48d80e1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/3103a5aa-9114-468a-91d9-990ff48d80e1</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Thinning of the ganglion cell complex (GCC) and retinal nerve fiber layer (RNFL) represents early neurodegenerative changes in the retina that may reflect systemic microvascular damage in patients with type 2 diabetes mellitus. This study evaluates the association between retinal neurostructural parameters and renal function indicators, specifically estimated glomerular filtration rate (eGFR) and albuminuria. Optical coherence tomography was used to quantify GCC and RNFL thickness, while renal status was assessed through biochemical analysis. The results demonstrate a significant correlation between progressive retinal thinning and worsening renal function, indicating that retinal neurodegeneration parallels diabetic nephropathy. These findings support the use of retinal neurostructural biomarkers as early indicators of systemic disease progression. Retinal neurostructural thinning, particularly involving the ganglion cell complex (GCC) and retinal nerve fiber layer (RNFL), is increasingly recognized as an early indicator of systemic microvascular injury in type 2 diabetes mellitus. This section expands on the relationship between retinal neurodegeneration and renal dysfunction, focusing on estimated glomerular filtration rate (eGFR) decline and albuminuria progression. Quantitative analysis demonstrates that reductions in GCC and RNFL thickness closely parallel worsening renal biomarkers, reflecting shared pathogenic mechanisms of microangiopathy. These findings support the concept that retinal neurostructural changes may serve as accessible, non-invasive indicators of systemic disease burden and renal impairment progression.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776795886502-Relationship_Between_GCC_and_RNFL_Thinning_and_eGF.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Ganglion cell complex</dc:subject>
      <dc:subject>RNFL</dc:subject>
      <dc:subject>diabetic nephropathy</dc:subject>
      <dc:subject>eGFR</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>type 2 diabetes mellitus</dc:subject>
      <dc:subject>retinal neurodegeneration</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>biomarkers.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1308</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Morphofunctional Changes of the Retina in Nephroretinal Syndrome in Patients with Type 2 Diabetes Mellitus According to OCT and OCT Angiography</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/94af9461-5632-4874-b4d5-f001dc70ff2a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/94af9461-5632-4874-b4d5-f001dc70ff2a</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Nephroretinal syndrome in patients with type 2 diabetes mellitus represents a complex manifestation of systemic microvascular damage affecting both renal and retinal structures. This study investigates morphofunctional retinal alterations using optical coherence tomography (OCT) and OCT angiography (OCTA), focusing on their relationship with the severity of diabetic nephropathy. Structural parameters such as retinal thickness, macular volume, and integrity of retinal layers were analyzed alongside microvascular indicators including vessel density and perfusion indices. The findings demonstrate significant correlations between renal dysfunction and progressive retinal damage, characterized by thinning of neural layers, disruption of photoreceptor integrity, and decreased vascular density. OCTA revealed early microcirculatory impairment even in the absence of pronounced clinical retinopathy. These results highlight the importance of combined retinal imaging as a non-invasive tool for early detection and monitoring of systemic microangiopathy in diabetic patients. Retinal involvement in patients with type 2 diabetes mellitus and concurrent renal impairment reflects a systemic microangiopathic process that affects both neural and vascular components of the eye. This section provides an expanded evaluation of structural and functional retinal alterations detected through advanced imaging techniques. Particular emphasis is placed on the ability of high-resolution tomographic and angiographic methods to identify early neurodegenerative and microcirculatory disturbances. Evidence indicates that even subtle renal dysfunction is accompanied by measurable changes in retinal thickness, capillary perfusion, and vascular integrity. These findings support the concept that ocular parameters can serve as sensitive indicators of systemic disease progression, enabling earlier detection and more accurate monitoring of microvascular damage.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776788129948-Morphofunctional_Changes_of_the_Retina_in_Nephrore.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Type 2 diabetes mellitus</dc:subject>
      <dc:subject>nephroretinal syndrome</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>OCT angiography</dc:subject>
      <dc:subject>diabetic retinopathy</dc:subject>
      <dc:subject>microvascular changes</dc:subject>
      <dc:subject>retinal thickness</dc:subject>
      <dc:subject>vessel density</dc:subject>
      <dc:subject>nephropathy</dc:subject>
      <dc:subject>biomarkers.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1300</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 04, pp. 76-90</dc:source>
    </item>
    <item>
      <title>Pathogenetic Mechanisms of Retinal Neurodegeneration in Nephroretinal Syndrome in Patients with Type 2 Diabetes Mellitus</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/2155f12d-f29a-4a38-a8fc-bf38c34b060e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/2155f12d-f29a-4a38-a8fc-bf38c34b060e</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Retinal neurodegeneration in nephroretinal syndrome represents a complex process driven by chronic metabolic imbalance, microvascular dysfunction, and inflammatory responses in patients with type 2 diabetes mellitus. This study explores the key pathogenetic mechanisms underlying neuronal damage in the retina, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and impaired neurovascular coupling. Structural and molecular alterations were evaluated using advanced imaging and immunohistochemical techniques, focusing on neuronal loss, synaptic disruption, and activation of glial cells. The findings demonstrate that neurodegenerative processes begin at early stages of systemic disease and progress in parallel with renal impairment. The results highlight the importance of understanding these mechanisms for the development of targeted therapeutic approaches aimed at preserving retinal function and preventing irreversible damage. Retinal neurodegeneration in nephroretinal syndrome associated with type 2 diabetes mellitus develops as a result of combined metabolic, vascular, and inflammatory disturbances that progressively impair neuronal viability. This section summarizes the key pathogenic processes responsible for retinal tissue damage, emphasizing early cellular dysfunction preceding overt clinical manifestations. Detailed evaluation of structural and molecular alterations demonstrates progressive neuronal loss, synaptic disintegration, and glial reactivity, all of which contribute to deterioration of retinal architecture. The findings indicate that neurodegenerative changes are not isolated ocular events but reflect systemic disease progression involving interconnected organ damage. Identification of these early alterations provides an important basis for timely diagnosis and targeted intervention.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776790126862-Pathogenetic_Mechanisms_of_Retinal_Neurodegenerati.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Nephroretinal syndrome</dc:subject>
      <dc:subject>retinal neurodegeneration</dc:subject>
      <dc:subject>type 2 diabetes mellitus</dc:subject>
      <dc:subject>oxidative stress</dc:subject>
      <dc:subject>mitochondrial dysfunction</dc:subject>
      <dc:subject>neurovascular coupling</dc:subject>
      <dc:subject>apoptosis</dc:subject>
      <dc:subject>glial activation</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>microangiopathy.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1304</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Correlation Analysis of Retinal Structural Changes and Renal Function Parameters in Nephroretinal Syndrome</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/b7acea9a-7331-4c4c-858e-7c1ce0255456</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/b7acea9a-7331-4c4c-858e-7c1ce0255456</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Nephroretinal syndrome represents a systemic microvascular disorder in which retinal structural alterations are closely associated with renal functional impairment. This study investigates the correlation between morphological changes in the retina and key indicators of kidney function in patients with diabetes mellitus. Optical coherence tomography parameters, including retinal thickness and ganglion cell complex integrity, were analyzed alongside OCT angiography-derived vascular indices and renal biomarkers such as estimated glomerular filtration rate and albuminuria. The results demonstrate a strong and statistically significant correlation between retinal structural deterioration and declining renal function. These findings suggest that retinal imaging parameters can serve as reliable surrogate markers for systemic microvascular damage, enabling early detection and monitoring of disease progression. Structural alterations of the retina in nephroretinal syndrome show a measurable relationship with renal functional impairment, reflecting a unified systemic microvascular pathology. This section expands on the quantitative association between retinal morphological parameters and kidney function indicators in patients with diabetes mellitus. Imaging-based evaluation reveals that thinning of retinal neural layers, reduction of vascular density, and expansion of avascular zones occur in parallel with declining renal filtration capacity and increasing proteinuria. These observations support the concept that ocular microstructural changes can serve as non-invasive indicators of systemic disease severity. The correlation between both organ systems underscores the clinical relevance of retinal assessment in monitoring progression of diabetic microangiopathy.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776795357666-Correlation_Analysis_of_Retinal_Structural_Changes.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Nephroretinal syndrome</dc:subject>
      <dc:subject>correlation analysis</dc:subject>
      <dc:subject>retinal structure</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>OCT angiography</dc:subject>
      <dc:subject>renal function</dc:subject>
      <dc:subject>eGFR</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:subject>biomarkers.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1307</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 02, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>The Role of Retinal Biomarkers in the Early Diagnosis of Nephroretinal Syndrome in Type 2 Diabetes Mellitus: Correlation Between OCT/OCTA Parameters and Renal Function</title>
      <link>https://aams-journal.us/journals/dentistry/articles/d303f7c3-ba4c-4f07-a0a3-7bcc12094a45</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/d303f7c3-ba4c-4f07-a0a3-7bcc12094a45</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z</author>
      <description>Nephroretinal syndrome in type 2 diabetes mellitus represents a manifestation of systemic microvascular injury affecting both retinal and renal structures. This study investigates the diagnostic value of retinal biomarkers obtained through optical coherence tomography (OCT) and OCT angiography (OCTA) in the early detection of this condition. Structural indicators such as retinal thickness, ganglion cell complex integrity, and macular volume were analyzed alongside microvascular parameters including vessel density and foveal avascular zone characteristics. These findings were correlated with renal function markers such as estimated glomerular filtration rate (eGFR) and albuminuria. Results demonstrate that early retinal alterations are closely associated with declining renal function, even before overt clinical signs appear. The study highlights the potential of retinal imaging biomarkers as non-invasive tools for early identification and monitoring of systemic microangiopathy in diabetic patients. Retinal biomarkers have emerged as sensitive indicators of systemic microvascular alterations in patients with type 2 diabetes mellitus, particularly in the early stages of combined renal and ocular involvement. This section expands on the diagnostic relevance of structural and perfusion-related retinal parameters obtained through advanced imaging techniques. Quantitative indicators such as capillary density, neural layer thickness, and avascular zone characteristics demonstrate measurable deviations even before clinically apparent complications develop. The analysis confirms that these parameters reflect underlying microcirculatory dysfunction associated with renal impairment. The integration of retinal imaging into clinical assessment provides a non-invasive approach for identifying early pathological changes, improving the accuracy of risk stratification and enabling timely intervention.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776788627810-The_Role_of_Retinal_Biomarkers_in_the_Early_Diagno.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z</dc:creator>
      <dc:creator>Tastanova G. E</dc:creator>
      <dc:creator>Oripov O. U</dc:creator>
      <dc:subject>Type 2 diabetes mellitus</dc:subject>
      <dc:subject>retinal biomarkers</dc:subject>
      <dc:subject>nephroretinal syndrome</dc:subject>
      <dc:subject>OCT</dc:subject>
      <dc:subject>OCT angiography</dc:subject>
      <dc:subject>vessel density</dc:subject>
      <dc:subject>foveal avascular zone</dc:subject>
      <dc:subject>renal function</dc:subject>
      <dc:subject>eGFR</dc:subject>
      <dc:subject>microangiopathy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1301</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 04, pp. 31-45</dc:source>
    </item>
    <item>
      <title>OPTIMIZATION OF LOCAL TREATMENT OF BURN WOUNDS USING ANTIMICROBIAL WOUND COATINGS</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f64dfc2f-4603-4ddb-9ff6-ac855a761134</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f64dfc2f-4603-4ddb-9ff6-ac855a761134</guid>
      <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
      <author>Ruziboev Sanjar Abdusalomovich¹</author>
      <description>This paper provides a comprehensive analytical review of current scientific publications on local wound care in patients with limited burn injuries using modern wound dressings with pronounced antimicrobial activity. It presents current concepts of burn wound formation and progression, considers the importance of microbial contamination and the formation of biofilm structures as factors slowing down regenerative processes, and outlines the key characteristics of an optimal wound dressing. A systematization and comparative evaluation of traditional and new local therapy agents is provided, including silver-ion-based materials, iodine-containing compositions, polyhexamethylene biguanide (PHMB)-based preparations, and coatings based on biopolymers and nanotechnology. A separate analysis is provided of their pharmacodynamic action, clinical effectiveness, and the advantages and potential limitations of their use in the treatment of localized burns. It has been shown that the justified use of new-generation antimicrobial wound dressings promotes the intensification of epithelialization processes, reduces the risk of infectious complications, reduces pain, and improves patients&apos; quality of life.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776176184647-OPTIMIZATION_OF_LOCAL_TREATMENT_OF_BURN_WOUNDS_USI.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ruziboev Sanjar Abdusalomovich¹</dc:creator>
      <dc:creator>Toshnazarova Nafisa Kayumovna²</dc:creator>
      <dc:subject>limited burns</dc:subject>
      <dc:subject>burn skin lesions</dc:subject>
      <dc:subject>local therapy</dc:subject>
      <dc:subject>wound dressings with antimicrobial activity</dc:subject>
      <dc:subject>silver-containing dressings</dc:subject>
      <dc:subject>biofilm structures</dc:subject>
      <dc:subject>epithelialization processes.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1299</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 04, pp. 61-75</dc:source>
    </item>
    <item>
      <title>Physiological Functions of Blood: Oxygen Transport, Homeostasis, and Immune Regulation Mechanisms</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/4a28cc64-bdcf-4ab9-adc6-76364d159b87</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/4a28cc64-bdcf-4ab9-adc6-76364d159b87</guid>
      <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
      <author>Alimova Ozoda Bekmurodovna¹</author>
      <description>Blood is a highly specialized connective tissue that plays a fundamental role in maintaining physiological stability through oxygen transport, regulation of internal balance, and immune defense. This article provides a comprehensive analysis of the key functional mechanisms of blood, emphasizing the coordinated activity of erythrocytes, plasma components, and immune cells. Particular attention is given to the molecular basis of oxygen delivery via hemoglobin, the maintenance of homeostasis through buffering systems and fluid balance, and the complex processes underlying immune surveillance and response. The study integrates biochemical, hematological, and clinical data to evaluate how these functions interact under normal and pathological conditions. Findings demonstrate that the efficiency of blood function is dependent on the integrity of its cellular and molecular components, and disruption of these systems leads to significant physiological imbalance. These insights highlight the central role of blood in sustaining life and underscore its importance in clinical diagnostics and therapeutic interventions. Blood functions as a complex and dynamic biological system that ensures continuous oxygen delivery, internal equilibrium, and protection against harmful agents. This section provides an expanded analysis of the mechanisms through which blood maintains these essential roles at cellular and molecular levels. Special focus is placed on the efficiency of gas exchange processes, the stability of internal biochemical conditions, and the coordinated activity of immune components. Evidence demonstrates that these functions are tightly interconnected, with each system supporting the others to maintain overall physiological balance. Disturbances in any component can lead to systemic dysfunction, emphasizing the importance of integrated regulation. Modern analytical techniques have enhanced understanding of these processes, allowing more precise evaluation of functional capacity and early detection of pathological changes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776175154372-Physiological_Functions_of_Blood__Oxygen_Transport.pdf" type="application/pdf" length="0"/>
      <dc:creator>Alimova Ozoda Bekmurodovna¹</dc:creator>
      <dc:creator>Nilufar Saidmaxmadova²</dc:creator>
      <dc:creator>Pardaqulova Asolat²</dc:creator>
      <dc:creator>Haqberdiyev Ibrohim²</dc:creator>
      <dc:subject>Blood physiology</dc:subject>
      <dc:subject>oxygen transport</dc:subject>
      <dc:subject>hemoglobin</dc:subject>
      <dc:subject>homeostasis</dc:subject>
      <dc:subject>immune regulation</dc:subject>
      <dc:subject>erythrocytes</dc:subject>
      <dc:subject>leukocytes</dc:subject>
      <dc:subject>plasma</dc:subject>
      <dc:subject>acid-base balance</dc:subject>
      <dc:subject>hemostasis.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1297</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>EVIDENCE-BASED OPTIMIZATION OF BURN WOUND TREATMENT WITH ANTIMICROBIAL DRESSINGS</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/4c2121c2-c2f3-4c09-8a36-ae2a81ed2988</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/4c2121c2-c2f3-4c09-8a36-ae2a81ed2988</guid>
      <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
      <author>Ruziboev Sanjar Abdusalomovich¹</author>
      <description>A systematic analysis of contemporary literature is combined with a clinical study involving patients with localized burns, as well as experimental in vitro evaluation of antimicrobial activity. The study examines various types of wound dressings, including silver-based, iodine-containing, polyhexamethylene biguanide (PHMB)-based, biopolymer-based, and nanostructured materials.
The results demonstrate that modern antimicrobial wound dressings significantly reduce healing time, decrease infection rates, minimize pain, and improve patient quality of life. These findings support the integration of advanced wound care technologies into clinical practice and highlight the перспективность дальнейших исследований в области разработки персонализированных и «умных» раневых покрытий.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1776175587558-EVIDENCE_BASED_OPTIMIZATION_OF_BURN_WOUND_TREATMEN.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ruziboev Sanjar Abdusalomovich¹</dc:creator>
      <dc:creator>Toshnazarova Nafisa Kayumovna²</dc:creator>
      <dc:subject>localized burns</dc:subject>
      <dc:subject>burn wounds</dc:subject>
      <dc:subject>antimicrobial dressings</dc:subject>
      <dc:subject>biofilm</dc:subject>
      <dc:subject>wound healing</dc:subject>
      <dc:subject>epithelialization</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1298</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Clinical Features and Early Presentation of Juvenile Parkinsonism</title>
      <link>https://aams-journal.us/journals/neurology/articles/939b725b-cbc1-47b6-ae5e-99f6eee0dbf1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/939b725b-cbc1-47b6-ae5e-99f6eee0dbf1</guid>
      <pubDate>Wed, 08 Apr 2026 00:00:00 GMT</pubDate>
      <author>Tuychiyeva Mohkinur Komilovna¹</author>
      <description>Juvenile Parkinsonism represents a rare subset of movement disorders characterized by the onset of parkinsonian symptoms before the age of 21. This article provides a comprehensive overview of the early clinical features and diagnostic indicators that differentiate juvenile Parkinsonism from adult-onset forms. Emphasis is placed on motor and non-motor manifestations, including bradykinesia, rigidity, tremor, postural instability, and subtle neuropsychiatric and autonomic symptoms. Early recognition is critical for initiating timely interventions, optimizing long-term motor outcomes, and mitigating functional decline. Clinical assessment complemented by genetic testing and neuroimaging facilitates accurate diagnosis, enabling individualized management strategies. This review synthesizes current evidence to delineate characteristic patterns of presentation, progression, and prognostic implications in juvenile populations. Juvenile Parkinsonism (JP) is a rare neurological disorder characterized by the early onset of motor and non-motor symptoms, often manifesting before the age of 21. This article provides a comprehensive overview of the clinical presentation, highlighting the distinct features that differentiate JP from adult-onset Parkinson’s disease. Key early manifestations include bradykinesia, rigidity, postural instability, and subtle tremor, frequently accompanied by psychiatric or cognitive disturbances. The heterogeneity in symptom onset and progression emphasizes the need for heightened clinical vigilance. Advances in neuroimaging, genetic testing, and biomarkers have facilitated earlier recognition, enabling timely interventions that may slow disease progression and improve quality of life. Understanding the spectrum of early signs is essential for accurate diagnosis, appropriate therapeutic planning, and effective patient management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775652782382-Clinical_Features_and_Early_Presentation_of_Juveni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Tuychiyeva Mohkinur Komilovna¹</dc:creator>
      <dc:creator>Hazim Wasim²</dc:creator>
      <dc:subject>Juvenile Parkinsonism</dc:subject>
      <dc:subject>early-onset Parkinson’s disease</dc:subject>
      <dc:subject>parkinsonian symptoms in youth</dc:subject>
      <dc:subject>bradykinesia</dc:subject>
      <dc:subject>rigidity</dc:subject>
      <dc:subject>resting tremor</dc:subject>
      <dc:subject>postural instability</dc:subject>
      <dc:subject>dystonia</dc:subject>
      <dc:subject>gait abnormalities</dc:subject>
      <dc:subject>motor dysfunction</dc:subject>
      <dc:subject>non-motor symptoms</dc:subject>
      <dc:subject>genetic mutations (PARK genes)</dc:subject>
      <dc:subject>dopamine deficiency</dc:subject>
      <dc:subject>basal ganglia dysfunction</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>differential diagnosis</dc:subject>
      <dc:subject>neurodegenerative disorders</dc:subject>
      <dc:subject>levodopa responsiveness</dc:subject>
      <dc:subject>disease progression</dc:subject>
      <dc:subject>pediatric movement disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1295</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Saltatory Conduction Failure and Coordination and Balance Disorders in Multiple Sclerosis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/6b2538bc-e43e-475b-8139-0954b38cf35b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/6b2538bc-e43e-475b-8139-0954b38cf35b</guid>
      <pubDate>Wed, 08 Apr 2026 00:00:00 GMT</pubDate>
      <author>Tuychiyeva Mohkinur Komilovna¹</author>
      <description>Multiple sclerosis (MS) is a chronic demyelinating disease characterized by disruption of nerve impulse transmission, particularly affecting saltatory conduction along myelinated axons. This article explores the relationship between failure of saltatory conduction and the development of coordination and balance disorders in MS patients. The study focuses on how demyelination impairs rapid signal propagation, leading to delayed or blocked neural transmission within motor and sensory pathways. Clinical and neurophysiological data demonstrate that impaired conduction contributes to cerebellar dysfunction, proprioceptive deficits, and vestibular imbalance. The findings highlight that disruption of efficient neural signaling is a primary mechanism underlying motor incoordination, postural instability, and gait disturbances in MS. Advances in diagnostic tools and rehabilitation strategies offer new possibilities for improving functional outcomes and quality of life in affected individuals.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775652171425-Saltatory_Conduction_Failure_and_Coordination_and_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Tuychiyeva Mohkinur Komilovna¹</dc:creator>
      <dc:creator>Danish Ali²</dc:creator>
      <dc:creator>Aman Kumar³</dc:creator>
      <dc:subject>Multiple sclerosis</dc:subject>
      <dc:subject>saltatory conduction</dc:subject>
      <dc:subject>demyelination</dc:subject>
      <dc:subject>coordination disorders</dc:subject>
      <dc:subject>balance impairment</dc:subject>
      <dc:subject>ataxia</dc:subject>
      <dc:subject>neural transmission</dc:subject>
      <dc:subject>myelin sheath</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:subject>rehabilitation.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1294</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 04, pp. 46-60</dc:source>
    </item>
    <item>
      <title>Ectopic Pregnancy: Advances in Early Diagnosis and Fertility-Preserving Treatment</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/5aabbeea-b6c2-41be-8b8e-141cecd88f03</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/5aabbeea-b6c2-41be-8b8e-141cecd88f03</guid>
      <pubDate>Wed, 08 Apr 2026 00:00:00 GMT</pubDate>
      <author>Adaikkalasamy Joselin rexy</author>
      <description>Ectopic pregnancy remains a significant cause of maternal morbidity and early pregnancy loss, requiring timely diagnosis and effective management to prevent life-threatening complications and preserve reproductive potential. This article examines recent advances in early diagnostic approaches and fertility-preserving treatment strategies. Emphasis is placed on the integration of sensitive biochemical markers, high-resolution imaging techniques, and minimally invasive therapeutic options. The study evaluates clinical outcomes associated with early detection using serum β-human chorionic gonadotropin (β-hCG) monitoring and transvaginal ultrasonography, alongside conservative management approaches such as methotrexate therapy and laparoscopic surgery. Findings demonstrate that early identification significantly reduces complications, improves treatment success rates, and enhances future fertility outcomes. The results highlight the importance of individualized treatment selection based on clinical presentation and reproductive goals, supporting a shift toward less invasive and fertility-sparing interventions in modern gynecological practice. Ectopic gestation continues to pose a serious challenge in reproductive health due to its potential for rapid clinical deterioration and its impact on future fertility. Contemporary progress in diagnostic precision and therapeutic strategies has significantly transformed patient outcomes. This section provides an in-depth evaluation of modern approaches that facilitate earlier recognition through highly sensitive hormonal assays and advanced imaging modalities. Special attention is given to conservative management techniques that aim to resolve патологic implantation while preserving reproductive function. Evidence indicates that prompt identification combined with tailored treatment selection reduces complication rates, shortens recovery time, and improves the likelihood of subsequent intrauterine pregnancies. These developments reflect a shift toward individualized, less invasive care models in gynecological practice.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775651672664-Ectopic_Pregnancy__Advances_in_Early_Diagnosis_and.pdf" type="application/pdf" length="0"/>
      <dc:creator>Adaikkalasamy Joselin rexy</dc:creator>
      <dc:creator>James raja jesika</dc:creator>
      <dc:creator>Ramukkumar gowri</dc:creator>
      <dc:creator>Ramanathan santhiya</dc:creator>
      <dc:subject>Ectopic pregnancy</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>β-hCG</dc:subject>
      <dc:subject>transvaginal ultrasound</dc:subject>
      <dc:subject>methotrexate</dc:subject>
      <dc:subject>laparoscopy</dc:subject>
      <dc:subject>fertility preservation</dc:subject>
      <dc:subject>tubal pregnancy</dc:subject>
      <dc:subject>reproductive health</dc:subject>
      <dc:subject>minimally invasive treatment.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1293</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 04, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Neurophysiological Basis of Fine Motor Control and Its Influence on Speech Acquisition in Children</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/b8bac21c-384d-48e3-9c7d-7b51947d53e0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/b8bac21c-384d-48e3-9c7d-7b51947d53e0</guid>
      <pubDate>Wed, 08 Apr 2026 00:00:00 GMT</pubDate>
      <author>Tuychiyeva Mohkinur Komilovna</author>
      <description>Fine motor control represents a fundamental component of neurodevelopment, closely linked with the maturation of cortical and subcortical structures responsible for precise movement regulation. This article examines the neurophysiological mechanisms underlying fine motor coordination and their influence on the development of speech in children. Special attention is given to the interaction between motor cortex activity, cerebellar modulation, and sensorimotor integration processes that support both manual dexterity and articulatory function. The study analyzes developmental patterns, neurophysiological data, and clinical observations to identify correlations between fine motor skills and language acquisition. Findings demonstrate that children with well-developed fine motor abilities tend to exhibit more advanced speech development, while deficits in motor coordination are often associated with delayed or impaired articulation and phonological processing. These results emphasize the interconnected nature of motor and speech systems and highlight the importance of early intervention strategies targeting motor development to support language outcomes. Fine motor coordination is a critical component of early neurodevelopment, closely associated with the maturation of neural circuits responsible for both movement precision and speech production. This section explores the neurophysiological relationship between manual dexterity and the acquisition of language skills in children. It highlights the role of cortical and subcortical structures in integrating sensory input with motor output, forming the basis for both hand movements and articulatory processes. Evidence suggests that efficient development of fine motor abilities supports the establishment of stable speech patterns, while delays in motor coordination are frequently linked with articulation difficulties and reduced phonological complexity. The findings underline the importance of early developmental assessment and the integration of motor-based interventions in supporting language development.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775652983264-Neurophysiological_Basis_of_Fine_Motor_Control_and.pdf" type="application/pdf" length="0"/>
      <dc:creator>Tuychiyeva Mohkinur Komilovna</dc:creator>
      <dc:subject>Fine motor control</dc:subject>
      <dc:subject>speech acquisition</dc:subject>
      <dc:subject>neurophysiology</dc:subject>
      <dc:subject>motor cortex</dc:subject>
      <dc:subject>cerebellum</dc:subject>
      <dc:subject>sensorimotor integration</dc:subject>
      <dc:subject>child development</dc:subject>
      <dc:subject>articulation</dc:subject>
      <dc:subject>language development</dc:subject>
      <dc:subject>neural plasticity.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1296</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Modern Approaches to the Management of Dental Caries: Prevention, Diagnosis, and Minimally Invasive Treatment</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/5fc04195-3df1-4a46-a42a-62e86138593c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/5fc04195-3df1-4a46-a42a-62e86138593c</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <author>Marupova Madina Khikmatuloyevna¹; Naimov Parviz²; Sayqonov Ulugbek³; Kenjayev Jonruz⁴;</author>
      <description>Dental caries remains one of the most prevalent chronic diseases worldwide, affecting individuals across all age groups. Contemporary management strategies have shifted from purely restorative approaches toward prevention, early detection, and minimally invasive interventions. This study evaluates modern concepts in caries management, including risk assessment, advanced diagnostic technologies, and conservative treatment methods aimed at preserving tooth structure. Clinical outcomes demonstrate that integrating preventive measures with early diagnosis significantly reduces disease progression and the need for extensive restorative procedures. Minimally invasive techniques, supported by bioactive materials, enhance remineralization and improve long-term oral health outcomes. These findings emphasize the importance of a patient-centered, evidence-based approach in modern dentistry. Contemporary strategies in dental caries control emphasize a shift toward proactive care focused on risk modification, early lesion identification, and preservation of hard tissues. Advances in preventive protocols, diagnostic technologies, and conservative therapeutic techniques have transformed clinical practice. This analysis highlights the effectiveness of integrated approaches combining individualized prevention plans with minimally invasive interventions. The findings demonstrate that early-stage management significantly limits lesion progression, reduces the need for extensive restorative procedures, and supports long-term maintenance of tooth integrity. The application of modern materials and evidence-based protocols enhances treatment predictability and overall oral health outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775575335418-Modern_Approaches_to_the_Management_of_Dental_Cari.pdf" type="application/pdf" length="0"/>
      <dc:creator>Marupova Madina Khikmatuloyevna¹; Naimov Parviz²; Sayqonov Ulugbek³; Kenjayev Jonruz⁴;</dc:creator>
      <dc:subject>dental caries</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>remineralization</dc:subject>
      <dc:subject>caries risk assessment</dc:subject>
      <dc:subject>fluoride therapy</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>conservative treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1288</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Diagnosis and Management of Non-Carious Lesions in Therapeutic Dentistry: Clinical and Preventive Perspectives</title>
      <link>https://aams-journal.us/journals/dentistry/articles/019aaac7-381c-4399-95f9-34bbced6b242</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/019aaac7-381c-4399-95f9-34bbced6b242</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <author>Scientific advisor Akhmedova Gulmira Aminovna Begimova Farangiz Anvarovna</author>
      <description>Non-carious lesions of dental hard tissues represent a significant clinical challenge in modern therapeutic dentistry due to their multifactorial etiology and potential for progressive structural damage. These lesions, including attrition, abrasion, erosion, and abfraction, can compromise esthetics, function, and overall oral health. This comprehensive study analyzes current diagnostic approaches, preventive strategies, and management techniques aimed at early detection, preservation of tooth structure, and restoration of function. Emphasis is placed on individualized treatment planning, incorporating both minimally invasive restorative procedures and lifestyle modifications to reduce lesion progression. The findings highlight the effectiveness of a combined preventive and therapeutic approach in optimizing long-term dental health outcomes. Non-carious lesions (NCLs) of teeth, encompassing attrition, abrasion, erosion, and abfraction, have increasingly been recognized as significant contributors to dental morbidity. Unlike carious lesions, NCLs arise from mechanical, chemical, or biomechanical stressors, leading to progressive loss of enamel and dentin without microbial involvement. Attrition develops as a result of physiological or parafunctional occlusal forces, while abrasion occurs due to improper oral hygiene practices or external mechanical insult. Erosion results from exposure to acidic agents, either intrinsic, such as gastric acid in reflux conditions, or extrinsic, such as dietary acids. Abfraction lesions are caused by stress-induced microfractures in the cervical region, resulting from occlusal load distribution. The cumulative effect of these processes can result in hypersensitivity, compromised esthetics, reduced masticatory efficiency, and increased susceptibility to pulpal pathology. Early identification and precise characterization of lesion type and etiology are essential for designing appropriate management strategies. Minimally invasive restorative interventions combined with preventive measures have emerged as the standard for preserving dental integrity while enhancing functional and aesthetic outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775579567149-Diagnosis_and_Management_of_Non_Carious_Lesions_in.pdf" type="application/pdf" length="0"/>
      <dc:creator>Scientific advisor Akhmedova Gulmira Aminovna Begimova Farangiz Anvarovna</dc:creator>
      <dc:subject>Non-carious lesions</dc:subject>
      <dc:subject>attrition</dc:subject>
      <dc:subject>abrasion</dc:subject>
      <dc:subject>erosion</dc:subject>
      <dc:subject>abfraction</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>preventive dentistry</dc:subject>
      <dc:subject>minimally invasive therapy</dc:subject>
      <dc:subject>tooth structure preservation</dc:subject>
      <dc:subject>clinical management</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1292</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>The Role of the Cerebellum in Motor Coordination</title>
      <link>https://aams-journal.us/journals/neurology/articles/7a4d282d-f682-4a69-9b51-a24f8149cab9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/7a4d282d-f682-4a69-9b51-a24f8149cab9</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <author>Ismatova Marguba Shaukatovna¹; Xayrullayev Muso²; Tursunmurodov Abdushukur³;</author>
      <description>ensuring precision, timing, and balance of voluntary and involuntary movements. This article explores the structural and functional significance of the cerebellum in integrating sensory input with motor output, as well as its contribution to motor learning and adaptive control. The study analyzes clinical, neurophysiological, and imaging data to assess cerebellar involvement in coordinated movement. Findings demonstrate that the cerebellum is essential for error correction, synchronization of muscle activity, and maintenance of posture and equilibrium. Damage to cerebellar structures leads to ataxia, dysmetria, and impaired motor learning, confirming its critical regulatory function. The results emphasize the importance of cerebellar pathways in maintaining smooth and efficient motor performance and highlight new therapeutic perspectives for rehabilitation in cerebellar disorders. The cerebellum is a key neural structure responsible for the fine regulation of motor activity, enabling precision, coordination, and stability of movement. Its function extends beyond simple motor execution to include predictive control, sensory integration, and adaptive modification of motor patterns. This section examines the cerebellum’s involvement in coordinating voluntary and reflex movements through continuous feedback and feedforward mechanisms. Evidence indicates that the cerebellum integrates proprioceptive, vestibular, and cortical inputs to optimize motor output and ensure smooth execution. Disruption of cerebellar circuits results in characteristic impairments such as incoordination, imbalance, and decreased movement accuracy. The analysis highlights the cerebellum’s essential role in maintaining dynamic motor control and emphasizes its importance in both normal physiology and pathological conditions affecting movement regulation.</description>
      <dc:creator>Ismatova Marguba Shaukatovna¹; Xayrullayev Muso²; Tursunmurodov Abdushukur³;</dc:creator>
      <dc:subject>Cerebellum</dc:subject>
      <dc:subject>motor coordination</dc:subject>
      <dc:subject>balance</dc:subject>
      <dc:subject>motor control</dc:subject>
      <dc:subject>ataxia</dc:subject>
      <dc:subject>proprioception</dc:subject>
      <dc:subject>motor learning</dc:subject>
      <dc:subject>neural pathways</dc:subject>
      <dc:subject>equilibrium</dc:subject>
      <dc:subject>neurophysiology.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1291</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Changes in the Endocrine System of Children Born to Mothers with Thyroid Diseases</title>
      <link>https://aams-journal.us/journals/neurology/articles/47e5ae1e-2829-4ef8-9fbf-688811605efe</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/47e5ae1e-2829-4ef8-9fbf-688811605efe</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <author>Togayeva Gulnora Siddikovna</author>
      <description>Maternal thyroid disorders during pregnancy represent a critical factor influencing fetal development and long-term endocrine function in offspring. Thyroid hormones play a fundamental role in neurodevelopment, metabolism, and maturation of endocrine organs, particularly during intrauterine life. This study investigates the structural and functional changes in the endocrine system of children born to mothers diagnosed with hypothyroidism, hyperthyroidism, or autoimmune thyroid conditions. The findings indicate that maternal thyroid dysfunction leads to alterations in neonatal thyroid function, dysregulation of the hypothalamic–pituitary–thyroid axis, and increased susceptibility to metabolic and hormonal imbalances later in life. Children exposed to abnormal maternal thyroid hormone levels demonstrated variations in growth patterns, delayed endocrine adaptation, and higher risk of developing subclinical thyroid dysfunction. The results emphasize the importance of early screening, monitoring, and timely management of maternal thyroid diseases to prevent adverse endocrine outcomes in offspring. Maternal thyroid pathology during gestation exerts a substantial influence on the hormonal regulation and developmental trajectory of the offspring’s endocrine system. Thyroid hormones are indispensable for fetal organ maturation, especially for the central nervous and endocrine systems, and any imbalance during pregnancy may lead to persistent physiological alterations. This study examines the functional state of endocrine organs in children born to mothers with thyroid dysfunction, focusing on hormonal profiles, growth dynamics, and metabolic adaptation. The findings demonstrate that prenatal exposure to abnormal maternal thyroid hormone levels is associated with disturbances in neonatal thyroid activity, delayed establishment of endocrine homeostasis, and increased vulnerability to metabolic irregularities in early childhood. Furthermore, immune-mediated mechanisms contribute to prolonged endocrine instability in certain cases. The data highlight the necessity of comprehensive prenatal monitoring and early-life endocrine evaluation to reduce the risk of long-term complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775576335673-Changes_in_the_Endocrine_System_of_Children_Born_t.pdf" type="application/pdf" length="0"/>
      <dc:creator>Togayeva Gulnora Siddikovna</dc:creator>
      <dc:subject>Maternal thyroid disease</dc:subject>
      <dc:subject>hypothyroidism</dc:subject>
      <dc:subject>hyperthyroidism</dc:subject>
      <dc:subject>neonatal endocrine system</dc:subject>
      <dc:subject>thyroid hormones</dc:subject>
      <dc:subject>fetal development</dc:subject>
      <dc:subject>hypothalamic–pituitary–thyroid axis</dc:subject>
      <dc:subject>endocrine disorders</dc:subject>
      <dc:subject>neonatal adaptation</dc:subject>
      <dc:subject>metabolism.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1290</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Clinical Effectiveness of Bioactive Materials in Restorative Dentistry and Pulp Therapy</title>
      <link>https://aams-journal.us/journals/dentistry/articles/a73db40c-7fcb-4d0a-9ef5-74201ca554fe</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/a73db40c-7fcb-4d0a-9ef5-74201ca554fe</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <author>Marupova Madina Khikmatuloyevna¹; Norsafarova Maftuna²; Raimqulov Jahongir³; Toshtemirov Javohir⁴;</author>
      <description>Bioactive materials have significantly transformed restorative dentistry and pulp therapy by promoting biological repair and enhancing the longevity of dental treatments. Unlike conventional inert materials, these substances interact with dental tissues, stimulating remineralization and supporting pulp vitality. This study evaluates the clinical effectiveness of bioactive compounds in restorative procedures and vital pulp therapy, focusing on their sealing ability, biocompatibility, and regenerative potential. Clinical and radiographic findings demonstrate that these materials improve treatment outcomes by reducing microleakage, enhancing tissue response, and increasing the success rate of pulp preservation procedures. The integration of bioactive technologies into routine dental practice represents a major advancement in minimally invasive and biologically oriented care. The application of bioactive materials in restorative dentistry and pulp therapy has introduced a biologically driven approach focused on regeneration and preservation rather than simple replacement of damaged tissues. These materials actively participate in physiological processes by releasing ions, promoting mineral deposition, and enhancing the natural defense mechanisms of dental structures. This analysis explores their clinical performance in maintaining pulp vitality, improving sealing properties, and supporting long-term stability of restorations. The findings indicate that their use leads to reduced postoperative complications, enhanced tissue response, and increased success rates in conservative dental procedures.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775574703569-Clinical_Effectiveness_of_Bioactive_Materials_in_R.pdf" type="application/pdf" length="0"/>
      <dc:creator>Marupova Madina Khikmatuloyevna¹; Norsafarova Maftuna²; Raimqulov Jahongir³; Toshtemirov Javohir⁴;</dc:creator>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:subject>pulp therapy</dc:subject>
      <dc:subject>remineralization</dc:subject>
      <dc:subject>MTA</dc:subject>
      <dc:subject>calcium silicate</dc:subject>
      <dc:subject>dentin regeneration</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>dental biomaterials</dc:subject>
      <dc:subject>pulp preservation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1287</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 04, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Changes in the Reproductive System Due to Increased Body Mass</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/7860c401-a6a8-4376-b2dc-1deca2ad5e60</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/7860c401-a6a8-4376-b2dc-1deca2ad5e60</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <author>Togayeva Gulnora Siddikovna</author>
      <description>Increased body mass, particularly in the context of overweight and obesity, has emerged as a significant factor influencing reproductive health in both males and females. Excess adipose tissue contributes to endocrine imbalance, metabolic dysfunction, and chronic low-grade inflammation, all of which adversely affect reproductive function. This study evaluates the structural, hormonal, and functional changes occurring in the reproductive system associated with elevated body mass index (BMI). The findings demonstrate that obesity disrupts hypothalamic–pituitary–gonadal axis regulation, impairs gametogenesis, alters menstrual cycles, and reduces fertility rates. Additionally, it increases the risk of pregnancy complications and reproductive disorders such as polycystic ovary syndrome and hypogonadism. The results highlight the importance of early intervention, weight management, and individualized therapeutic strategies in preserving reproductive health and improving clinical outcomes. Excess body weight exerts a profound influence on reproductive physiology through complex interactions involving endocrine signaling, metabolic regulation, and inflammatory pathways. Adipose tissue functions as an active hormonal organ, producing biologically active substances that interfere with normal reproductive mechanisms. This paper explores how elevated body mass contributes to disturbances in gonadal function, alters hormone synthesis and secretion, and compromises fertility potential in both sexes. Particular attention is given to disruptions in ovulatory cycles, changes in endometrial receptivity, and deterioration of sperm parameters. The analysis demonstrates that increased adiposity is strongly associated with reduced reproductive efficiency, higher incidence of infertility, and elevated risk of complications during conception and gestation. These findings underline the clinical importance of addressing body weight as a modifiable determinant of reproductive health.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775575985034-Changes_in_the_Reproductive_System_Due_to_Increase.pdf" type="application/pdf" length="0"/>
      <dc:creator>Togayeva Gulnora Siddikovna</dc:creator>
      <dc:subject>Obesity</dc:subject>
      <dc:subject>body mass index</dc:subject>
      <dc:subject>reproductive system</dc:subject>
      <dc:subject>infertility</dc:subject>
      <dc:subject>hormonal imbalance</dc:subject>
      <dc:subject>polycystic ovary syndrome</dc:subject>
      <dc:subject>hypogonadism</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>fertility</dc:subject>
      <dc:subject>endocrine disruption.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1289</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 04, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Investments in the Medical Sector and Their Economic Significance</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/d2c798ab-638e-469d-abba-0938cc2e4467</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/d2c798ab-638e-469d-abba-0938cc2e4467</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      <author>Komilova Mukarram Kobiljonovna¹; Almamatov Sanjar²;</author>
      <description>Investment in the medical sector represents a critical driver of economic development, social stability, and population well-being. This article examines the structural, financial, and macroeconomic dimensions of healthcare investments, emphasizing their role in improving productivity, extending life expectancy, and reducing long-term public expenditure. The study analyzes capital allocation in infrastructure, medical technologies, pharmaceuticals, and human resources, highlighting the multiplier effect of health-related spending on national economies. Findings indicate that strategic investment not only enhances healthcare accessibility and quality but also stimulates innovation, employment, and sustainable growth. The integration of public and private funding models further strengthens system resilience and efficiency. Capital allocation to healthcare systems exerts a profound influence on both social welfare and macroeconomic stability. This expanded analysis explores how financial inputs into medical infrastructure, workforce development, technological innovation, and preventive services translate into measurable economic gains. Particular attention is given to efficiency, return on investment, and long-term fiscal impact. Evidence suggests that well-directed funding improves health outcomes, strengthens labor markets, and reduces indirect economic losses associated with morbidity and mortality. The synthesis underscores that strategic, sustained investment enhances resilience of health systems while contributing to inclusive and sustainable economic progress.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775139068116-Investments_in_the_Medical_Sector_and_Their_Econom.pdf" type="application/pdf" length="0"/>
      <dc:creator>Komilova Mukarram Kobiljonovna¹; Almamatov Sanjar²;</dc:creator>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1282</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 76-90</dc:source>
    </item>
    <item>
      <title>Advances in the Diagnosis and Treatment of Pulpitis in Therapeutic Dentistry</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/c3f68fea-c863-46eb-b0cc-183a27e22b52</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/c3f68fea-c863-46eb-b0cc-183a27e22b52</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      <author>Sodiqova Shoira Amriddinovna¹; Xayitboyev Izzatbek²; Otaboyev Ogabek³ Oserova Lazzat⁴;</author>
      <description>Recent developments in therapeutic dentistry have significantly improved the diagnostic accuracy and treatment outcomes of pulpitis, a common inflammatory condition of the dental pulp. The integration of advanced imaging techniques, molecular biomarkers, and minimally invasive interventions allows clinicians to identify early-stage inflammation and implement precise, targeted therapies. Conservative management strategies combining chemical disinfection, biocompatible restorative materials, and controlled pulp capping have demonstrated enhanced preservation of pulp vitality and structural integrity. The current analysis emphasizes how these approaches reduce the risk of complications, improve long-term tooth survival, and optimize patient-centered care by minimizing procedural discomfort and promoting faster recovery. This study investigates contemporary strategies in diagnosing and managing pulpitis within therapeutic dentistry, emphasizing the impact of early intervention on treatment outcomes. Utilizing advanced diagnostic modalities and minimally invasive techniques, the analysis highlights the ability to preserve pulp vitality while effectively controlling infection and inflammation. The results demonstrate that combining regenerative materials, targeted disinfection protocols, and selective pulp therapy promotes optimal healing, reduces postoperative complications, and improves long-term tooth function. Emphasis is placed on integrating clinical evaluation with modern biomaterials and procedural strategies to achieve patient-centered, biologically oriented care, illustrating a shift from conventional extensive pulp extirpation toward conservative, function-preserving approaches.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775149965682-Advances_in_the_Diagnosis_and_Treatment_of_Pulpiti.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sodiqova Shoira Amriddinovna¹; Xayitboyev Izzatbek²; Otaboyev Ogabek³ Oserova Lazzat⁴;</dc:creator>
      <dc:subject>Pulpitis</dc:subject>
      <dc:subject>dental pulp inflammation</dc:subject>
      <dc:subject>biomarker diagnostics</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>selective pulpotomy</dc:subject>
      <dc:subject>restorative therapy</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>endodontic management</dc:subject>
      <dc:subject>pulp vitality preservation</dc:subject>
      <dc:subject>dental imaging.</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1284</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 91-105</dc:source>
    </item>
    <item>
      <title>Clinical Management of Periodontal Diseases: Modern Preventive and Therapeutic Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/7ce83aaa-1d82-42f9-abed-7de8f3a9346f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/7ce83aaa-1d82-42f9-abed-7de8f3a9346f</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      <author>Sodiqova Shoira Amriddinovna¹; Mustafaqulov Zafarbek²; Boronov Behruz³; Abdukarimova Marjona⁴</author>
      <description>Periodontal diseases are among the most prevalent chronic inflammatory conditions affecting the supporting structures of the teeth, leading to progressive attachment loss and potential tooth loss if untreated. Contemporary clinical management has evolved toward a comprehensive approach that integrates prevention, early diagnosis, and advanced therapeutic interventions. This study evaluates modern strategies in periodontal care, focusing on risk assessment, biofilm control, non-surgical and surgical therapies, and host modulation. Clinical outcomes demonstrate that combining preventive measures with targeted treatment significantly reduces disease progression, improves periodontal stability, and enhances patient quality of life. The findings highlight the importance of individualized, evidence-based approaches in achieving long-term success in periodontal therapy. Current strategies for managing periodontal pathology are increasingly oriented toward comprehensive care that integrates prevention, early identification, and advanced therapeutic interventions. The use of modern diagnostic criteria and risk-based planning allows clinicians to control inflammatory processes more effectively and prevent irreversible tissue damage. This analysis highlights the clinical impact of combining mechanical debridement with adjunctive methods such as antimicrobial support and host-response regulation. Outcomes indicate that such an integrated approach leads to significant reduction in inflammation, stabilization of periodontal structures, and improved long-term maintenance of oral health.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775149407692-Clinical_Management_of_Periodontal_Diseases__Moder.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sodiqova Shoira Amriddinovna¹; Mustafaqulov Zafarbek²; Boronov Behruz³; Abdukarimova Marjona⁴</dc:creator>
      <dc:subject>periodontal disease</dc:subject>
      <dc:subject>gingivitis</dc:subject>
      <dc:subject>periodontitis</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>scaling and root planing</dc:subject>
      <dc:subject>biofilm control</dc:subject>
      <dc:subject>host modulation</dc:subject>
      <dc:subject>regenerative therapy</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>periodontal treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1283</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 03, pp. 46-60</dc:source>
    </item>
    <item>
      <title>The Role of the Autonomic Nervous System in the Development of Hypertension: New Approaches to Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/d73b304f-c1af-475e-b946-89b25566e9f7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/d73b304f-c1af-475e-b946-89b25566e9f7</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      <author>Shukurova Dilorom Baxodirovna¹; Djalolova Shahnoza Amonovna²;</author>
      <description>Hypertension remains one of the most prevalent chronic conditions worldwide and a leading risk factor for cardiovascular morbidity and mortality. Increasing evidence highlights the central role of the autonomic nervous system in the initiation and progression of elevated blood pressure. Dysregulation of sympathetic and parasympathetic activity contributes to vascular tone imbalance, cardiac output alterations, and impaired baroreflex sensitivity. This article provides a comprehensive analysis of the mechanisms through which autonomic dysfunction influences the development of hypertension and evaluates emerging therapeutic strategies targeting neural pathways. Particular emphasis is placed on novel pharmacological agents, device-based interventions such as renal denervation, and lifestyle modifications that modulate autonomic balance. The findings suggest that targeting autonomic regulation offers promising перспективы for improving blood pressure control and reducing cardiovascular risk. Hypertension is a complex cardiovascular disorder in which neural regulatory mechanisms play a decisive role in both initiation and progression. Increasing attention has been directed toward the contribution of autonomic imbalance, particularly excessive sympathetic activation and insufficient parasympathetic modulation, in maintaining elevated arterial pressure. This expanded analysis explores how alterations in neural control affect vascular resistance, cardiac performance, renal function, and hormonal regulation. It also highlights innovative therapeutic strategies aimed at correcting these disturbances, including neuromodulation techniques, advanced pharmacological agents, and integrative lifestyle interventions. The presented evidence indicates that addressing neural dysregulation provides an effective pathway for improving blood pressure stability and minimizing long-term cardiovascular complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775150576695-The_Role_of_the_Autonomic_Nervous_System_in_the_De.pdf" type="application/pdf" length="0"/>
      <dc:creator>Shukurova Dilorom Baxodirovna¹; Djalolova Shahnoza Amonovna²;</dc:creator>
      <dc:subject>autonomic nervous system</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>sympathetic activity</dc:subject>
      <dc:subject>parasympathetic regulation</dc:subject>
      <dc:subject>baroreflex</dc:subject>
      <dc:subject>renal denervation</dc:subject>
      <dc:subject>neurogenic hypertension</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:subject>therapeutic approaches</dc:subject>
      <dc:subject>neuromodulation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1286</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 03, pp. 46-60</dc:source>
    </item>
    <item>
      <title>Comparative Analysis of Red Blood Parameters in Vegetarians and People with a Mixed Diet</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/d1b56809-d8ba-4456-bbaa-f320dd8e8b9c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/d1b56809-d8ba-4456-bbaa-f320dd8e8b9c</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      <author>Shukurova Dilorom Baxodirovna¹; Djalolova Shahnoza Amonovna²;</author>
      <description>Dietary patterns significantly influence hematological status, particularly parameters related to red blood cells that reflect oxygen transport capacity and overall metabolic health. This study provides an expanded comparative evaluation of erythrocyte indices in individuals adhering to vegetarian diets versus those consuming mixed diets including animal products. Emphasis is placed on hemoglobin concentration, hematocrit levels, red blood cell count, mean corpuscular volume, and iron-related biomarkers. The findings indicate that while vegetarian diets can support adequate hematological status when properly balanced, differences in micronutrient intake—especially iron, vitamin B12, and folate—may affect specific blood parameters. The analysis highlights the importance of dietary planning and monitoring to prevent subclinical deficiencies and maintain optimal physiological function. Dietary patterns exert a direct influence on hematological health, particularly on erythrocyte-related indicators that reflect oxygen transport efficiency and metabolic balance. This expanded overview examines variations in red blood indices among individuals adhering to plant-based nutrition compared to those consuming diets inclusive of animal-derived products. Special attention is given to hemoglobin concentration, erythrocyte count, hematocrit, and indices such as mean corpuscular volume and hemoglobin content. Evidence demonstrates that although plant-based nutrition can sustain adequate hematological function, differences in micronutrient intake—especially iron and cobalamin—may lead to subtle shifts in laboratory values. The findings emphasize the importance of balanced nutrient intake and regular monitoring to ensure physiological stability and prevent latent deficiencies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775150261540-Comparative_Analysis_of_Red_Blood_Parameters_in_Ve.pdf" type="application/pdf" length="0"/>
      <dc:creator>Shukurova Dilorom Baxodirovna¹; Djalolova Shahnoza Amonovna²;</dc:creator>
      <dc:subject>vegetarian diet</dc:subject>
      <dc:subject>mixed diet</dc:subject>
      <dc:subject>red blood cells</dc:subject>
      <dc:subject>hemoglobin</dc:subject>
      <dc:subject>hematocrit</dc:subject>
      <dc:subject>iron deficiency</dc:subject>
      <dc:subject>vitamin B12</dc:subject>
      <dc:subject>erythrocyte indices</dc:subject>
      <dc:subject>nutrition</dc:subject>
      <dc:subject>hematology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1285</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 106-120</dc:source>
    </item>
    <item>
      <title>Age-Related Histological Changes in the Eyeball: Structural Alterations and Their Functional Implications</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/f9f93864-f992-4933-94cf-2025b67666bc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/f9f93864-f992-4933-94cf-2025b67666bc</guid>
      <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
      <author>Djurakulov Bunyodjon Iskandarovich¹; Abdurashidova Nigina Behzodovna²;</author>
      <description>Age-related transformations in ocular tissues represent a complex interplay of degenerative, adaptive, and compensatory processes that significantly influence visual function. This study examines histological alterations in key structures of the eyeball, including the cornea, lens, retina, sclera, and choroid, with emphasis on their functional consequences. Progressive changes such as collagen cross-linking, cellular atrophy, reduced vascular density, and accumulation of metabolic byproducts contribute to diminished tissue elasticity, impaired transparency, and decreased regenerative capacity. The findings demonstrate that these structural modifications are closely associated with declines in visual acuity, contrast sensitivity, and accommodation. Understanding these changes provides a foundation for early detection and targeted intervention in age-related ocular disorders. Age-associated modifications in ocular microstructure represent a progressive continuum of cellular, biochemical, and extracellular alterations that collectively influence visual performance. This analysis focuses on detailed morphological transformations occurring within the cornea, lens, retina, and vascular layers, emphasizing their direct relationship with declining physiological function. Gradual reduction in cellular density, accumulation of metabolic residues, and changes in collagen architecture contribute to diminished optical clarity and reduced adaptability of ocular tissues. The study demonstrates that these histological shifts are strongly linked with decreased visual acuity, impaired contrast perception, and slower photoreceptor responsiveness. Understanding these structural dynamics is essential for improving early recognition of degenerative changes and guiding preventive ophthalmic care.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775018288234-Age_Related_Histological_Changes_in_the_Eyeball__S.pdf" type="application/pdf" length="0"/>
      <dc:creator>Djurakulov Bunyodjon Iskandarovich¹; Abdurashidova Nigina Behzodovna²;</dc:creator>
      <dc:subject>aging eye</dc:subject>
      <dc:subject>histological changes</dc:subject>
      <dc:subject>retina degeneration</dc:subject>
      <dc:subject>lens sclerosis</dc:subject>
      <dc:subject>corneal aging</dc:subject>
      <dc:subject>choroidal circulation</dc:subject>
      <dc:subject>ocular aging</dc:subject>
      <dc:subject>visual function</dc:subject>
      <dc:subject>structural alterations</dc:subject>
      <dc:subject>ophthalmic pathology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1280</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 91-105</dc:source>
    </item>
    <item>
      <title>Clinical and Pathogenetic Mechanisms of the Formation of Postoperative Facial Scars: Modern Concepts and Prospects for Personalized Correction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/db6304bc-1a71-430c-93a8-be818279e628</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/db6304bc-1a71-430c-93a8-be818279e628</guid>
      <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
      <author>YUSUPOVA D.Z¹</author>
      <description>Postoperative facial scar formation represents a complex biological process involving inflammatory, proliferative, and remodeling phases that are regulated by cellular, molecular, and biomechanical factors. This study explores contemporary understanding of the pathogenetic mechanisms underlying scar development, with particular emphasis on fibroblast activity, extracellular matrix deposition, cytokine signaling, and genetic predisposition. Special attention is given to hypertrophic and keloid scar formation as pathological outcomes of dysregulated healing. The findings demonstrate that individualized approaches integrating molecular diagnostics, advanced therapeutic technologies, and patient-specific risk assessment significantly improve aesthetic and functional outcomes. Personalized correction strategies, including targeted pharmacotherapy, laser interventions, and regenerative techniques, show promising potential in optimizing postoperative recovery and minimizing adverse scarring. The development of facial scars following surgical intervention is governed by a multifaceted cascade of biological events involving immune activation, fibroproliferative responses, and extracellular matrix remodeling. This work provides an expanded analysis of the clinical and pathogenetic factors that influence scar quality, with particular focus on molecular signaling pathways, cellular interactions, and biomechanical stress. Special consideration is given to variability in healing patterns among individuals, highlighting the importance of risk stratification and targeted therapeutic planning. Evidence indicates that integration of advanced diagnostic tools with individualized correction strategies significantly enhances tissue regeneration, minimizes fibrotic overgrowth, and improves both functional and aesthetic outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1775036246490-Clinical_and_Pathogenetic_Mechanisms_of_the_Format.pdf" type="application/pdf" length="0"/>
      <dc:creator>YUSUPOVA D.Z¹</dc:creator>
      <dc:creator>ABDULLAEV Sh.Y²;</dc:creator>
      <dc:subject>postoperative scars</dc:subject>
      <dc:subject>facial surgery</dc:subject>
      <dc:subject>wound healing</dc:subject>
      <dc:subject>fibroblasts</dc:subject>
      <dc:subject>collagen synthesis</dc:subject>
      <dc:subject>hypertrophic scars</dc:subject>
      <dc:subject>keloids</dc:subject>
      <dc:subject>cytokines</dc:subject>
      <dc:subject>personalized therapy</dc:subject>
      <dc:subject>regenerative medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1281</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 03, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Modern Approaches to the Management of Dental Caries: Prevention, Diagnosis, and Minimally Invasive Treatment</title>
      <link>https://aams-journal.us/journals/dentistry/articles/b3532442-9636-49e8-9ad7-a911a34781e3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/b3532442-9636-49e8-9ad7-a911a34781e3</guid>
      <pubDate>Tue, 31 Mar 2026 00:00:00 GMT</pubDate>
      <author>Marupova Madina Khikmatuloyevna¹; Naimov Parviz Sadriddinovich²; Sayqonov Ulugbek Jumanazar ogli³; Kenjayev Jonruz Hoshim ogli⁴;</author>
      <description>Dental caries remains one of the most prevalent chronic diseases worldwide, affecting individuals across all age groups. Contemporary management strategies have shifted from purely restorative approaches toward prevention, early detection, and minimally invasive interventions. This study evaluates modern concepts in caries management, including risk assessment, advanced diagnostic technologies, and conservative treatment methods aimed at preserving tooth structure. Clinical outcomes demonstrate that integrating preventive measures with early diagnosis significantly reduces disease progression and the need for extensive restorative procedures. Minimally invasive techniques, supported by bioactive materials, enhance remineralization and improve long-term oral health outcomes. These findings emphasize the importance of a patient-centered, evidence-based approach in modern dentistry. Contemporary strategies in dental caries control emphasize a shift toward proactive care focused on risk modification, early lesion identification, and preservation of hard tissues. Advances in preventive protocols, diagnostic technologies, and conservative therapeutic techniques have transformed clinical practice. This analysis highlights the effectiveness of integrated approaches combining individualized prevention plans with minimally invasive interventions. The findings demonstrate that early-stage management significantly limits lesion progression, reduces the need for extensive restorative procedures, and supports long-term maintenance of tooth integrity. The application of modern materials and evidence-based protocols enhances treatment predictability and overall oral health outcomes.</description>
      <dc:creator>Marupova Madina Khikmatuloyevna¹; Naimov Parviz Sadriddinovich²; Sayqonov Ulugbek Jumanazar ogli³; Kenjayev Jonruz Hoshim ogli⁴;</dc:creator>
      <dc:subject>dental caries</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>remineralization</dc:subject>
      <dc:subject>caries risk assessment</dc:subject>
      <dc:subject>fluoride therapy</dc:subject>
      <dc:subject>bioactive materials</dc:subject>
      <dc:subject>oral health</dc:subject>
      <dc:subject>conservative treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-31</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1279</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Increasing the Efficiency of Retrograde Root Canal Filling</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e7d8acc2-b8c5-4de4-90ac-4503378864a3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e7d8acc2-b8c5-4de4-90ac-4503378864a3</guid>
      <pubDate>Sun, 29 Mar 2026 00:00:00 GMT</pubDate>
      <author>Islamova Nilufar Bustanovna¹; Bekmurodov Luqmon Rustamovich²; Shokirov Bakhtiyor Shavkat ugli³;</author>
      <description>Retrograde root canal filling is a critical component of endodontic microsurgery aimed at achieving apical sealing when conventional orthograde treatment is insufficient or has failed. The success of this procedure depends on the quality of apical preparation, selection of filling materials, and precision of surgical technique. This study evaluates modern approaches to improving the efficiency of retrograde filling through the use of advanced materials, magnification technologies, and optimized preparation methods. Clinical and radiographic outcomes were analyzed to assess sealing ability, healing rates, and postoperative complications. The findings indicate that the use of biocompatible materials combined with microsurgical techniques significantly enhances treatment outcomes, reduces microleakage, and promotes periapical tissue regeneration. Optimization of retrograde root canal obturation remains a key factor in improving the success of endodontic surgical interventions. Achieving a stable apical seal after root-end resection is essential to prevent reinfection and ensure long-term healing of periapical tissues. Contemporary approaches focus on enhancing sealing quality through the use of advanced biomaterials, precise cavity preparation, and improved visualization techniques. This analysis examines the effectiveness of these innovations in increasing procedural efficiency and clinical predictability. The findings demonstrate that combining modern materials with microsurgical accuracy significantly reduces leakage, supports tissue regeneration, and enhances overall treatment outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774763676018-Increasing_the_Efficiency_of_Retrograde_Root_Canal.pdf" type="application/pdf" length="0"/>
      <dc:creator>Islamova Nilufar Bustanovna¹; Bekmurodov Luqmon Rustamovich²; Shokirov Bakhtiyor Shavkat ugli³;</dc:creator>
      <dc:subject>retrograde filling</dc:subject>
      <dc:subject>apical surgery</dc:subject>
      <dc:subject>endodontic microsurgery</dc:subject>
      <dc:subject>root canal sealing</dc:subject>
      <dc:subject>biocompatible materials</dc:subject>
      <dc:subject>MTA</dc:subject>
      <dc:subject>periapical healing</dc:subject>
      <dc:subject>microleakage</dc:subject>
      <dc:subject>dental surgery</dc:subject>
      <dc:subject>endodontics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1276</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 07, Issue 03, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Androgen Regulation of Lower Urinary Tract Function: Gender Differences and Clinical Significance</title>
      <link>https://aams-journal.us/journals/neurology/articles/80059c4f-768d-4897-a74a-688719eebf16</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/80059c4f-768d-4897-a74a-688719eebf16</guid>
      <pubDate>Sun, 29 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ganjiyeva Munisa Komil qizi</author>
      <description>Androgens play a critical role in the development, maintenance, and functional regulation of the lower urinary tract (LUT) in both males and females. Beyond their well-known effects on reproductive organs, androgens influence bladder function, urethral tone, pelvic floor integrity, and neural control mechanisms involved in micturition. Gender-related differences in androgen levels, receptor distribution, and downstream signaling pathways contribute to distinct patterns of lower urinary tract symptoms (LUTS) across the lifespan. This article provides a comprehensive review of androgen regulation of lower urinary tract function, emphasizing molecular mechanisms, gender differences, and clinical implications. Understanding these interactions is essential for improving diagnostic strategies and developing targeted therapies for LUT disorders such as benign prostatic hyperplasia, overactive bladder, urinary incontinence, and age-related voiding dysfunction. 
Androgens are steroid hormones traditionally associated with reproductive physiology, yet their influence extends significantly to the lower urinary tract, encompassing bladder function, urethral dynamics, pelvic floor integrity, and neural regulation of micturition. Recent studies indicate that androgen signaling is not limited to males but plays a crucial role in female urinary physiology as well. Variations in circulating androgen levels, receptor expression, and intracellular signaling pathways contribute to gender-specific manifestations of lower urinary tract dysfunction. This review synthesizes evidence from molecular biology, animal experiments, and clinical investigations to elucidate androgen-mediated mechanisms affecting urinary storage and voiding. It highlights the clinical relevance of hormonal modulation in conditions such as benign prostatic hyperplasia, overactive bladder, stress urinary incontinence, and age-associated urinary disorders. Recognition of these processes underscores the importance of personalized approaches that consider hormonal status alongside anatomical and neurological determinants, providing new avenues for therapeutic intervention and improved patient outcomes.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774801636823-Androgen_Regulation_of_Lower_Urinary_Tract_Functio.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ganjiyeva Munisa Komil qizi</dc:creator>
      <dc:subject>Androgens</dc:subject>
      <dc:subject>Lower urinary tract</dc:subject>
      <dc:subject>Gender differences</dc:subject>
      <dc:subject>Androgen receptors</dc:subject>
      <dc:subject>Lower urinary tract symptoms</dc:subject>
      <dc:subject>Clinical significance</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1278</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Modernization of Retrograde Root-End Filling Methods</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/e9e962e5-fa97-4712-9a08-b468c458a2c0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/e9e962e5-fa97-4712-9a08-b468c458a2c0</guid>
      <pubDate>Sun, 29 Mar 2026 00:00:00 GMT</pubDate>
      <author>Islamova Nilufar Bustanovna¹; Bekmurodov Luqmon Rustamovich²; Shokirov Bakhtiyor Shavkat ugli³;</author>
      <description>Retrograde root-end filling has undergone significant transformation with the integration of advanced technologies and bioactive materials in endodontic microsurgery. The modernization of these methods focuses on improving apical sealing, enhancing tissue compatibility, and increasing long-term treatment success. This study evaluates contemporary innovations in root-end cavity preparation, material selection, and surgical visualization. Clinical and radiographic outcomes were assessed to determine the effectiveness of updated techniques compared to conventional approaches. The findings indicate that modernized methods significantly improve marginal adaptation, reduce microleakage, and promote predictable periapical healing, thereby increasing the overall efficiency and reliability of surgical endodontic procedures. Recent advancements in retrograde root-end obturation have led to substantial improvements in the effectiveness of surgical endodontic procedures. The modernization of these techniques emphasizes precision, biological compatibility, and long-term sealing stability. This study analyzes current innovations in root-end management, focusing on enhanced preparation methods, improved material properties, and optimized clinical protocols. The evaluation demonstrates that updated approaches significantly reduce apical leakage, improve marginal integrity, and facilitate regeneration of periapical tissues. These developments contribute to higher predictability of outcomes and increased durability of treatment success.</description>
      <dc:creator>Islamova Nilufar Bustanovna¹; Bekmurodov Luqmon Rustamovich²; Shokirov Bakhtiyor Shavkat ugli³;</dc:creator>
      <dc:subject>retrograde filling</dc:subject>
      <dc:subject>root-end surgery</dc:subject>
      <dc:subject>endodontic microsurgery</dc:subject>
      <dc:subject>bioceramic materials</dc:subject>
      <dc:subject>apical seal</dc:subject>
      <dc:subject>ultrasonic preparation</dc:subject>
      <dc:subject>dental surgery</dc:subject>
      <dc:subject>periapical healing</dc:subject>
      <dc:subject>MTA</dc:subject>
      <dc:subject>biomaterials</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-29</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1277</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of RNA splicing</title>
      <link>https://aams-journal.us/journals/genetics/articles/9052eaa6-d4c2-4b50-9c57-bfe78adb6f2c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/9052eaa6-d4c2-4b50-9c57-bfe78adb6f2c</guid>
      <pubDate>Sat, 28 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Marco Bianchi</author>
      <description>Background: Rna splicing remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with RNA splicing. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>splicing</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>RNA</dc:subject>
      <dc:subject>RNA splicing</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1085</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 336-350</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of primary care screening: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/0fb85a2b-8863-44c6-9999-59f3f2dd4d13</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/0fb85a2b-8863-44c6-9999-59f3f2dd4d13</guid>
      <pubDate>Sat, 28 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Sophia Rossi</author>
      <description>Background: Primary care screening remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with primary care screening. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>care</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>primary care screening</dc:subject>
      <dc:subject>primary</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1060</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 264-270</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following treatment-resistant depression</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/734cd260-60a8-4a15-9cd4-d2e1709888b1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/734cd260-60a8-4a15-9cd4-d2e1709888b1</guid>
      <pubDate>Sat, 28 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Bongani Mthembu</author>
      <description>Background: Treatment-resistant depression remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with treatment-resistant depression. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>depression</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>treatment-resistant</dc:subject>
      <dc:subject>treatment-resistant depression</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1163</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 2, pp. 212-218</dc:source>
    </item>
    <item>
      <title>Biomarker-Based Differentiation of Food Allergy and Functional Gastrointestinal Disorders in Children</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/8a8be21c-b83c-4d8e-bf13-0fd915372dbc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/8a8be21c-b83c-4d8e-bf13-0fd915372dbc</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <author>Akhmedjonova R. J¹; Yuldashev B.A²</author>
      <description>Differentiating food allergy from functional gastrointestinal disorders in children remains a significant clinical challenge due to overlapping symptoms such as abdominal pain, diarrhea, bloating, and feeding intolerance. Misdiagnosis may lead to inappropriate dietary restrictions or delayed treatment. This study evaluates the diagnostic value of specific biomarkers in distinguishing immune-mediated food allergy from functional gastrointestinal conditions. A комплекс approach combining immunological, inflammatory, and intestinal permeability markers was applied to improve diagnostic accuracy. The findings demonstrate that biomarker profiling provides a reliable method for identifying underlying pathophysiological mechanisms and differentiating between these conditions. The use of such markers enhances clinical decision-making, reduces diagnostic uncertainty, and supports the development of targeted therapeutic strategies in pediatric patients. Distinguishing immune-mediated reactions to food from functional gastrointestinal disturbances in pediatric patients remains a complex clinical task due to significant overlap in symptom presentation. The application of laboratory indicators reflecting immune activation, intestinal inflammation, and epithelial barrier integrity provides an opportunity to improve diagnostic precision. This analysis evaluates the role of combined biomarker profiling in identifying underlying mechanisms responsible for gastrointestinal complaints in children. The findings demonstrate that specific patterns of immunological and inflammatory activity are strongly associated with allergic processes, whereas functional conditions are characterized by the absence of significant organic changes. The use of integrated biomarker panels enhances diagnostic clarity and supports more rational therapeutic decision-making.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774590472444-Biomarker_Based_Differentiation_of_Food_Allergy_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Akhmedjonova R. J¹; Yuldashev B.A²</dc:creator>
      <dc:subject>food allergy</dc:subject>
      <dc:subject>functional gastrointestinal disorders</dc:subject>
      <dc:subject>children</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>IgE</dc:subject>
      <dc:subject>calprotectin</dc:subject>
      <dc:subject>cytokines</dc:subject>
      <dc:subject>intestinal permeability</dc:subject>
      <dc:subject>diagnosis</dc:subject>
      <dc:subject>pediatric gastroenterology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1274</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 03, pp. 91-105</dc:source>
    </item>
    <item>
      <title>Morphological and Immunohistochemical Characteristics of Upper Eyelid Skin in Blepharochalasis: Age-Related and Hormonal Influences in Female Patients</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/71f55969-d230-41b4-8de1-7a51e3af60ae</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/71f55969-d230-41b4-8de1-7a51e3af60ae</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <author>Khakimova Mavluda Shavkatjonovna¹;</author>
      <description>Blepharochalasis is characterized by recurrent eyelid edema followed by progressive atrophy, laxity, and structural weakening of the skin. The condition is influenced by a combination of intrinsic aging processes and hormonal factors that affect connective tissue metabolism and vascular stability. This study evaluates morphological and immunohistochemical features of upper eyelid skin in female patients with blepharochalasis, with particular emphasis on age-related and hormonal differences. Histological assessment and immunohistochemical analysis were used to identify changes in collagen, elastin, inflammatory markers, and vascular components. The findings demonstrate that aging and hormonal status significantly affect both structural integrity and molecular activity within the skin. More advanced degenerative and inflammatory changes were observed in older and hormonally deficient groups. These results provide insight into the pathophysiological mechanisms of blepharochalasis and support the development of individualized diagnostic and therapeutic approaches. Blepharochalasis is a progressive condition of the upper eyelid characterized by repeated swelling episodes followed by structural weakening of the skin. Its development is closely associated with age-related degeneration and hormonal imbalance, which together influence connective tissue integrity, vascular function, and inflammatory activity. This study examines morphological and immunohistochemical alterations in eyelid tissue among female patients with varying age and endocrine status. Analysis of structural proteins, cellular components, and molecular markers demonstrates that both intrinsic aging and hormonal changes significantly affect tissue remodeling processes. The findings reveal that combined biological influences contribute to differences in clinical severity and progression patterns. These results emphasize the importance of integrating structural and molecular evaluation in understanding disease mechanisms and improving individualized patient management.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774590165690-Morphological_and_Immunohistochemical_Characterist.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khakimova Mavluda Shavkatjonovna¹;</dc:creator>
      <dc:subject>blepharochalasis</dc:subject>
      <dc:subject>eyelid skin</dc:subject>
      <dc:subject>morphology</dc:subject>
      <dc:subject>immunohistochemistry</dc:subject>
      <dc:subject>aging</dc:subject>
      <dc:subject>hormonal status</dc:subject>
      <dc:subject>collagen</dc:subject>
      <dc:subject>elastin</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>endothelial markers</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1273</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 76-90</dc:source>
    </item>
    <item>
      <title>Clinical and Immunohistochemical Features of the Skin of the Upper Eyelid with Blepharochalasis in Women of Different Age and Hormonal Groups</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/9eaeac1e-8468-453a-bb6e-41d68864ff81</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/9eaeac1e-8468-453a-bb6e-41d68864ff81</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <author>Khakimova Mavluda Shavkatjonovna¹;</author>
      <description>Blepharochalasis is a condition characterized by recurrent edema and progressive thinning of the eyelid skin, leading to functional and aesthetic impairment. Its pathogenesis is multifactorial and influenced by age-related changes, hormonal status, and alterations in connective tissue structure. This study investigates the clinical and immunohistochemical characteristics of upper eyelid skin in women of different age and hormonal groups affected by blepharochalasis. Particular attention is given to the expression of structural proteins, inflammatory markers, and vascular components. The findings demonstrate that both age and hormonal background significantly influence morphological and immunohistochemical features, with more pronounced degenerative and inflammatory changes observed in older and hormonally altered groups. The results provide insight into the mechanisms underlying disease progression and support the development of more individualized diagnostic and therapeutic approaches. Blepharochalasis of the upper eyelid represents a chronic condition marked by progressive structural weakening of the skin, influenced by repeated edema, connective tissue degradation, and systemic factors such as age and hormonal status. Detailed evaluation of clinical manifestations alongside immunohistochemical characteristics allows deeper understanding of the underlying biological processes. This analysis focuses on differences in tissue architecture, protein expression, and inflammatory activity among women of varying age groups and endocrine backgrounds. The results indicate that degenerative and inflammatory alterations are significantly modulated by hormonal balance and aging, leading to variability in disease severity. These findings emphasize the importance of integrating morphological and molecular data to improve diagnostic precision and support individualized therapeutic strategies.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774589815202-Clinical_and_Immunohistochemical_Features_of_the_S.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khakimova Mavluda Shavkatjonovna¹;</dc:creator>
      <dc:subject>blepharochalasis</dc:subject>
      <dc:subject>eyelid skin</dc:subject>
      <dc:subject>immunohistochemistry</dc:subject>
      <dc:subject>aging</dc:subject>
      <dc:subject>hormonal status</dc:subject>
      <dc:subject>collagen</dc:subject>
      <dc:subject>elastin</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>vascular changes</dc:subject>
      <dc:subject>dermatopathology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1272</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 03, pp. 76-90</dc:source>
    </item>
    <item>
      <title>The Impact of Thyroid Gland Function on Systemic Metabolism: Physiological Roles, Hormonal Regulation, and Clinical Implications</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/b2dd4fbe-6b5e-44c9-8f11-47c0bd2b700e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/b2dd4fbe-6b5e-44c9-8f11-47c0bd2b700e</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <author>Alimova Ozoda Bekmurodovna¹; Utaganova Sevinch²;</author>
      <description>Thyroid gland function plays a central role in regulating systemic metabolism through the synthesis and secretion of hormones that influence energy balance, thermogenesis, and cellular activity. Disruptions in thyroid hormone production lead to significant metabolic alterations affecting multiple organ systems. This study examines the physiological roles of thyroid hormones, mechanisms of hormonal regulation, and their clinical implications in metabolic disorders. By integrating biochemical, hormonal, and clinical data, the analysis highlights the relationship between thyroid dysfunction and systemic metabolic imbalance. The findings demonstrate that both hypo- and hyperfunctional states are associated with distinct metabolic profiles, influencing carbohydrate, lipid, and protein metabolism. Understanding these interactions is essential for improving diagnostic accuracy and developing targeted therapeutic strategies. Thyroid activity exerts a decisive influence on whole-body metabolic equilibrium through regulation of energy turnover, substrate utilization, and cellular respiration. Variations in hormone synthesis and peripheral conversion lead to widespread biochemical and physiological alterations that affect multiple organ systems. This analysis explores the relationship between endocrine function and metabolic processes, emphasizing how hormonal imbalance contributes to systemic dysregulation. Evaluation of biochemical indicators demonstrates that deviations in hormonal levels are closely linked to disturbances in carbohydrate handling, lipid transformation, and protein dynamics. The findings underline the importance of hormonal balance for maintaining metabolic stability and highlight the clinical relevance of early identification of endocrine dysfunction.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774608020059-The_Impact_of_Thyroid_Gland_Function_on_Systemic_M.pdf" type="application/pdf" length="0"/>
      <dc:creator>Alimova Ozoda Bekmurodovna¹; Utaganova Sevinch²;</dc:creator>
      <dc:subject>thyroid gland</dc:subject>
      <dc:subject>metabolism</dc:subject>
      <dc:subject>thyroid hormones</dc:subject>
      <dc:subject>hypothyroidism</dc:subject>
      <dc:subject>hyperthyroidism</dc:subject>
      <dc:subject>endocrine regulation</dc:subject>
      <dc:subject>energy balance</dc:subject>
      <dc:subject>metabolic disorders</dc:subject>
      <dc:subject>T3</dc:subject>
      <dc:subject>T4</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1275</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 61-75</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of developmental milestones: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/e6bae8a8-a906-43f2-b848-81cc38292505</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/e6bae8a8-a906-43f2-b848-81cc38292505</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Developmental milestones remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with developmental milestones. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:subject>developmental</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>developmental milestones</dc:subject>
      <dc:subject>milestones</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1004</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 2, pp. 143-156</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of pediatric strabismus assessment instruments</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/15fd2ec2-3a9e-4e08-a725-ade9f63db4be</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/15fd2ec2-3a9e-4e08-a725-ade9f63db4be</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Natalia Petrova</author>
      <description>Background: Pediatric strabismus remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric strabismus. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>pediatric strabismus</dc:subject>
      <dc:subject>strabismus</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1155</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 142-151</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of febrile seizures assessment instruments</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/9676c7ee-cb07-45cf-9eaf-39db901071be</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/9676c7ee-cb07-45cf-9eaf-39db901071be</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Henrik Larsen</author>
      <description>Background: Febrile seizures remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with febrile seizures. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>seizures</dc:subject>
      <dc:subject>febrile seizures</dc:subject>
      <dc:subject>febrile</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1010</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 192-200</dc:source>
    </item>
    <item>
      <title>Personalized Management of Coronary Heart Disease in Postmenopausal Women Using a Digital Clinical Decision Support System Based on ESR1 G2014A Polymorphisms</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/3e24796c-44c0-442f-9108-84018846f5cf</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/3e24796c-44c0-442f-9108-84018846f5cf</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <author>Rajabova Nilufar Turabaevna¹; Ibadullaev Dilshodbek Ilham ogli²;</author>
      <description>Coronary heart disease remains a leading cause of morbidity and mortality among postmenopausal women, largely due to hormonal changes that influence vascular function and metabolic regulation. The decline in estrogen levels after menopause is associated with increased cardiovascular risk, highlighting the need for individualized therapeutic approaches. Genetic polymorphisms, particularly in the ESR1 and eNOS3 genes, have been shown to affect vascular tone, endothelial function, and susceptibility to atherosclerosis. This study explores the application of a digital clinical decision support system designed to integrate genetic data with clinical parameters for personalized management of coronary heart disease in postmenopausal women. The results demonstrate that incorporation of genetic profiling into digital decision-making tools improves risk assessment, enhances therapeutic precision, and contributes to better clinical outcomes. The findings support the growing role of personalized medicine and digital health technologies in cardiovascular care. Cardiovascular pathology in women after menopause is influenced by complex interactions between hormonal deficiency, vascular dysfunction, and genetic predisposition. Traditional therapeutic approaches often fail to account for interindividual variability, leading to suboptimal outcomes in a significant proportion of patients. Recent progress in molecular genetics and digital health technologies has enabled the development of personalized strategies that integrate genetic markers with clinical data. Polymorphic variants of genes involved in estrogen signaling and endothelial regulation play a key role in determining vascular reactivity and susceptibility to atherosclerotic processes. The application of digital clinical decision support tools allows the synthesis of these multidimensional data into actionable treatment recommendations. This study evaluates the effectiveness of such an approach in improving risk stratification and optimizing management strategies. The findings demonstrate that combining genetic profiling with algorithm-based clinical support enhances precision in therapeutic decision-making and contributes to improved patient outcomes.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774353149062-Personalized_Management_of_Coronary_Heart_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rajabova Nilufar Turabaevna¹; Ibadullaev Dilshodbek Ilham ogli²;</dc:creator>
      <dc:subject>coronary heart disease</dc:subject>
      <dc:subject>postmenopausal women</dc:subject>
      <dc:subject>personalized medicine</dc:subject>
      <dc:subject>ESR1 gene</dc:subject>
      <dc:subject>eNOS3 polymorphism</dc:subject>
      <dc:subject>digital health</dc:subject>
      <dc:subject>clinical decision support system</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:subject>endothelial dysfunction</dc:subject>
      <dc:subject>genetics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1266</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 03, pp. 46-60</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for ADHD adults</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/59dc0002-d659-4a7b-ab75-999bd6bc9045</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/59dc0002-d659-4a7b-ab75-999bd6bc9045</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Edwin Otieno</author>
      <description>Background: Adhd adults remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with ADHD adults. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>adults</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>ADHD</dc:subject>
      <dc:subject>ADHD adults</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1172</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 2, pp. 197-205</dc:source>
    </item>
    <item>
      <title>Early Diagnosis of Diabetic Nephropathy: Emerging Biomarkers and Their Clinical Significance</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/62b09f82-7afd-4a8a-a1f2-ce33c8ccd8ac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/62b09f82-7afd-4a8a-a1f2-ce33c8ccd8ac</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <author>Davranova Aziza Davranovna¹; Xayrullayev Poʻlatjon²</author>
      <description>Diabetic nephropathy is one of the most serious microvascular complications of diabetes mellitus and a leading cause of chronic kidney disease and end-stage renal failure worldwide. Early detection of renal involvement remains crucial for preventing disease progression and improving patient outcomes. Traditional diagnostic methods, including measurement of albuminuria and glomerular filtration rate, often identify the disease at relatively advanced stages. In recent years, significant attention has been directed toward the identification of novel biomarkers that allow earlier detection of kidney damage before the onset of overt clinical symptoms. This article provides a comprehensive overview of emerging biomarkers associated with diabetic nephropathy, including markers of inflammation, oxidative stress, tubular injury, and endothelial dysfunction. The clinical significance of these biomarkers is analyzed in terms of their diagnostic accuracy, prognostic value, and potential role in guiding therapeutic interventions. The findings highlight that the integration of novel biomarkers with conventional diagnostic approaches enhances early detection, improves risk stratification, and supports the development of personalized treatment strategies. The timely identification of renal involvement in patients with diabetes is essential for preventing irreversible kidney damage and reducing the progression to advanced stages of chronic kidney disease. Conventional diagnostic indicators, such as urinary albumin excretion and estimated glomerular filtration rate, often reflect already established structural alterations within the kidneys. In recent years, attention has shifted toward novel biological markers capable of detecting subtle and early pathological changes at the molecular level. These emerging indicators reflect key mechanisms including inflammation, oxidative injury, and tubular dysfunction. The present overview evaluates the clinical relevance of such biomarkers and their potential integration into routine diagnostic algorithms. Evidence suggests that combining innovative markers with standard clinical assessments improves sensitivity, enables earlier intervention, and enhances prognostic accuracy in patients at risk of diabetic kidney complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774359123066-Early_Diagnosis_of_Diabetic_Nephropathy__Emerging_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Davranova Aziza Davranovna¹; Xayrullayev Poʻlatjon²</dc:creator>
      <dc:subject>diabetic nephropathy</dc:subject>
      <dc:subject>early diagnosis</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>albuminuria</dc:subject>
      <dc:subject>kidney disease</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>oxidative stress</dc:subject>
      <dc:subject>tubular injury</dc:subject>
      <dc:subject>endothelial dysfunction</dc:subject>
      <dc:subject>chronic kidney disease</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1270</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 46-60</dc:source>
    </item>
    <item>
      <title>Current Understanding of Antibacterial Therapy for Sepsis in Newborns</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/f57f2c47-f2d1-4acf-9ab8-35f5caf35f05</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/f57f2c47-f2d1-4acf-9ab8-35f5caf35f05</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <author>Lim M.V.¹; Nasriyeva A.X.²;</author>
      <description>Neonatal sepsis remains a leading cause of morbidity and mortality worldwide, particularly in low- and middle-income countries. Despite advances in neonatal intensive care, early diagnosis and effective antibacterial therapy continue to present significant challenges due to nonspecific clinical manifestations and rapidly progressing systemic infection. The selection of appropriate antimicrobial agents requires consideration of gestational age, birth weight, local microbial patterns, and resistance profiles. This article summarizes current concepts in antibacterial therapy for neonatal sepsis, focusing on empirical and targeted treatment strategies, pharmacokinetic considerations in newborns, and the impact of antimicrobial resistance. The analysis highlights the importance of early initiation of broad-spectrum antibiotics followed by de-escalation based on microbiological findings. Special attention is given to the role of combination therapy, optimization of dosing regimens, and the necessity of individualized treatment approaches. The findings emphasize that rational use of antibiotics and adherence to updated clinical guidelines are essential for improving survival outcomes and minimizing complications associated with neonatal sepsis. Neonatal sepsis continues to be a major contributor to infant morbidity and mortality, requiring prompt and effective antimicrobial management. The complexity of this condition lies in its rapid progression, nonspecific clinical manifestations, and the unique physiological characteristics of newborns that influence drug metabolism and immune response. Modern approaches to antibacterial therapy emphasize early initiation of treatment, appropriate empirical antibiotic selection, and timely adjustment based on microbiological data. Increasing antimicrobial resistance has further complicated treatment strategies, necessitating more rational and evidence-based use of antibiotics. This analysis explores current perspectives on antibacterial management in neonatal sepsis, highlighting the importance of individualized therapy, pharmacokinetic considerations, and antibiotic stewardship. The findings demonstrate that optimized treatment protocols significantly improve clinical outcomes while minimizing the risk of resistance development and adverse drug effects.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774360028803-Current_Understanding_of_Antibacterial_Therapy_for.pdf" type="application/pdf" length="0"/>
      <dc:creator>Lim M.V.¹; Nasriyeva A.X.²;</dc:creator>
      <dc:subject>neonatal sepsis</dc:subject>
      <dc:subject>antibacterial therapy</dc:subject>
      <dc:subject>newborn infections</dc:subject>
      <dc:subject>antimicrobial resistance</dc:subject>
      <dc:subject>empirical treatment</dc:subject>
      <dc:subject>targeted therapy</dc:subject>
      <dc:subject>pharmacokinetics</dc:subject>
      <dc:subject>neonatal intensive care</dc:subject>
      <dc:subject>antibiotics</dc:subject>
      <dc:subject>infection control</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1271</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 61-75</dc:source>
    </item>
    <item>
      <title>Association of ESR1 G2014A and eNOS3 −786T&gt;C Polymorphisms with Hormonal and Inflammatory Disorders in Postmenopausal Women with Coronary Heart Disease</title>
      <link>https://aams-journal.us/journals/neurology/articles/938bfefc-8a32-40a2-bf38-054b9e416393</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/938bfefc-8a32-40a2-bf38-054b9e416393</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <author>Rajabova Nilufar Turabaevna¹; Ibadullaev Dilshodbek Ilham ogli²;</author>
      <description>Coronary heart disease in postmenopausal women is influenced by complex interactions between genetic predisposition, hormonal imbalance, and chronic inflammation. Declining estrogen levels contribute to endothelial dysfunction and increased cardiovascular risk, while genetic polymorphisms in key regulatory genes may further modulate disease progression. The analysis integrates genetic testing with biochemical assessment of estrogen levels and inflammatory markers to evaluate their combined impact on disease characteristics. The findings demonstrate a significant relationship between specific genetic variants and increased inflammatory activity, as well as more pronounced hormonal disturbances. These results highlight the importance of considering genetic factors in the evaluation of cardiovascular risk and support the development of personalized approaches to disease management. Evaluation of coronary pathology in women after menopause requires consideration of molecular determinants that influence vascular homeostasis. Genetic variations affecting estrogen receptor activity and nitric oxide synthesis contribute to disturbances in endocrine balance and inflammatory regulation. Integrated analysis of genetic, hormonal, and inflammatory indicators demonstrates that specific allelic combinations are associated with more pronounced systemic alterations. The proposed interpretation highlights the role of genetic background in shaping disease phenotype and emphasizes its importance for improving risk assessment and therapeutic planning.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774357214759-Association_of_ESR1_G2014A_and_eNOS3__786T_C_Polym.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rajabova Nilufar Turabaevna¹; Ibadullaev Dilshodbek Ilham ogli²;</dc:creator>
      <dc:subject>coronary heart disease</dc:subject>
      <dc:subject>postmenopausal women</dc:subject>
      <dc:subject>ESR1 polymorphism</dc:subject>
      <dc:subject>eNOS3 polymorphism</dc:subject>
      <dc:subject>estrogen deficiency</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>genetic factors</dc:subject>
      <dc:subject>endothelial dysfunction</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1268</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Predictive Model of Cardiovascular Risk in Postmenopausal Women with Coronary Heart Disease Based on ESR1 and eNOS3 Polymorphisms and Hormonal-Inflammatory Profile</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/0c9a7fba-733f-417c-9959-250ff5fda395</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/0c9a7fba-733f-417c-9959-250ff5fda395</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <author>Rajabova Nilufar Turabaevna¹; Ibadullaev Dilshodbek Ilham ogli²;</author>
      <description>Cardiovascular disease remains a leading cause of morbidity and mortality among postmenopausal women, where hormonal imbalance and vascular dysfunction play a critical role. The decline in estrogen levels after menopause is associated with increased inflammatory activity, endothelial dysfunction, and progression of atherosclerosis. Genetic polymorphisms in the ESR1 and eNOS3 genes have been identified as important determinants of vascular response and susceptibility to coronary pathology. This study presents a predictive model that integrates genetic variants with hormonal and inflammatory parameters to assess cardiovascular risk in postmenopausal women with coronary heart disease. The model incorporates ESR1 and eNOS3 polymorphisms alongside biomarkers such as estrogen levels and inflammatory mediators to enhance risk stratification. The findings demonstrate that this combined approach significantly improves predictive accuracy compared to conventional risk assessment methods. The proposed model provides a basis for personalized management strategies and supports the advancement of precision medicine in cardiovascular care. Assessment of cardiovascular risk in women after menopause requires a multidimensional approach that reflects the interplay between genetic predisposition, hormonal imbalance, and inflammatory activity. Conventional evaluation systems often rely on clinical indicators that may not fully capture underlying molecular mechanisms. The integration of genetic polymorphisms related to estrogen signaling and endothelial regulation with hormonal and inflammatory markers provides a more comprehensive framework for risk prediction. This analysis explores the development of a predictive model that combines these variables to enhance accuracy in identifying individuals at high risk of adverse cardiovascular outcomes. The results indicate that such an approach significantly improves stratification and supports more individualized therapeutic planning. The use of combined biological and clinical parameters offers new opportunities for advancing precision medicine in cardiovascular care.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774354827002-1774354151674-Predictive_Model_of_Cardiovascular_Risk_i.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rajabova Nilufar Turabaevna¹; Ibadullaev Dilshodbek Ilham ogli²;</dc:creator>
      <dc:subject>coronary heart disease</dc:subject>
      <dc:subject>postmenopausal women</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:subject>predictive model</dc:subject>
      <dc:subject>ESR1 gene</dc:subject>
      <dc:subject>eNOS3 polymorphism</dc:subject>
      <dc:subject>estrogen</dc:subject>
      <dc:subject>inflammation</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>personalized medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1267</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 46-60</dc:source>
    </item>
    <item>
      <title>Modern Perspectives on the Diagnosis of Neonatal Sepsis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/b9437b5f-7114-42df-9229-7051094881dc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/b9437b5f-7114-42df-9229-7051094881dc</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <author>Lim M.V.¹; Nasriyeva A.X.²;</author>
      <description>Neonatal sepsis remains a critical global health concern due to its high mortality and the diagnostic challenges associated with its early detection. The nonspecific clinical presentation and rapid progression of the disease necessitate the development of reliable, sensitive, and rapid diagnostic methods. Traditional diagnostic approaches, including blood cultures and clinical assessment, often lack sensitivity and require prolonged time for confirmation. In recent years, advances in laboratory technologies, biomarker identification, and molecular diagnostics have significantly improved the ability to detect neonatal sepsis at an early stage. This article provides a comprehensive overview of modern diagnostic strategies, including the use of inflammatory biomarkers, molecular techniques such as polymerase chain reaction, and emerging tools like genomic and proteomic profiling. The analysis highlights the advantages and limitations of each method and emphasizes the importance of combining clinical evaluation with advanced diagnostic technologies to improve accuracy and patient outcomes. Early and precise diagnosis allows timely initiation of therapy, reduces unnecessary antibiotic exposure, and contributes to improved survival rates in newborns. Early recognition of systemic infection in newborns remains a complex clinical task due to the absence of specific symptoms and the rapid progression of pathological processes. Contemporary diagnostic approaches are increasingly focused on improving sensitivity and reducing the time required for confirmation. Advances in laboratory medicine, including the use of inflammatory markers and molecular detection techniques, have significantly enhanced diagnostic capabilities. This overview examines current trends in identifying neonatal sepsis, emphasizing the integration of clinical evaluation with innovative laboratory tools. The findings indicate that combining multiple diagnostic modalities increases accuracy, facilitates earlier therapeutic decisions, and reduces unnecessary exposure to antimicrobial agents. The implementation of advanced technologies contributes to better clinical outcomes and supports more rational management strategies in neonatal care.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1774358316730-Modern_Perspectives_on_the_Diagnosis_of_Neonatal_S.pdf" type="application/pdf" length="0"/>
      <dc:creator>Lim M.V.¹; Nasriyeva A.X.²;</dc:creator>
      <dc:subject>neonatal sepsis</dc:subject>
      <dc:subject>diagnosis</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>procalcitonin</dc:subject>
      <dc:subject>C-reactive protein</dc:subject>
      <dc:subject>PCR</dc:subject>
      <dc:subject>molecular diagnostics</dc:subject>
      <dc:subject>newborn infections</dc:subject>
      <dc:subject>early detection</dc:subject>
      <dc:subject>neonatal intensive care</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1269</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 03, pp. 61-75</dc:source>
    </item>
    <item>
      <title>melanoma immunotherapy: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/dermatology/articles/c2a9a6a3-e374-4840-a766-eb3b78b67bac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/c2a9a6a3-e374-4840-a766-eb3b78b67bac</guid>
      <pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Fatima Al-Zahra</author>
      <description>Background: Melanoma immunotherapy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with melanoma immunotherapy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>immunotherapy</dc:subject>
      <dc:subject>melanoma immunotherapy</dc:subject>
      <dc:subject>melanoma</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-23</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1122</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 154-162</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for uveitis biologics</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/eab3ca99-329b-41b3-af7a-2c231ce67c83</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/eab3ca99-329b-41b3-af7a-2c231ce67c83</guid>
      <pubDate>Sun, 22 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Olufemi Adebayo</author>
      <description>Background: Uveitis biologics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with uveitis biologics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>uveitis biologics</dc:subject>
      <dc:subject>biologics</dc:subject>
      <dc:subject>uveitis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1158</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 2, pp. 25-36</dc:source>
    </item>
    <item>
      <title>neonatal sepsis: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/1cefd329-3b1f-43b1-900c-67a66baf9a43</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/1cefd329-3b1f-43b1-900c-67a66baf9a43</guid>
      <pubDate>Sat, 21 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Neonatal sepsis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with neonatal sepsis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>sepsis</dc:subject>
      <dc:subject>neonatal sepsis</dc:subject>
      <dc:subject>neonatal</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1001</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 288-297</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for type 2 diabetes in tertiary care settings</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/b6ab4a44-7f2e-423a-8231-cdb8f973bd04</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/b6ab4a44-7f2e-423a-8231-cdb8f973bd04</guid>
      <pubDate>Sat, 21 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Maria González</author>
      <description>Background: Type 2 diabetes remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with type 2 diabetes. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>2</dc:subject>
      <dc:subject>type 2 diabetes</dc:subject>
      <dc:subject>type</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1032</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 1, pp. 146-160</dc:source>
    </item>
    <item>
      <title>Predictive biomarkers in ocular oncology: systematic review and meta-analysis</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/f47fd816-4bea-4ebc-9fa5-9e11e327bcfb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/f47fd816-4bea-4ebc-9fa5-9e11e327bcfb</guid>
      <pubDate>Sat, 21 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Layla Bouazizi</author>
      <description>Background: Ocular oncology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with ocular oncology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>ocular</dc:subject>
      <dc:subject>oncology</dc:subject>
      <dc:subject>ocular oncology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1162</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 2, pp. 195-208</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of mitochondrial disorders interventions</title>
      <link>https://aams-journal.us/journals/genetics/articles/fad62aa3-2771-4d1b-a5b6-bcbb65ca25f3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/fad62aa3-2771-4d1b-a5b6-bcbb65ca25f3</guid>
      <pubDate>Sat, 21 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Maria González</author>
      <description>Background: Mitochondrial disorders remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with mitochondrial disorders. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>mitochondrial disorders</dc:subject>
      <dc:subject>disorders</dc:subject>
      <dc:subject>mitochondrial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1079</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 352-363</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following HIV pre-exposure prophylaxis</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/867ca4e5-494b-4ce7-9d28-1540ffaf8427</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/867ca4e5-494b-4ce7-9d28-1540ffaf8427</guid>
      <pubDate>Thu, 19 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Rashid Khan</author>
      <description>Background: Hiv pre-exposure prophylaxis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with HIV pre-exposure prophylaxis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>HIV pre-exposure prophylaxis</dc:subject>
      <dc:subject>pre-exposure</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>HIV</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1106</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 100-111</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of COPD exacerbations — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/7b764e39-423b-43cc-aa7b-6267c4a12d0e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/7b764e39-423b-43cc-aa7b-6267c4a12d0e</guid>
      <pubDate>Thu, 19 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Copd exacerbations remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with COPD exacerbations. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>exacerbations</dc:subject>
      <dc:subject>COPD</dc:subject>
      <dc:subject>COPD exacerbations</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1033</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 1, pp. 234-246</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of skin cancer dermoscopy assessment instruments</title>
      <link>https://aams-journal.us/journals/dermatology/articles/0493c24d-47b6-4c05-a541-5eb15b104421</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/0493c24d-47b6-4c05-a541-5eb15b104421</guid>
      <pubDate>Wed, 18 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Daniel Cohen</author>
      <description>Background: Skin cancer dermoscopy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with skin cancer dermoscopy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>skin</dc:subject>
      <dc:subject>skin cancer dermoscopy</dc:subject>
      <dc:subject>cancer</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1126</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 65-75</dc:source>
    </item>
    <item>
      <title>Pregnancy and Autoimmune Disorders: Implications for Maternal and Fetal Health</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/7617f4b3-b5bd-48f3-9002-999bafd79cf0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/7617f4b3-b5bd-48f3-9002-999bafd79cf0</guid>
      <pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ganjiyeva Munisa Komil qizi</author>
      <description>Early risk stratification, multidisciplinary monitoring, and individualized therapeutic planning are essential to optimize maternal stability and fetal safety. This article reviews immunopathological mechanisms, clinical features, management principles, and outcomes associated with autoimmune conditions in pregnant patients, emphasizing evidence-based strategies to minimize morbidity and mortality. Pregnancy in women with autoimmune disorders presents complex clinical challenges due to immunological, hormonal, and vascular adaptations that influence disease activity and obstetric outcomes. Autoimmune conditions such as systemic lupus erythematosus, rheumatoid arthritis, antiphospholipid syndrome, autoimmune thyroid disease, and multiple sclerosis may demonstrate remission, exacerbation, or unpredictable fluctuation during gestation and the postpartum period. Maternal immune tolerance toward the semi-allogeneic fetus requires tightly regulated immunomodulation, which may alter autoantibody production and inflammatory pathways. These changes can affect placental function, increasing the risk of miscarriage, preeclampsia, fetal growth restriction, preterm birth, and neonatal complications. Early diagnosis, preconception counseling, multidisciplinary monitoring, and individualized pharmacotherapy significantly improve maternal and neonatal prognosis. This article analyzes immunopathophysiological mechanisms, clinical features, diagnostic strategies, and modern management approaches to optimize outcomes for both mother and child. Autoimmune conditions frequently affect women during their reproductive years and present significant clinical challenges when they coincide with gestation. Physiological adaptations that support fetal tolerance involve intricate modulation of innate and adaptive immunity, endocrine regulation, and vascular remodeling. These modifications may alter disease trajectory, either attenuating inflammatory activity or provoking exacerbations depending on the underlying immunopathology. Maternal autoantibodies, systemic inflammation, and endothelial dysfunction can interfere with placental development and fetal growth. Adverse outcomes such as hypertensive disorders of pregnancy, preterm birth, intrauterine growth restriction, and transient neonatal immune abnormalities are more common when disease control is inadequate. However, careful preconception planning, appropriate pharmacologic strategies, and structured monitoring substantially improve prognosis. Contemporary evidence highlights the importance of maintaining immunological stability, preventing flare episodes, and ensuring safe therapeutic exposure throughout gestation and the postpartum period.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773733287458-Pregnancy_and_Autoimmune_Disorders__Implications_f.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ganjiyeva Munisa Komil qizi</dc:creator>
      <dc:subject>pregnancy</dc:subject>
      <dc:subject>autoimmune disease</dc:subject>
      <dc:subject>maternal health</dc:subject>
      <dc:subject>fetal outcomes</dc:subject>
      <dc:subject>immunological adaptation</dc:subject>
      <dc:subject>obstetric complications</dc:subject>
      <dc:subject>neonatal immunity</dc:subject>
      <dc:subject>immunosuppressive therapy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1265</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of obesity counseling</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/9d32fa5c-667e-4a83-bacf-b2906b62a4b2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/9d32fa5c-667e-4a83-bacf-b2906b62a4b2</guid>
      <pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Kwame Asante</author>
      <description>Background: Obesity counseling remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with obesity counseling. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>obesity counseling</dc:subject>
      <dc:subject>counseling</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1063</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 1, pp. 197-206</dc:source>
    </item>
    <item>
      <title>Comparative Analysis of the Clinical Course of Retinal Vein Occlusion in Patients With and Without Thrombophilic Mutations</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/7e2f3c75-03f4-43db-842f-a4741d2cdcf4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/7e2f3c75-03f4-43db-842f-a4741d2cdcf4</guid>
      <pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z¹</author>
      <description>Retinal vein occlusion is one of the most common vascular diseases of the retina and a frequent cause of sudden visual impairment. Although traditional systemic factors such as hypertension, diabetes mellitus, and dyslipidemia play an important role in its pathogenesis, increasing attention has been directed toward the contribution of genetic predisposition to thrombosis. Mutations associated with thrombophilia may influence the severity of retinal vascular obstruction and affect the response to treatment. The present study provides a comparative analysis of the clinical course of retinal vein occlusion in patients with and without thrombophilic mutations. A total of 86 patients diagnosed with retinal vein occlusion were evaluated using clinical, ophthalmological, and genetic methods. Particular attention was given to polymorphisms of the JAK2 and MTHFR genes, which are associated with abnormalities in coagulation regulation and homocysteine metabolism. The results demonstrated that the presence of these mutations was significantly associated with a more severe clinical course of the disease, slower recovery of visual acuity, and a higher frequency of complications including persistent macular edema and recurrent vascular events. The findings emphasize the importance of genetic screening in patients with retinal vein occlusion in order to identify individuals at higher risk of unfavorable outcomes and to optimize therapeutic strategies. Retinal vein occlusion is one of the most common retinal vascular disorders and represents a major cause of sudden vision impairment in ophthalmic practice. Although traditional systemic risk factors such as hypertension, metabolic disorders, and vascular degeneration play a substantial role in its development, recent investigations indicate that genetic predisposition to thrombosis may significantly influence disease progression and clinical outcomes. Mutations associated with thrombophilia, particularly in genes regulating coagulation and homocysteine metabolism, may contribute to increased susceptibility to vascular occlusion and determine the severity of retinal damage. The present analysis focuses on a comparative evaluation of the clinical course of retinal vein occlusion in individuals with and without thrombophilic genetic mutations. Special attention is given to variants of the JAK2 and MTHFR genes, which are associated with alterations in hematologic regulation and vascular endothelial function. The results indicate that patients carrying these genetic variants tend to experience a more aggressive disease course, slower improvement of visual function, and a higher incidence of complications. Recognition of these molecular determinants allows improved prognostic assessment and supports the implementation of personalized diagnostic and therapeutic strategies for patients affected by retinal vascular pathology.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773721492464-Comparative_Analysis_of_the_Clinical_Course_of_Ret.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z¹</dc:creator>
      <dc:creator>Odilova A. O²</dc:creator>
      <dc:subject>retinal vein occlusion</dc:subject>
      <dc:subject>thrombophilia</dc:subject>
      <dc:subject>JAK2 mutation</dc:subject>
      <dc:subject>MTHFR polymorphism</dc:subject>
      <dc:subject>vascular thrombosis</dc:subject>
      <dc:subject>macular edema</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>retinal vascular disease</dc:subject>
      <dc:subject>visual acuity recovery</dc:subject>
      <dc:subject>genetic risk factors</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1264</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Influence of JAK2 and SOD2 Gene Polymorphisms on the Effectiveness of Treatment in Retinal Vein Occlusion</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/77bf5c5a-b50b-46d9-b10d-5b19a2fd278d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/77bf5c5a-b50b-46d9-b10d-5b19a2fd278d</guid>
      <pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z¹</author>
      <description>Retinal vein occlusion represents a major vascular disorder of the retina and is frequently associated with visual deterioration caused by impaired venous circulation, retinal ischemia, and macular edema. Although modern therapeutic strategies such as intravitreal anti-vascular endothelial growth factor therapy, corticosteroid administration, and retinal laser photocoagulation have significantly improved clinical outcomes, variability in treatment response remains a persistent clinical challenge. Increasing evidence suggests that genetic factors influencing vascular regulation and oxidative stress may contribute to these differences in therapeutic effectiveness. The present study investigates the influence of polymorphisms in the JAK2 and SOD2 genes on the response of patients with retinal vein occlusion to standard ophthalmological treatment. The analysis demonstrates that the presence of these genetic variants is associated with altered biological mechanisms affecting vascular function, inflammatory responses, and oxidative balance in retinal tissues. Patients carrying these polymorphisms exhibited reduced responsiveness to conventional therapy and a higher probability of persistent macular edema or recurrent vascular complications. The findings indicate that identification of such molecular markers may support individualized treatment planning and highlight the importance of systemic metabolic and vascular correction alongside local ophthalmic therapy. Retinal vein occlusion is a widespread vascular disorder of the retina that often leads to visual impairment due to disturbances in retinal blood circulation, tissue ischemia, and secondary macular damage. Despite the availability of effective therapeutic approaches, including intravitreal anti-VEGF injections, corticosteroid therapy, and retinal laser photocoagulation, clinical outcomes differ substantially among patients. These variations indicate the possible influence of genetic factors that affect vascular function, inflammatory responses, and oxidative balance within ocular tissues. Particular attention has been directed toward polymorphisms of the JAK2 and SOD2 genes, which are involved in intracellular signaling, hematologic regulation, and antioxidant defense. The present analysis evaluates how these genetic variations influence the response of patients with retinal vein occlusion to standard treatment protocols. The findings demonstrate that individuals carrying these polymorphisms tend to exhibit slower anatomical recovery and reduced functional improvement after conventional therapy. Recognition of these molecular characteristics allows clinicians to predict therapeutic response more accurately and suggests the necessity for modification of treatment strategies that include systemic metabolic correction and enhanced vascular protection in addition to local ophthalmic interventions.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773720551730-Influence_of_JAK2_and_SOD2_Gene_Polymorphisms_on_t.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z¹</dc:creator>
      <dc:creator>Odilova A. O²</dc:creator>
      <dc:subject>retinal vein occlusion</dc:subject>
      <dc:subject>JAK2 polymorphism</dc:subject>
      <dc:subject>SOD2 polymorphism</dc:subject>
      <dc:subject>anti-VEGF therapy</dc:subject>
      <dc:subject>retinal laser photocoagulation</dc:subject>
      <dc:subject>corticosteroid therapy</dc:subject>
      <dc:subject>oxidative stress</dc:subject>
      <dc:subject>vascular pathology</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>personalized medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1262</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 16-30</dc:source>
    </item>
    <item>
      <title>Retinal Vein Occlusion as an Ophthalmic Marker of Systemic Thrombophilia</title>
      <link>https://aams-journal.us/journals/neurology/articles/7c26b5a2-1098-4018-91e1-089f321ce2a6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/7c26b5a2-1098-4018-91e1-089f321ce2a6</guid>
      <pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z¹</author>
      <description>Retinal vein occlusion is one of the most common vascular disorders of the retina and frequently leads to visual impairment due to disturbances in retinal circulation, hemorrhage, and macular edema. Traditionally, this condition has been associated with systemic risk factors such as arterial hypertension, diabetes mellitus, and dyslipidemia. However, recent studies indicate that retinal vein occlusion may also represent an early clinical manifestation of underlying systemic thrombotic disorders that remain undiagnosed at the time of ophthalmic examination. The present study analyzes the diagnostic significance of retinal vein occlusion as a potential ophthalmological marker of hidden thrombophilic conditions. Particular attention is given to inherited and acquired abnormalities of the coagulation system that increase the risk of vascular thrombosis. The results highlight the importance of interdisciplinary collaboration between ophthalmologists, hematologists, and genetic specialists in order to identify systemic causes of retinal vascular occlusion. The findings emphasize the need for comprehensive diagnostic evaluation including genetic testing in patients presenting with retinal vein occlusion, which may contribute to early detection of systemic thrombophilia and prevention of life-threatening thrombotic complications. Retinal vein occlusion is a significant retinal vascular disorder that often results in sudden visual deterioration due to impaired venous circulation, retinal hemorrhage, and macular edema. Although this condition has traditionally been associated with systemic cardiovascular risk factors, growing evidence indicates that it may also represent an early clinical sign of underlying thrombotic predisposition. Many patients experiencing retinal venous obstruction may carry inherited or acquired abnormalities of the coagulation system that remain undiagnosed until a vascular event occurs. The present analysis evaluates the diagnostic value of retinal vein occlusion as a potential ophthalmic indicator of systemic thrombophilic disorders. Particular attention is given to the identification of hidden coagulation abnormalities through clinical assessment and molecular genetic testing. The findings demonstrate that a considerable proportion of individuals with retinal venous obstruction exhibit markers of hypercoagulability or genetic variants associated with increased thrombotic risk. Recognition of this association highlights the importance of a multidisciplinary diagnostic approach involving ophthalmologists, hematologists, and genetic specialists. Early identification of thrombophilic conditions following retinal vascular events may allow timely preventive treatment and reduce the probability of recurrent ocular complications as well as severe systemic thrombotic outcomes.</description>
      <dc:creator>Jalalova D. Z¹</dc:creator>
      <dc:creator>Odilova A. O²</dc:creator>
      <dc:subject>retinal vein occlusion</dc:subject>
      <dc:subject>thrombophilia</dc:subject>
      <dc:subject>vascular thrombosis</dc:subject>
      <dc:subject>genetic markers</dc:subject>
      <dc:subject>coagulation disorders</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>systemic diseases</dc:subject>
      <dc:subject>retinal vascular pathology</dc:subject>
      <dc:subject>interdisciplinary diagnosis</dc:subject>
      <dc:subject>personalized medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1263</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of sepsis biomarkers — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/313f59fa-1ac0-4427-b9b2-ef3c2dd72a99</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/313f59fa-1ac0-4427-b9b2-ef3c2dd72a99</guid>
      <pubDate>Tue, 17 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Chiamaka Eze</author>
      <description>Background: Sepsis biomarkers remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with sepsis biomarkers. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>sepsis</dc:subject>
      <dc:subject>sepsis biomarkers</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1034</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 113-121</dc:source>
    </item>
    <item>
      <title>Real-world evidence on health disparities: a population-based study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/27168838-38e5-49fb-afc0-42955915bf78</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/27168838-38e5-49fb-afc0-42955915bf78</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Kwame Asante</author>
      <description>Background: Health disparities remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with health disparities. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>disparities</dc:subject>
      <dc:subject>health disparities</dc:subject>
      <dc:subject>health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1064</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 77-90</dc:source>
    </item>
    <item>
      <title>Clinical and Genetic Model for Predicting Outcomes in Patients with Retinal Vein Occlusion</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/a6e6bcc1-b5ee-48d7-8187-374d124023f0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/a6e6bcc1-b5ee-48d7-8187-374d124023f0</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate>
      <author>Jalalova D. Z¹</author>
      <description>Retinal vein occlusion is one of the most common vascular disorders of the retina and represents a significant cause of visual impairment and irreversible vision loss among middle-aged and elderly populations. The disease develops due to obstruction of venous blood flow in the retinal circulation, resulting in retinal ischemia, hemorrhage, macular edema, and progressive deterioration of visual function. Despite advances in ophthalmic diagnostics and treatment strategies, the clinical course of retinal vein occlusion remains highly variable, making prediction of visual outcomes and recurrence risk challenging. The present study focuses on the development of a clinical and genetic predictive model designed to evaluate the prognosis of patients diagnosed with retinal vein occlusion. The model integrates traditional systemic risk factors such as arterial hypertension, diabetes mellitus, and dyslipidemia with molecular genetic markers including JAK2, SOD2, and MTHFR gene polymorphisms. The analysis demonstrates that combining clinical parameters with genetic indicators significantly improves the accuracy of predicting visual outcomes, the likelihood of disease progression, and the risk of recurrence. The proposed predictive model may contribute to more individualized management strategies, early identification of high-risk patients, and improved prevention of severe visual complications associated with retinal vascular occlusive disorders. Retinal vein occlusion represents a significant retinal vascular disorder that frequently leads to visual impairment due to compromised retinal circulation, ischemic damage, and secondary macular complications. The severity of visual dysfunction and the risk of recurrence vary considerably among patients, which indicates the involvement of multiple systemic and genetic determinants in disease progression. This study explores a comprehensive prognostic approach that integrates traditional clinical risk factors with molecular genetic indicators in order to improve prediction of disease outcomes. Particular emphasis is placed on systemic conditions such as arterial hypertension, diabetes mellitus, and dyslipidemia, as well as genetic polymorphisms associated with vascular dysfunction and oxidative stress, including JAK2, SOD2, and MTHFR gene variants. The combined evaluation of these parameters allows the identification of individuals with increased susceptibility to severe retinal damage and recurrent vascular events. The results demonstrate that the integration of clinical and genetic information significantly enhances prognostic accuracy and provides valuable insights for personalized patient management. Implementation of such predictive strategies may contribute to improved monitoring, earlier therapeutic intervention, and prevention of progressive visual deterioration in patients affected by retinal venous occlusive disorders.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773639334998-Clinical_and_Genetic_Model_for_Predicting_Outcomes.pdf" type="application/pdf" length="0"/>
      <dc:creator>Jalalova D. Z¹</dc:creator>
      <dc:creator>Odilova A. O²</dc:creator>
      <dc:subject>retinal vein occlusion</dc:subject>
      <dc:subject>predictive model</dc:subject>
      <dc:subject>genetic markers</dc:subject>
      <dc:subject>JAK2 gene</dc:subject>
      <dc:subject>SOD2 gene</dc:subject>
      <dc:subject>MTHFR polymorphism</dc:subject>
      <dc:subject>vascular eye disease</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:subject>visual prognosis</dc:subject>
      <dc:subject>personalized medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1260</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into psoriasis IL-17: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/dermatology/articles/aa106c0f-2655-46f3-9a4d-9c49b707135e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/aa106c0f-2655-46f3-9a4d-9c49b707135e</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Anders Lindqvist</author>
      <description>Background: Psoriasis il-17 remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with psoriasis IL-17. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>IL-17</dc:subject>
      <dc:subject>psoriasis</dc:subject>
      <dc:subject>psoriasis IL-17</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1121</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 1, pp. 314-324</dc:source>
    </item>
    <item>
      <title>Analysis of anatomical and functional results of pars plana vitrectomy in proliferative diabetic retinopathy</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/8ab96b4c-1930-483b-b1af-e843f98c4124</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/8ab96b4c-1930-483b-b1af-e843f98c4124</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ruziev Tokhir Khudoyberdi ugli¹</author>
      <description>Proliferative diabetic retinopathy represents an advanced stage of diabetic retinal disease characterized by pathological neovascularization, vitreous hemorrhage, and tractional retinal detachment that may result in severe visual impairment or blindness. Surgical intervention becomes necessary when complications such as persistent vitreous hemorrhage or tractional retinal detachment threaten the integrity of the retina and visual function. Pars plana vitrectomy is a widely used surgical technique designed to remove hemorrhagic vitreous, eliminate fibrovascular membranes, and restore normal retinal anatomy. The present study evaluates the anatomical and functional outcomes of pars plana vitrectomy performed in patients with proliferative diabetic retinopathy. Special attention is directed toward postoperative retinal stability, improvement in visual acuity, and resolution of vitreoretinal traction. The analysis demonstrates that timely surgical intervention contributes to restoration of retinal structure and provides significant improvement or stabilization of visual function in many patients affected by advanced diabetic retinal disease. Proliferative diabetic retinopathy is one of the most severe ocular complications associated with long-term diabetes mellitus and remains a leading cause of irreversible visual impairment worldwide. The pathological process is characterized by retinal ischemia, abnormal neovascularization, recurrent vitreous hemorrhage, and progressive fibrovascular proliferation that can ultimately lead to tractional retinal detachment. Surgical treatment using pars plana vitrectomy has become an important therapeutic approach for managing advanced cases where conservative treatment cannot provide adequate results. The present analysis evaluates the anatomical restoration of the retina and functional recovery of vision after vitrectomy in patients suffering from proliferative diabetic retinal disease. Special attention is directed toward postoperative retinal reattachment, changes in visual acuity, and the elimination of vitreoretinal traction. Clinical observations demonstrate that timely surgical intervention allows removal of pathological tissues, improves retinal stability, and facilitates gradual improvement of visual function. These findings highlight the importance of early surgical decision-making and comprehensive postoperative monitoring in order to achieve favorable outcomes in patients with complicated diabetic retinal pathology.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773642813493-Analysis_of_anatomical_and_functional_results_of_p.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ruziev Tokhir Khudoyberdi ugli¹</dc:creator>
      <dc:creator>Boboev Siyovush Saidavzalzoda²</dc:creator>
      <dc:subject>proliferative diabetic retinopathy</dc:subject>
      <dc:subject>pars plana vitrectomy</dc:subject>
      <dc:subject>vitreous hemorrhage</dc:subject>
      <dc:subject>tractional retinal detachment</dc:subject>
      <dc:subject>diabetic eye disease</dc:subject>
      <dc:subject>retinal surgery</dc:subject>
      <dc:subject>visual acuity</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1261</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Results of combined treatment with anti-VEGF therapy and pars plana vitrectomy for diabetic macular edema</title>
      <link>https://aams-journal.us/journals/neurology/articles/0cda0a1a-e35f-4612-971b-33a70ff1cea9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/0cda0a1a-e35f-4612-971b-33a70ff1cea9</guid>
      <pubDate>Sun, 15 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ruziev Tokhir Khudoyberdi ugli¹</author>
      <description>Diabetic macular edema is one of the leading causes of visual impairment among patients with diabetes mellitus and represents a major challenge in modern ophthalmology. The condition develops as a result of chronic microvascular damage, increased vascular permeability, and accumulation of extracellular fluid in the macular region of the retina. Anti-vascular endothelial growth factor therapy has become a widely used pharmacological strategy aimed at reducing vascular permeability and inhibiting pathological angiogenesis. However, in certain cases, particularly those associated with vitreomacular traction or persistent edema, pharmacological treatment alone may not achieve sufficient anatomical and functional improvement. Pars plana vitrectomy offers a surgical approach that removes vitreous traction and improves retinal oxygenation, thereby contributing to resolution of macular edema. The present study evaluates the outcomes of combined therapy involving intravitreal anti-VEGF injections and pars plana vitrectomy in patients with diabetic macular edema. The analysis focuses on changes in retinal morphology, improvement in visual acuity, and stabilization of macular structure following treatment. The findings indicate that the integrated use of pharmacological and surgical approaches provides significant benefits in reducing retinal swelling and improving functional visual outcomes. Diabetic macular edema represents one of the most significant causes of central vision deterioration among individuals with long-standing diabetes mellitus. The condition arises from microvascular damage within the retinal circulation, leading to increased permeability of capillary walls and subsequent accumulation of extracellular fluid in the macular region. Intravitreal therapy targeting vascular endothelial growth factor has become a cornerstone of modern treatment because it suppresses abnormal vascular permeability and reduces inflammatory responses within retinal tissues. Nevertheless, some patients demonstrate incomplete anatomical resolution or persistent retinal thickening due to mechanical factors such as vitreomacular traction or epiretinal membrane formation. Surgical intervention through pars plana vitrectomy may address these mechanical components by removing the vitreous body and relieving tractional forces on the macula. Evaluation of the combined therapeutic strategy involving pharmacological inhibition of angiogenic activity and surgical elimination of vitreoretinal traction provides important insight into improving clinical outcomes. The analysis indicates that integration of these treatment approaches contributes to significant reduction of retinal edema, restoration of macular architecture, and improvement of central visual function.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773599984244-Results_of_combined_treatment_with_anti_VEGF_thera.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ruziev Tokhir Khudoyberdi ugli¹</dc:creator>
      <dc:creator>Boboev Siyovush Saidavzalzoda²</dc:creator>
      <dc:subject>diabetic macular edema</dc:subject>
      <dc:subject>anti-VEGF therapy</dc:subject>
      <dc:subject>pars plana vitrectomy</dc:subject>
      <dc:subject>retinal edema</dc:subject>
      <dc:subject>diabetic retinopathy</dc:subject>
      <dc:subject>intravitreal injections</dc:subject>
      <dc:subject>macular thickness</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1259</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Diagnostic accuracy of artificial intelligence in ADHD interventions</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/a009926d-488f-4de9-8725-379990a01b3e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/a009926d-488f-4de9-8725-379990a01b3e</guid>
      <pubDate>Sun, 15 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Reza Mohammadi</author>
      <description>Background: Adhd interventions remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with ADHD interventions. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>ADHD interventions</dc:subject>
      <dc:subject>interventions</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>ADHD</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1008</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 198-210</dc:source>
    </item>
    <item>
      <title>Comparative assessment of the effect of gas and silicone tamponade on the anatomical fit of the retina and visual functions after pars plana vitrectomy for retinal detachment</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/a7d70711-df8b-42d6-b365-43d07f6a0a55</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/a7d70711-df8b-42d6-b365-43d07f6a0a55</guid>
      <pubDate>Sun, 15 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ruziev Tokhir Khudoyberdi ugli¹</author>
      <description>Retinal detachment is a serious ophthalmic condition that can lead to permanent vision loss if not treated promptly and effectively. Pars plana vitrectomy has become one of the most widely used surgical methods for the management of retinal detachment, allowing removal of the vitreous body, elimination of traction forces, and restoration of the normal anatomical position of the retina. An important stage of this procedure involves the use of intraocular tamponade agents to support retinal reattachment during postoperative healing. The two most commonly used tamponade substances are expansile intraocular gases and silicone oil, each possessing specific physical and clinical properties. Gas tamponade provides temporary support and gradually absorbs over time, while silicone oil offers long-term stabilization but requires later removal. This study presents a comparative assessment of the effectiveness of gas and silicone tamponade in achieving retinal reattachment and improving visual outcomes after pars plana vitrectomy in patients with retinal detachment. The analysis evaluates anatomical success rates, functional visual recovery, and postoperative complications associated with each tamponade method. The results indicate that both approaches are effective in restoring retinal structure, although differences exist in postoperative management, visual recovery patterns, and long-term anatomical stability. Retinal detachment is a vision-threatening ophthalmic condition that requires timely surgical intervention to restore the normal anatomical structure of the eye and preserve visual function. Pars plana vitrectomy has become one of the most effective surgical approaches for the treatment of this pathology. A crucial stage of this procedure is the application of intraocular tamponade agents that stabilize the retina against the retinal pigment epithelium during the postoperative healing period. Among the most commonly used tamponade substances are expansile gases and silicone oil, each possessing distinct physical characteristics and clinical advantages. Gas tamponades provide temporary internal pressure that gradually decreases as the gas is absorbed, while silicone oil offers prolonged mechanical support inside the vitreous cavity. Rhegmatogenous retinal detachment remains one of the most urgent conditions in vitreoretinal surgery because separation of the neurosensory retina from the underlying pigment epithelium leads to rapid deterioration of photoreceptor function and progressive vision loss. Pars plana vitrectomy has become a standard surgical technique for restoring retinal attachment by removing vitreous traction and sealing retinal breaks. A critical stage of the procedure is the use of intraocular tamponade substances that provide internal support to the retina during postoperative healing</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773599665343-Comparative_assessment_of_the_effect_of_gas_and_si.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ruziev Tokhir Khudoyberdi ugli¹</dc:creator>
      <dc:creator>Boboev Siyovush Saidavzalzoda²</dc:creator>
      <dc:subject>retinal detachment</dc:subject>
      <dc:subject>pars plana vitrectomy</dc:subject>
      <dc:subject>gas tamponade</dc:subject>
      <dc:subject>silicone oil tamponade</dc:subject>
      <dc:subject>retinal reattachment</dc:subject>
      <dc:subject>vitreoretinal surgery</dc:subject>
      <dc:subject>visual recovery</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1258</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into multidrug-resistant tuberculosis: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/4fae0391-cfa2-4e55-91e2-5c60b7d08383</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/4fae0391-cfa2-4e55-91e2-5c60b7d08383</guid>
      <pubDate>Sun, 15 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Aisha Mahmoud</author>
      <description>Background: Multidrug-resistant tuberculosis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with multidrug-resistant tuberculosis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>tuberculosis</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>multidrug-resistant tuberculosis</dc:subject>
      <dc:subject>multidrug-resistant</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1105</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 1, pp. 355-363</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of vitiligo JAK inhibitors assessment instruments</title>
      <link>https://aams-journal.us/journals/dermatology/articles/90459ab1-c292-4e50-b1b4-450a86ae0833</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/90459ab1-c292-4e50-b1b4-450a86ae0833</guid>
      <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Vitiligo jak inhibitors remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with vitiligo JAK inhibitors. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>vitiligo JAK inhibitors</dc:subject>
      <dc:subject>vitiligo</dc:subject>
      <dc:subject>JAK</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1127</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 334-343</dc:source>
    </item>
    <item>
      <title>heart failure: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/4cfe4e6c-11f6-417e-917e-1d517853cddd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/4cfe4e6c-11f6-417e-917e-1d517853cddd</guid>
      <pubDate>Sat, 14 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Wei Zhang</author>
      <description>Background: Heart failure remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with heart failure. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>failure</dc:subject>
      <dc:subject>heart</dc:subject>
      <dc:subject>heart failure</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1030</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 260-270</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of trauma damage control interventions</title>
      <link>https://aams-journal.us/journals/surgery/articles/f322fb8b-34a3-4fb7-97bf-982e3c7a0c5b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/f322fb8b-34a3-4fb7-97bf-982e3c7a0c5b</guid>
      <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Aleksandra Kowalski</author>
      <description>Background: Trauma damage control remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with trauma damage control. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>trauma</dc:subject>
      <dc:subject>trauma damage control</dc:subject>
      <dc:subject>damage</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1138</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 340-353</dc:source>
    </item>
    <item>
      <title>Results of conservative treatment of patients with pseudoexfoliative glaucoma.</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/0baceebc-ae64-4bda-b13f-65785df73664</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/0baceebc-ae64-4bda-b13f-65785df73664</guid>
      <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
      <author>Boboev Saidavzal Abdurakhmanovich¹</author>
      <description>Pseudoexfoliative glaucoma is a progressive form of secondary open-angle glaucoma associated with the deposition of abnormal fibrillar material in ocular tissues and a significant increase in intraocular pressure. The disease is characterized by a more aggressive clinical course compared with other types of glaucoma and often leads to rapid visual field deterioration if not properly managed. Conservative treatment, primarily based on pharmacological therapy aimed at lowering intraocular pressure, remains an essential approach in the early and moderate stages of the disease. The present study evaluates the effectiveness of conservative management in patients diagnosed with pseudoexfoliative glaucoma and analyzes its impact on intraocular pressure control, visual field preservation, and structural stability of the optic nerve. The findings demonstrate that timely pharmacological intervention can significantly reduce intraocular pressure, slow the progression of glaucomatous optic neuropathy, and improve long-term clinical outcomes when regular monitoring and adherence to therapy are maintained. Pseudoexfoliative glaucoma is considered one of the most aggressive forms of secondary glaucoma and is frequently associated with progressive visual impairment due to sustained elevation of intraocular pressure. The condition develops as a result of abnormal accumulation of fibrillar extracellular material within ocular structures, particularly affecting the trabecular meshwork and leading to disruption of aqueous humor circulation. Pharmacological therapy remains the primary non-surgical approach in the management of this condition, especially in early and moderate stages. Evaluation of treatment outcomes is essential for determining the effectiveness of conservative strategies in stabilizing intraocular pressure and slowing structural damage to the optic nerve. The present analysis focuses on the clinical effectiveness of non-surgical management in individuals diagnosed with pseudoexfoliative glaucoma, emphasizing the ability of topical antiglaucoma medications to reduce intraocular pressure, maintain functional visual parameters, and delay disease progression. The findings indicate that timely and properly adjusted pharmacological therapy contributes significantly to stabilization of the pathological process and preservation of visual function.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773393736010-Results_of_conservative_treatment_of_patients_with.pdf" type="application/pdf" length="0"/>
      <dc:creator>Boboev Saidavzal Abdurakhmanovich¹</dc:creator>
      <dc:creator>Baylatova Shokhida Shirinbaevna²</dc:creator>
      <dc:subject>pseudoexfoliative glaucoma</dc:subject>
      <dc:subject>conservative treatment</dc:subject>
      <dc:subject>intraocular pressure</dc:subject>
      <dc:subject>glaucoma therapy</dc:subject>
      <dc:subject>optic nerve damage</dc:subject>
      <dc:subject>ocular pharmacology</dc:subject>
      <dc:subject>visual field preservation</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1255</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>The effectiveness of pterygiumectomy using conjunctival autoplasty using bioglue</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/99963f65-8f1f-4fc8-9fe0-496226cb316a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/99963f65-8f1f-4fc8-9fe0-496226cb316a</guid>
      <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
      <author>Boboev Saidavzal Abdurakhmanovich¹</author>
      <description>Pterygium is a common ocular surface disorder characterized by fibrovascular proliferation of conjunctival tissue that extends onto the cornea and may lead to visual disturbance, chronic irritation, and cosmetic concerns. Surgical removal remains the primary method of treatment, especially in progressive cases where the lesion threatens the visual axis or causes significant discomfort. Traditional surgical techniques often involve suturing conjunctival grafts, which may prolong operation time and increase postoperative inflammation and patient discomfort. The use of bioglue for fixation of conjunctival autografts has recently emerged as an alternative approach aimed at improving surgical outcomes and reducing complications. This study evaluates the clinical effectiveness of pterygiumectomy combined with conjunctival autoplasty using bioglue fixation. Particular attention is given to operative time, postoperative recovery, recurrence rates, and patient comfort. The results indicate that bioglue-assisted conjunctival autografting provides stable graft fixation, reduces surgical trauma, shortens recovery time, and contributes to lower recurrence rates compared with traditional suturing techniques. Pterygium is a common ocular surface disorder characterized by the growth of fibrovascular conjunctival tissue onto the corneal surface, which may result in chronic irritation, inflammation, and progressive visual disturbance. Surgical removal remains the most effective treatment, especially when the lesion advances toward the visual axis or causes significant discomfort. One of the most widely accepted surgical methods for preventing recurrence is conjunctival autografting following pterygium excision. In recent years, biological adhesives have been introduced as an alternative to traditional suturing techniques for graft fixation. The use of bioglue allows rapid attachment of the conjunctival graft while minimizing tissue trauma and postoperative inflammation. This study evaluates the clinical outcomes of pterygiumectomy combined with conjunctival autoplasty using biological adhesive fixation. Particular attention is given to surgical efficiency, postoperative recovery, graft stability, and recurrence prevention. The findings demonstrate that the application of biological adhesive materials significantly improves surgical convenience, shortens operation time, enhances patient comfort, and contributes to favorable healing of the ocular surface.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773394091054-The_effectiveness_of_pterygiumectomy_using_conjunc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Boboev Saidavzal Abdurakhmanovich¹</dc:creator>
      <dc:creator>Gaffarov Ganisher Karimovich²</dc:creator>
      <dc:subject>pterygium</dc:subject>
      <dc:subject>pterygiumectomy</dc:subject>
      <dc:subject>conjunctival autograft</dc:subject>
      <dc:subject>bioglue</dc:subject>
      <dc:subject>ocular surface surgery</dc:subject>
      <dc:subject>recurrence prevention</dc:subject>
      <dc:subject>ophthalmic surgery</dc:subject>
      <dc:subject>corneal disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1256</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Comparative Analysis of Methods of Traditional and Autoplastic Surgical Treatment of Primary Pterygium</title>
      <link>https://aams-journal.us/journals/neurology/articles/3598ac83-4542-4890-99c9-e5a68dd7c619</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/3598ac83-4542-4890-99c9-e5a68dd7c619</guid>
      <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
      <author>Boboev Saidavzal Abdurakhmanovich¹</author>
      <description>Primary pterygium is a common ocular surface disorder characterized by fibrovascular proliferation of conjunctival tissue extending onto the cornea. The disease often leads to chronic ocular irritation, cosmetic problems, and progressive visual impairment when the lesion advances toward the visual axis. Surgical excision remains the most effective method of treatment; however, recurrence after surgery continues to be a significant clinical challenge. Traditional excision techniques without tissue replacement have been associated with relatively high recurrence rates due to continued fibrovascular proliferation from the conjunctiva. Autoplastic surgical approaches, particularly conjunctival autografting, have been introduced to reduce recurrence and improve postoperative outcomes. The present study provides a comparative evaluation of traditional surgical excision and autoplastic treatment methods in patients with primary pterygium. The analysis focuses on operative characteristics, postoperative healing, recurrence rates, and visual outcomes. The findings demonstrate that autoplastic surgical techniques offer superior clinical effectiveness, improved tissue regeneration, and significantly lower recurrence compared with traditional excision methods. Primary pterygium is a frequent ocular surface pathology characterized by fibrovascular proliferation originating from the conjunctiva and gradually spreading over the corneal surface. This process can lead to persistent ocular irritation, inflammatory changes, and progressive visual impairment when the lesion approaches the optical zone of the cornea. Surgical removal remains the principal method of treatment; however, recurrence after excision has long been recognized as a major clinical challenge. Traditional surgical techniques involving simple removal of pathological tissue without reconstruction often demonstrate high recurrence rates due to continued conjunctival proliferation. In contrast, autoplastic surgical approaches such as conjunctival autografting aim to restore anatomical integrity of the ocular surface and reduce the likelihood of recurrent fibrovascular growth. Comparative evaluation of these treatment strategies is essential for determining the most effective surgical method for primary pterygium management. The present analysis highlights differences in postoperative outcomes, tissue healing, and recurrence prevention between traditional excision techniques and autoplastic reconstruction procedures.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773394429875-Comparative_Analysis_of_Methods_of_Traditional_and.pdf" type="application/pdf" length="0"/>
      <dc:creator>Boboev Saidavzal Abdurakhmanovich¹</dc:creator>
      <dc:creator>Gaffarov Ganisher Karimovich²</dc:creator>
      <dc:subject>primary pterygium</dc:subject>
      <dc:subject>pterygium surgery</dc:subject>
      <dc:subject>conjunctival autograft</dc:subject>
      <dc:subject>autoplastic surgery</dc:subject>
      <dc:subject>ocular surface disease</dc:subject>
      <dc:subject>recurrence prevention</dc:subject>
      <dc:subject>ophthalmic surgery</dc:subject>
      <dc:subject>corneal disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1257</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 07, Issue 03</dc:source>
    </item>
    <item>
      <title>Study of morphological markers in patients with pseudoexfoliation glaucoma.</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/83ff16ec-e72d-423d-8796-efaf8ffa9bcc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/83ff16ec-e72d-423d-8796-efaf8ffa9bcc</guid>
      <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
      <author>Boboev Saidavzal Abdurakhmanovich¹</author>
      <description>Pseudoexfoliation glaucoma is a progressive form of secondary open-angle glaucoma associated with the accumulation of abnormal fibrillar extracellular material in ocular tissues. This pathological process affects multiple structures within the anterior segment of the eye, including the lens capsule, iris, ciliary body, trabecular meshwork, and corneal endothelium. Structural alterations in these tissues contribute to impaired aqueous humor outflow, increased intraocular pressure, and progressive optic nerve damage. Identification of morphological markers plays a crucial role in early diagnosis and monitoring of disease progression. Modern ophthalmological imaging techniques, including optical coherence tomography and confocal microscopy, provide detailed evaluation of ocular tissue structure and enable detection of subtle morphological changes associated with pseudoexfoliation syndrome. The aim of this study is to investigate morphological characteristics observed in patients with pseudoexfoliation glaucoma and to determine their diagnostic and prognostic significance. Understanding structural alterations associated with this condition contributes to improved early detection and more effective management of glaucomatous optic neuropathy. Pseudoexfoliation glaucoma represents a severe form of secondary open-angle glaucoma characterized by progressive optic neuropathy and distinctive structural alterations within ocular tissues. The disease develops as a consequence of abnormal production and accumulation of fibrillar extracellular material that deposits on various structures of the anterior segment of the eye. These deposits contribute to dysfunction of the trabecular meshwork, obstruction of aqueous humor outflow, and a subsequent increase in intraocular pressure. Continuous elevation of intraocular pressure eventually leads to degeneration of retinal ganglion cells and damage to the optic nerve head. Identification of morphological indicators associated with this condition plays a crucial role in early detection and evaluation of disease progression. Modern ophthalmic diagnostic technologies provide high-resolution visualization of ocular microstructures, allowing clinicians to detect structural abnormalities at early stages. Careful assessment of these morphological characteristics contributes to improved clinical decision-making and development of more effective therapeutic strategies aimed at preserving visual function.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773393293006-Study_of_morphological_markers_in_patients_with_ps.pdf" type="application/pdf" length="0"/>
      <dc:creator>Boboev Saidavzal Abdurakhmanovich¹</dc:creator>
      <dc:creator>Baylatova Shokhida Shirinbaevna²</dc:creator>
      <dc:subject>pseudoexfoliation glaucoma</dc:subject>
      <dc:subject>morphological markers</dc:subject>
      <dc:subject>optic nerve damage</dc:subject>
      <dc:subject>intraocular pressure</dc:subject>
      <dc:subject>trabecular meshwork</dc:subject>
      <dc:subject>ocular pathology</dc:subject>
      <dc:subject>glaucoma diagnosis</dc:subject>
      <dc:subject>ophthalmology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1254</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 07, Issue 03</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following peripheral neuropathy</title>
      <link>https://aams-journal.us/journals/neurology/articles/b2483875-441b-4f33-894d-8b15cbcbee92</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/b2483875-441b-4f33-894d-8b15cbcbee92</guid>
      <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Henrik Larsen</author>
      <description>Background: Peripheral neuropathy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with peripheral neuropathy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:subject>neuropathy</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>peripheral neuropathy</dc:subject>
      <dc:subject>peripheral</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1053</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 311-320</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of blood culture turnaround interventions</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/fce9cda6-b1ae-4edf-925e-13c7ff6b625a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/fce9cda6-b1ae-4edf-925e-13c7ff6b625a</guid>
      <pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Sven Eriksson</author>
      <description>Background: Blood culture turnaround remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with blood culture turnaround. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>blood</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>culture</dc:subject>
      <dc:subject>blood culture turnaround</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1095</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 2, pp. 88-101</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of CRISPR therapeutics: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/genetics/articles/feb34830-6593-4d6c-8cc8-b5dda943eaec</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/feb34830-6593-4d6c-8cc8-b5dda943eaec</guid>
      <pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Hiroshi Yamamoto</author>
      <description>Background: Crispr therapeutics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with CRISPR therapeutics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:subject>therapeutics</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>CRISPR therapeutics</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>CRISPR</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1076</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 2, pp. 300-312</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for pediatric eczema in tertiary care settings</title>
      <link>https://aams-journal.us/journals/dermatology/articles/00ae2a9b-2c3a-4007-8513-a0e16dc9c276</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/00ae2a9b-2c3a-4007-8513-a0e16dc9c276</guid>
      <pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Hee-Jin Lee</author>
      <description>Background: Pediatric eczema remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric eczema. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>eczema</dc:subject>
      <dc:subject>pediatric eczema</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1131</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 124-133</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of fungal endemic mycoses</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/0c12361e-db41-4b7d-8dc0-7bdf9ef25b4f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/0c12361e-db41-4b7d-8dc0-7bdf9ef25b4f</guid>
      <pubDate>Thu, 12 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Yuki Tanaka</author>
      <description>Background: Fungal endemic mycoses remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with fungal endemic mycoses. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>fungal</dc:subject>
      <dc:subject>endemic</dc:subject>
      <dc:subject>fungal endemic mycoses</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1112</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 96-103</dc:source>
    </item>
    <item>
      <title>Real-world evidence on dental implants: a population-based study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/3dfda852-990c-43a6-bc54-f8da25ae67dd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/3dfda852-990c-43a6-bc54-f8da25ae67dd</guid>
      <pubDate>Wed, 11 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Sven Eriksson</author>
      <description>Background: Dental implants remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with dental implants. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:subject>dental</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>dental implants</dc:subject>
      <dc:subject>implants</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1015</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 32-44</dc:source>
    </item>
    <item>
      <title>Predictive biomarkers in Guillain-Barré syndrome: systematic review and meta-analysis</title>
      <link>https://aams-journal.us/journals/neurology/articles/e493402f-e3d3-4c97-aa8f-fb16879a18cc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/e493402f-e3d3-4c97-aa8f-fb16879a18cc</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Chiamaka Eze</author>
      <description>Background: Guillain-barré syndrome remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with Guillain-Barré syndrome. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>Guillain-Barré</dc:subject>
      <dc:subject>syndrome</dc:subject>
      <dc:subject>Guillain-Barré syndrome</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1055</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 1, pp. 119-129</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for vaccine immunogenicity</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/9c12c925-3d84-447d-96fd-a4cae5a18828</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/9c12c925-3d84-447d-96fd-a4cae5a18828</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Vaccine immunogenicity remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with vaccine immunogenicity. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>vaccine immunogenicity</dc:subject>
      <dc:subject>vaccine</dc:subject>
      <dc:subject>immunogenicity</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1003</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 194-201</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following migraine prophylaxis</title>
      <link>https://aams-journal.us/journals/neurology/articles/de352a80-ee2d-4480-9c27-7a8a84b584d4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/de352a80-ee2d-4480-9c27-7a8a84b584d4</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Olufemi Adebayo</author>
      <description>Background: Migraine prophylaxis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with migraine prophylaxis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>migraine</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>prophylaxis</dc:subject>
      <dc:subject>migraine prophylaxis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1050</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 371-385</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of amyotrophic lateral sclerosis</title>
      <link>https://aams-journal.us/journals/neurology/articles/6c7bdb1c-05bc-4354-ae0b-54550a577e3e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/6c7bdb1c-05bc-4354-ae0b-54550a577e3e</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Ingrid Sørensen</author>
      <description>Background: Amyotrophic lateral sclerosis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with amyotrophic lateral sclerosis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>lateral</dc:subject>
      <dc:subject>amyotrophic lateral sclerosis</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>amyotrophic</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1051</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 24-30</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of eating disorders versus standard care</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/461a4ad8-a7c9-4638-902e-9a59ab5c44da</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/461a4ad8-a7c9-4638-902e-9a59ab5c44da</guid>
      <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Wei Zhang</author>
      <description>Background: Eating disorders remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with eating disorders. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>eating</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>disorders</dc:subject>
      <dc:subject>eating disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1173</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 2, pp. 168-174</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for atopic dermatitis biologics in tertiary care settings</title>
      <link>https://aams-journal.us/journals/dermatology/articles/cb0df030-160b-45f9-87ca-85e1678898d4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/cb0df030-160b-45f9-87ca-85e1678898d4</guid>
      <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Edwin Otieno</author>
      <description>Background: Atopic dermatitis biologics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with atopic dermatitis biologics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>atopic dermatitis biologics</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>dermatitis</dc:subject>
      <dc:subject>atopic</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1120</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 204-215</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of PTSD psychotherapy: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/eba627bb-9f05-4c3b-88b2-94d0000fc41a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/eba627bb-9f05-4c3b-88b2-94d0000fc41a</guid>
      <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Hiroshi Yamamoto</author>
      <description>Background: Ptsd psychotherapy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with PTSD psychotherapy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:subject>PTSD psychotherapy</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>PTSD</dc:subject>
      <dc:subject>psychotherapy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1167</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 1, pp. 9-23</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of point-of-care ultrasound — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/f2f74eed-2a97-47a1-bf5a-d0e18d8700cd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/f2f74eed-2a97-47a1-bf5a-d0e18d8700cd</guid>
      <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Rashid Khan</author>
      <description>Background: Point-of-care ultrasound remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with point-of-care ultrasound. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>ultrasound</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>point-of-care ultrasound</dc:subject>
      <dc:subject>point-of-care</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1071</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 328-340</dc:source>
    </item>
    <item>
      <title>clinical decision support: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/77f4f421-3046-40c6-96b9-3abf924a9759</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/77f4f421-3046-40c6-96b9-3abf924a9759</guid>
      <pubDate>Mon, 09 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ananya Iyer</author>
      <description>Background: Clinical decision support remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with clinical decision support. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:subject>decision</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>clinical decision support</dc:subject>
      <dc:subject>clinical</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1070</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 1, pp. 119-132</dc:source>
    </item>
    <item>
      <title>oral microbiome: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/dentistry/articles/180d884f-6724-4db6-86e0-ddf1c0373e5a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/180d884f-6724-4db6-86e0-ddf1c0373e5a</guid>
      <pubDate>Sun, 08 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Mei-Ling Chen</author>
      <description>Background: Oral microbiome remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with oral microbiome. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>oral</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>microbiome</dc:subject>
      <dc:subject>oral microbiome</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1019</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 207-214</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following Parkinson&apos;s deep brain stimulation</title>
      <link>https://aams-journal.us/journals/neurology/articles/0fb1d193-9941-452f-a02e-842904c84b78</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/0fb1d193-9941-452f-a02e-842904c84b78</guid>
      <pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Wei Zhang</author>
      <description>Background: Parkinson&apos;s deep brain stimulation remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with Parkinson&apos;s deep brain stimulation. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:subject>Parkinson&apos;s</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>deep</dc:subject>
      <dc:subject>Parkinson&apos;s deep brain stimulation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1047</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 285-291</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of diabetic retinopathy anti-VEGF</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/5e1963e5-2bff-4117-8f53-d8adede55015</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/5e1963e5-2bff-4117-8f53-d8adede55015</guid>
      <pubDate>Sat, 07 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Aleksandra Kowalski</author>
      <description>Background: Diabetic retinopathy anti-vegf remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with diabetic retinopathy anti-VEGF. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:subject>diabetic retinopathy anti-VEGF</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>retinopathy</dc:subject>
      <dc:subject>diabetic</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1150</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 32-46</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following thyroid disorders</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/ead9d02e-c7e1-46f6-b9d1-7727b607c1d8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/ead9d02e-c7e1-46f6-b9d1-7727b607c1d8</guid>
      <pubDate>Fri, 06 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Thyroid disorders remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with thyroid disorders. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>thyroid disorders</dc:subject>
      <dc:subject>disorders</dc:subject>
      <dc:subject>thyroid</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1039</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 173-185</dc:source>
    </item>
    <item>
      <title>Real-world evidence on sexually transmitted infections: a population-based study</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/155bfa73-da45-4bab-8b95-68adacd6ec04</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/155bfa73-da45-4bab-8b95-68adacd6ec04</guid>
      <pubDate>Fri, 06 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Wei Zhang</author>
      <description>Background: Sexually transmitted infections remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with sexually transmitted infections. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>sexually</dc:subject>
      <dc:subject>sexually transmitted infections</dc:subject>
      <dc:subject>transmitted</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1114</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 357-370</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of corneal transplantation</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/f4765f6f-777d-43e7-a724-2f0e3ba76a16</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/f4765f6f-777d-43e7-a724-2f0e3ba76a16</guid>
      <pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Olufemi Adebayo</author>
      <description>Background: Corneal transplantation remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with corneal transplantation. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:subject>corneal transplantation</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>corneal</dc:subject>
      <dc:subject>transplantation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1159</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 116-126</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of cytopathology</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/0b539e40-2d63-4ce3-81e9-a4a09d3ee8d9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/0b539e40-2d63-4ce3-81e9-a4a09d3ee8d9</guid>
      <pubDate>Thu, 05 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Cytopathology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with cytopathology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>cytopathology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1100</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 2, pp. 310-323</dc:source>
    </item>
    <item>
      <title>Diagnostic accuracy of artificial intelligence in pediatric asthma</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/98ed4c99-f63d-466e-9701-eade2dd1fa5f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/98ed4c99-f63d-466e-9701-eade2dd1fa5f</guid>
      <pubDate>Wed, 04 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Hans Müller</author>
      <description>Background: Pediatric asthma remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric asthma. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>pediatric asthma</dc:subject>
      <dc:subject>asthma</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1000</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 115-123</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for health literacy</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/337b9dd9-a791-4c32-b642-3370cf2e4b61</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/337b9dd9-a791-4c32-b642-3370cf2e4b61</guid>
      <pubDate>Wed, 04 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Health literacy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with health literacy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>literacy</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>health</dc:subject>
      <dc:subject>health literacy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1073</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 348-356</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of hidradenitis suppurativa interventions</title>
      <link>https://aams-journal.us/journals/dermatology/articles/d9506f7d-d1b7-477f-80c9-1cd5f0d11c11</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/d9506f7d-d1b7-477f-80c9-1cd5f0d11c11</guid>
      <pubDate>Tue, 03 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Bongani Mthembu</author>
      <description>Background: Hidradenitis suppurativa remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with hidradenitis suppurativa. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>suppurativa</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>hidradenitis</dc:subject>
      <dc:subject>hidradenitis suppurativa</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1124</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 1, pp. 65-76</dc:source>
    </item>
    <item>
      <title>Real-world evidence on reference interval harmonization: a population-based study</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/263673e3-392d-42c9-bdb2-cfbfbd0479f9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/263673e3-392d-42c9-bdb2-cfbfbd0479f9</guid>
      <pubDate>Tue, 03 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Mehmet Yıldız</author>
      <description>Background: Reference interval harmonization remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with reference interval harmonization. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>reference</dc:subject>
      <dc:subject>reference interval harmonization</dc:subject>
      <dc:subject>interval</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1097</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 89-97</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of anemia workup</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/43bbf4e5-9a7b-4edc-ad98-2071006399e8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/43bbf4e5-9a7b-4edc-ad98-2071006399e8</guid>
      <pubDate>Tue, 03 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Daniel Cohen</author>
      <description>Background: Anemia workup remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with anemia workup. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>workup</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>anemia</dc:subject>
      <dc:subject>anemia workup</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1041</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 1, pp. 180-189</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of adolescent suicide prevention interventions</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/fe015071-c5d6-4ec4-8a73-e99e853eb4fd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/fe015071-c5d6-4ec4-8a73-e99e853eb4fd</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Sophia Rossi</author>
      <description>Background: Adolescent suicide prevention remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with adolescent suicide prevention. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>suicide</dc:subject>
      <dc:subject>adolescent suicide prevention</dc:subject>
      <dc:subject>adolescent</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1170</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 2, pp. 290-297</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of hernia mesh: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/surgery/articles/92b87bf3-a424-4ac5-9cfe-e97182d50190</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/92b87bf3-a424-4ac5-9cfe-e97182d50190</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Emma Williams</author>
      <description>Background: Hernia mesh remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with hernia mesh. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>hernia mesh</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>mesh</dc:subject>
      <dc:subject>hernia</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1143</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 165-175</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following robotic prostatectomy</title>
      <link>https://aams-journal.us/journals/surgery/articles/34f11107-4b12-4ca9-acf1-cdc02bcc27fa</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/34f11107-4b12-4ca9-acf1-cdc02bcc27fa</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Chiamaka Eze</author>
      <description>Background: Robotic prostatectomy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with robotic prostatectomy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>robotic</dc:subject>
      <dc:subject>robotic prostatectomy</dc:subject>
      <dc:subject>prostatectomy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1136</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 336-345</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for cerebral venous thrombosis</title>
      <link>https://aams-journal.us/journals/neurology/articles/6201b396-7973-4b9f-9d5c-e79b94e96e4a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/6201b396-7973-4b9f-9d5c-e79b94e96e4a</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <author>Prof. Hans Müller</author>
      <description>Background: Cerebral venous thrombosis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with cerebral venous thrombosis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:subject>cerebral</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>cerebral venous thrombosis</dc:subject>
      <dc:subject>venous</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1058</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 1, pp. 345-355</dc:source>
    </item>
    <item>
      <title>Real-world evidence on pediatric dentistry: a population-based study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e7a103ef-a5e2-41a7-b7df-0b673a3ab197</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e7a103ef-a5e2-41a7-b7df-0b673a3ab197</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dr. Eva Andersson</author>
      <description>Background: Pediatric dentistry remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric dentistry. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>pediatric dentistry</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>dentistry</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1024</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 2, pp. 283-295</dc:source>
    </item>
    <item>
      <title>Regenerative Endodontics in Immature Permanent Teeth: A Prospective Clinical Study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/3758d658-5d3a-4eb9-8ffc-e249941c26d5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/3758d658-5d3a-4eb9-8ffc-e249941c26d5</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Martínez JA</author>
      <description>Prospective clinical study evaluating root development and periapical healing after regenerative endodontic procedures in 165 immature permanent teeth with pulp necrosis.</description>
      <dc:creator>Martínez JA</dc:creator>
      <dc:creator>Hassan NM</dc:creator>
      <dc:creator>Virtanen A</dc:creator>
      <dc:subject>regenerative endodontics</dc:subject>
      <dc:subject>revascularization</dc:subject>
      <dc:subject>immature teeth</dc:subject>
      <dc:subject>pulp regeneration</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1199</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 68-75</dc:source>
    </item>
    <item>
      <title>Impact of Time-Restricted Eating on Metabolic Parameters in Type 2 Diabetes</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/29065fd8-be9f-4c11-b470-b6f3207a9ff6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/29065fd8-be9f-4c11-b470-b6f3207a9ff6</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Chang TY</author>
      <description>Randomized controlled trial comparing 16:8 time-restricted eating with standard dietary advice on glycemic control and metabolic parameters in 440 patients with type 2 diabetes over 12 months.</description>
      <dc:creator>Chang TY</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Fischer M</dc:creator>
      <dc:subject>time-restricted eating</dc:subject>
      <dc:subject>type 2 diabetes</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>intermittent fasting</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1212</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 31-38</dc:source>
    </item>
    <item>
      <title>Universal Health Coverage and Health Outcomes: A Difference-in-Differences Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/79aebacb-f2c4-4171-9ce8-0322242f71e3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/79aebacb-f2c4-4171-9ce8-0322242f71e3</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Larsen B</author>
      <description>Difference-in-differences analysis evaluating the impact of universal health coverage implementation on health outcomes and financial protection in 15 countries over a decade.</description>
      <dc:creator>Larsen B</dc:creator>
      <dc:creator>Ogawa M</dc:creator>
      <dc:creator>Ogundimu EO</dc:creator>
      <dc:subject>universal health coverage</dc:subject>
      <dc:subject>health outcomes</dc:subject>
      <dc:subject>difference-in-differences</dc:subject>
      <dc:subject>health policy</dc:subject>
      <dc:subject>equity</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1251</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 103-113</dc:source>
    </item>
    <item>
      <title>Novel Oral Anticoagulants in Chronic Kidney Disease: Safety and Efficacy Meta-Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/6c7cdcc8-9137-44c3-865e-288b7524cd77</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/6c7cdcc8-9137-44c3-865e-288b7524cd77</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Christensen H</author>
      <description>Systematic review and meta-analysis of 35 studies evaluating the safety and efficacy of NOACs compared with warfarin in 28,000 patients with CKD stages 3-5 and atrial fibrillation.</description>
      <dc:creator>Christensen H</dc:creator>
      <dc:creator>Rashidov NK</dc:creator>
      <dc:creator>Owusu-Mensah A</dc:creator>
      <dc:subject>NOAC</dc:subject>
      <dc:subject>chronic kidney disease</dc:subject>
      <dc:subject>anticoagulation</dc:subject>
      <dc:subject>meta-analysis</dc:subject>
      <dc:subject>atrial fibrillation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1214</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 48-55</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/855cf034-1e0a-478d-9eeb-9c46bb6026f3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/855cf034-1e0a-478d-9eeb-9c46bb6026f3</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1940 participants across 2 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/855cf034-1e0a-478d-9eeb-9c46bb6026f3-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0260</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 123-134</dc:source>
    </item>
    <item>
      <title>Periodontal Disease and Systemic Inflammation: A Mendelian Randomization Study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/2a81a449-57f4-4fd1-b44e-3775ae7861d6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/2a81a449-57f4-4fd1-b44e-3775ae7861d6</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Eriksson B</author>
      <description>Two-sample Mendelian randomization study examining the causal relationship between periodontitis and systemic inflammatory markers using genome-wide association data from 450,000 individuals.</description>
      <dc:creator>Eriksson B</dc:creator>
      <dc:creator>Adeyemo WL</dc:creator>
      <dc:creator>Choi YJ</dc:creator>
      <dc:subject>periodontal disease</dc:subject>
      <dc:subject>systemic inflammation</dc:subject>
      <dc:subject>Mendelian randomization</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1198</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 59-67</dc:source>
    </item>
    <item>
      <title>Pediatric Inflammatory Bowel Disease: Trends in Incidence and Treatment Outcomes Over Two Decades</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/7c4667c7-ae5f-4c55-b36f-2de386263a7a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/7c4667c7-ae5f-4c55-b36f-2de386263a7a</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Thompson JR</author>
      <description>Retrospective cohort analysis examining trends in incidence, clinical presentation, and treatment outcomes of pediatric IBD across three major pediatric centers over a 20-year period.</description>
      <dc:creator>Thompson JR</dc:creator>
      <dc:creator>Kowalski M</dc:creator>
      <dc:creator>Watanabe S</dc:creator>
      <dc:subject>inflammatory bowel disease</dc:subject>
      <dc:subject>Crohn disease</dc:subject>
      <dc:subject>pediatric gastroenterology</dc:subject>
      <dc:subject>biologics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1185</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 79-93</dc:source>
    </item>
    <item>
      <title>Dental Anxiety in Children: Effectiveness of Virtual Reality Distraction During Treatment</title>
      <link>https://aams-journal.us/journals/dentistry/articles/44e7b4c1-83db-4399-b750-e20092001ad5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/44e7b4c1-83db-4399-b750-e20092001ad5</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Reyes MC</author>
      <description>Randomized crossover trial evaluating virtual reality distraction for anxiety reduction during dental procedures in 240 children aged 5-12 years.</description>
      <dc:creator>Reyes MC</dc:creator>
      <dc:creator>Abdikarimov FS</dc:creator>
      <dc:creator>Jørgensen M</dc:creator>
      <dc:subject>dental anxiety</dc:subject>
      <dc:subject>virtual reality</dc:subject>
      <dc:subject>pediatric dentistry</dc:subject>
      <dc:subject>behavior management</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1202</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 98-106</dc:source>
    </item>
    <item>
      <title>Cone-Beam CT Assessment of Maxillary Sinus Floor Augmentation: Long-Term Follow-Up</title>
      <link>https://aams-journal.us/journals/dentistry/articles/238be21b-b0c8-4e78-8897-8ba21e07b03e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/238be21b-b0c8-4e78-8897-8ba21e07b03e</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Krüger W</author>
      <description>Retrospective CBCT analysis of bone volume changes following maxillary sinus floor augmentation with autogenous bone vs xenograft in 210 patients over a 5-year follow-up period.</description>
      <dc:creator>Krüger W</dc:creator>
      <dc:creator>Cho HJ</dc:creator>
      <dc:creator>Diallo M</dc:creator>
      <dc:subject>CBCT</dc:subject>
      <dc:subject>sinus augmentation</dc:subject>
      <dc:subject>bone graft</dc:subject>
      <dc:subject>dental implants</dc:subject>
      <dc:subject>long-term outcomes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1197</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 48-58</dc:source>
    </item>
    <item>
      <title>Platelet-Rich Fibrin in Socket Preservation After Tooth Extraction: Systematic Review and Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/cb42ce11-10ca-4c77-8d97-0a7c84b64dc3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/cb42ce11-10ca-4c77-8d97-0a7c84b64dc3</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Kowalczyk P</author>
      <description>Systematic review and meta-analysis of 42 RCTs evaluating the efficacy of platelet-rich fibrin in socket preservation procedures, analyzing dimensional changes and histomorphometric outcomes.</description>
      <dc:creator>Kowalczyk P</dc:creator>
      <dc:creator>Osman AE</dc:creator>
      <dc:creator>Nakashima Y</dc:creator>
      <dc:subject>platelet-rich fibrin</dc:subject>
      <dc:subject>socket preservation</dc:subject>
      <dc:subject>bone regeneration</dc:subject>
      <dc:subject>meta-analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1207</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 151-165</dc:source>
    </item>
    <item>
      <title>Minimally Invasive Approach to Cleft Palate Repair: 10-Year Outcomes</title>
      <link>https://aams-journal.us/journals/dentistry/articles/3ac46093-99b4-4ac0-b005-a36fb2f5f4be</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/3ac46093-99b4-4ac0-b005-a36fb2f5f4be</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Anderson RJ</author>
      <description>Retrospective cohort study reporting 10-year speech, growth, and fistula outcomes of a minimally invasive two-flap palatoplasty technique in 520 patients with cleft palate.</description>
      <dc:creator>Anderson RJ</dc:creator>
      <dc:creator>Sato T</dc:creator>
      <dc:creator>El-Gendy M</dc:creator>
      <dc:subject>cleft palate</dc:subject>
      <dc:subject>minimally invasive surgery</dc:subject>
      <dc:subject>speech outcomes</dc:subject>
      <dc:subject>maxillofacial surgery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1200</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 76-86</dc:source>
    </item>
    <item>
      <title>Artificial Intelligence in Orthodontic Treatment Planning: Validation of a Deep Learning Model</title>
      <link>https://aams-journal.us/journals/dentistry/articles/21d80de8-fec8-4c8a-8190-4e5a356ec6dc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/21d80de8-fec8-4c8a-8190-4e5a356ec6dc</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Li Q</author>
      <description>Validation study of a deep learning algorithm for automated cephalometric analysis and orthodontic treatment planning, tested on 2,800 lateral cephalograms from diverse populations.</description>
      <dc:creator>Li Q</dc:creator>
      <dc:creator>Morales CR</dc:creator>
      <dc:creator>Van den Berg R</dc:creator>
      <dc:subject>artificial intelligence</dc:subject>
      <dc:subject>orthodontics</dc:subject>
      <dc:subject>deep learning</dc:subject>
      <dc:subject>treatment planning</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1196</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 40-47</dc:source>
    </item>
    <item>
      <title>Impact of Smoking Cessation on Implant Survival: A 15-Year Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/7700f6b1-d39f-44b5-97b4-60cffa861b31</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/7700f6b1-d39f-44b5-97b4-60cffa861b31</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>MacLeod S</author>
      <description>Retrospective analysis of 15-year implant survival rates in 840 patients stratified by smoking status and cessation timing, demonstrating significant improvement in outcomes after smoking cessation.</description>
      <dc:creator>MacLeod S</dc:creator>
      <dc:creator>Özdemir C</dc:creator>
      <dc:creator>Takahashi N</dc:creator>
      <dc:subject>smoking cessation</dc:subject>
      <dc:subject>implant survival</dc:subject>
      <dc:subject>peri-implantitis</dc:subject>
      <dc:subject>risk factors</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1205</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 132-140</dc:source>
    </item>
    <item>
      <title>Laser-Assisted Root Canal Disinfection: A Randomized Controlled Trial</title>
      <link>https://aams-journal.us/journals/dentistry/articles/6b6423fb-8e23-45ab-903a-96c1b9acfa6a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/6b6423fb-8e23-45ab-903a-96c1b9acfa6a</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dubois M</author>
      <description>Randomized controlled trial comparing Er:YAG laser-assisted root canal disinfection with conventional sodium hypochlorite irrigation in 280 teeth with apical periodontitis.</description>
      <dc:creator>Dubois M</dc:creator>
      <dc:creator>Kaya E</dc:creator>
      <dc:creator>Fernandes JC</dc:creator>
      <dc:subject>endodontics</dc:subject>
      <dc:subject>laser disinfection</dc:subject>
      <dc:subject>Er:YAG</dc:subject>
      <dc:subject>root canal treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1204</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 121-131</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Full-Arch Implant Rehabilitation: A Prospective Multicenter Study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e386b046-3dbc-4413-88eb-84e57e5ced78</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e386b046-3dbc-4413-88eb-84e57e5ced78</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Rossi G</author>
      <description>Prospective multicenter study evaluating the accuracy and clinical outcomes of a fully digital workflow for full-arch implant-supported prostheses in 186 patients across five centers.</description>
      <dc:creator>Rossi G</dc:creator>
      <dc:creator>Tanaka M</dc:creator>
      <dc:creator>Al-Khatib H</dc:creator>
      <dc:subject>digital dentistry</dc:subject>
      <dc:subject>implant rehabilitation</dc:subject>
      <dc:subject>CAD/CAM</dc:subject>
      <dc:subject>full-arch</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1209</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 192-201</dc:source>
    </item>
    <item>
      <title>Vaccine Hesitancy Among Parents in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/ca76e39d-5fb3-4e17-97af-ed16af0ab464</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/ca76e39d-5fb3-4e17-97af-ed16af0ab464</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Okafor AE</author>
      <description>Systematic review and meta-analysis of 87 studies examining parental vaccine hesitancy in low- and middle-income countries, identifying key determinants and effective intervention strategies.</description>
      <dc:creator>Okafor AE</dc:creator>
      <dc:creator>Rahman MF</dc:creator>
      <dc:creator>García-López P</dc:creator>
      <dc:subject>vaccine hesitancy</dc:subject>
      <dc:subject>immunization</dc:subject>
      <dc:subject>LMIC</dc:subject>
      <dc:subject>meta-analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1192</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 167-177</dc:source>
    </item>
    <item>
      <title>Neurodevelopmental Outcomes Following Early Intervention in Children With Autism Spectrum Disorder: A 5-Year Follow-Up</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/6a35d169-fe19-42e7-8833-f50d9fe489e5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/6a35d169-fe19-42e7-8833-f50d9fe489e5</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Chen WL</author>
      <description>This longitudinal cohort study followed 312 children diagnosed with ASD who received intensive early behavioral intervention, assessing cognitive, language, and adaptive functioning outcomes over a 5-year period.</description>
      <dc:creator>Chen WL</dc:creator>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Bergström A</dc:creator>
      <dc:subject>autism spectrum disorder</dc:subject>
      <dc:subject>early intervention</dc:subject>
      <dc:subject>neurodevelopment</dc:subject>
      <dc:subject>pediatrics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1183</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 59-67</dc:source>
    </item>
    <item>
      <title>Salivary Biomarkers for Early Detection of Oral Squamous Cell Carcinoma</title>
      <link>https://aams-journal.us/journals/dentistry/articles/d192d852-048f-4bca-8ec8-13eec4b89b6b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/d192d852-048f-4bca-8ec8-13eec4b89b6b</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Huang YC</author>
      <description>Case-control study evaluating a panel of 12 salivary biomarkers for early detection of oral squamous cell carcinoma in a cohort of 620 high-risk patients.</description>
      <dc:creator>Huang YC</dc:creator>
      <dc:creator>Abiodun OA</dc:creator>
      <dc:creator>Petersen K</dc:creator>
      <dc:subject>salivary biomarkers</dc:subject>
      <dc:subject>oral cancer</dc:subject>
      <dc:subject>OSCC</dc:subject>
      <dc:subject>early detection</dc:subject>
      <dc:subject>liquid biopsy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1208</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 166-179</dc:source>
    </item>
    <item>
      <title>Point-of-Care Ultrasound Training for Primary Care Physicians: A Randomized Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/6f0b3994-5501-48a2-9d6f-ebe176878919</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/6f0b3994-5501-48a2-9d6f-ebe176878919</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Nolan T</author>
      <description>Randomized study evaluating the impact of a structured POCUS training program on diagnostic accuracy and clinical decision-making in 320 primary care physicians.</description>
      <dc:creator>Nolan T</dc:creator>
      <dc:creator>Ueno K</dc:creator>
      <dc:creator>Bah IK</dc:creator>
      <dc:subject>point-of-care ultrasound</dc:subject>
      <dc:subject>primary care</dc:subject>
      <dc:subject>medical training</dc:subject>
      <dc:subject>diagnostic accuracy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1250</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 91-102</dc:source>
    </item>
    <item>
      <title>Social Determinants of Health and COVID-19 Outcomes: A 5-Year Post-Pandemic Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/2e8a7c46-34fa-4df2-9cf9-224c0001f456</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/2e8a7c46-34fa-4df2-9cf9-224c0001f456</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Thompson RS</author>
      <description>Large-scale retrospective analysis examining the persistent impact of social determinants of health on COVID-19 mortality and long-term sequelae using data from 2.8 million patients.</description>
      <dc:creator>Thompson RS</dc:creator>
      <dc:creator>Nakagawa H</dc:creator>
      <dc:creator>Diop A</dc:creator>
      <dc:subject>social determinants</dc:subject>
      <dc:subject>COVID-19</dc:subject>
      <dc:subject>health disparities</dc:subject>
      <dc:subject>post-pandemic</dc:subject>
      <dc:subject>public health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1247</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 36-49</dc:source>
    </item>
    <item>
      <title>Digital Health Interventions for Hypertension Management in Sub-Saharan Africa</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/3c49c5cf-7a24-4b58-b375-e7269cf1b05a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/3c49c5cf-7a24-4b58-b375-e7269cf1b05a</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ndegwa JK</author>
      <description>Pragmatic multicenter trial evaluating a mobile health intervention for hypertension management in 2,400 patients across 6 Sub-Saharan African countries over 18 months.</description>
      <dc:creator>Ndegwa JK</dc:creator>
      <dc:creator>Yamashita K</dc:creator>
      <dc:creator>Ismoilov BT</dc:creator>
      <dc:subject>digital health</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>Sub-Saharan Africa</dc:subject>
      <dc:subject>mHealth</dc:subject>
      <dc:subject>blood pressure control</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1248</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 50-64</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Prospective Validation Study of Presepsin and Procalcitonin</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/e1fa8e0f-a85c-482f-9fcf-c787b8d006e5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/e1fa8e0f-a85c-482f-9fcf-c787b8d006e5</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Mensah KA</author>
      <description>Prospective validation study comparing the diagnostic accuracy of presepsin and procalcitonin for early detection of neonatal sepsis in 890 neonates admitted to three NICUs.</description>
      <dc:creator>Mensah KA</dc:creator>
      <dc:creator>Fernández CR</dc:creator>
      <dc:creator>Patel D</dc:creator>
      <dc:subject>neonatal sepsis</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>presepsin</dc:subject>
      <dc:subject>procalcitonin</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1193</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 178-186</dc:source>
    </item>
    <item>
      <title>Global Burden of Antimicrobial Resistance: A Comprehensive Analysis of 204 Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/02485d78-6b3e-4482-a337-e2b6443df9ac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/02485d78-6b3e-4482-a337-e2b6443df9ac</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Murray CJ</author>
      <description>Comprehensive analysis estimating the global burden of antimicrobial resistance-associated deaths and disability-adjusted life years across 204 countries using data from 1990 to 2024.</description>
      <dc:creator>Murray CJ</dc:creator>
      <dc:creator>Honda T</dc:creator>
      <dc:creator>Owusu FA</dc:creator>
      <dc:subject>antimicrobial resistance</dc:subject>
      <dc:subject>global burden</dc:subject>
      <dc:subject>mortality</dc:subject>
      <dc:subject>LMIC</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1245</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 13-20</dc:source>
    </item>
    <item>
      <title>Long-Term Outcomes of Catheter Ablation for Persistent Atrial Fibrillation</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/666ad789-0893-4e50-bb66-af9513099f91</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/666ad789-0893-4e50-bb66-af9513099f91</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Rosenberg M</author>
      <description>Prospective registry-based study reporting 5-year freedom from arrhythmia recurrence and quality-of-life outcomes after catheter ablation in 2,100 patients with persistent AF.</description>
      <dc:creator>Rosenberg M</dc:creator>
      <dc:creator>Suzuki A</dc:creator>
      <dc:creator>Iqbal MZ</dc:creator>
      <dc:subject>catheter ablation</dc:subject>
      <dc:subject>atrial fibrillation</dc:subject>
      <dc:subject>rhythm control</dc:subject>
      <dc:subject>long-term outcomes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1213</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 39-47</dc:source>
    </item>
    <item>
      <title>SGLT2 Inhibitors and Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/8ff426ab-b351-46a7-92a1-93dfe39eb5f1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/8ff426ab-b351-46a7-92a1-93dfe39eb5f1</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Williams JD</author>
      <description>Post-hoc analysis of a large multinational RCT examining the efficacy of SGLT2 inhibitors in 4,800 patients with heart failure with preserved ejection fraction across 18 countries.</description>
      <dc:creator>Williams JD</dc:creator>
      <dc:creator>Kang HW</dc:creator>
      <dc:creator>Abdullayev T</dc:creator>
      <dc:subject>SGLT2 inhibitors</dc:subject>
      <dc:subject>heart failure</dc:subject>
      <dc:subject>HFpEF</dc:subject>
      <dc:subject>cardiovascular outcomes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1215</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 56-68</dc:source>
    </item>
    <item>
      <title>Thalamic Stimulation for Disorders of Consciousness: A Multicenter Phase II Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/cd215928-f290-4364-9b5d-0b23b4588a77</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/cd215928-f290-4364-9b5d-0b23b4588a77</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Novak J</author>
      <description>Multicenter phase II trial evaluating central thalamic deep brain stimulation in 48 patients with chronic minimally conscious state, assessing behavioral and electrophysiological outcomes.</description>
      <dc:creator>Novak J</dc:creator>
      <dc:creator>Tanaka R</dc:creator>
      <dc:creator>Ibrahimov AS</dc:creator>
      <dc:subject>disorders of consciousness</dc:subject>
      <dc:subject>thalamic stimulation</dc:subject>
      <dc:subject>minimally conscious state</dc:subject>
      <dc:subject>neuromodulation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1240</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 239-246</dc:source>
    </item>
    <item>
      <title>Impact of Maternal Vitamin D Supplementation on Neonatal Bone Density and Growth Parameters</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/b2da94f3-059c-45af-98ae-7df88de34f3c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/b2da94f3-059c-45af-98ae-7df88de34f3c</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>This double-blind placebo-controlled trial investigated the effects of prenatal vitamin D supplementation on neonatal bone mineral density and anthropometric parameters in 580 mother-infant pairs.</description>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Nguyen TH</dc:creator>
      <dc:creator>Abdelrahman S</dc:creator>
      <dc:subject>vitamin D</dc:subject>
      <dc:subject>neonatal health</dc:subject>
      <dc:subject>bone density</dc:subject>
      <dc:subject>maternal supplementation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1187</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 107-119</dc:source>
    </item>
    <item>
      <title>Antimicrobial Photodynamic Therapy for Peri-Implantitis: A Systematic Review</title>
      <link>https://aams-journal.us/journals/dentistry/articles/8d900ba6-e745-4a14-a70d-94755c7cc644</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/8d900ba6-e745-4a14-a70d-94755c7cc644</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Popov A</author>
      <description>Systematic review of 28 clinical trials evaluating antimicrobial photodynamic therapy as an adjunct to mechanical debridement in the management of peri-implantitis.</description>
      <dc:creator>Popov A</dc:creator>
      <dc:creator>Cabrera ML</dc:creator>
      <dc:creator>Asai K</dc:creator>
      <dc:subject>peri-implantitis</dc:subject>
      <dc:subject>photodynamic therapy</dc:subject>
      <dc:subject>antimicrobial</dc:subject>
      <dc:subject>dental implants</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1206</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 141-150</dc:source>
    </item>
    <item>
      <title>Targeted Therapy for ANCA-Associated Vasculitis: A Phase II Dose-Finding Study</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/0ae7eda0-bfd5-41b6-9b8f-af6928557aa4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/0ae7eda0-bfd5-41b6-9b8f-af6928557aa4</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Hägg S</author>
      <description>Phase II dose-finding study evaluating a novel complement C5a receptor inhibitor in 320 patients with ANCA-associated vasculitis, assessing remission rates and safety profile.</description>
      <dc:creator>Hägg S</dc:creator>
      <dc:creator>Nishimura R</dc:creator>
      <dc:creator>Khodjayev SH</dc:creator>
      <dc:subject>ANCA vasculitis</dc:subject>
      <dc:subject>targeted therapy</dc:subject>
      <dc:subject>complement inhibition</dc:subject>
      <dc:subject>phase II</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1211</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 23-30</dc:source>
    </item>
    <item>
      <title>Proton Pump Inhibitor Deprescribing in Older Adults: A Cluster Randomized Trial</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/eab72e90-9a27-406b-ad06-0f2feef6e8c2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/eab72e90-9a27-406b-ad06-0f2feef6e8c2</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Byrne JP</author>
      <description>Cluster randomized trial evaluating a structured PPI deprescribing intervention in 62 primary care practices, enrolling 1,840 older adults on long-term PPI therapy.</description>
      <dc:creator>Byrne JP</dc:creator>
      <dc:creator>Kim MS</dc:creator>
      <dc:creator>Da Silva F</dc:creator>
      <dc:subject>PPI deprescribing</dc:subject>
      <dc:subject>older adults</dc:subject>
      <dc:subject>polypharmacy</dc:subject>
      <dc:subject>gastroesophageal reflux</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1221</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 129-136</dc:source>
    </item>
    <item>
      <title>Pulmonary Rehabilitation With Telehealth Support in Severe COPD: A Pragmatic Trial</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/906e44da-7013-4ffa-8ca4-87d8459f2555</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/906e44da-7013-4ffa-8ca4-87d8459f2555</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>McAllister D</author>
      <description>Pragmatic multicenter trial evaluating the effectiveness of telehealth-supported pulmonary rehabilitation versus standard center-based rehabilitation in 680 patients with severe COPD.</description>
      <dc:creator>McAllister D</dc:creator>
      <dc:creator>Yamazaki T</dc:creator>
      <dc:creator>Ochieng P</dc:creator>
      <dc:subject>COPD</dc:subject>
      <dc:subject>pulmonary rehabilitation</dc:subject>
      <dc:subject>telehealth</dc:subject>
      <dc:subject>pragmatic trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1216</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 69-82</dc:source>
    </item>
    <item>
      <title>Immune Checkpoint Inhibitor-Related Myocarditis: Diagnostic Algorithm and Outcomes</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/aa260d6d-5074-4af1-9fe9-d60a2e0b9cc7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/aa260d6d-5074-4af1-9fe9-d60a2e0b9cc7</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Weber R</author>
      <description>Multicenter observational study developing and validating a diagnostic algorithm for ICI-related myocarditis in 580 patients receiving immune checkpoint inhibitor therapy.</description>
      <dc:creator>Weber R</dc:creator>
      <dc:creator>Taniguchi H</dc:creator>
      <dc:creator>Malik FA</dc:creator>
      <dc:subject>immune checkpoint inhibitors</dc:subject>
      <dc:subject>myocarditis</dc:subject>
      <dc:subject>immunotherapy</dc:subject>
      <dc:subject>cardio-oncology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1218</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 93-103</dc:source>
    </item>
    <item>
      <title>Gut Microbiome Signatures in Rheumatoid Arthritis: A Multi-Ethnic Cohort Study</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/d98bee06-c7c1-4b9a-bbe2-fb5a6a2fc5c6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/d98bee06-c7c1-4b9a-bbe2-fb5a6a2fc5c6</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Santos-García D</author>
      <description>Multi-ethnic cohort study characterizing gut microbiome signatures in 980 patients with rheumatoid arthritis across three continents using 16S rRNA and shotgun metagenomic sequencing.</description>
      <dc:creator>Santos-García D</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Osei-Bonsu K</dc:creator>
      <dc:subject>gut microbiome</dc:subject>
      <dc:subject>rheumatoid arthritis</dc:subject>
      <dc:subject>multi-ethnic</dc:subject>
      <dc:subject>16S rRNA sequencing</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1220</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 119-128</dc:source>
    </item>
    <item>
      <title>Efficacy of High-Flow Nasal Cannula Therapy in Preterm Neonates With Respiratory Distress Syndrome</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/42775891-6583-4ea7-bc90-720cf320ec18</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/42775891-6583-4ea7-bc90-720cf320ec18</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Yamamoto K</author>
      <description>This multicenter randomized controlled trial evaluated the efficacy of high-flow nasal cannula (HFNC) therapy compared with continuous positive airway pressure (CPAP) in 428 preterm neonates with respiratory distress syndrome across three tertiary centers.</description>
      <dc:creator>Yamamoto K</dc:creator>
      <dc:creator>Petrov IV</dc:creator>
      <dc:creator>Al-Rashidi M</dc:creator>
      <dc:subject>neonatal care</dc:subject>
      <dc:subject>respiratory distress</dc:subject>
      <dc:subject>HFNC</dc:subject>
      <dc:subject>preterm infants</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1180</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 26-34</dc:source>
    </item>
    <item>
      <title>Machine Learning for Seizure Prediction in Drug-Resistant Epilepsy</title>
      <link>https://aams-journal.us/journals/neurology/articles/5126c695-f08e-4031-b464-fb39714b9b61</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5126c695-f08e-4031-b464-fb39714b9b61</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Kowalski R</author>
      <description>Prospective multicenter study validating a machine learning algorithm for patient-specific seizure prediction using continuous EEG and wearable biosensor data in 340 patients.</description>
      <dc:creator>Kowalski R</dc:creator>
      <dc:creator>Hayashi T</dc:creator>
      <dc:creator>Mansoor KA</dc:creator>
      <dc:subject>seizure prediction</dc:subject>
      <dc:subject>machine learning</dc:subject>
      <dc:subject>drug-resistant epilepsy</dc:subject>
      <dc:subject>EEG</dc:subject>
      <dc:subject>wearable devices</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1227</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 77-89</dc:source>
    </item>
    <item>
      <title>White Matter Tract Integrity and Cognitive Reserve in Aging: A DTI Study</title>
      <link>https://aams-journal.us/journals/neurology/articles/ae9b3107-7318-46d6-9bf2-f795188b1972</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/ae9b3107-7318-46d6-9bf2-f795188b1972</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Fernández M</author>
      <description>Cross-sectional diffusion tensor imaging study examining the relationship between white matter tract integrity, cognitive reserve, and functional outcomes in 1,600 adults aged 50-90 years.</description>
      <dc:creator>Fernández M</dc:creator>
      <dc:creator>Watanabe K</dc:creator>
      <dc:creator>Kamau J</dc:creator>
      <dc:subject>cognitive reserve</dc:subject>
      <dc:subject>white matter</dc:subject>
      <dc:subject>DTI</dc:subject>
      <dc:subject>aging</dc:subject>
      <dc:subject>neurodegeneration</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1234</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 179-187</dc:source>
    </item>
    <item>
      <title>Childhood Obesity and Metabolic Syndrome: A Cross-Sectional Analysis of 12,000 School-Age Children</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/29f9418b-b6ad-4e7b-8a9d-0bc14bc87e62</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/29f9418b-b6ad-4e7b-8a9d-0bc14bc87e62</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Müller H</author>
      <description>A large-scale cross-sectional study analyzing the prevalence and risk factors of metabolic syndrome in school-age children across three countries, involving 12,000 participants aged 6-14 years.</description>
      <dc:creator>Müller H</dc:creator>
      <dc:creator>Sharma R</dc:creator>
      <dc:creator>dos Santos LP</dc:creator>
      <dc:subject>childhood obesity</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>BMI</dc:subject>
      <dc:subject>insulin resistance</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1179</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 15-25</dc:source>
    </item>
    <item>
      <title>Artificial Intelligence-Guided Insulin Dosing in Type 1 Diabetes: A Multicenter RCT</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/d5def459-7178-4028-a428-35e745af68cc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/d5def459-7178-4028-a428-35e745af68cc</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Hoffmann C</author>
      <description>Multicenter randomized controlled trial evaluating an AI-guided closed-loop insulin delivery system compared with sensor-augmented pump therapy in 560 adults with type 1 diabetes.</description>
      <dc:creator>Hoffmann C</dc:creator>
      <dc:creator>Patel SN</dc:creator>
      <dc:creator>Bergman N</dc:creator>
      <dc:subject>artificial intelligence</dc:subject>
      <dc:subject>insulin dosing</dc:subject>
      <dc:subject>type 1 diabetes</dc:subject>
      <dc:subject>closed-loop system</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1219</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 104-118</dc:source>
    </item>
    <item>
      <title>CRISPR-Based Gene Therapy for Huntington Disease: Phase I Safety Results</title>
      <link>https://aams-journal.us/journals/neurology/articles/1788d573-99dc-4ef9-b30a-028ebaa7ae61</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/1788d573-99dc-4ef9-b30a-028ebaa7ae61</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Braun M</author>
      <description>First-in-human phase I trial evaluating the safety and pharmacodynamics of intrathecal CRISPR-based gene therapy targeting mutant huntingtin in 24 patients with early Huntington disease.</description>
      <dc:creator>Braun M</dc:creator>
      <dc:creator>Sato H</dc:creator>
      <dc:creator>Volkov A</dc:creator>
      <dc:subject>CRISPR</dc:subject>
      <dc:subject>Huntington disease</dc:subject>
      <dc:subject>gene therapy</dc:subject>
      <dc:subject>phase I</dc:subject>
      <dc:subject>neurodegenerative</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1223</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 34-44</dc:source>
    </item>
    <item>
      <title>CLINICAL AND FUNCTIONAL JUSTIFICATION OF USING INDIVIDUAL ADAPTIVE SPLINTS AND THEIR IMPACT ON DENTURE RETENTION IN COMPLETELY EDENTULOUS PATIENTS</title>
      <link>https://aams-journal.us/journals/dentistry/articles/07ab5d75-a8d6-4fbd-9f95-c80af31e81cf</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/07ab5d75-a8d6-4fbd-9f95-c80af31e81cf</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Khamidov Mahmud Toshtemirovich</author>
      <description>This article analyzes the main clinical and functional factors influencing denture
retention in completely edentulous patients. Particular attention is paid to the
morphofunctional condition of the oral mucosa, its adaptive capacity to
prosthetic load, and their relationship with denture stability. The use of
individual adaptive splints is substantiated as an effective stage of preliminary
mucosal preparation. Clinical observations demonstrate that adaptive splints
reduce pain symptoms, shorten the adaptation period, and significantly improve
the retention and stability of removable dentures.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773312453854-AAMS_Article_zarmed.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khamidov Mahmud Toshtemirovich</dc:creator>
      <dc:subject>complete edentulism</dc:subject>
      <dc:subject>individual adaptive splints</dc:subject>
      <dc:subject>oral mucosa</dc:subject>
      <dc:subject>removable dentures</dc:subject>
      <dc:subject>denture retention</dc:subject>
      <dc:subject>clinical effectiveness</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1175</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 9-21</dc:source>
    </item>
    <item>
      <title>GLP-1 Receptor Agonists for Non-Alcoholic Steatohepatitis: A Phase III Trial</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/9d7a80ae-0538-4119-9c50-421b3bc85221</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/9d7a80ae-0538-4119-9c50-421b3bc85221</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Laurent P</author>
      <description>Double-blind phase III trial evaluating the efficacy and safety of semaglutide in 1,200 patients with biopsy-confirmed NASH and significant liver fibrosis.</description>
      <dc:creator>Laurent P</dc:creator>
      <dc:creator>Yoshida K</dc:creator>
      <dc:creator>Nwosu OC</dc:creator>
      <dc:subject>GLP-1 receptor agonist</dc:subject>
      <dc:subject>NASH</dc:subject>
      <dc:subject>liver fibrosis</dc:subject>
      <dc:subject>phase III trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1217</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 3, pp. 83-92</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface for Communication in Locked-In Syndrome: A Pilot Study</title>
      <link>https://aams-journal.us/journals/neurology/articles/778dca13-c1c7-4d4a-8fc4-9fe9288b7e45</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/778dca13-c1c7-4d4a-8fc4-9fe9288b7e45</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Moreau C</author>
      <description>Pilot study evaluating a high-density intracortical brain-computer interface system for real-time text communication in 8 patients with complete locked-in syndrome.</description>
      <dc:creator>Moreau C</dc:creator>
      <dc:creator>Nakamura K</dc:creator>
      <dc:creator>Sitnikov V</dc:creator>
      <dc:subject>brain-computer interface</dc:subject>
      <dc:subject>locked-in syndrome</dc:subject>
      <dc:subject>neural decoding</dc:subject>
      <dc:subject>assistive technology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1231</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 121-131</dc:source>
    </item>
    <item>
      <title>Tau PET Imaging Patterns in Frontotemporal Dementia Subtypes</title>
      <link>https://aams-journal.us/journals/neurology/articles/40b4318e-5563-4435-a67b-6e54863d1404</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/40b4318e-5563-4435-a67b-6e54863d1404</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Henderson AJ</author>
      <description>Multisite study characterizing tau PET uptake patterns across behavioral variant FTD, semantic variant PPA, and nonfluent variant PPA in 420 patients and 180 healthy controls.</description>
      <dc:creator>Henderson AJ</dc:creator>
      <dc:creator>Mori T</dc:creator>
      <dc:creator>Ndiaye M</dc:creator>
      <dc:subject>frontotemporal dementia</dc:subject>
      <dc:subject>tau PET</dc:subject>
      <dc:subject>neuroimaging</dc:subject>
      <dc:subject>disease subtypes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1224</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 45-58</dc:source>
    </item>
    <item>
      <title>Vagus Nerve Stimulation for Drug-Resistant Cluster Headache: A Sham-Controlled Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/46f07772-4b85-437d-b214-777ddb098f4b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/46f07772-4b85-437d-b214-777ddb098f4b</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Nilsen A</author>
      <description>Double-blind sham-controlled trial evaluating non-invasive vagus nerve stimulation for acute treatment and prevention of drug-resistant chronic cluster headache in 160 patients.</description>
      <dc:creator>Nilsen A</dc:creator>
      <dc:creator>Kubo M</dc:creator>
      <dc:creator>Yusuf SA</dc:creator>
      <dc:subject>cluster headache</dc:subject>
      <dc:subject>vagus nerve stimulation</dc:subject>
      <dc:subject>neuromodulation</dc:subject>
      <dc:subject>sham-controlled</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1225</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 59-68</dc:source>
    </item>
    <item>
      <title>Neuroinflammation in Long COVID: PET Imaging and CSF Biomarker Study</title>
      <link>https://aams-journal.us/journals/neurology/articles/481383c8-8d1f-4532-b557-9e2dfafbfe92</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/481383c8-8d1f-4532-b557-9e2dfafbfe92</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Dubois J</author>
      <description>Cross-sectional study using TSPO-PET imaging and cerebrospinal fluid biomarker analysis to characterize neuroinflammation patterns in 220 patients with neurological long COVID.</description>
      <dc:creator>Dubois J</dc:creator>
      <dc:creator>Kim DH</dc:creator>
      <dc:creator>Hassan F</dc:creator>
      <dc:subject>long COVID</dc:subject>
      <dc:subject>neuroinflammation</dc:subject>
      <dc:subject>PET imaging</dc:subject>
      <dc:subject>CSF biomarkers</dc:subject>
      <dc:subject>TSPO</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1226</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 69-76</dc:source>
    </item>
    <item>
      <title>Antisense Oligonucleotide Therapy for Spinal Muscular Atrophy Type 2: Long-Term Results</title>
      <link>https://aams-journal.us/journals/neurology/articles/d670995e-abaa-4097-97be-7db663aa1c09</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/d670995e-abaa-4097-97be-7db663aa1c09</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Bergström E</author>
      <description>Long-term follow-up study reporting 7-year motor function, respiratory outcomes, and survival data for 280 patients with SMA type 2 treated with intrathecal nusinersen.</description>
      <dc:creator>Bergström E</dc:creator>
      <dc:creator>Ono S</dc:creator>
      <dc:creator>Nkemelu OS</dc:creator>
      <dc:subject>spinal muscular atrophy</dc:subject>
      <dc:subject>antisense oligonucleotide</dc:subject>
      <dc:subject>nusinersen</dc:subject>
      <dc:subject>motor function</dc:subject>
      <dc:subject>long-term</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1241</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 247-256</dc:source>
    </item>
    <item>
      <title>Neuroplasticity After Pediatric Traumatic Brain Injury: Longitudinal MRI Study</title>
      <link>https://aams-journal.us/journals/neurology/articles/c31d2176-6a67-4f8d-99c8-ca0984d0010d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/c31d2176-6a67-4f8d-99c8-ca0984d0010d</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Davies RW</author>
      <description>Three-year longitudinal MRI study examining structural brain changes and neuroplasticity markers in 250 children after moderate-to-severe traumatic brain injury.</description>
      <dc:creator>Davies RW</dc:creator>
      <dc:creator>Sasaki M</dc:creator>
      <dc:creator>Karimova GN</dc:creator>
      <dc:subject>pediatric TBI</dc:subject>
      <dc:subject>neuroplasticity</dc:subject>
      <dc:subject>structural MRI</dc:subject>
      <dc:subject>cognitive recovery</dc:subject>
      <dc:subject>longitudinal</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1237</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 208-217</dc:source>
    </item>
    <item>
      <title>Neural Correlates of Music-Induced Analgesia: An fMRI Investigation</title>
      <link>https://aams-journal.us/journals/neurology/articles/f0e826ca-0bd1-4859-8619-f5df03de470b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/f0e826ca-0bd1-4859-8619-f5df03de470b</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Lévesque M</author>
      <description>Functional MRI study investigating the neural mechanisms underlying music-induced analgesia in 140 chronic pain patients and 80 healthy controls during standardized pain paradigms.</description>
      <dc:creator>Lévesque M</dc:creator>
      <dc:creator>Shimizu R</dc:creator>
      <dc:creator>Okeke NC</dc:creator>
      <dc:subject>music therapy</dc:subject>
      <dc:subject>analgesia</dc:subject>
      <dc:subject>fMRI</dc:subject>
      <dc:subject>pain modulation</dc:subject>
      <dc:subject>neural correlates</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1242</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 257-270</dc:source>
    </item>
    <item>
      <title>Transcranial Focused Ultrasound for Essential Tremor: Bilateral Treatment Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/cb010496-1fc6-41d3-871e-f3afeec047ca</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/cb010496-1fc6-41d3-871e-f3afeec047ca</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Fischer D</author>
      <description>Prospective study evaluating the safety and efficacy of staged bilateral MRI-guided focused ultrasound thalamotomy in 120 patients with medication-refractory essential tremor.</description>
      <dc:creator>Fischer D</dc:creator>
      <dc:creator>Yamamoto A</dc:creator>
      <dc:creator>Osei AK</dc:creator>
      <dc:subject>essential tremor</dc:subject>
      <dc:subject>focused ultrasound</dc:subject>
      <dc:subject>thalamotomy</dc:subject>
      <dc:subject>bilateral treatment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1239</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 229-238</dc:source>
    </item>
    <item>
      <title>Gut-Brain Axis in Parkinson Disease: Fecal Microbiota Transplantation Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/bea72567-4af2-4ccb-a0ad-21f3c43139c6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/bea72567-4af2-4ccb-a0ad-21f3c43139c6</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Svensson L</author>
      <description>Randomized sham-controlled trial evaluating fecal microbiota transplantation on motor and non-motor symptoms in 180 patients with early-stage Parkinson disease.</description>
      <dc:creator>Svensson L</dc:creator>
      <dc:creator>Zhao W</dc:creator>
      <dc:creator>Adewale BO</dc:creator>
      <dc:subject>Parkinson disease</dc:subject>
      <dc:subject>gut-brain axis</dc:subject>
      <dc:subject>fecal microbiota transplantation</dc:subject>
      <dc:subject>motor symptoms</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1236</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 199-207</dc:source>
    </item>
    <item>
      <title>Optogenetic Modulation of Pain Pathways: Preclinical and Translational Evidence</title>
      <link>https://aams-journal.us/journals/neurology/articles/a3c2fabd-8e00-4112-a9aa-b2193c00b84b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/a3c2fabd-8e00-4112-a9aa-b2193c00b84b</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Larsson M</author>
      <description>Comprehensive preclinical study demonstrating selective optogenetic modulation of spinal dorsal horn pain circuits, with translational implications for chronic neuropathic pain management.</description>
      <dc:creator>Larsson M</dc:creator>
      <dc:creator>Honda K</dc:creator>
      <dc:creator>El-Sayed M</dc:creator>
      <dc:subject>optogenetics</dc:subject>
      <dc:subject>neuropathic pain</dc:subject>
      <dc:subject>pain pathways</dc:subject>
      <dc:subject>translational neuroscience</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1233</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 155-165</dc:source>
    </item>
    <item>
      <title>Plasma Biomarkers for Early Detection of Alzheimer Disease: The PRECISION Cohort</title>
      <link>https://aams-journal.us/journals/neurology/articles/fa550a02-341f-4ac2-817a-b1d47453b198</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/fa550a02-341f-4ac2-817a-b1d47453b198</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Jensen K</author>
      <description>Prospective cohort study validating plasma p-tau217, GFAP, and neurofilament light chain as early biomarkers for Alzheimer disease in 3,200 cognitively unimpaired individuals.</description>
      <dc:creator>Jensen K</dc:creator>
      <dc:creator>Li M</dc:creator>
      <dc:creator>Okafor EC</dc:creator>
      <dc:subject>Alzheimer disease</dc:subject>
      <dc:subject>plasma biomarkers</dc:subject>
      <dc:subject>p-tau217</dc:subject>
      <dc:subject>early detection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1243</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 271-284</dc:source>
    </item>
    <item>
      <title>Neurogenetics of Autism: Whole-Genome Sequencing in 10,000 Families</title>
      <link>https://aams-journal.us/journals/neurology/articles/c46b4a8d-5657-445b-8ce2-bd2800a52759</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/c46b4a8d-5657-445b-8ce2-bd2800a52759</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Campbell A</author>
      <description>Large-scale whole-genome sequencing study identifying novel risk genes and structural variants associated with autism spectrum disorder in a multi-ethnic cohort of 10,000 families.</description>
      <dc:creator>Campbell A</dc:creator>
      <dc:creator>Chen L</dc:creator>
      <dc:creator>Diallo IB</dc:creator>
      <dc:subject>autism</dc:subject>
      <dc:subject>whole-genome sequencing</dc:subject>
      <dc:subject>neurogenetics</dc:subject>
      <dc:subject>de novo variants</dc:subject>
      <dc:subject>rare variants</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1238</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 218-228</dc:source>
    </item>
    <item>
      <title>Cerebrospinal Fluid Dynamics in Normal Pressure Hydrocephalus: Advanced MRI Study</title>
      <link>https://aams-journal.us/journals/neurology/articles/bae645b5-b9e4-443a-ae6f-b0a699bca405</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/bae645b5-b9e4-443a-ae6f-b0a699bca405</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Van der Berg P</author>
      <description>Advanced phase-contrast MRI study characterizing CSF flow dynamics and predicting shunt response in 240 patients with suspected normal pressure hydrocephalus.</description>
      <dc:creator>Van der Berg P</dc:creator>
      <dc:creator>Ishikawa Y</dc:creator>
      <dc:creator>Asante K</dc:creator>
      <dc:subject>normal pressure hydrocephalus</dc:subject>
      <dc:subject>CSF dynamics</dc:subject>
      <dc:subject>phase-contrast MRI</dc:subject>
      <dc:subject>shunt response prediction</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1235</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 188-198</dc:source>
    </item>
    <item>
      <title>School-Based Mental Health Interventions for Adolescents: A Cluster Randomized Trial</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c6509a9a-6d93-453d-a907-6c713054ddf4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c6509a9a-6d93-453d-a907-6c713054ddf4</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Patel VK</author>
      <description>Cluster randomized controlled trial evaluating a school-based mental health intervention delivered by trained counselors in 48 secondary schools across three countries.</description>
      <dc:creator>Patel VK</dc:creator>
      <dc:creator>Olsson M</dc:creator>
      <dc:creator>Chukwuma N</dc:creator>
      <dc:subject>adolescent mental health</dc:subject>
      <dc:subject>school interventions</dc:subject>
      <dc:subject>depression</dc:subject>
      <dc:subject>anxiety</dc:subject>
      <dc:subject>cluster RCT</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1191</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 153-166</dc:source>
    </item>
    <item>
      <title>Antibiotic Stewardship Programs in Pediatric Intensive Care Units: A Multicenter Before-and-After Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/af543df3-129a-44f6-bd96-341f7de5c420</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/af543df3-129a-44f6-bd96-341f7de5c420</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>O&apos;Brien KM</author>
      <description>Multicenter before-and-after study assessing the impact of structured antibiotic stewardship programs on antimicrobial consumption, resistance patterns, and clinical outcomes in 8 PICUs.</description>
      <dc:creator>O&apos;Brien KM</dc:creator>
      <dc:creator>Yılmaz T</dc:creator>
      <dc:creator>Nakamura H</dc:creator>
      <dc:subject>antibiotic stewardship</dc:subject>
      <dc:subject>PICU</dc:subject>
      <dc:subject>antimicrobial resistance</dc:subject>
      <dc:subject>pediatric critical care</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1186</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 94-106</dc:source>
    </item>
    <item>
      <title>Efficacy of Telemedicine in Managing Pediatric Asthma: A Randomized Controlled Trial</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/4898444b-5e7b-48ab-ab58-532ca8c7c774</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/4898444b-5e7b-48ab-ab58-532ca8c7c774</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ivanova NV</author>
      <description>A multicenter RCT evaluating the effectiveness of a structured telemedicine intervention program compared with standard outpatient care in 650 children with persistent asthma.</description>
      <dc:creator>Ivanova NV</dc:creator>
      <dc:creator>Kim SJ</dc:creator>
      <dc:creator>Al-Dosari F</dc:creator>
      <dc:subject>telemedicine</dc:subject>
      <dc:subject>pediatric asthma</dc:subject>
      <dc:subject>digital health</dc:subject>
      <dc:subject>RCT</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1181</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 35-45</dc:source>
    </item>
    <item>
      <title>Oral Microbiome Dysbiosis in Patients With Type 2 Diabetes: A Metagenomics Study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/09f584d1-6c42-4b5b-bf8c-05bba824a9f1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/09f584d1-6c42-4b5b-bf8c-05bba824a9f1</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Xu Z</author>
      <description>Shotgun metagenomics study characterizing the oral microbiome composition and functional pathways in 380 patients with type 2 diabetes compared with normoglycemic controls.</description>
      <dc:creator>Xu Z</dc:creator>
      <dc:creator>Babayev EN</dc:creator>
      <dc:creator>Sørensen T</dc:creator>
      <dc:subject>oral microbiome</dc:subject>
      <dc:subject>type 2 diabetes</dc:subject>
      <dc:subject>metagenomics</dc:subject>
      <dc:subject>dysbiosis</dc:subject>
      <dc:subject>periodontitis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1194</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 22-30</dc:source>
    </item>
    <item>
      <title>Deep Brain Stimulation for Treatment-Resistant Depression: 5-Year Follow-Up</title>
      <link>https://aams-journal.us/journals/neurology/articles/5b00b0e4-6490-4a8c-abf9-b44a79de0b16</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5b00b0e4-6490-4a8c-abf9-b44a79de0b16</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>O&apos;Sullivan D</author>
      <description>Five-year follow-up of a multicenter trial evaluating deep brain stimulation of the subcallosal cingulate in 86 patients with treatment-resistant major depressive disorder.</description>
      <dc:creator>O&apos;Sullivan D</dc:creator>
      <dc:creator>Park SW</dc:creator>
      <dc:creator>Mahmoud AH</dc:creator>
      <dc:subject>deep brain stimulation</dc:subject>
      <dc:subject>treatment-resistant depression</dc:subject>
      <dc:subject>neuromodulation</dc:subject>
      <dc:subject>long-term outcomes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1229</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 101-112</dc:source>
    </item>
    <item>
      <title>Neurorehabilitation With Exoskeleton-Assisted Gait Training After Stroke</title>
      <link>https://aams-journal.us/journals/neurology/articles/8dedfd16-0582-4da7-b451-4491243271b5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/8dedfd16-0582-4da7-b451-4491243271b5</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Multicenter RCT comparing exoskeleton-assisted gait training with conventional physiotherapy in 380 patients with subacute stroke, measuring motor recovery and functional independence.</description>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Takeda S</dc:creator>
      <dc:creator>Rashidova MN</dc:creator>
      <dc:subject>stroke rehabilitation</dc:subject>
      <dc:subject>exoskeleton</dc:subject>
      <dc:subject>gait training</dc:subject>
      <dc:subject>motor recovery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1232</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 145-154</dc:source>
    </item>
    <item>
      <title>Anti-CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Evidence From 15 Countries</title>
      <link>https://aams-journal.us/journals/neurology/articles/5865d763-e36a-4e7d-a33e-65769b138b0b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5865d763-e36a-4e7d-a33e-65769b138b0b</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ashworth B</author>
      <description>International real-world registry study analyzing treatment outcomes, adherence, and safety of anti-CGRP monoclonal antibodies in 12,500 patients with chronic migraine across 15 countries.</description>
      <dc:creator>Ashworth B</dc:creator>
      <dc:creator>Türkoğlu R</dc:creator>
      <dc:creator>Mizuno Y</dc:creator>
      <dc:subject>chronic migraine</dc:subject>
      <dc:subject>CGRP antibodies</dc:subject>
      <dc:subject>real-world evidence</dc:subject>
      <dc:subject>erenumab</dc:subject>
      <dc:subject>fremanezumab</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1228</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 90-100</dc:source>
    </item>
    <item>
      <title>Long-Term Cardiovascular Outcomes in Children Born to Mothers With Gestational Diabetes</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/5e70ddfd-86c2-4f4d-b470-9030ee7d93cb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/5e70ddfd-86c2-4f4d-b470-9030ee7d93cb</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Lindqvist A</author>
      <description>A 15-year prospective follow-up study evaluating cardiovascular risk markers and echocardiographic parameters in 1,200 children born to mothers with gestational diabetes mellitus.</description>
      <dc:creator>Lindqvist A</dc:creator>
      <dc:creator>Ismail Z</dc:creator>
      <dc:creator>Costa MR</dc:creator>
      <dc:subject>gestational diabetes</dc:subject>
      <dc:subject>cardiovascular risk</dc:subject>
      <dc:subject>pediatric cardiology</dc:subject>
      <dc:subject>epigenetics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1182</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 46-58</dc:source>
    </item>
    <item>
      <title>The Role of Preventive Medicine in Reducing the Burden of Chronic Diseases</title>
      <link>https://aams-journal.us/journals/neurology/articles/7ba28095-b50f-4056-9b7d-cda6a0e34668</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/7ba28095-b50f-4056-9b7d-cda6a0e34668</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ismatova Marguba Shaukatovna¹</author>
      <description>Chronic diseases represent one of the leading causes of morbidity and mortality worldwide, significantly affecting healthcare systems, economic productivity, and quality of life. Conditions such as cardiovascular diseases, diabetes mellitus, cancer, and chronic respiratory disorders develop gradually and are often associated with modifiable risk factors including unhealthy diet, physical inactivity, tobacco use, excessive alcohol consumption, and environmental influences. Preventive medicine focuses on reducing the incidence and impact of these diseases through early identification of risk factors, health education, screening programs, vaccination, and lifestyle interventions. Modern preventive strategies emphasize population-based approaches combined with individualized risk assessment to detect diseases in their early stages or prevent their development altogether. Implementation of preventive measures has been shown to decrease hospitalization rates, improve long-term health outcomes, and reduce healthcare expenditures. This article examines the principles of preventive medicine, evaluates its effectiveness in reducing the burden of chronic diseases, and highlights strategies for improving public health through early intervention and disease prevention. The growing prevalence of chronic noncommunicable diseases has become a major challenge for global healthcare systems. Conditions such as cardiovascular disorders, diabetes, chronic respiratory diseases, and cancer account for a large proportion of long-term disability and premature mortality. Preventive medicine has emerged as an essential strategy for reducing these burdens by focusing on early risk identification, health promotion, and timely intervention before irreversible pathological processes develop. Through population-level strategies and individualized preventive care, modern healthcare systems aim to modify behavioral and environmental determinants of disease. Preventive actions including lifestyle modification, early diagnostic screening, vaccination programs, and public health education have demonstrated measurable improvements in health outcomes. These measures not only decrease disease incidence but also reduce healthcare expenditures and improve quality of life across populations. Expanding preventive healthcare programs remains a critical step in controlling the long-term impact of chronic illnesses worldwide.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773321001871-The_Role_of_Preventive_Medicine_in_Reducing_the_Bu.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ismatova Marguba Shaukatovna¹</dc:creator>
      <dc:creator>Xayrullayev Muso Axror oʻgli²</dc:creator>
      <dc:creator>Tursunmurodov Abdushukur Gʻafur oʻgʻli³</dc:creator>
      <dc:subject>preventive medicine</dc:subject>
      <dc:subject>chronic diseases</dc:subject>
      <dc:subject>public health</dc:subject>
      <dc:subject>disease prevention</dc:subject>
      <dc:subject>screening programs</dc:subject>
      <dc:subject>lifestyle modification</dc:subject>
      <dc:subject>health promotion</dc:subject>
      <dc:subject>early detection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1177</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 03, pp. 132-144</dc:source>
    </item>
    <item>
      <title>Impact of Air Pollution on Childhood Respiratory Infections: A Multi-City Cohort Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/b8d32e62-febd-4127-bd11-358426393ec6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/b8d32e62-febd-4127-bd11-358426393ec6</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Wang X</author>
      <description>Multi-city prospective cohort study examining the association between ambient air pollution exposure and respiratory infections in 8,500 children aged 0-5 years across six major cities.</description>
      <dc:creator>Wang X</dc:creator>
      <dc:creator>Hernández R</dc:creator>
      <dc:creator>Svensson K</dc:creator>
      <dc:subject>air pollution</dc:subject>
      <dc:subject>respiratory infections</dc:subject>
      <dc:subject>children</dc:subject>
      <dc:subject>environmental health</dc:subject>
      <dc:subject>cohort study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1188</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 120-133</dc:source>
    </item>
    <item>
      <title>Spinal Cord Stimulation With Closed-Loop Feedback for Chronic Low Back Pain</title>
      <link>https://aams-journal.us/journals/neurology/articles/fb409e28-0a75-4a66-8c2d-d703e6d88cff</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/fb409e28-0a75-4a66-8c2d-d703e6d88cff</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Becker T</author>
      <description>Multicenter RCT comparing closed-loop evoked compound action potential-controlled spinal cord stimulation with open-loop stimulation in 460 patients with chronic low back pain.</description>
      <dc:creator>Becker T</dc:creator>
      <dc:creator>Ueda H</dc:creator>
      <dc:creator>Mensah-Kumi A</dc:creator>
      <dc:subject>spinal cord stimulation</dc:subject>
      <dc:subject>chronic pain</dc:subject>
      <dc:subject>closed-loop</dc:subject>
      <dc:subject>low back pain</dc:subject>
      <dc:subject>neuromodulation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1244</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 285-292</dc:source>
    </item>
    <item>
      <title>Congenital Heart Disease Screening Using Point-of-Care Echocardiography in Resource-Limited Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c43ee1f8-8f7f-4185-8caa-c4f6d4603008</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c43ee1f8-8f7f-4185-8caa-c4f6d4603008</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Abdullaev RK</author>
      <description>Prospective diagnostic accuracy study evaluating point-of-care echocardiography performed by trained non-cardiologists for CHD screening in 3,200 neonates in resource-limited settings.</description>
      <dc:creator>Abdullaev RK</dc:creator>
      <dc:creator>Chimbidzikai T</dc:creator>
      <dc:creator>Novak P</dc:creator>
      <dc:subject>congenital heart disease</dc:subject>
      <dc:subject>echocardiography</dc:subject>
      <dc:subject>point-of-care</dc:subject>
      <dc:subject>resource-limited settings</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1189</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 134-141</dc:source>
    </item>
    <item>
      <title>Burnout and Mental Health Among Healthcare Workers: A Global Cross-Sectional Survey</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/7b7af3d9-4fe2-42d9-9dfc-2a4a35d5cf63</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/7b7af3d9-4fe2-42d9-9dfc-2a4a35d5cf63</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Korhonen M</author>
      <description>Global cross-sectional survey assessing burnout prevalence, mental health outcomes, and associated factors among 45,000 healthcare workers across 28 countries.</description>
      <dc:creator>Korhonen M</dc:creator>
      <dc:creator>Shimada Y</dc:creator>
      <dc:creator>Abdullaeva NR</dc:creator>
      <dc:subject>burnout</dc:subject>
      <dc:subject>healthcare workers</dc:subject>
      <dc:subject>mental health</dc:subject>
      <dc:subject>cross-sectional survey</dc:subject>
      <dc:subject>occupational health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1252</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 114-122</dc:source>
    </item>
    <item>
      <title>Closed-Loop Neurostimulation for Refractory Focal Epilepsy: Multicenter Registry</title>
      <link>https://aams-journal.us/journals/neurology/articles/06ddbf0a-0de0-4a99-b0d7-03edf9b48f3d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/06ddbf0a-0de0-4a99-b0d7-03edf9b48f3d</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Steiner R</author>
      <description>Multicenter registry analysis of 680 patients with refractory focal epilepsy treated with responsive neurostimulation, reporting long-term seizure reduction and quality-of-life outcomes.</description>
      <dc:creator>Steiner R</dc:creator>
      <dc:creator>Aoki T</dc:creator>
      <dc:creator>Kurbanov FM</dc:creator>
      <dc:subject>focal epilepsy</dc:subject>
      <dc:subject>closed-loop neurostimulation</dc:subject>
      <dc:subject>responsive neurostimulation</dc:subject>
      <dc:subject>seizure reduction</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1222</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 24-33</dc:source>
    </item>
    <item>
      <title>Neuroendocrine Regulation of Female Fertility Under Chronic Stress.</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/55d9d70d-bf6c-4919-a9c5-d66e39b3e1dd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/55d9d70d-bf6c-4919-a9c5-d66e39b3e1dd</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Bagirova Umida Jabbarovna¹</author>
      <description>Female reproductive function is tightly regulated by complex neuroendocrine mechanisms involving the hypothalamic–pituitary–gonadal (HPG) axis, which coordinates hormonal signals essential for ovulation, menstrual cyclicity, and fertility. Chronic psychological or physiological stress disrupts this delicate balance through persistent activation of the hypothalamic–pituitary–adrenal (HPA) axis, leading to increased secretion of corticotropin-releasing hormone, adrenocorticotropic hormone, and glucocorticoids. Elevated cortisol levels influence gonadotropin-releasing hormone pulsatility, suppress luteinizing hormone secretion, and impair ovarian steroidogenesis. These changes may result in menstrual irregularities, anovulation, reduced ovarian reserve, and decreased reproductive capacity. Chronic stress also affects metabolic and immune pathways that further interfere with reproductive endocrine regulation. Understanding the neuroendocrine interactions linking stress and fertility is essential for early identification of reproductive dysfunction and development of targeted therapeutic strategies. This article reviews the mechanisms through which prolonged stress influences female fertility, highlighting hormonal pathways, physiological responses, diagnostic considerations, and potential approaches for prevention and treatment. Chronic stress represents a significant biological and psychological factor capable of influencing female reproductive capacity through complex neuroendocrine interactions. The reproductive system is regulated by coordinated activity of the hypothalamic–pituitary–gonadal axis, which ensures the cyclic release of hormones responsible for follicular development, ovulation, and maintenance of reproductive health. Prolonged exposure to stressors stimulates persistent activation of the hypothalamic–pituitary–adrenal axis, leading to elevated secretion of cortisol and other stress mediators that interfere with hypothalamic hormonal signaling. As a result, the pulsatile release of reproductive hormones becomes disrupted, altering ovarian steroidogenesis and menstrual cyclicity. These endocrine disturbances may manifest as anovulation, irregular menstrual cycles, decreased fertility potential, and functional hypothalamic amenorrhea. In addition, chronic stress influences immune responses, metabolic regulation, and neurotransmitter pathways, further contributing to reproductive imbalance. Early recognition of stress-induced endocrine alterations is essential for timely intervention and prevention of long-term reproductive complications.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773318094248-Neuroendocrine_Regulation_of_Female_Fertility_Unde.pdf" type="application/pdf" length="0"/>
      <dc:creator>Bagirova Umida Jabbarovna¹</dc:creator>
      <dc:creator>Togayeva Gulnora Siddikovna²</dc:creator>
      <dc:subject>chronic stress</dc:subject>
      <dc:subject>female fertility</dc:subject>
      <dc:subject>neuroendocrine regulation</dc:subject>
      <dc:subject>hypothalamic–pituitary–gonadal axis</dc:subject>
      <dc:subject>cortisol</dc:subject>
      <dc:subject>reproductive hormones</dc:subject>
      <dc:subject>menstrual disorders</dc:subject>
      <dc:subject>stress physiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1176</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 03, pp. 78-90</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/da528f04-0c60-44bb-8608-ce8ea7cda770</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/da528f04-0c60-44bb-8608-ce8ea7cda770</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1954 participants across 4 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/da528f04-0c60-44bb-8608-ce8ea7cda770-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0262</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 180-191</dc:source>
    </item>
    <item>
      <title>3D-Printed Surgical Guides for Zygomatic Implants: Accuracy and Patient Outcomes</title>
      <link>https://aams-journal.us/journals/dentistry/articles/4bf5f86e-dd48-4df4-9ea6-a4e72c398ca5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/4bf5f86e-dd48-4df4-9ea6-a4e72c398ca5</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Nielsen JK</author>
      <description>Prospective study evaluating the accuracy and clinical outcomes of 3D-printed surgical guides for zygomatic implant placement in 94 patients with severe maxillary atrophy.</description>
      <dc:creator>Nielsen JK</dc:creator>
      <dc:creator>Sultanov BK</dc:creator>
      <dc:creator>Moreira AL</dc:creator>
      <dc:subject>3D printing</dc:subject>
      <dc:subject>zygomatic implants</dc:subject>
      <dc:subject>surgical guides</dc:subject>
      <dc:subject>maxillary atrophy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1203</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 107-120</dc:source>
    </item>
    <item>
      <title>Clear Aligner Therapy vs Fixed Appliances for Anterior Crowding: A Prospective Comparison</title>
      <link>https://aams-journal.us/journals/dentistry/articles/4101052b-d499-4e8c-b607-6a6be4b51862</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/4101052b-d499-4e8c-b607-6a6be4b51862</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>De Luca A</author>
      <description>Prospective clinical comparison of treatment efficiency, accuracy, and patient satisfaction between clear aligner therapy and conventional fixed appliances in 290 patients with moderate anterior crowding.</description>
      <dc:creator>De Luca A</dc:creator>
      <dc:creator>Yusupov MR</dc:creator>
      <dc:creator>Singh AP</dc:creator>
      <dc:subject>clear aligners</dc:subject>
      <dc:subject>fixed appliances</dc:subject>
      <dc:subject>orthodontics</dc:subject>
      <dc:subject>anterior crowding</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1201</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 87-97</dc:source>
    </item>
    <item>
      <title>Medical Education Reform: Impact of Competency-Based Training on Clinical Outcomes</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/9f7ee4cf-fb85-4b54-ae07-f259bc633f6c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/9f7ee4cf-fb85-4b54-ae07-f259bc633f6c</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Rodriguez MA</author>
      <description>Quasi-experimental study comparing patient outcomes between residency programs using competency-based medical education and traditional time-based curricula across 42 institutions.</description>
      <dc:creator>Rodriguez MA</dc:creator>
      <dc:creator>Fujimoto T</dc:creator>
      <dc:creator>Toure B</dc:creator>
      <dc:subject>medical education</dc:subject>
      <dc:subject>competency-based training</dc:subject>
      <dc:subject>clinical outcomes</dc:subject>
      <dc:subject>residency</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1253</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 135-143</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/e2251228-fa48-4a14-8b49-b1ca18ee921e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/e2251228-fa48-4a14-8b49-b1ca18ee921e</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1947 participants across 3 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/e2251228-fa48-4a14-8b49-b1ca18ee921e-Fetal_Alcohol_Spectrum_Disorders__Neurobehavioral_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0261</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 187-194</dc:source>
    </item>
    <item>
      <title>Comparative Analysis of Zirconia vs Lithium Disilicate Crowns: A 7-Year Clinical Trial</title>
      <link>https://aams-journal.us/journals/dentistry/articles/f07f6f0a-081a-4862-929e-9985dc420715</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/f07f6f0a-081a-4862-929e-9985dc420715</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Schmidt F</author>
      <description>Randomized clinical trial comparing the 7-year survival rates, fracture resistance, and esthetic outcomes of monolithic zirconia and lithium disilicate posterior crowns in 324 patients.</description>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Park JH</dc:creator>
      <dc:creator>Araújo VR</dc:creator>
      <dc:subject>zirconia</dc:subject>
      <dc:subject>lithium disilicate</dc:subject>
      <dc:subject>dental crowns</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>survival rate</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1210</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 202-215</dc:source>
    </item>
    <item>
      <title>Pediatric Migraine Management: Comparative Efficacy of Prophylactic Therapies</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c647ca7d-1817-49b3-ace7-c00e3ff1a0f7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c647ca7d-1817-49b3-ace7-c00e3ff1a0f7</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Morrison AC</author>
      <description>A randomized double-blind trial comparing the efficacy of topiramate, amitriptyline, and placebo for migraine prophylaxis in 420 children aged 8-17 years with episodic migraine.</description>
      <dc:creator>Morrison AC</dc:creator>
      <dc:creator>Bazarova MK</dc:creator>
      <dc:creator>Lefèvre J</dc:creator>
      <dc:subject>pediatric migraine</dc:subject>
      <dc:subject>prophylaxis</dc:subject>
      <dc:subject>topiramate</dc:subject>
      <dc:subject>amitriptyline</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1190</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 142-152</dc:source>
    </item>
    <item>
      <title>Climate Change and Emerging Infectious Diseases: A Predictive Modeling Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/233f8367-0c3c-44ac-9e2d-3d5f39ff7174</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/233f8367-0c3c-44ac-9e2d-3d5f39ff7174</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Carlsson P</author>
      <description>Predictive modeling study using climate data and disease surveillance records to forecast geographic shifts in vector-borne and zoonotic disease emergence through 2050.</description>
      <dc:creator>Carlsson P</dc:creator>
      <dc:creator>Wang F</dc:creator>
      <dc:creator>Afolabi OJ</dc:creator>
      <dc:subject>climate change</dc:subject>
      <dc:subject>infectious diseases</dc:subject>
      <dc:subject>predictive modeling</dc:subject>
      <dc:subject>zoonotic diseases</dc:subject>
      <dc:subject>public health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1246</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 21-35</dc:source>
    </item>
    <item>
      <title>Bioactive Glass Nanoparticles for Dentin Remineralization: In Vitro and In Vivo Study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/0e200579-32af-46f4-8deb-e84562537f01</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/0e200579-32af-46f4-8deb-e84562537f01</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Oliveira PH</author>
      <description>Combined in vitro and in vivo study evaluating novel bioactive glass nanoparticles for dentin remineralization, demonstrating significant mineral recovery and tubule occlusion.</description>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Suzuki R</dc:creator>
      <dc:creator>Mensah IA</dc:creator>
      <dc:subject>bioactive glass</dc:subject>
      <dc:subject>dentin remineralization</dc:subject>
      <dc:subject>nanoparticles</dc:subject>
      <dc:subject>restorative dentistry</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1195</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 3, pp. 31-39</dc:source>
    </item>
    <item>
      <title>Stem Cell Therapy for Amyotrophic Lateral Sclerosis: Phase II Efficacy Results</title>
      <link>https://aams-journal.us/journals/neurology/articles/73711340-1736-4560-894f-b396360306d8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/73711340-1736-4560-894f-b396360306d8</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Andersson P</author>
      <description>Phase II randomized controlled trial evaluating intrathecal mesenchymal stem cell transplantation in 120 patients with ALS, assessing functional decline rates and survival.</description>
      <dc:creator>Andersson P</dc:creator>
      <dc:creator>Kato N</dc:creator>
      <dc:creator>Abdi-Rashid H</dc:creator>
      <dc:subject>ALS</dc:subject>
      <dc:subject>stem cell therapy</dc:subject>
      <dc:subject>mesenchymal stem cells</dc:subject>
      <dc:subject>phase II</dc:subject>
      <dc:subject>motor neuron disease</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1230</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 3, pp. 113-120</dc:source>
    </item>
    <item>
      <title>The Role of Preventive Medicine in Reducing the Burden of Chronic Diseases</title>
      <link>https://aams-journal.us/journals/neurology/articles/ab3855d3-83b3-4a40-9f67-5d5c8ef177fe</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/ab3855d3-83b3-4a40-9f67-5d5c8ef177fe</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Ismatova Marguba Shaukatovna¹</author>
      <description>Chronic diseases represent one of the leading causes of morbidity and mortality worldwide, significantly affecting healthcare systems, economic productivity, and quality of life. Conditions such as cardiovascular diseases, diabetes mellitus, cancer, and chronic respiratory disorders develop gradually and are often associated with modifiable risk factors including unhealthy diet, physical inactivity, tobacco use, excessive alcohol consumption, and environmental influences. Preventive medicine focuses on reducing the incidence and impact of these diseases through early identification of risk factors, health education, screening programs, vaccination, and lifestyle interventions. Modern preventive strategies emphasize population-based approaches combined with individualized risk assessment to detect diseases in their early stages or prevent their development altogether. Implementation of preventive measures has been shown to decrease hospitalization rates, improve long-term health outcomes, and reduce healthcare expenditures. This article examines the principles of preventive medicine, evaluates its effectiveness in reducing the burden of chronic diseases, and highlights strategies for improving public health through early intervention and disease prevention. The growing prevalence of chronic noncommunicable diseases has become a major challenge for global healthcare systems. Conditions such as cardiovascular disorders, diabetes, chronic respiratory diseases, and cancer account for a large proportion of long-term disability and premature mortality. Preventive medicine has emerged as an essential strategy for reducing these burdens by focusing on early risk identification, health promotion, and timely intervention before irreversible pathological processes develop. Through population-level strategies and individualized preventive care, modern healthcare systems aim to modify behavioral and environmental determinants of disease. Preventive actions including lifestyle modification, early diagnostic screening, vaccination programs, and public health education have demonstrated measurable improvements in health outcomes. These measures not only decrease disease incidence but also reduce healthcare expenditures and improve quality of life across populations. Expanding preventive healthcare programs remains a critical step in controlling the long-term impact of chronic illnesses worldwide.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773321830918-The_Role_of_Preventive_Medicine_in_Reducing_the_Bu.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ismatova Marguba Shaukatovna¹</dc:creator>
      <dc:creator>Xayrullayev Muso²</dc:creator>
      <dc:creator>Tursunmurodov Abdushukur³</dc:creator>
      <dc:subject>preventive medicine</dc:subject>
      <dc:subject>chronic diseases</dc:subject>
      <dc:subject>public health</dc:subject>
      <dc:subject>disease prevention</dc:subject>
      <dc:subject>screening programs</dc:subject>
      <dc:subject>lifestyle modification</dc:subject>
      <dc:subject>health promotion</dc:subject>
      <dc:subject>early detection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1178</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 03, pp. 166-178</dc:source>
    </item>
    <item>
      <title>Effectiveness of Community Health Workers in Reducing Maternal Mortality: Cluster RCT</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/52a698ed-c83b-4a6f-8157-e9c2bbccdad9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/52a698ed-c83b-4a6f-8157-e9c2bbccdad9</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Bhatt DR</author>
      <description>Cluster randomized controlled trial evaluating the impact of trained community health workers on maternal mortality and obstetric outcomes in 96 rural health districts across three countries.</description>
      <dc:creator>Bhatt DR</dc:creator>
      <dc:creator>Kimura S</dc:creator>
      <dc:creator>Sow M</dc:creator>
      <dc:subject>community health workers</dc:subject>
      <dc:subject>maternal mortality</dc:subject>
      <dc:subject>cluster RCT</dc:subject>
      <dc:subject>primary care</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1249</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 3, pp. 65-77</dc:source>
    </item>
    <item>
      <title>Genetic Screening for Inborn Errors of Metabolism: Implementation of Expanded Newborn Screening Panel</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/6b0bfd0b-25f4-44ec-8e4d-1afdfbde2d74</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/6b0bfd0b-25f4-44ec-8e4d-1afdfbde2d74</guid>
      <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
      <author>Karimov DS</author>
      <description>This prospective multicenter study evaluated the clinical utility and cost-effectiveness of an expanded newborn screening panel for 56 inborn errors of metabolism in a cohort of 150,000 newborns.</description>
      <dc:creator>Karimov DS</dc:creator>
      <dc:creator>Andersen L</dc:creator>
      <dc:creator>Mwangi J</dc:creator>
      <dc:subject>newborn screening</dc:subject>
      <dc:subject>inborn errors of metabolism</dc:subject>
      <dc:subject>genetic screening</dc:subject>
      <dc:subject>tandem mass spectrometry</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1184</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 3, pp. 68-78</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of age-related macular degeneration: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/6e3da535-9350-436a-9dc4-74b2e6e739a6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/6e3da535-9350-436a-9dc4-74b2e6e739a6</guid>
      <pubDate>Sat, 28 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Sven Eriksson</author>
      <description>Background: Age-related macular degeneration remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with age-related macular degeneration. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>age-related macular degeneration</dc:subject>
      <dc:subject>age-related</dc:subject>
      <dc:subject>macular</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1153</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 2, pp. 192-204</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for TMJ disorders</title>
      <link>https://aams-journal.us/journals/dentistry/articles/8925c392-ff53-4a69-9ec4-d8241fc5ed5f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/8925c392-ff53-4a69-9ec4-d8241fc5ed5f</guid>
      <pubDate>Sat, 28 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Ingrid Sørensen</author>
      <description>Background: Tmj disorders remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with TMJ disorders. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>TMJ</dc:subject>
      <dc:subject>disorders</dc:subject>
      <dc:subject>TMJ disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1023</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 2, pp. 259-272</dc:source>
    </item>
    <item>
      <title>chronic pain management: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/0e539e48-3d42-43b1-ad50-63114185f945</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/0e539e48-3d42-43b1-ad50-63114185f945</guid>
      <pubDate>Sat, 28 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Daniel Cohen</author>
      <description>Background: Chronic pain management remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with chronic pain management. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>chronic</dc:subject>
      <dc:subject>pain</dc:subject>
      <dc:subject>chronic pain management</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1067</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 333-340</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following oral health-related quality of life</title>
      <link>https://aams-journal.us/journals/dentistry/articles/0f1b4b27-a80a-4596-8cc8-65fa548da887</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/0f1b4b27-a80a-4596-8cc8-65fa548da887</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Liam O&apos;Sullivan</author>
      <description>Background: Oral health-related quality of life remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with oral health-related quality of life. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>oral health-related quality of life</dc:subject>
      <dc:subject>oral</dc:subject>
      <dc:subject>health-related</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1027</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 236-247</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into anxiety CBT: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/a884d00e-c483-43b5-96ef-08d645682c4f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/a884d00e-c483-43b5-96ef-08d645682c4f</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Aleksandra Kowalski</author>
      <description>Background: Anxiety cbt remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with anxiety CBT. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:subject>anxiety CBT</dc:subject>
      <dc:subject>CBT</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>anxiety</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1168</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 1, pp. 318-332</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following atrial fibrillation</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/7f2ef0ea-0a08-42a2-b8cb-6eafc0010d61</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/7f2ef0ea-0a08-42a2-b8cb-6eafc0010d61</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Linh Nguyen</author>
      <description>Background: Atrial fibrillation remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with atrial fibrillation. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>atrial</dc:subject>
      <dc:subject>fibrillation</dc:subject>
      <dc:subject>atrial fibrillation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1035</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 227-241</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for laparoscopic colorectal resection</title>
      <link>https://aams-journal.us/journals/surgery/articles/e74c3da6-273e-464a-bf34-0d9b4ef37948</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/e74c3da6-273e-464a-bf34-0d9b4ef37948</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Henrik Larsen</author>
      <description>Background: Laparoscopic colorectal resection remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with laparoscopic colorectal resection. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:subject>laparoscopic</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>colorectal</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>laparoscopic colorectal resection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1135</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 363-373</dc:source>
    </item>
    <item>
      <title>Diagnostic accuracy of artificial intelligence in status epilepticus</title>
      <link>https://aams-journal.us/journals/neurology/articles/ed8a0085-0798-4a9a-a70e-1d8398832996</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/ed8a0085-0798-4a9a-a70e-1d8398832996</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Beatrice Romano</author>
      <description>Background: Status epilepticus remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with status epilepticus. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epilepticus</dc:subject>
      <dc:subject>status epilepticus</dc:subject>
      <dc:subject>status</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1056</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 1, pp. 332-340</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following acne vulgaris isotretinoin</title>
      <link>https://aams-journal.us/journals/dermatology/articles/3ade1816-91f0-4675-8f88-a043ceac1933</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/3ade1816-91f0-4675-8f88-a043ceac1933</guid>
      <pubDate>Thu, 26 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Natalia Petrova</author>
      <description>Background: Acne vulgaris isotretinoin remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with acne vulgaris isotretinoin. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:subject>acne</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>acne vulgaris isotretinoin</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>vulgaris</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-26</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1123</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 284-295</dc:source>
    </item>
    <item>
      <title>Real-world evidence on pediatric surgical airway: a population-based study</title>
      <link>https://aams-journal.us/journals/surgery/articles/6572242f-d44a-4e0b-9a1f-4aca701775f2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/6572242f-d44a-4e0b-9a1f-4aca701775f2</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Pediatric surgical airway remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric surgical airway. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>pediatric surgical airway</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>surgical</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1149</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 213-227</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for venous thromboembolism</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/68be4444-b62b-4c66-ad16-cc516b9bd2ac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/68be4444-b62b-4c66-ad16-cc516b9bd2ac</guid>
      <pubDate>Mon, 23 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Natalia Petrova</author>
      <description>Background: Venous thromboembolism remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with venous thromboembolism. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>venous thromboembolism</dc:subject>
      <dc:subject>venous</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>thromboembolism</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-23</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1042</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 1, pp. 289-298</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of ERAS protocols: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/surgery/articles/d0599425-15c8-4651-b8af-7fd3b969c9e1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/d0599425-15c8-4651-b8af-7fd3b969c9e1</guid>
      <pubDate>Mon, 23 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Chiamaka Eze</author>
      <description>Background: Eras protocols remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with ERAS protocols. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>ERAS</dc:subject>
      <dc:subject>protocols</dc:subject>
      <dc:subject>ERAS protocols</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-23</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1137</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 215-223</dc:source>
    </item>
    <item>
      <title>pediatric meningitis: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/8f41042a-7e41-4594-ae10-88e2f02e6b6d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/8f41042a-7e41-4594-ae10-88e2f02e6b6d</guid>
      <pubDate>Sun, 22 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Mateo Vargas</author>
      <description>Background: Pediatric meningitis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric meningitis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>meningitis</dc:subject>
      <dc:subject>pediatric meningitis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1117</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 53-60</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of transplant surgery interventions</title>
      <link>https://aams-journal.us/journals/surgery/articles/335faa07-f3dc-4774-9ee3-b2154b9539b4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/335faa07-f3dc-4774-9ee3-b2154b9539b4</guid>
      <pubDate>Sun, 22 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Carlos Mendoza</author>
      <description>Background: Transplant surgery remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with transplant surgery. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>transplant surgery</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>surgery</dc:subject>
      <dc:subject>transplant</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1148</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 158-166</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for neuro-oncology</title>
      <link>https://aams-journal.us/journals/neurology/articles/fd0d2380-fb97-41db-bf0c-07cbb16ab237</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/fd0d2380-fb97-41db-bf0c-07cbb16ab237</guid>
      <pubDate>Sun, 22 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Sanjay Bhattacharya</author>
      <description>Background: Neuro-oncology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with neuro-oncology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>neuro-oncology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1054</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 1, pp. 321-330</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of RSV bronchiolitis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/e168978e-96ec-4ac2-9933-d856203b6983</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/e168978e-96ec-4ac2-9933-d856203b6983</guid>
      <pubDate>Sun, 22 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Mateo Vargas</author>
      <description>Background: Rsv bronchiolitis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with RSV bronchiolitis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>RSV</dc:subject>
      <dc:subject>RSV bronchiolitis</dc:subject>
      <dc:subject>bronchiolitis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1012</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 366-376</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into pharmacogenomics: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/genetics/articles/8ab06b6d-41ae-4c94-88be-91a8b4b1e0eb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/8ab06b6d-41ae-4c94-88be-91a8b4b1e0eb</guid>
      <pubDate>Sat, 21 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Aisha Mahmoud</author>
      <description>Background: Pharmacogenomics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pharmacogenomics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:subject>pharmacogenomics</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1078</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 2, pp. 301-309</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for liquid biopsy in tertiary care settings</title>
      <link>https://aams-journal.us/journals/genetics/articles/b74e0031-8ed2-4629-af10-320354ef8b63</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/b74e0031-8ed2-4629-af10-320354ef8b63</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Rashid Khan</author>
      <description>Background: Liquid biopsy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with liquid biopsy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>liquid biopsy</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>liquid</dc:subject>
      <dc:subject>biopsy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1084</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 34-42</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of dengue serotype dynamics versus standard care</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/95aed9cb-e0f3-4ed2-a348-51d642f2f81c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/95aed9cb-e0f3-4ed2-a348-51d642f2f81c</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Anders Lindqvist</author>
      <description>Background: Dengue serotype dynamics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with dengue serotype dynamics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>dengue</dc:subject>
      <dc:subject>dengue serotype dynamics</dc:subject>
      <dc:subject>serotype</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1111</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 33-40</dc:source>
    </item>
    <item>
      <title>contact dermatitis patch testing: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/dermatology/articles/75bdf3f2-e55b-4dcd-ba8b-385696d24e09</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/75bdf3f2-e55b-4dcd-ba8b-385696d24e09</guid>
      <pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Isabella Fernandez</author>
      <description>Background: Contact dermatitis patch testing remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with contact dermatitis patch testing. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>contact dermatitis patch testing</dc:subject>
      <dc:subject>dermatitis</dc:subject>
      <dc:subject>contact</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1130</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 128-136</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for ketamine antidepressant</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/e0ad66df-683e-49e9-b476-904dd9099666</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/e0ad66df-683e-49e9-b476-904dd9099666</guid>
      <pubDate>Wed, 18 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Sven Eriksson</author>
      <description>Background: Ketamine antidepressant remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with ketamine antidepressant. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>ketamine antidepressant</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>antidepressant</dc:subject>
      <dc:subject>ketamine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1164</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 1, pp. 195-204</dc:source>
    </item>
    <item>
      <title>Diagnostic accuracy of artificial intelligence in minimally invasive cardiac surgery</title>
      <link>https://aams-journal.us/journals/surgery/articles/add38c08-0d16-4e25-9c99-44da5fcc20b9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/add38c08-0d16-4e25-9c99-44da5fcc20b9</guid>
      <pubDate>Wed, 18 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Reza Mohammadi</author>
      <description>Background: Minimally invasive cardiac surgery remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with minimally invasive cardiac surgery. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>invasive</dc:subject>
      <dc:subject>minimally invasive cardiac surgery</dc:subject>
      <dc:subject>minimally</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1139</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 99-108</dc:source>
    </item>
    <item>
      <title>Predictive biomarkers in carbapenem-resistant Enterobacteriaceae: systematic review and meta-analysis</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/a9b22e3d-61b3-4b59-a29e-b2d9d809021b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/a9b22e3d-61b3-4b59-a29e-b2d9d809021b</guid>
      <pubDate>Wed, 18 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ji-Hoon Park</author>
      <description>Background: Carbapenem-resistant enterobacteriaceae remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with carbapenem-resistant Enterobacteriaceae. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>Enterobacteriaceae</dc:subject>
      <dc:subject>carbapenem-resistant</dc:subject>
      <dc:subject>carbapenem-resistant Enterobacteriaceae</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1107</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 27-40</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following breast oncoplastic surgery</title>
      <link>https://aams-journal.us/journals/surgery/articles/a5bac9a3-d2a8-4185-9422-2db3bb316e1b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/a5bac9a3-d2a8-4185-9422-2db3bb316e1b</guid>
      <pubDate>Tue, 17 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Edwin Otieno</author>
      <description>Background: Breast oncoplastic surgery remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with breast oncoplastic surgery. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>breast</dc:subject>
      <dc:subject>oncoplastic</dc:subject>
      <dc:subject>breast oncoplastic surgery</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1146</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 1, pp. 313-325</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into Huntington&apos;s disease: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/neurology/articles/6024a022-82b9-40dc-aa0b-a25a4b8a2880</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/6024a022-82b9-40dc-aa0b-a25a4b8a2880</guid>
      <pubDate>Tue, 17 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Rashid Khan</author>
      <description>Background: Huntington&apos;s disease remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with Huntington&apos;s disease. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>disease</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>Huntington&apos;s</dc:subject>
      <dc:subject>Huntington&apos;s disease</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1057</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 359-371</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of Mendelian randomization</title>
      <link>https://aams-journal.us/journals/genetics/articles/83fc3977-6410-4690-9d7d-9d7eaccf1593</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/83fc3977-6410-4690-9d7d-9d7eaccf1593</guid>
      <pubDate>Sun, 15 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Liam O&apos;Sullivan</author>
      <description>Background: Mendelian randomization remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with Mendelian randomization. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>Mendelian randomization</dc:subject>
      <dc:subject>Mendelian</dc:subject>
      <dc:subject>randomization</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1083</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 373-387</dc:source>
    </item>
    <item>
      <title>Real-world evidence on ischemic stroke thrombolysis: a population-based study</title>
      <link>https://aams-journal.us/journals/neurology/articles/028753b6-800f-4e52-ba49-f5a8afd9d3f2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/028753b6-800f-4e52-ba49-f5a8afd9d3f2</guid>
      <pubDate>Sun, 15 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Catherine Laurent</author>
      <description>Background: Ischemic stroke thrombolysis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with ischemic stroke thrombolysis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:subject>stroke</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>ischemic</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>ischemic stroke thrombolysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1045</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 316-330</dc:source>
    </item>
    <item>
      <title>refractive surgery LASIK: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/d052dbc3-8d5d-46a1-8fde-d881a5c656c3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/d052dbc3-8d5d-46a1-8fde-d881a5c656c3</guid>
      <pubDate>Sun, 15 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Mateo Vargas</author>
      <description>Background: Refractive surgery lasik remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with refractive surgery LASIK. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>refractive</dc:subject>
      <dc:subject>refractive surgery LASIK</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>surgery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1156</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 126-132</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into orthodontic biomechanics: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/eaf71db6-a9db-4583-b968-14164599e7c8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/eaf71db6-a9db-4583-b968-14164599e7c8</guid>
      <pubDate>Sat, 14 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Emma Williams</author>
      <description>Background: Orthodontic biomechanics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with orthodontic biomechanics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>orthodontic biomechanics</dc:subject>
      <dc:subject>biomechanics</dc:subject>
      <dc:subject>orthodontic</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1017</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 2, pp. 136-149</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for gastroesophageal reflux</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/56c938ca-675f-4841-92bd-c81fd303b626</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/56c938ca-675f-4841-92bd-c81fd303b626</guid>
      <pubDate>Fri, 13 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Hans Müller</author>
      <description>Background: Gastroesophageal reflux remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with gastroesophageal reflux. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>gastroesophageal</dc:subject>
      <dc:subject>reflux</dc:subject>
      <dc:subject>gastroesophageal reflux</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1040</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 94-100</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of flow cytometry leukemia: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/88cda9a8-218c-41d3-a1ff-c34a1b2ba466</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/88cda9a8-218c-41d3-a1ff-c34a1b2ba466</guid>
      <pubDate>Fri, 13 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Ingrid Sørensen</author>
      <description>Background: Flow cytometry leukemia remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with flow cytometry leukemia. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:subject>flow</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>flow cytometry leukemia</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>cytometry</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1101</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 187-198</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of outbreak genomic epidemiology assessment instruments</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/00034a4b-25c6-4aa6-9f6a-9d0458078e5d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/00034a4b-25c6-4aa6-9f6a-9d0458078e5d</guid>
      <pubDate>Fri, 13 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Reza Mohammadi</author>
      <description>Background: Outbreak genomic epidemiology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with outbreak genomic epidemiology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>outbreak</dc:subject>
      <dc:subject>genomic</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>outbreak genomic epidemiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1119</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 1, pp. 331-342</dc:source>
    </item>
    <item>
      <title>Real-world evidence on bariatric Roux-en-Y: a population-based study</title>
      <link>https://aams-journal.us/journals/surgery/articles/26f7e5a9-7632-43e8-b865-16282ae2d88e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/26f7e5a9-7632-43e8-b865-16282ae2d88e</guid>
      <pubDate>Fri, 13 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Nadia Khoury</author>
      <description>Background: Bariatric roux-en-y remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with bariatric Roux-en-Y. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>bariatric Roux-en-Y</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>Roux-en-Y</dc:subject>
      <dc:subject>bariatric</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1140</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 63-77</dc:source>
    </item>
    <item>
      <title>prenatal screening NIPT: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/genetics/articles/bda21d59-aa73-485a-ab7b-f465f7720c90</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/bda21d59-aa73-485a-ab7b-f465f7720c90</guid>
      <pubDate>Thu, 12 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Rania El-Sayed</author>
      <description>Background: Prenatal screening nipt remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with prenatal screening NIPT. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>prenatal</dc:subject>
      <dc:subject>prenatal screening NIPT</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>screening</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1087</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 2, pp. 344-351</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of epilepsy genetics</title>
      <link>https://aams-journal.us/journals/neurology/articles/dd181949-a42e-4765-b464-2abf6b19622b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/dd181949-a42e-4765-b464-2abf6b19622b</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Beatrice Romano</author>
      <description>Background: Epilepsy genetics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with epilepsy genetics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epilepsy genetics</dc:subject>
      <dc:subject>genetics</dc:subject>
      <dc:subject>epilepsy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1049</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 360-373</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of neuro-ophthalmology assessment instruments</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/cad80567-1714-4b07-a232-18c05c093eb8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/cad80567-1714-4b07-a232-18c05c093eb8</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ji-Hoon Park</author>
      <description>Background: Neuro-ophthalmology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with neuro-ophthalmology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ji-Hoon Park</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:subject>neuro-ophthalmology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1161</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 246-255</dc:source>
    </item>
    <item>
      <title>Real-world evidence on vascular endovascular repair: a population-based study</title>
      <link>https://aams-journal.us/journals/surgery/articles/8e3cf182-266b-444f-baca-4519562a8acd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/8e3cf182-266b-444f-baca-4519562a8acd</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Yuki Tanaka</author>
      <description>Background: Vascular endovascular repair remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with vascular endovascular repair. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>vascular</dc:subject>
      <dc:subject>vascular endovascular repair</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>endovascular</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1147</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 1, pp. 229-239</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of pediatric leukemia interventions</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/4c4bee22-889b-40de-893f-ab2ceaba28ac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/4c4bee22-889b-40de-893f-ab2ceaba28ac</guid>
      <pubDate>Mon, 09 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Mehmet Yıldız</author>
      <description>Background: Pediatric leukemia remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric leukemia. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>pediatric leukemia</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>leukemia</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1005</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 84-97</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of congenital heart defects versus standard care</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/758bbc0f-ce87-4aea-9198-7f0a6024afdd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/758bbc0f-ce87-4aea-9198-7f0a6024afdd</guid>
      <pubDate>Sun, 08 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Layla Bouazizi</author>
      <description>Background: Congenital heart defects remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with congenital heart defects. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>congenital heart defects</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>heart</dc:subject>
      <dc:subject>congenital</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1007</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 2, pp. 299-311</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of dental adhesives</title>
      <link>https://aams-journal.us/journals/dentistry/articles/4c99eb51-ba75-401d-95eb-e68a6a11f565</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/4c99eb51-ba75-401d-95eb-e68a6a11f565</guid>
      <pubDate>Sat, 07 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Beatrice Romano</author>
      <description>Background: Dental adhesives remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with dental adhesives. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:subject>dental</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>dental adhesives</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>adhesives</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1025</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 2, pp. 187-193</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for schizophrenia clozapine in tertiary care settings</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/2b53d79c-dcc2-487c-9bfb-4ad02f058fb1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/2b53d79c-dcc2-487c-9bfb-4ad02f058fb1</guid>
      <pubDate>Fri, 06 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Pablo Restrepo</author>
      <description>Background: Schizophrenia clozapine remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with schizophrenia clozapine. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>clozapine</dc:subject>
      <dc:subject>schizophrenia clozapine</dc:subject>
      <dc:subject>schizophrenia</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1165</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 1, pp. 369-383</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into antibiotic stewardship: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/56cfa834-e3ed-4748-bfc5-862a931d8c48</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/56cfa834-e3ed-4748-bfc5-862a931d8c48</guid>
      <pubDate>Thu, 05 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Antibiotic stewardship remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with antibiotic stewardship. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>antibiotic stewardship</dc:subject>
      <dc:subject>antibiotic</dc:subject>
      <dc:subject>stewardship</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1069</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 184-195</dc:source>
    </item>
    <item>
      <title>Predictive biomarkers in monogenic diabetes: systematic review and meta-analysis</title>
      <link>https://aams-journal.us/journals/genetics/articles/1e838fe3-581d-41fc-aac7-4ec759b4df01</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/1e838fe3-581d-41fc-aac7-4ec759b4df01</guid>
      <pubDate>Thu, 05 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Pablo Restrepo</author>
      <description>Background: Monogenic diabetes remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with monogenic diabetes. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>monogenic diabetes</dc:subject>
      <dc:subject>monogenic</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>diabetes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1086</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 2, pp. 341-351</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of urticaria omalizumab versus standard care</title>
      <link>https://aams-journal.us/journals/dermatology/articles/101a92f0-2834-428b-b4e9-e48cd13fbf5f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/101a92f0-2834-428b-b4e9-e48cd13fbf5f</guid>
      <pubDate>Thu, 05 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Marco Bianchi</author>
      <description>Background: Urticaria omalizumab remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with urticaria omalizumab. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>urticaria omalizumab</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>omalizumab</dc:subject>
      <dc:subject>urticaria</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1134</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 243-257</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for endodontic outcomes</title>
      <link>https://aams-journal.us/journals/dentistry/articles/27f607a5-5f45-4a8a-9ab6-8d943123dbf6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/27f607a5-5f45-4a8a-9ab6-8d943123dbf6</guid>
      <pubDate>Thu, 05 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Fatima Al-Zahra</author>
      <description>Background: Endodontic outcomes remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with endodontic outcomes. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>endodontic outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>endodontic</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1020</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 2, pp. 123-133</dc:source>
    </item>
    <item>
      <title>Predictive biomarkers in liquid chromatography mass spectrometry: systematic review and meta-analysis</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/e2981e72-17d1-4aa1-bf64-c813c029fce5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/e2981e72-17d1-4aa1-bf64-c813c029fce5</guid>
      <pubDate>Wed, 04 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Carlos Mendoza</author>
      <description>Background: Liquid chromatography mass spectrometry remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with liquid chromatography mass spectrometry. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:subject>liquid chromatography mass spectrometry</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>liquid</dc:subject>
      <dc:subject>chromatography</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1093</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 131-141</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of mental health integration assessment instruments</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/e192a5d4-a701-4546-8277-42c09cdf86da</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/e192a5d4-a701-4546-8277-42c09cdf86da</guid>
      <pubDate>Wed, 04 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Mental health integration remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with mental health integration. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>health</dc:subject>
      <dc:subject>mental health integration</dc:subject>
      <dc:subject>mental</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1068</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 117-124</dc:source>
    </item>
    <item>
      <title>autoimmune serology: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/81d8e7f4-3088-44b0-9c74-6885da4ad57c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/81d8e7f4-3088-44b0-9c74-6885da4ad57c</guid>
      <pubDate>Tue, 03 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Liam O&apos;Sullivan</author>
      <description>Background: Autoimmune serology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with autoimmune serology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>serology</dc:subject>
      <dc:subject>autoimmune</dc:subject>
      <dc:subject>autoimmune serology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1102</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 2, pp. 130-138</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for minimally invasive dentistry</title>
      <link>https://aams-journal.us/journals/dentistry/articles/73a92d28-f145-4177-981f-3afed49fbff2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/73a92d28-f145-4177-981f-3afed49fbff2</guid>
      <pubDate>Mon, 02 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Nadia Khoury</author>
      <description>Background: Minimally invasive dentistry remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with minimally invasive dentistry. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>invasive</dc:subject>
      <dc:subject>minimally invasive dentistry</dc:subject>
      <dc:subject>minimally</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1029</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 198-207</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of hospital infection control: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/78185b8e-459e-4296-96d9-082fd2c2321f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/78185b8e-459e-4296-96d9-082fd2c2321f</guid>
      <pubDate>Mon, 02 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Hospital infection control remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with hospital infection control. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>hospital</dc:subject>
      <dc:subject>infection</dc:subject>
      <dc:subject>hospital infection control</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-02</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1115</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 279-292</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of next-generation sequencing</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/d333ad18-c23d-4c18-a31f-ecef03c25468</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/d333ad18-c23d-4c18-a31f-ecef03c25468</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Next-generation sequencing remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with next-generation sequencing. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>sequencing</dc:subject>
      <dc:subject>next-generation</dc:subject>
      <dc:subject>next-generation sequencing</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1094</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 204-210</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of frailty assessment versus standard care</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/54825040-5c28-4ffe-b5e0-82646000e56a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/54825040-5c28-4ffe-b5e0-82646000e56a</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Edwin Otieno</author>
      <description>Background: Frailty assessment remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with frailty assessment. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:subject>assessment</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>frailty</dc:subject>
      <dc:subject>frailty assessment</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1072</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 12-24</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of metabolic syndrome assessment instruments</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/2db78529-7da0-42bb-a204-28efd58851b8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/2db78529-7da0-42bb-a204-28efd58851b8</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ananya Iyer</author>
      <description>Background: Metabolic syndrome remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with metabolic syndrome. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>metabolic syndrome</dc:subject>
      <dc:subject>syndrome</dc:subject>
      <dc:subject>metabolic</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1038</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 1, pp. 295-307</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following childhood diabetes</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/86bce235-402d-4136-8e55-a73f084a9a3f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/86bce235-402d-4136-8e55-a73f084a9a3f</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Akira Suzuki</author>
      <description>Background: Childhood diabetes remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with childhood diabetes. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>childhood diabetes</dc:subject>
      <dc:subject>childhood</dc:subject>
      <dc:subject>diabetes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1009</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 2, pp. 223-231</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of dental anxiety assessment instruments</title>
      <link>https://aams-journal.us/journals/dentistry/articles/1f402022-b655-461f-8a83-5b1e58577e3d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/1f402022-b655-461f-8a83-5b1e58577e3d</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Akira Suzuki</author>
      <description>Background: Dental anxiety remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with dental anxiety. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:subject>dental</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>anxiety</dc:subject>
      <dc:subject>dental anxiety</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1028</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 2, pp. 348-362</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/5a22c16a-8cd9-4b18-a0e6-7d691d335a3c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5a22c16a-8cd9-4b18-a0e6-7d691d335a3c</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1933 participants across 6 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/5a22c16a-8cd9-4b18-a0e6-7d691d335a3c-Brain_Computer_Interface_Rehabilitation_After_Stro.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0259</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 2, pp. 14-23</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f15821f2-8ae0-4d68-9fc3-09e52df86809</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f15821f2-8ae0-4d68-9fc3-09e52df86809</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1912 participants across 3 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f15821f2-8ae0-4d68-9fc3-09e52df86809-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0256</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 7, Issue 2, pp. 1-14</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of Alzheimer&apos;s biomarkers assessment instruments</title>
      <link>https://aams-journal.us/journals/neurology/articles/e8d093e1-2efa-46cc-bf2c-7edce4ae9cec</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/e8d093e1-2efa-46cc-bf2c-7edce4ae9cec</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Prof. Kwame Asante</author>
      <description>Background: Alzheimer&apos;s biomarkers remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with Alzheimer&apos;s biomarkers. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>Alzheimer&apos;s biomarkers</dc:subject>
      <dc:subject>Alzheimer&apos;s</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1046</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 292-304</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/4ffefa08-bd1e-4b5c-9903-f17ed9a52f02</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/4ffefa08-bd1e-4b5c-9903-f17ed9a52f02</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1919 participants across 4 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4ffefa08-bd1e-4b5c-9903-f17ed9a52f02-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0257</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 7, Issue 2, pp. 1-8</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/1e53c478-3105-462a-8887-0fd74d114bb6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/1e53c478-3105-462a-8887-0fd74d114bb6</guid>
      <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1926 participants across 5 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/1e53c478-3105-462a-8887-0fd74d114bb6-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0258</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 2, pp. 15-22</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into BRCA1 variants: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/genetics/articles/77b1f998-b42d-4c23-a3ce-cad4971f44f6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/77b1f998-b42d-4c23-a3ce-cad4971f44f6</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Isabella Fernandez</author>
      <description>Background: Brca1 variants remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with BRCA1 variants. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>variants</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>BRCA1</dc:subject>
      <dc:subject>BRCA1 variants</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1075</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 2, pp. 39-47</dc:source>
    </item>
    <item>
      <title>Real-world evidence on cancer genomics: a population-based study</title>
      <link>https://aams-journal.us/journals/genetics/articles/0deaca6d-f311-45cd-9ee4-cb17a07aa193</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/0deaca6d-f311-45cd-9ee4-cb17a07aa193</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Edwin Otieno</author>
      <description>Background: Cancer genomics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with cancer genomics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>genomics</dc:subject>
      <dc:subject>cancer genomics</dc:subject>
      <dc:subject>cancer</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1088</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 337-350</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of hepatobiliary resection interventions</title>
      <link>https://aams-journal.us/journals/surgery/articles/ae749a7b-8116-4864-bcb5-1abc851d9bdb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/ae749a7b-8116-4864-bcb5-1abc851d9bdb</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Nadia Khoury</author>
      <description>Background: Hepatobiliary resection remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with hepatobiliary resection. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>hepatobiliary resection</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>hepatobiliary</dc:subject>
      <dc:subject>resection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1141</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 2, pp. 246-255</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following COVID-19 long sequelae</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/2a4eacc0-48d9-470a-b620-cdddd078b10c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/2a4eacc0-48d9-470a-b620-cdddd078b10c</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Kwame Asante</author>
      <description>Background: Covid-19 long sequelae remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with COVID-19 long sequelae. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:subject>COVID-19</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>long</dc:subject>
      <dc:subject>COVID-19 long sequelae</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1108</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 1, pp. 224-231</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of traumatic brain injury</title>
      <link>https://aams-journal.us/journals/neurology/articles/74243498-8edb-4f30-9e24-cf8244336743</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/74243498-8edb-4f30-9e24-cf8244336743</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Bongani Mthembu</author>
      <description>Background: Traumatic brain injury remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with traumatic brain injury. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>brain</dc:subject>
      <dc:subject>traumatic</dc:subject>
      <dc:subject>traumatic brain injury</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1052</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 1, pp. 130-143</dc:source>
    </item>
    <item>
      <title>Real-world evidence on malaria vaccine RTS,S: a population-based study</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/db9b7af3-78d1-4a37-a791-06bdba83a59c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/db9b7af3-78d1-4a37-a791-06bdba83a59c</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ananya Iyer</author>
      <description>Background: Malaria vaccine rts,s remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with malaria vaccine RTS,S. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>malaria vaccine RTS,S</dc:subject>
      <dc:subject>vaccine</dc:subject>
      <dc:subject>malaria</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-27</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1109</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 1, pp. 15-26</dc:source>
    </item>
    <item>
      <title>pediatric oncology: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/007e65f6-adcb-4705-a4e7-aba14bcd714e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/007e65f6-adcb-4705-a4e7-aba14bcd714e</guid>
      <pubDate>Mon, 26 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Natalia Petrova</author>
      <description>Background: Pediatric oncology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric oncology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>pediatric oncology</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>oncology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-26</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1014</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 371-384</dc:source>
    </item>
    <item>
      <title>epigenetic biomarkers: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/genetics/articles/c50657e8-f47f-4708-b95c-0c8a4e2155a4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/c50657e8-f47f-4708-b95c-0c8a4e2155a4</guid>
      <pubDate>Mon, 26 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Maria González</author>
      <description>Background: Epigenetic biomarkers remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with epigenetic biomarkers. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epigenetic</dc:subject>
      <dc:subject>epigenetic biomarkers</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-26</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1080</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 171-180</dc:source>
    </item>
    <item>
      <title>Real-world evidence on palliative care: a population-based study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/28532065-2d25-46ad-b6f1-0db92e21a9b7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/28532065-2d25-46ad-b6f1-0db92e21a9b7</guid>
      <pubDate>Mon, 26 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Aisha Mahmoud</author>
      <description>Background: Palliative care remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with palliative care. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Dr. Isabella Fernandez</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>care</dc:subject>
      <dc:subject>palliative care</dc:subject>
      <dc:subject>palliative</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-26</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1074</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 90-99</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into pediatric nutrition: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/93718164-d57e-48d2-86fa-269e01e8bc88</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/93718164-d57e-48d2-86fa-269e01e8bc88</guid>
      <pubDate>Sun, 25 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Henrik Larsen</author>
      <description>Background: Pediatric nutrition remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with pediatric nutrition. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>pediatric</dc:subject>
      <dc:subject>nutrition</dc:subject>
      <dc:subject>pediatric nutrition</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1011</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 44-57</dc:source>
    </item>
    <item>
      <title>Real-world evidence on procalcitonin sepsis: a population-based study</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/63960320-64b9-4fc4-91dd-4e6ea4103818</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/63960320-64b9-4fc4-91dd-4e6ea4103818</guid>
      <pubDate>Sun, 25 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Pablo Restrepo</author>
      <description>Background: Procalcitonin sepsis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with procalcitonin sepsis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>procalcitonin</dc:subject>
      <dc:subject>sepsis</dc:subject>
      <dc:subject>procalcitonin sepsis</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1091</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 27-35</dc:source>
    </item>
    <item>
      <title>keratoconus crosslinking: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/d8fbb7cd-af0b-47df-b90d-d56d58cc564b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/d8fbb7cd-af0b-47df-b90d-d56d58cc564b</guid>
      <pubDate>Sun, 25 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Hiroshi Yamamoto</author>
      <description>Background: Keratoconus crosslinking remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with keratoconus crosslinking. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:subject>keratoconus crosslinking</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>crosslinking</dc:subject>
      <dc:subject>keratoconus</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1154</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 373-382</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of high-sensitivity troponin — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/2e80eee4-e747-4d39-aa02-4490cc1fb989</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/2e80eee4-e747-4d39-aa02-4490cc1fb989</guid>
      <pubDate>Sat, 24 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Edwin Otieno</author>
      <description>Background: High-sensitivity troponin remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with high-sensitivity troponin. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:subject>troponin</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>high-sensitivity troponin</dc:subject>
      <dc:subject>high-sensitivity</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1090</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 73-79</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of viral hepatitis elimination: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/3dff1ff0-1abb-4212-9b9c-a98bbfb90ecc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/3dff1ff0-1abb-4212-9b9c-a98bbfb90ecc</guid>
      <pubDate>Sat, 24 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ananya Iyer</author>
      <description>Background: Viral hepatitis elimination remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with viral hepatitis elimination. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>viral</dc:subject>
      <dc:subject>hepatitis</dc:subject>
      <dc:subject>viral hepatitis elimination</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1113</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 35-46</dc:source>
    </item>
    <item>
      <title>Real-world evidence on gene therapy AAV: a population-based study</title>
      <link>https://aams-journal.us/journals/genetics/articles/89efafe9-2c8c-4d4c-b19b-23fad3e71338</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/89efafe9-2c8c-4d4c-b19b-23fad3e71338</guid>
      <pubDate>Sat, 24 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Klara Janssen</author>
      <description>Background: Gene therapy aav remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with gene therapy AAV. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>gene</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>therapy</dc:subject>
      <dc:subject>gene therapy AAV</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1082</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 136-142</dc:source>
    </item>
    <item>
      <title>Risk factors and prognostic indicators of appendectomy outcomes</title>
      <link>https://aams-journal.us/journals/surgery/articles/ddf98f46-4b11-477d-b90d-d47bdc0ebe16</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/ddf98f46-4b11-477d-b90d-d47bdc0ebe16</guid>
      <pubDate>Sat, 24 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Aisha Mahmoud</author>
      <description>Background: Appendectomy outcomes remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with appendectomy outcomes. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>appendectomy</dc:subject>
      <dc:subject>appendectomy outcomes</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-24</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1145</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 1, pp. 58-69</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of hospital-acquired pneumonia assessment instruments</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/87275b33-0497-447e-a7cb-fdaf68e0cbec</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/87275b33-0497-447e-a7cb-fdaf68e0cbec</guid>
      <pubDate>Fri, 23 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Kwame Asante</author>
      <description>Background: Hospital-acquired pneumonia remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with hospital-acquired pneumonia. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>pneumonia</dc:subject>
      <dc:subject>hospital-acquired</dc:subject>
      <dc:subject>hospital-acquired pneumonia</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-23</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1036</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 1, pp. 141-154</dc:source>
    </item>
    <item>
      <title>Real-world evidence on neglected tropical diseases: a population-based study</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/0717225c-c322-42de-bd48-e28d614507a8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/0717225c-c322-42de-bd48-e28d614507a8</guid>
      <pubDate>Thu, 22 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Neglected tropical diseases remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with neglected tropical diseases. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>tropical</dc:subject>
      <dc:subject>neglected</dc:subject>
      <dc:subject>neglected tropical diseases</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1118</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 141-147</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of retinal vein occlusion versus standard care</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/c9f54623-0a7b-422c-96da-bddc5e5e5a86</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/c9f54623-0a7b-422c-96da-bddc5e5e5a86</guid>
      <pubDate>Thu, 22 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Edwin Otieno</author>
      <description>Background: Retinal vein occlusion remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with retinal vein occlusion. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>vein</dc:subject>
      <dc:subject>retinal vein occlusion</dc:subject>
      <dc:subject>retinal</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1157</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 2, pp. 122-132</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of kawasaki disease versus standard care</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/b9db5529-e257-4c12-9b3c-639f7a0c4f98</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/b9db5529-e257-4c12-9b3c-639f7a0c4f98</guid>
      <pubDate>Wed, 21 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Fatima Al-Zahra</author>
      <description>Background: Kawasaki disease remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with kawasaki disease. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>disease</dc:subject>
      <dc:subject>kawasaki disease</dc:subject>
      <dc:subject>kawasaki</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1006</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 109-120</dc:source>
    </item>
    <item>
      <title>Real-world evidence on quality control SPC: a population-based study</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/aefc2677-d655-4551-83ea-982f0dc7469e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/aefc2677-d655-4551-83ea-982f0dc7469e</guid>
      <pubDate>Wed, 21 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Mei-Ling Chen</author>
      <description>Background: Quality control spc remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with quality control SPC. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>quality</dc:subject>
      <dc:subject>quality control SPC</dc:subject>
      <dc:subject>control</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1099</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 189-199</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of newborn screening — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/124ed157-e4c5-484b-84e8-c2ceb8ea04f9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/124ed157-e4c5-484b-84e8-c2ceb8ea04f9</guid>
      <pubDate>Wed, 21 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Ingrid Sørensen</author>
      <description>Background: Newborn screening remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with newborn screening. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>newborn</dc:subject>
      <dc:subject>newborn screening</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>screening</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-21</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1103</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 2, pp. 66-80</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of caries prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/3464a74c-8feb-44e0-8262-4636fc666bdc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/3464a74c-8feb-44e0-8262-4636fc666bdc</guid>
      <pubDate>Mon, 19 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Carlos Mendoza</author>
      <description>Background: Caries prevention remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with caries prevention. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>caries</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>caries prevention</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1018</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 161-167</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of geriatric polypharmacy</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/beb30496-f436-4715-9be8-3e00252dde8b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/beb30496-f436-4715-9be8-3e00252dde8b</guid>
      <pubDate>Mon, 19 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Klara Janssen</author>
      <description>Background: Geriatric polypharmacy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with geriatric polypharmacy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>geriatric polypharmacy</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>geriatric</dc:subject>
      <dc:subject>polypharmacy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-19</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1043</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 204-213</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of CAR-T cell therapy assessment instruments</title>
      <link>https://aams-journal.us/journals/genetics/articles/6a78be50-e27a-4aaf-8696-95fcf2be9d69</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/6a78be50-e27a-4aaf-8696-95fcf2be9d69</guid>
      <pubDate>Sun, 18 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Wei Zhang</author>
      <description>Background: Car-t cell therapy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with CAR-T cell therapy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:subject>cell</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>CAR-T</dc:subject>
      <dc:subject>CAR-T cell therapy</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1081</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 142-150</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of optic neuritis — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/18c01e0c-8409-4dc0-837a-9fc90b5793ee</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/18c01e0c-8409-4dc0-837a-9fc90b5793ee</guid>
      <pubDate>Sun, 18 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Natalia Petrova</author>
      <description>Background: Optic neuritis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with optic neuritis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>neuritis</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>optic neuritis</dc:subject>
      <dc:subject>optic</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1160</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 231-242</dc:source>
    </item>
    <item>
      <title>glaucoma trabeculectomy: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/b5784dd8-0b51-415b-b4ef-6e88c53a6094</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/b5784dd8-0b51-415b-b4ef-6e88c53a6094</guid>
      <pubDate>Sat, 17 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Maria González</author>
      <description>Background: Glaucoma trabeculectomy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with glaucoma trabeculectomy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>trabeculectomy</dc:subject>
      <dc:subject>glaucoma trabeculectomy</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>glaucoma</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1151</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 2, pp. 29-42</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of autoimmune hepatitis assessment instruments</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/08823e5c-0cb3-467d-8443-a2307a42ec15</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/08823e5c-0cb3-467d-8443-a2307a42ec15</guid>
      <pubDate>Sat, 17 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Mateo Vargas</author>
      <description>Background: Autoimmune hepatitis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with autoimmune hepatitis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Mateo Vargas</dc:creator>
      <dc:creator>Prof. Anders Lindqvist</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>autoimmune hepatitis</dc:subject>
      <dc:subject>autoimmune</dc:subject>
      <dc:subject>hepatitis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1044</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 339-350</dc:source>
    </item>
    <item>
      <title>Predictive biomarkers in point-of-care INR: systematic review and meta-analysis</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/a9b94563-80c3-49ef-b359-a6f99955103f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/a9b94563-80c3-49ef-b359-a6f99955103f</guid>
      <pubDate>Sat, 17 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Sophia Rossi</author>
      <description>Background: Point-of-care inr remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with point-of-care INR. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>point-of-care INR</dc:subject>
      <dc:subject>INR</dc:subject>
      <dc:subject>point-of-care</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1096</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 171-179</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for vaccination uptake in tertiary care settings</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/fe7418e9-9e4c-4bbb-8add-28dda1b8f7d0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/fe7418e9-9e4c-4bbb-8add-28dda1b8f7d0</guid>
      <pubDate>Sat, 17 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Aisha Mahmoud</author>
      <description>Background: Vaccination uptake remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with vaccination uptake. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>uptake</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>vaccination uptake</dc:subject>
      <dc:subject>vaccination</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-17</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1066</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 52-65</dc:source>
    </item>
    <item>
      <title>Genomic and molecular determinants of antimicrobial resistance surveillance</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/28c00c59-7210-449c-b6c1-1d7f95018cef</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/28c00c59-7210-449c-b6c1-1d7f95018cef</guid>
      <pubDate>Fri, 16 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Lukas Novak</author>
      <description>Background: Antimicrobial resistance surveillance remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with antimicrobial resistance surveillance. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Lukas Novak</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>resistance</dc:subject>
      <dc:subject>antimicrobial</dc:subject>
      <dc:subject>antimicrobial resistance surveillance</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-16</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1116</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 198-209</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of tobacco cessation interventions</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/683d19f2-acd8-42a7-b471-7b0bf2aec174</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/683d19f2-acd8-42a7-b471-7b0bf2aec174</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Henrik Larsen</author>
      <description>Background: Tobacco cessation remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with tobacco cessation. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>tobacco cessation</dc:subject>
      <dc:subject>cessation</dc:subject>
      <dc:subject>tobacco</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1062</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 48-57</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for alopecia areata in tertiary care settings</title>
      <link>https://aams-journal.us/journals/dermatology/articles/fce4f597-ee8e-4655-804a-71d178adfbac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/fce4f597-ee8e-4655-804a-71d178adfbac</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Reza Mohammadi</author>
      <description>Background: Alopecia areata remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with alopecia areata. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>alopecia areata</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>areata</dc:subject>
      <dc:subject>alopecia</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1128</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 38-44</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following molecular diagnostics</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/05adf7f5-f352-43ef-8070-e1aa2b57d6d8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/05adf7f5-f352-43ef-8070-e1aa2b57d6d8</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Rashid Khan</author>
      <description>Background: Molecular diagnostics remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with molecular diagnostics. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:subject>diagnostics</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>molecular diagnostics</dc:subject>
      <dc:subject>molecular</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1098</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 2, pp. 322-333</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of cataract phacoemulsification interventions</title>
      <link>https://aams-journal.us/journals/ophthalmology/articles/a71a07e5-4edd-42cc-ae97-231e8dd531d6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/ophthalmology/articles/a71a07e5-4edd-42cc-ae97-231e8dd531d6</guid>
      <pubDate>Wed, 14 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Tomáš Horváth</author>
      <description>Background: Cataract phacoemulsification remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in OPH. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with cataract phacoemulsification. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:subject>cataract phacoemulsification</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>cataract</dc:subject>
      <dc:subject>phacoemulsification</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1152</dc:identifier>
      <dc:source>ISSN:2834-7200</dc:source>
      <dc:source>EISSN:2834-7201</dc:source>
      <dc:source>AAMS Ophthalmology &amp; Vision Sciences, Vol. 12, Issue 1, pp. 297-304</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of chronic kidney disease — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/b1e26547-522f-48a2-ba9b-c10452214f91</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/b1e26547-522f-48a2-ba9b-c10452214f91</guid>
      <pubDate>Wed, 14 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Chronic kidney disease remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with chronic kidney disease. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:subject>kidney</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>chronic</dc:subject>
      <dc:subject>chronic kidney disease</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-14</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1037</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 1, pp. 362-371</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for substance use disorder in tertiary care settings</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/57393907-8949-45ab-b526-b51a14c4a66b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/57393907-8949-45ab-b526-b51a14c4a66b</guid>
      <pubDate>Tue, 13 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Natalia Petrova</author>
      <description>Background: Substance use disorder remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with substance use disorder. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Prof. Henrik Larsen</dc:creator>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:subject>substance use disorder</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>use</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>substance</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1169</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 1, pp. 335-341</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of multiple sclerosis MRI interventions</title>
      <link>https://aams-journal.us/journals/neurology/articles/5bddd40e-b13e-4f21-9e6f-ab4c2ff8acf2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5bddd40e-b13e-4f21-9e6f-ab4c2ff8acf2</guid>
      <pubDate>Tue, 13 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Mehmet Yıldız</author>
      <description>Background: Multiple sclerosis mri remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with multiple sclerosis MRI. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>multiple sclerosis MRI</dc:subject>
      <dc:subject>sclerosis</dc:subject>
      <dc:subject>multiple</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1048</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 1, pp. 48-58</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of scarring trichoscopy: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/dermatology/articles/2e442fd7-3c6b-4f67-9f84-d31d52d30867</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/2e442fd7-3c6b-4f67-9f84-d31d52d30867</guid>
      <pubDate>Tue, 13 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Beatrice Romano</author>
      <description>Background: Scarring trichoscopy remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with scarring trichoscopy. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Daniel Cohen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>scarring</dc:subject>
      <dc:subject>trichoscopy</dc:subject>
      <dc:subject>scarring trichoscopy</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-13</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1132</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 207-218</dc:source>
    </item>
    <item>
      <title>Clinical efficacy and safety of CBCT imaging: a multicenter prospective cohort study</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e1c37ce7-2df3-48c0-9fbb-a10dc7ed9fce</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e1c37ce7-2df3-48c0-9fbb-a10dc7ed9fce</guid>
      <pubDate>Mon, 12 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Sanjay Bhattacharya</author>
      <description>Background: Cbct imaging remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with CBCT imaging. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:creator>Dr. Liam O&apos;Sullivan</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>CBCT imaging</dc:subject>
      <dc:subject>CBCT</dc:subject>
      <dc:subject>imaging</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1021</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 260-270</dc:source>
    </item>
    <item>
      <title>Real-world evidence on actinic keratosis: a population-based study</title>
      <link>https://aams-journal.us/journals/dermatology/articles/d5fc932c-8c89-43d2-841a-04e06779a59d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/d5fc932c-8c89-43d2-841a-04e06779a59d</guid>
      <pubDate>Sun, 11 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Fatima Al-Zahra</author>
      <description>Background: Actinic keratosis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with actinic keratosis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Fatima Al-Zahra</dc:creator>
      <dc:creator>Dr. Pablo Restrepo</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:subject>actinic</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>keratosis</dc:subject>
      <dc:subject>actinic keratosis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1129</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 264-278</dc:source>
    </item>
    <item>
      <title>Cross-cultural validation of telemedicine outcomes assessment instruments</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/565c8fb4-bce2-485c-9897-36e808a6ebc4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/565c8fb4-bce2-485c-9897-36e808a6ebc4</guid>
      <pubDate>Sun, 11 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Chiamaka Eze</author>
      <description>Background: Telemedicine outcomes remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with telemedicine outcomes. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Edwin Otieno</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>telemedicine</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>telemedicine outcomes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1065</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 2, pp. 120-132</dc:source>
    </item>
    <item>
      <title>Predictive biomarkers in myasthenia gravis: systematic review and meta-analysis</title>
      <link>https://aams-journal.us/journals/neurology/articles/fb47df27-ee2d-4c60-a4d8-478889de8019</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/fb47df27-ee2d-4c60-a4d8-478889de8019</guid>
      <pubDate>Sun, 11 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Hee-Jin Lee</author>
      <description>Background: Myasthenia gravis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in NEU. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with myasthenia gravis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Dr. Bongani Mthembu</dc:creator>
      <dc:creator>Dr. Nadia Khoury</dc:creator>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>myasthenia</dc:subject>
      <dc:subject>gravis</dc:subject>
      <dc:subject>myasthenia gravis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-11</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1059</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 12, Issue 2, pp. 165-172</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into surgical site infection: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/surgery/articles/36949add-f52e-4c8c-a5af-b887afc5094b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/36949add-f52e-4c8c-a5af-b887afc5094b</guid>
      <pubDate>Sat, 10 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Priya Sharma</author>
      <description>Background: Surgical site infection remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with surgical site infection. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Priya Sharma</dc:creator>
      <dc:creator>Prof. Tomáš Horváth</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>surgical site infection</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>site</dc:subject>
      <dc:subject>surgical</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1144</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 1, pp. 149-155</dc:source>
    </item>
    <item>
      <title>Diagnostic accuracy of artificial intelligence in hypertension management</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/0a67c84e-d0de-4179-95d3-2584b5d3655c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/0a67c84e-d0de-4179-95d3-2584b5d3655c</guid>
      <pubDate>Sat, 10 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Reza Mohammadi</author>
      <description>Background: Hypertension management remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in IM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with hypertension management. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>hypertension management</dc:subject>
      <dc:subject>hypertension</dc:subject>
      <dc:subject>management</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1031</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 12, Issue 2, pp. 208-222</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for preventive cardiology</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/371ad288-b400-4fe0-93a4-e6fb5986657d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/371ad288-b400-4fe0-93a4-e6fb5986657d</guid>
      <pubDate>Sat, 10 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Eva Andersson</author>
      <description>Background: Preventive cardiology remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with preventive cardiology. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:subject>preventive cardiology</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>preventive</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>cardiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1061</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 12, Issue 1, pp. 137-151</dc:source>
    </item>
    <item>
      <title>Novel therapeutic strategies for HbA1c standardization in tertiary care settings</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/7e10c84e-3229-4fdf-b3af-de0960748847</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/7e10c84e-3229-4fdf-b3af-de0960748847</guid>
      <pubDate>Sat, 10 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Rashid Khan</author>
      <description>Background: Hba1c standardization remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with HbA1c standardization. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Prof. Maria González</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>standardization</dc:subject>
      <dc:subject>HbA1c</dc:subject>
      <dc:subject>HbA1c standardization</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1092</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 177-189</dc:source>
    </item>
    <item>
      <title>Diagnostic accuracy of artificial intelligence in cutaneous lupus</title>
      <link>https://aams-journal.us/journals/dermatology/articles/eeff7f5a-f8bd-49de-9ac8-019ae3b97ff2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/eeff7f5a-f8bd-49de-9ac8-019ae3b97ff2</guid>
      <pubDate>Sat, 10 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Olufemi Adebayo</author>
      <description>Background: Cutaneous lupus remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with cutaneous lupus. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Olufemi Adebayo</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>cutaneous</dc:subject>
      <dc:subject>lupus</dc:subject>
      <dc:subject>cutaneous lupus</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1125</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 1, pp. 64-78</dc:source>
    </item>
    <item>
      <title>Diagnostic accuracy of artificial intelligence in autism comorbidity</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/1a3a8285-e412-44a0-a13b-722fa8d455c9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/1a3a8285-e412-44a0-a13b-722fa8d455c9</guid>
      <pubDate>Fri, 09 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Linh Nguyen</author>
      <description>Background: Autism comorbidity remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with autism comorbidity. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Dr. Ananya Iyer</dc:creator>
      <dc:creator>Prof. Sophia Rossi</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>comorbidity</dc:subject>
      <dc:subject>autism</dc:subject>
      <dc:subject>autism comorbidity</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1174</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 2, pp. 127-134</dc:source>
    </item>
    <item>
      <title>Health economic evaluation of oral cancer screening interventions</title>
      <link>https://aams-journal.us/journals/dentistry/articles/24c17d42-9b24-4ff5-b918-7ecb340de642</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/24c17d42-9b24-4ff5-b918-7ecb340de642</guid>
      <pubDate>Fri, 09 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Sanjay Bhattacharya</author>
      <description>Background: Oral cancer screening remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with oral cancer screening. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:creator>Dr. Yuki Tanaka</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>oral</dc:subject>
      <dc:subject>oral cancer screening</dc:subject>
      <dc:subject>cancer</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-09</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1022</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 2, pp. 340-347</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following childhood obesity</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/67e31061-1cca-47ac-aa63-5bf6d4761814</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/67e31061-1cca-47ac-aa63-5bf6d4761814</guid>
      <pubDate>Wed, 07 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Stefan Berger</author>
      <description>Background: Childhood obesity remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with childhood obesity. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Dr. Emma Williams</dc:creator>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>childhood obesity</dc:subject>
      <dc:subject>childhood</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>obesity</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1002</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 2, pp. 175-185</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into perinatal depression: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/fcf64ba1-f7de-4c05-85ba-cdb14560df6a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/fcf64ba1-f7de-4c05-85ba-cdb14560df6a</guid>
      <pubDate>Wed, 07 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Reza Mohammadi</author>
      <description>Background: Perinatal depression remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with perinatal depression. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Reza Mohammadi</dc:creator>
      <dc:creator>Prof. Kwame Asante</dc:creator>
      <dc:creator>Dr. Hiroshi Yamamoto</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>depression</dc:subject>
      <dc:subject>perinatal depression</dc:subject>
      <dc:subject>perinatal</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1171</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 1, pp. 92-103</dc:source>
    </item>
    <item>
      <title>Patient-reported outcomes following bipolar lithium</title>
      <link>https://aams-journal.us/journals/psychiatry/articles/28685755-fd4a-47f9-b8c5-1d82d155fe25</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/psychiatry/articles/28685755-fd4a-47f9-b8c5-1d82d155fe25</guid>
      <pubDate>Wed, 07 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Sven Eriksson</author>
      <description>Background: Bipolar lithium remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PSY. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with bipolar lithium. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Sven Eriksson</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:subject>bipolar lithium</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>lithium</dc:subject>
      <dc:subject>bipolar</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-07</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1166</dc:identifier>
      <dc:source>ISSN:2834-7210</dc:source>
      <dc:source>EISSN:2834-7211</dc:source>
      <dc:source>AAMS Psychiatry &amp; Behavioral Health, Vol. 12, Issue 1, pp. 35-43</dc:source>
    </item>
    <item>
      <title>Implementation of evidence-based protocols for Wilson disease</title>
      <link>https://aams-journal.us/journals/genetics/articles/30d6a13c-9bec-41d3-b274-a2368ac8096d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/30d6a13c-9bec-41d3-b274-a2368ac8096d</guid>
      <pubDate>Tue, 06 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Beatrice Romano</author>
      <description>Background: Wilson disease remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with Wilson disease. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Beatrice Romano</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>disease</dc:subject>
      <dc:subject>Wilson disease</dc:subject>
      <dc:subject>Wilson</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1089</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 1, pp. 312-322</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into peri-implantitis: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e61f99d6-3f5b-4845-8186-0e54aae032ec</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e61f99d6-3f5b-4845-8186-0e54aae032ec</guid>
      <pubDate>Tue, 06 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Sanjay Bhattacharya</author>
      <description>Background: Peri-implantitis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with peri-implantitis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Sanjay Bhattacharya</dc:creator>
      <dc:creator>Prof. Rania El-Sayed</dc:creator>
      <dc:creator>Prof. Jean-Pierre Dubois</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:subject>peri-implantitis</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-06</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1026</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 91-103</dc:source>
    </item>
    <item>
      <title>Real-world evidence on whole-genome sequencing: a population-based study</title>
      <link>https://aams-journal.us/journals/genetics/articles/e1fde2d2-7964-48de-96b9-2c7560a25d63</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/e1fde2d2-7964-48de-96b9-2c7560a25d63</guid>
      <pubDate>Mon, 05 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Ahmad Hassan</author>
      <description>Background: Whole-genome sequencing remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in GEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with whole-genome sequencing. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Ahmad Hassan</dc:creator>
      <dc:creator>Prof. Mehmet Yıldız</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:creator>Dr. Eva Andersson</dc:creator>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>sequencing</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>whole-genome</dc:subject>
      <dc:subject>whole-genome sequencing</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1077</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 12, Issue 2, pp. 333-345</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of thyroidectomy outcomes versus standard care</title>
      <link>https://aams-journal.us/journals/surgery/articles/3aa29509-df48-434b-92ff-fc307d590581</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/3aa29509-df48-434b-92ff-fc307d590581</guid>
      <pubDate>Sun, 04 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Carlos Mendoza</author>
      <description>Background: Thyroidectomy outcomes remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in SUR. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with thyroidectomy outcomes. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Carlos Mendoza</dc:creator>
      <dc:creator>Dr. Linh Nguyen</dc:creator>
      <dc:creator>Prof. Aleksandra Kowalski</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>thyroidectomy</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>thyroidectomy outcomes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1142</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 12, Issue 1, pp. 327-336</dc:source>
    </item>
    <item>
      <title>cutaneous lymphoma: insights from a randomized controlled trial in adults</title>
      <link>https://aams-journal.us/journals/dermatology/articles/ac8c3116-e78d-4d78-96f3-1524a28f863a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/ac8c3116-e78d-4d78-96f3-1524a28f863a</guid>
      <pubDate>Sun, 04 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Marco Bianchi</author>
      <description>Background: Cutaneous lymphoma remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DRM. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with cutaneous lymphoma. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Marco Bianchi</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Prof. Layla Bouazizi</dc:creator>
      <dc:subject>biomarkers</dc:subject>
      <dc:subject>cutaneous</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>lymphoma</dc:subject>
      <dc:subject>cutaneous lymphoma</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-04</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1133</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 12, Issue 2, pp. 320-327</dc:source>
    </item>
    <item>
      <title>Comparative effectiveness of autism spectrum versus standard care</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/6cf77d5e-353c-488c-85c4-ae6012b18693</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/6cf77d5e-353c-488c-85c4-ae6012b18693</guid>
      <pubDate>Sat, 03 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Wei Zhang</author>
      <description>Background: Autism spectrum remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in PED. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with autism spectrum. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Hans Müller</dc:creator>
      <dc:creator>Prof. Klara Janssen</dc:creator>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>autism</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>spectrum</dc:subject>
      <dc:subject>autism spectrum</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1013</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 12, Issue 1, pp. 302-311</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of periodontitis — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/5fd15dca-31ca-46c7-a8c0-2288f4b8be21</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/5fd15dca-31ca-46c7-a8c0-2288f4b8be21</guid>
      <pubDate>Sat, 03 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Catherine Laurent</author>
      <description>Background: Periodontitis remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in DEN. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with periodontitis. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Catherine Laurent</dc:creator>
      <dc:creator>Prof. Natalia Petrova</dc:creator>
      <dc:creator>Dr. Mei-Ling Chen</dc:creator>
      <dc:creator>Dr. Rashid Khan</dc:creator>
      <dc:subject>periodontitis</dc:subject>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1016</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 12, Issue 1, pp. 26-40</dc:source>
    </item>
    <item>
      <title>Long-term outcomes of laboratory automation — a 5-year follow-up analysis</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/b7688405-4d60-4fac-a1eb-36d4a7fad919</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/b7688405-4d60-4fac-a1eb-36d4a7fad919</guid>
      <pubDate>Sat, 03 Jan 2026 00:00:00 GMT</pubDate>
      <author>Prof. Wei Zhang</author>
      <description>Background: Laboratory automation remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in LAB. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with laboratory automation. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Prof. Wei Zhang</dc:creator>
      <dc:creator>Prof. Akira Suzuki</dc:creator>
      <dc:creator>Prof. Hee-Jin Lee</dc:creator>
      <dc:subject>systematic review</dc:subject>
      <dc:subject>automation</dc:subject>
      <dc:subject>laboratory automation</dc:subject>
      <dc:subject>clinical trial</dc:subject>
      <dc:subject>laboratory</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-03</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1104</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 12, Issue 1, pp. 116-124</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/45a988b4-a984-4c96-b8d9-93b8fec23686</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/45a988b4-a984-4c96-b8d9-93b8fec23686</guid>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1905 participants across 2 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/45a988b4-a984-4c96-b8d9-93b8fec23686-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0255</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 7, Issue 1, pp. 1-12</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/816570eb-c763-4cfc-be9e-62d84ce9ec47</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/816570eb-c763-4cfc-be9e-62d84ce9ec47</guid>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1898 participants across 6 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0254</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 7, Issue 1, pp. 1-13</dc:source>
    </item>
    <item>
      <title>Mechanistic insights into C. difficile recurrence: bench-to-bedside translation</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/0d420274-2a57-456b-ba55-293e1c9c0c44</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/0d420274-2a57-456b-ba55-293e1c9c0c44</guid>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <author>Dr. Chiamaka Eze</author>
      <description>Background: C. difficile recurrence remains a significant clinical challenge with substantial morbidity. This study aimed to evaluate contemporary diagnostic and therapeutic approaches in ID. Methods: We conducted a prospective multicenter investigation enrolling consecutive adult patients across five tertiary academic medical centers between 2022 and 2024. Standardized clinical, laboratory, and imaging assessments were performed, with primary outcomes adjudicated by a blinded committee. Results: A total of 412 participants (mean age 54.3 years; 51.2% female) met inclusion criteria. The intervention group demonstrated statistically significant improvement in the primary endpoint compared with controls (relative risk 0.68, 95% CI 0.54-0.85, p&lt;0.001). Adverse events were comparable between arms. Conclusions: Our findings support evidence-based integration of these approaches into routine clinical practice for patients with C. difficile recurrence. Further multinational randomized trials are warranted to confirm generalizability and inform international guidelines.</description>
      <dc:creator>Dr. Chiamaka Eze</dc:creator>
      <dc:creator>Dr. Aisha Mahmoud</dc:creator>
      <dc:creator>Dr. Stefan Berger</dc:creator>
      <dc:creator>Prof. Ingrid Sørensen</dc:creator>
      <dc:subject>C.</dc:subject>
      <dc:subject>outcomes</dc:subject>
      <dc:subject>epidemiology</dc:subject>
      <dc:subject>difficile</dc:subject>
      <dc:subject>C. difficile recurrence</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.1110</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 12, Issue 2, pp. 230-236</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/46d0f54e-6c23-4072-b2b2-1260a17fb65f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/46d0f54e-6c23-4072-b2b2-1260a17fb65f</guid>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1891 participants across 5 centers. Data collection spanned from 2024 to 2025. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/46d0f54e-6c23-4072-b2b2-1260a17fb65f-Sepsis_Bundle_Compliance_and_Mortality__A_Large_Sc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2026-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2026.0253</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 7, Issue 1, pp. 1-14</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/c2f67263-6565-4898-92e0-09eae7036f5f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/c2f67263-6565-4898-92e0-09eae7036f5f</guid>
      <pubDate>Mon, 01 Dec 2025 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1884 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/c2f67263-6565-4898-92e0-09eae7036f5f-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0252</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 12, pp. 102-114</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/d54574be-f4d6-4162-a1d7-b60dabb97e88</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/d54574be-f4d6-4162-a1d7-b60dabb97e88</guid>
      <pubDate>Mon, 01 Dec 2025 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1870 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d54574be-f4d6-4162-a1d7-b60dabb97e88-Workplace_Burnout_Among_Healthcare_Professionals__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0250</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 12, pp. 91-100</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/8dbd3a29-9bf9-4883-a0ea-7abf12cb76d0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/8dbd3a29-9bf9-4883-a0ea-7abf12cb76d0</guid>
      <pubDate>Mon, 01 Dec 2025 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1877 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8dbd3a29-9bf9-4883-a0ea-7abf12cb76d0-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0251</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 12, pp. 94-108</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/dfe29c1a-c3a5-49e7-8cfa-cc78eae8ace2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/dfe29c1a-c3a5-49e7-8cfa-cc78eae8ace2</guid>
      <pubDate>Sat, 01 Nov 2025 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1849 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0247</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 11, pp. 88-101</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/3154ea0f-ef93-49d5-aa53-b144fe3f236c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/3154ea0f-ef93-49d5-aa53-b144fe3f236c</guid>
      <pubDate>Sat, 01 Nov 2025 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1856 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/3154ea0f-ef93-49d5-aa53-b144fe3f236c-Pulmonary_Embolism_Risk_Stratification__Machine_Le.pdf" type="application/pdf" length="0"/>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0248</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 11, pp. 79-93</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/e3124b66-3d26-479e-a1e4-cd775edd4251</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/e3124b66-3d26-479e-a1e4-cd775edd4251</guid>
      <pubDate>Sat, 01 Nov 2025 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1842 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0246</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 11, pp. 84-93</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/46c07d4e-017e-4ac0-b94c-5e8310ef834a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/46c07d4e-017e-4ac0-b94c-5e8310ef834a</guid>
      <pubDate>Sat, 01 Nov 2025 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1863 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0249</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 11, pp. 84-97</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/a63c2823-3e80-47ad-8942-894f390eb063</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/a63c2823-3e80-47ad-8942-894f390eb063</guid>
      <pubDate>Wed, 01 Oct 2025 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1835 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/a63c2823-3e80-47ad-8942-894f390eb063-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0245</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 10, pp. 78-90</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/69210ce5-9b39-4f0d-b464-306484231fda</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/69210ce5-9b39-4f0d-b464-306484231fda</guid>
      <pubDate>Wed, 01 Oct 2025 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1821 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/69210ce5-9b39-4f0d-b464-306484231fda-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0243</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 10, pp. 66-78</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/da71ac5a-171f-457b-8cb6-a9ae1a5efad3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/da71ac5a-171f-457b-8cb6-a9ae1a5efad3</guid>
      <pubDate>Wed, 01 Oct 2025 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1828 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/da71ac5a-171f-457b-8cb6-a9ae1a5efad3-Stroke_Thrombectomy_Time_Window_Extension__Perfusi.pdf" type="application/pdf" length="0"/>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0244</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 10, pp. 70-83</dc:source>
    </item>
    <item>
      <title>AI-Assisted Surgical Planning for Complex Spinal Deformity Correction</title>
      <link>https://aams-journal.us/journals/surgery/articles/7c5fa6af-d29b-4d0a-93f4-4cd4d65f1157</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/7c5fa6af-d29b-4d0a-93f4-4cd4d65f1157</guid>
      <pubDate>Wed, 10 Sep 2025 00:00:00 GMT</pubDate>
      <author>Reddy KN</author>
      <description>Prospective study evaluating AI-powered 3D surgical planning software for complex spinal deformity correction in 120 patients, demonstrating improved accuracy in screw placement (97.8%) and reduced revision rates.</description>
      <dc:creator>Reddy KN</dc:creator>
      <dc:creator>Iyer MS</dc:creator>
      <dc:creator>Joshi PV</dc:creator>
      <dc:subject>Artificial Intelligence</dc:subject>
      <dc:subject>Spine Surgery</dc:subject>
      <dc:subject>Surgical Planning</dc:subject>
      <dc:subject>Spinal Deformity</dc:subject>
      <dc:subject>3D Navigation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-09-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0029</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 2, Issue 3, pp. 33-47</dc:source>
    </item>
    <item>
      <title>Mpox Virus Evolution and Immune Evasion: Genomic Analysis of Clade IIb Lineages</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/49ead0c8-4240-4b9d-b68a-042915827360</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/49ead0c8-4240-4b9d-b68a-042915827360</guid>
      <pubDate>Mon, 08 Sep 2025 00:00:00 GMT</pubDate>
      <author>O&apos;Brien KC</author>
      <description>Genomic analysis of 2,500 mpox virus sequences from the 2022-2024 outbreak identifies mutations associated with enhanced human-to-human transmission and potential immune evasion mechanisms.</description>
      <dc:creator>O&apos;Brien KC</dc:creator>
      <dc:creator>Wallace TJ</dc:creator>
      <dc:subject>Mpox</dc:subject>
      <dc:subject>Genomic Analysis</dc:subject>
      <dc:subject>Viral Evolution</dc:subject>
      <dc:subject>Immune Evasion</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-09-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0037</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 2, Issue 3, pp. 35-50</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/9b9aaa1f-4d37-4c47-b269-6afbfbbdf8c5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/9b9aaa1f-4d37-4c47-b269-6afbfbbdf8c5</guid>
      <pubDate>Mon, 01 Sep 2025 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1807 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9b9aaa1f-4d37-4c47-b269-6afbfbbdf8c5-Neonatal_Sepsis_Biomarkers__A_Multicenter_Prospect.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0241</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 9, pp. 75-83</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/3b716b43-a8ff-457d-8f02-63c0a1716807</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/3b716b43-a8ff-457d-8f02-63c0a1716807</guid>
      <pubDate>Mon, 01 Sep 2025 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1814 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/3b716b43-a8ff-457d-8f02-63c0a1716807-Digital_Workflow_in_Complete_Denture_Fabrication__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0242</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 9, pp. 77-87</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/ca6b2d48-69b1-4131-b6e7-b4cf857c5172</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/ca6b2d48-69b1-4131-b6e7-b4cf857c5172</guid>
      <pubDate>Mon, 01 Sep 2025 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1793 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ca6b2d48-69b1-4131-b6e7-b4cf857c5172-Normal_Pressure_Hydrocephalus__Shunt_Surgery_Patie.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0239</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 9, pp. 62-69</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/ed310f09-d2db-45ac-a2ac-830aa9e91e77</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/ed310f09-d2db-45ac-a2ac-830aa9e91e77</guid>
      <pubDate>Mon, 01 Sep 2025 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1800 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ed310f09-d2db-45ac-a2ac-830aa9e91e77-Palliative_Care_Integration_in_Primary_Healthcare_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0240</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 9, pp. 63-77</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f8d0d5fc-f5ad-4469-b3b9-95ad5f4eeed7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f8d0d5fc-f5ad-4469-b3b9-95ad5f4eeed7</guid>
      <pubDate>Fri, 01 Aug 2025 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1772 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f8d0d5fc-f5ad-4469-b3b9-95ad5f4eeed7-Childhood_Type_1_Diabetes__Continuous_Glucose_Moni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0236</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 8, pp. 63-74</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/8c816d91-6b11-43fd-b465-ea15b5acf7a0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/8c816d91-6b11-43fd-b465-ea15b5acf7a0</guid>
      <pubDate>Fri, 01 Aug 2025 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1786 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8c816d91-6b11-43fd-b465-ea15b5acf7a0-Perioperative_Cardiac_Risk_Assessment__Revised_Gui.pdf" type="application/pdf" length="0"/>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0238</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 8, pp. 51-65</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/a62fa661-ddb9-4e90-b9b0-c9a888cbcd87</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/a62fa661-ddb9-4e90-b9b0-c9a888cbcd87</guid>
      <pubDate>Fri, 01 Aug 2025 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1779 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/a62fa661-ddb9-4e90-b9b0-c9a888cbcd87-Alveolar_Ridge_Preservation_Techniques__A_Systemat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0237</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 8, pp. 62-76</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/f471f630-2191-4c39-bccb-8a81a2a8f9d2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/f471f630-2191-4c39-bccb-8a81a2a8f9d2</guid>
      <pubDate>Tue, 01 Jul 2025 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1751 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f471f630-2191-4c39-bccb-8a81a2a8f9d2-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0233</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 7, pp. 43-50</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/95afd8f2-8af8-41ba-bd8b-1b1716715fa3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/95afd8f2-8af8-41ba-bd8b-1b1716715fa3</guid>
      <pubDate>Tue, 01 Jul 2025 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1758 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0234</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 7, pp. 48-61</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/919e4a2b-47b7-403d-8d47-25f9e3b76610</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/919e4a2b-47b7-403d-8d47-25f9e3b76610</guid>
      <pubDate>Tue, 01 Jul 2025 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1765 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/919e4a2b-47b7-403d-8d47-25f9e3b76610-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0235</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 7, pp. 50-62</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/31be2539-df3c-4529-977d-ca71a6cbed9e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/31be2539-df3c-4529-977d-ca71a6cbed9e</guid>
      <pubDate>Tue, 01 Jul 2025 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1744 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/31be2539-df3c-4529-977d-ca71a6cbed9e-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0232</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 7, pp. 53-61</dc:source>
    </item>
    <item>
      <title>Transplant Surgery Innovations: Machine Perfusion of Donor Kidneys - A Multicenter RCT</title>
      <link>https://aams-journal.us/journals/surgery/articles/ab4becdd-c8ed-4897-9b9c-b716f9b432f6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/ab4becdd-c8ed-4897-9b9c-b716f9b432f6</guid>
      <pubDate>Fri, 20 Jun 2025 00:00:00 GMT</pubDate>
      <author>van der Berg JW</author>
      <description>Multicenter randomized trial comparing hypothermic machine perfusion versus cold storage for deceased donor kidneys in 500 transplants, demonstrating reduced delayed graft function (18% vs 29%) and improved 1-year graft survival.</description>
      <dc:creator>van der Berg JW</dc:creator>
      <dc:creator>de Vries R</dc:creator>
      <dc:creator>Bakker M</dc:creator>
      <dc:subject>Kidney Transplant</dc:subject>
      <dc:subject>Machine Perfusion</dc:subject>
      <dc:subject>Organ Preservation</dc:subject>
      <dc:subject>Delayed Graft Function</dc:subject>
      <dc:subject>RCT</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-06-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0016</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 2, Issue 2, pp. 17-32</dc:source>
    </item>
    <item>
      <title>Liquid Biopsy ctDNA Analysis for Early Cancer Detection: Validation of a Multi-Cancer Panel</title>
      <link>https://aams-journal.us/journals/genetics/articles/30330bec-be03-41db-a547-4c566597b1c6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/30330bec-be03-41db-a547-4c566597b1c6</guid>
      <pubDate>Sun, 15 Jun 2025 00:00:00 GMT</pubDate>
      <author>Anderson KL</author>
      <description>Validation study of a circulating tumor DNA panel for simultaneous detection of 15 cancer types in 8,500 asymptomatic individuals, achieving 93% specificity and 67% sensitivity for early-stage cancers.</description>
      <dc:creator>Anderson KL</dc:creator>
      <dc:creator>Brown DM</dc:creator>
      <dc:creator>Taylor RJ</dc:creator>
      <dc:subject>Liquid Biopsy</dc:subject>
      <dc:subject>ctDNA</dc:subject>
      <dc:subject>Cancer Screening</dc:subject>
      <dc:subject>Multi-Cancer Detection</dc:subject>
      <dc:subject>Early Diagnosis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-06-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0018</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 2, Issue 2, pp. 19-35</dc:source>
    </item>
    <item>
      <title>Immunotherapy-Related Cutaneous Adverse Events: A Clinical Practice Guideline</title>
      <link>https://aams-journal.us/journals/dermatology/articles/f1990852-7c37-4bc4-8347-b13e4db9b107</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/f1990852-7c37-4bc4-8347-b13e4db9b107</guid>
      <pubDate>Thu, 12 Jun 2025 00:00:00 GMT</pubDate>
      <author>Brown SJ</author>
      <description>Evidence-based clinical practice guideline for management of immune checkpoint inhibitor-related cutaneous adverse events, developed through systematic review and Delphi consensus of international experts.</description>
      <dc:creator>Brown SJ</dc:creator>
      <dc:creator>Mitchell PA</dc:creator>
      <dc:creator>Lewis RC</dc:creator>
      <dc:subject>Immunotherapy</dc:subject>
      <dc:subject>Cutaneous Adverse Events</dc:subject>
      <dc:subject>Clinical Guideline</dc:subject>
      <dc:subject>Checkpoint Inhibitors</dc:subject>
      <dc:subject>Dermatologic Oncology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-06-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0027</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 2, Issue 2, pp. 16-32</dc:source>
    </item>
    <item>
      <title>Fungal Infections in Immunocompromised Patients: A Comprehensive Review of Diagnostic Approaches</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/c9f06c1f-5bdc-4e3a-a0bf-8afd0690b39e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/c9f06c1f-5bdc-4e3a-a0bf-8afd0690b39e</guid>
      <pubDate>Tue, 10 Jun 2025 00:00:00 GMT</pubDate>
      <author>Watanabe K</author>
      <description>Comprehensive review evaluating diagnostic performance of galactomannan, beta-D-glucan, PCR, and metagenomic sequencing for invasive fungal infections in immunocompromised patients across 85 studies.</description>
      <dc:creator>Watanabe K</dc:creator>
      <dc:creator>Ishikawa M</dc:creator>
      <dc:subject>Fungal Infections</dc:subject>
      <dc:subject>Immunocompromised</dc:subject>
      <dc:subject>Diagnostics</dc:subject>
      <dc:subject>Galactomannan</dc:subject>
      <dc:subject>Metagenomics</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0024</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 2, Issue 2, pp. 18-34</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/64472077-e79a-4697-a836-2cc60abd1c3b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/64472077-e79a-4697-a836-2cc60abd1c3b</guid>
      <pubDate>Sun, 01 Jun 2025 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1723 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/64472077-e79a-4697-a836-2cc60abd1c3b-Brain_Computer_Interface_Rehabilitation_After_Stro.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0229</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 6, pp. 33-47</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/756771cd-dc24-4a2d-932e-5a46a4f6696c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/756771cd-dc24-4a2d-932e-5a46a4f6696c</guid>
      <pubDate>Sun, 01 Jun 2025 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1737 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0231</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 6, pp. 50-62</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/64b6981c-d293-41dc-9230-983c31c5ed39</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/64b6981c-d293-41dc-9230-983c31c5ed39</guid>
      <pubDate>Sun, 01 Jun 2025 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1730 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/64b6981c-d293-41dc-9230-983c31c5ed39-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0230</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 6, pp. 38-49</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/bfe80abb-9d1b-4faf-8092-c74809e915f9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/bfe80abb-9d1b-4faf-8092-c74809e915f9</guid>
      <pubDate>Thu, 01 May 2025 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1695 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/bfe80abb-9d1b-4faf-8092-c74809e915f9-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0225</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 5, pp. 25-37</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e6b97765-b833-435d-867e-c8ff32f9ec21</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e6b97765-b833-435d-867e-c8ff32f9ec21</guid>
      <pubDate>Thu, 01 May 2025 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1709 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/e6b97765-b833-435d-867e-c8ff32f9ec21-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0227</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 5, pp. 42-52</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/b6019b52-b66b-40f7-8015-1fd13d7fad1c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/b6019b52-b66b-40f7-8015-1fd13d7fad1c</guid>
      <pubDate>Thu, 01 May 2025 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1702 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/b6019b52-b66b-40f7-8015-1fd13d7fad1c-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0226</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 5, pp. 36-49</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/2fcbaa31-719b-42f2-b0f9-8483354c49bf</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/2fcbaa31-719b-42f2-b0f9-8483354c49bf</guid>
      <pubDate>Thu, 01 May 2025 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1716 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/2fcbaa31-719b-42f2-b0f9-8483354c49bf-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0228</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 5, pp. 34-42</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/9faa8aa7-5926-493a-95d5-e7ef80d6e54b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/9faa8aa7-5926-493a-95d5-e7ef80d6e54b</guid>
      <pubDate>Tue, 01 Apr 2025 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1681 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9faa8aa7-5926-493a-95d5-e7ef80d6e54b-Sepsis_Bundle_Compliance_and_Mortality__A_Large_Sc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0223</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 4, pp. 25-33</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/3bab4198-39e4-4b67-9f0a-6c25f92eef31</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/3bab4198-39e4-4b67-9f0a-6c25f92eef31</guid>
      <pubDate>Tue, 01 Apr 2025 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1674 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/3bab4198-39e4-4b67-9f0a-6c25f92eef31-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0222</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 4, pp. 34-41</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/5c6ce9ad-05bc-46a7-8337-485ec888d542</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5c6ce9ad-05bc-46a7-8337-485ec888d542</guid>
      <pubDate>Tue, 01 Apr 2025 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1688 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0224</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 4, pp. 20-32</dc:source>
    </item>
    <item>
      <title>Dengue Fever Epidemiology and Climate Change: Modeling Future Transmission Dynamics</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/69118991-2b4a-4c66-8a7b-b4b7fbe86738</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/69118991-2b4a-4c66-8a7b-b4b7fbe86738</guid>
      <pubDate>Sat, 22 Mar 2025 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Mathematical modeling of dengue transmission dynamics under climate change scenarios predicts 40% expansion of endemic zones by 2050, with Southeast Asia and Latin America facing the highest burden.</description>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira CL</dc:creator>
      <dc:subject>Dengue Fever</dc:subject>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Epidemiological Modeling</dc:subject>
      <dc:subject>Vector-Borne Diseases</dc:subject>
      <dc:subject>Global Health</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0011</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 2, Issue 1, pp. 1-17</dc:source>
    </item>
    <item>
      <title>Laser Therapy for Melasma in Diverse Skin Types: A Prospective Comparative Study</title>
      <link>https://aams-journal.us/journals/dermatology/articles/fb349381-5d84-4275-bc1e-1eebe6c737a5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/fb349381-5d84-4275-bc1e-1eebe6c737a5</guid>
      <pubDate>Thu, 20 Mar 2025 00:00:00 GMT</pubDate>
      <author>Okonkwo NC</author>
      <description>Prospective comparative study of fractional CO2 laser versus Q-switched Nd:YAG laser for melasma treatment in 180 patients with Fitzpatrick skin types IV-VI, with 12-month follow-up assessing efficacy and post-inflammatory hyperpigmentation risk.</description>
      <dc:creator>Okonkwo NC</dc:creator>
      <dc:creator>Adeyemi OA</dc:creator>
      <dc:subject>Melasma</dc:subject>
      <dc:subject>Laser Therapy</dc:subject>
      <dc:subject>Skin of Color</dc:subject>
      <dc:subject>Hyperpigmentation</dc:subject>
      <dc:subject>Comparative Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0014</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 2, Issue 1, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Next-Generation Sequencing in Clinical Microbiology: Pathogen Identification from Sterile Body Fluids</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/e994845b-d876-48ee-94fa-650726df63ea</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/e994845b-d876-48ee-94fa-650726df63ea</guid>
      <pubDate>Tue, 18 Mar 2025 00:00:00 GMT</pubDate>
      <author>Rodriguez AM</author>
      <description>Evaluation of metagenomic next-generation sequencing for pathogen identification in 800 sterile body fluid specimens, demonstrating 32% higher detection rate compared to conventional culture methods.</description>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Fernandez JL</dc:creator>
      <dc:subject>Next-Generation Sequencing</dc:subject>
      <dc:subject>Metagenomics</dc:subject>
      <dc:subject>Clinical Microbiology</dc:subject>
      <dc:subject>Pathogen Detection</dc:subject>
      <dc:subject>Body Fluids</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0008</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 2, Issue 1, pp. 1-16</dc:source>
    </item>
    <item>
      <title>Damage Control Surgery in Civilian Mass Casualty Events: A 15-Year Experience</title>
      <link>https://aams-journal.us/journals/surgery/articles/1e3ea39b-04d1-4abb-8cbb-89f270e4fc0f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/1e3ea39b-04d1-4abb-8cbb-89f270e4fc0f</guid>
      <pubDate>Sat, 15 Mar 2025 00:00:00 GMT</pubDate>
      <author>Martinez JR</author>
      <description>Retrospective analysis of damage control surgery outcomes in 180 patients from civilian mass casualty events over 15 years, demonstrating evolving protocols and improved survival from 62% to 84%.</description>
      <dc:creator>Martinez JR</dc:creator>
      <dc:creator>Gonzalez CA</dc:creator>
      <dc:subject>Damage Control Surgery</dc:subject>
      <dc:subject>Mass Casualty</dc:subject>
      <dc:subject>Trauma Surgery</dc:subject>
      <dc:subject>Surgical Outcomes</dc:subject>
      <dc:subject>Civilian Trauma</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0003</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 2, Issue 1, pp. 1-16</dc:source>
    </item>
    <item>
      <title>Mitochondrial DNA Variants and Their Association with Neurodegenerative Diseases: A Population-Based Study</title>
      <link>https://aams-journal.us/journals/genetics/articles/6f77cd51-2d94-4fa7-bb41-ed9deb37e4e0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/6f77cd51-2d94-4fa7-bb41-ed9deb37e4e0</guid>
      <pubDate>Wed, 12 Mar 2025 00:00:00 GMT</pubDate>
      <author>Tanaka Y</author>
      <description>Analysis of mitochondrial DNA variants in 28,000 Japanese individuals reveals significant associations between specific haplogroups and risk of Alzheimer disease and Parkinson disease.</description>
      <dc:creator>Tanaka Y</dc:creator>
      <dc:creator>Suzuki H</dc:creator>
      <dc:creator>Nakamura T</dc:creator>
      <dc:subject>Mitochondrial DNA</dc:subject>
      <dc:subject>Neurodegeneration</dc:subject>
      <dc:subject>Population Genetics</dc:subject>
      <dc:subject>Alzheimer Disease</dc:subject>
      <dc:subject>Haplogroups</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0005</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 2, Issue 1, pp. 1-18</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/698f7ace-1d24-489d-a0ba-b6f5af011afc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/698f7ace-1d24-489d-a0ba-b6f5af011afc</guid>
      <pubDate>Sat, 01 Mar 2025 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1660 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/698f7ace-1d24-489d-a0ba-b6f5af011afc-Workplace_Burnout_Among_Healthcare_Professionals__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0220</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 3, pp. 11-24</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/0d256b6c-d03b-4ddd-8400-64a8b0f3d02b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/0d256b6c-d03b-4ddd-8400-64a8b0f3d02b</guid>
      <pubDate>Sat, 01 Mar 2025 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1667 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/0d256b6c-d03b-4ddd-8400-64a8b0f3d02b-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0221</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 3, pp. 24-35</dc:source>
    </item>
    <item>
      <title>CLINICAL AND FUNCTIONAL JUSTIFICATION OF USING INDIVIDUAL ADAPTIVE SPLINTS AND THEIR IMPACT ON DENTURE RETENTION IN COMPLETELY EDENTULOUS PATIENTS</title>
      <link>https://aams-journal.us/journals/dentistry/articles/7682b0c1-5de9-4528-801d-1185ddf0f577</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/7682b0c1-5de9-4528-801d-1185ddf0f577</guid>
      <pubDate>Sat, 01 Mar 2025 00:00:00 GMT</pubDate>
      <author>Khamidov Mahmud Toshtemirovich</author>
      <description>This article analyzes the main clinical and functional factors influencing denture
retention in completely edentulous patients. Particular attention is paid to the
morphofunctional condition of the oral mucosa, its adaptive capacity to
prosthetic load, and their relationship with denture stability. The use of
individual adaptive splints is substantiated as an effective stage of preliminary
mucosal preparation. Clinical observations demonstrate that adaptive splints
reduce pain symptoms, shorten the adaptation period, and significantly improve
the retention and stability of removable dentures.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/1773307160577-AAMS_Article_zarmed.pdf" type="application/pdf" length="0"/>
      <dc:creator>Khamidov Mahmud Toshtemirovich</dc:creator>
      <dc:subject>complete edentulism</dc:subject>
      <dc:subject>individual adaptive splints</dc:subject>
      <dc:subject>oral mucosa</dc:subject>
      <dc:subject>removable dentures</dc:subject>
      <dc:subject>denture retention</dc:subject>
      <dc:subject>clinical effectiveness</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0253</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 3, pp. 25-33</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/4718ac15-dcef-4ff5-84b8-8017ac5a6a8f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/4718ac15-dcef-4ff5-84b8-8017ac5a6a8f</guid>
      <pubDate>Sat, 01 Mar 2025 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1646 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4718ac15-dcef-4ff5-84b8-8017ac5a6a8f-Pulmonary_Embolism_Risk_Stratification__Machine_Le.pdf" type="application/pdf" length="0"/>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0218</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 3, pp. 12-24</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/ce8b505f-12a1-4c87-a350-24d1f04973f3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/ce8b505f-12a1-4c87-a350-24d1f04973f3</guid>
      <pubDate>Sat, 01 Mar 2025 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1653 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ce8b505f-12a1-4c87-a350-24d1f04973f3-Amyotrophic_Lateral_Sclerosis__Antisense_Oligonucl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0219</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 3, pp. 11-19</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/5aa20dea-d1eb-40a0-8987-7ee3f6074490</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/5aa20dea-d1eb-40a0-8987-7ee3f6074490</guid>
      <pubDate>Sat, 01 Feb 2025 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1625 participants across 2 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/5aa20dea-d1eb-40a0-8987-7ee3f6074490-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0215</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 6, Issue 2, pp. 1-10</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/e9c15537-2e16-4e56-a521-381f64183793</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/e9c15537-2e16-4e56-a521-381f64183793</guid>
      <pubDate>Sat, 01 Feb 2025 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1639 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/e9c15537-2e16-4e56-a521-381f64183793-Peri_Implantitis_Treatment__Surgical_vs_Non_Surgic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0217</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 2, pp. 16-24</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/4e7cd6b4-f7c3-444f-b496-f5000d55c12b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/4e7cd6b4-f7c3-444f-b496-f5000d55c12b</guid>
      <pubDate>Sat, 01 Feb 2025 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1632 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4e7cd6b4-f7c3-444f-b496-f5000d55c12b-Pediatric_Asthma_Exacerbations__Role_of_Environmen.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0216</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 2, pp. 12-23</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c70c927d-ca8e-4b83-bf51-606cbe71773d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c70c927d-ca8e-4b83-bf51-606cbe71773d</guid>
      <pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1597 participants across 3 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0211</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 6, Issue 1, pp. 1-11</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/2e0b3a2b-78f2-426e-aa20-41f2f0569a4f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/2e0b3a2b-78f2-426e-aa20-41f2f0569a4f</guid>
      <pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1611 participants across 5 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0213</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 6, Issue 1, pp. 1-11</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/4ce8365f-56ce-489a-8add-b66f3bfc0b6c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/4ce8365f-56ce-489a-8add-b66f3bfc0b6c</guid>
      <pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1604 participants across 4 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4ce8365f-56ce-489a-8add-b66f3bfc0b6c-Digital_Workflow_in_Complete_Denture_Fabrication__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0212</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 6, Issue 1, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/49a1aeba-476f-4772-abe9-e9c908769ef8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/49a1aeba-476f-4772-abe9-e9c908769ef8</guid>
      <pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1618 participants across 6 centers. Data collection spanned from 2023 to 2024. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/49a1aeba-476f-4772-abe9-e9c908769ef8-Stroke_Thrombectomy_Time_Window_Extension__Perfusi.pdf" type="application/pdf" length="0"/>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2025-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2025.0214</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 6, Issue 1, pp. 1-10</dc:source>
    </item>
    <item>
      <title>Single-Port Thoracoscopic Lobectomy for Non-Small Cell Lung Cancer: Learning Curve Analysis</title>
      <link>https://aams-journal.us/journals/surgery/articles/da7bd4eb-9b14-4112-b2d2-6719fc45d73e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/da7bd4eb-9b14-4112-b2d2-6719fc45d73e</guid>
      <pubDate>Sun, 15 Dec 2024 00:00:00 GMT</pubDate>
      <author>Sato K</author>
      <description>Analysis of the surgical learning curve for single-port video-assisted thoracoscopic lobectomy in 300 consecutive NSCLC patients, identifying 40 cases as the threshold for technical proficiency.</description>
      <dc:creator>Sato K</dc:creator>
      <dc:creator>Mori T</dc:creator>
      <dc:creator>Hashimoto A</dc:creator>
      <dc:subject>Thoracoscopic Surgery</dc:subject>
      <dc:subject>Lung Cancer</dc:subject>
      <dc:subject>VATS</dc:subject>
      <dc:subject>Learning Curve</dc:subject>
      <dc:subject>Single-Port</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0253</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 1, Issue 4, pp. 59-72</dc:source>
    </item>
    <item>
      <title>Tuberculosis Treatment Outcomes with Novel Bedaquiline-Based Regimens: A Phase III Trial</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/be0d9814-3636-4d8a-a1a0-fb079b86ce31</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/be0d9814-3636-4d8a-a1a0-fb079b86ce31</guid>
      <pubDate>Thu, 12 Dec 2024 00:00:00 GMT</pubDate>
      <author>Ndlovu ZM</author>
      <description>Phase III randomized trial of 450 patients with drug-resistant tuberculosis demonstrates that bedaquiline-pretomanid-linezolid regimen achieves 90% culture conversion at 6 months with acceptable safety profile.</description>
      <dc:creator>Ndlovu ZM</dc:creator>
      <dc:creator>Mthembu S</dc:creator>
      <dc:creator>Dlamini P</dc:creator>
      <dc:subject>Tuberculosis</dc:subject>
      <dc:subject>Bedaquiline</dc:subject>
      <dc:subject>Drug Resistance</dc:subject>
      <dc:subject>Phase III Trial</dc:subject>
      <dc:subject>Treatment Outcomes</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0134</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 1, Issue 4, pp. 53-68</dc:source>
    </item>
    <item>
      <title>Mass Spectrometry-Based Metabolomics for Inborn Errors of Metabolism Screening</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/51e871c3-bb0a-47db-a556-31803bba4011</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/51e871c3-bb0a-47db-a556-31803bba4011</guid>
      <pubDate>Tue, 10 Dec 2024 00:00:00 GMT</pubDate>
      <author>Harrison EC</author>
      <description>Implementation of a targeted metabolomics platform using LC-MS/MS for expanded newborn screening, detecting 58 metabolic disorders with a false-positive rate below 0.01% in 120,000 neonatal dried blood spots.</description>
      <dc:creator>Harrison EC</dc:creator>
      <dc:creator>Clarke JD</dc:creator>
      <dc:subject>Metabolomics</dc:subject>
      <dc:subject>Mass Spectrometry</dc:subject>
      <dc:subject>Newborn Screening</dc:subject>
      <dc:subject>Inborn Errors of Metabolism</dc:subject>
      <dc:subject>LC-MS/MS</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0081</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 1, Issue 4, pp. 43-57</dc:source>
    </item>
    <item>
      <title>Gut-Skin Axis in Psoriasis: Microbiome Alterations and Therapeutic Implications</title>
      <link>https://aams-journal.us/journals/dermatology/articles/ca3f1730-3bbb-407b-bb15-b196b01b0ab5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/ca3f1730-3bbb-407b-bb15-b196b01b0ab5</guid>
      <pubDate>Sun, 08 Dec 2024 00:00:00 GMT</pubDate>
      <author>Meyer K</author>
      <description>Metagenomic analysis of gut microbiome in 400 psoriasis patients reveals significant dysbiosis patterns correlated with disease severity, identifying potential microbiome-targeted therapeutic strategies.</description>
      <dc:creator>Meyer K</dc:creator>
      <dc:creator>Schulz B</dc:creator>
      <dc:creator>Wagner E</dc:creator>
      <dc:subject>Psoriasis</dc:subject>
      <dc:subject>Gut Microbiome</dc:subject>
      <dc:subject>Gut-Skin Axis</dc:subject>
      <dc:subject>Metagenomics</dc:subject>
      <dc:subject>Dysbiosis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-08</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0187</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 1, Issue 4, pp. 45-60</dc:source>
    </item>
    <item>
      <title>Pharmacogenomic Predictors of Adverse Drug Reactions in Cardiovascular Therapy</title>
      <link>https://aams-journal.us/journals/genetics/articles/783a62d9-0609-4f48-88e3-e600fa77cd45</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/783a62d9-0609-4f48-88e3-e600fa77cd45</guid>
      <pubDate>Thu, 05 Dec 2024 00:00:00 GMT</pubDate>
      <author>Williams JA</author>
      <description>This study evaluates pharmacogenomic variants in CYP2C19, CYP2D6, and VKORC1 as predictors of adverse drug reactions in 3,200 patients receiving cardiovascular medications, demonstrating significant clinical utility.</description>
      <dc:creator>Williams JA</dc:creator>
      <dc:creator>Thompson SR</dc:creator>
      <dc:subject>Pharmacogenomics</dc:subject>
      <dc:subject>Adverse Drug Reactions</dc:subject>
      <dc:subject>Cardiovascular</dc:subject>
      <dc:subject>CYP2C19</dc:subject>
      <dc:subject>Personalized Medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-05</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0038</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 1, Issue 4, pp. 49-63</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/f237c6b9-5f4c-4661-a6d2-32011ae74b17</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/f237c6b9-5f4c-4661-a6d2-32011ae74b17</guid>
      <pubDate>Sun, 01 Dec 2024 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1569 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f237c6b9-5f4c-4661-a6d2-32011ae74b17-Alveolar_Ridge_Preservation_Techniques__A_Systemat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0207</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 12, pp. 73-87</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/ea9831a8-de80-4930-adf2-172f43347457</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/ea9831a8-de80-4930-adf2-172f43347457</guid>
      <pubDate>Sun, 01 Dec 2024 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1583 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ea9831a8-de80-4930-adf2-172f43347457-Normal_Pressure_Hydrocephalus__Shunt_Surgery_Patie.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0209</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 12, pp. 84-91</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/9d47d16b-bcec-4282-bd2c-68b5948a5084</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/9d47d16b-bcec-4282-bd2c-68b5948a5084</guid>
      <pubDate>Sun, 01 Dec 2024 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1576 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9d47d16b-bcec-4282-bd2c-68b5948a5084-Perioperative_Cardiac_Risk_Assessment__Revised_Gui.pdf" type="application/pdf" length="0"/>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0208</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 12, pp. 97-109</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/a207050b-00c7-43f1-beb9-f123825a4f35</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/a207050b-00c7-43f1-beb9-f123825a4f35</guid>
      <pubDate>Sun, 01 Dec 2024 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1590 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/a207050b-00c7-43f1-beb9-f123825a4f35-Palliative_Care_Integration_in_Primary_Healthcare_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0210</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 12, pp. 94-106</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/4134f748-4d11-4559-8b60-48d5d979f23d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/4134f748-4d11-4559-8b60-48d5d979f23d</guid>
      <pubDate>Fri, 01 Nov 2024 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1555 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4134f748-4d11-4559-8b60-48d5d979f23d-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0205</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 11, pp. 86-93</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/e348e3b0-c853-49fe-b2f6-32955e837f76</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/e348e3b0-c853-49fe-b2f6-32955e837f76</guid>
      <pubDate>Fri, 01 Nov 2024 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1548 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/e348e3b0-c853-49fe-b2f6-32955e837f76-Cluster_Headache__Vagus_Nerve_Stimulation_Efficacy.pdf" type="application/pdf" length="0"/>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0204</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 11, pp. 76-83</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/82c02abd-2a3a-407f-a6aa-fd9fe82dd9f3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/82c02abd-2a3a-407f-a6aa-fd9fe82dd9f3</guid>
      <pubDate>Fri, 01 Nov 2024 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1562 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/82c02abd-2a3a-407f-a6aa-fd9fe82dd9f3-Childhood_Type_1_Diabetes__Continuous_Glucose_Moni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0206</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 11, pp. 77-87</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/d10ce67c-25fe-4fea-9c50-064c1691b9e5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/d10ce67c-25fe-4fea-9c50-064c1691b9e5</guid>
      <pubDate>Tue, 01 Oct 2024 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1527 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d10ce67c-25fe-4fea-9c50-064c1691b9e5-Fetal_Alcohol_Spectrum_Disorders__Neurobehavioral_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0201</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 10, pp. 65-76</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/c383d862-3b06-425c-9bc3-331db8e28e0f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/c383d862-3b06-425c-9bc3-331db8e28e0f</guid>
      <pubDate>Tue, 01 Oct 2024 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1520 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/c383d862-3b06-425c-9bc3-331db8e28e0f-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0200</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 10, pp. 72-85</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/29de56dc-92b4-450c-9465-b21046ddd6a5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/29de56dc-92b4-450c-9465-b21046ddd6a5</guid>
      <pubDate>Tue, 01 Oct 2024 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1534 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/29de56dc-92b4-450c-9465-b21046ddd6a5-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0202</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 10, pp. 61-72</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/84115069-8867-44b1-aca2-cc6e5a22f79c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/84115069-8867-44b1-aca2-cc6e5a22f79c</guid>
      <pubDate>Tue, 01 Oct 2024 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1541 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/84115069-8867-44b1-aca2-cc6e5a22f79c-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0203</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 10, pp. 82-96</dc:source>
    </item>
    <item>
      <title>Novel mRNA Vaccine Platform Against Emerging Coronaviruses: Preclinical Evaluation</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/eec0a5b7-0609-496f-bd6b-c0cf39df43e8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/eec0a5b7-0609-496f-bd6b-c0cf39df43e8</guid>
      <pubDate>Fri, 20 Sep 2024 00:00:00 GMT</pubDate>
      <author>Becker F</author>
      <description>Development and preclinical evaluation of a pan-coronavirus mRNA vaccine targeting conserved spike protein epitopes, demonstrating broad neutralizing antibody responses against SARS-CoV-2 variants and related coronaviruses.</description>
      <dc:creator>Becker F</dc:creator>
      <dc:creator>Schneider T</dc:creator>
      <dc:creator>Richter L</dc:creator>
      <dc:subject>mRNA Vaccine</dc:subject>
      <dc:subject>Coronavirus</dc:subject>
      <dc:subject>Preclinical Study</dc:subject>
      <dc:subject>Neutralizing Antibodies</dc:subject>
      <dc:subject>Pan-Coronavirus</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0121</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 1, Issue 3, pp. 37-52</dc:source>
    </item>
    <item>
      <title>Platelet-Rich Plasma in Androgenetic Alopecia: A Systematic Review and Dose-Response Analysis</title>
      <link>https://aams-journal.us/journals/dermatology/articles/9c941586-d3df-4cf0-b81f-71e586602a2b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/9c941586-d3df-4cf0-b81f-71e586602a2b</guid>
      <pubDate>Wed, 18 Sep 2024 00:00:00 GMT</pubDate>
      <author>Garcia-Lopez M</author>
      <description>Systematic review and dose-response meta-analysis of 28 RCTs evaluating platelet-rich plasma injections for androgenetic alopecia, demonstrating optimal efficacy at 3 sessions with 1-month intervals.</description>
      <dc:creator>Garcia-Lopez M</dc:creator>
      <dc:creator>Hernandez-Ruiz A</dc:creator>
      <dc:subject>Platelet-Rich Plasma</dc:subject>
      <dc:subject>Androgenetic Alopecia</dc:subject>
      <dc:subject>Hair Loss</dc:subject>
      <dc:subject>Systematic Review</dc:subject>
      <dc:subject>Regenerative Medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0174</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 1, Issue 3, pp. 31-44</dc:source>
    </item>
    <item>
      <title>Novel Biomarkers for Acute Kidney Injury: A Prospective Cohort Study in ICU Patients</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/0237debf-ed8c-4826-9ab2-58339b8c813c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/0237debf-ed8c-4826-9ab2-58339b8c813c</guid>
      <pubDate>Sun, 15 Sep 2024 00:00:00 GMT</pubDate>
      <author>Singh AK</author>
      <description>Prospective evaluation of urinary NGAL, KIM-1, and IL-18 as early biomarkers for acute kidney injury in 600 ICU patients, demonstrating superior predictive performance compared to serum creatinine.</description>
      <dc:creator>Singh AK</dc:creator>
      <dc:creator>Gupta RK</dc:creator>
      <dc:creator>Verma P</dc:creator>
      <dc:subject>Acute Kidney Injury</dc:subject>
      <dc:subject>Biomarkers</dc:subject>
      <dc:subject>NGAL</dc:subject>
      <dc:subject>KIM-1</dc:subject>
      <dc:subject>Critical Care</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0068</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 1, Issue 3, pp. 29-42</dc:source>
    </item>
    <item>
      <title>3D-Printed Patient-Specific Implants in Orthopedic Trauma Surgery: A Case Series</title>
      <link>https://aams-journal.us/journals/surgery/articles/8f9864ce-931c-474b-9ea5-5ec38f0cb227</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/8f9864ce-931c-474b-9ea5-5ec38f0cb227</guid>
      <pubDate>Thu, 12 Sep 2024 00:00:00 GMT</pubDate>
      <author>Bauer S</author>
      <description>Case series of 45 patients with complex periarticular fractures treated with 3D-printed titanium patient-specific implants, demonstrating excellent anatomical reduction and functional outcomes at 2-year follow-up.</description>
      <dc:creator>Bauer S</dc:creator>
      <dc:creator>Krause N</dc:creator>
      <dc:creator>Lehmann P</dc:creator>
      <dc:subject>3D Printing</dc:subject>
      <dc:subject>Patient-Specific Implants</dc:subject>
      <dc:subject>Orthopedic Trauma</dc:subject>
      <dc:subject>Titanium Implants</dc:subject>
      <dc:subject>Fracture Surgery</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-12</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0240</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 1, Issue 3, pp. 46-58</dc:source>
    </item>
    <item>
      <title>Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia: A Multi-Omics Approach</title>
      <link>https://aams-journal.us/journals/genetics/articles/388e2b27-1aa2-47d3-9682-7eff73daa698</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/388e2b27-1aa2-47d3-9682-7eff73daa698</guid>
      <pubDate>Tue, 10 Sep 2024 00:00:00 GMT</pubDate>
      <author>Schmidt H</author>
      <description>Multi-omics profiling of 200 pediatric ALL cases reveals distinct epigenetic signatures associated with treatment response and relapse risk, identifying potential biomarkers for risk stratification.</description>
      <dc:creator>Schmidt H</dc:creator>
      <dc:creator>Weber M</dc:creator>
      <dc:creator>Fischer K</dc:creator>
      <dc:subject>Epigenetics</dc:subject>
      <dc:subject>Pediatric Leukemia</dc:subject>
      <dc:subject>Multi-Omics</dc:subject>
      <dc:subject>Biomarkers</dc:subject>
      <dc:subject>Risk Stratification</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0025</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 1, Issue 3, pp. 33-48</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/fd10939a-73f3-420e-a388-1147c738048b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/fd10939a-73f3-420e-a388-1147c738048b</guid>
      <pubDate>Sun, 01 Sep 2024 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1499 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/fd10939a-73f3-420e-a388-1147c738048b-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0197</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 9, pp. 47-60</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/98e7898a-65d3-4b49-b649-e556d3b65cad</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/98e7898a-65d3-4b49-b649-e556d3b65cad</guid>
      <pubDate>Sun, 01 Sep 2024 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1506 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/98e7898a-65d3-4b49-b649-e556d3b65cad-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0198</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 9, pp. 68-81</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/91c5f898-ad46-4ae4-ad92-b1a7d7f3bed2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/91c5f898-ad46-4ae4-ad92-b1a7d7f3bed2</guid>
      <pubDate>Sun, 01 Sep 2024 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1513 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0199</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 9, pp. 68-75</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f0aed7a9-669e-4b7f-a016-f20fef5920a7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f0aed7a9-669e-4b7f-a016-f20fef5920a7</guid>
      <pubDate>Thu, 01 Aug 2024 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1492 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f0aed7a9-669e-4b7f-a016-f20fef5920a7-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0196</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 8, pp. 50-64</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/81ca716d-8c4e-45c4-b6b7-050696685c07</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/81ca716d-8c4e-45c4-b6b7-050696685c07</guid>
      <pubDate>Thu, 01 Aug 2024 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1478 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/81ca716d-8c4e-45c4-b6b7-050696685c07-Status_Epilepticus__Refractory_Cases_and_Novel_Ane.pdf" type="application/pdf" length="0"/>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0194</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 8, pp. 57-67</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/621253c6-1537-458c-ae4b-6619dd1feb83</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/621253c6-1537-458c-ae4b-6619dd1feb83</guid>
      <pubDate>Thu, 01 Aug 2024 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1471 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0193</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 8, pp. 54-67</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/ee7b55f9-e70c-4c4e-8ca2-968d1f1b33f4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/ee7b55f9-e70c-4c4e-8ca2-968d1f1b33f4</guid>
      <pubDate>Thu, 01 Aug 2024 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1485 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ee7b55f9-e70c-4c4e-8ca2-968d1f1b33f4-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0195</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 8, pp. 57-71</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/22519788-07f2-4fcd-b83c-07876c00302b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/22519788-07f2-4fcd-b83c-07876c00302b</guid>
      <pubDate>Mon, 01 Jul 2024 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1464 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/22519788-07f2-4fcd-b83c-07876c00302b-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0192</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 7, pp. 39-46</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/9bca5c66-d87f-49d5-a672-217da4e79542</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/9bca5c66-d87f-49d5-a672-217da4e79542</guid>
      <pubDate>Mon, 01 Jul 2024 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1457 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9bca5c66-d87f-49d5-a672-217da4e79542-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0191</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 7, pp. 40-49</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/afa501b6-357a-4b00-b24b-a3ccada52734</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/afa501b6-357a-4b00-b24b-a3ccada52734</guid>
      <pubDate>Mon, 01 Jul 2024 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1450 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/afa501b6-357a-4b00-b24b-a3ccada52734-Workplace_Burnout_Among_Healthcare_Professionals__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0190</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 7, pp. 47-56</dc:source>
    </item>
    <item>
      <title>Artificial Intelligence in Dermoscopy: A Multicenter Validation of a Skin Cancer Detection Algorithm</title>
      <link>https://aams-journal.us/journals/dermatology/articles/43876b91-8ebf-49dc-95bf-19cd6dd3c362</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/43876b91-8ebf-49dc-95bf-19cd6dd3c362</guid>
      <pubDate>Sat, 22 Jun 2024 00:00:00 GMT</pubDate>
      <author>Kumar A</author>
      <description>Multicenter validation of a deep learning algorithm for dermoscopic skin lesion classification across 12,000 images from diverse skin phototypes, achieving 94.5% accuracy with improved performance on Fitzpatrick types IV-VI.</description>
      <dc:creator>Kumar A</dc:creator>
      <dc:creator>Reddy SP</dc:creator>
      <dc:creator>Nair M</dc:creator>
      <dc:subject>Artificial Intelligence</dc:subject>
      <dc:subject>Dermoscopy</dc:subject>
      <dc:subject>Skin Cancer</dc:subject>
      <dc:subject>Deep Learning</dc:subject>
      <dc:subject>Melanoma Detection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0161</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 1, Issue 2, pp. 17-30</dc:source>
    </item>
    <item>
      <title>Whole Genome Sequencing Identifies Novel Risk Loci for Type 2 Diabetes in South Asian Populations</title>
      <link>https://aams-journal.us/journals/genetics/articles/12204ac5-5ebf-45d5-afda-ac9d4622fe9e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/12204ac5-5ebf-45d5-afda-ac9d4622fe9e</guid>
      <pubDate>Thu, 20 Jun 2024 00:00:00 GMT</pubDate>
      <author>Sharma R</author>
      <description>A genome-wide association study of 45,000 South Asian individuals identifies 12 novel risk loci for type 2 diabetes, revealing population-specific genetic architecture and potential therapeutic targets.</description>
      <dc:creator>Sharma R</dc:creator>
      <dc:creator>Patel VK</dc:creator>
      <dc:creator>Deshmukh A</dc:creator>
      <dc:subject>GWAS</dc:subject>
      <dc:subject>Type 2 Diabetes</dc:subject>
      <dc:subject>South Asian</dc:subject>
      <dc:subject>Genetic Risk Loci</dc:subject>
      <dc:subject>Precision Medicine</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0012</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 1, Issue 2, pp. 16-32</dc:source>
    </item>
    <item>
      <title>Indocyanine Green Fluorescence-Guided Surgery for Hepatocellular Carcinoma</title>
      <link>https://aams-journal.us/journals/surgery/articles/47638381-02b6-4fdf-8ec5-e83cdf4c6756</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/47638381-02b6-4fdf-8ec5-e83cdf4c6756</guid>
      <pubDate>Tue, 18 Jun 2024 00:00:00 GMT</pubDate>
      <author>Chen WL</author>
      <description>Prospective study evaluating indocyanine green fluorescence imaging for intraoperative detection of hepatocellular carcinoma in 250 patients, improving R0 resection rates from 82% to 94%.</description>
      <dc:creator>Chen WL</dc:creator>
      <dc:creator>Liu YH</dc:creator>
      <dc:creator>Zhang XM</dc:creator>
      <dc:subject>ICG Fluorescence</dc:subject>
      <dc:subject>Hepatocellular Carcinoma</dc:subject>
      <dc:subject>Liver Surgery</dc:subject>
      <dc:subject>Surgical Navigation</dc:subject>
      <dc:subject>R0 Resection</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-18</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0227</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 1, Issue 2, pp. 31-45</dc:source>
    </item>
    <item>
      <title>Antimicrobial Resistance Patterns in Gram-Negative Bacteria: A 10-Year Surveillance Study</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/de0ff28c-ceb7-48a5-828e-0d4eea77ff70</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/de0ff28c-ceb7-48a5-828e-0d4eea77ff70</guid>
      <pubDate>Sat, 15 Jun 2024 00:00:00 GMT</pubDate>
      <author>Das S</author>
      <description>Ten-year surveillance data from 45 Indian hospitals reveals alarming trends in carbapenem-resistant Enterobacteriaceae, with prevalence increasing from 8.2% to 34.7% and identification of novel resistance mechanisms.</description>
      <dc:creator>Das S</dc:creator>
      <dc:creator>Chatterjee B</dc:creator>
      <dc:creator>Roy A</dc:creator>
      <dc:subject>Antimicrobial Resistance</dc:subject>
      <dc:subject>Gram-Negative Bacteria</dc:subject>
      <dc:subject>Carbapenem Resistance</dc:subject>
      <dc:subject>Surveillance</dc:subject>
      <dc:subject>Enterobacteriaceae</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0108</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 1, Issue 2, pp. 19-36</dc:source>
    </item>
    <item>
      <title>Artificial Intelligence in Hematology: Automated Blood Cell Classification Using Deep Learning</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/ebb9b117-30ac-4e42-8086-8e58a41f1c3e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/ebb9b117-30ac-4e42-8086-8e58a41f1c3e</guid>
      <pubDate>Mon, 10 Jun 2024 00:00:00 GMT</pubDate>
      <author>Choi MJ</author>
      <description>Development and clinical validation of a convolutional neural network for automated peripheral blood smear analysis, achieving 98.2% accuracy in classifying 15 cell types across 50,000 cell images.</description>
      <dc:creator>Choi MJ</dc:creator>
      <dc:creator>Yoon SH</dc:creator>
      <dc:creator>Kang JW</dc:creator>
      <dc:subject>Artificial Intelligence</dc:subject>
      <dc:subject>Deep Learning</dc:subject>
      <dc:subject>Hematology</dc:subject>
      <dc:subject>Blood Cell Classification</dc:subject>
      <dc:subject>Digital Pathology</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-10</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0055</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 1, Issue 2, pp. 15-28</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/ccd78ecf-fd65-4e84-81d0-1dbce60b971b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/ccd78ecf-fd65-4e84-81d0-1dbce60b971b</guid>
      <pubDate>Sat, 01 Jun 2024 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1429 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ccd78ecf-fd65-4e84-81d0-1dbce60b971b-Peri_Implantitis_Treatment__Surgical_vs_Non_Surgic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0187</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 6, pp. 30-38</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/baa36dad-5ec8-4c92-a4c2-d43d8ea3b580</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/baa36dad-5ec8-4c92-a4c2-d43d8ea3b580</guid>
      <pubDate>Sat, 01 Jun 2024 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1422 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/baa36dad-5ec8-4c92-a4c2-d43d8ea3b580-Pediatric_Asthma_Exacerbations__Role_of_Environmen.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0186</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 6, pp. 29-39</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/b917d9e1-a0b6-4522-ad26-195932442a08</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/b917d9e1-a0b6-4522-ad26-195932442a08</guid>
      <pubDate>Sat, 01 Jun 2024 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1436 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/b917d9e1-a0b6-4522-ad26-195932442a08-Pulmonary_Embolism_Risk_Stratification__Machine_Le.pdf" type="application/pdf" length="0"/>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0188</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 6, pp. 39-53</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/855a1ae1-d012-4c1e-afd5-c48ce8dabe05</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/855a1ae1-d012-4c1e-afd5-c48ce8dabe05</guid>
      <pubDate>Sat, 01 Jun 2024 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1443 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/855a1ae1-d012-4c1e-afd5-c48ce8dabe05-Amyotrophic_Lateral_Sclerosis__Antisense_Oligonucl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0189</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 6, pp. 42-56</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/ee75d3a1-2cc9-41a0-aece-ad230206af29</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/ee75d3a1-2cc9-41a0-aece-ad230206af29</guid>
      <pubDate>Wed, 01 May 2024 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1401 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ee75d3a1-2cc9-41a0-aece-ad230206af29-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0183</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 5, pp. 24-38</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/613d6cc8-99fb-4156-a6ff-9fcc75084c51</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/613d6cc8-99fb-4156-a6ff-9fcc75084c51</guid>
      <pubDate>Wed, 01 May 2024 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1408 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/613d6cc8-99fb-4156-a6ff-9fcc75084c51-Stroke_Thrombectomy_Time_Window_Extension__Perfusi.pdf" type="application/pdf" length="0"/>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0184</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 5, pp. 34-41</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/9b795665-a5d5-41a1-a2e2-75dab361032b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/9b795665-a5d5-41a1-a2e2-75dab361032b</guid>
      <pubDate>Wed, 01 May 2024 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1415 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9b795665-a5d5-41a1-a2e2-75dab361032b-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0185</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 5, pp. 36-46</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/b5443a78-9b5c-4b83-9f99-5eea618c1e9f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/b5443a78-9b5c-4b83-9f99-5eea618c1e9f</guid>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1394 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0182</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 4, pp. 22-29</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/79861aa6-43e6-4c09-adde-c0c7219f3799</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/79861aa6-43e6-4c09-adde-c0c7219f3799</guid>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1380 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/79861aa6-43e6-4c09-adde-c0c7219f3799-Palliative_Care_Integration_in_Primary_Healthcare_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0180</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 4, pp. 22-35</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/b9c69fa8-cf59-4c91-9271-0317353e7cc6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/b9c69fa8-cf59-4c91-9271-0317353e7cc6</guid>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1387 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0181</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 4, pp. 21-28</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/60e43095-dab3-48c2-a4d7-54694a3c0a23</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/60e43095-dab3-48c2-a4d7-54694a3c0a23</guid>
      <pubDate>Mon, 01 Apr 2024 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1373 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/60e43095-dab3-48c2-a4d7-54694a3c0a23-Normal_Pressure_Hydrocephalus__Shunt_Surgery_Patie.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0179</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 4, pp. 21-33</dc:source>
    </item>
    <item>
      <title>Biologics in Moderate-to-Severe Atopic Dermatitis: A Network Meta-Analysis of Randomized Trials</title>
      <link>https://aams-journal.us/journals/dermatology/articles/3d7ba03b-5306-44e0-90b3-aa8397242990</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dermatology/articles/3d7ba03b-5306-44e0-90b3-aa8397242990</guid>
      <pubDate>Thu, 28 Mar 2024 00:00:00 GMT</pubDate>
      <author>Nakagawa T</author>
      <description>Network meta-analysis of 42 randomized controlled trials involving 18,000 patients compares efficacy and safety of dupilumab, tralokinumab, abrocitinib, and upadacitinib for moderate-to-severe atopic dermatitis.</description>
      <dc:creator>Nakagawa T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Ito H</dc:creator>
      <dc:subject>Atopic Dermatitis</dc:subject>
      <dc:subject>Biologics</dc:subject>
      <dc:subject>Network Meta-Analysis</dc:subject>
      <dc:subject>Dupilumab</dc:subject>
      <dc:subject>JAK Inhibitors</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0148</dc:identifier>
      <dc:source>ISSN:2834-7180</dc:source>
      <dc:source>EISSN:2834-7181</dc:source>
      <dc:source>AAMS Dermatology &amp; Cosmetology, Vol. 1, Issue 1, pp. 1-16</dc:source>
    </item>
    <item>
      <title>Enhanced Recovery After Surgery (ERAS) in Colorectal Cancer: 5-Year Outcomes</title>
      <link>https://aams-journal.us/journals/surgery/articles/dec9015a-92ea-4d09-88db-f2fa87355128</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/dec9015a-92ea-4d09-88db-f2fa87355128</guid>
      <pubDate>Thu, 28 Mar 2024 00:00:00 GMT</pubDate>
      <author>Thompson RA</author>
      <description>Five-year follow-up of 800 colorectal cancer patients managed with ERAS protocol demonstrates sustained benefits in reduced complications, shorter hospital stay, and comparable oncological outcomes to conventional care.</description>
      <dc:creator>Thompson RA</dc:creator>
      <dc:creator>Hughes JK</dc:creator>
      <dc:creator>Clark MN</dc:creator>
      <dc:subject>ERAS</dc:subject>
      <dc:subject>Colorectal Cancer</dc:subject>
      <dc:subject>Enhanced Recovery</dc:subject>
      <dc:subject>Surgical Outcomes</dc:subject>
      <dc:subject>Long-Term Follow-Up</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-28</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0214</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 1, Issue 1, pp. 15-30</dc:source>
    </item>
    <item>
      <title>Long COVID Neurological Manifestations: A Prospective 3-Year Follow-Up Study</title>
      <link>https://aams-journal.us/journals/infectious-diseases/articles/ed096656-2574-43ed-b34c-33d3bd03d105</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/infectious-diseases/articles/ed096656-2574-43ed-b34c-33d3bd03d105</guid>
      <pubDate>Mon, 25 Mar 2024 00:00:00 GMT</pubDate>
      <author>Johnson ML</author>
      <description>Three-year prospective follow-up of 1,200 COVID-19 survivors reveals persistent neurological symptoms in 23% of patients, with cognitive impairment and autonomic dysfunction as predominant manifestations.</description>
      <dc:creator>Johnson ML</dc:creator>
      <dc:creator>Davis RW</dc:creator>
      <dc:creator>Cooper HA</dc:creator>
      <dc:subject>Long COVID</dc:subject>
      <dc:subject>Neurological Manifestations</dc:subject>
      <dc:subject>Post-COVID Syndrome</dc:subject>
      <dc:subject>Cognitive Impairment</dc:subject>
      <dc:subject>Prospective Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-25</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0095</dc:identifier>
      <dc:source>ISSN:2834-7170</dc:source>
      <dc:source>EISSN:2834-7171</dc:source>
      <dc:source>AAMS Infectious Diseases &amp; Microbiology, Vol. 1, Issue 1, pp. 1-18</dc:source>
    </item>
    <item>
      <title>Robotic-Assisted Versus Laparoscopic Cholecystectomy: A Randomized Controlled Trial</title>
      <link>https://aams-journal.us/journals/surgery/articles/5c54d9fd-80b3-46af-90e8-2d6802a86f68</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/surgery/articles/5c54d9fd-80b3-46af-90e8-2d6802a86f68</guid>
      <pubDate>Fri, 22 Mar 2024 00:00:00 GMT</pubDate>
      <author>Kim DH</author>
      <description>Randomized controlled trial of 600 patients comparing robotic-assisted versus conventional laparoscopic cholecystectomy, demonstrating reduced operative time and lower conversion rates with robotic approach.</description>
      <dc:creator>Kim DH</dc:creator>
      <dc:creator>Lee JM</dc:creator>
      <dc:creator>Cho YK</dc:creator>
      <dc:subject>Robotic Surgery</dc:subject>
      <dc:subject>Cholecystectomy</dc:subject>
      <dc:subject>Laparoscopic Surgery</dc:subject>
      <dc:subject>RCT</dc:subject>
      <dc:subject>Minimally Invasive</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-22</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0201</dc:identifier>
      <dc:source>ISSN:2834-7190</dc:source>
      <dc:source>EISSN:2834-7191</dc:source>
      <dc:source>AAMS Surgery &amp; Clinical Practice, Vol. 1, Issue 1, pp. 1-14</dc:source>
    </item>
    <item>
      <title>Point-of-Care Multiplex PCR for Rapid Diagnosis of Respiratory Infections: A Multicenter Validation Study</title>
      <link>https://aams-journal.us/journals/laboratory-medicine/articles/497b489b-36be-48dc-b17d-273caf8efe59</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/laboratory-medicine/articles/497b489b-36be-48dc-b17d-273caf8efe59</guid>
      <pubDate>Wed, 20 Mar 2024 00:00:00 GMT</pubDate>
      <author>Müller A</author>
      <description>Multicenter validation of a novel point-of-care multiplex PCR system detecting 22 respiratory pathogens in under 45 minutes, demonstrating 97.8% concordance with reference laboratory methods across 2,400 clinical specimens.</description>
      <dc:creator>Müller A</dc:creator>
      <dc:creator>Braun S</dc:creator>
      <dc:creator>Hoffmann C</dc:creator>
      <dc:subject>Point-of-Care Testing</dc:subject>
      <dc:subject>Multiplex PCR</dc:subject>
      <dc:subject>Respiratory Infections</dc:subject>
      <dc:subject>Rapid Diagnostics</dc:subject>
      <dc:subject>Clinical Validation</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-20</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0042</dc:identifier>
      <dc:source>ISSN:2834-7160</dc:source>
      <dc:source>EISSN:2834-7161</dc:source>
      <dc:source>AAMS Laboratory Medicine &amp; Diagnostics, Vol. 1, Issue 1, pp. 1-14</dc:source>
    </item>
    <item>
      <title>CRISPR-Cas12a Mediated Gene Editing for Sickle Cell Disease: A Preclinical Study</title>
      <link>https://aams-journal.us/journals/genetics/articles/423a5cca-73a2-4ec6-a252-092d0e0d0a9a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/genetics/articles/423a5cca-73a2-4ec6-a252-092d0e0d0a9a</guid>
      <pubDate>Fri, 15 Mar 2024 00:00:00 GMT</pubDate>
      <author>Park JH</author>
      <description>This preclinical study evaluates the efficacy and safety of CRISPR-Cas12a-based gene editing targeting the BCL11A enhancer in CD34+ hematopoietic stem cells for sickle cell disease treatment. Results demonstrate 89% editing efficiency with sustained fetal hemoglobin induction.</description>
      <dc:creator>Park JH</dc:creator>
      <dc:creator>Kim SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>CRISPR-Cas12a</dc:subject>
      <dc:subject>Sickle Cell Disease</dc:subject>
      <dc:subject>Gene Editing</dc:subject>
      <dc:subject>Hematopoietic Stem Cells</dc:subject>
      <dc:subject>Fetal Hemoglobin</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-15</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0001</dc:identifier>
      <dc:source>ISSN:2834-7150</dc:source>
      <dc:source>EISSN:2834-7151</dc:source>
      <dc:source>AAMS Genetics &amp; Molecular Medicine, Vol. 1, Issue 1, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/d664054d-1e0d-4712-8ad4-b2bce5328073</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/d664054d-1e0d-4712-8ad4-b2bce5328073</guid>
      <pubDate>Fri, 01 Mar 2024 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1366 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0178</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 3, pp. 13-23</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/8c9d4883-91ab-4cb1-9bf8-cf1a457e746e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/8c9d4883-91ab-4cb1-9bf8-cf1a457e746e</guid>
      <pubDate>Fri, 01 Mar 2024 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1359 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8c9d4883-91ab-4cb1-9bf8-cf1a457e746e-Alveolar_Ridge_Preservation_Techniques__A_Systemat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0177</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 3, pp. 9-21</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/4f8c9748-aa7e-4ea4-87ce-b568288f1b2f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/4f8c9748-aa7e-4ea4-87ce-b568288f1b2f</guid>
      <pubDate>Fri, 01 Mar 2024 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1352 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4f8c9748-aa7e-4ea4-87ce-b568288f1b2f-Childhood_Type_1_Diabetes__Continuous_Glucose_Moni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0176</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 3, pp. 13-20</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/6ec6ff44-2478-4395-a4f6-b7c177d4d4a9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/6ec6ff44-2478-4395-a4f6-b7c177d4d4a9</guid>
      <pubDate>Thu, 01 Feb 2024 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1345 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/6ec6ff44-2478-4395-a4f6-b7c177d4d4a9-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0175</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 2, pp. 10-21</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/f4b913fc-7f2d-423e-b96d-b9a9f96d784c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/f4b913fc-7f2d-423e-b96d-b9a9f96d784c</guid>
      <pubDate>Thu, 01 Feb 2024 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1331 participants across 5 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f4b913fc-7f2d-423e-b96d-b9a9f96d784c-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0173</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 5, Issue 2, pp. 1-12</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/eabfbb76-2520-47c4-98dc-d540d097f4a3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/eabfbb76-2520-47c4-98dc-d540d097f4a3</guid>
      <pubDate>Thu, 01 Feb 2024 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1338 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/eabfbb76-2520-47c4-98dc-d540d097f4a3-Cluster_Headache__Vagus_Nerve_Stimulation_Efficacy.pdf" type="application/pdf" length="0"/>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0174</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 2, pp. 11-20</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/1ff96c00-a43c-4339-b10d-3098d15f6ec8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/1ff96c00-a43c-4339-b10d-3098d15f6ec8</guid>
      <pubDate>Thu, 01 Feb 2024 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1324 participants across 4 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/1ff96c00-a43c-4339-b10d-3098d15f6ec8-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0172</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 5, Issue 2, pp. 1-8</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f4a6c364-83bf-4e91-8d82-a2780fd7172b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f4a6c364-83bf-4e91-8d82-a2780fd7172b</guid>
      <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1317 participants across 3 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f4a6c364-83bf-4e91-8d82-a2780fd7172b-Fetal_Alcohol_Spectrum_Disorders__Neurobehavioral_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0171</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 5, Issue 1, pp. 1-12</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/5e0bc4ba-792e-4481-bf7a-dcefe5a874b1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5e0bc4ba-792e-4481-bf7a-dcefe5a874b1</guid>
      <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1303 participants across 6 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0169</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 5, Issue 1, pp. 1-10</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/76dbba79-3486-41f1-9faf-9ef4e5cfc996</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/76dbba79-3486-41f1-9faf-9ef4e5cfc996</guid>
      <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1310 participants across 2 centers. Data collection spanned from 2022 to 2023. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/76dbba79-3486-41f1-9faf-9ef4e5cfc996-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2024-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2024.0170</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 5, Issue 1, pp. 1-9</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/8f59fbd0-e8ac-405a-89ba-2687e46986b7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/8f59fbd0-e8ac-405a-89ba-2687e46986b7</guid>
      <pubDate>Fri, 01 Dec 2023 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1296 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8f59fbd0-e8ac-405a-89ba-2687e46986b7-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0168</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 12, pp. 86-93</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/8ab10fb5-0942-49d0-8f72-db4a1b87b809</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/8ab10fb5-0942-49d0-8f72-db4a1b87b809</guid>
      <pubDate>Fri, 01 Dec 2023 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1289 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8ab10fb5-0942-49d0-8f72-db4a1b87b809-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0167</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 12, pp. 94-104</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c7fe7597-2994-4d17-bb21-0e76efaae836</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c7fe7597-2994-4d17-bb21-0e76efaae836</guid>
      <pubDate>Fri, 01 Dec 2023 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1282 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/c7fe7597-2994-4d17-bb21-0e76efaae836-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0166</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 12, pp. 77-85</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/dc54ab8f-e511-4ef5-b0c8-917d581e036c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/dc54ab8f-e511-4ef5-b0c8-917d581e036c</guid>
      <pubDate>Wed, 01 Nov 2023 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1268 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0164</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 11, pp. 83-91</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/656b04bf-ab63-4506-b025-d6c484f5aa53</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/656b04bf-ab63-4506-b025-d6c484f5aa53</guid>
      <pubDate>Wed, 01 Nov 2023 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1261 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/656b04bf-ab63-4506-b025-d6c484f5aa53-Sepsis_Bundle_Compliance_and_Mortality__A_Large_Sc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0163</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 11, pp. 71-85</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/e44562c6-2934-4a6e-9522-6cc7999da4e7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/e44562c6-2934-4a6e-9522-6cc7999da4e7</guid>
      <pubDate>Wed, 01 Nov 2023 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1275 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/e44562c6-2934-4a6e-9522-6cc7999da4e7-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0165</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 11, pp. 84-93</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/f4220a5a-041f-4eba-aafc-73e588c7e5e0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/f4220a5a-041f-4eba-aafc-73e588c7e5e0</guid>
      <pubDate>Wed, 01 Nov 2023 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1254 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f4220a5a-041f-4eba-aafc-73e588c7e5e0-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0162</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 11, pp. 80-93</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/2e086b5a-a3dd-4772-a0ca-594941163d17</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/2e086b5a-a3dd-4772-a0ca-594941163d17</guid>
      <pubDate>Sun, 01 Oct 2023 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1233 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/2e086b5a-a3dd-4772-a0ca-594941163d17-Amyotrophic_Lateral_Sclerosis__Antisense_Oligonucl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0159</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 10, pp. 73-82</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/34fdacdc-7647-46f8-9455-2d52e20adcfd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/34fdacdc-7647-46f8-9455-2d52e20adcfd</guid>
      <pubDate>Sun, 01 Oct 2023 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1240 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/34fdacdc-7647-46f8-9455-2d52e20adcfd-Workplace_Burnout_Among_Healthcare_Professionals__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0160</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 10, pp. 72-83</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/3d920c4f-b618-4cfd-8ec7-62a421cec77d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/3d920c4f-b618-4cfd-8ec7-62a421cec77d</guid>
      <pubDate>Sun, 01 Oct 2023 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1247 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/3d920c4f-b618-4cfd-8ec7-62a421cec77d-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0161</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 10, pp. 62-76</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/0ca689d9-58f9-438e-80ac-c6eae6b75965</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/0ca689d9-58f9-438e-80ac-c6eae6b75965</guid>
      <pubDate>Fri, 01 Sep 2023 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1205 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/0ca689d9-58f9-438e-80ac-c6eae6b75965-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0155</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 9, pp. 63-71</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/ee0c5fc7-a414-4160-8582-be1947be0e0a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/ee0c5fc7-a414-4160-8582-be1947be0e0a</guid>
      <pubDate>Fri, 01 Sep 2023 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1219 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ee0c5fc7-a414-4160-8582-be1947be0e0a-Peri_Implantitis_Treatment__Surgical_vs_Non_Surgic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0157</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 9, pp. 71-79</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/8df96a8b-3f97-4d70-b693-07b610b01416</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/8df96a8b-3f97-4d70-b693-07b610b01416</guid>
      <pubDate>Fri, 01 Sep 2023 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1212 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0156</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 9, pp. 49-61</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/e2daa425-7df0-4fd8-af3a-1b0c1f6535ce</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/e2daa425-7df0-4fd8-af3a-1b0c1f6535ce</guid>
      <pubDate>Fri, 01 Sep 2023 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1226 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/e2daa425-7df0-4fd8-af3a-1b0c1f6535ce-Pulmonary_Embolism_Risk_Stratification__Machine_Le.pdf" type="application/pdf" length="0"/>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0158</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 9, pp. 60-70</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/d896b56a-2aa6-4907-ac01-770b4933c795</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/d896b56a-2aa6-4907-ac01-770b4933c795</guid>
      <pubDate>Tue, 01 Aug 2023 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1184 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d896b56a-2aa6-4907-ac01-770b4933c795-Digital_Workflow_in_Complete_Denture_Fabrication__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0152</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 8, pp. 57-70</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/47dd65f0-bc2a-4707-8a46-e1eb60f75847</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/47dd65f0-bc2a-4707-8a46-e1eb60f75847</guid>
      <pubDate>Tue, 01 Aug 2023 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1191 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/47dd65f0-bc2a-4707-8a46-e1eb60f75847-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0153</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 8, pp. 52-59</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/291ca653-2ffe-4d82-80c8-4d9dec51183c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/291ca653-2ffe-4d82-80c8-4d9dec51183c</guid>
      <pubDate>Tue, 01 Aug 2023 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1198 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/291ca653-2ffe-4d82-80c8-4d9dec51183c-Stroke_Thrombectomy_Time_Window_Extension__Perfusi.pdf" type="application/pdf" length="0"/>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0154</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 8, pp. 62-72</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/feef2652-59fa-418f-a7c4-fdfebcc70667</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/feef2652-59fa-418f-a7c4-fdfebcc70667</guid>
      <pubDate>Sat, 01 Jul 2023 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1170 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/feef2652-59fa-418f-a7c4-fdfebcc70667-Palliative_Care_Integration_in_Primary_Healthcare_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0150</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 7, pp. 49-62</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/80b612f7-2c42-4f2a-a1c0-113d82adb26b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/80b612f7-2c42-4f2a-a1c0-113d82adb26b</guid>
      <pubDate>Sat, 01 Jul 2023 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1177 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/80b612f7-2c42-4f2a-a1c0-113d82adb26b-Neonatal_Sepsis_Biomarkers__A_Multicenter_Prospect.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0151</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 7, pp. 40-48</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/d7ff1c24-3cf1-4008-b734-7afb504222ac</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/d7ff1c24-3cf1-4008-b734-7afb504222ac</guid>
      <pubDate>Sat, 01 Jul 2023 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1163 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d7ff1c24-3cf1-4008-b734-7afb504222ac-Normal_Pressure_Hydrocephalus__Shunt_Surgery_Patie.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0149</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 7, pp. 50-61</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/0156f891-a71f-4a62-a0b3-1f5ddcf90fe7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/0156f891-a71f-4a62-a0b3-1f5ddcf90fe7</guid>
      <pubDate>Sat, 01 Jul 2023 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1156 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/0156f891-a71f-4a62-a0b3-1f5ddcf90fe7-Perioperative_Cardiac_Risk_Assessment__Revised_Gui.pdf" type="application/pdf" length="0"/>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0148</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 7, pp. 43-51</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/9a7895de-f329-4cef-94cf-e39ff8dbe3e8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/9a7895de-f329-4cef-94cf-e39ff8dbe3e8</guid>
      <pubDate>Thu, 01 Jun 2023 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1149 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0147</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 6, pp. 47-56</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/48e7b6ad-8c55-4385-818c-49d37bf7f24b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/48e7b6ad-8c55-4385-818c-49d37bf7f24b</guid>
      <pubDate>Thu, 01 Jun 2023 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1135 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/48e7b6ad-8c55-4385-818c-49d37bf7f24b-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0145</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 6, pp. 36-48</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/5019eaf8-8de7-47a4-8da8-0ef98d5a6aeb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/5019eaf8-8de7-47a4-8da8-0ef98d5a6aeb</guid>
      <pubDate>Thu, 01 Jun 2023 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1142 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0146</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 6, pp. 32-39</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/49c0dc35-cfdd-484a-8740-14e0b9383787</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/49c0dc35-cfdd-484a-8740-14e0b9383787</guid>
      <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1114 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/49c0dc35-cfdd-484a-8740-14e0b9383787-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0142</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 5, pp. 34-46</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/2dd9106c-4643-4ed7-ac4a-10c1a328b73c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/2dd9106c-4643-4ed7-ac4a-10c1a328b73c</guid>
      <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1121 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/2dd9106c-4643-4ed7-ac4a-10c1a328b73c-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0143</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 5, pp. 31-42</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/1874e165-bc2c-44ef-ae52-52f16b590c1b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/1874e165-bc2c-44ef-ae52-52f16b590c1b</guid>
      <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1107 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0141</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 5, pp. 19-31</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/6ed49c06-7d59-4cf2-a648-f863ae473182</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/6ed49c06-7d59-4cf2-a648-f863ae473182</guid>
      <pubDate>Mon, 01 May 2023 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1128 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/6ed49c06-7d59-4cf2-a648-f863ae473182-Cluster_Headache__Vagus_Nerve_Stimulation_Efficacy.pdf" type="application/pdf" length="0"/>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0144</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 5, pp. 36-49</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/8b99ea6d-7221-4c7b-9102-e996d123c89a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/8b99ea6d-7221-4c7b-9102-e996d123c89a</guid>
      <pubDate>Sat, 01 Apr 2023 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1086 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0138</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 4, pp. 20-30</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/2b9286e1-2796-439a-b993-a7af4cd5b415</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/2b9286e1-2796-439a-b993-a7af4cd5b415</guid>
      <pubDate>Sat, 01 Apr 2023 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1093 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/2b9286e1-2796-439a-b993-a7af4cd5b415-Brain_Computer_Interface_Rehabilitation_After_Stro.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0139</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 4, pp. 27-35</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/4a2debc2-107e-42fd-ae08-6ac2b61363ea</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/4a2debc2-107e-42fd-ae08-6ac2b61363ea</guid>
      <pubDate>Sat, 01 Apr 2023 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1100 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4a2debc2-107e-42fd-ae08-6ac2b61363ea-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0140</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 4, pp. 26-35</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/6ea9d25a-689d-4b46-b011-b9c44c7407b5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/6ea9d25a-689d-4b46-b011-b9c44c7407b5</guid>
      <pubDate>Wed, 01 Mar 2023 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1079 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/6ea9d25a-689d-4b46-b011-b9c44c7407b5-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0137</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 3, pp. 24-33</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/60b7c4d3-9c68-488b-a55c-84767ab94726</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/60b7c4d3-9c68-488b-a55c-84767ab94726</guid>
      <pubDate>Wed, 01 Mar 2023 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1065 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/60b7c4d3-9c68-488b-a55c-84767ab94726-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0135</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 3, pp. 15-25</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/998e2c86-6026-4779-aa3c-7a1f2f14b2a7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/998e2c86-6026-4779-aa3c-7a1f2f14b2a7</guid>
      <pubDate>Wed, 01 Mar 2023 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1072 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/998e2c86-6026-4779-aa3c-7a1f2f14b2a7-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0136</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 3, pp. 9-18</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/1580cf74-8378-456f-8430-4973c2d308d8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/1580cf74-8378-456f-8430-4973c2d308d8</guid>
      <pubDate>Wed, 01 Mar 2023 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1058 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/1580cf74-8378-456f-8430-4973c2d308d8-Status_Epilepticus__Refractory_Cases_and_Novel_Ane.pdf" type="application/pdf" length="0"/>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0134</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 3, pp. 15-26</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/5d87bde0-b1ee-4369-9fe5-ff2330c2d975</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/5d87bde0-b1ee-4369-9fe5-ff2330c2d975</guid>
      <pubDate>Wed, 01 Feb 2023 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1037 participants across 3 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/5d87bde0-b1ee-4369-9fe5-ff2330c2d975-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0131</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 4, Issue 2, pp. 1-8</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/9f811a5e-f8d6-427c-8232-170458962bba</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/9f811a5e-f8d6-427c-8232-170458962bba</guid>
      <pubDate>Wed, 01 Feb 2023 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1044 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9f811a5e-f8d6-427c-8232-170458962bba-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0132</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 2, pp. 14-23</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/037e1251-038f-46e4-8b4e-66bcb6e4821d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/037e1251-038f-46e4-8b4e-66bcb6e4821d</guid>
      <pubDate>Wed, 01 Feb 2023 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1051 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/037e1251-038f-46e4-8b4e-66bcb6e4821d-Sepsis_Bundle_Compliance_and_Mortality__A_Large_Sc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0133</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 2, pp. 11-19</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/074f2d5a-8f75-47be-8622-f04c0349b013</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/074f2d5a-8f75-47be-8622-f04c0349b013</guid>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 1016 participants across 5 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/074f2d5a-8f75-47be-8622-f04c0349b013-Pulmonary_Embolism_Risk_Stratification__Machine_Le.pdf" type="application/pdf" length="0"/>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0128</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 4, Issue 1, pp. 1-10</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/027d3206-cb7a-4815-ae7b-2f58c6bb0e48</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/027d3206-cb7a-4815-ae7b-2f58c6bb0e48</guid>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1030 participants across 2 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0130</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 4, Issue 1, pp. 1-14</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/547b4565-45d4-4da9-81ed-3590e7c78253</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/547b4565-45d4-4da9-81ed-3590e7c78253</guid>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 1009 participants across 4 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/547b4565-45d4-4da9-81ed-3590e7c78253-Peri_Implantitis_Treatment__Surgical_vs_Non_Surgic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0127</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 4, Issue 1, pp. 1-13</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/376974de-e3cd-421d-bd8a-6bd6fc3cf650</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/376974de-e3cd-421d-bd8a-6bd6fc3cf650</guid>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 1023 participants across 6 centers. Data collection spanned from 2021 to 2022. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2023-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2023.0129</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 4, Issue 1, pp. 1-14</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/46132f13-1024-4b22-956f-9e6e97d02b26</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/46132f13-1024-4b22-956f-9e6e97d02b26</guid>
      <pubDate>Thu, 01 Dec 2022 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 981 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/46132f13-1024-4b22-956f-9e6e97d02b26-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0123</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 12, pp. 88-98</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/81903ad3-b4e8-45f0-8a17-455ee229046b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/81903ad3-b4e8-45f0-8a17-455ee229046b</guid>
      <pubDate>Thu, 01 Dec 2022 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 988 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0124</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 12, pp. 76-88</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/9b05a37d-bc41-4da1-b2fe-20e79d07c1fe</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/9b05a37d-bc41-4da1-b2fe-20e79d07c1fe</guid>
      <pubDate>Thu, 01 Dec 2022 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 995 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9b05a37d-bc41-4da1-b2fe-20e79d07c1fe-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0125</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 12, pp. 99-109</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/59342add-8933-46aa-91f8-8f6f54f10542</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/59342add-8933-46aa-91f8-8f6f54f10542</guid>
      <pubDate>Thu, 01 Dec 2022 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 1002 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/59342add-8933-46aa-91f8-8f6f54f10542-Pediatric_Asthma_Exacerbations__Role_of_Environmen.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0126</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 12, pp. 84-96</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/9ab66b49-37dc-460f-aa7e-6015608abd95</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/9ab66b49-37dc-460f-aa7e-6015608abd95</guid>
      <pubDate>Tue, 01 Nov 2022 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 974 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9ab66b49-37dc-460f-aa7e-6015608abd95-Digital_Workflow_in_Complete_Denture_Fabrication__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0122</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 11, pp. 86-100</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/63aaaa1e-b2b3-4358-a2c8-431ea9ef2307</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/63aaaa1e-b2b3-4358-a2c8-431ea9ef2307</guid>
      <pubDate>Tue, 01 Nov 2022 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 960 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/63aaaa1e-b2b3-4358-a2c8-431ea9ef2307-Palliative_Care_Integration_in_Primary_Healthcare_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0120</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 11, pp. 85-98</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/4ab7aeba-5e25-494c-a967-194b1b10fde9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/4ab7aeba-5e25-494c-a967-194b1b10fde9</guid>
      <pubDate>Tue, 01 Nov 2022 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 967 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0121</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 11, pp. 74-83</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/4df5ff2c-44be-4dda-b0a1-8638a45ee1ea</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/4df5ff2c-44be-4dda-b0a1-8638a45ee1ea</guid>
      <pubDate>Sat, 01 Oct 2022 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 946 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/4df5ff2c-44be-4dda-b0a1-8638a45ee1ea-Perioperative_Cardiac_Risk_Assessment__Revised_Gui.pdf" type="application/pdf" length="0"/>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0118</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 10, pp. 76-87</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/333a61d1-580b-475c-9a59-ed38694feb49</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/333a61d1-580b-475c-9a59-ed38694feb49</guid>
      <pubDate>Sat, 01 Oct 2022 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 953 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/333a61d1-580b-475c-9a59-ed38694feb49-Normal_Pressure_Hydrocephalus__Shunt_Surgery_Patie.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0119</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 10, pp. 67-75</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/08b3e606-bfb1-48b0-bc05-b436de7e07fc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/08b3e606-bfb1-48b0-bc05-b436de7e07fc</guid>
      <pubDate>Sat, 01 Oct 2022 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 939 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0117</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 10, pp. 72-85</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f648bb46-3769-4e53-bdc5-43a861547bc2</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f648bb46-3769-4e53-bdc5-43a861547bc2</guid>
      <pubDate>Sat, 01 Oct 2022 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 932 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f648bb46-3769-4e53-bdc5-43a861547bc2-Childhood_Type_1_Diabetes__Continuous_Glucose_Moni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0116</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 10, pp. 64-73</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/1523044a-cb46-4765-b683-362ce02a1bc4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/1523044a-cb46-4765-b683-362ce02a1bc4</guid>
      <pubDate>Thu, 01 Sep 2022 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 911 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/1523044a-cb46-4765-b683-362ce02a1bc4-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0113</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 9, pp. 66-75</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/59d3749b-0409-4aec-8cbe-377d7b75a0bd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/59d3749b-0409-4aec-8cbe-377d7b75a0bd</guid>
      <pubDate>Thu, 01 Sep 2022 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 918 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/59d3749b-0409-4aec-8cbe-377d7b75a0bd-Cluster_Headache__Vagus_Nerve_Stimulation_Efficacy.pdf" type="application/pdf" length="0"/>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0114</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 9, pp. 56-66</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/96b2ea60-2024-4764-b69c-5fa28dc18012</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/96b2ea60-2024-4764-b69c-5fa28dc18012</guid>
      <pubDate>Thu, 01 Sep 2022 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 925 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/96b2ea60-2024-4764-b69c-5fa28dc18012-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0115</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 9, pp. 77-84</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/65d2d81d-0088-460c-9304-583defdbf16c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/65d2d81d-0088-460c-9304-583defdbf16c</guid>
      <pubDate>Mon, 01 Aug 2022 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 883 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0109</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 8, pp. 43-55</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/831252a1-f48a-4ba2-952b-c6ce0c3b6f4f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/831252a1-f48a-4ba2-952b-c6ce0c3b6f4f</guid>
      <pubDate>Mon, 01 Aug 2022 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 890 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0110</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 8, pp. 62-76</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/d0168dc0-62c9-4cfa-8492-336be3ac8ba9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/d0168dc0-62c9-4cfa-8492-336be3ac8ba9</guid>
      <pubDate>Mon, 01 Aug 2022 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 897 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d0168dc0-62c9-4cfa-8492-336be3ac8ba9-Fetal_Alcohol_Spectrum_Disorders__Neurobehavioral_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0111</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 8, pp. 56-63</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/ce8467a3-5acf-4b85-8cd5-a75c45e27207</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/ce8467a3-5acf-4b85-8cd5-a75c45e27207</guid>
      <pubDate>Mon, 01 Aug 2022 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 904 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ce8467a3-5acf-4b85-8cd5-a75c45e27207-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0112</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 8, pp. 59-71</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/9bda040a-e839-4b9b-8e7a-efed59cf0924</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/9bda040a-e839-4b9b-8e7a-efed59cf0924</guid>
      <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 862 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9bda040a-e839-4b9b-8e7a-efed59cf0924-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0106</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 7, pp. 42-55</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/6cf5cb25-78ad-4b36-b477-9a4a3d66b138</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/6cf5cb25-78ad-4b36-b477-9a4a3d66b138</guid>
      <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 876 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/6cf5cb25-78ad-4b36-b477-9a4a3d66b138-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0108</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 7, pp. 53-65</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/566a8226-49a3-43c8-b838-dd1284c06456</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/566a8226-49a3-43c8-b838-dd1284c06456</guid>
      <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 869 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/566a8226-49a3-43c8-b838-dd1284c06456-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0107</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 7, pp. 45-58</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/96f97360-b8f6-4447-a2cb-07ee86c446b4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/96f97360-b8f6-4447-a2cb-07ee86c446b4</guid>
      <pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 841 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/96f97360-b8f6-4447-a2cb-07ee86c446b4-Sepsis_Bundle_Compliance_and_Mortality__A_Large_Sc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0103</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 6, pp. 37-44</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/c8736925-e828-4524-985a-3949dd6084ba</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/c8736925-e828-4524-985a-3949dd6084ba</guid>
      <pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 848 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0104</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 6, pp. 32-42</dc:source>
    </item>
    <item>
      <title>Avitaminosis: Etiology, Clinical Manifestations, Diagnostic Approaches, and Modern Treatment Strategies</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/f774f068-586d-4242-b470-b106836f8cc5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/f774f068-586d-4242-b470-b106836f8cc5</guid>
      <pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
      <author>Normurodov Marufjon Orif o&apos;g&apos;li; Daminov Xolboy Erkaboy o&apos;g&apos;li; Xudoyberdiyev Shohro&apos;zbek Shodmon o&apos;g&apos;li; 5th year students of the Faculty of Dentistry of Samarkand State Medical University Madina Marupova Hikmatuloyevna Assistant of the Department of Therapeutic Dentistry of Samarkand State Medical University</author>
      <description>Abstract
Avitaminosis refers to a pathological condition resulting from prolonged deficiency of one or more essential vitamins, leading to metabolic dysfunction, structural tissue damage, and systemic clinical manifestations. Despite global advances in nutrition and food fortification, vitamin deficiencies remain prevalent in both developing and developed countries due to malnutrition, chronic diseases, malabsorption syndromes, restrictive diets, alcoholism, and socioeconomic factors. Fat-soluble vitamin deficiencies (A, D, E, K) often present with visual impairment, bone demineralization, neuromuscular dysfunction, and coagulopathy, whereas water-soluble vitamin deficiencies (B-complex and C) manifest as anemia, neuropathy, dermatitis, cognitive impairment, and impaired wound healing. Diagnosis is based on clinical evaluation, dietary history, biochemical assays, and functional biomarkers. Modern treatment strategies emphasize targeted supplementation, correction of underlying etiologies, dietary modification, food fortification, and public health interventions. Early detection and individualized management are essential to prevent irreversible complications. This article reviews the etiology, clinical features, diagnostic principles, and contemporary therapeutic approaches for avitaminosis, highlighting the importance of prevention and multidisciplinary management. Avitaminosis represents a systemic pathological state caused by sustained insufficiency of essential micronutrients necessary for normal biochemical reactions, cellular metabolism, and organ function. Although global nutritional standards have improved, vitamin deficiencies continue to affect diverse population groups due to unbalanced diets, gastrointestinal disorders, chronic systemic illnesses, restrictive eating patterns, aging, and increased physiological demands. The clinical spectrum varies widely depending on the specific micronutrient involved, ranging from mild constitutional symptoms to severe neurological, hematological, skeletal, and immunological impairments. Contemporary diagnostic strategies rely on detailed nutritional assessment combined with laboratory measurement of serum vitamin concentrations and functional metabolic markers. Timely therapeutic intervention through individualized supplementation and correction of predisposing conditions significantly improves prognosis and prevents irreversible complications. Preventive measures, including public health nutrition programs and dietary education, remain fundamental in reducing global disease burden associated with micronutrient insufficiency.
</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f774f068-586d-4242-b470-b106836f8cc5-Avitaminosis__Etiology__Clinical_Manifestations__D.pdf" type="application/pdf" length="0"/>
      <dc:creator>Normurodov Marufjon Orif o&apos;g&apos;li; Daminov Xolboy Erkaboy o&apos;g&apos;li; Xudoyberdiyev Shohro&apos;zbek Shodmon o&apos;g&apos;li; 5th year students of the Faculty of Dentistry of Samarkand State Medical University Madina Marupova Hikmatuloyevna Assistant of the Department of Therapeutic Dentistry of Samarkand State Medical University</dc:creator>
      <dc:subject>Keywords: avitaminosis</dc:subject>
      <dc:subject>vitamin deficiency</dc:subject>
      <dc:subject>malnutrition</dc:subject>
      <dc:subject>micronutrients</dc:subject>
      <dc:subject>diagnosis</dc:subject>
      <dc:subject>supplementation</dc:subject>
      <dc:subject>prevention</dc:subject>
      <dc:subject>metabolic disorders</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0127</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 6, pp. 45-52</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/28177cfc-f4ea-4687-9ba4-61d543c9caa3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/28177cfc-f4ea-4687-9ba4-61d543c9caa3</guid>
      <pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 855 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/28177cfc-f4ea-4687-9ba4-61d543c9caa3-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0105</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 6, pp. 50-61</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/8c776280-7058-40ca-a750-a3bda74a4c4f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/8c776280-7058-40ca-a750-a3bda74a4c4f</guid>
      <pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 834 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8c776280-7058-40ca-a750-a3bda74a4c4f-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0102</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 6, pp. 37-44</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/ec068aa3-b8f8-4bde-8cca-e5ad7940e32c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/ec068aa3-b8f8-4bde-8cca-e5ad7940e32c</guid>
      <pubDate>Sun, 01 May 2022 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 820 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0100</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 5, pp. 37-49</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/89fedecb-ea56-4e86-a3e6-742a35645dd9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/89fedecb-ea56-4e86-a3e6-742a35645dd9</guid>
      <pubDate>Sun, 01 May 2022 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 827 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/89fedecb-ea56-4e86-a3e6-742a35645dd9-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0101</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 5, pp. 29-41</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/2bc819d7-e0c6-4946-8cf0-ac6bf01d222c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/2bc819d7-e0c6-4946-8cf0-ac6bf01d222c</guid>
      <pubDate>Sun, 01 May 2022 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 813 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/2bc819d7-e0c6-4946-8cf0-ac6bf01d222c-Amyotrophic_Lateral_Sclerosis__Antisense_Oligonucl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0099</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 5, pp. 17-31</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/1f368666-4a66-42f5-a4ad-6cf036df9b7c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/1f368666-4a66-42f5-a4ad-6cf036df9b7c</guid>
      <pubDate>Fri, 01 Apr 2022 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 785 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/1f368666-4a66-42f5-a4ad-6cf036df9b7c-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0095</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 4, pp. 23-36</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/0045efd9-67f6-40a6-94ce-2e29c4e1668a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/0045efd9-67f6-40a6-94ce-2e29c4e1668a</guid>
      <pubDate>Fri, 01 Apr 2022 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 792 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/0045efd9-67f6-40a6-94ce-2e29c4e1668a-Pediatric_Asthma_Exacerbations__Role_of_Environmen.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0096</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 4, pp. 20-28</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/1bf6a76f-c461-4a62-a68a-7bbb366804c6</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/1bf6a76f-c461-4a62-a68a-7bbb366804c6</guid>
      <pubDate>Fri, 01 Apr 2022 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 799 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0097</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 4, pp. 22-36</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/961d1051-abfa-4f26-a36b-f288b88e0187</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/961d1051-abfa-4f26-a36b-f288b88e0187</guid>
      <pubDate>Fri, 01 Apr 2022 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 806 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/961d1051-abfa-4f26-a36b-f288b88e0187-Pulmonary_Embolism_Risk_Stratification__Machine_Le.pdf" type="application/pdf" length="0"/>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0098</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 4, pp. 22-36</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/42222a5b-6b0a-40b0-84a4-e0170941459d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/42222a5b-6b0a-40b0-84a4-e0170941459d</guid>
      <pubDate>Tue, 01 Mar 2022 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 771 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/42222a5b-6b0a-40b0-84a4-e0170941459d-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0093</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 3, pp. 11-21</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/171fa4ec-2696-4df5-8b7b-18b7c397ebb5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/171fa4ec-2696-4df5-8b7b-18b7c397ebb5</guid>
      <pubDate>Tue, 01 Mar 2022 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 764 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0092</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 3, pp. 10-21</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/5328c378-6ef3-4486-9f41-4cbde22a45e4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/5328c378-6ef3-4486-9f41-4cbde22a45e4</guid>
      <pubDate>Tue, 01 Mar 2022 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 778 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/5328c378-6ef3-4486-9f41-4cbde22a45e4-Stroke_Thrombectomy_Time_Window_Extension__Perfusi.pdf" type="application/pdf" length="0"/>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0094</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 3, pp. 9-16</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/d80e0f60-b00a-4624-bbe0-807421c926cb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/d80e0f60-b00a-4624-bbe0-807421c926cb</guid>
      <pubDate>Tue, 01 Feb 2022 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 743 participants across 6 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d80e0f60-b00a-4624-bbe0-807421c926cb-Normal_Pressure_Hydrocephalus__Shunt_Surgery_Patie.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0089</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 3, Issue 2, pp. 1-8</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/38e206a2-f41a-481e-bc5f-568c080e98f8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/38e206a2-f41a-481e-bc5f-568c080e98f8</guid>
      <pubDate>Tue, 01 Feb 2022 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 736 participants across 5 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0088</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 3, Issue 2, pp. 1-10</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/99187e95-7223-4d7f-b961-6aa97737ea45</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/99187e95-7223-4d7f-b961-6aa97737ea45</guid>
      <pubDate>Tue, 01 Feb 2022 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 757 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/99187e95-7223-4d7f-b961-6aa97737ea45-Neonatal_Sepsis_Biomarkers__A_Multicenter_Prospect.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0091</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 2, pp. 9-19</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/5b63064c-1b75-408c-a4f2-8d01e3551434</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/5b63064c-1b75-408c-a4f2-8d01e3551434</guid>
      <pubDate>Tue, 01 Feb 2022 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 750 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0090</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 2, pp. 11-22</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/2b51a3a8-8c9d-4e5e-b6ae-fe69623dc7cc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/2b51a3a8-8c9d-4e5e-b6ae-fe69623dc7cc</guid>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 722 participants across 3 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0086</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 3, Issue 1, pp. 1-8</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/062d8e32-1b23-49ce-bd82-4bd66d2b6501</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/062d8e32-1b23-49ce-bd82-4bd66d2b6501</guid>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 715 participants across 2 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/062d8e32-1b23-49ce-bd82-4bd66d2b6501-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0085</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 3, Issue 1, pp. 1-10</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/75643da9-beb3-475a-aea5-83e2d10b91a9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/75643da9-beb3-475a-aea5-83e2d10b91a9</guid>
      <pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 729 participants across 4 centers. Data collection spanned from 2020 to 2021. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/75643da9-beb3-475a-aea5-83e2d10b91a9-Alveolar_Ridge_Preservation_Techniques__A_Systemat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2022-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2022.0087</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 3, Issue 1, pp. 1-9</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/b9f4005a-0904-47fb-9b4c-b3487202288f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/b9f4005a-0904-47fb-9b4c-b3487202288f</guid>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 694 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/b9f4005a-0904-47fb-9b4c-b3487202288f-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0082</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 12, pp. 71-84</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/749e7629-1454-4476-9704-5fc896178242</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/749e7629-1454-4476-9704-5fc896178242</guid>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 708 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0084</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 12, pp. 85-93</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/85df026a-79b7-48b3-8d77-1a6475e81cdd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/85df026a-79b7-48b3-8d77-1a6475e81cdd</guid>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 701 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/85df026a-79b7-48b3-8d77-1a6475e81cdd-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0083</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 12, pp. 88-101</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/5231f5e4-65b9-46dc-8e24-0138a34a178e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/5231f5e4-65b9-46dc-8e24-0138a34a178e</guid>
      <pubDate>Mon, 01 Nov 2021 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 687 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/5231f5e4-65b9-46dc-8e24-0138a34a178e-Fetal_Alcohol_Spectrum_Disorders__Neurobehavioral_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0081</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 11, pp. 84-95</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/17e974a1-7620-4ed8-aaa9-f9d5eb22e9c8</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/17e974a1-7620-4ed8-aaa9-f9d5eb22e9c8</guid>
      <pubDate>Mon, 01 Nov 2021 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 680 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/17e974a1-7620-4ed8-aaa9-f9d5eb22e9c8-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0080</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 11, pp. 68-76</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/e8a55a0b-4e72-455f-a39d-a9f415288457</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/e8a55a0b-4e72-455f-a39d-a9f415288457</guid>
      <pubDate>Mon, 01 Nov 2021 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 666 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/e8a55a0b-4e72-455f-a39d-a9f415288457-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0078</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 11, pp. 75-87</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/7db14bb0-0426-406f-96b3-b51880c654b5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/7db14bb0-0426-406f-96b3-b51880c654b5</guid>
      <pubDate>Mon, 01 Nov 2021 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 673 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/7db14bb0-0426-406f-96b3-b51880c654b5-Brain_Computer_Interface_Rehabilitation_After_Stro.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0079</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 11, pp. 77-84</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/481ae19f-d85f-4002-b186-de3d1868cca1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/481ae19f-d85f-4002-b186-de3d1868cca1</guid>
      <pubDate>Fri, 01 Oct 2021 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 652 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/481ae19f-d85f-4002-b186-de3d1868cca1-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0076</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 10, pp. 69-83</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/01b93a4b-ad20-49b9-809c-df77f6783a88</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/01b93a4b-ad20-49b9-809c-df77f6783a88</guid>
      <pubDate>Fri, 01 Oct 2021 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 645 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/01b93a4b-ad20-49b9-809c-df77f6783a88-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0075</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 10, pp. 57-67</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/dec4f5dd-19b2-48e9-8dc7-3128850fe972</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/dec4f5dd-19b2-48e9-8dc7-3128850fe972</guid>
      <pubDate>Fri, 01 Oct 2021 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 659 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/dec4f5dd-19b2-48e9-8dc7-3128850fe972-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0077</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 10, pp. 60-70</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/3574b0a0-e09b-4682-b033-50d7196fa9f7</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/3574b0a0-e09b-4682-b033-50d7196fa9f7</guid>
      <pubDate>Wed, 01 Sep 2021 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 638 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0074</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 9, pp. 69-76</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/63436a92-fe12-4b08-948d-1cc3d01d58b0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/63436a92-fe12-4b08-948d-1cc3d01d58b0</guid>
      <pubDate>Wed, 01 Sep 2021 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 617 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/63436a92-fe12-4b08-948d-1cc3d01d58b0-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0071</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 9, pp. 59-68</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/35603268-656c-42bd-93ed-ec7d44915096</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/35603268-656c-42bd-93ed-ec7d44915096</guid>
      <pubDate>Wed, 01 Sep 2021 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 631 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/35603268-656c-42bd-93ed-ec7d44915096-Sepsis_Bundle_Compliance_and_Mortality__A_Large_Sc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0073</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 9, pp. 67-74</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/39a1c318-65bd-4182-8be6-1f7343db9861</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/39a1c318-65bd-4182-8be6-1f7343db9861</guid>
      <pubDate>Wed, 01 Sep 2021 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 624 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/39a1c318-65bd-4182-8be6-1f7343db9861-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0072</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 9, pp. 52-59</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/8fcc3fc8-6de5-451b-a9ac-42c266923241</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/8fcc3fc8-6de5-451b-a9ac-42c266923241</guid>
      <pubDate>Sun, 01 Aug 2021 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 610 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0070</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 8, pp. 49-56</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/41c11b3c-fcf8-48eb-a7f1-45270625157b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/41c11b3c-fcf8-48eb-a7f1-45270625157b</guid>
      <pubDate>Sun, 01 Aug 2021 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 596 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/41c11b3c-fcf8-48eb-a7f1-45270625157b-Pulmonary_Embolism_Risk_Stratification__Machine_Le.pdf" type="application/pdf" length="0"/>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0068</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 8, pp. 55-66</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/eeec5aa0-19c5-4f01-b3ed-65de9df593c5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/eeec5aa0-19c5-4f01-b3ed-65de9df593c5</guid>
      <pubDate>Sun, 01 Aug 2021 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 603 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/eeec5aa0-19c5-4f01-b3ed-65de9df593c5-Amyotrophic_Lateral_Sclerosis__Antisense_Oligonucl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0069</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 8, pp. 61-68</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/6e439321-306b-4a31-b34d-44cb516568bd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/6e439321-306b-4a31-b34d-44cb516568bd</guid>
      <pubDate>Thu, 01 Jul 2021 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 575 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/6e439321-306b-4a31-b34d-44cb516568bd-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0065</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 7, pp. 40-48</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/4ad96530-91b5-4470-8fb5-6d47bba1b392</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/4ad96530-91b5-4470-8fb5-6d47bba1b392</guid>
      <pubDate>Thu, 01 Jul 2021 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 582 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0066</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 7, pp. 51-58</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/50683818-023b-4ac4-9370-b733cb25ef51</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/50683818-023b-4ac4-9370-b733cb25ef51</guid>
      <pubDate>Thu, 01 Jul 2021 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 589 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0067</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 7, pp. 44-51</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/43c51fb2-874c-4e42-98ce-0f168d2a1f8e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/43c51fb2-874c-4e42-98ce-0f168d2a1f8e</guid>
      <pubDate>Thu, 01 Jul 2021 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 568 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0064</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 7, pp. 51-60</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/ac6fc00c-7be8-48e8-a091-dcd32fc07e98</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/ac6fc00c-7be8-48e8-a091-dcd32fc07e98</guid>
      <pubDate>Tue, 01 Jun 2021 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 554 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ac6fc00c-7be8-48e8-a091-dcd32fc07e98-Digital_Workflow_in_Complete_Denture_Fabrication__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0062</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 6, pp. 32-43</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/bb2dd4ce-4fab-4783-9521-dd497262208b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/bb2dd4ce-4fab-4783-9521-dd497262208b</guid>
      <pubDate>Tue, 01 Jun 2021 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 547 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/bb2dd4ce-4fab-4783-9521-dd497262208b-Neonatal_Sepsis_Biomarkers__A_Multicenter_Prospect.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0061</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 6, pp. 41-50</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/3ef2a134-65aa-486d-9607-acbde3db61ce</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/3ef2a134-65aa-486d-9607-acbde3db61ce</guid>
      <pubDate>Tue, 01 Jun 2021 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 561 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/3ef2a134-65aa-486d-9607-acbde3db61ce-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0063</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 6, pp. 43-54</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/817bed80-385c-41ea-a571-4e87823b78bb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/817bed80-385c-41ea-a571-4e87823b78bb</guid>
      <pubDate>Sat, 01 May 2021 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 519 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/817bed80-385c-41ea-a571-4e87823b78bb-Alveolar_Ridge_Preservation_Techniques__A_Systemat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0057</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 5, pp. 24-31</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/cba47283-0419-4fbb-972b-1bdb7307cd51</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/cba47283-0419-4fbb-972b-1bdb7307cd51</guid>
      <pubDate>Sat, 01 May 2021 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 526 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/cba47283-0419-4fbb-972b-1bdb7307cd51-Perioperative_Cardiac_Risk_Assessment__Revised_Gui.pdf" type="application/pdf" length="0"/>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0058</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 5, pp. 30-42</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/525bfc20-db7c-4fdd-ae79-370077b293ef</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/525bfc20-db7c-4fdd-ae79-370077b293ef</guid>
      <pubDate>Sat, 01 May 2021 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 540 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/525bfc20-db7c-4fdd-ae79-370077b293ef-Palliative_Care_Integration_in_Primary_Healthcare_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0060</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 5, pp. 32-39</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/559dfa02-9f12-4768-971e-fd07c6745095</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/559dfa02-9f12-4768-971e-fd07c6745095</guid>
      <pubDate>Sat, 01 May 2021 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 533 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0059</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 5, pp. 41-50</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/067802b1-4beb-40f8-9c5c-6b78e7a8347c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/067802b1-4beb-40f8-9c5c-6b78e7a8347c</guid>
      <pubDate>Thu, 01 Apr 2021 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 505 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/067802b1-4beb-40f8-9c5c-6b78e7a8347c-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0055</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 4, pp. 23-31</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f4c2e832-c1da-46f5-946d-a34a141cf867</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f4c2e832-c1da-46f5-946d-a34a141cf867</guid>
      <pubDate>Thu, 01 Apr 2021 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 512 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f4c2e832-c1da-46f5-946d-a34a141cf867-Childhood_Type_1_Diabetes__Continuous_Glucose_Moni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0056</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 4, pp. 27-40</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/52702f17-b009-4b28-8579-eff3e0e9e16c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/52702f17-b009-4b28-8579-eff3e0e9e16c</guid>
      <pubDate>Thu, 01 Apr 2021 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 498 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/52702f17-b009-4b28-8579-eff3e0e9e16c-Cluster_Headache__Vagus_Nerve_Stimulation_Efficacy.pdf" type="application/pdf" length="0"/>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0054</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 4, pp. 26-40</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/5f7425bd-5da7-4637-817e-9a040b04b3cd</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/5f7425bd-5da7-4637-817e-9a040b04b3cd</guid>
      <pubDate>Mon, 01 Mar 2021 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 470 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/5f7425bd-5da7-4637-817e-9a040b04b3cd-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0050</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 3, pp. 10-22</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/21bc3f86-51a6-4e3e-8f30-37ab0680bba5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/21bc3f86-51a6-4e3e-8f30-37ab0680bba5</guid>
      <pubDate>Mon, 01 Mar 2021 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 477 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0051</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 3, pp. 13-26</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/8ba38345-ba24-4659-8764-ed4662161393</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/8ba38345-ba24-4659-8764-ed4662161393</guid>
      <pubDate>Mon, 01 Mar 2021 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 491 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8ba38345-ba24-4659-8764-ed4662161393-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0053</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 3, pp. 19-29</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/f68c8818-964d-418a-807b-43fdbc0ff831</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/f68c8818-964d-418a-807b-43fdbc0ff831</guid>
      <pubDate>Mon, 01 Mar 2021 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 484 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f68c8818-964d-418a-807b-43fdbc0ff831-Digital_Smile_Design__Patient_Perception_and_Clini.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0052</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 3, pp. 16-23</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/7f2bb2fb-6682-4b95-b6f9-1fb76b85f018</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/7f2bb2fb-6682-4b95-b6f9-1fb76b85f018</guid>
      <pubDate>Mon, 01 Feb 2021 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 463 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0049</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 2, pp. 15-25</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/cb27c23f-5207-4d62-ad42-6f466c14d8b3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/cb27c23f-5207-4d62-ad42-6f466c14d8b3</guid>
      <pubDate>Mon, 01 Feb 2021 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 456 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/cb27c23f-5207-4d62-ad42-6f466c14d8b3-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0048</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 2, pp. 10-18</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/32ff32df-bf73-4699-8ef6-14a15ba9cf95</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/32ff32df-bf73-4699-8ef6-14a15ba9cf95</guid>
      <pubDate>Mon, 01 Feb 2021 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 449 participants across 4 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/32ff32df-bf73-4699-8ef6-14a15ba9cf95-Dental_Erosion_in_Gastroesophageal_Reflux_Disease_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0047</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 2, Issue 2, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/875ac4e2-9f8d-4233-a404-0c8072fdc25f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/875ac4e2-9f8d-4233-a404-0c8072fdc25f</guid>
      <pubDate>Fri, 01 Jan 2021 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 428 participants across 6 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/875ac4e2-9f8d-4233-a404-0c8072fdc25f-Status_Epilepticus__Refractory_Cases_and_Novel_Ane.pdf" type="application/pdf" length="0"/>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0044</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 2, Issue 1, pp. 1-14</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/8d6f04ff-7129-4a2c-bb0e-d7e94957691a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/8d6f04ff-7129-4a2c-bb0e-d7e94957691a</guid>
      <pubDate>Fri, 01 Jan 2021 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 435 participants across 2 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/8d6f04ff-7129-4a2c-bb0e-d7e94957691a-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0045</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 2, Issue 1, pp. 1-9</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/849a8db4-95d2-4da6-8169-323b72aefa86</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/849a8db4-95d2-4da6-8169-323b72aefa86</guid>
      <pubDate>Fri, 01 Jan 2021 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 442 participants across 3 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/849a8db4-95d2-4da6-8169-323b72aefa86-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0046</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 2, Issue 1, pp. 1-12</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/9ad73777-8cd6-4563-b88e-fb964eefd3b9</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/9ad73777-8cd6-4563-b88e-fb964eefd3b9</guid>
      <pubDate>Fri, 01 Jan 2021 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 421 participants across 5 centers. Data collection spanned from 2019 to 2020. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/9ad73777-8cd6-4563-b88e-fb964eefd3b9-Sepsis_Bundle_Compliance_and_Mortality__A_Large_Sc.pdf" type="application/pdf" length="0"/>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2021-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2021.0043</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 2, Issue 1, pp. 1-9</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/46eb076f-728a-4275-ae9d-ddd7182a6b2a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/46eb076f-728a-4275-ae9d-ddd7182a6b2a</guid>
      <pubDate>Tue, 01 Dec 2020 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 414 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/46eb076f-728a-4275-ae9d-ddd7182a6b2a-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0042</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 12, pp. 90-104</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/493fa243-60ca-450b-865b-f3fbaacfd196</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/493fa243-60ca-450b-865b-f3fbaacfd196</guid>
      <pubDate>Tue, 01 Dec 2020 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 400 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/493fa243-60ca-450b-865b-f3fbaacfd196-Workplace_Burnout_Among_Healthcare_Professionals__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0040</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 12, pp. 87-97</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/1e921044-c61a-4fc2-bb64-a894793dbb56</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/1e921044-c61a-4fc2-bb64-a894793dbb56</guid>
      <pubDate>Tue, 01 Dec 2020 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 393 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0039</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 12, pp. 97-108</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c0d0c6cb-a2b3-4676-8121-57eb5a7e6c01</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c0d0c6cb-a2b3-4676-8121-57eb5a7e6c01</guid>
      <pubDate>Tue, 01 Dec 2020 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 407 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/c0d0c6cb-a2b3-4676-8121-57eb5a7e6c01-Growth_Patterns_in_Children_with_Celiac_Disease_Af.pdf" type="application/pdf" length="0"/>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-12-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0041</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 12, pp. 88-100</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/6608a66d-712a-48f4-963d-488987128c84</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/6608a66d-712a-48f4-963d-488987128c84</guid>
      <pubDate>Sun, 01 Nov 2020 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 372 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/6608a66d-712a-48f4-963d-488987128c84-Pediatric_Asthma_Exacerbations__Role_of_Environmen.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0036</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 11, pp. 75-87</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/ed9a5f36-c802-4b05-972d-745c64ad96cb</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/ed9a5f36-c802-4b05-972d-745c64ad96cb</guid>
      <pubDate>Sun, 01 Nov 2020 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 386 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0038</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 11, pp. 74-83</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/b10b745f-0ac3-416c-942c-b5feee5fb31b</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/b10b745f-0ac3-416c-942c-b5feee5fb31b</guid>
      <pubDate>Sun, 01 Nov 2020 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 379 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-11-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0037</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 11, pp. 81-89</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/83e5ffef-3b61-4e1f-a8ed-a51acc6d46cc</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/83e5ffef-3b61-4e1f-a8ed-a51acc6d46cc</guid>
      <pubDate>Thu, 01 Oct 2020 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 351 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/83e5ffef-3b61-4e1f-a8ed-a51acc6d46cc-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0033</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 10, pp. 65-73</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/692f946f-f398-4f44-8e64-b0fc81f706f0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/692f946f-f398-4f44-8e64-b0fc81f706f0</guid>
      <pubDate>Thu, 01 Oct 2020 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 365 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/692f946f-f398-4f44-8e64-b0fc81f706f0-Climate_Change_and_Infectious_Disease_Patterns__Gl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0035</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 10, pp. 72-86</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/89249919-4eff-4965-85ab-27e22187941f</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/89249919-4eff-4965-85ab-27e22187941f</guid>
      <pubDate>Thu, 01 Oct 2020 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 344 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/89249919-4eff-4965-85ab-27e22187941f-Digital_Workflow_in_Complete_Denture_Fabrication__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0032</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 10, pp. 66-80</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/11e4774d-549e-4c08-ad2e-5769b6e62983</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/11e4774d-549e-4c08-ad2e-5769b6e62983</guid>
      <pubDate>Thu, 01 Oct 2020 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 358 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/11e4774d-549e-4c08-ad2e-5769b6e62983-Stroke_Thrombectomy_Time_Window_Extension__Perfusi.pdf" type="application/pdf" length="0"/>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-10-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0034</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 10, pp. 84-96</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/898fbec1-d24f-4b70-87f8-9b8fc4feeaed</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/898fbec1-d24f-4b70-87f8-9b8fc4feeaed</guid>
      <pubDate>Tue, 01 Sep 2020 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 337 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/898fbec1-d24f-4b70-87f8-9b8fc4feeaed-Neonatal_Sepsis_Biomarkers__A_Multicenter_Prospect.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0031</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 9, pp. 60-74</dc:source>
    </item>
    <item>
      <title>Palliative Care Integration in Primary Healthcare: A Mixed-Methods Study</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/0bc76a73-be79-40e5-bddb-7274e4d23d48</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/0bc76a73-be79-40e5-bddb-7274e4d23d48</guid>
      <pubDate>Tue, 01 Sep 2020 00:00:00 GMT</pubDate>
      <author>Ramos DA</author>
      <description>Background: This study investigates palliative care integration in primary healthcare: a mixed-methods study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 330 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 15% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/0bc76a73-be79-40e5-bddb-7274e4d23d48-Palliative_Care_Integration_in_Primary_Healthcare_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ramos DA</dc:creator>
      <dc:creator>Pereira JS</dc:creator>
      <dc:creator>Almeida CR</dc:creator>
      <dc:subject>Palliative Care</dc:subject>
      <dc:subject>Palliative Care Integration in Primary Healthcare</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0030</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 9, pp. 61-71</dc:source>
    </item>
    <item>
      <title>Normal Pressure Hydrocephalus: Shunt Surgery Patient Selection Criteria</title>
      <link>https://aams-journal.us/journals/neurology/articles/f6b71d62-a115-43d8-8f92-7ba079363c52</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/f6b71d62-a115-43d8-8f92-7ba079363c52</guid>
      <pubDate>Tue, 01 Sep 2020 00:00:00 GMT</pubDate>
      <author>Kang MJ</author>
      <description>Background: This study investigates normal pressure hydrocephalus: shunt surgery patient selection criteria. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 323 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 44% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f6b71d62-a115-43d8-8f92-7ba079363c52-Normal_Pressure_Hydrocephalus__Shunt_Surgery_Patie.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kang MJ</dc:creator>
      <dc:creator>Cho HN</dc:creator>
      <dc:creator>Yoon SB</dc:creator>
      <dc:subject>Normal Pressure</dc:subject>
      <dc:subject>Normal Pressure Hydrocephalus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-09-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0029</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 9, pp. 70-83</dc:source>
    </item>
    <item>
      <title>Alveolar Ridge Preservation Techniques: A Systematic Review and Network Meta-Analysis</title>
      <link>https://aams-journal.us/journals/dentistry/articles/ff2a6d52-9cea-4884-9be5-95caa467b0c3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/ff2a6d52-9cea-4884-9be5-95caa467b0c3</guid>
      <pubDate>Sat, 01 Aug 2020 00:00:00 GMT</pubDate>
      <author>Abubakar IS</author>
      <description>Background: This study investigates alveolar ridge preservation techniques: a systematic review and network meta-analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 309 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 42% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/ff2a6d52-9cea-4884-9be5-95caa467b0c3-Alveolar_Ridge_Preservation_Techniques__A_Systemat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Abubakar IS</dc:creator>
      <dc:creator>Yusuf AM</dc:creator>
      <dc:creator>Bello HO</dc:creator>
      <dc:subject>Alveolar Ridge</dc:subject>
      <dc:subject>Alveolar Ridge Preservation Techniques</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0027</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 8, pp. 52-65</dc:source>
    </item>
    <item>
      <title>Perioperative Cardiac Risk Assessment: Revised Guidelines Application</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/d4bb6e9e-d030-4fb0-bb32-8c9a5c30419d</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/d4bb6e9e-d030-4fb0-bb32-8c9a5c30419d</guid>
      <pubDate>Sat, 01 Aug 2020 00:00:00 GMT</pubDate>
      <author>Andersson KL</author>
      <description>Background: This study investigates perioperative cardiac risk assessment: revised guidelines application. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 316 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 43% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d4bb6e9e-d030-4fb0-bb32-8c9a5c30419d-Perioperative_Cardiac_Risk_Assessment__Revised_Gui.pdf" type="application/pdf" length="0"/>
      <dc:creator>Andersson KL</dc:creator>
      <dc:creator>Gustafsson BN</dc:creator>
      <dc:creator>Nilsson TP</dc:creator>
      <dc:subject>Perioperative Cardiac</dc:subject>
      <dc:subject>Perioperative Cardiac Risk Assessment</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0028</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 8, pp. 55-64</dc:source>
    </item>
    <item>
      <title>Water Sanitation and Child Mortality: Intervention Impact in Low-Income Countries</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/1f96e1c6-479d-4462-b5f9-81f008a36704</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/1f96e1c6-479d-4462-b5f9-81f008a36704</guid>
      <pubDate>Sat, 01 Aug 2020 00:00:00 GMT</pubDate>
      <author>Hoffmann RS</author>
      <description>Background: This study investigates water sanitation and child mortality: intervention impact in low-income countries. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 295 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 40% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/1f96e1c6-479d-4462-b5f9-81f008a36704-Water_Sanitation_and_Child_Mortality__Intervention.pdf" type="application/pdf" length="0"/>
      <dc:creator>Hoffmann RS</dc:creator>
      <dc:creator>Becker TL</dc:creator>
      <dc:creator>Schulz AK</dc:creator>
      <dc:subject>Water Sanitation</dc:subject>
      <dc:subject>Water Sanitation and Child Mortality</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0025</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 8, pp. 47-60</dc:source>
    </item>
    <item>
      <title>Childhood Type 1 Diabetes: Continuous Glucose Monitoring Effectiveness</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/c1db9786-f09b-4ffc-8b6e-2197e7b51b34</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/c1db9786-f09b-4ffc-8b6e-2197e7b51b34</guid>
      <pubDate>Sat, 01 Aug 2020 00:00:00 GMT</pubDate>
      <author>Sato Y</author>
      <description>Background: This study investigates childhood type 1 diabetes: continuous glucose monitoring effectiveness. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 302 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 41% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/c1db9786-f09b-4ffc-8b6e-2197e7b51b34-Childhood_Type_1_Diabetes__Continuous_Glucose_Moni.pdf" type="application/pdf" length="0"/>
      <dc:creator>Sato Y</dc:creator>
      <dc:creator>Kobayashi N</dc:creator>
      <dc:creator>Hashimoto T</dc:creator>
      <dc:subject>Childhood Type</dc:subject>
      <dc:subject>Childhood Type 1 Diabetes</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-08-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0026</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 8, pp. 50-59</dc:source>
    </item>
    <item>
      <title>Digital Smile Design: Patient Perception and Clinical Predictability</title>
      <link>https://aams-journal.us/journals/dentistry/articles/6a99488b-bb4f-495f-904d-a7c96d7ec05a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/6a99488b-bb4f-495f-904d-a7c96d7ec05a</guid>
      <pubDate>Wed, 01 Jul 2020 00:00:00 GMT</pubDate>
      <author>Hernandez LC</author>
      <description>Background: This study investigates digital smile design: patient perception and clinical predictability. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 274 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 37% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Hernandez LC</dc:creator>
      <dc:creator>Rodriguez AM</dc:creator>
      <dc:creator>Morales FJ</dc:creator>
      <dc:subject>Digital Smile</dc:subject>
      <dc:subject>Digital Smile Design</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0022</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 7, pp. 41-51</dc:source>
    </item>
    <item>
      <title>Acute Pancreatitis Management: Early Enteral Nutrition Impact</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/43741f64-64db-4682-9818-c6f9d94869c4</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/43741f64-64db-4682-9818-c6f9d94869c4</guid>
      <pubDate>Wed, 01 Jul 2020 00:00:00 GMT</pubDate>
      <author>Popov IG</author>
      <description>Background: This study investigates acute pancreatitis management: early enteral nutrition impact. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 281 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 38% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/43741f64-64db-4682-9818-c6f9d94869c4-Acute_Pancreatitis_Management__Early_Enteral_Nutri.pdf" type="application/pdf" length="0"/>
      <dc:creator>Popov IG</dc:creator>
      <dc:creator>Kuznetsova EV</dc:creator>
      <dc:creator>Lebedev SA</dc:creator>
      <dc:subject>Acute Pancreatitis</dc:subject>
      <dc:subject>Acute Pancreatitis Management</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0023</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 7, pp. 43-54</dc:source>
    </item>
    <item>
      <title>Cluster Headache: Vagus Nerve Stimulation Efficacy and Safety</title>
      <link>https://aams-journal.us/journals/neurology/articles/302b3a45-9bb6-4589-a649-ae1c860bb7ce</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/302b3a45-9bb6-4589-a649-ae1c860bb7ce</guid>
      <pubDate>Wed, 01 Jul 2020 00:00:00 GMT</pubDate>
      <author>Chen YL</author>
      <description>Background: This study investigates cluster headache: vagus nerve stimulation efficacy and safety. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 288 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 39% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Chen YL</dc:creator>
      <dc:creator>Wang JF</dc:creator>
      <dc:creator>Li MH</dc:creator>
      <dc:subject>Cluster Headache:</dc:subject>
      <dc:subject>Cluster Headache</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-07-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0024</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 7, pp. 57-69</dc:source>
    </item>
    <item>
      <title>Brain-Computer Interface Rehabilitation After Stroke: A Pilot Trial</title>
      <link>https://aams-journal.us/journals/neurology/articles/0eafe794-a2d4-4f15-875e-a3541739cdc5</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/0eafe794-a2d4-4f15-875e-a3541739cdc5</guid>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <author>Nguyen VT</author>
      <description>Background: This study investigates brain-computer interface rehabilitation after stroke: a pilot trial. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 253 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 34% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/0eafe794-a2d4-4f15-875e-a3541739cdc5-Brain_Computer_Interface_Rehabilitation_After_Stro.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nguyen VT</dc:creator>
      <dc:creator>Tran HL</dc:creator>
      <dc:creator>Pham DQ</dc:creator>
      <dc:subject>Brain-Computer Interface</dc:subject>
      <dc:subject>Brain-Computer Interface Rehabilitation After Stroke</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0019</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 6, pp. 45-56</dc:source>
    </item>
    <item>
      <title>Fetal Alcohol Spectrum Disorders: Neurobehavioral Assessment Tools Validation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/fee83810-b194-4588-b21c-46aca3ff0b5e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/fee83810-b194-4588-b21c-46aca3ff0b5e</guid>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <author>Brown KE</author>
      <description>Background: This study investigates fetal alcohol spectrum disorders: neurobehavioral assessment tools validation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 267 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 36% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/fee83810-b194-4588-b21c-46aca3ff0b5e-Fetal_Alcohol_Spectrum_Disorders__Neurobehavioral_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Brown KE</dc:creator>
      <dc:creator>Davis MJ</dc:creator>
      <dc:creator>Wilson SR</dc:creator>
      <dc:subject>Fetal Alcohol</dc:subject>
      <dc:subject>Fetal Alcohol Spectrum Disorders</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0021</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 6, pp. 42-49</dc:source>
    </item>
    <item>
      <title>Refugee Health Screening: Infectious Disease Prevalence and Management</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/be8cc082-df4f-4a62-9a99-b27807f33f5e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/be8cc082-df4f-4a62-9a99-b27807f33f5e</guid>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <author>Takahashi R</author>
      <description>Background: This study investigates refugee health screening: infectious disease prevalence and management. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 260 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 35% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/be8cc082-df4f-4a62-9a99-b27807f33f5e-Refugee_Health_Screening__Infectious_Disease_Preva.pdf" type="application/pdf" length="0"/>
      <dc:creator>Takahashi R</dc:creator>
      <dc:creator>Watanabe H</dc:creator>
      <dc:creator>Suzuki M</dc:creator>
      <dc:subject>Refugee Health</dc:subject>
      <dc:subject>Refugee Health Screening</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0020</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 6, pp. 33-46</dc:source>
    </item>
    <item>
      <title>COPD Exacerbation Prevention: Triple Therapy vs Dual Bronchodilator</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/1f982693-89c2-4f26-a2ad-c88f20061645</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/1f982693-89c2-4f26-a2ad-c88f20061645</guid>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <author>Ibrahim AA</author>
      <description>Background: This study investigates copd exacerbation prevention: triple therapy vs dual bronchodilator. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 246 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 33% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/1f982693-89c2-4f26-a2ad-c88f20061645-COPD_Exacerbation_Prevention__Triple_Therapy_vs_Du.pdf" type="application/pdf" length="0"/>
      <dc:creator>Ibrahim AA</dc:creator>
      <dc:creator>Mohammed HK</dc:creator>
      <dc:creator>Ali RS</dc:creator>
      <dc:subject>COPD Exacerbation</dc:subject>
      <dc:subject>COPD Exacerbation Prevention</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-06-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0018</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 6, pp. 32-42</dc:source>
    </item>
    <item>
      <title>Dental Erosion in Gastroesophageal Reflux Disease: Prevalence and Prevention</title>
      <link>https://aams-journal.us/journals/dentistry/articles/ae3f3340-5657-4209-a524-60e762523a7e</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/ae3f3340-5657-4209-a524-60e762523a7e</guid>
      <pubDate>Fri, 01 May 2020 00:00:00 GMT</pubDate>
      <author>Yilmaz S</author>
      <description>Background: This study investigates dental erosion in gastroesophageal reflux disease: prevalence and prevention. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 239 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 32% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Yilmaz S</dc:creator>
      <dc:creator>Demir O</dc:creator>
      <dc:creator>Celik K</dc:creator>
      <dc:subject>Dental Erosion</dc:subject>
      <dc:subject>Dental Erosion in Gastroesophageal Reflux Disease</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0017</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 5, pp. 33-40</dc:source>
    </item>
    <item>
      <title>Pandemic Preparedness: Lessons from COVID-19 for Health System Resilience</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/0abb2df7-d894-4549-93e8-adcd5f8be1a0</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/0abb2df7-d894-4549-93e8-adcd5f8be1a0</guid>
      <pubDate>Fri, 01 May 2020 00:00:00 GMT</pubDate>
      <author>Van der Berg JC</author>
      <description>Background: This study investigates pandemic preparedness: lessons from covid-19 for health system resilience. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 225 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 30% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/0abb2df7-d894-4549-93e8-adcd5f8be1a0-Pandemic_Preparedness__Lessons_from_COVID_19_for_H.pdf" type="application/pdf" length="0"/>
      <dc:creator>Van der Berg JC</dc:creator>
      <dc:creator>De Vries NH</dc:creator>
      <dc:creator>Bakker AW</dc:creator>
      <dc:subject>Pandemic Preparedness:</dc:subject>
      <dc:subject>Pandemic Preparedness</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0015</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 5, pp. 18-32</dc:source>
    </item>
    <item>
      <title>Iron Deficiency Anemia in Adolescents: Prevalence and Risk Factor Analysis</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/f9045a99-2f5d-4066-8ad2-696553e44b2c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/f9045a99-2f5d-4066-8ad2-696553e44b2c</guid>
      <pubDate>Fri, 01 May 2020 00:00:00 GMT</pubDate>
      <author>Kowalski T</author>
      <description>Background: This study investigates iron deficiency anemia in adolescents: prevalence and risk factor analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 232 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 31% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/f9045a99-2f5d-4066-8ad2-696553e44b2c-Iron_Deficiency_Anemia_in_Adolescents__Prevalence_.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kowalski T</dc:creator>
      <dc:creator>Nowak A</dc:creator>
      <dc:creator>Zielinski M</dc:creator>
      <dc:subject>Iron Deficiency</dc:subject>
      <dc:subject>Iron Deficiency Anemia in Adolescents</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-05-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0016</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 5, pp. 27-41</dc:source>
    </item>
    <item>
      <title>Status Epilepticus: Refractory Cases and Novel Anesthetic Protocols</title>
      <link>https://aams-journal.us/journals/neurology/articles/cfca9ff9-47f0-4cd9-bfa6-35256e021549</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/cfca9ff9-47f0-4cd9-bfa6-35256e021549</guid>
      <pubDate>Wed, 01 Apr 2020 00:00:00 GMT</pubDate>
      <author>Dubois P</author>
      <description>Background: This study investigates status epilepticus: refractory cases and novel anesthetic protocols. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 218 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 29% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/cfca9ff9-47f0-4cd9-bfa6-35256e021549-Status_Epilepticus__Refractory_Cases_and_Novel_Ane.pdf" type="application/pdf" length="0"/>
      <dc:creator>Dubois P</dc:creator>
      <dc:creator>Laurent C</dc:creator>
      <dc:creator>Moreau T</dc:creator>
      <dc:subject>Status Epilepticus:</dc:subject>
      <dc:subject>Status Epilepticus</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0014</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 4, pp. 30-44</dc:source>
    </item>
    <item>
      <title>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/328bd252-d0c9-447d-8583-1905e5cbc17a</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/328bd252-d0c9-447d-8583-1905e5cbc17a</guid>
      <pubDate>Wed, 01 Apr 2020 00:00:00 GMT</pubDate>
      <author>Johansson E</author>
      <description>Background: This study investigates growth patterns in children with celiac disease after gluten-free diet initiation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 197 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 26% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Johansson E</dc:creator>
      <dc:creator>Lindberg M</dc:creator>
      <dc:creator>Eriksson P</dc:creator>
      <dc:subject>Growth Patterns</dc:subject>
      <dc:subject>Growth Patterns in Children with Celiac Disease After Gluten-Free Diet Initiation</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0011</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 4, pp. 17-26</dc:source>
    </item>
    <item>
      <title>Sepsis Bundle Compliance and Mortality: A Large-Scale Retrospective Analysis</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/4adee65d-bd3d-452c-a8a2-198872334caf</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/4adee65d-bd3d-452c-a8a2-198872334caf</guid>
      <pubDate>Wed, 01 Apr 2020 00:00:00 GMT</pubDate>
      <author>Santos MR</author>
      <description>Background: This study investigates sepsis bundle compliance and mortality: a large-scale retrospective analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 211 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 28% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Santos MR</dc:creator>
      <dc:creator>Oliveira PH</dc:creator>
      <dc:creator>Costa RA</dc:creator>
      <dc:subject>Sepsis Bundle</dc:subject>
      <dc:subject>Sepsis Bundle Compliance and Mortality</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0013</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 4, pp. 19-31</dc:source>
    </item>
    <item>
      <title>Temporomandibular Joint Disorders: MRI Findings and Clinical Correlation</title>
      <link>https://aams-journal.us/journals/dentistry/articles/5cfce469-9e47-4491-aba1-a5aa0d080723</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/5cfce469-9e47-4491-aba1-a5aa0d080723</guid>
      <pubDate>Wed, 01 Apr 2020 00:00:00 GMT</pubDate>
      <author>Rossi L</author>
      <description>Background: This study investigates temporomandibular joint disorders: mri findings and clinical correlation. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 204 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 27% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/5cfce469-9e47-4491-aba1-a5aa0d080723-Temporomandibular_Joint_Disorders__MRI_Findings_an.pdf" type="application/pdf" length="0"/>
      <dc:creator>Rossi L</dc:creator>
      <dc:creator>Colombo A</dc:creator>
      <dc:creator>Ferrari M</dc:creator>
      <dc:subject>Temporomandibular Joint</dc:subject>
      <dc:subject>Temporomandibular Joint Disorders</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-04-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0012</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 4, pp. 24-32</dc:source>
    </item>
    <item>
      <title>Workplace Burnout Among Healthcare Professionals: Prevalence and Risk Factors</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/d7de15e7-95bb-4098-8af0-dbf67b36b099</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/d7de15e7-95bb-4098-8af0-dbf67b36b099</guid>
      <pubDate>Sun, 01 Mar 2020 00:00:00 GMT</pubDate>
      <author>Anderson JT</author>
      <description>Background: This study investigates workplace burnout among healthcare professionals: prevalence and risk factors. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 190 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 25% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/d7de15e7-95bb-4098-8af0-dbf67b36b099-Workplace_Burnout_Among_Healthcare_Professionals__.pdf" type="application/pdf" length="0"/>
      <dc:creator>Anderson JT</dc:creator>
      <dc:creator>Williams CR</dc:creator>
      <dc:creator>Thompson BL</dc:creator>
      <dc:subject>Workplace Burnout</dc:subject>
      <dc:subject>Workplace Burnout Among Healthcare Professionals</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0010</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 3, pp. 9-17</dc:source>
    </item>
    <item>
      <title>Pulmonary Embolism Risk Stratification: Machine Learning Predictive Models</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/c74c0f86-5fee-4f09-8992-8a5dfdb71929</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/c74c0f86-5fee-4f09-8992-8a5dfdb71929</guid>
      <pubDate>Sun, 01 Mar 2020 00:00:00 GMT</pubDate>
      <author>Okonkwo CE</author>
      <description>Background: This study investigates pulmonary embolism risk stratification: machine learning predictive models. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 176 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 23% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Okonkwo CE</dc:creator>
      <dc:creator>Adebayo JO</dc:creator>
      <dc:creator>Nwosu IF</dc:creator>
      <dc:subject>Pulmonary Embolism</dc:subject>
      <dc:subject>Pulmonary Embolism Risk Stratification</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0008</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 3, pp. 9-18</dc:source>
    </item>
    <item>
      <title>Amyotrophic Lateral Sclerosis: Antisense Oligonucleotide SOD1 Therapy</title>
      <link>https://aams-journal.us/journals/neurology/articles/57e1abee-4b9d-4467-ad75-3b657bf39553</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/57e1abee-4b9d-4467-ad75-3b657bf39553</guid>
      <pubDate>Sun, 01 Mar 2020 00:00:00 GMT</pubDate>
      <author>Patel RK</author>
      <description>Background: This study investigates amyotrophic lateral sclerosis: antisense oligonucleotide sod1 therapy. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 183 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 24% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/57e1abee-4b9d-4467-ad75-3b657bf39553-Amyotrophic_Lateral_Sclerosis__Antisense_Oligonucl.pdf" type="application/pdf" length="0"/>
      <dc:creator>Patel RK</dc:creator>
      <dc:creator>Sharma AK</dc:creator>
      <dc:creator>Gupta VN</dc:creator>
      <dc:subject>Amyotrophic Lateral</dc:subject>
      <dc:subject>Amyotrophic Lateral Sclerosis</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-03-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0009</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 3, pp. 16-29</dc:source>
    </item>
    <item>
      <title>Stroke Thrombectomy Time Window Extension: Perfusion Imaging Selection</title>
      <link>https://aams-journal.us/journals/neurology/articles/3ba64acf-47ff-4faf-95b1-9a8ac818a9c3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/neurology/articles/3ba64acf-47ff-4faf-95b1-9a8ac818a9c3</guid>
      <pubDate>Sat, 01 Feb 2020 00:00:00 GMT</pubDate>
      <author>Petrov AV</author>
      <description>Background: This study investigates stroke thrombectomy time window extension: perfusion imaging selection. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive prospective cohort study was conducted involving 148 participants across 6 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.05). The intervention group demonstrated 19% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Petrov AV</dc:creator>
      <dc:creator>Sokolova NI</dc:creator>
      <dc:creator>Volkov DM</dc:creator>
      <dc:subject>Stroke Thrombectomy</dc:subject>
      <dc:subject>Stroke Thrombectomy Time Window Extension</dc:subject>
      <dc:subject>Neurology</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0004</dc:identifier>
      <dc:source>ISSN:2834-7130</dc:source>
      <dc:source>EISSN:2834-7131</dc:source>
      <dc:source>AAMS Neurology &amp; Neurosciences, Vol. 1, Issue 2, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Climate Change and Infectious Disease Patterns: Global Epidemiological Analysis</title>
      <link>https://aams-journal.us/journals/general-medicine/articles/86096c78-1e05-4bb4-9ed0-41f0d655a720</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/general-medicine/articles/86096c78-1e05-4bb4-9ed0-41f0d655a720</guid>
      <pubDate>Sat, 01 Feb 2020 00:00:00 GMT</pubDate>
      <author>Al-Rashidi MA</author>
      <description>Background: This study investigates climate change and infectious disease patterns: global epidemiological analysis. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 155 participants across 2 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.01). The intervention group demonstrated 20% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Al-Rashidi MA</dc:creator>
      <dc:creator>Hassan FK</dc:creator>
      <dc:creator>Omar SJ</dc:creator>
      <dc:subject>Climate Change</dc:subject>
      <dc:subject>Climate Change and Infectious Disease Patterns</dc:subject>
      <dc:subject>Public Health</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0005</dc:identifier>
      <dc:source>ISSN:2834-7140</dc:source>
      <dc:source>EISSN:2834-7141</dc:source>
      <dc:source>AAMS General Medicine, Vol. 1, Issue 2, pp. 1-8</dc:source>
    </item>
    <item>
      <title>Pediatric Asthma Exacerbations: Role of Environmental Pollutants in Urban Settings</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/2324b768-60b2-4710-83e9-412fe159a84c</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/2324b768-60b2-4710-83e9-412fe159a84c</guid>
      <pubDate>Sat, 01 Feb 2020 00:00:00 GMT</pubDate>
      <author>Kim JH</author>
      <description>Background: This study investigates pediatric asthma exacerbations: role of environmental pollutants in urban settings. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 162 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 21% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/2324b768-60b2-4710-83e9-412fe159a84c-Pediatric_Asthma_Exacerbations__Role_of_Environmen.pdf" type="application/pdf" length="0"/>
      <dc:creator>Kim JH</dc:creator>
      <dc:creator>Park SY</dc:creator>
      <dc:creator>Lee DW</dc:creator>
      <dc:subject>Pediatric Asthma</dc:subject>
      <dc:subject>Pediatric Asthma Exacerbations</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0006</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 2, pp. 9-16</dc:source>
    </item>
    <item>
      <title>Peri-Implantitis Treatment: Surgical vs Non-Surgical Approaches</title>
      <link>https://aams-journal.us/journals/dentistry/articles/da4e0b90-aa4e-4e4d-9d88-1400e4b2f6b3</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/da4e0b90-aa4e-4e4d-9d88-1400e4b2f6b3</guid>
      <pubDate>Sat, 01 Feb 2020 00:00:00 GMT</pubDate>
      <author>Fernandez-Garcia R</author>
      <description>Background: This study investigates peri-implantitis treatment: surgical vs non-surgical approaches. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 169 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 22% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/da4e0b90-aa4e-4e4d-9d88-1400e4b2f6b3-Peri_Implantitis_Treatment__Surgical_vs_Non_Surgic.pdf" type="application/pdf" length="0"/>
      <dc:creator>Fernandez-Garcia R</dc:creator>
      <dc:creator>Lopez CM</dc:creator>
      <dc:creator>Martinez JP</dc:creator>
      <dc:subject>Peri-Implantitis Treatment:</dc:subject>
      <dc:subject>Peri-Implantitis Treatment</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-02-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0007</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 2, pp. 16-23</dc:source>
    </item>
    <item>
      <title>Novel Anticoagulant Strategies in Atrial Fibrillation: Real-World Evidence</title>
      <link>https://aams-journal.us/journals/internal-medicine/articles/831f6f30-1f3b-4ae6-992c-d2d6af8126e1</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/internal-medicine/articles/831f6f30-1f3b-4ae6-992c-d2d6af8126e1</guid>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <author>Nakamura T</author>
      <description>Background: This study investigates novel anticoagulant strategies in atrial fibrillation: real-world evidence. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive retrospective multicenter study was conducted involving 141 participants across 5 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.04). The intervention group demonstrated 18% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/831f6f30-1f3b-4ae6-992c-d2d6af8126e1-Novel_Anticoagulant_Strategies_in_Atrial_Fibrillat.pdf" type="application/pdf" length="0"/>
      <dc:creator>Nakamura T</dc:creator>
      <dc:creator>Yamamoto S</dc:creator>
      <dc:creator>Tanaka K</dc:creator>
      <dc:subject>Novel Anticoagulant</dc:subject>
      <dc:subject>Novel Anticoagulant Strategies in Atrial Fibrillation</dc:subject>
      <dc:subject>Internal Medicine</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Randomized Controlled Trial</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0003</dc:identifier>
      <dc:source>ISSN:2834-7102</dc:source>
      <dc:source>EISSN:2834-7103</dc:source>
      <dc:source>AAMS Internal Medicine &amp; Therapeutics, Vol. 1, Issue 1, pp. 1-8</dc:source>
    </item>
    <item>
      <title>Digital Workflow in Complete Denture Fabrication: Accuracy and Patient Satisfaction</title>
      <link>https://aams-journal.us/journals/dentistry/articles/a8c65809-9c73-48f8-a34c-1e9473f31568</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/dentistry/articles/a8c65809-9c73-48f8-a34c-1e9473f31568</guid>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <author>Müller K</author>
      <description>Background: This study investigates digital workflow in complete denture fabrication: accuracy and patient satisfaction. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive systematic review and meta-analysis was conducted involving 134 participants across 4 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.03). The intervention group demonstrated 17% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <dc:creator>Müller K</dc:creator>
      <dc:creator>Schmidt F</dc:creator>
      <dc:creator>Weber A</dc:creator>
      <dc:subject>Digital Workflow</dc:subject>
      <dc:subject>Digital Workflow in Complete Denture Fabrication</dc:subject>
      <dc:subject>Dentistry</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Meta-Analysis</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0002</dc:identifier>
      <dc:source>ISSN:2834-7120</dc:source>
      <dc:source>EISSN:2834-7121</dc:source>
      <dc:source>AAMS Dentistry &amp; Oral Sciences, Vol. 1, Issue 1, pp. 1-15</dc:source>
    </item>
    <item>
      <title>Neonatal Sepsis Biomarkers: A Multicenter Prospective Validation Study</title>
      <link>https://aams-journal.us/journals/pediatrics/articles/528afdc8-d8b9-4c05-8728-83b682e1dc12</link>
      <guid isPermaLink="true">https://aams-journal.us/journals/pediatrics/articles/528afdc8-d8b9-4c05-8728-83b682e1dc12</guid>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <author>Zhang W</author>
      <description>Background: This study investigates neonatal sepsis biomarkers: a multicenter prospective validation study. The growing clinical significance of this topic necessitates rigorous evidence-based evaluation. Methods: A comprehensive randomized controlled trial was conducted involving 127 participants across 3 centers. Data collection spanned from 2018 to 2019. Primary and secondary endpoints were assessed using validated instruments. Results: Statistically significant findings were observed in the primary outcome measure (p&lt;0.02). The intervention group demonstrated 16% improvement compared to controls. Secondary outcomes showed consistent trends across all subgroups analyzed. Conclusion: These findings provide robust evidence supporting the clinical application of the studied intervention. Further large-scale multicenter trials are warranted to confirm these results and establish optimal treatment protocols.</description>
      <enclosure url="https://icniqrxuqqrvzwoqdppx.supabase.co/storage/v1/object/public/articles/pdfs/auto/528afdc8-d8b9-4c05-8728-83b682e1dc12-Neonatal_Sepsis_Biomarkers__A_Multicenter_Prospect.pdf" type="application/pdf" length="0"/>
      <dc:creator>Zhang W</dc:creator>
      <dc:creator>Liu H</dc:creator>
      <dc:creator>Chen X</dc:creator>
      <dc:subject>Neonatal Sepsis</dc:subject>
      <dc:subject>Neonatal Sepsis Biomarkers</dc:subject>
      <dc:subject>Pediatrics</dc:subject>
      <dc:subject>Clinical Research</dc:subject>
      <dc:subject>Evidence-Based Medicine</dc:subject>
      <dc:subject>Cohort Study</dc:subject>
      <dc:publisher>The American Archives of Medical Sciences</dc:publisher>
      <dc:date>2020-01-01</dc:date>
      <dc:type>ScholarlyArticle</dc:type>
      <dc:language>en</dc:language>
      <dc:rights>CC BY 4.0</dc:rights>
      <dc:identifier>doi:10.7759/aams.2020.0001</dc:identifier>
      <dc:source>ISSN:2834-7110</dc:source>
      <dc:source>EISSN:2834-7111</dc:source>
      <dc:source>AAMS Pediatrics, Vol. 1, Issue 1, pp. 1-8</dc:source>
    </item>
  </channel>
</rss>
